
<html lang="en"     class="pb-page"  data-request-id="7d20bcc5-86fe-41f7-b56e-6033a361be67"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2017.60.issue-1;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.6b00964;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Targeting the Nerve Growth Factor (NGF) Pathway in Drug Discovery. Potential Applications to New Therapies for Chronic Pain" /></meta><meta name="dc.Creator" content="Bryan H.  Norman" /></meta><meta name="dc.Creator" content="Jeff S.  McDermott" /></meta><meta name="dc.Description" content="The neurotrophin nerve growth factor (NGF) has been implicated as a key mediator of chronic pain. NGF binds the tropomysin receptor kinase A (TrkA) and p75, resulting in the activation of downstrea..." /></meta><meta name="Description" content="The neurotrophin nerve growth factor (NGF) has been implicated as a key mediator of chronic pain. NGF binds the tropomysin receptor kinase A (TrkA) and p75, resulting in the activation of downstrea..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 25, 2016" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00964" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00964" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00964" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00964" /></link>
        
    
    

<title>Targeting the Nerve Growth Factor (NGF) Pathway in Drug Discovery. Potential Applications to New Therapies for Chronic Pain | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00964" /></meta><meta property="og:title" content="Targeting the Nerve Growth Factor (NGF) Pathway in Drug Discovery. Potential Applications to New Therapies for Chronic Pain" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0021.jpeg" /></meta><meta property="og:description" content="The neurotrophin nerve growth factor (NGF) has been implicated as a key mediator of chronic pain. NGF binds the tropomysin receptor kinase A (TrkA) and p75, resulting in the activation of downstream signaling pathways that have been linked to pro-nociception. While anti-NGF antibodies have demonstrated analgesia both preclinically and in patients, the mechanism of action of these agents remains unclear. We describe ligands targeting NGF, its receptors, and downstream/related targets. This Perspective highlights large and small molecule approaches to targeting the NGF–TrkA pathway both extra- and intracellularly. In addition, we present a strategic framework for future drug discovery efforts in this pathway beyond the targeting of NGF or its receptors. While existing tools have greatly informed NGF-mediated signaling, ongoing and future pathway research may help focus new drug discovery efforts on key novel targets and mechanisms. This may result in highly differentiated therapeutics with greater efficacy and/or improved safety profiles." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00964"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00964">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00964&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00964&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00964&amp;href=/doi/10.1021/acs.jmedchem.6b00964" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 66-88</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00963" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.6b01123" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Targeting the Nerve Growth Factor (NGF) Pathway in Drug Discovery. Potential Applications to New Therapies for Chronic Pain</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bryan+H.++Norman">Bryan H. Norman</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"> and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeff+S.++McDermott">Jeff S. McDermott</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Discovery Chemistry Research and Technologies and <sup>‡</sup>Neurophysiology, Lilly Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Lilly Corporate Center, Indiana 46285, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 317-277-2235. Fax: 317-277-3652. E-mail: <a href="/cdn-cgi/l/email-protection#5937362b343837193530353520773a3634"><span class="__cf_email__" data-cfemail="3e50514c535f507e5257525247105d5153">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00964&amp;href=/doi/10.1021%2Facs.jmedchem.6b00964" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 66–88</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 25, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 July 2016</li><li><span class="item_label"><b>Published</b> online</span>25 October 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 January 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00964" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00964</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D66%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBryan%2BH.%2BNorman%252C%2BJeff%2BS.%2BMcDermott%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D1%26contentID%3Dacs.jmedchem.6b00964%26title%3DTargeting%2Bthe%2BNerve%2BGrowth%2BFactor%2B%2528NGF%2529%2BPathway%2Bin%2BDrug%2BDiscovery.%2BPotential%2BApplications%2Bto%2BNew%2BTherapies%2Bfor%2BChronic%2BPain%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D88%26publicationDate%3DJanuary%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00964"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3355</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">25</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00964" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Targeting the Nerve Growth Factor (NGF) Pathway in Drug Discovery. Potential Applications to New Therapies for Chronic Pain&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Bryan&quot;,&quot;last_name&quot;:&quot;H. Norman&quot;},{&quot;first_name&quot;:&quot;Jeff&quot;,&quot;last_name&quot;:&quot;S. McDermott&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;66-88&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00964&quot;},&quot;abstract&quot;:&quot;The neurotrophin nerve growth factor (NGF) has been implicated as a key mediator of chronic pain. NGF binds the tropomysin receptor kinase A (TrkA) and p75, resulting in the activation of downstream signaling pathways that have been linked to pro-nociception. While anti-NGF antibodies have demonstrated analgesia both preclinically and in patients, the mechanism of action of these agents remains unclear. We describe ligands targeting NGF, its receptors, and downstream/related targets. This Perspective highlights large and small molecule approaches to targeting the NGF–TrkA pathway both extra- and intracellularly. In addition, we present a strategic framework for future drug discovery efforts in this pathway beyond the targeting of NGF or its receptors. While existing tools have greatly informed NGF-mediated signaling, ongoing and future pathway research may help focus new drug discovery efforts on key novel targets and mechanisms. This may result in highly differentiated therapeutics with greater efficacy and/&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00964&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00964" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00964&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00964" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00964&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00964" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00964&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00964&amp;href=/doi/10.1021/acs.jmedchem.6b00964" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00964" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00964" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00964%26sid%3Dliteratum%253Aachs%26pmid%3D27779399%26genre%3Darticle%26aulast%3DNorman%26date%3D2017%26atitle%3DTargeting%2Bthe%2BNerve%2BGrowth%2BFactor%2B%2528NGF%2529%2BPathway%2Bin%2BDrug%2BDiscovery.%2BPotential%2BApplications%2Bto%2BNew%2BTherapies%2Bfor%2BChronic%2BPain%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D1%26spage%3D66%26epage%3D88%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291297" title="Cell signaling">Cell signaling</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292461" title="Neurophysiology">Neurophysiology</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/jmcmar.2017.60.issue-1/20170112/jmcmar.2017.60.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The neurotrophin nerve growth factor (NGF) has been implicated as a key mediator of chronic pain. NGF binds the tropomysin receptor kinase A (TrkA) and p75, resulting in the activation of downstream signaling pathways that have been linked to pro-nociception. While anti-NGF antibodies have demonstrated analgesia both preclinically and in patients, the mechanism of action of these agents remains unclear. We describe ligands targeting NGF, its receptors, and downstream/related targets. This Perspective highlights large and small molecule approaches to targeting the NGF–TrkA pathway both extra- and intracellularly. In addition, we present a strategic framework for future drug discovery efforts in this pathway beyond the targeting of NGF or its receptors. While existing tools have greatly informed NGF-mediated signaling, ongoing and future pathway research may help focus new drug discovery efforts on key novel targets and mechanisms. This may result in highly differentiated therapeutics with greater efficacy and/or improved safety profiles.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82337" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82337" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Pain is a subjective term that is used to describe sensations associated with a multitude of conditions, ranging from minor injuries to serious pathological disorders.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Acute pain, resulting from some specific event that causes tissue damage (such as surgery or injury),<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> is generally mitigated when the condition has resolved and/or the tissue has healed. Chronic pain, on the other hand, may persist long after the resolution of injury or may be associated with an ongoing chronic condition such as osteoarthritis (OA) or cancer.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> Additionally, chronic pain may or may not be associated with ongoing inflammation, one of the body’s innate responses to tissue injury, which can exacerbate the painful response.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> While pain is an important human response that provides avoidance signals for our protection, the management of uncontrollable chronic pain remains a significant unmet medical need.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> In recent years, efforts to identify novel analgesic agents has been disappointing and drug discovery researchers have been confounded by the discovery of preclinical analgesic agents that did not transfer sufficient pain efficacy to humans.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> Thus, some of the most prescribed analgesics today represent drug classes, such as opioids and NSAIDs, that have been known for many decades. Unfortunately, these agents frequently either do not provide sufficient pain relief, have unacceptable side effects, or both.<a onclick="showRef(event, 'ref1 ref9'); return false;" href="javascript:void(0);" class="ref ref1 ref9">(1, 9)</a> New, transformative analgesic therapies are greatly needed to combat many chronic pain conditions for which no meaningful therapy currently exists. Preclinical and clinical research over the past 20–25 years has demonstrated a role for the neurotrophin nerve growth factor (NGF) in the transmission of both acute and chronic pain signals.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> Because of recently reported clinical efficacy of NGF neutralizing antibodies,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> the pain research community is hopeful that modulation of the NGF signaling pathway may provide significant analgesia for multiple painful conditions. In this Perspective, we will provide an overview of NGF target validation in pain and try to connect the many NGF signaling pathways to pain mechanisms. We will also review the current methods that have been used to interrogate the NGF pathway in drug discovery and how these approaches may result in new analgesic agents with a superior efficacy and safety profile relative to the current standards of care.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Background</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51414" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51414" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">NGF was discovered by Levi-Montalcini and Cohen during their collaboration at Washington University in the late 1950s. Their work grew from earlier collaborations between Levi-Montalcini and Hamburger, a colleague and mentor who remains an underappreciated contributor to the NGF discovery story.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Levi-Montalcini and Cohen’s original trilogy of manuscripts, published in 1960,<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14-16)</a> described the discovery and characterization of NGF. This work was recognized in 1986 when they were awarded the Nobel Prize in Medicine. In these seminal publications, they revealed a protein derived from the mouse salivary gland that was responsible for the development of a subset of neural crest cells, mainly primary afferent and sympathetic neuronal populations. As part of their experimental strategy, they employed the use of polyclonal antibodies to NGF and showed that sequestering NGF had its most dramatic effects on neuronal survival during prenatal development. Interestingly, they also noted morphological changes in sympathetic ganglia neurons with NGF sequestration in adult rodents. This latter finding is noteworthy in that it may have foretold the sympathetic neuronal changes observed in the preclinical toxicology studies with the contemporary anti-NGF antibodies still in late stage development for chronic pain conditions. (vide infra).</div><div class="NLM_p">NGF is the founding member of a group of neurotrophins that has classically included brain-derived neurotrophic factor (BDNF), neurotrophin 3 (NT-3), and neurotrophin-4 (NT-4). NT-4 is also sometimes referred to as NT-5, and there has been an NT-6 described in teleost fish.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Glial cell line-derived neurotrophic factor (GDNF), as well as several other trophic factors such as ciliary neurotrophic factor (CNTF), are not grouped classically with the neurotrophins but belong to a wider group of neurotrophic factors. As shown in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>, neurotrophins bind, as dimers, to several related receptors: a unique high affinity tropomysin receptor kinase (Trk) as well as to a common 75 kDa low affinity neurotrophin receptor known as p75. Trks are receptor tyrosine kinases (RTKs), a class of proteins that have extracellular, intracellular, and membrane spanning domains. Upon binding its extracellular ligand, RTKs dimerize, autophosphorylate on various tyrosine residues, and begin a cascade of downstream intracellular signaling events that are responsible for a multitude of physiological effects.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> In the case of NGF, its unique binding partner is the 140 kDa TrkA receptor (encoded by the <i>NTRK1</i> gene). BDNF and NT-4 bind preferentially to TrkB (<i>NTRK2</i>), and NT-3 is the high affinity ligand for TrkC (<i>NTRK3</i>) but has shown some affinity for TrkA and TrkB. All four neurotrophins bind with similar affinity to p75 (<i>NGFR</i>), a member of the tumor necrosis factor (TNF) receptor family of receptors.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> It should be pointed out that this two receptor view of each neurotrophin, as depicted in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>, is likely overly simplistic and not reflective of the more complex underlying biology. The p75 protein has been shown to act as a coreceptor to the various Trks,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> affecting binding affinities. Likewise, the sortilin protein has been implicated in both the anterograde trafficking of the NGF-bound TrkA signaling endosome to the primary afferent nerve terminal<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> in addition to its role as an active coreceptor with p75, where it is thought to play a key role in proNGF/p75/sortilin signaling.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Neurotrophin dimers NGF, BDNF, NT-4, and NT-3 bind to their cognate receptors TrkA, TrkB, and TrkC, as well as to the common p75 receptor. Binding to the extracellular receptors triggers downstream intracellular signaling pathways.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">NGF is synthesized as a prepro-form, which is cleaved to the 25 kDa pro-form upon release from the endoplasmic reticulum.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Upon dimerization, this 50 kDa pro-form dimer of NGF (proNGF) can be cleaved within the cell to release the 26 kDa mature NGF dimer, which shows picomolar binding affinity to TrkA receptors (see <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Unprocessed proNGF may also be secreted.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Cells that respond to NGF include primary afferent neurons, keratinocytes, pancreatic β-islet cells, osteal cells, vascular epithelial cells, and immune cells (mast cells, eosinophils, monocytes) among others.<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25-27)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. NGF–TrkA canonical pathway, showing potential mechanisms for pharmacological intervention. Dimers of proNGF are converted to mature NGF dimers, which can initiate receptor dimerization and bind to TrkA and p75. In neuronal cells, NGF–TrkA binding induces the phosphorylation of multiple tyrosines and triggers downstream signaling through the PI3K, Ras, and PLCγ pathways. This leads to neurite outgrowth and other pharmacodymanic effects. Intervention of NGF–TrkA mediated signaling can occur via several mechanisms. Mechanism A: Sequestration of the NGF dimer. Mechanism B: Antagonism of the TrkA receptor. Mechanism C: Antagonism of the p75 receptor. Mechanism D: Inhibition of the intracellular TrkA kinase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">NGF Pathway Validation</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04388" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04388" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Validation for Pain</h3><div class="NLM_p last">For 30 years after the reported discovery of NGF in 1960, academic work in the field continued to focus almost exclusively on its role in neuronal development. However, two unrelated events occurred in the early 1990s that led to a key breakthrough in pain research. The first of these was the initiation of clinical trials using recombinant human NGF to treat painful diabetic neuropathies.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In the course of these early clinical studies, it was noted that there were consistent reports of injection site reactions and hyperalgesia lasting weeks or even months. Around this time, the seminal work of Mendell and co-workers was just beginning. Mendell and his colleagues, Lewin and Ritter, were in the process of doing developmental studies on the effects of NGF on adult rat nociceptors when they noticed that some rodents seemed to be experiencing profound hyperalgesia. While behavioral end points were not the original goal of these studies, the group was nevertheless the first to report a detailed description of the hyperalgesia induced by NGF in rodents in 1993.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Combined, these reports led to a rapid expansion of academic and industrial work on the relationship between NGF and pain. Some key events in the latter part of the decade were the failure of the phase 3 trial of recombinant human NGF for neuropathy, the genetic linkage of mutations in both <i>NGFB</i> and <i>NTRK1</i> to several congenital insensitivity to pain with anhidrosis (CIPA) populations,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> as well as two key preclinical pharmacology studies revealing that in vivo sequestration of NGF was efficacious in animal models of inflammatory pain. The first of these two preclinical studies utilized a sheep anti-NGF polyclonal antibody, while the second employed a soluble TrkA receptor. Both successfully sequestered NGF in vivo and demonstrated analgesia. This evidence led to the development of a mouse anti-NGF antibody, muMab911 by Genentech, which was later humanized by Rinat to become the human anti-NGF antibody RN624.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Rinat was the first to initiate testing of the NGF sequestration hypothesis in a clinical pain population. The early clinical work by Rinat was followed by several companies entering clinical studies with additional anti-NGF antibodies. A string of positive phase 2 data in multiple pain indications was encouraging. Unfortunately, reports of drug-related joint necrosis began to emerge in 2010, leading to a class hold by the FDA on further clinical testing, except in terminal cancer studies. After much adjudication, the vast majority of these cases were more accurately diagnosed as rapidly progressing osteoarthritis (RPOA). With the adoption of a risk mitigation strategy, which included dosing restrictions and a recommendation against concomitant NSAID use in osteoarthritis patients, the FDA lifted this clinical hold in 2012.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> However, a short time thereafter, a second clinical hold was put in place in late 2012 based on preclinical toxicology findings of sympathetic neuronal changes. Extensive additional preclinical investigation into these sympathetic effects demonstrated no sympathetic neuronal loss, only small changes in neuronal size, which was reversible upon cessation of treatment. The clinical hold related to these findings was lifted by the FDA in the spring of 2015.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Phase 3 trials for anti-NGF antibodies are ongoing in OA, chronic low back pain, and cancer pain. Researchers and clinicians have become increasingly optimistic that anti-NGF therapies can become novel and highly efficacious treatments for chronic pain. What remains less clear is the precise mechanism or mechanisms underlying the efficacy of these agents. Answering these questions will require additional detailed pathway analysis and likely the availability of specific new pharmacological tools.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Validation for Other Diseases</h3><div class="NLM_p">While the focus of this perspective is NGF’s role in chronic pain, other areas of ongoing therapeutic interest include oncology, neurodegeneration, and allergic airway disease. In oncology, an in-frame deletion in the <i>NTRK1</i> gene and a splice variant in the TrkA receptor have been linked to a form of acute myeloid leukemia and neuroblastoma, respectively.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> However, most of the recent interest in TrkA from the oncology field lies in numerous reports of Trk fusion proteins as oncogenes. These Trk fusions often lack an extracellular neurotrophin binding domain, and the resulting constitutively active isoforms have led to small molecule approaches targeting the TrkA kinase domain.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Numerous efforts in the Trk kinase inhibitor space are ongoing for oncology, and many of these inhibitors would likely have analgesic potential as well. These efforts will be covered in depth in a following section.</div><div class="NLM_p">A second area of interest for NGF lies in neurodegeneration. Studies in the late 1980s and early 1990s showed that icv NGF injections improved basal forebrain cholinergic neuron survival in aged rodents as well as improved performance in several models of cognition.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36, 37)</a> However, attempts at NGF therapy to date have been hampered by delivery and/or pharmacokinetic concerns. In addition, in small human pilot studies where NGF was injected icv, severe spinal pain in the lower back resulted, halting the studies.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> In the case of neurodegeneration, both TrkA agonists and antagonists of proNGF/p75 apoptotic signaling may be of interest and are under current investigation.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> However, not unlike the earlier NGF efforts, there will likely need to be a strategy in place to avoid the hyperalgesic effects of TrkA agonism. These areas of investigation are not within scope of this perspective.</div><div class="NLM_p last">Finally, NGF and its receptors have also been implicated in airway inflammatory disease. Many of the pathways involved in antigen-triggered allergic asthma involve the neurotrophins and particularly NGF. An excellent review of this biology may be found elsewhere.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">NGF Pathway Modulation Approaches</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82831" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82831" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In a phenotypic sense, anti-NGF antibodies provide strong validation for the disruption of NGF signaling leading to analgesic effects both preclinically and in patients.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> However, clarity around TrkA vs p75 signaling pathways and their relative contributions to these effects is still evolving.<a onclick="showRef(event, 'ref19 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref19 ref40 ref41">(19, 40, 41)</a> There are data that would support the importance of each and these pathways, and interpretations are further complicated by potential cross-talk between the TrkA and p75 pathways. <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> shows the various potential mechanisms whereby disruption of NGF-mediated signaling could be achieved pharmacologically. NGF neutralizing antibodies and NGF binding small molecules would function extracellularly and likely disrupt both TrkA and p75 mediated signaling (mechanism A). Receptor antibodies and small molecule antagonists (mechanisms B and C) would target the extracellular domain of the receptors and disrupt NGF binding to TrkA and p75, respectively. This approach could potentially provide specificity for each target receptor. Finally, TrkA kinase inhibitors (mechanism D) would target the intracellular kinase domain. Both large and small molecule tools have provided opportunities to probe these mechanisms, and thus both will be reviewed.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Large Molecules</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78701" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78701" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">While the history of the anti-NGF antibodies was covered in the previous section, there have also been additional ligands developed within the large molecule/peptide space. These have included TrkA receptor truncation proteins, such as the second immunoglobulin (Ig2) domain for TrkA, which is known as TrkAIg2 or TrkA domain 5 (TrkAd5).<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> This protein is believed to bind to and sequester NGF in a mechanism not unlike the anti-NGF antibodies (however with potentially differing effects on proNGF sequestration, mechanism A, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). While the TrkAd5 construct demonstrated preclinical analgesic activity,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> human clinical testing has not been reported, likely due to less than optimal pharmacokinetic properties. Many other peptide-based approaches have been described that either block or inhibit NGF/TrkA interactions, NGF/p75 interactions, or both. However, none of these efforts have moved beyond the tool generation stage and typically suffer from weak potency and/or pharmacokinetic deficits that would be expected of small therapeutic peptides.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><div class="NLM_p">There have been several reports of functional antibodies to the p75 receptor (mechanism C, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). The first was a rabbit polyclonal antibody from the Reichardt Lab.<a onclick="showRef(event, 'ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref44 ref45 ref46">(44-46)</a> Additionally, Rogers and co-workers developed several mouse monoclonal antibodies to p75,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> although none of these ligands has been characterized extensively in the literature. Khodorova and co-workers have described evidence that some NGF-mediated mechanisms of peripheral neuronal sensitization are likely driven through the p75 receptor.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Thus, a well characterized p75 in vivo tool would certainly be of interest to the field.</div><div class="NLM_p last">A more recent and active clinical program has been disclosed around an anti-TrkA antibody (mechanism B, <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) that is currently being developed by Glenmark and reported to be completing phase 1 testing. This was derived from an earlier rodent antibody, MNAC13, described by Lay-Line Genomics.<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48, 49)</a> This antibody may provide the first clinical reports of the effects of TrkA antagonism and could reveal a potentially different safety and efficacy profile compared to the more clinically advanced anti-NGF antibodies.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Small Molecules</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34771" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34771" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Historically, most approaches to the discovery of small molecule NGF-targeted analgesics have focused on the inhibition of signaling through the TrkA pathway. <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a> shows a simplified version of the NGF–TrkA canonical signaling pathway. Briefly, upon binding of the NGF dimer to the TrkA receptor tyrosine kinase dimer, three tyrosines in the TrkA activation domain (Y670, Y674, and Y675) undergo autophosphorylation. This enables the autophosphorylation of additional tyrosines, specifically Y490 and Y785, which trigger activation of the PI3K, Ras, and phospholipase C-γ-1 (PLC-γ1) pathways.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a> Activation of these pathways in vivo has been linked to multiple pharmacodynamic end points, including pain.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> In vitro, a commonly measured end point for the activation of these pathways in neuronal cells is neurite outgrowth.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Another likely relevant downstream effect of NGF–TrkA mediated signaling (not shown in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) is the rapid increase in membrane expression and activation of the transient receptor potential vanilloid I (TRPV1) channel, an important nociceptive mediator. It was shown that TrkA-mediated PI3K pathway activation is responsible for TRPV1 phosphorylation, resulting in membrane localization and activation of the TRPV1 channel.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> This may explain the acute thermal nociceptive effects of NGF.</div><div class="NLM_p">Small molecule interrogation of the NGF–TrkA pathway has focused on two primary approaches, each with different challenges. Extracellular antagonism of the NGF–TrkA binding event (mechanisms A or B in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) is one approach that may modulate TrkA-mediated downstream signaling and was reviewed by Longo and Massa in 2013.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> One potential benefit to this strategy may be greater likelihood of TrkA specificity. Since TrkB and TrkC bind different neurotrophins (BDNF, NT-3, NT-4), receptor homology is not as great in the extracellular region.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Thus, the medicinal chemist has a greater likelihood of finding a unique binding motif on the neurotrophin extracellular binding domain of TrkA vs the TrkB and TrkC receptors. However, disruption of this sort of protein–protein interaction has historically proven difficult.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Thus, it is unsurprising that to date, only a few compounds with this mechanism of action have been identified, all with unremarkable potency.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Alternatively, inhibition of the TrkA kinase activity (mechanism D in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), an intracellular event, should also result in the modulation of downstream NGF–TrkA mediated signaling. This approach has been more successful in finding drug-like small molecules, many with good selectivity across the kinome.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56, 57)</a> However, the identification of TrkA kinase inhibitors with isoform selectivity vs TrkB and TrkC has proven much more difficult. It has been postulated that improved subtype specificity may improve the safety profile of Trk inhibitors. Both extracellular antagonism and intracellular kinase inhibition approaches are described in greater detail below.</div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Extracellular Antagonism of NGF–TrkA Binding</h3><div class="NLM_p last">As was previously described, the binding of NGF to the extracellular binding domain of TrkA results in a cascade of signaling events that are believed to be responsible for (at least) some of the pro-nociceptive properties of NGF. Thus, antagonism of NGF–TrkA binding is expected to reduce TrkA activation and subsequent downstream signaling. Similar to the large molecule approach, disruption of this protein–protein interaction with a small molecule could be accomplished via two specific mechanisms of action. First, the small molecule antagonist could bind directly to NGF (similar to NGF sequestering antibodies) in a fashion that renders the NGF protein dimer incapable of making a productive contact with the TrkA receptor. It should be pointed out that, similar to NGF antibodies, this approach would have the potential to disrupt NGF–p75 interactions as well. Alternatively, a small molecule antagonist could bind to the TrkA receptor (similar to TrkA receptor antibodies), thus preventing NGF from appropriately accessing the receptor. This approach would be more likely to leave NGF-mediated p75 signaling intact. Both types of modulators have been described. It turns out that most reported functional antagonists have been shown to function via the former mechanism. In contrast, compounds reported to bind the TrkA receptor have generally been NGF mimetics (agonists), producing NGF-like effects. It may be possible to optimize a TrkA binding agonist into an antagonist, especially if there is structural information to inform the binding site and binding mode on TrkA relative to NGF itself. For the purpose of this Perspective, we will describe a few of the better characterized compounds in each class.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> NGF Binders</h3><div class="NLM_p">Several NGF binders have been described and are shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>. In PC12 cells, ALE-0540 (<b>1</b>, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) inhibited both <sup>125</sup>I-NGF binding to TrkA (IC<sub>50</sub> = 5.88 μM) and NGF-induced TrkA autophosphorylation (EC<sub>50</sub> = 22 μM).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Furthermore, in DRG neurons, <b>1</b> dose dependently inhibited NGF-mediated neurite outgrowth. The authors commented that preliminary mechanistic results using NGF-affinity chromatography suggested that <b>1</b> did not bind NGF directly and likely bound to receptors TrkA and p75. However, in later reports, it was determined that <b>1</b> did, indeed, bind directly to NGF (vide infra). In vivo, <b>1</b> blocked mechanical allodynia in the L5/L6 nerve ligation model (rats) after ip dosing (ED<sub>50</sub> = 38 mg/kg). When dosed it, <b>1</b> blocked mechanical allodynia in the same model and also blocked tactile allodynia produced by thermal sensitization in the rat hindpaw (ED<sub>50</sub> = 34.6 and 50 μg, respectively). While these data are consistent with functional antagonism of the NGF–TrkA interaction, one cannot rule out the potential contributions due to p75 modulation. Functional studies to specifically assess p75-mediated events were not reported in this manuscript. Later in this Perspective, we will discuss the role of NGF–p75-mediated effects on intracellular ceramide–sphingolipid signaling that has been associated with hypersensitivity.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Chemical structures of NGF binders.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to <b>1</b>, PD90780 (<b>2</b>, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>)<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> and Ro 08-2750 (<b>3</b>, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>)<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> have been shown to bind NGF and prevent NGF association with both TrkA and p75. These studies also demonstrated functional antagonism of downstream TrkA-mediated signaling events, such as TrkA autophosphorylation and neurite outgrowth, as well as p75-mediated events, such as apoptosis, when tested in the p75-positive/TrkA-negative cell line SK-N-MC. Another small molecule, PQC 083 (<b>4</b>, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>),<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> as well as several related analogues and compound <b>1</b>–<b>3</b>, were shown to disrupt cell differentiation, another downstream NGF-mediated signaling event<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> in PC12 cells (<b>4</b>: IC<sub>50</sub> = 7 μM).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Through the use of 3D docking analysis, the authors hypothesized that all four antagonists bound similarly to NGF (in the loop I/IV cleft).</div><div class="NLM_p">Recently, surface plasmon resonance (SPR) spectroscopy was used to assess all four compounds’ ability to inhibit NGF binding to immobilized TrkA and p75 receptors.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Under the conditions, the binding affinities of NGF–TrkA and NGF–p75 were determined to be 13 and 15 nM, respectively. <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> summarizes the ability of each compound to inhibit 10 nM NGF binding to both receptors. It should be pointed out that the studies using <b>4</b> were confounded due to nonspecific binding of that molecule to NGF and both receptors. This property rendered <b>4</b> inappropriate for use in SPR assays. Of the other three compounds, it is interesting to note that none achieved maximum inhibition of NGF–p75 binding and all showed more potent inhibition of NGF–TrkA association vs NGF–p75. Furthermore, it was shown that <b>1</b>, <b>2</b>, and <b>3</b> did not show any direct binding to TrkA nor p75.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SPR Derived IC<sub>50</sub>s for Small Molecule Inhibitors of NGF Binding to p75 and TrkA<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (max inhib)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">P75 (μM)</th><th class="colsep0 rowsep0" align="center">TrkA (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="center">>300 (6.2%)</td><td class="colsep0 rowsep0" align="center">149 (44%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="center">110 (65%)</td><td class="colsep0 rowsep0" align="center">47 (100%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="center">244 (37%)</td><td class="colsep0 rowsep0" align="center">33 (100%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="center">n.d. (70%)</td><td class="colsep0 rowsep0" align="center">nd (nd)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Table 1 used with permission from <contrib-group>Sheffield, K. S.; Kennedy, A. E.; Scott, J. A.; Ross, G. M.</contrib-group>Characterizing nerve growth factor-p75(NTR) interactions and small molecule inhibition using surface plasmon resonance spectroscopy.  <cite>Anal. Biochem.</cite> <span class="NLM_year">2016</span>, <em>493</em>, 21–26, Elsevier.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></p></div></div></div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> TrkA Binders/NGF Mimetics</h3><div class="NLM_p">Several compounds have been reported to bind directly to TrkA.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Interestingly, none of these agents have demonstrated convincing antagonist function and are thus better referred to as NGF mimetics. However, none can truly recapitulate NGF-like agonist function. This perspective will highlight the data for the most characterized TrkA binder, antidepressant amitriptyline (<b>5</b>, <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Chemical structures of potential TrkA binders.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Jang and co-workers showed that <b>5</b> could bind to the TrkA and TrkB extracellular domains (ECDs) with <i>K</i><sub>i</sub>s of 3 and 14 μM, respectively.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Similar to NGF, <b>5</b> triggered dimerization and activation of downstream signaling such as TrkA autophosphorylation and MAP kinase and PI3K/AKT pathway activation in primary hippocampal and cortical cultures that express TrkA. Other related tricyclic antidepressants, such as imipramine (<b>6</b>, <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>),<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> did not show these activities. Similar to NGF, amitriptyline induced neurite outgrowth in PC12 cells and this effect was blocked by inhibitors of TrkA kinase, PI3K and MEK1. In vivo, <b>5</b> (15 mg/kg, ip) induced tyrosine phosphorylation of TrkA and TrkB in mouse brain. All of these activities are consistent with neurotrophin mimetic behavior. However, in addition to binding TrkB with similar affinity as TrkA, <b>5</b> demonstrated some non-NGF-like activities both in vitro and in vivo. Specifically, <b>5</b> induced TrkA phosphorylation of Tyr751 but not Tyr490 in hippocampal neurons. Additionally, after 5 days of dosing, <b>5</b> promoted TrkA-TrkB heterodimerization in mouse brain. This effect was also observed in vitro in HEK293 cells that had been cotransfected with TrkA and TrkB.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><div class="NLM_p">Clearly, <b>5</b> represents an interesting small molecule in that it binds to TrkA. It may represent a good starting point for the optimization of more potent analogues with either NGF–TrkA agonist or antagonist function. Of course, for analgesic activity, TrkA antagonism would be desired. Thus, optimizing this molecule into a selective TrkA antagonist would be significantly assisted by structural information describing its binding mode to both TrkA and TrkB. Jang and co-workers began to map possible binding sites for <b>5</b> on TrkA. They showed that deletion of the immoglobulin domains Ig1, Ig2, and Ig1+Ig2 in TrkA had no effect on the binding of <b>5</b>, while removal of the entire extracellular domain significantly diminished binding. TrkA truncation studies showed that the first leucine-rich motif (LRM1) was required for binding <b>5</b>. This is a bit surprising due to the evidence that suggests that the TrkAIg2 domain, also known as TrkA domain 5 (TrkAd5), represents the NGF binding domain of the receptor. This evidence includes mutagenesis/domain deletion<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> and structural information such as protein–protein X-ray crystal structures of the NGF dimer associated with two molecules of TrkAIg2.<a onclick="showRef(event, 'ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref66 ref67">(66, 67)</a> Furthermore, as already described, TrkAIg2 functions as a soluble NGF receptor with picomolar affinity. It was shown to sequester NGF and was analgesic in multiple preclinical pain models.<a onclick="showRef(event, 'ref42 ref68'); return false;" href="javascript:void(0);" class="ref ref42 ref68">(42, 68)</a></div><div class="NLM_p last">More recently, Shoemark and co-workers have used nuclear magnetic resonance (NMR) to inform a solution structure of a <sup>13</sup>C, <sup>15</sup>N-labeled TrkAIg2 analogue, known as TrkAIg2-NMR.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> This construct demonstrated wild-type TrkAIg2 activity such as NGF binding and inhibition of NGF-induced neurite outgrowth. <sup>1</sup>H–<sup>15</sup>N heteronuclear single quantum correlation (HSQC) spectra showed significant chemical shift perturbations (CSPs) or line broadening in the presence of NGF, with most of the spectral changes occurring in the region that binds the N-terminal helix of NGF. This is consistent with the 2.2 Å X-ray crystal structure of NGF bound to TrkAIg2.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Similar <sup>1</sup>H–<sup>15</sup>N HSQC studies using amitriptyline and TrkAIg2-NMR revealed over 20 CSPs, 13 of which were common with the NGF structure and map to the binding site of the N-terminal helix of NGF. This is consistent with <b>5</b> and NGF having overlapping binding sites on TrkAIg2. Using a docking program, the group hypothesized a putative <b>5</b>–TrkAIg2 binding pose. They confirmed <b>5</b>–TrkAIg2 binding (IC<sub>50</sub> = 60 μM) in a competition binding assay using <sup>125</sup>I-NGF in HEK cells. Interestingly, they also showed that <b>5</b> inhibited NGF-induced phospho-MAPK formation in HEK293 cells (IC<sub>50</sub> = 86 μM), in contrast to the previously reported NGF agonist-like function in different cells/tissues such as PC12 and DRGs. Further exploration will be required to better understand the function of <b>5</b> in tissues most relevant to pain states.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> TrkA Kinase Inhibitors</h3><div class="NLM_p">Because of the NGF–TrkA target validation story in the early 2000s, many research groups have targeted TrkA with small molecule kinase inhibitors. As one might expect, finding potent inhibitors of the TrkA kinase has not proven as difficult as finding selective inhibitors. Two excellent reviews on TrkA inhibitors have been published. The first covered the work from publications and patent applications from 2002 to 2008<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> and the second from 2009 to 2013.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Because these are exhaustive reviews with associated references, we would refer the readers to these papers for details. As previously mentioned, there has been much interest in the development of TrkA kinase inhibitors for oncology indications and clinical progress in oncology is probably more advanced, compared to pain indications. The majority of these inhibitors are multitargeted kinase inhibitors, although a few have been reported as pan-Trk inhibitors with good selectivity vs the rest of the kinome. While oncologic indications are not within the scope of this perspective, we will provide a brief update on clinical oncolytic agents targeting TrkA in a later section. Here, we will provide an overview of the evolution of TrkA inhibitors through the years from a more historical and strategic viewpoint and highlight the more recent identification of novel inhibitors with specific emphasis on applications to pain research.</div><div class="NLM_p">In pharma, initial work to discover novel TrkA inhibitors was probably opportunistic, likely emerging from kinase inhibitor libraries from previous kinase target efforts. Most of these compounds likely bound in the conserved ATP binding site and engaged the hinge residues in a manner that allowed the activation loop residues Asp-Phe-Gly (DFG) to be in a DFG-in conformation, which is similar to the unliganded (apo) conformation. These are known as type I inhibitors. Some, however, bound to the ATP site but also extended into a hydrophobic pocket that is accessible when the DFG residues fold out (DFG-out conformation). These are known as type II inhibitors. Several papers have described the nature of type I, type II, type III (ATP site/nonhinge binders), and type IV (allosteric) kinase inhibitors, and the reader is encouraged to review those manuscripts for a more thorough explanation of kinase enzyme inhibition modes.<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70, 71)</a> Most of the early TrkA inhibitors inhibited multiple additional off-target kinases. Furthermore, it was realized that it may be unlikely to see high TrkA selectivity vs TrkB and TrkC with these types of inhibitors due to the very high sequence homology in the kinase domains. Using an analysis previously described by Cherry and Williams<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> for ATP binding site kinase inhibitors, there are 49 residues in each Trk kinase domain that could potentially interact with an inhibitor binding in either a type I or type II fashion. Of those, all but two residues are common among the three isoforms and those two differences are quite conservative. Specifically, two arginines in TrkA (R593/R599) are replaced by lysines (K638/K644 and K622/K630) in TrkB and TrkC, respectively.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> In the absence of ligand–protein X-ray crystal structures in these early years, some groups built homology models to help understand and visualize inhibitor binding modes. Nonetheless, the compounds reported during the first decade of TrkA inhibitor research remained largely pan-Trk inhibitors with significant off-target kinase activity. Many of these compounds were reported to have efficacy in preclinical models for pain and oncology end points, albeit with less than desirable safety profiles.</div><div class="NLM_p">Starting in 2012, several groups reported ligand–protein X-ray crystal structures of all three Trk isoforms.<a onclick="showRef(event, 'ref73 ref74 ref75 ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref73 ref74 ref75 ref76 ref77">(73-77)</a> This advance allowed medicinal chemists to use structure-based drug design to rapidly identify compounds with improved potency and selectivity vs non-Trk kinases. Initially, these methods did not seem to provide a route to TrkA selectivity vs TrkB and TrkC. <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a> shows an overlay of several ligand–TrkA X-ray crystal structures from the Protein Data Bank (PDB). All of these structures engage the hinge and are either type I or type II inhibitors. It can be observed that the two unique TrkA residue side chains, R593 and R599, do not seem to make significant productive interactions with any of these ligands and generally project their side chain atoms outside of the kinase binding pocket. Thus, it is apparent why all of the early reports described only pan-Trk inhibitors. Nonetheless, with improved potency and selectivity vs non-Trk kinases, several groups were able to optimize properties and pharmacokinetic parameters and demonstrate efficacy in multiple rodent pain models. Below, we will highlight several specific demonstrations of this approach.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Aligned overlay of seven pan-Trk inhibitors bound to the TrkA ATP site. The image was derived from the following ligand–protein structures: PDB ID codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4A0J">4A0J</a> (red), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMS">4PMS</a> (pink), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMP">4PMP</a> (blue), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMT">4PMT</a> (yellow), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMM">4PMM</a> (brown), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YNE">4YNE</a> (orange), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YPS">4YPS</a> (light blue). Two apo structures (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GT5">4GT5</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4F0I">4F0I</a>) were included. The residues unique to TrkA (R593 and R599) are highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A few years prior to 2012, AstraZeneca reported on the optimization of a screen hit to give AZ-23 (<b>7</b>, <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>),<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> a potent (<3 nM) pan-Trk inhibitor with modest selectivity across a panel of selected kinases. The authors hypothesized, on the basis of homology models and an X-ray crystal structure of an analogue bound to cyclin dependent kinase 2 (CDK2), that the pyrazole motif bound to the hinge region of the TrkA ATP binding site. To assess its suitability for antitumor applications, <b>7</b> was profiled in multiple cellular assays and in vivo models, where it demonstrated in vivo target inhibition of phospho-TrkA in tumors and antitumor activity in xenograft models after oral dosing.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> In 2012, the group reported the solution of an X-ray crystal structure of <b>7</b> bound to TrkA, confirming their hypothesized binding pose. They utilized structure-based drug design (SBDD) to identify two additional related “fused” scaffolds, exemplified by AZ-12607092 (<b>8</b>) and compound <b>9</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>).<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> The new compounds had similar in vitro potencies in the enzyme and cell-based assays. Compounds from both scaffolds showed antitumor efficacy in vivo, similar to <b>7</b>, albeit at lower doses. While these compounds did not greatly differentiate from <b>7</b>, they demonstrated the value of SBDD for expanding the SAR into two new scaffolds.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. AstraZeneca pan-Trk inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, <b>7</b> and <b>8</b><a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> were profiled in a CFA-induced pain model and compared to an NGF neutralizing antibody (MEDI-578) and other analgesic agents, such as a TRPV1 antagonist and several NSAIDs.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> It was shown that after CFA was injected intra-articularly into the tibio-tarsal joint, NGF levels in synovial fluid rose over 3-fold and remained about 2-fold higher than normal levels through 10 days. The animals demonstrated a significant behavioral response whereby they distributed less weight on the ipsilateral limb during locomotion. This impaired gait behavior was termed “guarding index” (GI). All of the compounds were assessed for their ability to improve guarding index in rats on days 1–3. Both pan-Trk inhibitors showed dose dependent beneficial effects (improved guarding index scores), with maximal effect occurring at doses of 100 μmol/kg (<b>7</b>) and 20 μmol/kg (<b>8</b>). This corresponds to 39 and 8 mg/kg, respectively. The anti-NGF antibody MEDI-578 showed a similar effect, while several NSAIDs demonstrated inferior efficacy. Interestingly, a potent TRPV1 antagonist showed no effect in this model.</div><div class="NLM_p">Another success of this approach was recently highlighted by work from the Merck group, where they demonstrated that four structurally diverse hits could each be optimized to lead-like pan-Trk inhibitors with good properties via the use of SBDD. <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a> shows each of the optimized pan-Trk inhibitors (<b>10</b>–<b>13</b>), all of which had TrkA IC<sub>50</sub>s < 100 nM.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> The SBDD approach also allowed the group to study the binding mode (DFG-in vs DFG-out) impact on TrkA binding kinetics. SPR studies showed that DFG-out (type II) analogues had longer residence times and potency increases were largely the result of decreasing dissociation constants (<i>k</i><sub>off</sub>). Finally, upon oral administration of the most characterized inhibitor, <b>11</b>, they observed pharmacodynamic effects in rat models of inflammatory pain (CFA-induced mechanical hypersensitivity) and neuropathic pain (Chung spinal ligation) similar to naproxen and pregabalin, respectively. In both models, maximal efficacy was observed when unbound exposures were 5–25-fold above the IC<sub>50</sub>s in the cell-based assays.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Merck pan-Trk inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">One concern regarding the development of Trk inhibitors is whether central exposure would result in Trk-mediated CNS adverse events. Pfizer reported that a Tie-2/pan-Trk inhibitor with central exposure, CE-245677 (<b>14</b>, <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>),<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> produced multiple CNS adverse effects (cognitive deficits, personality, and sleep changes) in a phase 1 oncology trial. While the effects were reversible, the study was terminated and it was hypothesized that the CNS effects were Trk related. Thus, Skerratt and co-workers have recently reported on the optimization of this pyrrolopyrimidine series, using a variety of tools, including X-ray crystallography and SBDD.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> In addition to solving many of the traditional issues addressed during lead optimization (selectivity, solubility, metabolism, hERG activity), the group utilized a strategy to increase p-glycoprotein (Pgp) substrate potential as an approach to keeping inhibitors out of the brain. As shown in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>, urea <b>15</b>, a close analogue of <b>14</b>, showed excellent TrkA potency in a cell-based assay but had a low Pgp efflux ratio (ER = 2.1).<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> While optimizing for increased ERs, they identified related compounds, such as amide <b>16</b>, which maintained potency and was a good Pgp substrate (efflux ratio = 35.7). Furthermore, experimental brain and plasma exposures demonstrated a good correlation between Pgp ER and relative unbound brain–plasma exposures (Br<sub>u</sub>/Pl<sub>u</sub>) in this series. Consistent with the high efflux ratio, <b>16</b> was highly peripherally restricted in rodents (Br<sub>u</sub>/Pl<sub>u</sub> = 0.026). Finally, upon demonstration of efficacy in the UV induced hyperalgesia model of inflammatory pain, <b>16</b> (PF-06273340) was chosen as a clinical candidate.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Pfizer pan-Trk inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The most recent chapter in the pursuit of small molecule TrkA inhibitors is focused on compounds which are selective against the other Trk isoforms B and C. As previously described, Trk subtype selectivity seems unlikely if targeting the ATP binding site of the kinase domain due to high homology between all of the Trks in this region. Bertrand and co-workers have recently described the potential to target the kinase insert domain (KID) adjacent to the ATP binding site, where there is less sequence homology between the subtypes.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> To date, nobody has reported on TrkA inhibitors that exploit these differences. However, Array, who has been a visible player in the pan-Trk inhibitor field for many years, has recently disclosed the design of potent and selective TrkA inhibitors. These compounds, described as allosteric, were discovered using an induced fit approach that depended heavily on X-ray crystallography and structure-based drug design.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> The disclosure of selective TrkA inhibitors has enabled the opportunity to characterize some differences and similarities between pan-Trk and selective TrkA inhibitors on measures of both preclinical efficacy and adverse effect profiles. Thus, we feel that a closer review of these data is warranted here.</div><div class="NLM_p">Array has shown that two pan-Trk inhibitors, ARRY-470 (<b>17</b>, <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>, also known as LOXO-101, and in development as an oncolytic)<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> and AR523 (structure not disclosed), demonstrated robust efficacy in multiple models of acute and chronic pain.<a onclick="showRef(event, 'ref83 ref85'); return false;" href="javascript:void(0);" class="ref ref83 ref85">(83, 85)</a> Similar to the data reported on the AstraZeneca compounds, <b>17</b> was superior to NSAIDs in the CFA-induced joint pain model in rats, with maximal effect at 30 mg/kg. It should also be pointed out that there were no findings associated with neuronal safety up to 300 mg/kg for 28 days in rats. However, both <b>17</b> and AR523 were hyperphagic in rats, producing increased food consumption and weight gain during chronic dosing. The effect was dose dependent (30–300 mg/kg), and weight gain was observed even when the rats’ food consumption was controlled. Because of the hyperphagic and obese TrkB knockout phenotype in mice, this effect is thought to be BDNF/TrkB signaling related. Thus, it was hypothesized that a selective TrkA inhibitor would avoid this adverse effect. While these compounds were mostly peripherally restricted (>15:1 peripheral to CNS exposed), ataxia was observed at higher doses that resulted in brain target coverage. Thus, another medicinal chemistry goal would be to design compounds with even less CNS exposure.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structure of <b>17</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The Array group has recently reported on the design of TrkA inhibitors with cellular potency less than 1 nM and >1000-fold selectivity vs TrkB and TrkC. They have shown that selective TrkA inhibitors have similar efficacy to pan-Trk inhibitors in multiple models of both acute and chronic pain, including the rat CFA model, at similar doses and exposures. A selective TrkA inhibitor did not induce hyperphagia in rats, which supports the hypothesis that this adverse effect was BDNF/TrkB-related. Additionally, it was shown that a selective TrkA inhibitor did not show ataxia, even though it had only modest improvement in peripheral to CNS exposure (48:1). Recently, the most characterized molecule from this work, AR786 (structure not disclosed),<a onclick="showRef(event, 'ref83 ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref83 ref85 ref86">(83, 85, 86)</a> was shown to have similar efficacy in two models of OA pain: the monoiodoacetate (MIA) and medial meniscal transection (MNX) models. AR786 (30 mg/kg, PO, BID) attenuated weight bearing asymmetry and paw withdrawal threshold in both models relative to sham controls. AR786 had no effect on joint pathology, however, it did reduce MIA-induced synovitis.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> In a separate report, AR786 demonstrated analgesia in the intra-articular carrageenan model, where it attenuated weight bearing asymmetry and paw withdrawal threshold to von Frey stimulation after an oral dose of 30 mg/kg (BID). The effect was observed through 4 days of dosing, post injury. Partial improvements on inflammation end points were also observed. Additionally, AR786 reduced paw withdrawal to ankle compression and joint swelling in the collagen-induced arthritis (CIA) model, also at 30 mg/kg (PO, BID), similar to the maximally efficacious dose of ibuprofen. Finally, it was noted that AR786 unexpectedly improved histological scores in the CIA model.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> Additional research will be required to understand the potential mechanisms that may be involved in these disease modification end points.</div><div class="NLM_p">Array has not specifically disclosed the structure of AR786, nor any other selective TrkA inhibitor, in association with in vivo results. However, several patent applications identify compounds that are described as selective TrkA inhibitors,<a onclick="showRef(event, 'ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref89 ref90">(89, 90)</a> and other patent applications describe related compounds that are less selective or nonselective.<a onclick="showRef(event, 'ref91 ref92 ref93 ref94 ref95 ref96 ref97 ref98'); return false;" href="javascript:void(0);" class="ref ref91 ref92 ref93 ref94 ref95 ref96 ref97 ref98">(91-98)</a> Four of these structures are highlighted in <a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>. All four compounds were reported to have IC<sub>50</sub>s < 100 nM in a TrkA kinase binding assay and were tested in a panel of 230 off target kinases at 10 μM. It was reported that <b>18</b> and <b>19</b> showed no inhibition of any off target kinases,<a onclick="showRef(event, 'ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref89 ref90">(89, 90)</a> including TrkB, while examples <b>20</b> and <b>21</b> were similarly selective vs non-Trk kinases but showed near-maximal inhibition of TrkB at 10 uM.<a onclick="showRef(event, 'ref91 ref93'); return false;" href="javascript:void(0);" class="ref ref91 ref93">(91, 93)</a> TrkC data was not reported. It is particularly interesting to note the subtle differences in structures between some of the TrkA selective and nonselective (vs TrkB) inhibitors. Array recently announced a collaboration with the Asahi Kasei Pharma Corporation to co-develop their selective TrkA inhibitors for pain and inflammation.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Array TrkA inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Very recently, the Merck group reported on the discovery of selective TrkA inhibitors, unrelated to their previous pan-Trk inhibitors.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> The most characterized molecule, compound <b>22</b>, is shown in <a class="ref internalNav" href="#fig11" aria-label="Figure 11">Figure 11</a>.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> The group described TrkA in vitro potency (cellular) of 6 nM, with 230- and 190-fold selectivity vs TrkB and TrkC, respectively. Similar to the Pfizer approach, the Merck group increased Pgp substrate potential to reduce central exposure and assessed peripheral to central target engagement by measuring phospho-TrkA levels in skin and brain. Compound <b>22</b> demonstrated a 6.8-fold preference for skin vs brain target engagement.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Merck selective TrkA inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">TrkA Kinase Inhibitors in the Clinic</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04254" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04254" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">While the preclinical evaluation of multiple TrkA kinase inhibitors for pain conditions have been described, there have been very few reports on the clinical experiences with TrkA inhibitors for pain-related conditions and no published clinical POCs. While the intent of this perspective is to focus on analgesia, we felt that it would be helpful to include some of the TrkA inhibitors currently being studied in the clinic for other indications such as oncology and psoriasis. It should be pointed out that some of the agents described in the previous sections have demonstrated preclinical antitumor efficacy and may be on a path toward clinical investigations in oncology. Conversely, some of the drug candidates being pursued for oncological indications may prove beneficial for analgesia.</div><div class="NLM_p">For pain and psoriasis, some investigators have explored alternative routes of administration of TrkA inhibitors in an effort to maximize local exposures and minimize systemic exposures of the agents. Creabilis has demonstrated that CT327 (structure not disclosed), a pegylated analogue of K252a (<b>23</b>, <a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>) and potent pan-Trk inhibitor,<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> was effective in reducing the pruritis associated with psoriasis after topical administration in patients.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Creabilis has also communicated that they are investigating an additional topical TrkA inhibitor, CT340 (structure not disclosed), for neuropathic pain and inflammation.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Clinical TrkA inhibitors for pain and psoriasis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In another example of local delivery investigations, Sanofi-Genzyme is studying the intra-articular delivery of the TrkA inhibitor GZ389988 (structure not disclosed). Intra-articular injection of this agent in two preclinical rat models of joint pain, the streptococcal peptidoglycan polysaccharide (PGPS) and monoiodoacetate (MIA) models, demonstrated gait improvement and joint analgesia, respectively.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> In 2015, clinical studies began with intra-articular GZ389988 in patients with painful knee OA.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> While not specifically disclosed, the structure of GZ389988 may be related to compound <b>24</b> (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>), which was described in a recent patent application.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> This compound was reported as a potent TrkA and TrkB inhibitor, with selectivity over TrkC, in a kinase assay.</div><div class="NLM_p">In 2015, Purdue Pharma acquired the selective TrkA inhibitor VM-902A (structure not disclosed) from VM Pharma.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> VM-902A was described as an orally bioavailable, allosteric inhibitor with peripheral only distribution. VM-902A may be related to the compounds described in patent applications by VM Pharma, such as compound <b>25</b> (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>).<a onclick="showRef(event, 'ref108 ref109'); return false;" href="javascript:void(0);" class="ref ref108 ref109">(108, 109)</a> Compound <b>25</b> was reported to inhibit TrkA, but not TrkB nor TrkC, in a cell-based functional assay. Additionally, it demonstrated efficacy in multiple rat pain models, including the CFA-induced inflammatory pain model and the chronic constriction injury (CCI) model after either sc or po dosing.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> Purdue Pharma has reported that this compound has completed phase I studies and phase II studies will commence in 2016 for the potential treatment of chronic pain.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a></div><div class="NLM_p">Finally, Ono Pharmaceuticals has announced the development of Ono-4474 (structure not disclosed) for pain indications. Ono-4474 was described as a selective pan-Trk inhibitor with low CNS exposure. Preclinical efficacy in the rat monoiodoacetate (MIA) model after oral administration was recently described. Similar to the hyperphagic effects described by some Array pan-Trk inhibitors, Ono also described adverse effects associated with increased food consumption, albeit at exposures 36-fold higher than the efficacy exposures.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Ono has announced the start of phase I clinical trials to assess the safety, tolerability, and pharmacokinetic properties of Ono-4474 in humans. Additionally, they intend to assess effects on NGF-induced hyperalgesia in healthy volunteers.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></div><div class="NLM_p">Several Trk kinase inhibitors have been explored clinically for cancer indications and there have been several recent publications on this topic,<a onclick="showRef(event, 'ref35 cit112a ref113'); return false;" href="javascript:void(0);" class="ref ref35 cit112a ref113">(35, 112a, 113)</a> highlighting some of the recent clinical outcomes. One important difference between oncological and pain indications for TrkA inhibitors is safety assessment. Because phase I trials in oncology utilize cancer patients, there exists no information on adverse effects of these agents in healthy volunteers. Furthermore, the tolerance for drug related adverse effects for nononcological indications would be significantly less than for oncology indications. <a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a> shows the structural diversity identified in Trk kinase inhibitors in current clinical development in oncology. All of these drug candidates are described as potent pan-Trk inhibitors. It should be pointed out that <b>17</b> is the only drug candidate in this group that has been reported to be selective for the Trks vs a large collection of other kinases.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Drug candidates MGCD-516 (<b>26</b>),<a onclick="showRef(event, 'cit112b'); return false;" href="javascript:void(0);" class="ref cit112b">(112b)</a> RXDX-101 (<b>27</b>),<a onclick="showRef(event, 'ref115 ref117'); return false;" href="javascript:void(0);" class="ref ref115 ref117">(115, 117)</a> DCC-2701 (<b>28</b>),<a onclick="showRef(event, 'cit112c'); return false;" href="javascript:void(0);" class="ref cit112c">(112c)</a> TSR-011 (<b>29</b>),<a onclick="showRef(event, 'cit112a ref113'); return false;" href="javascript:void(0);" class="ref cit112a ref113">(112a, 113)</a> and XL-184 (<b>30</b>)<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> are all reported to inhibit a range of other kinase targets such as c-Met, ALK, Tie2, ROS1, VEGFR2, and others. Thus, any reported clinical outcomes will not provide definitive validation for the NGF–TrkA pathway in oncology. Nonetheless, we will review a few valuable and interesting learnings from these studies that may help inform the role of TrkA inhibition in cancer and analgesia.</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Clinical TrkA inhibitors for oncological indications.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It has recently been reported that some <i>NTRK</i> chromosomal rearrangements result in oncogenic fusion proteins.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> These Trk-overexpressing fusions are constitutively active, with increased canonical Trk pathway signaling, and are responsive to Trk kinase inhibitors both in vitro and in vivo. In fact, because these fusion proteins lack the Trk extracellular binding domains, small molecule kinase inhibitors would clearly be the most appropriate intervention approach. Several clinical studies have reported robust efficacy with the Trk kinase inhibitors <b>17</b> and <b>27</b> in patients with oncogenic TrkA fusion proteins. These reports have described responses in patients with multiple tumor types containing Trk fusions such as lung,<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> colorectal,<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> and soft tissue sarcoma.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> In the case of <b>27</b>, which also targets the anaplastic lymphoma kinase (ALK) and the proto-oncogene tyrosine–protein kinase ROS1, it was noted that after a remarkable initial response, a patient experienced drug resistance to <b>27</b> and disease progression. It was determined that this patient’s resistance was the result of two TrkA kinase domain mutations. Specifically, G595 was mutated to arginine (G595R) and G667 was mutated to cysteine (G667C). This exact resistance mechanism could be recapitulated in mice by implanting tumor cells from the patient (pretreatment) and dosing the animal with <b>27</b> until resistance developed. While there exist no published X-ray crystal structures of the <b>27</b>–TrkA complex, there was a recent disclosure of <b>27</b> bound to ALK in the conserved hinge region of the ATP binding site.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Thus, it seems likely that it would bind similarly to the hinge in TrkA. In fact, Doebele and co-workers modeled <b>27</b> in the TrkA kinase binding site, showing the potential impact of each mutation on ligand binding. This model predicted that the G595R mutation would confer greater resistance than the G667C mutation based on the proximity of the mutation relative to the inhibitor in the putative modeled binding site. It should be pointed out that kinase inhibitor-induced acquired resistance was also observed in related tyrosine kinase targets (ALK, ROS1, EGFR, and KIT), with mutations occurring at the same conserved kinase domain residues.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Experimentally, using engineered Ba/F3 TPM3-TrkA fusion protein containing cells, it was indeed shown that wild-type (WT), G595R, and G667C mutants differentiated in vitro with respect to sensitivity toward this inhibitor. Compound <b>27</b> reduced cell viability in WT cells (IC<sub>50</sub> = 0.006 μM) but required about 10× higher concentrations to achieve similar effects in the G667C mutants (IC<sub>50</sub> = 0.061 μM). In the G595R mutants, <b>27</b> was inactive (IC<sub>50</sub> > 1.0 μM). Similar results were described for both <b>17</b> and <b>29</b>, both of which likely bind similarly in the ATP pocket. To help with the visualization of these mutants in the TrkA kinase binding pocket, we have included two structures from the Protein Data Bank. <a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>A shows the structure of a typical type I inhibitor (<b>31</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YPS">4YPS</a>)<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> bound to TrkA while <a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>B represents a typical type II inhibitor (<b>32</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMM">4PMM</a>).<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> The chemical structures of the ligands are shown in <a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>C. As can be seen in <a class="ref internalNav" href="#fig14" aria-label="Figure 14">Figure 14</a>A,B, the residue at position 595 sits almost directly below the hinge. Thus, one would expect that the mutation of glycine to arginine would almost certainly disrupt hinge binding inhibitors. It is this mutation that confers the greatest resistance to the inhibitors that were tested, which were all hinge binders. Alternatively, residue 667 is located just before the DFG motif and thus might be less likely to display broad resistance among some type I and II inhibitors. Type III inhibitors, which bind in the hydrophobic pocket in a DFG-out conformation, but not in the hinge, may not be impacted by the G595R mutation and may be more likely to be resistant to the G667C mutation. Finally, allosteric (type IV) inhibitors may not be impacted by either mutation. Of course, nonkinase domain mutations could always occur and confer resistance to allosteric inhibitors as well.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. X-ray crystal structures of type I and type II inhibitors in the TrkA active site. These structures demonstrate the relative proximity of mutant TrkA residues to the ligands. (A) X-ray crystal structure of <b>31</b> bound to TrkA (PDB ID code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YPS">4YPS</a>), with highlighted mutations. (B) X-ray crystal structure of <b>32</b> bound to TrkA (PDB ID code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMM">4PMM</a>), with highlighted mutations. (C) Chemical structures of <b>31</b> and <b>32</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In addition to responses of patients harboring oncogenic <i>NTRK1–3</i> fusions, there was another interesting report of clinical efficacy with cabozantinib (<b>30</b>, <a class="ref internalNav" href="#fig13" aria-label="Figure 13">Figure 13</a>) in castration-resistant prostate cancer patients with bone metastases.<a onclick="showRef(event, 'ref118 ref119'); return false;" href="javascript:void(0);" class="ref ref118 ref119">(118, 119)</a> Bone pain is a debilitating condition associated with bone metastases, and most patients who have bone metastases require narcotics for pain control. Compound <b>30</b> is a potent pan-Trk inhibitor with multikinase activity, so the specific role of TrkA in the response cannot be determined. However, in addition to significant positive responses on bone scan and survival end points, there was a clinically meaningful improvement in pain relief. It is impossible to know the source of this analgesic response, and it is quite possible that it is solely attributable to the patients’ improved condition as represented by the bone scan data. Nonetheless, the analgesia is encouraging and may suggest a role for TrkA in cancer pain.</div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Emerging Potential Drug Targets within the NGF Pathway</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44713" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44713" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As was demonstrated in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>, much is known about the canonical signaling pathways downstream of the NGF-induced TrkA activation event. Many of these downstream effectors are well characterized historic drug targets for oncology and a host of additional indications. These include kinase targets such as Ras, Raf, MEK, MAPK, PI3K, AKT, and others.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> On the basis of past clinical investigations, it seems unlikely that inhibitors of such ubiquitous signaling mechanisms would have the necessary safety profile required for analgesic therapies. However, inhibitor tools of these targets provide extraordinarily valuable preclinical information regarding NGF pathway mechanisms in pain states. NGF-mediated changes in various ion channel targets have been described.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> One well characterized downstream drug target of TrkA is the TRPV1 channel.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> Agonists and antagonists of this target have been studied for pain, both preclinically and clinically.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> In fact, TRPV1 is considered a highly validated target for several pain indications. Unfortunately, adverse effects related to thermoregulation have precluded the successful registration of TRPV1 modulators.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Because of the existing extensive literature treatment committed to both the canonical kinase pathways and TRPV1, we have not included them in this Perspective and the reader is encouraged to refer to the references cited herein. In recent years, several additional targets associated with preclinical and clinical pain end points have been linked to the NGF pathway, albeit with some incomplete understanding. Thus, we felt it was appropriate to include a few of these in this Perspective.</div><div id="sec8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Angiotensin II Type 2 Receptor Modulators</h3><div class="NLM_p">Over the past several decades, significant understanding of the renin–angiotensin system (RAS) has emerged with most of the attention being toward the role of the small peptide angiotensin II (Ang II) in cardiovascular disease.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> The RAS pathway is shown in <a class="ref internalNav" href="#fig15" aria-label="Figure 15">Figure 15</a>. Several targets along this pathway, specifically renin inhibitors, angiotensin converting enzyme (ACE) inhibitors, and Ang II receptor antagonists have demonstrated preclinical and clinical cardiovascular benefit.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Drugs that modulate this pathway are among the most prescribed agents in the world.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> While the pharmacological effects associated with cardiovascular end points, such as hypertension, are known to be mediated through the Ang II type 1 receptor (AT<sub>1</sub>R),<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> the role of the Ang II type 2 receptor (AT<sub>2</sub>R) in human disease has been studied significantly less. AT<sub>1</sub>R and AT<sub>2</sub>R are class A G-protein coupled receptors (GPCRs), which share only 32% sequence homology.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> The role of the RAS pathway in multiple pain conditions has been studied both preclinically and clinically, and two excellent reviews have been recently published.<a onclick="showRef(event, 'ref128 ref129'); return false;" href="javascript:void(0);" class="ref ref128 ref129">(128, 129)</a> However, understanding has been confounded by multiple paradoxical results. For example, modulators have been reported to have both analgesic and hyperalgesic effects in preclinical animals and in humans, depending upon the pain condition and specific target in the pathway.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Specifically, ACE inhibitors can show hyperalgesic effects in humans.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> On the basis of preclinical studies in rodents, it has been hypothesized that this is due to the role of ACE in degradation of pain and inflammation mediators such as bradykinin.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Renin–angiotensin system (RAS) pathway and differentiation of some effects mediated by the AT1R and AT2R receptors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Research in recent years has demonstrated a potential role for Ang II, via AT<sub>2</sub>R, in neuronal hyperexcitability and neurite outgrowth.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> Ang II and AT<sub>2</sub>R are present in sensory neurons of rat and human DRG and nerve fibers in peripheral nerves, skin, bowel, and urinary bladder.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> In 2006, Plouffe and co-workers showed that Ang II induced TrkA receptor phosphorylation (Y490), MAPK phosphorylation, and neurite outgrowth in NG108-15 cells.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> These Ang II-mediated effects could be abrogated by pan-Trk inhibitor AG879 (<b>33</b>), consistent with modulation of the NGF–TrkA signaling pathway. Furthermore, MEK inhibitor PD98059 (<b>34</b>) similarly inhibited Ang II-induced MAPK phosphorylation and neurite outgrowth in NG108-15 cells, also consistent with cross-talk between AT<sub>2</sub>R and the NGF/TrkA pathway. Subsequently, it was shown that in DRGs, while Ang II induced neurite outgrowth similar to NGF, AT<sub>2</sub>R antagonists were unable to modulate NGF-induced neurite outgrowth.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a><a class="ref internalNav" href="#fig16" aria-label="Figure 16">Figure 16</a> highlights some of the effects that have been observed that are consistent with AT<sub>2</sub>R-mediated transactivation of the TrkA signaling pathway. More recently, Guimond and co-workers have shown that the subtype selective small molecule AT<sub>2</sub>R agonist C21/M024 (<b>35</b>, <a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>)<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> stimulated MAPK phosphorylation and neurite outgrowth, similar to Ang II, in NG108-15 cells.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> Interestingly, the isomeric C38/M132 (<b>36</b>, <a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>),<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> an AT<sub>2</sub>R antagonist, was shown to inhibit these downstream effects in a manner similar to another AT<sub>2</sub>R antagonist PD123319 (<b>37</b>, <a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>).<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Collectively, these data seem consistent with pathway convergence at the TrkA phosphorylation event. Additional studies with these and other ligands should help clarify the connection between these two pathways.</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0017.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Ang II binds to the GPCR AT<sub>2</sub>R and triggers transactivation of the TrkA pathway, leading to end points such as neurite outgrowth. In a manner similar to NGF-stimulated downstream signaling, these effects can be inhibited by pan-Trk and MEK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0018.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Selective AT<sub>2</sub>R modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Several groups have described analgesic effects of AT<sub>2</sub>R antagonists in rodent pain models such as the chronic constriction injury (CCI) model of neuropathic pain,<a onclick="showRef(event, 'ref138 ref139'); return false;" href="javascript:void(0);" class="ref ref138 ref139">(138, 139)</a> the prostate cancer induced bone pain model,<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> and the CFA model for inflammatory pain<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> in both rats and mice. It was shown that efficacy was abolished in AT<sub>2</sub>R knockout mice, consistent with the effect being AT<sub>2</sub>R mediated.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> In humans, it has been reported that the potent and selective AT<sub>2</sub>R antagonist EMA401 (<b>38</b>, (<i>S</i>)-enantiomer of PD126055, <a class="ref internalNav" href="#fig17" aria-label="Figure 17">Figure 17</a>) demonstrated clinical efficacy in patients with post herpetic neuralgia after 4 weeks of dosing (PO, 100 mg, BID). Compound <b>38</b> was superior to placebo and similar to active comparators, such as pregabalin (300 and 600 mg) and gabapentin (1200 mg), and showed no serious adverse effects.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> While this is an exciting proof of concept study, multiple gaps exist in our understanding of the RAS pathway as it relates to both the NGF pathway and analgesic effects. As this molecule progresses in the clinic, additional preclinical studies will likely prove valuable in further understanding of this mechanism of action.</div></div><div id="sec8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Sphingosine-1-phosphate (S1P) Receptor Modulators</h3><div class="NLM_p">The ceramide–sphingosine–sphingosine-1-phosphate (S1P) signaling pathway has been studied extensively in association with many biological processes and diseases.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> In addition to signaling activities of their own that initiate various inflammation pathways,<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> ceramides are hydrolyzed by ceramidases to produce sphingosine, which can be elaborated to S1P by two sphingosine kinases, SphK1 and SphK2.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> S1P can bind to and activate at least five G-protein coupled receptors S1PR1–5 (<a class="ref internalNav" href="#fig18" aria-label="Figure 18">Figure 18</a>).<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Over the past few decades, this pathway has been linked to multiple pathological conditions such as cancer, inflammation, and autoimmune disorders.<a onclick="showRef(event, 'ref146 ref147'); return false;" href="javascript:void(0);" class="ref ref146 ref147">(146, 147)</a> Consequently, multiple approaches to modulation of the pathway have been explored, such as inhibition of sphingosine kinases,<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> S1P neutralizing antibodies,<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> and S1PR modulators.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> Perhaps the most clinically validated disease that is responsive to S1P pathway modulation is multiple sclerosis (MS), where numerous agents have demonstrated clinical improvement in MS patients.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> The S1PR modulator FTY720 (fingolimod, <b>39</b>, <a class="ref internalNav" href="#fig19" aria-label="Figure 19">Figure 19</a>) is approved for the treatment of MS.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> In the case of many S1PR<sub>1</sub> modulators, including <b>39</b>, the agents are difficult to categorize as agonists or antagonists. Many of these pro-drugs are metabolized to a phosphorylated form by sphingosine kinases, rendering them S1P1 agonists. Subsequently, upon binding to the S1P1 receptor, they can cause receptor internalization, making them functional antagonists in some tissues.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Because of the significant complexity and massive collection of literature dedicated to the study of the ceramide–S1P pathway in disease (see references cited above), we suggest that the readers consult many of the existing review articles on this pathway for nonpain indications.</div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0019.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Ceramide–S1P biosynthetic pathway. Ceramides are converted to S1P through the action of ceremidases and sphingosine kinases. S1P-mediated signaling occurs via five GPCRs S1PR1–5.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0020.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. S1P1 modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The role of the S1P pathway in peripheral pain circuits and, specifically, NGF-mediated end points, has been investigated through the years. As early as 1997, Edsall and co-workers described NGF-induced increases in sphingosine kinase activity and S1P levels in PC12 cells.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> These end points could be inhibited by the pan-Trk inhibitor <b>23</b> (<a class="ref internalNav" href="#fig12" aria-label="Figure 12">Figure 12</a>), suggesting a Trk-mediated effect. Later, Toman and co-workers showed more specifically that in PC12 cells, NGF translocated SphK1 to the plasma membrane, where its colocalization with substrate sphingosine produced S1P.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> NGF-mediated SphK1 translocation to the plasma membrane was not observed in the TrkA negative mutant PC12 nnr5 cells, providing further evidence for the involvement of TrkA signaling in neuronal S1P synthesis.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> As previously described, NGF causes neurite outgrowth in PC12 cells in a TrkA-dependent fashion. Toman and co-workers further showed, via S1PR1 knock-down, that NGF-induced neurite outgrowth was S1PR1 dependent.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a></div><div class="NLM_p">A role for the NGF–TrkA–S1P pathway in chemotherapy-induced peripheral neuropathy (CIPN) has recently been described. Many patients on paclitaxel, which is indicated for the treatment of multiple types of cancer, experience painful CIPN, a significant dose-limiting adverse effect.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> The mechanism underlying this effect in humans is unknown. Preclinically, it has been shown that paclitaxel induces hypersensitivity and allodynia in rats and these effects correlate with increased expression of NGF, TrkA, and phospho-TrkA in DRGs. Additionally, pan-Trk inhibitor <b>23</b> partially reversed these effects in paclitaxel-treated rats.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> In a separate report, it was shown that, in rats, paclitaxel-induced neuropathic pain end points could be blocked by S1PR1 modulators <b>39</b>, CYM5442 (<b>40</b>), ponesimod (<b>41</b>), and NIBR14 (<b>42</b>) in a dose-dependent fashion.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> These results are supportive of a role for the NGF–TrkA–S1P pathway modulators in paclitaxel-induced CIPN.</div><div class="NLM_p">Alternatively, there is an emerging story around the importance of NGF signaling, via the p75 receptor, to activate sphingomyelin signaling, leading to an increase in intracellular ceramides and sphingolipids and increased neuronal sensitization. Specifically, it was shown by Zhang and co-workers that NGF, via production of ceramide, was associated with an increase in action potential firing in isolated sensory neurons.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> This group also demonstrated that a p75 antibody could prevent NGF-induced neuronal excitability and sensitization, however, the effect was restored by the addition of exogenous ceramide.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> The group ultimately designed a collection of experiments to inform the mechanism of action for the enhancement of action potentials (APs) in sensory neurons. It was shown that both sphingosine and S1P, when intracellularly perfused, similarly enhanced APs and the effects of NGF, ceramide, and sphingosine could be inhibited by the SphK1/2 inhibitor dimethylsphingosine (DMS, <b>43</b>).<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> APs enhanced by the intracellular perfusion of S1P were unchanged by the addition of <b>43</b>. These data are consistent with S1P, via one of the S1P receptors, playing a direct role in NGF–p75-induced neuronal sensitization. While the relative contributions of TrkA and p75 toward activating neuronal excitation pathways may be unclear, the evidence does seem to suggest a convergence toward S1P and the S1P receptors.</div><div class="NLM_p">Recently, multiple authors have published thorough reviews on the role of the ceramide–S1P pathway in pain.<a onclick="showRef(event, 'ref161 ref162 ref163'); return false;" href="javascript:void(0);" class="ref ref161 ref162 ref163">(161-163)</a> These reviews document many additional converging lines of evidence implicating this pathway in both peripheral and centrally mediated sensitization and highlight multiple studies, both in vitro and in vivo, that demonstrate how activation of the pathway can lead to neuron excitability and hyperalgesia in rodents. Correspondingly, many examples of pathway modulation have demonstrated the ability to block pain end points such as thermal and mechanical hyperalgesia. Perhaps one of the more convincing data sets describing the role of the S1P pathway in pain states was described by Doyle and co-workers.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> They showed that intraplantar injection of ceramide produced thermal hyperalgesia in rats, which could be attenuated by the SphK1/2 inhibitor SKI-I (<b>44</b>) in a dose response fashion. It was also shown that the anti-S1P antibody LT1002 had a similar effect, as did the S1PR1 antagonist W146 (<b>45</b>, <a class="ref internalNav" href="#fig19" aria-label="Figure 19">Figure 19</a>). Importantly, both the control antibody LT1017 and the inactive enantiomer of W146 (W140, <b>46</b>) showed no effect on ceramide induced hyperalgesia, consistent with an S1PR mediated effect. Similarly, <b>39</b>, a functional antagonist of S1PR1, showed dose-dependent antinociceptive activity in both the formalin and spared nerve ligation models.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a></div><div class="NLM_p last">In spite of preclinical validation and pharmacological evidence for a role in multiple pain states, clinical studies with S1PR modulators for pain indications have not yet been reported. As previously discussed, several S1PR modulators are in development for MS and other autoimmune/immune-modulatory indications. Perhaps some of those agents will ultimately be investigated for uses in pain relief.</div></div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusions and Future Approaches for Therapies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24126" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24126" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The unprecedented efficacy of the anti-NGF therapies currently in late stage clinical testing makes this pathway an intriguing opportunity for future drug development efforts. As is often the case when trying to deconvolute clinical efficacy, the precise mechanism of action of the anti-NGF therapies is not completely understood. While sequestration of NGF and the resulting dampening of NGF-dependent signaling is the presumed primary mechanism of action, even this could be called into question. There is good evidence that proNGF can play a prominent role in neuronal excitability.<a onclick="showRef(event, 'ref46 ref166'); return false;" href="javascript:void(0);" class="ref ref46 ref166">(46, 166)</a> It is unclear if anti-NGF therapies may also sequester proNGF. ProNGF is the preferred ligand of p75, especially in the background of sortilin as a coreceptor and is often linked to pro-apoptotic pathways.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> However, it has also been shown that proNGF can serve as a trophic factor in cellular contexts where TrkA is the dominant receptor vs p75. Similarly, NGF’s actions are more complex than simply TrkA receptor preference. NGF binding to TrkA may be influenced by p75 acting as a co-receptor. Furthermore, NGF appears to bind to p75 when sortilin is not present, activating a different kinase pathway than that modulated by proNGF/p75/sortilin activity.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> A good argument can be made for efficacy attributable to either NGF or proNGF sequestration, via either p75 or TrkA mediated signaling or a combination of all of the above. Clearly, selective ligands for each of these mechanisms will help answer some of these questions. Given the degree of activity currently directed toward the development of TrkA inhibitors and antagonists, this will likely be the first NGF receptor to achieve clinical proof of concept in a chronic pain population. In addition, there is certainly a reasonable hypothesis to develop p75 antagonists for pain, but these efforts have not yet been reported to be in development.</div><div class="NLM_p">Beyond modulating the more proximal receptors, there are a multitude of other points of intervention in the NGF pathway that may be relevant for analgesic drug discovery. The classical mechanisms of NGF-dependent hyperalgesia have typically included systemic (non-neuronal) pro-inflammatory effects of NGF, direct effects of NGF on primary afferent neuron sensitization, and central sensitization of the spinal cord dorsal horn circuits. Additionally, given the aforementioned effects of the anti-NGF antibodies on autonomic neuronal morphology, it is also worth considering this as an additional potential mode of action. Many chronic pain conditions have been shown to have a strong sympathetic component, often involving sympathetic postganglionic neuronal dendrites. These dendrites form basket-like structures around primary afferent DRG somas, directly sensitizing these neurons through increased adrenergic signaling.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> The anti-NGF therapies could be causing an atrophy of these sympathetic dendritic processes and reversing primary afferent sympathetic sensitization. <a class="ref internalNav" href="#fig20" aria-label="Figure 20">Figure 20</a> shows four distinct areas through which NGF (and proNGF) may produce their pro-nociceptive effects. These include non-neuronal pro-inflammatory effects, central and peripheral neuronal sensitization, and sympathetic driven adrenergic effects.</div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0001.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. NGF and proNGF-mediated effects have been linked to inflammation, peripheral sensitization, central sensitization, and sympathetic neuron effects. All of these effects may play distinct roles in NGF-mediated hyperalgesia.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The pro-inflammatory effects of NGF are well described and have been reviewed in detail.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> NGF has the ability to trigger mast cell degranulation, is involved in some immune cell maturation, and is expressed on mononuclear cells. While there are certainly secondary effects of these pro-inflammatory mediators on neuronal sensitization, this mechanism of action and related drug targets have been reviewed in detail in many prior reports on general inflammation.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> For the purposes of this Perspective, we have chosen to focus on the direct neuronal actions of NGF and related targets.</div><div class="NLM_p">NGF-dependent primary afferent sensitization is typically discussed in terms of either thermal or mechanical hyperalgesia. However, in considering potential drug discovery opportunities, it may be more beneficial to consider acute/post-translational mechanisms versus transcriptionally dependent mechanisms of sensitization. These acute circuits have been described in great detail and usually involve experiments in isolated DRG neurons. NGF triggers multiple phosphorylation pathways resulting in up- or down-regulation of terminal proteins, usually ion channels or other cell surface receptors.<a onclick="showRef(event, 'ref172 ref173'); return false;" href="javascript:void(0);" class="ref ref172 ref173">(172, 173)</a> There have been numerous reports of NGF acutely potentiating TRPV1 currents, and while various mechanisms have been proposed for this effect, they all typically involve a variation of TrkA phosphorylation leading to activation of downstream kinases and the eventual up-regulation of TRPV1 function.<a onclick="showRef(event, 'ref53 ref174'); return false;" href="javascript:void(0);" class="ref ref53 ref174">(53, 174)</a> Likewise, the acute effects of p75 activation have been studied in detail. An elegant set of experiments from Nicol and co-workers showed that NGF upregulates tetrodotoxin-resistant sodium current and decreases a delayed rectifier potassium current in isolated DRGs, both within a few minutes of NGF exposure.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> Many other similar experiments have implicated a plethora of other ion channels including KCNQ2/3, Nav1.7, calcium channels, etc.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> What remains unanswered is how relevant these more acute pathways may be to the observed clinical efficacy with the anti-NGF antibodies. The onset of observed efficacy would provide some insight into the mechanism, but, unfortunately, this is difficult to determine with antibodies due to their longer term exposure characteristics. If some of the TrkA targeted small molecule therapies demonstrate acute effects, it may implicate these proximal phosphorylation pathways as likely axes for efficacy. In some of the previously described preclinical pain assays, many TrkA ligands have shown efficacy within minutes to an hour, but it remains to be seen how this translates into the clinic.</div><div class="NLM_p">In the case of chronic peripheral sensitization, this is likely supported by new transcriptional activity dependent on the retrograde transport of the NGF bound TrkA signaling endosome.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> Many of the same ion channels mentioned for the acute circuits are also supported by increased transcriptional activity to maintain this sensitization over extended timeframes. However, while there is evidence of p75 having the ability to form signaling endosomes as well,<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> this is less well described in the background of DRG signaling and certainly warrants further investigation. TrkA, or perhaps p75, receptor antagonism would be expected to inhibit these transcriptional events, but an open question is how different modes of attack may affect these transcriptional events. As mentioned previously, there are multiple TrkA receptor modulation approaches currently being assessed, including antibodies, peptides, small molecules targeting the external NGF binding site, and small molecules directed at the internal kinase domain through both orthosteric and allosteric mechanisms. Targeting the external domain may prevent TrkA internalization and the formation of the signaling endosome. Alternatively, depending on the antibody, this approach may induce receptor internalization and lead to lysosomal degradation rather than formation of the signaling endosome. While a kinase directed mode of action may not prevent the formation of the endosome, it would be expected to modulate most of the transcriptional signaling, as the kinase domain would presumably remain occupied and inhibited throughout the retrograde transport process. In addition, it is not entirely clear if there may be other signaling mechanisms that are dependent on endosome formation but perhaps not dependent on the canonical kinase pathways currently targeted by the existing kinase inhibitors. As TrkA ligand drug discovery continues, some of these fundamental questions will likely be addressed.</div><div class="NLM_p">Central sensitization refers to the phenomena where nonpainful or lightly painful stimuli are transmitted to spinal cord circuits wherein a pathological amplification takes place, resulting in exaggerated perception.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> This occurs as a result of both synaptic changes at the first-order primary afferent synapse but also changes in the second-order neurons of the spinal cord dorsal horn. NGF has been shown to increase the transcription and transport of several key neurotransmitters to the proximal primary afferent synapses. These include CGRP, substance P, and glutamate, among others.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> In addition, it has been shown that chronic NGF activation of primary afferents can result in BDNF release at the spinal terminals.<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a> BDNF has multiple roles on the secondary spinal dorsal horn neuron, including potentiation of postsynaptic NMDA current<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> as well as affecting the chloride reversal potential likely through action on the potassium–chloride transporter KCC2.<a onclick="showRef(event, 'ref179 ref180'); return false;" href="javascript:void(0);" class="ref ref179 ref180">(179, 180)</a> This latter effect can lead to excitatory chloride conductances from GABA and/or glycine channels versus their typical inhibitory effects. Release of BDNF from primary afferent terminals is not the only source of BDNF within the spinal cord, as it has also been shown to be released from activated microglia.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> Nonetheless, the NGF/BDNF connections are an intriguing and active area of research and future points of intervention may well emerge in this pathway.</div><div class="NLM_p">Key questions remain regarding the more relevant pathological ligand for chronic pain: NGF and/or proNGF. Likewise, full understanding of the importance of the TrkA and/or p75 receptors in the transmission of pain signals remains outstanding. Beyond these primary signaling questions, there also remain larger questions around the primary mechanism of analgesia for the current anti-NGF therapies. Reversal of inflammatory responses, dampening of peripheral and central sensitization, and sympathetic dendritic atrophy are all plausible candidates for the primary mechanism of action. As the anti-NGF antibodies have achieved thousands of patient exposures, it is clear these therapies are safe over months of exposure. With longer duration, late-stage trials currently ongoing, it always remains a possibility that a new safety signal may emerge. However, barring such an event, these therapies may prove to be excellent options for multiple chronic pain indications.</div><div class="NLM_p last">From a drug discovery perspective, several key considerations remain. Any future therapy in this pathway that could be safely co-administered with NSAIDS would be desirable and may differentiate from the first-generation anti-NGF antibodies. Likewise, oral small molecules with both a more convenient route of administration and a shorter duration of action versus the current antibodies may be beneficial for certain indications and patient populations. One could imagine an acute acting therapy being useful for breakthrough pain. Another key question is whether the current antibodies have achieved maximum efficacy within this pathway. An argument could be made that sequestering NGF should inhibit nearly all NGF (or proNGF)-mediated signaling and that maximum efficacy has been achieved. However, there are many local autocrine-like circuits where NGF is released proximal to the active receptor(s). In these cases, receptor antagonism may be a preferred strategy for modulating these local circuits versus a ligand sequestration strategy. Likewise, if shutting down a particular component of the NGF pathway only results in a partial down- or up-regulation of a key signaling protein, then perhaps a more targeted therapy would be more efficacious. It is reasonable to expect that TrkA directed therapies will be the next to make it into clinical proof of concept trials. Beyond this, it will be essential to deconvolute the primary mechanism of action for the anti-NGF therapies. This will help focus future drug discovery efforts on a more narrow range of possible targets.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00964" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08558" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08558" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryan H. Norman</span> - <span class="hlFld-Affiliation affiliation">†Discovery Chemistry
Research and Technologies and ‡Neurophysiology, Lilly Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Lilly
Corporate Center, Indiana 46285, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#264849544b4748664a4f4a4a5f0845494b"><span class="__cf_email__" data-cfemail="4c22233e212d220c2025202035622f2321">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeff S. McDermott</span> - <span class="hlFld-Affiliation affiliation">†Discovery Chemistry
Research and Technologies and ‡Neurophysiology, Lilly Research Laboratories, A Division of Eli Lilly and Company, Indianapolis, Lilly
Corporate Center, Indiana 46285, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85037" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85037" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Bryan H. Norman</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=BIO-d137e1887-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Bryan H. Norman</b> is a Senior Research Advisor in Discovery Chemistry at Eli Lilly and Company. He received his Ph.D. at Emory University and was an NIH Postdoctoral Fellow at Penn State University. After three years at Monstanto/Searle, Bryan joined Lilly in 1993, where he has led multiple drug discovery efforts through the years, many of which culminated in clinical candidates for endocrine and pain indications. Bryan has served on the Editorial Board of Burger’s Medicinal Chemistry and is currently on the Board of Directors of the Medicinal and Bioorganic Chemistry Foundation. He has published over 40 papers and given many invited lectures at scientific conferences and universities. His current research interests are focused on the discovery of novel analgesic agents for use in chronic pain.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Jeff S. McDermott</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=BIO-d137e1892-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jeff S. McDermott</b> is a Principal Research Scientist in Neuroscience Discovery at Eli Lilly and Company. He received his B.S. in Biology from the University of California—Irvine in 1994 and attended graduate and medical school at The Chicago Medical School, receiving an M.S. in Physiology in 1995. He joined Lilly in 2012 and currently leads multiple large and small molecule drug discovery efforts focused on chronic pain. He is a cellular electrophysiologist with over 25 years of research experience, including prior drug discovery positions with Abbott Laboratories and Amgen. He has presented numerous abstracts at national scientific conferences and coauthored 18 publications in the areas of ion channel physiology and pharmacology. His interests include chronic pain, ion channels, and mechanisms ion channel regulation.</p></figure></div><div class="ack" id="ACK-d137e1897-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46218" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46218" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. David Evans, Senior Research Scientist at Eli Lilly and Company (Erl Wood, UK), for the generation of the protein–ligand structure images shown in <a class="ref internalNav" href="#fig5" aria-label="Figures 5">Figures 5</a> and <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>.</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00263" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00263" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="first last">After this paper was published ASAP October 25, 2016, Figure 17 was replaced. The revised version was reposted November 10, 2016.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i22" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i22"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i23" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i23"> Abbreviations Used</h2><tr><td class="NLM_term">Ang II</td><td class="NLM_def"><p class="first last">angiotensin II</p></td></tr><tr><td class="NLM_term">AT<sub>1</sub>R</td><td class="NLM_def"><p class="first last">angiotensin receptor subtype 1</p></td></tr><tr><td class="NLM_term">AT<sub>2</sub>R</td><td class="NLM_def"><p class="first last">angiotensin receptor subtype 2</p></td></tr><tr><td class="NLM_term">BDNF</td><td class="NLM_def"><p class="first last">brain derived growth factor</p></td></tr><tr><td class="NLM_term">CFA</td><td class="NLM_def"><p class="first last">complete freund’s adjuvant</p></td></tr><tr><td class="NLM_term">CGRP</td><td class="NLM_def"><p class="first last">calcitonin gene related peptide</p></td></tr><tr><td class="NLM_term">CIA</td><td class="NLM_def"><p class="first last">collagen-induced arthritis</p></td></tr><tr><td class="NLM_term">CIPA</td><td class="NLM_def"><p class="first last">congenital insensitivity to pain with anhidrosis</p></td></tr><tr><td class="NLM_term">CIPN</td><td class="NLM_def"><p class="first last">chemotherapy-induced neuropathic pain, CNTF, ciliary neurotrophic factor</p></td></tr><tr><td class="NLM_term">CSP</td><td class="NLM_def"><p class="first last">chemical shift perturbations</p></td></tr><tr><td class="NLM_term">DFG</td><td class="NLM_def"><p class="first last">Asp-Phe-Gly</p></td></tr><tr><td class="NLM_term">DRG</td><td class="NLM_def"><p class="first last">dorsal root ganglion</p></td></tr><tr><td class="NLM_term">ECD</td><td class="NLM_def"><p class="first last">extracellular domain</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">efflux ratio</p></td></tr><tr><td class="NLM_term">GDNF</td><td class="NLM_def"><p class="first last">glial cell line-derived neurotrophic factor</p></td></tr><tr><td class="NLM_term">KCC2</td><td class="NLM_def"><p class="first last">potassium–chloride transporter</p></td></tr><tr><td class="NLM_term">KID</td><td class="NLM_def"><p class="first last">kinase insert domain</p></td></tr><tr><td class="NLM_term">LRM1</td><td class="NLM_def"><p class="first last">leucine rich motif</p></td></tr><tr><td class="NLM_term">MIA</td><td class="NLM_def"><p class="first last">monoiodoacetate</p></td></tr><tr><td class="NLM_term">MNX</td><td class="NLM_def"><p class="first last">meniscal transection</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">multiple sclerosis</p></td></tr><tr><td class="NLM_term">NGF</td><td class="NLM_def"><p class="first last">nerve growth factor</p></td></tr><tr><td class="NLM_term">OA</td><td class="NLM_def"><p class="first last">osteoarthritis</p></td></tr><tr><td class="NLM_term">PGPS</td><td class="NLM_def"><p class="first last">streptococcal peptidoglycan polysaccharide</p></td></tr><tr><td class="NLM_term">RPOA</td><td class="NLM_def"><p class="first last">rapidly progressive osteoarthritis</p></td></tr><tr><td class="NLM_term">RTK</td><td class="NLM_def"><p class="first last">receptor tyrosine kinase</p></td></tr><tr><td class="NLM_term">S1P</td><td class="NLM_def"><p class="first last">sphingosine-1-phosphate</p></td></tr><tr><td class="NLM_term">S1PR</td><td class="NLM_def"><p class="first last">sphingosine-1-phosphate receptor subtype 1</p></td></tr><tr><td class="NLM_term">SphK</td><td class="NLM_def"><p class="first last">sphingosine kinase</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">Trk</td><td class="NLM_def"><p class="first last">tropomysin receptor kinase</p></td></tr><tr><td class="NLM_term">TRPV1</td><td class="NLM_def"><p class="first last">transient receptor potential vanilloid I</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50760" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50760" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 180 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Wolkerstorfer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handler, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buschmann, H.</span><span> </span><span class="NLM_article-title">New approaches to treating pain</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1103</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.12.103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.bmcl.2015.12.103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1103-1119&issue=4&author=A.+Wolkerstorferauthor=N.+Handlerauthor=H.+Buschmann&title=New+approaches+to+treating+pain&doi=10.1016%2Fj.bmcl.2015.12.103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.12.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.12.103%26sid%3Dliteratum%253Aachs%26aulast%3DWolkerstorfer%26aufirst%3DA.%26aulast%3DHandler%26aufirst%3DN.%26aulast%3DBuschmann%26aufirst%3DH.%26atitle%3DNew%2520approaches%2520to%2520treating%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D4%26spage%3D1103%26epage%3D1119%26doi%3D10.1016%2Fj.bmcl.2015.12.103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Wu, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raja, S. N.</span><span> </span><span class="NLM_article-title">Treatment of acute postoperative pain</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x"> (</span><span class="NLM_issue">9784</span><span class="NLM_x">) </span> <span class="NLM_fpage">2215</span><span class="NLM_x">–</span> <span class="NLM_lpage">2225</span><span class="refDoi"> DOI: 10.1016/S0140-6736(11)60245-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2FS0140-6736%2811%2960245-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2011&pages=2215-2225&issue=9784&author=C.+L.+Wuauthor=S.+N.+Raja&title=Treatment+of+acute+postoperative+pain&doi=10.1016%2FS0140-6736%2811%2960245-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2811%2960245-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252811%252960245-6%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BL.%26aulast%3DRaja%26aufirst%3DS.%2BN.%26atitle%3DTreatment%2520of%2520acute%2520postoperative%2520pain%26jtitle%3DLancet%26date%3D2011%26volume%3D377%26issue%3D9784%26spage%3D2215%26epage%3D2225%26doi%3D10.1016%2FS0140-6736%2811%2960245-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Barkin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barkin, D.</span><span> </span><span class="NLM_article-title">Pharmacologic management of acute and chronic pain: focus on drug interactions and patient-specific pharmacotherapeutic selection</span> <span class="citation_source-journal">South. Med. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">756</span><span class="NLM_x">–</span> <span class="NLM_lpage">770</span><span class="refDoi"> DOI: 10.1097/00007611-200108000-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1097%2F00007611-200108000-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=11549189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADC%252BD3MvpvFOksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2001&pages=756-770&issue=8&author=R.+L.+Barkinauthor=D.+Barkin&title=Pharmacologic+management+of+acute+and+chronic+pain%3A+focus+on+drug+interactions+and+patient-specific+pharmacotherapeutic+selection&doi=10.1097%2F00007611-200108000-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic management of acute and chronic pain: focus on drug interactions and patient-specific pharmacotherapeutic selection</span></div><div class="casAuthors">Barkin R L; Barkin D</div><div class="citationInfo"><span class="NLM_cas:title">Southern medical journal</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">756-70</span>
        ISSN:<span class="NLM_cas:issn">0038-4348</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7vc2U2qv_wmgRQsDqrjW_fW6udTcc2eYFcBCNyigqUrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MvpvFOksQ%253D%253D&md5=fd08ceb6c29f6678479b8bd7fb69d27d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2F00007611-200108000-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00007611-200108000-00003%26sid%3Dliteratum%253Aachs%26aulast%3DBarkin%26aufirst%3DR.%2BL.%26aulast%3DBarkin%26aufirst%3DD.%26atitle%3DPharmacologic%2520management%2520of%2520acute%2520and%2520chronic%2520pain%253A%2520focus%2520on%2520drug%2520interactions%2520and%2520patient-specific%2520pharmacotherapeutic%2520selection%26jtitle%3DSouth.%2520Med.%2520J.%26date%3D2001%26volume%3D94%26issue%3D8%26spage%3D756%26epage%3D770%26doi%3D10.1097%2F00007611-200108000-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Kuner, R.</span><span> </span><span class="NLM_article-title">Central mechanisms of pathological pain</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1258</span><span class="NLM_x">–</span> <span class="NLM_lpage">1266</span><span class="refDoi"> DOI: 10.1038/nm.2231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnm.2231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=20948531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1yrs7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=1258-1266&issue=11&author=R.+Kuner&title=Central+mechanisms+of+pathological+pain&doi=10.1038%2Fnm.2231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Central mechanisms of pathological pain</span></div><div class="casAuthors">Kuner, Rohini</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1258-1266</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chronic pain is a major challenge to clin. practice and basic science.  The peripheral and central neural networks that mediate nociception show extensive plasticity in pathol. disease states.  Disease-induced plasticity can occur at both structural and functional levels and is manifest as changes in individual mols., synapses, cellular function and network activity.  Recent work has yielded a better understanding of communication within the neural matrix of physiol. pain and has also brought important advances in concepts of injury-induced hyperalgesia and tactile allodynia and how these might contribute to the complex, multidimensional state of chronic pain.  This review focuses on the mol. determinants of network plasticity in the central nervous system (CNS) and discusses their relevance to the development of new therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL6m9PZhXyPbVg90H21EOLACvtfcHk0lgqOWjgKUOWHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1yrs7vJ&md5=5ab1f2a13d957c8d5cfe10ff596c7ba2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnm.2231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2231%26sid%3Dliteratum%253Aachs%26aulast%3DKuner%26aufirst%3DR.%26atitle%3DCentral%2520mechanisms%2520of%2520pathological%2520pain%26jtitle%3DNat.%2520Med.%26date%3D2010%26volume%3D16%26issue%3D11%26spage%3D1258%26epage%3D1266%26doi%3D10.1038%2Fnm.2231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Neumann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doubell, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, C. J.</span><span> </span><span class="NLM_article-title">Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">384</span><span class="NLM_x"> (</span><span class="NLM_issue">6607</span><span class="NLM_x">) </span> <span class="NLM_fpage">360</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1038/384360a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2F384360a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=1996&pages=360-364&issue=6607&author=S.+Neumannauthor=T.+P.+Doubellauthor=T.+Leslieauthor=C.+J.+Woolf&title=Inflammatory+pain+hypersensitivity+mediated+by+phenotypic+switch+in+myelinated+primary+sensory+neurons&doi=10.1038%2F384360a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F384360a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F384360a0%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DS.%26aulast%3DDoubell%26aufirst%3DT.%2BP.%26aulast%3DLeslie%26aufirst%3DT.%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26atitle%3DInflammatory%2520pain%2520hypersensitivity%2520mediated%2520by%2520phenotypic%2520switch%2520in%2520myelinated%2520primary%2520sensory%2520neurons%26jtitle%3DNature%26date%3D1996%26volume%3D384%26issue%3D6607%26spage%3D360%26epage%3D364%26doi%3D10.1038%2F384360a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Turk, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahana, A.</span><span> </span><span class="NLM_article-title">Treatment of chronic non-cancer pain</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x"> (</span><span class="NLM_issue">9784</span><span class="NLM_x">) </span> <span class="NLM_fpage">2226</span><span class="NLM_x">–</span> <span class="NLM_lpage">2235</span><span class="refDoi"> DOI: 10.1016/S0140-6736(11)60402-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2FS0140-6736%2811%2960402-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2011&pages=2226-2235&issue=9784&author=D.+C.+Turkauthor=H.+D.+Wilsonauthor=A.+Cahana&title=Treatment+of+chronic+non-cancer+pain&doi=10.1016%2FS0140-6736%2811%2960402-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2811%2960402-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252811%252960402-9%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DD.%2BC.%26aulast%3DWilson%26aufirst%3DH.%2BD.%26aulast%3DCahana%26aufirst%3DA.%26atitle%3DTreatment%2520of%2520chronic%2520non-cancer%2520pain%26jtitle%3DLancet%26date%3D2011%26volume%3D377%26issue%3D9784%26spage%3D2226%26epage%3D2235%26doi%3D10.1016%2FS0140-6736%2811%2960402-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Moore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccleston, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalso, E.</span><span> </span><span class="NLM_article-title">Expect analgesic failure; pursue analgesic success</span> <span class="citation_source-journal">BMJ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">f2690</span><span class="refDoi"> DOI: 10.1136/bmj.f2690</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1136%2Fbmj.f2690" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2013&pages=f2690&author=A.+Mooreauthor=S.+Derryauthor=C.+Ecclestonauthor=E.+Kalso&title=Expect+analgesic+failure%3B+pursue+analgesic+success&doi=10.1136%2Fbmj.f2690"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1136%2Fbmj.f2690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.f2690%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DDerry%26aufirst%3DS.%26aulast%3DEccleston%26aufirst%3DC.%26aulast%3DKalso%26aufirst%3DE.%26atitle%3DExpect%2520analgesic%2520failure%253B%2520pursue%2520analgesic%2520success%26jtitle%3DBMJ.%26date%3D2013%26volume%3D346%26spage%3Df2690%26doi%3D10.1136%2Fbmj.f2690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Whiteside, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adedoyin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leventhal, L.</span><span> </span><span class="NLM_article-title">Predictive validity of animal pain models? A comparison of the pharmacokinetic-pharmacodynamic relationship for pain drugs in rats and humans</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">775</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2008.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.neuropharm.2008.01.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2008&pages=767-775&issue=5&author=G.+T.+Whitesideauthor=A.+Adedoyinauthor=L.+Leventhal&title=Predictive+validity+of+animal+pain+models%3F+A+comparison+of+the+pharmacokinetic-pharmacodynamic+relationship+for+pain+drugs+in+rats+and+humans&doi=10.1016%2Fj.neuropharm.2008.01.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DWhiteside%26aufirst%3DG.%2BT.%26aulast%3DAdedoyin%26aufirst%3DA.%26aulast%3DLeventhal%26aufirst%3DL.%26atitle%3DPredictive%2520validity%2520of%2520animal%2520pain%2520models%253F%2520A%2520comparison%2520of%2520the%2520pharmacokinetic-pharmacodynamic%2520relationship%2520for%2520pain%2520drugs%2520in%2520rats%2520and%2520humans%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D54%26issue%3D5%26spage%3D767%26epage%3D775%26doi%3D10.1016%2Fj.neuropharm.2008.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Vanderah, T. W.</span><span> </span><span class="NLM_article-title">Pathophysiology of pain</span> <span class="citation_source-journal">Med. Clin. North Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1016/j.mcna.2006.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.mcna.2006.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=17164100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADC%252BD28jis1CrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2007&pages=1-12&issue=1&author=T.+W.+Vanderah&title=Pathophysiology+of+pain&doi=10.1016%2Fj.mcna.2006.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Pathophysiology of pain</span></div><div class="casAuthors">Vanderah Todd W</div><div class="citationInfo"><span class="NLM_cas:title">The Medical clinics of North America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>
        ISSN:<span class="NLM_cas:issn">0025-7125</span>.
    </div><div class="casAbstract">The processing and interpretation of pain signals is a complex process that entails excitation of peripheral nerves, local interactions within the spinal dorsal horn, and the activation of ascending and descending circuits that comprise a loop from the spinal cord to supraspinal structures and finally exciting nociceptive inputs at the spinal level.  Although the "circuits" described here appear to be part of normal pain processing, the system demonstrates a remarkable ability to undergo neuroplastic transformations when nociceptive inputs are extended over time, and such adaptations function as a pronociceptive positive feedback loop.  Manipulations directed to disrupt any of the nodes of this pain facilitatory loop may effectively disrupt the maintenance of the sensitized pain state and diminish or abolish neuropathic pain.  Understanding the ascending and descending pain facilitatory circuits may provide for the design of rational therapies that do not interfere with normal sensory processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2WlrXRgm5ODDnmmyUf5qOfW6udTcc2eZe5TnaD0HX_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jis1CrsQ%253D%253D&md5=b1c1ee6f2fc3564bd7546aa230a31fe1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.mcna.2006.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcna.2006.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26atitle%3DPathophysiology%2520of%2520pain%26jtitle%3DMed.%2520Clin.%2520North%2520Am.%26date%3D2007%26volume%3D91%26issue%3D1%26spage%3D1%26epage%3D12%26doi%3D10.1016%2Fj.mcna.2006.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Watson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawbarn, D.</span><span> </span><span class="NLM_article-title">Targeting nerve growth factor in pain: what is the therapeutic potential?</span> <span class="citation_source-journal">BioDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span><span class="refDoi"> DOI: 10.2165/0063030-200822060-00002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.2165%2F0063030-200822060-00002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=349-359&issue=6&author=J.+J.+Watsonauthor=S.+J.+Allenauthor=D.+Dawbarn&title=Targeting+nerve+growth+factor+in+pain%3A+what+is+the+therapeutic+potential%3F&doi=10.2165%2F0063030-200822060-00002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2165%2F0063030-200822060-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F0063030-200822060-00002%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DJ.%2BJ.%26aulast%3DAllen%26aufirst%3DS.%2BJ.%26aulast%3DDawbarn%26aufirst%3DD.%26atitle%3DTargeting%2520nerve%2520growth%2520factor%2520in%2520pain%253A%2520what%2520is%2520the%2520therapeutic%2520potential%253F%26jtitle%3DBioDrugs%26date%3D2008%26volume%3D22%26issue%3D6%26spage%3D349%26epage%3D359%26doi%3D10.2165%2F0063030-200822060-00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Aloe, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocco, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manni, L.</span><span> </span><span class="NLM_article-title">Nerve growth factor: from the early discoveries to the potential clinical use</span> <span class="citation_source-journal">J. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="refDoi"> DOI: 10.1186/1479-5876-10-239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1186%2F1479-5876-10-239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23190582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVygu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=239&author=L.+Aloeauthor=M.+L.+Roccoauthor=P.+Bianchiauthor=L.+Manni&title=Nerve+growth+factor%3A+from+the+early+discoveries+to+the+potential+clinical+use&doi=10.1186%2F1479-5876-10-239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Nerve growth factor: from the early discoveries to the potential clinical use</span></div><div class="casAuthors">Aloe, Luigi; Rocco, Maria Luisa; Bianchi, Patrizia; Manni, Luigi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Translational Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">239</span>CODEN:
                <span class="NLM_cas:coden">JTMOBV</span>;
        ISSN:<span class="NLM_cas:issn">1479-5876</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  The physiol. role of the neurotrophin nerve growth factor (NGF) has been characterized, since its discovery in the 1950s, first in the sensory and autonomic nervous system, then in central nervous, endocrine and immune systems.  NGF plays its trophic role both during development and in adulthood, ensuring the maintenance of phenotypic and functional characteristic of several populations of neurons as well as immune cells.  From a translational standpoint, the action of NGF on cholinergic neurons of the basal forebrain and on sensory neurons in dorsal root ganglia first gained researcher's attention, in view of possible clin. use in Alzheimer's disease patients and in peripheral neuropathies resp.  The translational and clin. research on NGF have, since then, enlarged the spectrum of diseases that could benefit from NGF treatment, at the same time highlighting possible limitations in the use of the neurotrophin as a drug.  In this review we give a comprehensive account for almost all of the clin. trials attempted until now by using NGF.  A perspective on future development for translational research on NGF is also discussed, in view of recent proposals for innovative delivery strategies and/or for addnl. pathologies to be treated, such as ocular and skin diseases, gliomas, traumatic brain injuries, vascular and immune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDpiSAKFf3brVg90H21EOLACvtfcHk0lgQmVy4Bl37tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVygu7s%253D&md5=0f77c7c760a53f4e8268ba9d6ea7a769</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1186%2F1479-5876-10-239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-5876-10-239%26sid%3Dliteratum%253Aachs%26aulast%3DAloe%26aufirst%3DL.%26aulast%3DRocco%26aufirst%3DM.%2BL.%26aulast%3DBianchi%26aufirst%3DP.%26aulast%3DManni%26aufirst%3DL.%26atitle%3DNerve%2520growth%2520factor%253A%2520from%2520the%2520early%2520discoveries%2520to%2520the%2520potential%2520clinical%2520use%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2012%26volume%3D10%26spage%3D239%26doi%3D10.1186%2F1479-5876-10-239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bannwarth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostine, M.</span><span> </span><span class="NLM_article-title">Targeting nerve growth factor (NGF) for pain management: what does the future hold for NGF antagonists?</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">619</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span><span class="refDoi"> DOI: 10.1007/s40265-014-0208-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1007%2Fs40265-014-0208-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=619-626&issue=6&author=B.+Bannwarthauthor=M.+Kostine&title=Targeting+nerve+growth+factor+%28NGF%29+for+pain+management%3A+what+does+the+future+hold+for+NGF+antagonists%3F&doi=10.1007%2Fs40265-014-0208-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs40265-014-0208-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-014-0208-6%26sid%3Dliteratum%253Aachs%26aulast%3DBannwarth%26aufirst%3DB.%26aulast%3DKostine%26aufirst%3DM.%26atitle%3DTargeting%2520nerve%2520growth%2520factor%2520%2528NGF%2529%2520for%2520pain%2520management%253A%2520what%2520does%2520the%2520future%2520hold%2520for%2520NGF%2520antagonists%253F%26jtitle%3DDrugs%26date%3D2014%26volume%3D74%26issue%3D6%26spage%3D619%26epage%3D626%26doi%3D10.1007%2Fs40265-014-0208-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Ribatti, D.</span><span> </span><span class="NLM_article-title">The failed attribution of the Nobel Prize for Medicine or Physiology to Viktor Hamburger for the discovery of nerve growth factor</span> <span class="citation_source-journal">Brain Res. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="refDoi"> DOI: 10.1016/j.brainresbull.2016.02.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.brainresbull.2016.02.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=26930162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1Ghu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2016&pages=306&author=D.+Ribatti&title=The+failed+attribution+of+the+Nobel+Prize+for+Medicine+or+Physiology+to+Viktor+Hamburger+for+the+discovery+of+nerve+growth+factor&doi=10.1016%2Fj.brainresbull.2016.02.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The failed attribution of the Nobel Prize for Medicine or Physiology to Viktor Hamburger for the discovery of Nerve Growth Factor</span></div><div class="casAuthors">Ribatti, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">306-309</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The announcement in Oct. 1986 that the Nobel Prize for Physiol. or Medicine was to awarded to Rita Levi Montalcini and Stanley Cohen for the discovery of nerve growth factor (NGF) and epidermal growth factor, resp., caused many to wonder why Viktor Hamburger in whose lab. the initial work was done had not been included in the award.  This article try to reconstruct the history of the discovery of NGF with the aim to re-establish a correct dynamic of the events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGqu8dstVhcLVg90H21EOLACvtfcHk0lgQmVy4Bl37tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1Ghu7w%253D&md5=c30d7ddaf3262e46675da5870a3cc18a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresbull.2016.02.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresbull.2016.02.019%26sid%3Dliteratum%253Aachs%26aulast%3DRibatti%26aufirst%3DD.%26atitle%3DThe%2520failed%2520attribution%2520of%2520the%2520Nobel%2520Prize%2520for%2520Medicine%2520or%2520Physiology%2520to%2520Viktor%2520Hamburger%2520for%2520the%2520discovery%2520of%2520nerve%2520growth%2520factor%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2016%26volume%3D124%26spage%3D306%26doi%3D10.1016%2Fj.brainresbull.2016.02.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Cohen, S.</span><span> </span><span class="NLM_article-title">Purification of a nerve-growth promoting protein from the mouse salivary gland and its neuro-cytotoxic antiserum</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span><span class="refDoi"> DOI: 10.1073/pnas.46.3.302</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1073%2Fpnas.46.3.302" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1960&pages=302-311&issue=3&author=S.+Cohen&title=Purification+of+a+nerve-growth+promoting+protein+from+the+mouse+salivary+gland+and+its+neuro-cytotoxic+antiserum&doi=10.1073%2Fpnas.46.3.302"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.46.3.302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.46.3.302%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DS.%26atitle%3DPurification%2520of%2520a%2520nerve-growth%2520promoting%2520protein%2520from%2520the%2520mouse%2520salivary%2520gland%2520and%2520its%2520neuro-cytotoxic%2520antiserum%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1960%26volume%3D46%26issue%3D3%26spage%3D302%26epage%3D311%26doi%3D10.1073%2Fpnas.46.3.302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Levi-Montalcini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booker, B.</span><span> </span><span class="NLM_article-title">Excessive growth of the sympathetic ganglia evoked by a protein isolated from mouse salivary glands</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span><span class="refDoi"> DOI: 10.1073/pnas.46.3.373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1073%2Fpnas.46.3.373" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1960&pages=373-384&issue=3&author=R.+Levi-Montalciniauthor=B.+Booker&title=Excessive+growth+of+the+sympathetic+ganglia+evoked+by+a+protein+isolated+from+mouse+salivary+glands&doi=10.1073%2Fpnas.46.3.373"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.46.3.373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.46.3.373%26sid%3Dliteratum%253Aachs%26aulast%3DLevi-Montalcini%26aufirst%3DR.%26aulast%3DBooker%26aufirst%3DB.%26atitle%3DExcessive%2520growth%2520of%2520the%2520sympathetic%2520ganglia%2520evoked%2520by%2520a%2520protein%2520isolated%2520from%2520mouse%2520salivary%2520glands%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1960%26volume%3D46%26issue%3D3%26spage%3D373%26epage%3D384%26doi%3D10.1073%2Fpnas.46.3.373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Levi-Montalcini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booker, B.</span><span> </span><span class="NLM_article-title">Destruction of the sympathetic ganglia in mammals by an antiserum to a nerve-growth protein</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span><span class="refDoi"> DOI: 10.1073/pnas.46.3.384</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1073%2Fpnas.46.3.384" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1960&pages=384-391&issue=3&author=R.+Levi-Montalciniauthor=B.+Booker&title=Destruction+of+the+sympathetic+ganglia+in+mammals+by+an+antiserum+to+a+nerve-growth+protein&doi=10.1073%2Fpnas.46.3.384"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.46.3.384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.46.3.384%26sid%3Dliteratum%253Aachs%26aulast%3DLevi-Montalcini%26aufirst%3DR.%26aulast%3DBooker%26aufirst%3DB.%26atitle%3DDestruction%2520of%2520the%2520sympathetic%2520ganglia%2520in%2520mammals%2520by%2520an%2520antiserum%2520to%2520a%2520nerve-growth%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1960%26volume%3D46%26issue%3D3%26spage%3D384%26epage%3D391%26doi%3D10.1073%2Fpnas.46.3.384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Gotz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raulf, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lottspeich, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schartl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoenen, H.</span><span> </span><span class="NLM_article-title">Neurotrophin-6 is a new member of the nerve growth factor family</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x"> (</span><span class="NLM_issue">6503</span><span class="NLM_x">) </span> <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1038/372266a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2F372266a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=1994&pages=266-269&issue=6503&author=R.+Gotzauthor=R.+Kosterauthor=C.+Winklerauthor=F.+Raulfauthor=F.+Lottspeichauthor=M.+Schartlauthor=H.+Thoenen&title=Neurotrophin-6+is+a+new+member+of+the+nerve+growth+factor+family&doi=10.1038%2F372266a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2F372266a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F372266a0%26sid%3Dliteratum%253Aachs%26aulast%3DGotz%26aufirst%3DR.%26aulast%3DKoster%26aufirst%3DR.%26aulast%3DWinkler%26aufirst%3DC.%26aulast%3DRaulf%26aufirst%3DF.%26aulast%3DLottspeich%26aufirst%3DF.%26aulast%3DSchartl%26aufirst%3DM.%26aulast%3DThoenen%26aufirst%3DH.%26atitle%3DNeurotrophin-6%2520is%2520a%2520new%2520member%2520of%2520the%2520nerve%2520growth%2520factor%2520family%26jtitle%3DNature%26date%3D1994%26volume%3D372%26issue%3D6503%26spage%3D266%26epage%3D269%26doi%3D10.1038%2F372266a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Robinson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. F.</span><span> </span><span class="NLM_article-title">The protein tyrosine kinase family of the human genome</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">49</span><span class="NLM_x">) </span> <span class="NLM_fpage">5548</span><span class="NLM_x">–</span> <span class="NLM_lpage">5557</span><span class="refDoi"> DOI: 10.1038/sj.onc.1203957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fsj.onc.1203957" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=5548-5557&issue=49&author=D.+R.+Robinsonauthor=Y.+M.+Wuauthor=S.+F.+Lin&title=The+protein+tyrosine+kinase+family+of+the+human+genome&doi=10.1038%2Fsj.onc.1203957"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1203957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1203957%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DD.%2BR.%26aulast%3DWu%26aufirst%3DY.%2BM.%26aulast%3DLin%26aufirst%3DS.%2BF.%26atitle%3DThe%2520protein%2520tyrosine%2520kinase%2520family%2520of%2520the%2520human%2520genome%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26issue%3D49%26spage%3D5548%26epage%3D5557%26doi%3D10.1038%2Fsj.onc.1203957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Longo, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massa, S. M.</span><span> </span><span class="NLM_article-title">Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span><span class="refDoi"> DOI: 10.1038/nrd4024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnrd4024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=507-525&issue=7&author=F.+M.+Longoauthor=S.+M.+Massa&title=Small-molecule+modulation+of+neurotrophin+receptors%3A+a+strategy+for+the+treatment+of+neurological+disease&doi=10.1038%2Fnrd4024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrd4024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4024%26sid%3Dliteratum%253Aachs%26aulast%3DLongo%26aufirst%3DF.%2BM.%26aulast%3DMassa%26aufirst%3DS.%2BM.%26atitle%3DSmall-molecule%2520modulation%2520of%2520neurotrophin%2520receptors%253A%2520a%2520strategy%2520for%2520the%2520treatment%2520of%2520neurological%2520disease%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26issue%3D7%26spage%3D507%26epage%3D525%26doi%3D10.1038%2Fnrd4024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Huang, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichardt, L. F.</span><span> </span><span class="NLM_article-title">TRK receptors: roles in neuronal signal transduction</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">642</span><span class="refDoi"> DOI: 10.1146/annurev.biochem.72.121801.161629</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1146%2Fannurev.biochem.72.121801.161629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=12676795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntFSgtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2003&pages=609-642&author=E.+J.+Huangauthor=L.+F.+Reichardt&title=TRK+receptors%3A+roles+in+neuronal+signal+transduction&doi=10.1146%2Fannurev.biochem.72.121801.161629"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Trk receptors: roles in neuronal signal transduction</span></div><div class="casAuthors">Huang, Eric J.; Reichardt, Louis F.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">609-642</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Trk receptors are a family of 3 receptor tyrosine kinases, each of which can be activated by ≥1 of 4 neurotrophins-nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophins 3 and 4 (NT3 and NT4).  Neurotrophin signaling through these receptors regulates cell survival, proliferation, the fate of neural precursors, axon and dendrite growth and patterning, and the expression and activity of functionally important proteins, such as ion channels and neurotransmitter receptors.  In the adult nervous system, the Trk receptors regulate synaptic strength and plasticity.  The cytoplasmic domains of Trk receptors contain several sites of tyrosine phosphorylation that recruit intermediates in intracellular signaling cascades.  As a result, Trk receptor signaling activates several small G proteins, including Ras, Rap-1, and the Cdc-42-Rac-Rho family, as well as pathways regulated by MAP kinase, PI 3-kinase and phospholipase-C-γ (PLC-γ).  Trk receptor activation has different consequences in different cells, and the specificity of downstream Trk receptor-mediated signaling is controlled through expression of intermediates in these signaling pathways and membrane trafficking that regulates localization of different signaling constituents.  Perhaps the most fascinating aspect of Trk receptor-mediated signaling is its interplay with signaling promoted by the pan-neurotrophin receptor p75NTR.  P75NTR activates a distinct set of signaling pathways within cells that are in some instances synergistic and in other instances antagonistic to those activated by Trk receptors.  Several of these are proapoptotic but are suppressed by Trk receptor-initiated signaling.  P75NTR also influences the conformations of Trk receptors; this modifies ligand-binding specificity and affinity with important developmental consequences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooH3Pdvfi72LVg90H21EOLACvtfcHk0ljz3lJMNnK6bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntFSgtbo%253D&md5=939bf60802da0a203c2e0d8585e28dd9</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.72.121801.161629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.72.121801.161629%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DE.%2BJ.%26aulast%3DReichardt%26aufirst%3DL.%2BF.%26atitle%3DTRK%2520receptors%253A%2520roles%2520in%2520neuronal%2520signal%2520transduction%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2003%26volume%3D72%26spage%3D609%26epage%3D642%26doi%3D10.1146%2Fannurev.biochem.72.121801.161629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Vaegter, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fjorback, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glerup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skeldal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kjolby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyengaard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessarollo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewin, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willnow, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nykjaer, A.</span><span> </span><span class="NLM_article-title">Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span><span class="refDoi"> DOI: 10.1038/nn.2689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnn.2689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=21102451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGhsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=54-61&issue=1&author=C.+B.+Vaegterauthor=P.+Jansenauthor=A.+W.+Fjorbackauthor=S.+Glerupauthor=S.+Skeldalauthor=M.+Kjolbyauthor=M.+Richnerauthor=B.+Erdmannauthor=J.+R.+Nyengaardauthor=L.+Tessarolloauthor=G.+R.+Lewinauthor=T.+E.+Willnowauthor=M.+V.+Chaoauthor=A.+Nykjaer&title=Sortilin+associates+with+Trk+receptors+to+enhance+anterograde+transport+and+neurotrophin+signaling&doi=10.1038%2Fnn.2689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling</span></div><div class="casAuthors">Vaegter, Christian B.; Jansen, Pernille; Fjorback, Anja W.; Glerup, Simon; Skeldal, Sune; Kjolby, Mads; Richner, Mette; Erdmann, Bettina; Nyengaard, Jens R.; Tessarollo, Lino; Lewin, Gary R.; Willnow, Thomas E.; Chao, Moses V.; Nykjaer, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-61</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Binding of target-derived neurotrophins to Trk receptors at nerve terminals is required to stimulate neuronal survival, differentiation, innervation and synaptic plasticity.  The distance between the soma and nerve terminal is great, making efficient anterograde Trk transport crit. for Trk synaptic translocation and signaling.  The mechanism responsible for this trafficking remains poorly understood.  Here we show that the sorting receptor sortilin interacts with TrkA, TrkB and TrkC and enables their anterograde axonal transport, thereby enhancing neurotrophin signaling.  Cultured DRG neurons lacking sortilin showed blunted MAP kinase signaling and reduced neurite outgrowth upon stimulation with NGF.  Moreover, deficiency for sortilin markedly aggravated TrkA, TrkB and TrkC phenotypes present in p75NTR knockouts, and resulted in increased embryonic lethality and sympathetic neuropathy in mice heterozygous for TrkA.  Our findings demonstrate a role for sortilin as an anterograde trafficking receptor for Trk and a pos. modulator of neurotrophin-induced neuronal survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZIPWyylrZS7Vg90H21EOLACvtfcHk0lj725iGymfQyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGhsrrO&md5=e1ca0f312adee49bc431849d7f2a4b59</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnn.2689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2689%26sid%3Dliteratum%253Aachs%26aulast%3DVaegter%26aufirst%3DC.%2BB.%26aulast%3DJansen%26aufirst%3DP.%26aulast%3DFjorback%26aufirst%3DA.%2BW.%26aulast%3DGlerup%26aufirst%3DS.%26aulast%3DSkeldal%26aufirst%3DS.%26aulast%3DKjolby%26aufirst%3DM.%26aulast%3DRichner%26aufirst%3DM.%26aulast%3DErdmann%26aufirst%3DB.%26aulast%3DNyengaard%26aufirst%3DJ.%2BR.%26aulast%3DTessarollo%26aufirst%3DL.%26aulast%3DLewin%26aufirst%3DG.%2BR.%26aulast%3DWillnow%26aufirst%3DT.%2BE.%26aulast%3DChao%26aufirst%3DM.%2BV.%26aulast%3DNykjaer%26aufirst%3DA.%26atitle%3DSortilin%2520associates%2520with%2520Trk%2520receptors%2520to%2520enhance%2520anterograde%2520transport%2520and%2520neurotrophin%2520signaling%26jtitle%3DNat.%2520Neurosci.%26date%3D2011%26volume%3D14%26issue%3D1%26spage%3D54%26epage%3D61%26doi%3D10.1038%2Fnn.2689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Nykjaer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kliemannel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willnow, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hempstead, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, C. M.</span><span> </span><span class="NLM_article-title">Sortilin is essential for proNGF-induced neuronal cell death</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">427</span><span class="NLM_x"> (</span><span class="NLM_issue">6977</span><span class="NLM_x">) </span> <span class="NLM_fpage">843</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span><span class="refDoi"> DOI: 10.1038/nature02319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnature02319" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2004&pages=843-848&issue=6977&author=A.+Nykjaerauthor=R.+Leeauthor=K.+K.+Tengauthor=P.+Jansenauthor=P.+Madsenauthor=M.+S.+Nielsenauthor=C.+Jacobsenauthor=M.+Kliemannelauthor=E.+Schwarzauthor=T.+E.+Willnowauthor=B.+L.+Hempsteadauthor=C.+M.+Petersen&title=Sortilin+is+essential+for+proNGF-induced+neuronal+cell+death&doi=10.1038%2Fnature02319"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnature02319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02319%26sid%3Dliteratum%253Aachs%26aulast%3DNykjaer%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DR.%26aulast%3DTeng%26aufirst%3DK.%2BK.%26aulast%3DJansen%26aufirst%3DP.%26aulast%3DMadsen%26aufirst%3DP.%26aulast%3DNielsen%26aufirst%3DM.%2BS.%26aulast%3DJacobsen%26aufirst%3DC.%26aulast%3DKliemannel%26aufirst%3DM.%26aulast%3DSchwarz%26aufirst%3DE.%26aulast%3DWillnow%26aufirst%3DT.%2BE.%26aulast%3DHempstead%26aufirst%3DB.%2BL.%26aulast%3DPetersen%26aufirst%3DC.%2BM.%26atitle%3DSortilin%2520is%2520essential%2520for%2520proNGF-induced%2520neuronal%2520cell%2520death%26jtitle%3DNature%26date%3D2004%26volume%3D427%26issue%3D6977%26spage%3D843%26epage%3D848%26doi%3D10.1038%2Fnature02319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Shooter, E. M.</span><span> </span><span class="NLM_article-title">Early days of the nerve growth factor proteins</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">629</span><span class="refDoi"> DOI: 10.1146/annurev.neuro.24.1.601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1146%2Fannurev.neuro.24.1.601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=11283322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD3MXls1Shs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2001&pages=601-629&author=E.+M.+Shooter&title=Early+days+of+the+nerve+growth+factor+proteins&doi=10.1146%2Fannurev.neuro.24.1.601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Early days of the nerve growth factor proteins</span></div><div class="casAuthors">Shooter, Eric M.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">601-629</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 131 refs.  Adult male mouse submaxillary glands served as the preferred starting material for the isolation of the nerve growth factor (NGF) proteins in most of the isolation studies done.  Two types of NGF proteins were isolated from exts. of the gland, a high-mol.-wt. 7S NGF complex and a low-mol.-wt. protein variously called NGF, βNGF, or 2.5S NGF.  The latter, which mediated all known biol. functions of NGF, were closely related forms of a basic NGF dimer in which the N and C termini of two monomers (chains) were modified by proteolytic enzymes to different extents with no effect on biol. activity.  The βNGF dimer showed a novel protein structure in which the two chains interacted non-covalently over a wide surface.  Correspondingly, the βNGF dimer was found to be unusually stable and the form through which NGFs actions were mediated at physiol. concns.  The βNGF dimer was one of three subunits in 7S NGF; the other two were the γ subunit, an arginine esteropeptidase or kallikrein, and the α subunit, an inactive kallikrein.  Two zinc ions were also present in the complex and contributed greatly to its stability.  There was much debate about whether 7S NGF was a specific protein complex of interacting subunits and, if so, what functions it might play in the biol. of NGF.  Observations of the inhibition of the enzyme activity of the γ subunit and of the biol. activity of βNGF in 7S NGF were important in detg. that 7S NGF was a naturally occurring complex and the sole source of NGF in the gland ext. or in saliva.  Specific interactions between the active site of the γ subunit and the C-terminal arginine residues of the NGF chains, confirmed in the three-dimensional structure of 7S NGF, suggested a role for the γ subunit in pro-NGF processing during the assembly of 7S NGF.  In spite of the detailed knowledge of 7S NGF structure, no information on the role of this complex in the neurobiol. of NGF has emerged.  With the exception of the submaxillary gland of an African rodent, no other source of NGF has been convincingly shown to synthesize the α and γ subunits, and they may well be irrelevant to NGFs actions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGid60QKZVx7Vg90H21EOLACvtfcHk0lj725iGymfQyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXls1Shs7k%253D&md5=d3d5b31b8aef548d95069ebd6c9ee27e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.24.1.601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.24.1.601%26sid%3Dliteratum%253Aachs%26aulast%3DShooter%26aufirst%3DE.%2BM.%26atitle%3DEarly%2520days%2520of%2520the%2520nerve%2520growth%2520factor%2520proteins%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2001%26volume%3D24%26spage%3D601%26epage%3D629%26doi%3D10.1146%2Fannurev.neuro.24.1.601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Lee, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kermani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hempstead, B. L.</span><span> </span><span class="NLM_article-title">Regulation of cell survival by secreted proneurotrophins</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x"> (</span><span class="NLM_issue">5548</span><span class="NLM_x">) </span> <span class="NLM_fpage">1945</span><span class="NLM_x">–</span> <span class="NLM_lpage">1948</span><span class="refDoi"> DOI: 10.1126/science.1065057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1126%2Fscience.1065057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2001&pages=1945-1948&issue=5548&author=R.+Leeauthor=P.+Kermaniauthor=K.+K.+Tengauthor=B.+L.+Hempstead&title=Regulation+of+cell+survival+by+secreted+proneurotrophins&doi=10.1126%2Fscience.1065057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1126%2Fscience.1065057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1065057%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DR.%26aulast%3DKermani%26aufirst%3DP.%26aulast%3DTeng%26aufirst%3DK.%2BK.%26aulast%3DHempstead%26aufirst%3DB.%2BL.%26atitle%3DRegulation%2520of%2520cell%2520survival%2520by%2520secreted%2520proneurotrophins%26jtitle%3DScience%26date%3D2001%26volume%3D294%26issue%3D5548%26spage%3D1945%26epage%3D1948%26doi%3D10.1126%2Fscience.1065057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Levi-Montalcini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaper, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Toso, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, A.</span><span> </span><span class="NLM_article-title">Nerve growth factor: from neurotrophin to neurokine</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">514</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span><span class="refDoi"> DOI: 10.1016/S0166-2236(96)10058-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2FS0166-2236%2896%2910058-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1996&pages=514-520&issue=11&author=R.+Levi-Montalciniauthor=S.+D.+Skaperauthor=R.+Dal+Tosoauthor=L.+Petrelliauthor=A.+Leon&title=Nerve+growth+factor%3A+from+neurotrophin+to+neurokine&doi=10.1016%2FS0166-2236%2896%2910058-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0166-2236%2896%2910058-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-2236%252896%252910058-8%26sid%3Dliteratum%253Aachs%26aulast%3DLevi-Montalcini%26aufirst%3DR.%26aulast%3DSkaper%26aufirst%3DS.%2BD.%26aulast%3DDal%2BToso%26aufirst%3DR.%26aulast%3DPetrelli%26aufirst%3DL.%26aulast%3DLeon%26aufirst%3DA.%26atitle%3DNerve%2520growth%2520factor%253A%2520from%2520neurotrophin%2520to%2520neurokine%26jtitle%3DTrends%2520Neurosci.%26date%3D1996%26volume%3D19%26issue%3D11%26spage%3D514%26epage%3D520%26doi%3D10.1016%2FS0166-2236%2896%2910058-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Asaumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asahara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takigawa, M.</span><span> </span><span class="NLM_article-title">Expression of neurotrophins and their receptors (TRK) during fracture healing</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">633</span><span class="refDoi"> DOI: 10.1016/S8756-3282(00)00281-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2FS8756-3282%2800%2900281-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2000&pages=625-633&issue=6&author=K.+Asaumiauthor=T.+Nakanishiauthor=H.+Asaharaauthor=H.+Inoueauthor=M.+Takigawa&title=Expression+of+neurotrophins+and+their+receptors+%28TRK%29+during+fracture+healing&doi=10.1016%2FS8756-3282%2800%2900281-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS8756-3282%2800%2900281-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS8756-3282%252800%252900281-7%26sid%3Dliteratum%253Aachs%26aulast%3DAsaumi%26aufirst%3DK.%26aulast%3DNakanishi%26aufirst%3DT.%26aulast%3DAsahara%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DH.%26aulast%3DTakigawa%26aufirst%3DM.%26atitle%3DExpression%2520of%2520neurotrophins%2520and%2520their%2520receptors%2520%2528TRK%2529%2520during%2520fracture%2520healing%26jtitle%3DBone%26date%3D2000%26volume%3D26%26issue%3D6%26spage%3D625%26epage%3D633%26doi%3D10.1016%2FS8756-3282%2800%2900281-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Vidaltamayo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mery, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles-Angeles, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robles-Diaz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiriart, M.</span><span> </span><span class="NLM_article-title">Expression of nerve growth factor in human pancreatic beta cells</span> <span class="citation_source-journal">Growth Factors</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">3–4</span><span class="NLM_x">) </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1080/08977190310001629566</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1080%2F08977190310001629566" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=103-107&issue=3%E2%80%934&author=R.+Vidaltamayoauthor=C.+M.+Meryauthor=A.+Angeles-Angelesauthor=G.+Robles-Diazauthor=M.+Hiriart&title=Expression+of+nerve+growth+factor+in+human+pancreatic+beta+cells&doi=10.1080%2F08977190310001629566"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1080%2F08977190310001629566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F08977190310001629566%26sid%3Dliteratum%253Aachs%26aulast%3DVidaltamayo%26aufirst%3DR.%26aulast%3DMery%26aufirst%3DC.%2BM.%26aulast%3DAngeles-Angeles%26aufirst%3DA.%26aulast%3DRobles-Diaz%26aufirst%3DG.%26aulast%3DHiriart%26aufirst%3DM.%26atitle%3DExpression%2520of%2520nerve%2520growth%2520factor%2520in%2520human%2520pancreatic%2520beta%2520cells%26jtitle%3DGrowth%2520Factors%26date%3D2003%26volume%3D21%26issue%3D3%25E2%2580%25934%26spage%3D103%26epage%3D107%26doi%3D10.1080%2F08977190310001629566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Apfel, S. C.</span><span> </span><span class="NLM_article-title">Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?</span> <span class="citation_source-journal">Int. Rev. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span><span class="refDoi"> DOI: 10.1016/S0074-7742(02)50083-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2FS0074-7742%2802%2950083-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=12198818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFaqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2002&pages=393-413&author=S.+C.+Apfel&title=Nerve+growth+factor+for+the+treatment+of+diabetic+neuropathy%3A+what+went+wrong%2C+what+went+right%2C+and+what+does+the+future+hold%3F&doi=10.1016%2FS0074-7742%2802%2950083-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Nerve growth factor for the treatment of diabetic neuropathy: What went wrong, what went right, and what does the future hold?</span></div><div class="casAuthors">Apfel, Stuart C.</div><div class="citationInfo"><span class="NLM_cas:title">International Review of Neurobiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">Neurobiology of Diabetic Neuropathy</span>),
    <span class="NLM_cas:pages">393-413</span>CODEN:
                <span class="NLM_cas:coden">IRNEAE</span>;
        ISSN:<span class="NLM_cas:issn">0074-7742</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review.  Since their discovery in the 1950s, neurotrophic factors have raised expectations that their clin. application to neurodegenerative diseases might provide an effective therapy for what are now un-treatable conditions.  Nerve growth factor (NGF) was the first neurotrophic factor to be discovered and was one of the earliest to proceed to clin. trials.  NGF, which is selectively trophic for small fiber sensory and sympathetic neurons, was selected as a potential therapy for diabetic polyneuropathy because of the serious consequences assocd. with degeneration of those neuronal populations in this condition.  In addn., evidence shows that reduced availability of NGF may contribute to the pathogenesis of diabetic neuropathy, and animal models of neuropathy respond to the exogenous administration of NGF.  Two sets of phase II clin. trials suggested that recombinant human NGF (rhNGF) administration was effective at ameliorating the symptoms assocd. with both diabetic polyneuropathy and HIV-related neuropathy.  These early studies, however, revealed that painful side effects were dose limiting for NGF.  A large-scale phase III clin. trial of 1019 patients randomized to receive either rhNGF or placebo for 48 wk failed to confirm the earlier indications of efficacy.  Among the explanations offered for the.  Discrepancy between the two sets of trials was a robust placebo effect, inadequate dosage, different study populations, and changes to the formulation of rhNGF for the phase III trial.  As a result of the phase III outcome, Genentech has decided not to proceed with further development of rhNGF.  (c) 2002 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq52cViByBYYLVg90H21EOLACvtfcHk0liRs1aXEwoTuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFaqu74%253D&md5=d6678c623fd58a4590863c74992d337d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0074-7742%2802%2950083-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0074-7742%252802%252950083-0%26sid%3Dliteratum%253Aachs%26aulast%3DApfel%26aufirst%3DS.%2BC.%26atitle%3DNerve%2520growth%2520factor%2520for%2520the%2520treatment%2520of%2520diabetic%2520neuropathy%253A%2520what%2520went%2520wrong%252C%2520what%2520went%2520right%252C%2520and%2520what%2520does%2520the%2520future%2520hold%253F%26jtitle%3DInt.%2520Rev.%2520Neurobiol.%26date%3D2002%26volume%3D50%26spage%3D393%26epage%3D413%26doi%3D10.1016%2FS0074-7742%2802%2950083-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Lewin, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendell, L. M.</span><span> </span><span class="NLM_article-title">Nerve growth factor-induced hyperalgesia in the neonatal and adult rat</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">2136</span><span class="NLM_x">–</span> <span class="NLM_lpage">2148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1523%2FJNEUROSCI.13-05-02136.1993" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=8478693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADyaK3sXksVWktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1993&pages=2136-2148&issue=5&author=G.+R.+Lewinauthor=A.+M.+Ritterauthor=L.+M.+Mendell&title=Nerve+growth+factor-induced+hyperalgesia+in+the+neonatal+and+adult+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Nerve growth factor-induced hyperalgesia in the neonatal and adult rat</span></div><div class="casAuthors">Lewin, Gary R.; Ritter, Amy M.; Mendell, Lorne M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2136-48</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">Recently, the authors have shown that the interaction between NGF and sensory neurons in early postnatal periods is restricted in nociceptive afferents.  Here the authors show that administration of excess NGF to neonatal or mature animals can lead to a profound behavioral hyperalgesia.  Neonatal NGF treatment (postnatal day 0-14) resulted in a profound mech. hyperalgesia that persisted until the rats had reached maturity (6 wk of age).  This hyperalgesia could be explained by an NGF-mediated sensitization of Aδ nociceptive efferents to mech. stimuli.  This peripheral sensitization wore off with a time course similar to that of the behavioral hyperalgesia.  Treatment of animals from the second postnatal week until 5 wk of age (juveniles) led to a very similar behavioral hyperalgesia; however, there was no corresponding sensitization of Aδ nociceptors to mech. stimuli.  Finally, one group of adult animals (5 wk old) was treated daily with single injections of NGF for between 1 and 4 days.  Within 24 h after the first NGF injection, these animals developed a mech. hyperalgesia of the same magnitude seen after neonatal and juvenile NGF treatments.  No sensitization of Aδ nociceptive afferents was obsd. in these animals.  In addn. to the mech. hyperalgesia, the animals also developed a heat hyperalgesia after one injection of NGF.  The heat hyperalgesia was apparent within 15 min after the injection; however, signs of mech. hyperalgesia were not seen until 6 h after the injection.  It appears that the NGF-induced mech. hyperalgesia is brought about by different mechanisms in neonatal and adult rats.  Furthermore, in adult animals the NGF-induced mech. and heat hyperalgesia also appear to be attributable to two different mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyAxazTfbN4bVg90H21EOLACvtfcHk0liRs1aXEwoTuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXksVWktbs%253D&md5=fdad295b662f2163d2bc7c8f095c9885</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.13-05-02136.1993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.13-05-02136.1993%26sid%3Dliteratum%253Aachs%26aulast%3DLewin%26aufirst%3DG.%2BR.%26aulast%3DRitter%26aufirst%3DA.%2BM.%26aulast%3DMendell%26aufirst%3DL.%2BM.%26atitle%3DNerve%2520growth%2520factor-induced%2520hyperalgesia%2520in%2520the%2520neonatal%2520and%2520adult%2520rat%26jtitle%3DJ.%2520Neurosci.%26date%3D1993%26volume%3D13%26issue%3D5%26spage%3D2136%26epage%3D2148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Indo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karim, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsubuchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonoki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awaya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, I.</span><span> </span><span class="NLM_article-title">Mutations in the TrkA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span><span class="refDoi"> DOI: 10.1038/ng0896-485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fng0896-485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=8696348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADyaK28XkslOmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1996&pages=485-488&issue=4&author=Y.+Indoauthor=M.+Tsurutaauthor=Y.+Hayashidaauthor=M.+A.+Karimauthor=K.+Ohtaauthor=T.+Kawanoauthor=H.+Mitsubuchiauthor=H.+Tonokiauthor=Y.+Awayaauthor=I.+Matsuda&title=Mutations+in+the+TrkA%2FNGF+receptor+gene+in+patients+with+congenital+insensitivity+to+pain+with+anhidrosis&doi=10.1038%2Fng0896-485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis</span></div><div class="casAuthors">Indo, Yasuhiro; Tsuruta, Motoko; Hayashida, Yumi; Karim, Mohammad Azharul; Ohta, Kohji; Kawano, Tomoyasu; Mitsubuchi, Hiroshi; Tonoki, Hidefumi; Awaya, Yutaka; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">485-488</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">Congenital insensitivity to pain with anhidrosis (CIPA; MIM 256800) is an autosomal-recessive disorder characterized by recurrent episodes of unexplained fever, anhidrosis (absence of sweating) and absence of reaction to noxious stimuli, self-mutilating behavior and mental retardation.  The genetic basis for CIPA is unknown.  Nerve growth factor (NGF) induces neurite outgrowth and promotes survival of embryonic sensory and sympathetic neurons.  Mice lacking the gene for TrkA, a receptor tyrosine kinase for NGF, share dramatic phenotypic features of CIPA, including loss of responses to painful stimuli, although anhidrosis is not apparent in these animals.  The authors therefore considered the human TRKA homolog as a candidate for the CIPA gene.  The mRNA and genomic DNA encoding TRKA were analyzed in three unrelated CIPA patients who had consanguineous parents.  The authors detected a deletion-, splice- and missense-mutation in the tyrosine kinase domain in these three patients.  The authors' findings strongly suggest that defects in TRKA cause CIPA and that the NGF-TRKA system has a crucial role in the development and function of the nociceptive reception as well as establishment of thermoregulation via sweating in humans.  These results also implicate genes encoding other TRK and neurotrophin family members as candidates for developmental defect(s) of the nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH30N0w9neObVg90H21EOLACvtfcHk0lhhFNlNvBX2kQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkslOmsr8%253D&md5=53c0d396e836a911528c2b9878bc0423</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fng0896-485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng0896-485%26sid%3Dliteratum%253Aachs%26aulast%3DIndo%26aufirst%3DY.%26aulast%3DTsuruta%26aufirst%3DM.%26aulast%3DHayashida%26aufirst%3DY.%26aulast%3DKarim%26aufirst%3DM.%2BA.%26aulast%3DOhta%26aufirst%3DK.%26aulast%3DKawano%26aufirst%3DT.%26aulast%3DMitsubuchi%26aufirst%3DH.%26aulast%3DTonoki%26aufirst%3DH.%26aulast%3DAwaya%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DI.%26atitle%3DMutations%2520in%2520the%2520TrkA%252FNGF%2520receptor%2520gene%2520in%2520patients%2520with%2520congenital%2520insensitivity%2520to%2520pain%2520with%2520anhidrosis%26jtitle%3DNat.%2520Genet.%26date%3D1996%26volume%3D13%26issue%3D4%26spage%3D485%26epage%3D488%26doi%3D10.1038%2Fng0896-485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Holmes, D.</span><span> </span><span class="NLM_article-title">Anti-NGF painkillers back on track?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span><span class="refDoi"> DOI: 10.1038/nrd3732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnrd3732" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=337-338&issue=5&author=D.+Holmes&title=Anti-NGF+painkillers+back+on+track%3F&doi=10.1038%2Fnrd3732"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnrd3732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3732%26sid%3Dliteratum%253Aachs%26aulast%3DHolmes%26aufirst%3DD.%26atitle%3DAnti-NGF%2520painkillers%2520back%2520on%2520track%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26issue%3D5%26spage%3D337%26epage%3D338%26doi%3D10.1038%2Fnrd3732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Mullard, A.</span><span> </span><span class="NLM_article-title">Drug developers reboot anti-NGF pain programmes</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span><span class="refDoi"> DOI: 10.1038/nrd4612</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnrd4612" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=297-298&issue=5&author=A.+Mullard&title=Drug+developers+reboot+anti-NGF+pain+programmes&doi=10.1038%2Fnrd4612"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnrd4612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4612%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DDrug%2520developers%2520reboot%2520anti-NGF%2520pain%2520programmes%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26issue%3D5%26spage%3D297%26epage%3D298%26doi%3D10.1038%2Fnrd4612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Reuther, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, Q. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caligiuri, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Der, C. J.</span><span> </span><span class="NLM_article-title">Identification and characterization of an activating TrkA deletion mutation in acute myeloid leukemia</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">8655</span><span class="NLM_x">–</span> <span class="NLM_lpage">8666</span><span class="refDoi"> DOI: 10.1128/MCB.20.23.8655-8666.2000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1128%2FMCB.20.23.8655-8666.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=11073967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFGkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=8655-8666&issue=23&author=G.+W.+Reutherauthor=Q.+T.+Lambertauthor=M.+A.+Caligiuriauthor=C.+J.+Der&title=Identification+and+characterization+of+an+activating+TrkA+deletion+mutation+in+acute+myeloid+leukemia&doi=10.1128%2FMCB.20.23.8655-8666.2000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of an activating TrkA deletion mutation in acute myeloid leukemia</span></div><div class="casAuthors">Reuther, Gary W.; Lambert, Que T.; Caligiuri, Michael A.; Der, Channing J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8655-8666</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">In this study, the authors utilized retroviral transfer of cDNA libraries to identify oncogenes that are expressed in acute myeloid leukemia (AML).  From screens using two different cell types as targets for cellular transformation, a single cDNA encoding a variant of the TrkA protooncogene was isolated.  The protein product of this protooncogene, TrkA, is a receptor tyrosine kinase for nerve growth factor.  The isolated transforming cDNA encoded a TrkA protein that contains a 75-amino-acid deletion in the extracellular domain of the receptor and was named ΔTrkA.  ΔTrkA readily transformed fibroblast and epithelial cell lines.  The deletion resulted in activation of the tyrosine kinase domain leading to constitutive tyrosine phosphorylation of the protein.  Expression of ΔTrkA in cells led to the constitutive activation of intracellular signaling pathways that include Ras, extracellular signal-regulated kinase/mitogen-activated protein kinase, and Akt.  Importantly, ΔTrkA altered the apoptotic and growth properties of 32D myeloid progenitor cells, suggesting ΔTrkA may have contributed to the development and/or maintenance of the myeloid leukemia from which it was isolated.  Unlike Bcr-Abl, expression of ΔTrkA did not activate Stat5 in these cells.  The authors have detected expression of ΔTrkA in the original AML sample by reverse transcriptase PCR and by Western blot anal.  While previous TrkA mutations identified from human tumors involved fusion to other proteins, this report is the initial demonstration that deletions within TrkA may play a role in human cancers.  Finally, this report is the first to indicate mutations in TrkA may contribute to leukemogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN8fS7H2J4Y7Vg90H21EOLACvtfcHk0lgZv59rsWW7bg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFGkurk%253D&md5=38b1eb897615f27b6034468a05cfb913</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1128%2FMCB.20.23.8655-8666.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.20.23.8655-8666.2000%26sid%3Dliteratum%253Aachs%26aulast%3DReuther%26aufirst%3DG.%2BW.%26aulast%3DLambert%26aufirst%3DQ.%2BT.%26aulast%3DCaligiuri%26aufirst%3DM.%2BA.%26aulast%3DDer%26aufirst%3DC.%2BJ.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520an%2520activating%2520TrkA%2520deletion%2520mutation%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2000%26volume%3D20%26issue%3D23%26spage%3D8655%26epage%3D8666%26doi%3D10.1128%2FMCB.20.23.8655-8666.2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Tacconelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappabianca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desantis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessitore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetuschi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sferra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rucci, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argenti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Screpanti, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, A. R.</span><span> </span><span class="NLM_article-title">TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.1016/j.ccr.2004.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.ccr.2004.09.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=347-360&issue=4&author=A.+Tacconelliauthor=A.+R.+Farinaauthor=L.+Cappabiancaauthor=G.+Desantisauthor=A.+Tessitoreauthor=A.+Vetuschiauthor=R.+Sferraauthor=N.+Rucciauthor=B.+Argentiauthor=I.+Screpantiauthor=A.+Gulinoauthor=A.+R.+Mackay&title=TrkA+alternative+splicing%3A+a+regulated+tumor-promoting+switch+in+human+neuroblastoma&doi=10.1016%2Fj.ccr.2004.09.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2004.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2004.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DTacconelli%26aufirst%3DA.%26aulast%3DFarina%26aufirst%3DA.%2BR.%26aulast%3DCappabianca%26aufirst%3DL.%26aulast%3DDesantis%26aufirst%3DG.%26aulast%3DTessitore%26aufirst%3DA.%26aulast%3DVetuschi%26aufirst%3DA.%26aulast%3DSferra%26aufirst%3DR.%26aulast%3DRucci%26aufirst%3DN.%26aulast%3DArgenti%26aufirst%3DB.%26aulast%3DScrepanti%26aufirst%3DI.%26aulast%3DGulino%26aufirst%3DA.%26aulast%3DMackay%26aufirst%3DA.%2BR.%26atitle%3DTrkA%2520alternative%2520splicing%253A%2520a%2520regulated%2520tumor-promoting%2520switch%2520in%2520human%2520neuroblastoma%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D6%26issue%3D4%26spage%3D347%26epage%3D360%26doi%3D10.1016%2Fj.ccr.2004.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Vaishnavi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebele, R. C.</span><span> </span><span class="NLM_article-title">TRKing down an old oncogene in a new era of targeted therapy</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-14-0765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1158%2F2159-8290.CD-14-0765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=25527197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=25-34&issue=1&author=A.+Vaishnaviauthor=A.+T.+Leauthor=R.+C.+Doebele&title=TRKing+down+an+old+oncogene+in+a+new+era+of+targeted+therapy&doi=10.1158%2F2159-8290.CD-14-0765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">TRKing Down an Old Oncogene in a New Era of Targeted Therapy</span></div><div class="casAuthors">Vaishnavi, Aria; Le, Anh T.; Doebele, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-34</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The use of high-throughput next-generation sequencing techniques in multiple tumor types during the last few years has identified NTRK1, 2, and 3 gene rearrangements encoding novel oncogenic fusions in 19 different tumor types to date.  These recent developments have led us to revisit an old oncogene, Trk (originally identified as OncD), which encodes the TPM3-NTRK1 gene fusion and was one of the first transforming chromosomal rearrangements identified 32 years ago.  However, no drug has yet been approved by the FDA for cancers harboring this oncogene.  This review will discuss the biol. of the TRK family of receptors, their role in human cancer, the types of oncogenic alterations, and drugs that are currently in development for this family of oncogene targets.  Significance: Precision oncol. approaches have accelerated recently due to advancements in our ability to detect oncogenic mutations in tumor samples.  Oncogenic alterations, most commonly gene fusions, have now been detected for the genes encoding the TRKA, TRKB, and TRKC receptor tyrosine kinases across multiple tumor types.  The scientific rationale for the targeting of the TRK oncogene family will be discussed here.  Cancer Discov; 5(1); 25-34. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKUH4ooHY0TbVg90H21EOLACvtfcHk0lhUzh0JJiDQTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCntbw%253D&md5=02103d46d85b6dc948dba58d32ffba9f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-14-0765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-14-0765%26sid%3Dliteratum%253Aachs%26aulast%3DVaishnavi%26aufirst%3DA.%26aulast%3DLe%26aufirst%3DA.%2BT.%26aulast%3DDoebele%26aufirst%3DR.%2BC.%26atitle%3DTRKing%2520down%2520an%2520old%2520oncogene%2520in%2520a%2520new%2520era%2520of%2520targeted%2520therapy%26jtitle%3DCancer%2520Discovery%26date%3D2015%26volume%3D5%26issue%3D1%26spage%3D25%26epage%3D34%26doi%3D10.1158%2F2159-8290.CD-14-0765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Fischer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wictorin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorklund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, F. H.</span><span> </span><span class="NLM_article-title">Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span><span class="refDoi"> DOI: 10.1038/329065a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2F329065a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=1987&pages=65-68&author=W.+Fischerauthor=K.+Wictorinauthor=A.+Bjorklundauthor=L.+R.+Williamsauthor=S.+Varonauthor=F.+H.+Gage&title=Amelioration+of+cholinergic+neuron+atrophy+and+spatial+memory+impairment+in+aged+rats+by+nerve+growth+factor&doi=10.1038%2F329065a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2F329065a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F329065a0%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DW.%26aulast%3DWictorin%26aufirst%3DK.%26aulast%3DBjorklund%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DL.%2BR.%26aulast%3DVaron%26aufirst%3DS.%26aulast%3DGage%26aufirst%3DF.%2BH.%26atitle%3DAmelioration%2520of%2520cholinergic%2520neuron%2520atrophy%2520and%2520spatial%2520memory%2520impairment%2520in%2520aged%2520rats%2520by%2520nerve%2520growth%2520factor%26jtitle%3DNature%26date%3D1987%26volume%3D329%26spage%3D65%26epage%3D68%26doi%3D10.1038%2F329065a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Fischer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorklund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, F. H.</span><span> </span><span class="NLM_article-title">NGF improves spatial memory in aged rodents as a function of age</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1889</span><span class="NLM_x">–</span> <span class="NLM_lpage">1906</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1523%2FJNEUROSCI.11-07-01889.1991" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1648601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADyaK3MXmslWnsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1991&pages=1889-1906&issue=7&author=W.+Fischerauthor=A.+Bjorklundauthor=K.+Chenauthor=F.+H.+Gage&title=NGF+improves+spatial+memory+in+aged+rodents+as+a+function+of+age"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">NGF improves spatial memory in aged rodents as a function of age</span></div><div class="casAuthors">Fischer, W.; Bjoerklund, A.; Chen, K.; Gage, F. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1889-906</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">Aged rats were tested for place navigation in a circular water maze for spatial memory ability at 18 and 30 mo of age; 45% of the 18-mo-old rats displayed impaired place navigation performance relative to young control rats, while all 30-mo-old rats were impaired.  The aged impaired rats were retested twice during nerve growth factor (NGF) infusion in the right lateral brain ventricle.  In the 18-mo-old group, NGF improved retention of previously acquired place navigation performance and improved spatial acuity over the former platform site when the invisible platform was removed.  NGF also had an effect in the much more severely impaired 30-mo-old rats.  While the vehicle-infused aged rats showed a progressive decline in the performance between the first and second test weeks, the performance of the NGF-infused rats remained stable.  These effects were confounded by a progressive decline in swim speed seen in the vehicle-infused animals.  The 30-mo-old vehicle-infused control rats showed a cell loss and cell shrinkage relative to the young control rats in the brain septal/diagonal band area, striatum, and nucleus basalis as assessed by NGF-receptor (NGFr) and choline acetyltransferase (ChAT) double-label immunocytochem.  An increase in the size but not in the no. of cells was obsd. on the side of the NGF infusion in the 30-mo-old NGF-infused rats.  While there was no decrease in the size or no. of labeled cells in the 18-mo-old rats, the ChAT-pos. neurons in the 18-mo-old NGF-infused rats showed hypertrophy on the side of infusion.  The effect of exogenous NGF on spatial memory performance is more pronounced in younger impaired (18-mo-old) animals than in those of more advanced age.  A morphol. response to NGF can be obtained not only in older animals where cholinergic neuronal shrinkage and cell loss occurs, but also in young impaired rats where cholinergic cellular atrophy has not yet evolved.  The behavioral effects of intraventricular NGF infusion may be mediated via the cholinergic/NGFr-pos. neurons in the forebrain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI6_uWuoF1zLVg90H21EOLACvtfcHk0lhUzh0JJiDQTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmslWnsL8%253D&md5=fd3c6ae9b86999445ede8e40f9f836a9</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.11-07-01889.1991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.11-07-01889.1991%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DW.%26aulast%3DBjorklund%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DGage%26aufirst%3DF.%2BH.%26atitle%3DNGF%2520improves%2520spatial%2520memory%2520in%2520aged%2520rodents%2520as%2520a%2520function%2520of%2520age%26jtitle%3DJ.%2520Neurosci.%26date%3D1991%26volume%3D11%26issue%3D7%26spage%3D1889%26epage%3D1906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Williams, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksdotter-Jonhagen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granholm, A. C.</span><span> </span><span class="NLM_article-title">Nerve growth factor in treatment and pathogenesis of Alzheimer’s disease</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span><span class="refDoi"> DOI: 10.1016/j.pneurobio.2006.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.pneurobio.2006.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=17084014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1agtrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2006&pages=114-128&issue=3&author=B.+J.+Williamsauthor=M.+Eriksdotter-Jonhagenauthor=A.+C.+Granholm&title=Nerve+growth+factor+in+treatment+and+pathogenesis+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.pneurobio.2006.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Nerve growth factor in treatment and pathogenesis of Alzheimer's disease</span></div><div class="casAuthors">Williams, Brice J.; Eriksdotter-Jonhagen, Maria; Granholm, Ann-Charlotte</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">114-128</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The etiol. of Alzheimer's disease (AD) is still unknown.  In addn., this terrible neurodegenerative disease will increase exponentially over the next two decades due to longer lifespan and an aging "baby-boomer" generation.  All treatments currently approved for AD have moderate efficacy in slowing the rate of cognitive decline in patients, and no efficacy in halting progression of the disease.  Hence, there is an urgent need for new drug targets and delivery methods to slow or reverse the progression of AD.  One mol. that has received much attention in its potential therapeutic role in AD is nerve growth factor (NGF).  This review will demonstrate data from humans and animals which promote NGF as a potential therapeutic target by (1) outlining the hypothesis behind using NGF for the treatment of AD, (2) reviewing both the normal and AD altered signaling pathways and effects of NGF in the central nervous system (CNS), and (3) examg. the results of NGF treatment obtained from animal models of AD and AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3F5y9G_7z2LVg90H21EOLACvtfcHk0lg9F-t43eQj8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1agtrrK&md5=60f6ce40adead8899dc71df667ce95cf</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2006.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2006.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DB.%2BJ.%26aulast%3DEriksdotter-Jonhagen%26aufirst%3DM.%26aulast%3DGranholm%26aufirst%3DA.%2BC.%26atitle%3DNerve%2520growth%2520factor%2520in%2520treatment%2520and%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DProg.%2520Neurobiol.%26date%3D2006%26volume%3D80%26issue%3D3%26spage%3D114%26epage%3D128%26doi%3D10.1016%2Fj.pneurobio.2006.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Freund-Michel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frossard, N.</span><span> </span><span class="NLM_article-title">The nerve growth factor and its receptors in airway inflammatory diseases</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2007.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.pharmthera.2007.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=17915332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2008&pages=52-76&issue=1&author=V.+Freund-Michelauthor=N.+Frossard&title=The+nerve+growth+factor+and+its+receptors+in+airway+inflammatory+diseases&doi=10.1016%2Fj.pharmthera.2007.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The nerve growth factor and its receptors in airway inflammatory diseases</span></div><div class="casAuthors">Freund-Michel, V.; Frossard, N.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-76</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The nerve growth factor (NGF) belongs to the neurotrophin family and induces its effects through activation of 2 distinct receptor types: the tropomyosin-related kinase A (TrkA) receptor, carrying an intrinsic tyrosine kinase activity in its intracellular domain, and the receptor p75 for neurotrophins (p75NTR), belonging to the death receptor family.  Through activation of its TrkA receptor, NGF activates signaling pathways, including phospholipase Cγ (PLCγ), phosphatidyl-inositol 3-kinase (PI3K), the small G protein Ras, and mitogen-activated protein kinases (MAPK).  Through its p75NTR receptor, NGF activates proapoptotic signaling pathways including the MAPK c-Jun N-terminal kinase (JNK), ceramides, and the small G protein Rac, but also activates pathways promoting cell survival through the transcription factor nuclear factor-κB (NF-κB).  NGF was first described by Rita Levi-Montalcini and collaborators as an important factor involved in nerve differentiation and survival.  Another role for NGF has since been established in inflammation, in particular of the airways, with increased NGF levels in chronic inflammatory diseases.  In this review, we will first describe NGF structure and synthesis and NGF receptors and their signaling pathways.  We will then provide information about NGF in the airways, describing its expression and regulation, as well as pointing out its potential role in inflammation, hyperresponsiveness, and remodelling process obsd. in airway inflammatory diseases, in particular in asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryL5sKp8p6obVg90H21EOLACvtfcHk0lg9F-t43eQj8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtL3I&md5=de21b156da9ed0e8629f4e413d394204</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DFreund-Michel%26aufirst%3DV.%26aulast%3DFrossard%26aufirst%3DN.%26atitle%3DThe%2520nerve%2520growth%2520factor%2520and%2520its%2520receptors%2520in%2520airway%2520inflammatory%2520diseases%26jtitle%3DPharmacol.%2520Ther.%26date%3D2008%26volume%3D117%26issue%3D1%26spage%3D52%26epage%3D76%26doi%3D10.1016%2Fj.pharmthera.2007.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Kumar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahal, B. A.</span><span> </span><span class="NLM_article-title">NGF - the TrkA to successful pain treatment</span> <span class="citation_source-journal">J. Pain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">287</span><span class="refDoi"> DOI: 10.2147/JPR.S33408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.2147%2FJPR.S33408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23028238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Gns73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=279-287&author=V.+Kumarauthor=B.+A.+Mahal&title=NGF+-+the+TrkA+to+successful+pain+treatment&doi=10.2147%2FJPR.S33408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">NGF - the TrkA to successful pain treatment</span></div><div class="casAuthors">Kumar, Vinayak; Mahal, Brandon A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">279-287</span>CODEN:
                <span class="NLM_cas:coden">JPROEV</span>;
        ISSN:<span class="NLM_cas:issn">1178-7090</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Chronic pain arising from various pathol. conditions such as osteoarthritis, low back or spinal injuries, cancer, and urol. chronic pelvic pain syndromes presents significant challenges in diagnosis and treatment.  Specifically, since the underlying cause of these pain syndromes is unknown or heterogeneous, physicians diagnose and treat patients based on the symptoms presented.  Nerve growth factor (NGF) has been recognized as an important mediator of chronic pain in many pathol. conditions, and has been shown to be upregulated in a subset of individuals suffering from such pain syndromes.  These findings have led to the development of anti-NGF monoclonal antibodies such as tanezumab as potentially effective therapeutics for chronic pain.  Although tanezumab has reached Phase II and III clin. trials, the trials of anti-NGF antibodies were halted due to safety concerns.  Some of these trials of anti-NGF treatment have had statistically significant decreases in pain, while others have yielded inconclusive results.  These findings are suggestive of, though do not prove, target (NGF) neutralization in chronic pain syndromes.  A biomarker-driven anti-NGF clin. study layout is proposed that incorporates NGF measurements in the relevant samples before and after treatment, in addn. to collecting the pain scores.  This approach might not only confirm the mechanism of tanezumab's action in these chronic pain patients, but should establish NGF levels as a predictive biomarker for patients who can benefit from anti-NGF treatment, thereby creating a personalized approach to pain treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTezlmq4_Q-LVg90H21EOLACvtfcHk0lg57eOrsrkOog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Gns73E&md5=b9d05c6bb8d1c9dc327755220d1cca9a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.2147%2FJPR.S33408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FJPR.S33408%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DMahal%26aufirst%3DB.%2BA.%26atitle%3DNGF%2520-%2520the%2520TrkA%2520to%2520successful%2520pain%2520treatment%26jtitle%3DJ.%2520Pain%2520Res.%26date%3D2012%26volume%3D5%26spage%3D279%26epage%3D287%26doi%3D10.2147%2FJPR.S33408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. T.</span><span> </span><span class="NLM_article-title">Neurotrophins and neuropathic pain: Role in pathobiology</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">10657</span><span class="NLM_x">–</span> <span class="NLM_lpage">10688</span><span class="refDoi"> DOI: 10.3390/molecules200610657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.3390%2Fmolecules200610657" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=10657-10688&issue=6&author=N.+Khanauthor=M.+T.+Smith&title=Neurotrophins+and+neuropathic+pain%3A+Role+in+pathobiology&doi=10.3390%2Fmolecules200610657"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.3390%2Fmolecules200610657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules200610657%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DM.%2BT.%26atitle%3DNeurotrophins%2520and%2520neuropathic%2520pain%253A%2520Role%2520in%2520pathobiology%26jtitle%3DMolecules%26date%3D2015%26volume%3D20%26issue%3D6%26spage%3D10657%26epage%3D10688%26doi%3D10.3390%2Fmolecules200610657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Watson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahey, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Worm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engels, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nijkamp, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroemer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawbarn, D.</span><span> </span><span class="NLM_article-title">TrkAd5: A novel therapeutic agent for treatment of inflammatory pain and asthma</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1122</span><span class="NLM_x">–</span> <span class="NLM_lpage">1129</span><span class="refDoi"> DOI: 10.1124/jpet.105.095844</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1124%2Fjpet.105.095844" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=16284276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1Sgsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2006&pages=1122-1129&issue=3&author=J.+J.+Watsonauthor=M.+S.+Faheyauthor=E.+van+den+Wormauthor=F.+Engelsauthor=F.+P.+Nijkampauthor=P.+Stroemerauthor=S.+McMahonauthor=S.+J.+Allenauthor=D.+Dawbarn&title=TrkAd5%3A+A+novel+therapeutic+agent+for+treatment+of+inflammatory+pain+and+asthma&doi=10.1124%2Fjpet.105.095844"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">TrkAd5: a novel therapeutic agent for treatment of inflammatory pain and asthma</span></div><div class="casAuthors">Watson, Judy J.; Fahey, Mark S.; van den Worm, Edwin; Engels, Ferdi; Nijkamp, Frans P.; Stroemer, Paul; McMahon, Steve; Allen, Shelley J.; Dawbarn, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1122-1129</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Elevated levels of nerve growth factor have been linked to the onset and persistence of many pain-related disorders and asthma.  Described here are the design, expression, refolding, and purifn. of a monomeric (nonstrand-swapped) form of the binding domain of the nerve growth factor receptor, designated TrkAd5.  We have shown that TrkAd5 produced recombinantly binds nerve growth factor with picomolar affinity.  TrkAd5 has been characterized using a variety of biophys. and biochem. assays and is shown here to be stable in both plasma and urine.  The palliative effects of TrkAd5 are demonstrated in animal models of inflammatory pain and allergic asthma.  We conclude that TrkAd5 will prove effective in ameliorating both acute and chronic conditions where nerve growth factor acts as a mediator and suggest a role for its application in vivo as a novel therapeutic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosUDfwwgGbFbVg90H21EOLACvtfcHk0lg57eOrsrkOog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1Sgsrs%253D&md5=78c386d11bfae7ac6704282cc2e524c8</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.095844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.095844%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DJ.%2BJ.%26aulast%3DFahey%26aufirst%3DM.%2BS.%26aulast%3Dvan%2Bden%2BWorm%26aufirst%3DE.%26aulast%3DEngels%26aufirst%3DF.%26aulast%3DNijkamp%26aufirst%3DF.%2BP.%26aulast%3DStroemer%26aufirst%3DP.%26aulast%3DMcMahon%26aufirst%3DS.%26aulast%3DAllen%26aufirst%3DS.%2BJ.%26aulast%3DDawbarn%26aufirst%3DD.%26atitle%3DTrkAd5%253A%2520A%2520novel%2520therapeutic%2520agent%2520for%2520treatment%2520of%2520inflammatory%2520pain%2520and%2520asthma%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D316%26issue%3D3%26spage%3D1122%26epage%3D1129%26doi%3D10.1124%2Fjpet.105.095844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Eibl, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, G. M.</span><span> </span><span class="NLM_article-title">Structural, biological, and pharmacological strategies for the inhibition of nerve growth factor</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1266</span><span class="NLM_x">–</span> <span class="NLM_lpage">1275</span><span class="refDoi"> DOI: 10.1016/j.neuint.2012.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.neuint.2012.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23103525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslSmur3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=1266-1275&issue=8&author=J.+K.+Eiblauthor=B.+C.+Strasserauthor=G.+M.+Ross&title=Structural%2C+biological%2C+and+pharmacological+strategies+for+the+inhibition+of+nerve+growth+factor&doi=10.1016%2Fj.neuint.2012.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structural, biological, and pharmacological strategies for the inhibition of nerve growth factor</span></div><div class="casAuthors">Eibl, Joseph K.; Strasser, Bridget C.; Ross, Gregory M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1266-1275</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Nerve growth factor (NGF) is crit. for the development and maintenance of sympathetic and sensory neurons in the developing nervous system, including nociceptors.  In the adult nervous system, NGF is known to produce significant pain signals by binding to the TrkA and p75NTR receptors.  Several pathol. pain disorders are assocd. with nerve growth factor dysregulation, including neuropathic pain, osteoarthritic pain, and hyperalgesia.  Currently, clin. management of these pathologies has relied on the use of opioid and non-steroidal anti-inflammatory drugs (NSAID).  However, several chronic pain conditions demonstrate insensitivity to NSAID treatment or the development of detrimental opioid-related side effects, including addiction.  As NGF plays an important role in pain generation; antibodies, small mols. and peptides have been designed to antagonize NGF.  In this review, we discuss the structural biol. of NGF ligand/receptor interaction, and we review current biol. and pharmacol. strategies to modulate NGF-related pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKGRvNw-JhELVg90H21EOLACvtfcHk0liye4vfbE9uxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslSmur3F&md5=a358288eb52094421bb4aa390a959f38</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2012.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2012.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DEibl%26aufirst%3DJ.%2BK.%26aulast%3DStrasser%26aufirst%3DB.%2BC.%26aulast%3DRoss%26aufirst%3DG.%2BM.%26atitle%3DStructural%252C%2520biological%252C%2520and%2520pharmacological%2520strategies%2520for%2520the%2520inhibition%2520of%2520nerve%2520growth%2520factor%26jtitle%3DNeurochem.%2520Int.%26date%3D2012%26volume%3D61%26issue%3D8%26spage%3D1266%26epage%3D1275%26doi%3D10.1016%2Fj.neuint.2012.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Weskamp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichardt, L. F.</span><span> </span><span class="NLM_article-title">Evidence that biological activity of NGF is mediated through a novel subclass of high affinity receptors</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">649</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span><span class="refDoi"> DOI: 10.1016/0896-6273(91)90067-A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2F0896-6273%2891%2990067-A" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1991&pages=649-663&issue=4&author=G.+Weskampauthor=L.+F.+Reichardt&title=Evidence+that+biological+activity+of+NGF+is+mediated+through+a+novel+subclass+of+high+affinity+receptors&doi=10.1016%2F0896-6273%2891%2990067-A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2F0896-6273%2891%2990067-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0896-6273%252891%252990067-A%26sid%3Dliteratum%253Aachs%26aulast%3DWeskamp%26aufirst%3DG.%26aulast%3DReichardt%26aufirst%3DL.%2BF.%26atitle%3DEvidence%2520that%2520biological%2520activity%2520of%2520NGF%2520is%2520mediated%2520through%2520a%2520novel%2520subclass%2520of%2520high%2520affinity%2520receptors%26jtitle%3DNeuron%26date%3D1991%26volume%3D6%26issue%3D4%26spage%3D649%26epage%3D663%26doi%3D10.1016%2F0896-6273%2891%2990067-A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Mischel, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vining, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valletta, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobley, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichardt, L. F.</span><span> </span><span class="NLM_article-title">The extracellular domain of p75NTR is necessary to inhibit neurotrophin-3 signaling through TrkA</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">11294</span><span class="NLM_x">–</span> <span class="NLM_lpage">11301</span><span class="refDoi"> DOI: 10.1074/jbc.M005132200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1074%2Fjbc.M005132200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=11294-11301&issue=14&author=P.+S.+Mischelauthor=S.+G.+Smithauthor=E.+R.+Viningauthor=J.+S.+Vallettaauthor=W.+C.+Mobleyauthor=L.+F.+Reichardt&title=The+extracellular+domain+of+p75NTR+is+necessary+to+inhibit+neurotrophin-3+signaling+through+TrkA&doi=10.1074%2Fjbc.M005132200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M005132200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M005132200%26sid%3Dliteratum%253Aachs%26aulast%3DMischel%26aufirst%3DP.%2BS.%26aulast%3DSmith%26aufirst%3DS.%2BG.%26aulast%3DVining%26aufirst%3DE.%2BR.%26aulast%3DValletta%26aufirst%3DJ.%2BS.%26aulast%3DMobley%26aufirst%3DW.%2BC.%26aulast%3DReichardt%26aufirst%3DL.%2BF.%26atitle%3DThe%2520extracellular%2520domain%2520of%2520p75NTR%2520is%2520necessary%2520to%2520inhibit%2520neurotrophin-3%2520signaling%2520through%2520TrkA%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D14%26spage%3D11294%26epage%3D11301%26doi%3D10.1074%2Fjbc.M005132200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Khodorova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicol, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strichartz, G.</span><span> </span><span class="NLM_article-title">The p75NTR signaling cascade mediates mechanical hyperalgesia induced by nerve growth factor injected into the rat hind paw</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">254</span><span class="NLM_x">, </span> <span class="NLM_fpage">312</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2013.09.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.neuroscience.2013.09.046" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2013&pages=312-323&author=A.+Khodorovaauthor=G.+D.+Nicolauthor=G.+Strichartz&title=The+p75NTR+signaling+cascade+mediates+mechanical+hyperalgesia+induced+by+nerve+growth+factor+injected+into+the+rat+hind+paw&doi=10.1016%2Fj.neuroscience.2013.09.046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2013.09.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2013.09.046%26sid%3Dliteratum%253Aachs%26aulast%3DKhodorova%26aufirst%3DA.%26aulast%3DNicol%26aufirst%3DG.%2BD.%26aulast%3DStrichartz%26aufirst%3DG.%26atitle%3DThe%2520p75NTR%2520signaling%2520cascade%2520mediates%2520mechanical%2520hyperalgesia%2520induced%2520by%2520nerve%2520growth%2520factor%2520injected%2520into%2520the%2520rat%2520hind%2520paw%26jtitle%3DNeuroscience%26date%3D2013%26volume%3D254%26spage%3D312%26epage%3D323%26doi%3D10.1016%2Fj.neuroscience.2013.09.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Rogers, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atmosukarto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berhanu, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matusica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macardle, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, R. A.</span><span> </span><span class="NLM_article-title">Functional monoclonal antibodies to p75 neurotrophin receptor raised in knockout mice</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span><span class="refDoi"> DOI: 10.1016/j.jneumeth.2006.05.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.jneumeth.2006.05.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=16828166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOrt7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2006&pages=109-120&issue=1&author=M.+L.+Rogersauthor=I.+Atmosukartoauthor=D.+A.+Berhanuauthor=D.+Matusicaauthor=P.+Macardleauthor=R.+A.+Rush&title=Functional+monoclonal+antibodies+to+p75+neurotrophin+receptor+raised+in+knockout+mice&doi=10.1016%2Fj.jneumeth.2006.05.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Functional monoclonal antibodies to p75 neurotrophin receptor raised in knockout mice</span></div><div class="casAuthors">Rogers, Mary-Louise; Atmosukarto, Ines; Berhanu, Degu A.; Matusica, Dusan; Macardle, Peter; Rush, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">109-120</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In this study, p75NTREXONIII knockout mice were used as immune-naive hosts to produce functional antibodies to human p75NTR.  Three monoclonal antibodies were produced and named MLR1, MLR2 and MLR3, and isotyped as IgG1, IgG2a and IgG2a, resp.  MLR1 and MLR2 bound to human p75NTR with higher affinity than the well-characterized ME20.4 in ELISA and also recognized p75NTR present on neurons in both rat and mouse.  MLR1 and MLR2 bound to nerves known to express p75NTR following injection into Balb/C mice but not p75NTREXONIII knockout mice, indicating the antibodies are directed against the ligand binding extracellular region absent in knockout mice.  Both MLR1 and MLR2 partially blocked NGF induced cell death in a mouse cell-line that expresses p75NTR but not TrKA.  Importantly, intracerebroventricular injections indicated MLR2 was internalized within the cell bodies of mouse basal forebrain neurons, further demonstrating that this antibody is biol. active.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz9-1b8V3Mb7Vg90H21EOLACvtfcHk0lgLf0TOuYQQ5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOrt7jK&md5=d393f749a916461e16b7a6e496daf521</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.jneumeth.2006.05.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneumeth.2006.05.022%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DM.%2BL.%26aulast%3DAtmosukarto%26aufirst%3DI.%26aulast%3DBerhanu%26aufirst%3DD.%2BA.%26aulast%3DMatusica%26aufirst%3DD.%26aulast%3DMacardle%26aufirst%3DP.%26aulast%3DRush%26aufirst%3DR.%2BA.%26atitle%3DFunctional%2520monoclonal%2520antibodies%2520to%2520p75%2520neurotrophin%2520receptor%2520raised%2520in%2520knockout%2520mice%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2006%26volume%3D158%26issue%3D1%26spage%3D109%26epage%3D120%26doi%3D10.1016%2Fj.jneumeth.2006.05.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Ugolini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covaceuszach, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattaneo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavone, F.</span><span> </span><span class="NLM_article-title">The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2985</span><span class="NLM_x">–</span> <span class="NLM_lpage">2990</span><span class="refDoi"> DOI: 10.1073/pnas.0611253104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1073%2Fpnas.0611253104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=2985-2990&issue=8&author=G.+Ugoliniauthor=S.+Marinelliauthor=S.+Covaceuszachauthor=A.+Cattaneoauthor=F.+Pavone&title=The+function+neutralizing+anti-TrkA+antibody+MNAC13+reduces+inflammatory+and+neuropathic+pain&doi=10.1073%2Fpnas.0611253104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0611253104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0611253104%26sid%3Dliteratum%253Aachs%26aulast%3DUgolini%26aufirst%3DG.%26aulast%3DMarinelli%26aufirst%3DS.%26aulast%3DCovaceuszach%26aufirst%3DS.%26aulast%3DCattaneo%26aufirst%3DA.%26aulast%3DPavone%26aufirst%3DF.%26atitle%3DThe%2520function%2520neutralizing%2520anti-TrkA%2520antibody%2520MNAC13%2520reduces%2520inflammatory%2520and%2520neuropathic%2520pain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26issue%3D8%26spage%3D2985%26epage%3D2990%26doi%3D10.1073%2Fpnas.0611253104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Rapp, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walmsley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mottl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ignatius, A.</span><span> </span><span class="NLM_article-title">Analgesia via blockade of NGF/TrkA signaling does not influence fracture healing in mice</span> <span class="citation_source-journal">J. Orthop. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1235</span><span class="NLM_x">–</span> <span class="NLM_lpage">1241</span><span class="refDoi"> DOI: 10.1002/jor.22892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1002%2Fjor.22892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=25876530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyjtLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=1235-1241&issue=8&author=A.+E.+Rappauthor=J.+Kronerauthor=S.+Baurauthor=F.+Schmidauthor=A.+Walmsleyauthor=H.+Mottlauthor=A.+Ignatius&title=Analgesia+via+blockade+of+NGF%2FTrkA+signaling+does+not+influence+fracture+healing+in+mice&doi=10.1002%2Fjor.22892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Analgesia via blockade of NGF/TrkA signaling does not influence fracture healing in mice</span></div><div class="casAuthors">Rapp, Anna E.; Kroner, Jochen; Baur, Stephanie; Schmid, Fabian; Walmsley, Adrian; Mottl, Harald; Ignatius, Anita</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Orthopaedic Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1235-1241</span>CODEN:
                <span class="NLM_cas:coden">JOREDR</span>;
        ISSN:<span class="NLM_cas:issn">0736-0266</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Abatement of fracture-related pain is important in patient welfare.  However, the frequently used non-steroidal anti-inflammatory drugs are considered to impair fracture healing through blockade of cyclooxygenase-2.  An alternative for fracture-related pain treatment may be blockade of nerve growth factor (NGF)/neurotrophic tyrosine kinase receptor type 1 (TrkA) signaling.  Because the effect of blocking this signal-pathway on bone healing has not been extensively investigated, we addressed this issue by applying neutralizing antibodies that target NGF and TrkA, resp., in a mouse fracture model.  Mice with a knock-in for human TrkA underwent femur osteotomy and were randomly allocated to phosphate-buffered-saline, anti-NGF-antibody, or anti-TrkA-antibody treatment.  The analgesic effect of the antibodies was detd. from the activity and the ground reaction force of the operated limb.  The effect of antibody administration on fracture healing was assessed by histomorphometry, micro-computed tomog., and biomechanics.  NGF/TrkA-signaling blockade had no neg. effect on fracture healing as callus formation and maturation were not altered.  Mice treated with anti-TrkA antibody displayed significantly greater activity on post-operative day 2 compared to PBS treatment indicating effective analgesia.  Our data indicate, that blockade of NGF/TrkA signaling via specific neutralizing antibodies for pain redn. during fracture healing does not influence fracture healing. cpr 2015 Orthopaedic Research Society.  Published by Wiley Periodicals, Inc.  J Orthop Res 33:1235-1241, 2015.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEtHU7OIeAtLVg90H21EOLACvtfcHk0lhlzggoT5eazA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyjtLrK&md5=caf13e9694d5a232164331078311c514</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fjor.22892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjor.22892%26sid%3Dliteratum%253Aachs%26aulast%3DRapp%26aufirst%3DA.%2BE.%26aulast%3DKroner%26aufirst%3DJ.%26aulast%3DBaur%26aufirst%3DS.%26aulast%3DSchmid%26aufirst%3DF.%26aulast%3DWalmsley%26aufirst%3DA.%26aulast%3DMottl%26aufirst%3DH.%26aulast%3DIgnatius%26aufirst%3DA.%26atitle%3DAnalgesia%2520via%2520blockade%2520of%2520NGF%252FTrkA%2520signaling%2520does%2520not%2520influence%2520fracture%2520healing%2520in%2520mice%26jtitle%3DJ.%2520Orthop.%2520Res.%26date%3D2015%26volume%3D33%26issue%3D8%26spage%3D1235%26epage%3D1241%26doi%3D10.1002%2Fjor.22892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Cunningham, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, L. A.</span><span> </span><span class="NLM_article-title">Autophosphorylation of activation loop tyrosines regulates signaling by the TRK nerve growth factor receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">10957</span><span class="NLM_x">–</span> <span class="NLM_lpage">10967</span><span class="refDoi"> DOI: 10.1074/jbc.272.16.10957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1074%2Fjbc.272.16.10957" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=10957-10967&issue=16&author=M.+E.+Cunninghamauthor=R.+M.+Stephensauthor=D.+R.+Kaplanauthor=L.+A.+Greene&title=Autophosphorylation+of+activation+loop+tyrosines+regulates+signaling+by+the+TRK+nerve+growth+factor+receptor&doi=10.1074%2Fjbc.272.16.10957"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.16.10957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.16.10957%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DM.%2BE.%26aulast%3DStephens%26aufirst%3DR.%2BM.%26aulast%3DKaplan%26aufirst%3DD.%2BR.%26aulast%3DGreene%26aufirst%3DL.%2BA.%26atitle%3DAutophosphorylation%2520of%2520activation%2520loop%2520tyrosines%2520regulates%2520signaling%2520by%2520the%2520TRK%2520nerve%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26issue%3D16%26spage%3D10957%26epage%3D10967%26doi%3D10.1074%2Fjbc.272.16.10957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Kaplan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, F. D.</span><span> </span><span class="NLM_article-title">Neurotrophin signal transduction in the nervous system</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span><span class="refDoi"> DOI: 10.1016/S0959-4388(00)00092-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2FS0959-4388%2800%2900092-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=381-391&issue=3&author=D.+R.+Kaplanauthor=F.+D.+Miller&title=Neurotrophin+signal+transduction+in+the+nervous+system&doi=10.1016%2FS0959-4388%2800%2900092-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS0959-4388%2800%2900092-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-4388%252800%252900092-1%26sid%3Dliteratum%253Aachs%26aulast%3DKaplan%26aufirst%3DD.%2BR.%26aulast%3DMiller%26aufirst%3DF.%2BD.%26atitle%3DNeurotrophin%2520signal%2520transduction%2520in%2520the%2520nervous%2520system%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D2000%26volume%3D10%26issue%3D3%26spage%3D381%26epage%3D391%26doi%3D10.1016%2FS0959-4388%2800%2900092-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Ji, R. R.; Kawasaki, Y.; Zhuang, Z. Y.; Wen, Y. R.; Zhang, Y. Q.</span><span> </span><span class="NLM_article-title">Protein kinases as potential targets for the treatment of pathological pain</span>. In  <span class="citation_source-book">Analgesia</span>; <span class="NLM_series">Handbook of Experimental Pharmacology</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin, Heidelberg</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">177</span>, pp  <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1007/978-3-540-33823-9_13</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1007%2F978-3-540-33823-9_13" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=359-389&author=R.+R.+Ji&author=Y.+Kawasaki&author=Z.+Y.+Zhuang&author=Y.+R.+Wen&author=Y.+Q.+Zhang&title=Analgesia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2F978-3-540-33823-9_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-540-33823-9_13%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DR.%2BR.%26atitle%3DProtein%2520kinases%2520as%2520potential%2520targets%2520for%2520the%2520treatment%2520of%2520pathological%2520pain%26btitle%3DAnalgesia%26pub%3DSpringer%26date%3D2007%26volume%3D177%26spage%3D359%26epage%3D389%26doi%3D10.1007%2F978-3-540-33823-9_13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNaughton, P. A.</span><span> </span><span class="NLM_article-title">NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">4211</span><span class="NLM_x">–</span> <span class="NLM_lpage">4223</span><span class="refDoi"> DOI: 10.1038/sj.emboj.7600893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fsj.emboj.7600893" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=4211-4223&issue=24&author=X.+Zhangauthor=J.+Huangauthor=P.+A.+McNaughton&title=NGF+rapidly+increases+membrane+expression+of+TRPV1+heat-gated+ion+channels&doi=10.1038%2Fsj.emboj.7600893"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7600893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7600893%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DMcNaughton%26aufirst%3DP.%2BA.%26atitle%3DNGF%2520rapidly%2520increases%2520membrane%2520expression%2520of%2520TRPV1%2520heat-gated%2520ion%2520channels%26jtitle%3DEMBO%2520J.%26date%3D2005%26volume%3D24%26issue%3D24%26spage%3D4211%26epage%3D4223%26doi%3D10.1038%2Fsj.emboj.7600893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Structural and functional properties of the TRK family of neurotrophin receptors</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">766</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">458</span><span class="refDoi"> DOI: 10.1111/j.1749-6632.1995.tb26693.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1111%2Fj.1749-6632.1995.tb26693.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=766&publication_year=1995&pages=442-458&author=M.+Barbacid&title=Structural+and+functional+properties+of+the+TRK+family+of+neurotrophin+receptors&doi=10.1111%2Fj.1749-6632.1995.tb26693.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.1995.tb26693.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.1995.tb26693.x%26sid%3Dliteratum%253Aachs%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DStructural%2520and%2520functional%2520properties%2520of%2520the%2520TRK%2520family%2520of%2520neurotrophin%2520receptors%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1995%26volume%3D766%26spage%3D442%26epage%3D458%26doi%3D10.1111%2Fj.1749-6632.1995.tb26693.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Wells, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClendon, C. L.</span><span> </span><span class="NLM_article-title">Reaching for high-hanging fruit in drug discovery at protein-protein interfaces</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x"> (</span><span class="NLM_issue">7172</span><span class="NLM_x">) </span> <span class="NLM_fpage">1001</span><span class="NLM_x">–</span> <span class="NLM_lpage">1009</span><span class="refDoi"> DOI: 10.1038/nature06526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnature06526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=18075579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVaqtr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2007&pages=1001-1009&issue=7172&author=J.+A.+Wellsauthor=C.+L.+McClendon&title=Reaching+for+high-hanging+fruit+in+drug+discovery+at+protein-protein+interfaces&doi=10.1038%2Fnature06526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Reaching for high-hanging fruit in drug discovery at protein-protein interfaces</span></div><div class="casAuthors">Wells, James A.; McClendon, Christopher L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">450</span>
        (<span class="NLM_cas:issue">7172</span>),
    <span class="NLM_cas:pages">1001-1009</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Targeting the interfaces between proteins has huge therapeutic potential, but discovering small-mol. drugs that disrupt protein-protein interactions is an enormous challenge.  Several recent success stories, however, indicate that protein-protein interfaces might be more tractable than has been thought.  These studies discovered small mols. that bind with drug-like potencies to 'hotspots' on the contact surfaces involved in protein-protein interactions.  Remarkably, these small mols. bind deeper within the contact surface of the target protein, and bind with much higher efficiencies, than do the contact atoms of the natural protein partner.  Some of these small mols. are now making their way through clin. trials, so this high-hanging fruit might not be far out of reach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj-nGR3BqqkrVg90H21EOLACvtfcHk0lgNYTQS5sHcXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVaqtr7F&md5=e7ed69fd8c362a71c4b99f029c16a6fc</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fnature06526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06526%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DMcClendon%26aufirst%3DC.%2BL.%26atitle%3DReaching%2520for%2520high-hanging%2520fruit%2520in%2520drug%2520discovery%2520at%2520protein-protein%2520interfaces%26jtitle%3DNature%26date%3D2007%26volume%3D450%26issue%3D7172%26spage%3D1001%26epage%3D1009%26doi%3D10.1038%2Fnature06526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span> </span><span class="NLM_article-title">Trk kinase inhibitors as new treatments for cancer and pain</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span><span class="refDoi"> DOI: 10.1517/13543770902721261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1517%2F13543770902721261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=19441906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjslWlu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=305-319&issue=3&author=T.+Wangauthor=D.+Yuauthor=M.+L.+Lamb&title=Trk+kinase+inhibitors+as+new+treatments+for+cancer+and+pain&doi=10.1517%2F13543770902721261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Trk kinase inhibitors as new treatments for cancer and pain</span></div><div class="casAuthors">Wang, Tao; Yu, Dingwei; Lamb, Michelle L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-319</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Tropomyosin-related kinases (Trks) are a family of receptor tyrosine kinases activated by neurotrophins.  Trks play important roles in pain sensation as well as tumor cell growth and survival signaling.  Thus, inhibitors of Trk receptor kinases might provide targeted treatments for pain and cancer.  Objective: This paper reviews those patent applications since 2002 claiming small-mol. inhibitors of Trk receptor kinases.  Methods: Primary literature and patents were searched with SciFinder and Google Scholar.  Patents were selected based on their relevance to Trks and were evaluated and representative compds. were listed as examples.  Results/conclusion: Several series of Trk inhibitors with excellent in vitro potencies have been reported and a no. of compds. have gone into the clinic.  It should be noted that few of these inhibitors are Trk selective, demonstrating that targeting Trk kinases for treatment of pain and/or cancer offers a promising but also challenging approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvknvXUUz2DbVg90H21EOLACvtfcHk0lgNYTQS5sHcXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjslWlu7o%253D&md5=ffc2d3e33102631cac7b89dce7f96a5a</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1517%2F13543770902721261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770902721261%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26atitle%3DTrk%2520kinase%2520inhibitors%2520as%2520new%2520treatments%2520for%2520cancer%2520and%2520pain%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26issue%3D3%26spage%3D305%26epage%3D319%26doi%3D10.1517%2F13543770902721261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">McCarthy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, E.</span><span> </span><span class="NLM_article-title">Tropomyosin receptor kinase inhibitors: a patent update 2009 – 2013</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">744</span><span class="refDoi"> DOI: 10.1517/13543776.2014.910195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1517%2F13543776.2014.910195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=24809946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVSqtr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=731-744&issue=7&author=C.+McCarthyauthor=E.+Walker&title=Tropomyosin+receptor+kinase+inhibitors%3A+a+patent+update+2009+%E2%80%93+2013&doi=10.1517%2F13543776.2014.910195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Tropomyosin receptor kinase inhibitors: a patent update 2009 - 2013</span></div><div class="casAuthors">McCarthy, Clive; Walker, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">731-744</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Tropomyosin receptor kinases (Trks) are a family of three similar tyrosine kinases activated by peptide hormones of the neurotrophin family.  The nerve growth factor antibody tanezumab has provided clin. proof of concept for inhibition of the TrkA pathway in pain.  As an alternative modality, small-mol. inhibitors of the Trks have been pursued in recent years to probe the role of these neurotrophin pathways in pain, cancer and other indications.  Areas covered: This paper reviews the patent literature between mid-2009 and 2013, claiming inhibitors of Trk family members as the primary biol. targets.  Addnl. patents have been reviewed where Trk is not the main kinase of interest but in which high Trk potency is obsd. and the chem. matter is particularly noteworthy.  Patents pre-dating this period have been reviewed previously.  Scifinder and Google were used to find relevant patents and clin. information using Trk or Tropomyosin as the search term.  Expert opinion: Considerable recent progress has been made in the identification of selective pan Trk inhibitors with pharmacodynamic and pharmacokinetic properties appropriate for clin. evaluation.  Inhibitors of both active and inactive conformations of the Trks as well as peripherally restricted mols. have been identified.  Furthermore, TrkA-selective allosteric inhibitors have recently been disclosed, which enables the biol. of this isoform to be probed.  The recent identification of a TrkA gene fusion in a subset of lung cancer patients will increase further the attraction of Trk inhibition to the pharmaceutical industry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjXwkruGnLXbVg90H21EOLACvtfcHk0liWrbxi0xiCqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVSqtr7L&md5=b924331cd9d69192bc10f53424997550</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.910195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.910195%26sid%3Dliteratum%253Aachs%26aulast%3DMcCarthy%26aufirst%3DC.%26aulast%3DWalker%26aufirst%3DE.%26atitle%3DTropomyosin%2520receptor%2520kinase%2520inhibitors%253A%2520a%2520patent%2520update%25202009%2520%25E2%2580%2593%25202013%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26issue%3D7%26spage%3D731%26epage%3D744%26doi%3D10.1517%2F13543776.2014.910195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Owolabi, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizkalla, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riopelle, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamboj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ossipov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. K. H.</span><span> </span><span class="NLM_article-title">Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the rat</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1271</span><span class="NLM_x">–</span> <span class="NLM_lpage">1276</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10336516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADyaK1MXjtlGnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=1271-1276&issue=3&author=J.+B.+Owolabiauthor=G.+Rizkallaauthor=A.+Tehimauthor=G.+M.+Rossauthor=R.+J.+Riopelleauthor=R.+Kambojauthor=M.+Ossipovauthor=D.+Bianauthor=S.+Wegertauthor=F.+Porrecaauthor=D.+K.+H.+Lee&title=Characterization+of+antiallodynic+actions+of+ALE-0540%2C+a+novel+nerve+growth+factor+receptor+antagonist%2C+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the rat</span></div><div class="casAuthors">Owolabi, Joshua B.; Rizkalla, Geihan; Tehim, Ashok; Ross, Gregory M.; Riopelle, Richard J.; Kamboj, Rajender; Ossipov, Michael; Bian, Di; Wegert, Sandara; Porreca, Frank; Lee, David K. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1271-1276</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">There is growing evidence that nerve growth factor (NGF) may function as a mediator of persistent pain states.  We have identified a novel nonpeptidic mol., ALE-0540, that inhibits the binding of NGF to tyrosine kinase (Trk) A or both p75 and TrkA (IC50 5.88±1.87 μM, 3.72±1.3 μM, resp.), as well as signal transduction and biol. responses mediated by TrkA receptors.  ALE-0540 was tested in models of neuropathic pain and thermally-induced inflammatory pain, using two routes of administration, a systemic i.p. and a spinal intrathecal (i.t.) route.  Morphine was also tested for comparison in the antiallodynia model using mech. stimuli.  We show that either i.p. or i.t. administration of ALE-0540 in rats produced antiallodynia in the L5/L6 ligation model of neuropathic pain.  The calcd. A50 values (and 95% confidence intervals) for ALE-0540 administered i.p. and i.t. were 38 (17.5-83) mg/kg and 34.6 (17.3-69.4) μg, resp.  ALE-0540 given i.t., at doses of 30 and 60 μg, also blocked tactile allodynia in the thermal sensitization model.  Although morphine displayed greater potency [A50 value of 7.1 (5.6-8.8) mg/kg] than ALE-0540 in anti-allodynic effect when given i.p. to L5/L6-ligated rats, it was not active when administered i.t.  These data suggest that a blockade of NGF bioactivity using a NGF receptor antagonist is capable of blocking neuropathic and inflammatory pain and further support the hypothesis that NGF is involved in signaling pathways assocd. with these pain states.  ALE-0540 represents a nonpeptidic small mol. which can be used to examine mechanisms leading to the development of agents for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw3lh6om5ZiLVg90H21EOLACvtfcHk0liWrbxi0xiCqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtlGnsrk%253D&md5=e1576d13ebdd40ab80a4dc1333a622bb</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOwolabi%26aufirst%3DJ.%2BB.%26aulast%3DRizkalla%26aufirst%3DG.%26aulast%3DTehim%26aufirst%3DA.%26aulast%3DRoss%26aufirst%3DG.%2BM.%26aulast%3DRiopelle%26aufirst%3DR.%2BJ.%26aulast%3DKamboj%26aufirst%3DR.%26aulast%3DOssipov%26aufirst%3DM.%26aulast%3DBian%26aufirst%3DD.%26aulast%3DWegert%26aufirst%3DS.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DD.%2BK.%2BH.%26atitle%3DCharacterization%2520of%2520antiallodynic%2520actions%2520of%2520ALE-0540%252C%2520a%2520novel%2520nerve%2520growth%2520factor%2520receptor%2520antagonist%252C%2520in%2520the%2520rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26issue%3D3%26spage%3D1271%26epage%3D1276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Colquhoun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrance, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shamovsky, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riopelle, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, G. M.</span><span> </span><span class="NLM_article-title">Differential activity of the nerve growth factor (NGF) antagonist PD90780 [7-(benzolylamino)-4,9-dihydro-4-methyl-9-oxo-pyrazolo[5,1-b]quinazoline-2-carbox ylic acid] suggests altered NGF–p75NTR interactions in the presence of TrkA</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">310</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span><span class="refDoi"> DOI: 10.1124/jpet.104.066225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1124%2Fjpet.104.066225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=15051797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVyks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2004&pages=505-511&issue=2&author=A.+Colquhounauthor=G.+M.+Lawranceauthor=I.+L.+Shamovskyauthor=R.+J.+Riopelleauthor=G.+M.+Ross&title=Differential+activity+of+the+nerve+growth+factor+%28NGF%29+antagonist+PD90780+%5B7-%28benzolylamino%29-4%2C9-dihydro-4-methyl-9-oxo-pyrazolo%5B5%2C1-b%5Dquinazoline-2-carbox+ylic+acid%5D+suggests+altered+NGF%E2%80%93p75NTR+interactions+in+the+presence+of+TrkA&doi=10.1124%2Fjpet.104.066225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Differential activity of the nerve growth factor (NGF) antagonist PD90780 [7-(benzolylamino)-4,9-dihydro-4-methyl-9-oxo-pyrazolo[5,1-b]quinazoline-2-carboxylic acid] suggests altered NGF-p75NTR interactions in the presence of TrkA</span></div><div class="casAuthors">Colquhoun, Amy; Lawrance, Gail M.; Shamovsky, Igor L.; Riopelle, Richard J.; Ross, Gregory M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">505-511</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The neurotrophin nerve growth factor (NGF) binds to two receptor types: the tyrosine kinase receptor TrkA and the common neurotrophin receptor p75NTR.  Although many of the biol. effects of NGF (such as neuronal growth and survival) are assocd. with TrkA activation, p75NTR also contributes to these activities by enhancing the action of TrkA when receptors are coexpressed.  The NGF antagonist PD90780 [7-(benzolylamino)-4,9-dihydro-4-methyl-9-oxo-pyrazolo[5,1-b]quinazoline-2-carboxylic acid] interacts with NGF, preventing its binding to p75NTR.  In this study, the actions of this compd. are further explored, and it is found that PD90780 is not able to inhibit the binding of either brain-derived neurotrophic factor or neurotrophin-3 to p75NTR, consistent with the direct interactions of the antagonist with NGF.  In addn., the authors demonstrate that the ability of PD90780 to inhibit NGF-p75NTR interactions is lower when receptors are coexpressed, compared with when p75NTR is the only neurotrophin receptor expressed.  These results suggest that the interaction between NGF and the p75NTR receptor is altered when TrkA is coexpressed.  This alteration can be exploited in the development of antagonists that will selectively inhibit the pro-apoptotic actions of p75NTR when expressed in the absence of TrkA, although having less effect on the pro-survival effects of p75NTR mediated by enhanced TrkA activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC9Y-OzilC0LVg90H21EOLACvtfcHk0ljQ09AeZ83gGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVyks7g%253D&md5=d9414b35a3360c1452e78f0034eeff99</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.066225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.066225%26sid%3Dliteratum%253Aachs%26aulast%3DColquhoun%26aufirst%3DA.%26aulast%3DLawrance%26aufirst%3DG.%2BM.%26aulast%3DShamovsky%26aufirst%3DI.%2BL.%26aulast%3DRiopelle%26aufirst%3DR.%2BJ.%26aulast%3DRoss%26aufirst%3DG.%2BM.%26atitle%3DDifferential%2520activity%2520of%2520the%2520nerve%2520growth%2520factor%2520%2528NGF%2529%2520antagonist%2520PD90780%2520%255B7-%2528benzolylamino%2529-4%252C9-dihydro-4-methyl-9-oxo-pyrazolo%255B5%252C1-b%255Dquinazoline-2-carbox%2520ylic%2520acid%255D%2520suggests%2520altered%2520NGF%25E2%2580%2593p75NTR%2520interactions%2520in%2520the%2520presence%2520of%2520TrkA%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D310%26issue%3D2%26spage%3D505%26epage%3D511%26doi%3D10.1124%2Fjpet.104.066225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Niederhauser, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubenel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusznir, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertel, C.</span><span> </span><span class="NLM_article-title">NGF ligand alters NGF signaling via p75NTR and TrkA</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span><span class="refDoi"> DOI: 10.1002/1097-4547(20000801)61:3<263::AID-JNR4>3.0.CO;2-M</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1002%2F1097-4547%2820000801%2961%3A3%3C263%3A%3AAID-JNR4%3E3.0.CO%3B2-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10900073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlslCnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2000&pages=263-272&issue=3&author=O.+Niederhauserauthor=M.+Mangoldauthor=R.+Schubenelauthor=E.+A.+Kusznirauthor=D.+Schmidtauthor=C.+Hertel&title=NGF+ligand+alters+NGF+signaling+via+p75NTR+and+TrkA&doi=10.1002%2F1097-4547%2820000801%2961%3A3%3C263%3A%3AAID-JNR4%3E3.0.CO%3B2-M"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">NGF ligand alters NGF signaling via p75NTR and TrkA</span></div><div class="casAuthors">Niederhauser, O.; Mangold, M.; Schubenel, R.; Kusznir, E. A.; Schmidt, D.; Hertel, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">263-272</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Nerve growth factor (NGF) binds to two neurotrophin receptors: p75NTR and p140Trk (TrkA).  Both receptors dimerize in response to NGF binding.  TrkA homodimers and heteromers of TrkA and p75NTR promote cell survival, whereas homodimers of p75NTR mediate apoptosis upon binding of NGF.  The interaction between receptor and NGF can be inhibited either on the level of the ligand by altering NGF conformation so that NGF is no longer recognized by the receptor or on the level of the receptor by blocking the binding site of p75NTR or TrkA.  The effect of altering NGF conformation on NGF signaling was investigated in two neuron-like cell lines: in human SK-N-MC cells that express only p75NTR and in rat PC12 cells that express both p75NTR and TrkA.  In the present study Ro 08-2750 binds to the NGF dimer thereby probably inducing a change in its conformation such that NGF cannot bind to p75NTR anymore.  In SK-N-MC cells this leads to inhibition of NGF-induced programmed cell death.  In PC12 cells enhanced signaling through TrkA was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbIJ4XSeSjorVg90H21EOLACvtfcHk0ljQ09AeZ83gGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlslCnt7k%253D&md5=1b080455cf33e1f2e307b7d3377b36ed</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2F1097-4547%2820000801%2961%3A3%3C263%3A%3AAID-JNR4%3E3.0.CO%3B2-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-4547%252820000801%252961%253A3%253C263%253A%253AAID-JNR4%253E3.0.CO%253B2-M%26sid%3Dliteratum%253Aachs%26aulast%3DNiederhauser%26aufirst%3DO.%26aulast%3DMangold%26aufirst%3DM.%26aulast%3DSchubenel%26aufirst%3DR.%26aulast%3DKusznir%26aufirst%3DE.%2BA.%26aulast%3DSchmidt%26aufirst%3DD.%26aulast%3DHertel%26aufirst%3DC.%26atitle%3DNGF%2520ligand%2520alters%2520NGF%2520signaling%2520via%2520p75NTR%2520and%2520TrkA%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2000%26volume%3D61%26issue%3D3%26spage%3D263%26epage%3D272%26doi%3D10.1002%2F1097-4547%2820000801%2961%3A3%3C263%3A%3AAID-JNR4%3E3.0.CO%3B2-M" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Eibl, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, G. M.</span><span> </span><span class="NLM_article-title">Identification of novel pyrazoloquinazolinecarboxilate analogues to inhibit nerve growth factor in vitro</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">708</span><span class="NLM_x"> (</span><span class="NLM_issue">1–3</span><span class="NLM_x">) </span> <span class="NLM_fpage">30</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2013.03.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.ejphar.2013.03.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23528360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnslChs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=708&publication_year=2013&pages=30-37&issue=1%E2%80%933&author=J.+K.+Eiblauthor=B.+C.+Strasserauthor=G.+M.+Ross&title=Identification+of+novel+pyrazoloquinazolinecarboxilate+analogues+to+inhibit+nerve+growth+factor+in+vitro&doi=10.1016%2Fj.ejphar.2013.03.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel pyrazoloquinazolinecarboxilate analogues to inhibit nerve growth factor in vitro</span></div><div class="casAuthors">Eibl, Joseph K.; Strasser, Bridget C.; Ross, Gregory M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">708</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">30-37</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nerve growth factor (NGF) is known to regulate the development and survival of select populations of neurons via its binding/activation of the TrkA and p75NTR receptors.  However, in some physiol. circumstances NGF dysregulation can result in debilitating pathologies, including diabetic neuropathies, interstitial cystitis and fibromyalgia.  Thus, the identification of small mols. which inhibit NGF signalling have significant therapeutic potential.  PD 90780, Ro 08-2750, and ALE 0540 are small mols. that have been reported to bind and inhibit NGF activity.  Importantly, the docking site of these compds. is hypothesised to occur at the loop I/IV cleft of NGF-a region which is required for efficient and selective binding of this neurotrophin to its receptor(s).  Mol. modeling predicts a no. of previously reported NGF antagonists (PD 90780, ALE 0540, and Ro 08-2750) share conserved mol. features, and these drug-like small mols. have the ability to bind and modify the mol. topol. of NGF.  In order to understand the putative mechanism of binding, we synthesized a pyrazoloquinazolinecarboxilate analog series and tested each compd. in an NGF-dependent PC12 cell differentiation assay.  In vitro data confirms that the pyrazoloquinazolinecarboxilate analogs functionally inhibit NGF's effects on PC12 cell differentiation.  The results of this study provide evidence to refine the docking mode of pyrazoloquinazolinecarboxilate based compds. for the purposes of inhibiting NGF in vitro.  In addn., we identified series analog PQC 083 (IC50=7.0 μM; CI=5.4-10.1 μM) which displays markedly higher potency than previously described NGF antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1TfVNfQymVLVg90H21EOLACvtfcHk0lhA_I7v2QPBjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnslChs7s%253D&md5=beaffd63679cf8794197a9791c0ac85e</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.03.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.03.029%26sid%3Dliteratum%253Aachs%26aulast%3DEibl%26aufirst%3DJ.%2BK.%26aulast%3DStrasser%26aufirst%3DB.%2BC.%26aulast%3DRoss%26aufirst%3DG.%2BM.%26atitle%3DIdentification%2520of%2520novel%2520pyrazoloquinazolinecarboxilate%2520analogues%2520to%2520inhibit%2520nerve%2520growth%2520factor%2520in%2520vitro%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D708%26issue%3D1%25E2%2580%25933%26spage%3D30%26epage%3D37%26doi%3D10.1016%2Fj.ejphar.2013.03.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Vaudry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stork, P. J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarovici, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiden, L. E.</span><span> </span><span class="NLM_article-title">Signaling pathways for PC12 cell differentiation: Making the right connections</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x"> (</span><span class="NLM_issue">5573</span><span class="NLM_x">) </span> <span class="NLM_fpage">1648</span><span class="NLM_x">–</span> <span class="NLM_lpage">1649</span><span class="refDoi"> DOI: 10.1126/science.1071552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1126%2Fscience.1071552" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=12040181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlCht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=1648-1649&issue=5573&author=D.+Vaudryauthor=P.+J.+S.+Storkauthor=P.+Lazaroviciauthor=L.+E.+Eiden&title=Signaling+pathways+for+PC12+cell+differentiation%3A+Making+the+right+connections&doi=10.1126%2Fscience.1071552"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Signaling pathways for PC12 cell differentiation: Making the right connections</span></div><div class="casAuthors">Vaudry, D.; Stork, P. J. S.; Lazarovici, P.; Elden, L. E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5573</span>),
    <span class="NLM_cas:pages">1648-1649</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 21 refs.  A key issue in signal transduction is how signaling pathways common to many systems, so-called canonical signaling cassettes, integrate signals from mols. having a wide spectrum of activities, such as hormones and neurotrophins, to deliver distinct biol. outcomes.  The neuroendocrine cell line PC12, derived from rat pheochromocytoma, provides an example of how one canonical signaling cassette, the Raf MAP kinase kinase (MEK)/ERK kinase pathway, can promote distinct outcomes, which in this case include neuritogenesis, gene induction, and proliferation.  Two growth hormones, epidermal growth factor (EGF) and nerve growth factor (NGF), use the same pathway to cause PC12 proliferation and differentiation, resp.  In addn., pituitary adenylate cyclase-activating polypeptide (PACAP), a neurotransmitter that also causes differentiation, uses the same canonical cassette as NGF but in a different way.  The connections Map for PC12 cell differentiation brings into focus the complex array of specific cellular responses that rely on canonical signal transduction systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSCVAyxMm8vbVg90H21EOLACvtfcHk0lhA_I7v2QPBjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlCht7Y%253D&md5=51576d884b0ad0ee49a869c5e3a3e5cd</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1126%2Fscience.1071552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1071552%26sid%3Dliteratum%253Aachs%26aulast%3DVaudry%26aufirst%3DD.%26aulast%3DStork%26aufirst%3DP.%2BJ.%2BS.%26aulast%3DLazarovici%26aufirst%3DP.%26aulast%3DEiden%26aufirst%3DL.%2BE.%26atitle%3DSignaling%2520pathways%2520for%2520PC12%2520cell%2520differentiation%253A%2520Making%2520the%2520right%2520connections%26jtitle%3DScience%26date%3D2002%26volume%3D296%26issue%3D5573%26spage%3D1648%26epage%3D1649%26doi%3D10.1126%2Fscience.1071552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Sheffield, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, G. M.</span><span> </span><span class="NLM_article-title">Characterizing nerve growth factor-p75(NTR) interactions and small molecule inhibition using surface plasmon resonance spectroscopy</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">493</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1016/j.ab.2015.09.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.ab.2015.09.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=493&publication_year=2016&pages=21-26&author=K.+S.+Sheffieldauthor=A.+E.+Kennedyauthor=J.+A.+Scottauthor=G.+M.+Ross&title=Characterizing+nerve+growth+factor-p75%28NTR%29+interactions+and+small+molecule+inhibition+using+surface+plasmon+resonance+spectroscopy&doi=10.1016%2Fj.ab.2015.09.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2015.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2015.09.019%26sid%3Dliteratum%253Aachs%26aulast%3DSheffield%26aufirst%3DK.%2BS.%26aulast%3DKennedy%26aufirst%3DA.%2BE.%26aulast%3DScott%26aufirst%3DJ.%2BA.%26aulast%3DRoss%26aufirst%3DG.%2BM.%26atitle%3DCharacterizing%2520nerve%2520growth%2520factor-p75%2528NTR%2529%2520interactions%2520and%2520small%2520molecule%2520inhibition%2520using%2520surface%2520plasmon%2520resonance%2520spectroscopy%26jtitle%3DAnal.%2520Biochem.%26date%3D2016%26volume%3D493%26spage%3D21%26epage%3D26%26doi%3D10.1016%2Fj.ab.2015.09.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Jang, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinshenker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, K.</span><span> </span><span class="NLM_article-title">Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">644</span><span class="NLM_x">–</span> <span class="NLM_lpage">656</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2009.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.chembiol.2009.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=19549602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFamurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=644-656&issue=6&author=S.+W.+Jangauthor=X.+Liuauthor=C.+B.+Chanauthor=D.+Weinshenkerauthor=R.+A.+Hallauthor=G.+Xiaoauthor=K.+Ye&title=Amitriptyline+is+a+TrkA+and+TrkB+receptor+agonist+that+promotes+TrkA%2FTrkB+heterodimerization+and+has+potent+neurotrophic+activity&doi=10.1016%2Fj.chembiol.2009.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Amitriptyline is a TrkA and TrkB Receptor Agonist that Promotes TrkA/TrkB Heterodimerization and Has Potent Neurotrophic Activity</span></div><div class="casAuthors">Jang, Sung-Wuk; Liu, Xia; Chan, Chi-Bun; Weinshenker, David; Hall, Randy A.; Xiao, Ge; Ye, Keqiang</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">644-656</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Neurotrophins, the cognate ligands for the Trk receptors, are homodimers and induce Trk dimerization through a sym. bivalent mechanism.  We report here that amitriptyline, an antidepressant drug, directly binds TrkA and TrkB and triggers their dimerization and activation.  Amitriptyline, but not any other tricyclic or selective serotonin reuptake inhibitor antidepressants, promotes TrkA autophosphorylation in primary neurons and induces neurite outgrowth in PC12 cells.  Amitriptyline binds the extracellular domain of both TrkA and TrkB and promotes TrkA-TrkB receptor heterodimerization.  Truncation of amitriptyline binding motif on TrkA abrogates the receptor dimerization by amitriptyline.  Administration of amitriptyline to mice activates both receptors and significantly reduces kainic acid-triggered neuronal cell death.  Inhibition of TrkA, but not TrkB, abolishes amitriptyline's neuroprotective effect without impairing its antidepressant activity.  Thus, amitriptyline acts as a TrkA and TrkB agonist and possesses marked neurotrophic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAY4RCL5dTxrVg90H21EOLACvtfcHk0lhM7Gfhs4rf1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFamurs%253D&md5=4dd25ed2cfe6ee57b17a6957dcfaeb1d</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DJang%26aufirst%3DS.%2BW.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DChan%26aufirst%3DC.%2BB.%26aulast%3DWeinshenker%26aufirst%3DD.%26aulast%3DHall%26aufirst%3DR.%2BA.%26aulast%3DXiao%26aufirst%3DG.%26aulast%3DYe%26aufirst%3DK.%26atitle%3DAmitriptyline%2520is%2520a%2520TrkA%2520and%2520TrkB%2520receptor%2520agonist%2520that%2520promotes%2520TrkA%252FTrkB%2520heterodimerization%2520and%2520has%2520potent%2520neurotrophic%2520activity%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26issue%3D6%26spage%3D644%26epage%3D656%26doi%3D10.1016%2Fj.chembiol.2009.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Urfer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsoulfas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parada, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presta, L. G.</span><span> </span><span class="NLM_article-title">An immunoglobulin-like domain determines the specificity of neurotrophin receptors</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">2795</span><span class="NLM_x">–</span> <span class="NLM_lpage">2805</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=2795-2805&issue=12&author=R.+Urferauthor=P.+Tsoulfasauthor=L.+O%E2%80%99Connellauthor=D.+L.+Sheltonauthor=L.+F.+Paradaauthor=L.+G.+Presta&title=An+immunoglobulin-like+domain+determines+the+specificity+of+neurotrophin+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUrfer%26aufirst%3DR.%26aulast%3DTsoulfas%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DL.%26aulast%3DShelton%26aufirst%3DD.%2BL.%26aulast%3DParada%26aufirst%3DL.%2BF.%26aulast%3DPresta%26aufirst%3DL.%2BG.%26atitle%3DAn%2520immunoglobulin-like%2520domain%2520determines%2520the%2520specificity%2520of%2520neurotrophin%2520receptors%26jtitle%3DEMBO%2520J.%26date%3D1995%26volume%3D14%26issue%3D12%26spage%3D2795%26epage%3D2805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vos, A. M.</span><span> </span><span class="NLM_article-title">Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">401</span><span class="NLM_x"> (</span><span class="NLM_issue">6749</span><span class="NLM_x">) </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span><span class="refDoi"> DOI: 10.1038/43705</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2F43705" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=1999&pages=184-188&issue=6749&author=C.+Wiesmannauthor=M.+H.+Ultschauthor=S.+H.+Bassauthor=A.+M.+de+Vos&title=Crystal+structure+of+nerve+growth+factor+in+complex+with+the+ligand-binding+domain+of+the+TrkA+receptor&doi=10.1038%2F43705"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2F43705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F43705%26sid%3Dliteratum%253Aachs%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DBass%26aufirst%3DS.%2BH.%26aulast%3Dde%2BVos%26aufirst%3DA.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520nerve%2520growth%2520factor%2520in%2520complex%2520with%2520the%2520ligand-binding%2520domain%2520of%2520the%2520TrkA%2520receptor%26jtitle%3DNature%26date%3D1999%26volume%3D401%26issue%3D6749%26spage%3D184%26epage%3D188%26doi%3D10.1038%2F43705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henrich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vos, A. M.</span><span> </span><span class="NLM_article-title">Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span><span class="refDoi"> DOI: 10.1006/jmbi.1999.2816</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1006%2Fjmbi.1999.2816" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=1999&pages=149-159&issue=1&author=M.+H.+Ultschauthor=C.+Wiesmannauthor=L.+C.+Simmonsauthor=J.+Henrichauthor=M.+Yangauthor=D.+Reillyauthor=S.+H.+Bassauthor=A.+M.+de+Vos&title=Crystal+structures+of+the+neurotrophin-binding+domain+of+TrkA%2C+TrkB+and+TrkC&doi=10.1006%2Fjmbi.1999.2816"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1999.2816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1999.2816%26sid%3Dliteratum%253Aachs%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DSimmons%26aufirst%3DL.%2BC.%26aulast%3DHenrich%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DReilly%26aufirst%3DD.%26aulast%3DBass%26aufirst%3DS.%2BH.%26aulast%3Dde%2BVos%26aufirst%3DA.%2BM.%26atitle%3DCrystal%2520structures%2520of%2520the%2520neurotrophin-binding%2520domain%2520of%2520TrkA%252C%2520TrkB%2520and%2520TrkC%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1999%26volume%3D290%26issue%3D1%26spage%3D149%26epage%3D159%26doi%3D10.1006%2Fjmbi.1999.2816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">McNamee, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burleigh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gompels, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawbarn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglis, J. J.</span><span> </span><span class="NLM_article-title">Treatment of murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non-inflammatory joint pain</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span><span class="refDoi"> DOI: 10.1016/j.pain.2010.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.pain.2010.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=20350782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1Smtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2010&pages=386-392&issue=2&author=K.+E.+McNameeauthor=A.+Burleighauthor=L.+L.+Gompelsauthor=M.+Feldmannauthor=S.+J.+Allenauthor=R.+O.+Williamsauthor=D.+Dawbarnauthor=T.+L.+Vincentauthor=J.+J.+Inglis&title=Treatment+of+murine+osteoarthritis+with+TrkAd5+reveals+a+pivotal+role+for+nerve+growth+factor+in+non-inflammatory+joint+pain&doi=10.1016%2Fj.pain.2010.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non-inflammatory joint pain</span></div><div class="casAuthors">McNamee, Kay E.; Burleigh, Annika; Gompels, Luke L.; Feldmann, Marc; Allen, Shelley J.; Williams, Richard O.; Dawbarn, David; Vincent, Tonia L.; Inglis, Julia J.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">386-392</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The origin of pain in osteoarthritis is poorly understood, but it is generally thought to arise from inflammation within the innervated structures of the joint, such as the synovium, capsule and bone.  We investigated the role of nerve growth factor (NGF) in pain development in murine OA, and the analgesic efficacy of the sol. NGF receptor, TrkAD5.  OA was induced in mice by destabilization of the medial meniscus and pain was assessed by measuring hind-limb wt. distribution.  RNA was extd. from joints, and NGF and TNF expressions were quantified.  The effect of tumor necrosis factor (TNF) and neutrophil blockade on NGF expression and pain were also assessed.  NGF was induced in the joints during both post-operative (day 3) and OA (16 wk) pain, but not in the non-painful stage of disease (8 wk post-surgery).  TrkAd5 was highly effective at suppressing pain in both phases.  Induction of NGF in the post-operative phase of pain was TNF-dependent as anti-TNF reduced NGF expression in the joint and abrogated pain.  However, TNF was not regulated in the late OA joints, and pain was not affected by anti-TNF therapy.  Fucoidan, by suppressing cellular infiltration into the joint, was able to suppress post-operative, but not late OA pain.  These results indicate that NGF is an important mediator of OA pain and that TrkAd5 represents a potent novel analgesic in this condition.  They also suggest that, unlike post-operative pain, induction of pain in OA may not necessarily be driven by classical inflammatory processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpebZ9OZVUorrVg90H21EOLACvtfcHk0ljlCBwDwMnS6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1Smtrk%253D&md5=a165ee69fc33270b1b12fce44509ec2c</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2010.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2010.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DMcNamee%26aufirst%3DK.%2BE.%26aulast%3DBurleigh%26aufirst%3DA.%26aulast%3DGompels%26aufirst%3DL.%2BL.%26aulast%3DFeldmann%26aufirst%3DM.%26aulast%3DAllen%26aufirst%3DS.%2BJ.%26aulast%3DWilliams%26aufirst%3DR.%2BO.%26aulast%3DDawbarn%26aufirst%3DD.%26aulast%3DVincent%26aufirst%3DT.%2BL.%26aulast%3DInglis%26aufirst%3DJ.%2BJ.%26atitle%3DTreatment%2520of%2520murine%2520osteoarthritis%2520with%2520TrkAd5%2520reveals%2520a%2520pivotal%2520role%2520for%2520nerve%2520growth%2520factor%2520in%2520non-inflammatory%2520joint%2520pain%26jtitle%3DPain%26date%3D2010%26volume%3D149%26issue%3D2%26spage%3D386%26epage%3D392%26doi%3D10.1016%2Fj.pain.2010.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Shoemark, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahey, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyler, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scoltock, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickenden, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmings, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawbarn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jane, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sessions, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crump, M. P.</span><span> </span><span class="NLM_article-title">Design and nuclear magnetic resonance (NMR) structure determination of the second extracellular immunoglobulin tyrosine kinase A (TrkAIg2) domain construct for binding site elucidation in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span><span class="refDoi"> DOI: 10.1021/jm501307e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501307e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=767-777&issue=2&author=D.+K.+Shoemarkauthor=C.+Williamsauthor=M.+S.+Faheyauthor=J.+J.+Watsonauthor=S.+J.+Tylerauthor=S.+J.+Scoltockauthor=R.+Z.+Ellisauthor=E.+Wickendenauthor=A.+J.+Burtonauthor=J.+L.+Hemmingsauthor=C.+D.+Baileyauthor=D.+Dawbarnauthor=D.+E.+Janeauthor=C.+L.+Willisauthor=R.+B.+Sessionsauthor=S.+J.+Allenauthor=M.+P.+Crump&title=Design+and+nuclear+magnetic+resonance+%28NMR%29+structure+determination+of+the+second+extracellular+immunoglobulin+tyrosine+kinase+A+%28TrkAIg2%29+domain+construct+for+binding+site+elucidation+in+drug+discovery&doi=10.1021%2Fjm501307e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm501307e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501307e%26sid%3Dliteratum%253Aachs%26aulast%3DShoemark%26aufirst%3DD.%2BK.%26aulast%3DWilliams%26aufirst%3DC.%26aulast%3DFahey%26aufirst%3DM.%2BS.%26aulast%3DWatson%26aufirst%3DJ.%2BJ.%26aulast%3DTyler%26aufirst%3DS.%2BJ.%26aulast%3DScoltock%26aufirst%3DS.%2BJ.%26aulast%3DEllis%26aufirst%3DR.%2BZ.%26aulast%3DWickenden%26aufirst%3DE.%26aulast%3DBurton%26aufirst%3DA.%2BJ.%26aulast%3DHemmings%26aufirst%3DJ.%2BL.%26aulast%3DBailey%26aufirst%3DC.%2BD.%26aulast%3DDawbarn%26aufirst%3DD.%26aulast%3DJane%26aufirst%3DD.%2BE.%26aulast%3DWillis%26aufirst%3DC.%2BL.%26aulast%3DSessions%26aufirst%3DR.%2BB.%26aulast%3DAllen%26aufirst%3DS.%2BJ.%26aulast%3DCrump%26aufirst%3DM.%2BP.%26atitle%3DDesign%2520and%2520nuclear%2520magnetic%2520resonance%2520%2528NMR%2529%2520structure%2520determination%2520of%2520the%2520second%2520extracellular%2520immunoglobulin%2520tyrosine%2520kinase%2520A%2520%2528TrkAIg2%2529%2520domain%2520construct%2520for%2520binding%2520site%2520elucidation%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D2%26spage%3D767%26epage%3D777%26doi%3D10.1021%2Fjm501307e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1038/nrc2559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&issue=1&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors&doi=10.1038%2Fnrc2559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0ljOLKOALGniOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26issue%3D1%26spage%3D28%26epage%3D39%26doi%3D10.1038%2Fnrc2559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Goodwin, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianchetta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgoon, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mabon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strobel, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamman, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlins, D. B.</span><span> </span><span class="NLM_article-title">Discovery of a Type III inhibitor of LIM kinase 2 that binds in a DFG-out conformation</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span><span class="refDoi"> DOI: 10.1021/ml500242y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500242y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=53-57&issue=1&author=N.+C.+Goodwinauthor=G.+Cianchettaauthor=H.+A.+Burgoonauthor=J.+Healyauthor=R.+Mabonauthor=E.+D.+Strobelauthor=J.+Allenauthor=S.+Wangauthor=B.+D.+Hammanauthor=D.+B.+Rawlins&title=Discovery+of+a+Type+III+inhibitor+of+LIM+kinase+2+that+binds+in+a+DFG-out+conformation&doi=10.1021%2Fml500242y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fml500242y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500242y%26sid%3Dliteratum%253Aachs%26aulast%3DGoodwin%26aufirst%3DN.%2BC.%26aulast%3DCianchetta%26aufirst%3DG.%26aulast%3DBurgoon%26aufirst%3DH.%2BA.%26aulast%3DHealy%26aufirst%3DJ.%26aulast%3DMabon%26aufirst%3DR.%26aulast%3DStrobel%26aufirst%3DE.%2BD.%26aulast%3DAllen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHamman%26aufirst%3DB.%2BD.%26aulast%3DRawlins%26aufirst%3DD.%2BB.%26atitle%3DDiscovery%2520of%2520a%2520Type%2520III%2520inhibitor%2520of%2520LIM%2520kinase%25202%2520that%2520binds%2520in%2520a%2520DFG-out%2520conformation%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D1%26spage%3D53%26epage%3D57%26doi%3D10.1021%2Fml500242y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Cherry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. H.</span><span> </span><span class="NLM_article-title">Recent kinase and kinase inhibitor X-ray structures: mechanisms of inhibition and selectivity insights</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span><span class="refDoi"> DOI: 10.2174/0929867043455792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.2174%2F0929867043455792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=15032722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWgs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=663-673&issue=6&author=M.+Cherryauthor=D.+H.+Williams&title=Recent+kinase+and+kinase+inhibitor+X-ray+structures%3A+mechanisms+of+inhibition+and+selectivity+insights&doi=10.2174%2F0929867043455792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Recent kinase and kinase inhibitor x-ray structures: mechanisms of inhibition and selectivity insights</span></div><div class="casAuthors">Cherry, M.; Williams, D. H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">663-673</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent years have seen an explosion in the no. of publicly available x-ray crystal structures of protein kinases.  These structures have provided a wealth of information on the regulatory mechanisms, conformational plasticity and drugability of this important family of enzymes.  Drawing upon structural information, new insights into the development of protein kinase inhibitors are discussed including de-novo design, mol. templates for ATP competitive inhibitors and alternative mechanisms of inhibition.  The highly conserved nature of the ATP binding site is of central concern to drug development and the concept of a selectivity profile has arisen with structure-based design emerging as a key tool for addressing the challenges of specificity.  In addn., protein-ligand complexes, where the enzyme is in an inactive conformation, signify an alternate approach to protein kinase inhibition.  The belief that an inactive kinase presents a less conserved target is reviewed using observations on the structural changes occurring during protein kinase regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB19ovXBL1mrVg90H21EOLACvtfcHk0liEkxasGWpLwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWgs7w%253D&md5=63c621c012a6e1cc9f795565580d7492</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.2174%2F0929867043455792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043455792%26sid%3Dliteratum%253Aachs%26aulast%3DCherry%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26atitle%3DRecent%2520kinase%2520and%2520kinase%2520inhibitor%2520X-ray%2520structures%253A%2520mechanisms%2520of%2520inhibition%2520and%2520selectivity%2520insights%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26issue%3D6%26spage%3D663%26epage%3D673%26doi%3D10.2174%2F0929867043455792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Bertrand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kothe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupuy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gladysheva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valtre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crenne, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M.</span><span> </span><span class="NLM_article-title">The crystal structures of TrkA and TrkB suggest key regions for achieving selective inhibition</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">423</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">453</span><span class="refDoi"> DOI: 10.1016/j.jmb.2012.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.jmb.2012.08.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=423&publication_year=2012&pages=439-453&issue=3&author=T.+Bertrandauthor=M.+Kotheauthor=J.+Liuauthor=A.+Dupuyauthor=A.+Rakauthor=P.+F.+Berneauthor=S.+Davisauthor=T.+Gladyshevaauthor=C.+Valtreauthor=J.+Y.+Crenneauthor=M.+Mathieu&title=The+crystal+structures+of+TrkA+and+TrkB+suggest+key+regions+for+achieving+selective+inhibition&doi=10.1016%2Fj.jmb.2012.08.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2012.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2012.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DT.%26aulast%3DKothe%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DDupuy%26aufirst%3DA.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DBerne%26aufirst%3DP.%2BF.%26aulast%3DDavis%26aufirst%3DS.%26aulast%3DGladysheva%26aufirst%3DT.%26aulast%3DValtre%26aufirst%3DC.%26aulast%3DCrenne%26aufirst%3DJ.%2BY.%26aulast%3DMathieu%26aufirst%3DM.%26atitle%3DThe%2520crystal%2520structures%2520of%2520TrkA%2520and%2520TrkB%2520suggest%2520key%2520regions%2520for%2520achieving%2520selective%2520inhibition%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2012%26volume%3D423%26issue%3D3%26spage%3D439%26epage%3D453%26doi%3D10.1016%2Fj.jmb.2012.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Albaugh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkisova, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreusch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karanewsky, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molteni, V.</span><span> </span><span class="NLM_article-title">Discovery of GNF-5837, a selective TRK inhibitor with efficacy in rodent cancer tumor models</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span><span class="refDoi"> DOI: 10.1021/ml200261d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200261d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=140-145&issue=2&author=P.+Albaughauthor=Y.+Fanauthor=Y.+Miauthor=F.+Sunauthor=F.+Adrianauthor=N.+Liauthor=Y.+Jiaauthor=Y.+Sarkisovaauthor=A.+Kreuschauthor=T.+Hoodauthor=M.+Luauthor=G.+Liuauthor=S.+Huangauthor=Z.+Liuauthor=J.+Lorenauthor=T.+Tuntlandauthor=D.+S.+Karanewskyauthor=H.+M.+Seidelauthor=V.+Molteni&title=Discovery+of+GNF-5837%2C+a+selective+TRK+inhibitor+with+efficacy+in+rodent+cancer+tumor+models&doi=10.1021%2Fml200261d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fml200261d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200261d%26sid%3Dliteratum%253Aachs%26aulast%3DAlbaugh%26aufirst%3DP.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DAdrian%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DSarkisova%26aufirst%3DY.%26aulast%3DKreusch%26aufirst%3DA.%26aulast%3DHood%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLoren%26aufirst%3DJ.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DKaranewsky%26aufirst%3DD.%2BS.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DMolteni%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520GNF-5837%252C%2520a%2520selective%2520TRK%2520inhibitor%2520with%2520efficacy%2520in%2520rodent%2520cancer%2520tumor%2520models%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26issue%3D2%26spage%3D140%26epage%3D145%26doi%3D10.1021%2Fml200261d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioannidis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyne, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjogren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thress, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. J.</span><span> </span><span class="NLM_article-title">Discovery of disubstituted imidazo[4,5-b]pyridines and purines as potent TrkA inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">709</span><span class="refDoi"> DOI: 10.1021/ml300074j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300074j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=705-709&issue=9&author=T.+Wangauthor=M.+L.+Lambauthor=M.+H.+Blockauthor=A.+M.+Daviesauthor=Y.+Hanauthor=E.+Hoffmannauthor=S.+Ioannidisauthor=J.+A.+Joseyauthor=Z.+Y.+Liuauthor=P.+D.+Lyneauthor=T.+MacIntyreauthor=P.+J.+Mohrauthor=C.+A.+Omerauthor=T.+Sjogrenauthor=K.+Thressauthor=B.+Wangauthor=H.+Wangauthor=D.+Yuauthor=H.+J.+Zhang&title=Discovery+of+disubstituted+imidazo%5B4%2C5-b%5Dpyridines+and+purines+as+potent+TrkA+inhibitors&doi=10.1021%2Fml300074j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fml300074j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300074j%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DBlock%26aufirst%3DM.%2BH.%26aulast%3DDavies%26aufirst%3DA.%2BM.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DHoffmann%26aufirst%3DE.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DLiu%26aufirst%3DZ.%2BY.%26aulast%3DLyne%26aufirst%3DP.%2BD.%26aulast%3DMacIntyre%26aufirst%3DT.%26aulast%3DMohr%26aufirst%3DP.%2BJ.%26aulast%3DOmer%26aufirst%3DC.%2BA.%26aulast%3DSjogren%26aufirst%3DT.%26aulast%3DThress%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DH.%2BJ.%26atitle%3DDiscovery%2520of%2520disubstituted%2520imidazo%255B4%252C5-b%255Dpyridines%2520and%2520purines%2520as%2520potent%2520TrkA%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26issue%3D9%26spage%3D705%26epage%3D709%26doi%3D10.1021%2Fml300074j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Stachel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henze, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanda, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egbertson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manley, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brnardic, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanney, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasowska-Zoladek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span> </span><span class="NLM_article-title">Maximizing diversity from a kinase screen: identification of novel and selective pan-Trk inhibitors for chronic pain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">5800</span><span class="NLM_x">–</span> <span class="NLM_lpage">5816</span><span class="refDoi"> DOI: 10.1021/jm5006429</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5006429" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5800-5816&issue=13&author=S.+J.+Stachelauthor=J.+M.+Sandersauthor=D.+A.+Henzeauthor=M.+T.+Ruddauthor=H.+P.+Suauthor=Y.+Liauthor=K.+K.+Nandaauthor=M.+S.+Egbertsonauthor=P.+J.+Manleyauthor=K.+L.+Jonesauthor=E.+J.+Brnardicauthor=A.+Greenauthor=J.+A.+Groblerauthor=B.+Hanneyauthor=M.+Leitlauthor=M.+T.+Laiauthor=V.+Munshiauthor=D.+Murphyauthor=K.+Rickertauthor=D.+Rileyauthor=A.+Krasowska-Zoladekauthor=C.+Daleyauthor=P.+Zuckauthor=S.+A.+Kaneauthor=M.+T.+Bilodeau&title=Maximizing+diversity+from+a+kinase+screen%3A+identification+of+novel+and+selective+pan-Trk+inhibitors+for+chronic+pain&doi=10.1021%2Fjm5006429"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm5006429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5006429%26sid%3Dliteratum%253Aachs%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DHenze%26aufirst%3DD.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DSu%26aufirst%3DH.%2BP.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DNanda%26aufirst%3DK.%2BK.%26aulast%3DEgbertson%26aufirst%3DM.%2BS.%26aulast%3DManley%26aufirst%3DP.%2BJ.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DBrnardic%26aufirst%3DE.%2BJ.%26aulast%3DGreen%26aufirst%3DA.%26aulast%3DGrobler%26aufirst%3DJ.%2BA.%26aulast%3DHanney%26aufirst%3DB.%26aulast%3DLeitl%26aufirst%3DM.%26aulast%3DLai%26aufirst%3DM.%2BT.%26aulast%3DMunshi%26aufirst%3DV.%26aulast%3DMurphy%26aufirst%3DD.%26aulast%3DRickert%26aufirst%3DK.%26aulast%3DRiley%26aufirst%3DD.%26aulast%3DKrasowska-Zoladek%26aufirst%3DA.%26aulast%3DDaley%26aufirst%3DC.%26aulast%3DZuck%26aufirst%3DP.%26aulast%3DKane%26aufirst%3DS.%2BA.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DMaximizing%2520diversity%2520from%2520a%2520kinase%2520screen%253A%2520identification%2520of%2520novel%2520and%2520selective%2520pan-Trk%2520inhibitors%2520for%2520chronic%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D13%26spage%3D5800%26epage%3D5816%26doi%3D10.1021%2Fjm5006429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Choi, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rucker, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albaugh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopiuk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culazzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tompkins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phung, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreusch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhary, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prashad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molteni, V.</span><span> </span><span class="NLM_article-title">(R)-2-Phenylpyrrolidine substituted imidazopyridazines: A new class of potent and selective pan-TRK inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00050</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00050" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=562-567&issue=5&author=H.+S.+Choiauthor=P.+V.+Ruckerauthor=Z.+Wangauthor=Y.+Fanauthor=P.+Albaughauthor=G.+Chopiukauthor=F.+Gessierauthor=F.+Sunauthor=F.+Adrianauthor=G.+Liuauthor=T.+Hoodauthor=N.+Liauthor=Y.+Jiaauthor=J.+Cheauthor=S.+McCormackauthor=A.+Liauthor=J.+Liauthor=A.+Steffyauthor=A.+Culazzoauthor=C.+Tompkinsauthor=V.+Phungauthor=A.+Kreuschauthor=M.+Luauthor=B.+Huauthor=A.+Chaudharyauthor=M.+Prashadauthor=T.+Tuntlandauthor=B.+Liuauthor=J.+Harrisauthor=H.+M.+Seidelauthor=J.+Lorenauthor=V.+Molteni&title=%28R%29-2-Phenylpyrrolidine+substituted+imidazopyridazines%3A+A+new+class+of+potent+and+selective+pan-TRK+inhibitors&doi=10.1021%2Facsmedchemlett.5b00050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00050%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BS.%26aulast%3DRucker%26aufirst%3DP.%2BV.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DAlbaugh%26aufirst%3DP.%26aulast%3DChopiuk%26aufirst%3DG.%26aulast%3DGessier%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DAdrian%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DHood%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DMcCormack%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSteffy%26aufirst%3DA.%26aulast%3DCulazzo%26aufirst%3DA.%26aulast%3DTompkins%26aufirst%3DC.%26aulast%3DPhung%26aufirst%3DV.%26aulast%3DKreusch%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DChaudhary%26aufirst%3DA.%26aulast%3DPrashad%26aufirst%3DM.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DHarris%26aufirst%3DJ.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DLoren%26aufirst%3DJ.%26aulast%3DMolteni%26aufirst%3DV.%26atitle%3D%2528R%2529-2-Phenylpyrrolidine%2520substituted%2520imidazopyridazines%253A%2520A%2520new%2520class%2520of%2520potent%2520and%2520selective%2520pan-TRK%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D5%26spage%3D562%26epage%3D567%26doi%3D10.1021%2Facsmedchemlett.5b00050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyne, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaus, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thress, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span> </span><span class="NLM_article-title">Identification of 4-aminopyrazolylpyrimidines as potent inhibitors of Trk kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4672</span><span class="NLM_x">–</span> <span class="NLM_lpage">4684</span><span class="refDoi"> DOI: 10.1021/jm800343j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800343j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4672-4684&issue=15&author=T.+Wangauthor=M.+L.+Lambauthor=D.+A.+Scottauthor=H.+Wangauthor=M.+H.+Blockauthor=P.+D.+Lyneauthor=J.+W.+Leeauthor=A.+M.+Daviesauthor=H.-J.+Zhangauthor=Y.+Zhuauthor=F.+Guauthor=Y.+Hanauthor=B.+Wangauthor=P.+J.+Mohrauthor=R.+J.+Kausauthor=J.+A.+Joseyauthor=E.+Hoffmannauthor=K.+Thressauthor=T.+MacIntyreauthor=H.+Wangauthor=C.+A.+Omerauthor=D.+Yu&title=Identification+of+4-aminopyrazolylpyrimidines+as+potent+inhibitors+of+Trk+kinases&doi=10.1021%2Fjm800343j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm800343j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800343j%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DScott%26aufirst%3DD.%2BA.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DBlock%26aufirst%3DM.%2BH.%26aulast%3DLyne%26aufirst%3DP.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BW.%26aulast%3DDavies%26aufirst%3DA.%2BM.%26aulast%3DZhang%26aufirst%3DH.-J.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DF.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%2BJ.%26aulast%3DKaus%26aufirst%3DR.%2BJ.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DHoffmann%26aufirst%3DE.%26aulast%3DThress%26aufirst%3DK.%26aulast%3DMacIntyre%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DOmer%26aufirst%3DC.%2BA.%26aulast%3DYu%26aufirst%3DD.%26atitle%3DIdentification%2520of%25204-aminopyrazolylpyrimidines%2520as%2520potent%2520inhibitors%2520of%2520Trk%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D15%26spage%3D4672%26epage%3D4684%26doi%3D10.1021%2Fjm800343j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Thress, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macintyre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zage, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweidler-McKay, P. A.</span><span> </span><span class="NLM_article-title">Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1818</span><span class="NLM_x">–</span> <span class="NLM_lpage">1827</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-0036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1158%2F1535-7163.MCT-09-0036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=19509272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVymsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1818-1827&issue=7&author=K.+Thressauthor=T.+Macintyreauthor=H.+Wangauthor=D.+Whitstonauthor=Z.+Y.+Liuauthor=E.+Hoffmannauthor=T.+Wangauthor=J.+L.+Brownauthor=K.+Websterauthor=C.+Omerauthor=P.+E.+Zageauthor=L.+Zengauthor=P.+A.+Zweidler-McKay&title=Identification+and+preclinical+characterization+of+AZ-23%2C+a+novel%2C+selective%2C+and+orally+bioavailable+inhibitor+of+the+Trk+kinase+pathway&doi=10.1158%2F1535-7163.MCT-09-0036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway</span></div><div class="casAuthors">Thress, Kenneth; MacIntyre, Terry; Wang, Haiyun; Whitston, Dave; Liu, Zhong-Ying; Hoffmann, Ethan; Wang, Tao; Brown, Jeffrey L.; Webster, Kevin; Omer, Charles; Zage, Peter E.; Zeng, Lizhi; Zweidler-McKay, Patrick A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1818-1827</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Tropomyosin-related kinases (TrkA, TrkB, and TrkC) are receptor tyrosine kinases that, along with their ligands, the neurotrophins, are involved in neuronal cell growth, development, and survival.  The Trk-neurotrophin pathway may also play a role in tumorigenesis through oncogenic fusions, mutations, and autocrine signaling, prompting the development of novel Trk inhibitors as agents for cancer therapy.  This report describes the identification of AZ-23, a novel, potent, and selective Trk kinase inhibitor.  In vitro studies with AZ-23 showed improved selectivity over previous compds. and inhibition of Trk kinase activity in cells at low nanomolar concns.  AZ-23 showed in vivo TrkA kinase inhibition and efficacy in mice following oral administration in a TrkA-driven allograft model and significant tumor growth inhibition in a Trk-expressing xenograft model of neuroblastoma.  AZ-23 represents a potent and selective Trk kinase inhibitor from a novel series with the potential for use as a treatment for cancer. [Mol Cancer Ther 2009;8(7):1818-27].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG2uvCSID5vbVg90H21EOLACvtfcHk0lixg-YtAxTkcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVymsro%253D&md5=8501f75147407ee64920fd4f5e733536</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0036%26sid%3Dliteratum%253Aachs%26aulast%3DThress%26aufirst%3DK.%26aulast%3DMacintyre%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWhitston%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DZ.%2BY.%26aulast%3DHoffmann%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DBrown%26aufirst%3DJ.%2BL.%26aulast%3DWebster%26aufirst%3DK.%26aulast%3DOmer%26aufirst%3DC.%26aulast%3DZage%26aufirst%3DP.%2BE.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DZweidler-McKay%26aufirst%3DP.%2BA.%26atitle%3DIdentification%2520and%2520preclinical%2520characterization%2520of%2520AZ-23%252C%2520a%2520novel%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520the%2520Trk%2520kinase%2520pathway%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26issue%3D7%26spage%3D1818%26epage%3D1827%26doi%3D10.1158%2F1535-7163.MCT-09-0036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Peer, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brassil, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeill, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreisl, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figg, W. D.</span><span> </span><span class="NLM_article-title">A novel uHPLC-MS/MS method for the quantitation of AZD7451 (AZ12607092) in human plasma</span> <span class="citation_source-journal">J. Chromatogr. B: Anal. Technol. Biomed. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">942–943</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1016/j.jchromb.2013.10.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.jchromb.2013.10.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=24239935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSjsr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=942%E2%80%93943&publication_year=2013&pages=107-112&author=C.+J.+Peerauthor=J.+L.+Brownauthor=T.+J.+Martinauthor=J.+Rothauthor=S.+D.+Spencerauthor=P.+Brassilauthor=K.+A.+McNeillauthor=T.+N.+Kreislauthor=H.+A.+Fineauthor=W.+D.+Figg&title=A+novel+uHPLC-MS%2FMS+method+for+the+quantitation+of+AZD7451+%28AZ12607092%29+in+human+plasma&doi=10.1016%2Fj.jchromb.2013.10.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">A novel uHPLC-MS/MS method for the quantitation of AZD7451 (AZ12607092) in human plasma</span></div><div class="casAuthors">Peer, Cody J.; Brown, Jeffrey L.; Martin, Timothy J.; Roth, Jeffrey; Spencer, Shawn D.; Brassil, Patrick; McNeill, Katharine A.; Kreisl, Teri N.; Fine, Howard A.; Figg, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">942-943</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107-112</span>CODEN:
                <span class="NLM_cas:coden">JCBAAI</span>;
        ISSN:<span class="NLM_cas:issn">1570-0232</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tropomyosin-related kinases (Trk) are tyrosine kinase receptors implicated in tumor proliferation, invasion, and survival signaling across a no. of tumors, making them potentially attractive targets for the treatment of cancer.  AZD7451 is a potent and selective inhibitor of Trk kinases currently undergoing a Phase I dose escalation in glioblastoma multiforme at the National Cancer Institute.  A key part of early clin. testing for AZD7451 involves demonstrating that pharmacokinetic half-life and clin. exposures of AZD7451 are sufficient to inhibit Trk receptors in preclin. models.  To address this need, an ultra sensitive anal. method was developed to measure the AZD7451 profile in human plasma.  A liq.-liq. extn. recovered >80% of AZD7451 before quant. anal. by ultra HPLC-MS/MS.  A Varian Polaris C18-A column and a mass transition of m/z 383.5 → 340.5 (m/z 389.6 → 342.0 for the internal std. [2H6]-AZD7451) was used, and a dynamic calibration range of 0.5-1000 ng/mL was established, which provided a sensitive (<8.5% deviation), and precise (<6%) quant. assay for AZD7451.  AZD7451 demonstrated stability in human plasma at room temp. for 24 h (<7% change) and after extn. at 4 °C for 24 h (<8% change), and was stable through 4 freeze/thaw cycles (<8% change).  This method was used to measure AZD7451 plasma levels in clin. samples to confirm the sensitivity at several time points following AZD7451 treatment in subjects with glioblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2cHE9S8DbbbVg90H21EOLACvtfcHk0lhLZ88sijVk9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSjsr7J&md5=5581356ffce207f1bdd08dcf7857be8f</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.jchromb.2013.10.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jchromb.2013.10.023%26sid%3Dliteratum%253Aachs%26aulast%3DPeer%26aufirst%3DC.%2BJ.%26aulast%3DBrown%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DT.%2BJ.%26aulast%3DRoth%26aufirst%3DJ.%26aulast%3DSpencer%26aufirst%3DS.%2BD.%26aulast%3DBrassil%26aufirst%3DP.%26aulast%3DMcNeill%26aufirst%3DK.%2BA.%26aulast%3DKreisl%26aufirst%3DT.%2BN.%26aulast%3DFine%26aufirst%3DH.%2BA.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26atitle%3DA%2520novel%2520uHPLC-MS%252FMS%2520method%2520for%2520the%2520quantitation%2520of%2520AZD7451%2520%2528AZ12607092%2529%2520in%2520human%2520plasma%26jtitle%3DJ.%2520Chromatogr.%2520B%253A%2520Anal.%2520Technol.%2520Biomed.%2520Life%2520Sci.%26date%3D2013%26volume%3D942%25E2%2580%2593943%26spage%3D107%26epage%3D112%26doi%3D10.1016%2Fj.jchromb.2013.10.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Ängeby Möller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berge, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenfors, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, C. I.</span><span> </span><span class="NLM_article-title">Using gait analysis to assess weight bearing in rats with Freunds complete adjuvant-induced monoarthritis to improve predictivity: Interfering with the cyclooxygenase and nerve growth factor pathways</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">756</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2015.02.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.ejphar.2015.02.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=25792342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADC%252BC2MnmtFyqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=756&publication_year=2015&pages=75-84&author=K.+%C3%84ngeby+M%C3%B6llerauthor=O.+G.+Bergeauthor=A.+Finnauthor=C.+Stenforsauthor=C.+I.+Svensson&title=Using+gait+analysis+to+assess+weight+bearing+in+rats+with+Freunds+complete+adjuvant-induced+monoarthritis+to+improve+predictivity%3A+Interfering+with+the+cyclooxygenase+and+nerve+growth+factor+pathways&doi=10.1016%2Fj.ejphar.2015.02.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Using gait analysis to assess weight bearing in rats with Freund s complete adjuvant-induced monoarthritis to improve predictivity: Interfering with the cyclooxygenase and nerve growth factor pathways</span></div><div class="casAuthors">Angeby Moller Kristina; Berge Odd-Geir; Finn Anja; Svensson Camilla I; Stenfors Carina</div><div class="citationInfo"><span class="NLM_cas:title">European journal of pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">756</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lack of predictive power for drug effects has been a major criticism against animal pain models.  It is therefore important to define the utility and limitations of different models.  The aim of this study was to extend previous work on gait analysis as a tool to investigate pharmacological effects in monoarthritic rats, specifically to test the hypothesis that monoarthritis induced by Freund s complete adjuvant (FCA) provides a better estimate of overall analgesic efficacy of established, and novel, clinically effective and ineffective therapeutic approaches.  Male rats injected intra-articularly into one ankle joint with FCA (1.0mg/ml) were treated with the monoclonal antibody to nerve growth factor (NGF), MEDI-578, the inhibitors of tropomyosin receptor kinases A, B and C (pan-Trk) AZ6623 or AZ7092, the transient receptor potential vanilloid 1 (TRPV1) inhibitor AZD1386, or the cyclooxygenase (COX) inhibitors naproxen, ibuprofen, valdecoxib or rofecoxib.  Effects on weight bearing during locomotion were tested using video capture of print images.  The apparent efficacy in this model was Trk inhibitors≥anti-NGF antibody>COX inhibitors.  The TRPV1 inhibitor was ineffective.  Together with previous data, the results support using gait-related parameters in the monoarthritis model.  FCA as induction agent seems to provide a good overall prediction of analgesic efficacy in disorders with inflammatory joint pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTQ30J7GRfW7ftos8R3JUhXfW6udTcc2eYzroNNUzLJ5Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnmtFyqtQ%253D%253D&md5=ceed9ee163ac51450b928170822887b1</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.02.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.02.050%26sid%3Dliteratum%253Aachs%26aulast%3D%25C3%2584ngeby%2BM%25C3%25B6ller%26aufirst%3DK.%26aulast%3DBerge%26aufirst%3DO.%2BG.%26aulast%3DFinn%26aufirst%3DA.%26aulast%3DStenfors%26aufirst%3DC.%26aulast%3DSvensson%26aufirst%3DC.%2BI.%26atitle%3DUsing%2520gait%2520analysis%2520to%2520assess%2520weight%2520bearing%2520in%2520rats%2520with%2520Freunds%2520complete%2520adjuvant-induced%2520monoarthritis%2520to%2520improve%2520predictivity%253A%2520Interfering%2520with%2520the%2520cyclooxygenase%2520and%2520nerve%2520growth%2520factor%2520pathways%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D756%26spage%3D75%26epage%3D84%26doi%3D10.1016%2Fj.ejphar.2015.02.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Skerratt, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagal, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilsland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bungay, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morao, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedderman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skinner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupple, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldrona, G.</span><span> </span><span class="NLM_article-title">he Discovery of a Potent, Selective and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of Pain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00850</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00850" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+E.+Skerrattauthor=M.+Andrewsauthor=S.+K.+Bagalauthor=J.+Bilslandauthor=D.+Brownauthor=P.+J.+Bungayauthor=S.+Coleauthor=K.+R.+Gibsonauthor=R.+Jonesauthor=I.+Moraoauthor=A.+Neddermanauthor=K.+Omotoauthor=C.+Robinsonauthor=T.+Ryckmansauthor=K.+Skinnerauthor=P.+Stuppleauthor=G.+Waldrona&title=he+Discovery+of+a+Potent%2C+Selective+and+Peripherally+Restricted+Pan-Trk+Inhibitor+%28PF-06273340%29+for+the+Treatment+of+Pain&doi=10.1021%2Facs.jmedchem.6b00850"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00850%26sid%3Dliteratum%253Aachs%26aulast%3DSkerratt%26aufirst%3DS.%2BE.%26aulast%3DAndrews%26aufirst%3DM.%26aulast%3DBagal%26aufirst%3DS.%2BK.%26aulast%3DBilsland%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBungay%26aufirst%3DP.%2BJ.%26aulast%3DCole%26aufirst%3DS.%26aulast%3DGibson%26aufirst%3DK.%2BR.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DMorao%26aufirst%3DI.%26aulast%3DNedderman%26aufirst%3DA.%26aulast%3DOmoto%26aufirst%3DK.%26aulast%3DRobinson%26aufirst%3DC.%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DSkinner%26aufirst%3DK.%26aulast%3DStupple%26aufirst%3DP.%26aulast%3DWaldrona%26aufirst%3DG.%26atitle%3Dhe%2520Discovery%2520of%2520a%2520Potent%252C%2520Selective%2520and%2520Peripherally%2520Restricted%2520Pan-Trk%2520Inhibitor%2520%2528PF-06273340%2529%2520for%2520the%2520Treatment%2520of%2520Pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26doi%3D10.1021%2Facs.jmedchem.6b00850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Andrews, S. W.</span>Allosteric Small Molecule Inhibitors of the NGF/TrkA Pathway, A New Approach to Treating Inflammatory Pain; <span class="NLM_publisher-name">Array Biopharma Publications</span>: <span class="NLM_publisher-loc">Boulder, CO</span>; <a href="http://www.arraybiopharma.com/files/6313/9810/8021/PubAttachment587.pdf" class="extLink">http://www.arraybiopharma.com/files/6313/9810/8021/PubAttachment587.pdf</a> (accessed August 25,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+W.+Andrews&title=Allosteric+Small+Molecule+Inhibitors+of+the+NGF%2FTrkA+Pathway%2C+A+New+Approach+to+Treating+Inflammatory+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26jtitle%3DAllosteric%2520Small%2520Molecule%2520Inhibitors%2520of%2520the%2520NGF%252FTrkA%2520Pathway%252C%2520A%2520New%2520Approach%2520to%2520Treating%2520Inflammatory%2520Pain%26pub%3DArray%2520Biopharma%2520Publications%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Burris, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brose, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farago, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebele, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruickshank, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, J. A.</span><span> </span><span class="NLM_article-title">A first-in-human study of LOXO-101, a highly selective inhibitor of the tropomyosin receptor kinase (TRK) family</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">15 suppl</span><span class="NLM_x">) </span> <span class="NLM_fpage">TPS2624</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=TPS2624&issue=15+suppl&author=H.+A.+Burrisauthor=M.+S.+Broseauthor=A.+T.+Shawauthor=T.+M.+Bauerauthor=A.+F.+Faragoauthor=R.+C.+Doebeleauthor=S.+Smithauthor=M.+Fernandesauthor=S.+Cruickshankauthor=J.+A.+Low&title=A+first-in-human+study+of+LOXO-101%2C+a+highly+selective+inhibitor+of+the+tropomyosin+receptor+kinase+%28TRK%29+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DBrose%26aufirst%3DM.%2BS.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DBauer%26aufirst%3DT.%2BM.%26aulast%3DFarago%26aufirst%3DA.%2BF.%26aulast%3DDoebele%26aufirst%3DR.%2BC.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DFernandes%26aufirst%3DM.%26aulast%3DCruickshank%26aufirst%3DS.%26aulast%3DLow%26aufirst%3DJ.%2BA.%26atitle%3DA%2520first-in-human%2520study%2520of%2520LOXO-101%252C%2520a%2520highly%2520selective%2520inhibitor%2520of%2520the%2520tropomyosin%2520receptor%2520kinase%2520%2528TRK%2529%2520family%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2015%26volume%3D33%26issue%3D15%2520suppl%26spage%3DTPS2624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Gomez Tromp, A.; Bouhana, K. S.; Jiang, Y.; Seo, J.; Wallace, R. D.; Lee, P. A.; Andrews, S. W.</span>Potent and Selective, Oral Small Molecule Inhibitors of Tropomyosin-Related Receptor Kinase A (TrkA) for the Treatment of Pain; <span class="NLM_publisher-name">Array Biopharma Publications</span>: <span class="NLM_publisher-loc">Boulder, CO</span>; <a href="http://www.arraybiopharma.com/files/9413/9810/7989/PubAttachment533.pdf" class="extLink">http://www.arraybiopharma.com/files/9413/9810/7989/PubAttachment533.pdf</a> (accessed August 25,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Gomez+Tromp&author=K.+S.+Bouhana&author=Y.+Jiang&author=J.+Seo&author=R.+D.+Wallace&author=P.+A.+Lee&author=S.+W.+Andrews&title=Potent+and+Selective%2C+Oral+Small+Molecule+Inhibitors+of+Tropomyosin-Related+Receptor+Kinase+A+%28TrkA%29+for+the+Treatment+of+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DGomez%2BTromp%26aufirst%3DA.%26jtitle%3DPotent%2520and%2520Selective%252C%2520Oral%2520Small%2520Molecule%2520Inhibitors%2520of%2520Tropomyosin-Related%2520Receptor%2520Kinase%2520A%2520%2528TrkA%2529%2520for%2520the%2520Treatment%2520of%2520Pain%26pub%3DArray%2520Biopharma%2520Publications%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Bouhana, K. S.; Pheneger, J.; Gomez, A. M.; Wallace, R. D.; Jiang, Y.; Seo, J.; Lee, P. A.; Andrews, S. W.</span>Oral selective small molecule inhibitors of the TrkA receptor are disease modifying and provide pain relief in a rat rheumatoid arthritis model<span class="NLM_publisher-name">Array Biopharma Publications</span>: <span class="NLM_publisher-loc">Boulder, CO</span>; <a href="http://www.arraybiopharma.com/files/1113/9810/7998/PubAttachment532.pdf" class="extLink">http://www.arraybiopharma.com/files/1113/9810/7998/PubAttachment532.pdf</a> (accessed<span class="NLM_x"> </span><span class="NLM_year">August 25, 2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=August+25%2C+2016&author=K.+S.+Bouhana&author=J.+Pheneger&author=A.+M.+Gomez&author=R.+D.+Wallace&author=Y.+Jiang&author=J.+Seo&author=P.+A.+Lee&author=S.+W.+Andrews&title=Oral+selective+small+molecule+inhibitors+of+the+TrkA+receptor+are+disease+modifying+and+provide+pain+relief+in+a+rat+rheumatoid+arthritis+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DBouhana%26aufirst%3DK.%2BS.%26jtitle%3DOral%2520selective%2520small%2520molecule%2520inhibitors%2520of%2520the%2520TrkA%2520receptor%2520are%2520disease%2520modifying%2520and%2520provide%2520pain%2520relief%2520in%2520a%2520rat%2520rheumatoid%2520arthritis%2520model%26pub%3DArray%2520Biopharma%2520Publications%26date%3DAugust%252025%252C%25202016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Nwosu, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mapp, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, D. A.</span><span> </span><span class="NLM_article-title">Blocking the tropomyosin receptor kinase A (TrkA) receptor inhibits pain behaviour in two rat models of osteoarthritis</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1246</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span><span class="refDoi"> DOI: 10.1136/annrheumdis-2014-207203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1136%2Fannrheumdis-2014-207203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=26286016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivV2qtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2016&pages=1246-1254&issue=6&author=L.+N.+Nwosuauthor=P.+I.+Mappauthor=V.+Chapmanauthor=D.+A.+Walsh&title=Blocking+the+tropomyosin+receptor+kinase+A+%28TrkA%29+receptor+inhibits+pain+behaviour+in+two+rat+models+of+osteoarthritis&doi=10.1136%2Fannrheumdis-2014-207203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Blocking the tropomyosin receptor kinase A (TrkA) receptor inhibits pain behaviour in two rat models of osteoarthritis</span></div><div class="casAuthors">Nwosu, Lilian N.; Mapp, Paul I.; Chapman, Victoria; Walsh, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1246-1254</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Objectives: Tropomyosin receptor kinase A (TrkA) mediates nociceptor sensitization by nerve growth factor (NGF), but it is unknown whether selective TrkA inhibition will be an effective strategy for treating osteoarthritis (OA) pain.  We detd. the effects of a TrkA inhibitor (AR786) on pain behavior, synovitis and joint pathol. in two rat OA models.  Methods: Knee OA was induced in rats by intraarticular monosodium-iodoacetate (MIA) injection or meniscal transection (MNX) and compared with saline injected or sham-operated controls.  Pain behavior was assessed as wt.-bearing asymmetry and paw withdrawal threshold to punctate stimulation.  Oral doses (30 mg/kg) of AR786 or vehicle were administered twice daily in either preventive (day -1 to -27) or treatment (day 14-28) protocols.  Effect maintenance was evaluated for 2 wk after treatment discontinuation.  Alterations in knee structure (cartilage, subchondral bone and synovium) were examd. by macroscopic visualization of articular surfaces and histopathol.  Results: Preventive AR786 treatment inhibited pain behavior development and therapeutic treatment attenuated established pain behavior.  Wt.-bearing asymmetry increased 1 wk after treatment discontinuation, but remained less than in vehicle-treated arthritic rats, whereas paw withdrawal thresholds returned to levels of untreated rats within 5 days of treatment discontinuation.  AR786 treatment reduced MIA-induced synovitis and did not significantly affect osteochondral pathol. in either model.  Conclusions: Blocking NGF activity by inhibiting TrkA reduced pain behavior in two rat models of OA.  Analgesia was obsd. both using preventive and treatment protocols, and was sustained after treatment discontinuation.  Selective inhibitors of TrkA therefore hold potential for OA pain relief.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWAm0vTz5k3rVg90H21EOLACvtfcHk0lhQEvY_rSW5jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivV2qtrc%253D&md5=a0159f007c97c40704266844aad93ca1</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2014-207203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2014-207203%26sid%3Dliteratum%253Aachs%26aulast%3DNwosu%26aufirst%3DL.%2BN.%26aulast%3DMapp%26aufirst%3DP.%2BI.%26aulast%3DChapman%26aufirst%3DV.%26aulast%3DWalsh%26aufirst%3DD.%2BA.%26atitle%3DBlocking%2520the%2520tropomyosin%2520receptor%2520kinase%2520A%2520%2528TrkA%2529%2520receptor%2520inhibits%2520pain%2520behaviour%2520in%2520two%2520rat%2520models%2520of%2520osteoarthritis%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2016%26volume%3D75%26issue%3D6%26spage%3D1246%26epage%3D1254%26doi%3D10.1136%2Fannrheumdis-2014-207203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Ashraf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouhana, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pheneger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, D. A.</span><span> </span><span class="NLM_article-title">Selective inhibition of tropomyosin-receptor-kinase A (TrkA) reduces pain and joint damage in two rat models of inflammatory arthritis</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">97</span><span class="refDoi"> DOI: 10.1186/s13075-016-0996-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1186%2Fs13075-016-0996-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=27145816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADC%252BC28bmsFenuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=97&issue=1&author=S.+Ashrafauthor=K.+S.+Bouhanaauthor=J.+Phenegerauthor=S.+W.+Andrewsauthor=D.+A.+Walsh&title=Selective+inhibition+of+tropomyosin-receptor-kinase+A+%28TrkA%29+reduces+pain+and+joint+damage+in+two+rat+models+of+inflammatory+arthritis&doi=10.1186%2Fs13075-016-0996-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of tropomyosin-receptor-kinase A (TrkA) reduces pain and joint damage in two rat models of inflammatory arthritis</span></div><div class="casAuthors">Ashraf Sadaf; Walsh David A; Bouhana Karyn S; Pheneger Jed; Andrews Steven W</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis research & therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Inflammation is an essential component of arthritis pain.  Nerve growth factor (NGF) plays a key role in acute and chronic pain states especially those associated with inflammation.  NGF acts through tropomyosin-receptor-kinase A (TrkA).  NGF blockade has reduced arthritis pain in clinical trials.  We explored the mechanisms within the joint which may contribute to the analgesic effects of NGF by selectively inhibiting TrkA in carrageenan-induced or collagen-induced joint pain behaviour.  The goal of the current study was to elucidate whether inflammation is central to the efficacy for NGF blockade.  METHODS:  Rats were injected in their left knees with 2 % carrageenan or saline.  Collagen-induced arthritis (CIA) was induced by intradermal injections of a mixture of bovine type II collagen (0.2 mg) and incomplete Freund's adjuvant (0.2 mg).  Oral doses (30 mg/kg) of AR786 or vehicle control were given twice daily after arthritis induction.  Ibuprofen-treated (35 mg/kg, orally, once daily) rats with CIA were used as positive analgesic controls.  Pain behaviour was measured as hind-limb weight-bearing asymmetry and hind-paw withdrawal thresholds to von Frey hair stimulation (carrageenan synovitis), or withdrawal to joint compression using a Randall Selitto device (CIA).  Inflammation was measured as increased knee joint diameter and by histopathological analysis.  RESULTS:  Intra-articular injections of carrageenan or induction of CIA was each associated with pain behaviour and synovial inflammation.  Systemic administration of the TrkA inhibitor AR786 reduced carrageenan-induced or CIA-induced pain behaviour to control values, and inhibited joint swelling and histological evidence of synovial inflammation and joint damage.  CONCLUSIONS:  By using two models of varying inflammation we demonstrate for the first time that selective inhibition of TrkA may reduce carrageenan-induced or CIA-induced pain behaviour in rats, in part through potentially inhibiting synovial inflammation, although direct effects on sensory nerves are also likely.  Our observations suggest that inflammatory arthritis causes pain and the presence of inflammation is fundamental to the beneficial effects (reduction in pain and pathology) of NGF blockade.  Further research should determine whether TrkA inhibition may ameliorate human inflammatory arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfpZvkFFze1ohLSh9fo81bfW6udTcc2eZLj6cEp40Qy7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bmsFenuw%253D%253D&md5=c9802179f8aa6e07b4fe5ff3a4e92a0b</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1186%2Fs13075-016-0996-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13075-016-0996-z%26sid%3Dliteratum%253Aachs%26aulast%3DAshraf%26aufirst%3DS.%26aulast%3DBouhana%26aufirst%3DK.%2BS.%26aulast%3DPheneger%26aufirst%3DJ.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DWalsh%26aufirst%3DD.%2BA.%26atitle%3DSelective%2520inhibition%2520of%2520tropomyosin-receptor-kinase%2520A%2520%2528TrkA%2529%2520reduces%2520pain%2520and%2520joint%2520damage%2520in%2520two%2520rat%2520models%2520of%2520inflammatory%2520arthritis%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2016%26volume%3D18%26issue%3D1%26spage%3D97%26doi%3D10.1186%2Fs13075-016-0996-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Andrews, S. W.; Blake, J. F.; Brandhuber, B. J.; Kercher, T.; Winski, S. L.</span><span> </span><span class="NLM_article-title"><i>N</i>-(Monocyclic aryl), <i>N</i>′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors</span>. WO2014/078325A1, May 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+W.+Andrews&author=J.+F.+Blake&author=B.+J.+Brandhuber&author=T.+Kercher&author=S.+L.+Winski&title=N-%28Monocyclic+aryl%29%2C+N%E2%80%B2-pyrazolyl-urea%2C+thiourea%2C+guanidine+and+cyanoguanidine+compounds+as+TrkA+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26atitle%3DN-%2528Monocyclic%2520aryl%2529%252C%2520N%25E2%2580%25B2-pyrazolyl-urea%252C%2520thiourea%252C%2520guanidine%2520and%2520cyanoguanidine%2520compounds%2520as%2520TrkA%2520kinase%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Brandhuber, B. J.; Jiang, Y.; Kolakowski, G. R.; Winski, S. L.</span><span> </span><span class="NLM_article-title">Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors</span>. WO2014/078417A1, May 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=B.+J.+Brandhuber&author=Y.+Jiang&author=G.+R.+Kolakowski&author=S.+L.+Winski&title=Pyrazolyl+urea%2C+thiourea%2C+guanidine+and+cyanoguanidine+compounds+as+TrkA+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrandhuber%26aufirst%3DB.%2BJ.%26atitle%3DPyrazolyl%2520urea%252C%2520thiourea%252C%2520guanidine%2520and%2520cyanoguanidine%2520compounds%2520as%2520TrkA%2520kinase%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Brandhuber, B. J.; Jiang, Y.; Kolakowski, G. R.; Winski, S. L.</span><span> </span><span class="NLM_article-title">Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors</span>. WO2014/078322A1, May 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=B.+J.+Brandhuber&author=Y.+Jiang&author=G.+R.+Kolakowski&author=S.+L.+Winski&title=Thiazolyl+and+oxazolyl+urea%2C+thiourea%2C+guanidine+and+cyanoguanidine+compounds+as+TrkA+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrandhuber%26aufirst%3DB.%2BJ.%26atitle%3DThiazolyl%2520and%2520oxazolyl%2520urea%252C%2520thiourea%252C%2520guanidine%2520and%2520cyanoguanidine%2520compounds%2520as%2520TrkA%2520kinase%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Allen, S.; Brandhuber, B. J.; Kercher, T.; Kolakowski, G. R.; Winski, S. L.</span><span> </span><span class="NLM_article-title"><i>N</i>-Pyrrolidinyl, <i>N</i>′-pyrazolyl- urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors</span>. WO2014/078323A1, May 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Allen&author=B.+J.+Brandhuber&author=T.+Kercher&author=G.+R.+Kolakowski&author=S.+L.+Winski&title=N-Pyrrolidinyl%2C+N%E2%80%B2-pyrazolyl-+urea%2C+thiourea%2C+guanidine+and+cyanoguanidine+compounds+as+TrkA+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DS.%26atitle%3DN-Pyrrolidinyl%252C%2520N%25E2%2580%25B2-pyrazolyl-%2520urea%252C%2520thiourea%252C%2520guanidine%2520and%2520cyanoguanidine%2520compounds%2520as%2520TrkA%2520kinase%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Allen, S.; Blake, J. F.; Brandhuber, B. J.; Jiang, Y.; Kolakowski, G. R.; Xu, R.; Winski, S. L.</span><span> </span><span class="NLM_article-title"><i>N</i>-Bicyclic aryl,<i>N</i>′-pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors</span>. WO2014/078328A1, May 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Allen&author=J.+F.+Blake&author=B.+J.+Brandhuber&author=Y.+Jiang&author=G.+R.+Kolakowski&author=R.+Xu&author=S.+L.+Winski&title=N-Bicyclic+aryl%2CN%E2%80%B2-pyrazolyl+urea%2C+thiourea%2C+guanidine+and+cyanoguanidine+compounds+as+TrkA+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DS.%26atitle%3DN-Bicyclic%2520aryl%252CN%25E2%2580%25B2-pyrazolyl%2520urea%252C%2520thiourea%252C%2520guanidine%2520and%2520cyanoguanidine%2520compounds%2520as%2520TrkA%2520kinase%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Blake, J. F.; Brandhuber, B. J.; Haas, J.; Newhouse, B.; Thomas, A. A.; Winski, S. L.</span><span> </span><span class="NLM_article-title"><i>N</i>-(Arylalkyl)-<i>N</i>′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors</span>. WO2014/078331A1, May 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=J.+F.+Blake&author=B.+J.+Brandhuber&author=J.+Haas&author=B.+Newhouse&author=A.+A.+Thomas&author=S.+L.+Winski&title=N-%28Arylalkyl%29-N%E2%80%B2-pyrazolyl-urea%2C+thiourea%2C+guanidine+and+cyanoguanidine+compounds+as+TrkA+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlake%26aufirst%3DJ.%2BF.%26atitle%3DN-%2528Arylalkyl%2529-N%25E2%2580%25B2-pyrazolyl-urea%252C%2520thiourea%252C%2520guanidine%2520and%2520cyanoguanidine%2520compounds%2520as%2520TrkA%2520kinase%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Allen, S.; Andrews, S. W.; Blake, J. F.; Brandhuber, B. J.; Jiang, Y.; Kercher, T.; Winski, S. L.</span><span> </span><span class="NLM_article-title">Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors</span>. WO2014/078372A1, May 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Allen&author=S.+W.+Andrews&author=J.+F.+Blake&author=B.+J.+Brandhuber&author=Y.+Jiang&author=T.+Kercher&author=S.+L.+Winski&title=Pyrrolidinyl+urea%2C+thiourea%2C+guanidine+and+cyanoguanidine+compounds+as+TrkA+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DS.%26atitle%3DPyrrolidinyl%2520urea%252C%2520thiourea%252C%2520guanidine%2520and%2520cyanoguanidine%2520compounds%2520as%2520TrkA%2520kinase%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Allen, S.; Andrews, S. W.; Blake, J. F.; Brandhuber, B. J.; Condroski, K. R.; Haas, J.; Jiang, Y.; Kercher, T.; Kolakowski, G. R.; Winski, S. L.</span><span> </span><span class="NLM_article-title">Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors</span>. WO2014/078378A1, May 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Allen&author=S.+W.+Andrews&author=J.+F.+Blake&author=B.+J.+Brandhuber&author=K.+R.+Condroski&author=J.+Haas&author=Y.+Jiang&author=T.+Kercher&author=G.+R.+Kolakowski&author=S.+L.+Winski&title=Pyrrolidinyl+urea%2C+thiourea%2C+guanidine+and+cyanoguanidine+compounds+as+TrkA+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DS.%26atitle%3DPyrrolidinyl%2520urea%252C%2520thiourea%252C%2520guanidine%2520and%2520cyanoguanidine%2520compounds%2520as%2520TrkA%2520kinase%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Allen, S.; Brandhuber, B. J.; Condroski, K. R.; Huang, L.; Kercher, T.; Winski, S. L.</span><span> </span><span class="NLM_article-title">Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors</span>. WO2014/078408A1, May 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Allen&author=B.+J.+Brandhuber&author=K.+R.+Condroski&author=L.+Huang&author=T.+Kercher&author=S.+L.+Winski&title=Bicyclic+heteroaryl+urea%2C+thiourea%2C+guanidine+and+cyanoguanidine+compounds+as+TrkA+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DS.%26atitle%3DBicyclic%2520heteroaryl%2520urea%252C%2520thiourea%252C%2520guanidine%2520and%2520cyanoguanidine%2520compounds%2520as%2520TrkA%2520kinase%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Allen, S.; Andrews, S. W.; Blake, J. F.; Brandhuber, B. J.; Haas, J.; Jiang, Y.; Kercher, T.; Kolakowski, G. R.; Thomas, A. A.; Winski, S. L.</span><span> </span><span class="NLM_article-title">Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain</span>. WO2014/078454A1, May 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Allen&author=S.+W.+Andrews&author=J.+F.+Blake&author=B.+J.+Brandhuber&author=J.+Haas&author=Y.+Jiang&author=T.+Kercher&author=G.+R.+Kolakowski&author=A.+A.+Thomas&author=S.+L.+Winski&title=Bicyclic+urea%2C+thiourea%2C+guanidine+and+cyanoguanidine+compounds+useful+for+the+treatment+of+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DS.%26atitle%3DBicyclic%2520urea%252C%2520thiourea%252C%2520guanidine%2520and%2520cyanoguanidine%2520compounds%2520useful%2520for%2520the%2520treatment%2520of%2520pain%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span> </span><span class="NLM_article-title">Array Biopharma and Asahi Kasei Pharma Corporation announce development and commercialization collaboration for novel pain and inflammation program</span>. Array Biopharma News; <span class="NLM_publisher-name">Array BioPharma</span>: <span class="NLM_publisher-loc">Boulder, CO</span>, March 31,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span><a href="http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&amp;p=irol-newsArticle&amp;ID=2152125" class="extLink">http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-newsArticle&ID=2152125</a> (accessed August 25,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Array+Biopharma+and+Asahi+Kasei+Pharma+Corporation+announce+development+and+commercialization+collaboration+for+novel+pain+and+inflammation+program.+Array+Biopharma+News%3B+Array+BioPharma%3A+Boulder%2C+CO%2C+March+31%2C+2016%3B+http%3A%2F%2Finvestor.arraybiopharma.com%2Fphoenix.zhtml%3Fc%3D123810%26p%3Dirol-newsArticle%26ID%3D2152125+%28accessed+August+25%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DArray%2520Biopharma%2520and%2520Asahi%2520Kasei%2520Pharma%2520Corporation%2520announce%2520development%2520and%2520commercialization%2520collaboration%2520for%2520novel%2520pain%2520and%2520inflammation%2520program%26jtitle%3DArray%2520Biopharma%2520News%26pub%3DArray%2520BioPharma%26date%3D2016%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Shipe, W.; Mercer, S.; Fraley, M.; Wood, B.; Babaoglu, K.; Bhandari, N.; Boyce, C.; Chen, Y.; Cooke, A.; Feng, K.; Henze, D.; Kim, A.; Kuo, Y.; Lee, J.; Liu, P.; Lu, X.; Ma, B.; Manley, P.; McCauley, J.; McWherter, M.; Meng, D.; Mitchell, H.; Morris, W.; Niu, X.; Parker, D.; Price, E.; Schirripa, K.; Struyk, A.; Stump, C.; Su, H.; Wu, J.</span><span> </span><span class="NLM_article-title">Lead optimization of a series of selective TrkA inhibitors for the treatment of pain</span>.  <span class="citation_source-book">251st National Meeting of the American Chemical Society, March 13–17, 2016, San Diego, CA</span>; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span> <span class="NLM_fpage">MEDI-23</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=MEDI-23&author=W.+Shipe&author=S.+Mercer&author=M.+Fraley&author=B.+Wood&author=K.+Babaoglu&author=N.+Bhandari&author=C.+Boyce&author=Y.+Chen&author=A.+Cooke&author=K.+Feng&author=D.+Henze&author=A.+Kim&author=Y.+Kuo&author=J.+Lee&author=P.+Liu&author=X.+Lu&author=B.+Ma&author=P.+Manley&author=J.+McCauley&author=M.+McWherter&author=D.+Meng&author=H.+Mitchell&author=W.+Morris&author=X.+Niu&author=D.+Parker&author=E.+Price&author=K.+Schirripa&author=A.+Struyk&author=C.+Stump&author=H.+Su&author=J.+Wu&title=251st+National+Meeting+of+the+American+Chemical+Society%2C+March+13%E2%80%9317%2C+2016%2C+San+Diego%2C+CA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DShipe%26aufirst%3DW.%26atitle%3DLead%2520optimization%2520of%2520a%2520series%2520of%2520selective%2520TrkA%2520inhibitors%2520for%2520the%2520treatment%2520of%2520pain%26btitle%3D251st%2520National%2520Meeting%2520of%2520the%2520American%2520Chemical%2520Society%252C%2520March%252013%25E2%2580%259317%252C%25202016%252C%2520San%2520Diego%252C%2520CA%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2016%26spage%3DMEDI-23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Gingrich, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessner, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudkins, R. L.</span><span> </span><span class="NLM_article-title">Synthesis, Modeling, and In Vitro Activity of (3′S)-epi-K-252a Analogues. Elucidating the Stereochemical Requirements of the 3′-Sugar Alcohol on TrkA Tyrosine Kinase Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">3776</span><span class="NLM_x">–</span> <span class="NLM_lpage">3783</span><span class="refDoi"> DOI: 10.1021/jm040178m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040178m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3776-3783&issue=11&author=D.+E.+Gingrichauthor=S.+X.+Yangauthor=G.+W.+Gessnerauthor=T.+S.+Angelesauthor=R.+L.+Hudkins&title=Synthesis%2C+Modeling%2C+and+In+Vitro+Activity+of+%283%E2%80%B2S%29-epi-K-252a+Analogues.+Elucidating+the+Stereochemical+Requirements+of+the+3%E2%80%B2-Sugar+Alcohol+on+TrkA+Tyrosine+Kinase+Activity&doi=10.1021%2Fjm040178m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjm040178m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040178m%26sid%3Dliteratum%253Aachs%26aulast%3DGingrich%26aufirst%3DD.%2BE.%26aulast%3DYang%26aufirst%3DS.%2BX.%26aulast%3DGessner%26aufirst%3DG.%2BW.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26atitle%3DSynthesis%252C%2520Modeling%252C%2520and%2520In%2520Vitro%2520Activity%2520of%2520%25283%25E2%2580%25B2S%2529-epi-K-252a%2520Analogues.%2520Elucidating%2520the%2520Stereochemical%2520Requirements%2520of%2520the%25203%25E2%2580%25B2-Sugar%2520Alcohol%2520on%2520TrkA%2520Tyrosine%2520Kinase%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D11%26spage%3D3776%26epage%3D3783%26doi%3D10.1021%2Fjm040178m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Roblin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yosipovitch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickramasinghe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, P.</span><span> </span><span class="NLM_article-title">Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis</span> <span class="citation_source-journal">Acta Derm. Venereol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span><span class="refDoi"> DOI: 10.2340/00015555-2047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.2340%2F00015555-2047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=25594427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvFKlsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2015&pages=542-548&issue=5&author=D.+Roblinauthor=G.+Yosipovitchauthor=B.+Boyceauthor=J.+Robinsonauthor=J.+Sandyauthor=V.+Maineroauthor=R.+Wickramasingheauthor=U.+Anandauthor=P.+Anand&title=Topical+TrkA+Kinase+Inhibitor+CT327+is+an+Effective%2C+Novel+Therapy+for+the+Treatment+of+Pruritus+due+to+Psoriasis%3A+Results+from+Experimental+Studies%2C+and+Efficacy+and+Safety+of+CT327+in+a+Phase+2b+Clinical+Trial+in+Patients+with+Psoriasis&doi=10.2340%2F00015555-2047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Topical TrkA kinase inhibitor CT327 is an effective, novel therapy for the treatment of pruritus due to psoriasis: results from experimental studies, and efficacy and safety of CT327 in a phase 2b clinical trial in patients with psoriasis</span></div><div class="casAuthors">Roblin, David; Yosipovitch, Gil; Boyce, Brent; Robinson, John; Sandy, James; Mainero, Valentina; Wickramasinghe, Ro; Anand, Uma; Anand, Praveen</div><div class="citationInfo"><span class="NLM_cas:title">Acta Dermato-Venereologica</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">542-548</span>CODEN:
                <span class="NLM_cas:coden">ADVEA4</span>;
        ISSN:<span class="NLM_cas:issn">1651-2057</span>.
    
            (<span class="NLM_cas:orgname">Acta Dermato-Venereologica</span>)
        </div><div class="casAbstract">Pruritus is an important symptom in psoriasis with no targeted treatment.  Tropomyosin-receptor kinase A (TrkA) is assocd. with pruritus and psoriatic plaque formation.  We report the efficacy of a TrkA inhibitor, CT327, on pruritus in psoriasis.  A randomized, double-blind, vehicle-controlled Phase 2b clin. trial was conducted in 160 subjects.  No effect was found on psoriasis severity using Investigator's Global Assessment (primary endpoint).  However, clin. and statistically significant redns. in pruritus were obsd. in the 108 patient subset reporting at least moderate pruritus at baseline (37.1 mm visual analog scale improvement (95% CI [-37.5, -6.2], p = 0.0067) for lowest dose; secondary endpoint).  Significant modified Psoriasis Area and Severity Index redns. were found in this subset (p < 0.05).  Expts. exploring capsaicin-mediated calcium influx, important in pruritus signalling, were performed in sensory neurons.  CT327 inhibited capsaicin responses, indicating action at the nerve growth factor-TrkA-TRPV1 pathway.  TrkA is a key target in pruritus, and CT327 has potential to become an effective and safe first-in-class treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8WBRUrNe3eLVg90H21EOLACvtfcHk0liptxiJMZrdoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvFKlsrY%253D&md5=b4d26ea98f83154edab76a0a8546717e</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.2340%2F00015555-2047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2340%252F00015555-2047%26sid%3Dliteratum%253Aachs%26aulast%3DRoblin%26aufirst%3DD.%26aulast%3DYosipovitch%26aufirst%3DG.%26aulast%3DBoyce%26aufirst%3DB.%26aulast%3DRobinson%26aufirst%3DJ.%26aulast%3DSandy%26aufirst%3DJ.%26aulast%3DMainero%26aufirst%3DV.%26aulast%3DWickramasinghe%26aufirst%3DR.%26aulast%3DAnand%26aufirst%3DU.%26aulast%3DAnand%26aufirst%3DP.%26atitle%3DTopical%2520TrkA%2520Kinase%2520Inhibitor%2520CT327%2520is%2520an%2520Effective%252C%2520Novel%2520Therapy%2520for%2520the%2520Treatment%2520of%2520Pruritus%2520due%2520to%2520Psoriasis%253A%2520Results%2520from%2520Experimental%2520Studies%252C%2520and%2520Efficacy%2520and%2520Safety%2520of%2520CT327%2520in%2520a%2520Phase%25202b%2520Clinical%2520Trial%2520in%2520Patients%2520with%2520Psoriasis%26jtitle%3DActa%2520Derm.%2520Venereol.%26date%3D2015%26volume%3D95%26issue%3D5%26spage%3D542%26epage%3D548%26doi%3D10.2340%2F00015555-2047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Creabilis, S. A.</span><span> </span><span class="NLM_article-title">Creabilis Announces Headline Results of its Phase 2b Trial of Topical TrkA Kinase Inhibitor CT327</span>. PRNewswire, May 10,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span><a href="http://www.prnewswire.com/news-releases/creabilis-announces-headline-results-of-its-phase-2b-trial-of-topical-TrkA-kinase-inhibitor-ct327-206885021.html" class="extLink">http://www.prnewswire.com/news-releases/creabilis-announces-headline-results-of-its-phase-2b-trial-of-topical-TrkA-kinase-inhibitor-ct327-206885021.html</a> (accessed August 25,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+A.+Creabilis&title=Creabilis+Announces+Headline+Results+of+its+Phase+2b+Trial+of+Topical+TrkA+Kinase+Inhibitor+CT327"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DCreabilis%26aufirst%3DS.%2BA.%26atitle%3DCreabilis%2520Announces%2520Headline%2520Results%2520of%2520its%2520Phase%25202b%2520Trial%2520of%2520Topical%2520TrkA%2520Kinase%2520Inhibitor%2520CT327%26jtitle%3DPRNewswire%26date%3D2013%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Flannery, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasioli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donahue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gladysheva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dagher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vardanyan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bangari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourque, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philbrook, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, G. L.</span><span> </span><span class="NLM_article-title">Efficacy of a novel, locally delivered TrkA inhibitor in preclinical models of OA and joint pain</span> <span class="citation_source-journal">Osteoarthritis Cartilage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">A45</span><span class="NLM_x">–</span> <span class="NLM_lpage">A46</span><span class="refDoi"> DOI: 10.1016/j.joca.2015.02.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.joca.2015.02.100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=A45-A46&author=C.+R.+Flanneryauthor=N.+Moranauthor=D.+Blasioliauthor=K.+Donahueauthor=J.+Kaneauthor=T.+Gladyshevaauthor=R.+Dagherauthor=R.+Fangauthor=A.+Vardanyanauthor=D.+Bangariauthor=C.+Hoauthor=A.+Bourqueauthor=M.+Santosauthor=M.+Philbrookauthor=G.+L.+Matthews&title=Efficacy+of+a+novel%2C+locally+delivered+TrkA+inhibitor+in+preclinical+models+of+OA+and+joint+pain&doi=10.1016%2Fj.joca.2015.02.100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2015.02.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2015.02.100%26sid%3Dliteratum%253Aachs%26aulast%3DFlannery%26aufirst%3DC.%2BR.%26aulast%3DMoran%26aufirst%3DN.%26aulast%3DBlasioli%26aufirst%3DD.%26aulast%3DDonahue%26aufirst%3DK.%26aulast%3DKane%26aufirst%3DJ.%26aulast%3DGladysheva%26aufirst%3DT.%26aulast%3DDagher%26aufirst%3DR.%26aulast%3DFang%26aufirst%3DR.%26aulast%3DVardanyan%26aufirst%3DA.%26aulast%3DBangari%26aufirst%3DD.%26aulast%3DHo%26aufirst%3DC.%26aulast%3DBourque%26aufirst%3DA.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DPhilbrook%26aufirst%3DM.%26aulast%3DMatthews%26aufirst%3DG.%2BL.%26atitle%3DEfficacy%2520of%2520a%2520novel%252C%2520locally%2520delivered%2520TrkA%2520inhibitor%2520in%2520preclinical%2520models%2520of%2520OA%2520and%2520joint%2520pain%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2015%26volume%3D23%26spage%3DA45%26epage%3DA46%26doi%3D10.1016%2Fj.joca.2015.02.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><div class="note"><p class="first last">Sanofi</p></div>. <span> </span><span class="NLM_article-title">First-in-human study with ascending single intra-articular doses of GZ389988 in patients with painful osteoarthritis of the knee</span>.  <span class="citation_source-book">ClinicalTrials.gov</span>; <span class="NLM_publisher-name">National Library of Medicine (U.S.)</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="https://clinicaltrials.gov/ct2/show/NCT02424942" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02424942</a> (accessed August 25,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sanofi.+First-in-human+study+with+ascending+single+intra-articular+doses+of+GZ389988+in+patients+with+painful+osteoarthritis+of+the+knee.+ClinicalTrials.gov%3B+National+Library+of+Medicine+%28U.S.%29%3A+Bethesda%2C+MD%2C+2015%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02424942+%28accessed+August+25%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DFirst-in-human%2520study%2520with%2520ascending%2520single%2520intra-articular%2520doses%2520of%2520GZ389988%2520in%2520patients%2520with%2520painful%2520osteoarthritis%2520of%2520the%2520knee%26btitle%3DClinicalTrials.gov%26pub%3DNational%2520Library%2520of%2520Medicine%2520%2528U.S.%2529%26date%3D2015%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Kane, J. L.,  Jr.; Matthews, G.; Metz, M.; Kothe, M.; Liu, J.; Scholte, A.</span><span> </span><span class="NLM_article-title">Tropomyosin-related kinase (TRK) inhibitors</span>. US 2015/0158847A1, June 11,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+L.+Kane&author=G.+Matthews&author=M.+Metz&author=M.+Kothe&author=J.+Liu&author=A.+Scholte&title=Tropomyosin-related+kinase+%28TRK%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKane%26aufirst%3DJ.%2BL.%26atitle%3DTropomyosin-related%2520kinase%2520%2528TRK%2529%2520inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span> </span><span class="NLM_article-title">Purdue Pharma L.P. announces acquisition of TrkA program from VM Pharma LLC</span>. PRNewswire, September 8,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.prnewswire.com/news-releases/purdue-pharma-lp-announces-acquisition-of-TrkA-program-from-vm-pharma-llc-300138832.html" class="extLink">http://www.prnewswire.com/news-releases/purdue-pharma-lp-announces-acquisition-of-TrkA-program-from-vm-pharma-llc-300138832.html</a> (accessed August 25,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Purdue+Pharma+L.P.+announces+acquisition+of+TrkA+program+from+VM+Pharma+LLC.+PRNewswire%2C+September+8%2C+2015%3B+http%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fpurdue-pharma-lp-announces-acquisition-of-TrkA-program-from-vm-pharma-llc-300138832.html+%28accessed+August+25%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DPurdue%2520Pharma%2520L.P.%2520announces%2520acquisition%2520of%2520TrkA%2520program%2520from%2520VM%2520Pharma%2520LLC%26jtitle%3DPRNewswire%26date%3D2015%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Wu, J. J.; Wang, L.</span><span> </span><span class="NLM_article-title">Crystalline forms of tryosine kinase inhibitors and their salts</span>. US 2015/0174124A1, June 25,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+J.+Wu&author=L.+Wang&title=Crystalline+forms+of+tryosine+kinase+inhibitors+and+their+salts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%2BJ.%26atitle%3DCrystalline%2520forms%2520of%2520tryosine%2520kinase%2520inhibitors%2520and%2520their%2520salts%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Wu, J. J.</span><span> </span><span class="NLM_article-title">Compositions of compounds and uses thereof</span>. US 2015/0218132A1, August 6,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+J.+Wu&title=Compositions+of+compounds+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%2BJ.%26atitle%3DCompositions%2520of%2520compounds%2520and%2520uses%2520thereof%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Nagaura, T.; Yasuhiro, T.; Oda, K.; Ezaki, Y.; Koyanagi, T.; Itadani, S.; Nitta, H.; Wakazono, H.; Katsumata, S.; Hirota, Y.</span><span> </span><span class="NLM_article-title">Selective and peripheral-specific TRK inhibitor shows potent analgesic effect comparable to morphine in rat osteoarthritis model without cns toxicity</span>.  <span class="citation_source-book">Abstracts of Papers, American College or Rheumatology Annual Meeting, Boston, MA November 14–19, 2014</span>; <span class="NLM_publisher-name">American College of Rheumatology</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span> <span class="NLM_fpage">Abstract 267</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=Abstract+267&author=T.+Nagaura&author=T.+Yasuhiro&author=K.+Oda&author=Y.+Ezaki&author=T.+Koyanagi&author=S.+Itadani&author=H.+Nitta&author=H.+Wakazono&author=S.+Katsumata&author=Y.+Hirota&title=Abstracts+of+Papers%2C+American+College+or+Rheumatology+Annual+Meeting%2C+Boston%2C+MA+November+14%E2%80%9319%2C+2014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNagaura%26aufirst%3DT.%26atitle%3DSelective%2520and%2520peripheral-specific%2520TRK%2520inhibitor%2520shows%2520potent%2520analgesic%2520effect%2520comparable%2520to%2520morphine%2520in%2520rat%2520osteoarthritis%2520model%2520without%2520cns%2520toxicity%26btitle%3DAbstracts%2520of%2520Papers%252C%2520American%2520College%2520or%2520Rheumatology%2520Annual%2520Meeting%252C%2520Boston%252C%2520MA%2520November%252014%25E2%2580%259319%252C%25202014%26pub%3DAmerican%2520College%2520of%2520Rheumatology%26date%3D2014%26spage%3DAbstract%2520267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><div class="note"><p class="first last">Ono Pharmaceutical Co. Ltd.</p></div><span> </span><span class="NLM_article-title">A study to evaluate safety, tolerability, pharmacokinetics and pharmacology of ONO-4474 in healthy volunteers</span>.  <span class="citation_source-book">ClinicalTrials.gov</span>; <span class="NLM_publisher-name">National Library of Medicine (U.S.)</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="https://clinicaltrials.gov/ct2/show/NCT02454387" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02454387</a> (accessed August 25,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ono+Pharmaceutical+Co.+Ltd.+A+study+to+evaluate+safety%2C+tolerability%2C+pharmacokinetics+and+pharmacology+of+ONO-4474+in+healthy+volunteers.+ClinicalTrials.gov%3B+National+Library+of+Medicine+%28U.S.%29%3A+Bethesda%2C+MD%2C+2015%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02454387+%28accessed+August+25%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520study%2520to%2520evaluate%2520safety%252C%2520tolerability%252C%2520pharmacokinetics%2520and%2520pharmacology%2520of%2520ONO-4474%2520in%2520healthy%2520volunteers%26btitle%3DClinicalTrials.gov%26pub%3DNational%2520Library%2520of%2520Medicine%2520%2528U.S.%2529%26date%3D2015%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Passiglia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caparica, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovannetti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giallombardo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Listi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diana, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirrincione, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caglevic, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raez, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolfo, C.</span><span> </span><span class="NLM_article-title">The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span><span class="refDoi"> DOI: 10.1517/13543784.2016.1152261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1517%2F13543784.2016.1152261" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=385-392&issue=4&author=F.+Passigliaauthor=R.+Caparicaauthor=E.+Giovannettiauthor=M.+Giallombardoauthor=A.+Listiauthor=P.+Dianaauthor=G.+Cirrincioneauthor=C.+Caglevicauthor=L.+E.+Raezauthor=A.+Russoauthor=C.+Rolfo&title=The+potential+of+neurotrophic+tyrosine+kinase+%28NTRK%29+inhibitors+for+treating+lung+cancer&doi=10.1517%2F13543784.2016.1152261"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112a&amp;dbid=16384&amp;doi=10.1517%2F13543784.2016.1152261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2016.1152261%26sid%3Dliteratum%253Aachs%26aulast%3DPassiglia%26aufirst%3DF.%26aulast%3DCaparica%26aufirst%3DR.%26aulast%3DGiovannetti%26aufirst%3DE.%26aulast%3DGiallombardo%26aufirst%3DM.%26aulast%3DListi%26aufirst%3DA.%26aulast%3DDiana%26aufirst%3DP.%26aulast%3DCirrincione%26aufirst%3DG.%26aulast%3DCaglevic%26aufirst%3DC.%26aulast%3DRaez%26aufirst%3DL.%2BE.%26aulast%3DRusso%26aufirst%3DA.%26aulast%3DRolfo%26aufirst%3DC.%26atitle%3DThe%2520potential%2520of%2520neurotrophic%2520tyrosine%2520kinase%2520%2528NTRK%2529%2520inhibitors%2520for%2520treating%2520lung%2520cancer%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2016%26volume%3D25%26issue%3D4%26spage%3D385%26epage%3D392%26doi%3D10.1517%2F13543784.2016.1152261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit112b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Patwardhan, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivy, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Stanchina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span> </span><span class="NLM_article-title">Significant blockade of multiple receptor tyrosine kinases by MGCD-516 (Sitravatinib), a novel small molecule inhibitor, shows potent anti-tumor activity in preclinical models of sarcoma</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">4093</span><span class="NLM_x">–</span> <span class="NLM_lpage">4109</span><span class="refDoi"> DOI: 10.18632/oncotarget.6547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.18632%2Foncotarget.6547" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=4093-4109&issue=4&author=P.+P.+Patwardhanauthor=K.+S.+Ivyauthor=E.+Musiauthor=E.+de+Stanchinaauthor=G.+K.+Schwartz&title=Significant+blockade+of+multiple+receptor+tyrosine+kinases+by+MGCD-516+%28Sitravatinib%29%2C+a+novel+small+molecule+inhibitor%2C+shows+potent+anti-tumor+activity+in+preclinical+models+of+sarcoma&doi=10.18632%2Foncotarget.6547"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112b&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.6547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.6547%26sid%3Dliteratum%253Aachs%26aulast%3DPatwardhan%26aufirst%3DP.%2BP.%26aulast%3DIvy%26aufirst%3DK.%2BS.%26aulast%3DMusi%26aufirst%3DE.%26aulast%3Dde%2BStanchina%26aufirst%3DE.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26atitle%3DSignificant%2520blockade%2520of%2520multiple%2520receptor%2520tyrosine%2520kinases%2520by%2520MGCD-516%2520%2528Sitravatinib%2529%252C%2520a%2520novel%2520small%2520molecule%2520inhibitor%252C%2520shows%2520potent%2520anti-tumor%2520activity%2520in%2520preclinical%2520models%2520of%2520sarcoma%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26issue%3D4%26spage%3D4093%26epage%3D4109%26doi%3D10.18632%2Foncotarget.6547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit112c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Smith, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leary, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ensinger, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patt, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patt, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutkoski, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samarakoon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telikepalli, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogeti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogeti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clare, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, D. L.</span><span> </span><span class="NLM_article-title">Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2023</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-1105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1158%2F1535-7163.MCT-14-1105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=26285778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVegs7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=2023-34&issue=9&author=B.+D.+Smithauthor=M.+D.+Kaufmanauthor=C.+B.+Learyauthor=B.+A.+Turnerauthor=S.+C.+Wiseauthor=Y.+M.+Ahnauthor=R.+J.+Boothauthor=T.+M.+Caldwellauthor=C.+L.+Ensingerauthor=M.+M.+Hoodauthor=W.+P.+Luauthor=T.+W.+Pattauthor=W.+C.+Pattauthor=T.+J.+Rutkoskiauthor=T.+Samarakoonauthor=H.+Telikepalliauthor=L.+Vogetiauthor=S.+Vogetiauthor=K.+M.+Yatesauthor=L.+Chunauthor=L.+J.+Stewartauthor=M.+Clareauthor=D.+L.+Flynn&title=Altiratinib+Inhibits+Tumor+Growth%2C+Invasion%2C+Angiogenesis%2C+and+Microenvironment-Mediated+Drug+Resistance+via+Balanced+Inhibition+of+MET%2C+TIE2%2C+and+VEGFR2&doi=10.1158%2F1535-7163.MCT-14-1105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112cR"><div class="casContent"><span class="casTitleNuber">112c</span><div class="casTitle"><span class="NLM_cas:atitle">Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2</span></div><div class="casAuthors">Smith, Bryan D.; Kaufman, Michael D.; Leary, Cynthia B.; Turner, Benjamin A.; Wise, Scott C.; Ahn, Yu Mi; Booth, R. John; Caldwell, Timothy M.; Ensinger, Carol L.; Hood, Molly M.; Lu, Wei-Ping; Patt, Tristan W.; Patt, William C.; Rutkoski, Thomas J.; Samarakoon, Thiwanka; Telikepalli, Hanumaiah; Vogeti, Lakshminarayana; Vogeti, Subha; Yates, Karen M.; Chun, Lawrence; Stewart, Lance J.; Clare, Michael; Flynn, Daniel L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2023-2034</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Altiratinib (DCC-2701) was designed based on the rationale of engineering a single therapeutic agent able to address multiple hallmarks of cancer (1).  Specifically, altiratinib inhibits not only mechanisms of tumor initiation and progression, but also drug resistance mechanisms in the tumor and microenvironment through balanced inhibition of MET, TIE2 (TEK), and VEGFR2 (KDR) kinases.  This profile was achieved by optimizing binding into the switch control pocket of all three kinases, inducing type II inactive conformations.  Altiratinib durably inhibits MET, both wild-type and mutated forms, in vitro and in vivo.  Through its balanced inhibitory potency vs. MET, TIE2, and VEGFR2, altiratinib provides an agent that inhibits three major evasive (re)vascularization and resistance pathways (HGF, ANG, and VEGF) and blocks tumor invasion and metastasis.  Altiratinib exhibits properties amenable to oral administration and exhibits substantial blood-brain barrier penetration, an attribute of significance for eventual treatment of brain cancers and brain metastases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9E33eWjRqBrVg90H21EOLACvtfcHk0liUwiwF41EbAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVegs7vE&md5=34170ba7d22a7fbcea68715fd6a2179b</span></div><a href="/servlet/linkout?suffix=cit112c&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-1105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-1105%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%2BD.%26aulast%3DKaufman%26aufirst%3DM.%2BD.%26aulast%3DLeary%26aufirst%3DC.%2BB.%26aulast%3DTurner%26aufirst%3DB.%2BA.%26aulast%3DWise%26aufirst%3DS.%2BC.%26aulast%3DAhn%26aufirst%3DY.%2BM.%26aulast%3DBooth%26aufirst%3DR.%2BJ.%26aulast%3DCaldwell%26aufirst%3DT.%2BM.%26aulast%3DEnsinger%26aufirst%3DC.%2BL.%26aulast%3DHood%26aufirst%3DM.%2BM.%26aulast%3DLu%26aufirst%3DW.%2BP.%26aulast%3DPatt%26aufirst%3DT.%2BW.%26aulast%3DPatt%26aufirst%3DW.%2BC.%26aulast%3DRutkoski%26aufirst%3DT.%2BJ.%26aulast%3DSamarakoon%26aufirst%3DT.%26aulast%3DTelikepalli%26aufirst%3DH.%26aulast%3DVogeti%26aufirst%3DL.%26aulast%3DVogeti%26aufirst%3DS.%26aulast%3DYates%26aufirst%3DK.%2BM.%26aulast%3DChun%26aufirst%3DL.%26aulast%3DStewart%26aufirst%3DL.%2BJ.%26aulast%3DClare%26aufirst%3DM.%26aulast%3DFlynn%26aufirst%3DD.%2BL.%26atitle%3DAltiratinib%2520Inhibits%2520Tumor%2520Growth%252C%2520Invasion%252C%2520Angiogenesis%252C%2520and%2520Microenvironment-Mediated%2520Drug%2520Resistance%2520via%2520Balanced%2520Inhibition%2520of%2520MET%252C%2520TIE2%252C%2520and%2520VEGFR2%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26issue%3D9%26spage%3D2023%26epage%3D34%26doi%3D10.1158%2F1535-7163.MCT-14-1105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Vaishnavi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelletti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kako, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butaney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahale, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisner, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilling, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berge, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kryukov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garraway, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammerman, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varella-Garcia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janne, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebele, R. C.</span><span> </span><span class="NLM_article-title">Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1469</span><span class="NLM_x">–</span> <span class="NLM_lpage">1472</span><span class="refDoi"> DOI: 10.1038/nm.3352</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnm.3352" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=24162815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yiurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1469-1472&issue=11&author=A.+Vaishnaviauthor=M.+Capellettiauthor=A.+T.+Leauthor=S.+Kakoauthor=M.+Butaneyauthor=D.+Ercanauthor=S.+Mahaleauthor=K.+D.+Daviesauthor=D.+L.+Aisnerauthor=A.+B.+Pillingauthor=E.+M.+Bergeauthor=J.+Kimauthor=H.+Sasakiauthor=S.+I.+Parkauthor=G.+Kryukovauthor=L.+A.+Garrawayauthor=P.+S.+Hammermanauthor=J.+Haasauthor=S.+W.+Andrewsauthor=D.+Lipsonauthor=P.+J.+Stephensauthor=V.+A.+Millerauthor=M.+Varella-Garciaauthor=P.+A.+Janneauthor=R.+C.+Doebele&title=Oncogenic+and+drug-sensitive+NTRK1+rearrangements+in+lung+cancer&doi=10.1038%2Fnm.3352"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer</span></div><div class="casAuthors">Vaishnavi, Aria; Capelletti, Marzia; Le, Anh T.; Kako, Severine; Butaney, Mohit; Ercan, Dalia; Mahale, Sakshi; Davies, Kurtis D.; Aisner, Dara L.; Pilling, Amanda B.; Berge, Eamon M.; Kim, Jhingook; Sasaki, Hidefumi; Park, Seung-il; Kryukov, Gregory; Garraway, Levi A.; Hammerman, Peter S.; Haas, Julia; Andrews, Steven W.; Lipson, Doron; Stephens, Philip J.; Miller, Vince A.; Varella-Garcia, Marileila; Jaenne, Pasi A.; Doebele, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1469-1472</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We identified new gene fusions in patients with lung cancer harboring the kinase domain of the NTRK1 gene that encodes the high-affinity nerve growth factor receptor (TRKA protein).  Both the MPRIP-NTRK1 and CD74-NTRK1 fusions lead to constitutive TRKA kinase activity and are oncogenic.  Treatment of cells expressing NTRK1 fusions with inhibitors of TRKA kinase activity inhibited autophosphorylation of TRKA and cell growth.  Tumor samples from 3 of 91 patients with lung cancer (3.3%) without known oncogenic alterations assayed by next-generation sequencing or fluorescence in situ hybridization demonstrated evidence of NTRK1 gene fusions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBHNoZGMQLMrVg90H21EOLACvtfcHk0liUwiwF41EbAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yiurrI&md5=23b413826ea700bd831eadbfde270615</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1038%2Fnm.3352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3352%26sid%3Dliteratum%253Aachs%26aulast%3DVaishnavi%26aufirst%3DA.%26aulast%3DCapelletti%26aufirst%3DM.%26aulast%3DLe%26aufirst%3DA.%2BT.%26aulast%3DKako%26aufirst%3DS.%26aulast%3DButaney%26aufirst%3DM.%26aulast%3DErcan%26aufirst%3DD.%26aulast%3DMahale%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DK.%2BD.%26aulast%3DAisner%26aufirst%3DD.%2BL.%26aulast%3DPilling%26aufirst%3DA.%2BB.%26aulast%3DBerge%26aufirst%3DE.%2BM.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DS.%2BI.%26aulast%3DKryukov%26aufirst%3DG.%26aulast%3DGarraway%26aufirst%3DL.%2BA.%26aulast%3DHammerman%26aufirst%3DP.%2BS.%26aulast%3DHaas%26aufirst%3DJ.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DLipson%26aufirst%3DD.%26aulast%3DStephens%26aufirst%3DP.%2BJ.%26aulast%3DMiller%26aufirst%3DV.%2BA.%26aulast%3DVarella-Garcia%26aufirst%3DM.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26aulast%3DDoebele%26aufirst%3DR.%2BC.%26atitle%3DOncogenic%2520and%2520drug-sensitive%2520NTRK1%2520rearrangements%2520in%2520lung%2520cancer%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26issue%3D11%26spage%3D1469%26epage%3D1472%26doi%3D10.1038%2Fnm.3352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Farago, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzikansky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drilon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Multani, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornby, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow-Maneval, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iafrate, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. T.</span><span> </span><span class="NLM_article-title">Durable clinical response to entrectinib in NTRK1-rearranged non-small cell lung cancer</span> <span class="citation_source-journal">J. Thorac. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1670</span><span class="NLM_x">–</span> <span class="NLM_lpage">1674</span><span class="refDoi"> DOI: 10.1097/01.JTO.0000473485.38553.f0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1097%2F01.JTO.0000473485.38553.f0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=26565381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvF2it7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1670-1674&issue=12&author=A.+F.+Faragoauthor=L.+P.+Leauthor=Z.+Zhengauthor=A.+Muzikanskyauthor=A.+Drilonauthor=M.+Patelauthor=T.+M.+Bauerauthor=S.+V.+Liuauthor=S.+H.+Ouauthor=D.+Jackmanauthor=D.+B.+Costaauthor=P.+S.+Multaniauthor=G.+G.+Liauthor=Z.+Hornbyauthor=E.+Chow-Manevalauthor=D.+Luoauthor=J.+E.+Limauthor=A.+J.+Iafrateauthor=A.+T.+Shaw&title=Durable+clinical+response+to+entrectinib+in+NTRK1-rearranged+non-small+cell+lung+cancer&doi=10.1097%2F01.JTO.0000473485.38553.f0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer</span></div><div class="casAuthors">Farago, Anna F.; Le, Long P.; Zheng, Zongli; Muzikansky, Alona; Drilon, Alexander; Patel, Manish; Bauer, Todd M.; Liu, Stephen V.; Ou, Sai-Hong I.; Jackman, David; Costa, Daniel B.; Multani, Pratik S.; Li, Gary G.; Hornby, Zachary; Chow-Maneval, Edna; Luo, David; Lim, Jonathan E.; Iafrate, Anthony J.; Shaw, Alice T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thoracic Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1670-1674</span>CODEN:
                <span class="NLM_cas:coden">JTOOB7</span>;
        ISSN:<span class="NLM_cas:issn">1556-0864</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Introduction: Chromosomal rearrangements involving neurotrophic tyrosine kinase 1 (NTRK1) occur in a subset of non-small cell lung cancers (NSCLCs) and other solid tumor malignancies, leading to expression of an oncogenic TrkA fusion protein.  Entrectinib (RXDX-101) is an orally available tyrosine kinase inhibitor, including TrkA.  We sought to det. the frequency of NTRK1 rearrangements in NSCLC and to assess the clin. activity of entrectinib.  Methods: We screened 1378 cases of NSCLC using anchored multiplex polymerase chain reaction (AMP).  A patient with an NTRK1 gene rearrangement was enrolled onto a Phase 1 dose escalation study of entrectinib in adult patients with locally advanced or metastatic tumors (NCT02097810).  We assessed safety and response to treatment.  Results: We identified NTRK1 gene rearrangements at a frequency of 0.1% in this cohort.  A patient with stage IV lung adenocrcinoma with an SQSTM1-NTRK1 fusion transcript expression was treated with entrectinib.  Entrectinib was well tolerated, with no grade 3-4 adverse events.  Within three weeks of starting on treatment, the patient reported resoln. of prior dyspnea and pain.  Restaging CT scans demonstrated a RECIST partial response (PR) and complete resoln. of all brain metastases.  This patient has continued on treatment for over 6 mo with an ongoing PR.  Conclusions: Entrectinib demonstrated significant anti-tumor activity in a patient with NSCLC harboring an SQSTM1-NTRK1 gene rearrangement, indicating that entrectinib may be an effective therapy for tumors with NTRK gene rearrangements, including those with central nervous system metastases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9e_5UdIxTprVg90H21EOLACvtfcHk0lgnkZqzOeGjkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvF2it7rN&md5=1d0160c35a3bdbdcb2ebd01313cc18ba</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1097%2F01.JTO.0000473485.38553.f0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.JTO.0000473485.38553.f0%26sid%3Dliteratum%253Aachs%26aulast%3DFarago%26aufirst%3DA.%2BF.%26aulast%3DLe%26aufirst%3DL.%2BP.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DMuzikansky%26aufirst%3DA.%26aulast%3DDrilon%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DT.%2BM.%26aulast%3DLiu%26aufirst%3DS.%2BV.%26aulast%3DOu%26aufirst%3DS.%2BH.%26aulast%3DJackman%26aufirst%3DD.%26aulast%3DCosta%26aufirst%3DD.%2BB.%26aulast%3DMultani%26aufirst%3DP.%2BS.%26aulast%3DLi%26aufirst%3DG.%2BG.%26aulast%3DHornby%26aufirst%3DZ.%26aulast%3DChow-Maneval%26aufirst%3DE.%26aulast%3DLuo%26aufirst%3DD.%26aulast%3DLim%26aufirst%3DJ.%2BE.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26atitle%3DDurable%2520clinical%2520response%2520to%2520entrectinib%2520in%2520NTRK1-rearranged%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DJ.%2520Thorac.%2520Oncol.%26date%3D2015%26volume%3D10%26issue%3D12%26spage%3D1670%26epage%3D1674%26doi%3D10.1097%2F01.JTO.0000473485.38553.f0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Russo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misale, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siravegna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crisafulli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzari, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rospo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novara, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mussolin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cam, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wild, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Nicolantonio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siena, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span> </span><span class="NLM_article-title">Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-15-0940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1158%2F2159-8290.CD-15-0940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=26546295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC28XptlCrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=36-44&issue=1&author=M.+Russoauthor=S.+Misaleauthor=G.+Weiauthor=G.+Siravegnaauthor=G.+Crisafulliauthor=L.+Lazzariauthor=G.+Cortiauthor=G.+Rospoauthor=L.+Novaraauthor=B.+Mussolinauthor=A.+Bartoliniauthor=N.+Camauthor=R.+Patelauthor=S.+Yanauthor=R.+Shoemakerauthor=R.+Wildauthor=F.+Di+Nicolantonioauthor=A.+S.+Bianchiauthor=G.+Liauthor=S.+Sienaauthor=A.+Bardelli&title=Acquired+resistance+to+the+TRK+inhibitor+entrectinib+in+colorectal+cancer&doi=10.1158%2F2159-8290.CD-15-0940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer</span></div><div class="casAuthors">Russo, Mariangela; Misale, Sandra; Wei, Ge; Siravegna, Giulia; Crisafulli, Giovanni; Lazzari, Luca; Corti, Giorgio; Rospo, Giuseppe; Novara, Luca; Mussolin, Benedetta; Bartolini, Alice; Cam, Nicholas; Patel, Roopal; Yan, Shunqi; Shoemaker, Robert; Wild, Robert; Di Nicolantonio, Federica; Bianchi, Andrea Sartore; Li, Gang; Siena, Salvatore; Bardelli, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-44</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Entrectinib is a first-in-class pan-TRK kinase inhibitor currently undergoing clin. testing in colorectal cancer and other tumor types.  A patient with metastatic colorectal cancer harboring an LMNA-NTRK1 rearrangement displayed a remarkable response to treatment with entrectinib, which was followed by the emergence of resistance.  To characterize the mol. bases of the patient's relapse, circulating tumor DNA (ctDNA) was collected longitudinally during treatment, and a tissue biopsy, obtained before entrectinib treatment, was transplanted in mice (xenopatient), which then received the same entrectinib regimen until resistance developed.  Genetic profiling of ctDNA and xenopatient samples showed acquisition of two point mutations in the catalytic domain of NTRK1, p.G595R and p.G667C.  Biochem. and pharmacol. anal. in multiple preclin. models confirmed that either mutation renders the TRKA kinase insensitive to entrectinib.  These findings can be immediately exploited to design next-generation TRKA inhibitors.  Significance: We provide proof of principle that analyses of xenopatients (avatar) and liq. biopsies allow the identification of drug resistance mechanisms in parallel with clin. treatment of an individual patient.  We describe for the first time that p.G595R and p.G667C TRKA mutations drive acquired resistance to entrectinib in colorectal cancers carrying NTRK1 rearrangements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1Unyh1xjaoLVg90H21EOLACvtfcHk0lgnkZqzOeGjkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptlCrsA%253D%253D&md5=5baa54a784e355b6afa50336b2708052</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-15-0940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-15-0940%26sid%3Dliteratum%253Aachs%26aulast%3DRusso%26aufirst%3DM.%26aulast%3DMisale%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DG.%26aulast%3DSiravegna%26aufirst%3DG.%26aulast%3DCrisafulli%26aufirst%3DG.%26aulast%3DLazzari%26aufirst%3DL.%26aulast%3DCorti%26aufirst%3DG.%26aulast%3DRospo%26aufirst%3DG.%26aulast%3DNovara%26aufirst%3DL.%26aulast%3DMussolin%26aufirst%3DB.%26aulast%3DBartolini%26aufirst%3DA.%26aulast%3DCam%26aufirst%3DN.%26aulast%3DPatel%26aufirst%3DR.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DShoemaker%26aufirst%3DR.%26aulast%3DWild%26aufirst%3DR.%26aulast%3DDi%2BNicolantonio%26aufirst%3DF.%26aulast%3DBianchi%26aufirst%3DA.%2BS.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DSiena%26aufirst%3DS.%26aulast%3DBardelli%26aufirst%3DA.%26atitle%3DAcquired%2520resistance%2520to%2520the%2520TRK%2520inhibitor%2520entrectinib%2520in%2520colorectal%2520cancer%26jtitle%3DCancer%2520Discovery%26date%3D2016%26volume%3D6%26issue%3D1%26spage%3D36%26epage%3D44%26doi%3D10.1158%2F2159-8290.CD-15-0940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Doebele, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaishnavi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada-Bernal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keysar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimeno, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varella-Garcia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisner, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morosini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuch, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, J. A.</span><span> </span><span class="NLM_article-title">An oncogenic NTRK fusion in a patient with soft-tissue sarcoma with response to the Tropomyosin-Related Kinase inhibitor LOXO-101</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1049</span><span class="NLM_x">–</span> <span class="NLM_lpage">1057</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-15-0443</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1158%2F2159-8290.CD-15-0443" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=1049-1057&issue=10&author=R.+C.+Doebeleauthor=L.+E.+Davisauthor=A.+Vaishnaviauthor=A.+T.+Leauthor=A.+Estrada-Bernalauthor=S.+Keysarauthor=A.+Jimenoauthor=M.+Varella-Garciaauthor=D.+L.+Aisnerauthor=Y.+Liauthor=P.+J.+Stephensauthor=D.+Morosiniauthor=B.+B.+Tuchauthor=M.+Fernandesauthor=N.+Nandaauthor=J.+A.+Low&title=An+oncogenic+NTRK+fusion+in+a+patient+with+soft-tissue+sarcoma+with+response+to+the+Tropomyosin-Related+Kinase+inhibitor+LOXO-101&doi=10.1158%2F2159-8290.CD-15-0443"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-15-0443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-15-0443%26sid%3Dliteratum%253Aachs%26aulast%3DDoebele%26aufirst%3DR.%2BC.%26aulast%3DDavis%26aufirst%3DL.%2BE.%26aulast%3DVaishnavi%26aufirst%3DA.%26aulast%3DLe%26aufirst%3DA.%2BT.%26aulast%3DEstrada-Bernal%26aufirst%3DA.%26aulast%3DKeysar%26aufirst%3DS.%26aulast%3DJimeno%26aufirst%3DA.%26aulast%3DVarella-Garcia%26aufirst%3DM.%26aulast%3DAisner%26aufirst%3DD.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DStephens%26aufirst%3DP.%2BJ.%26aulast%3DMorosini%26aufirst%3DD.%26aulast%3DTuch%26aufirst%3DB.%2BB.%26aulast%3DFernandes%26aufirst%3DM.%26aulast%3DNanda%26aufirst%3DN.%26aulast%3DLow%26aufirst%3DJ.%2BA.%26atitle%3DAn%2520oncogenic%2520NTRK%2520fusion%2520in%2520a%2520patient%2520with%2520soft-tissue%2520sarcoma%2520with%2520response%2520to%2520the%2520Tropomyosin-Related%2520Kinase%2520inhibitor%2520LOXO-101%26jtitle%3DCancer%2520Discovery%26date%3D2015%26volume%3D5%26issue%3D10%26spage%3D1049%26epage%3D1057%26doi%3D10.1158%2F2159-8290.CD-15-0443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Menichincheri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnaghi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avanzi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banfi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bossi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buffa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canevari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceriani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fasolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorentini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgia, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchionni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orrenius, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panzeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesenti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusconi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saccardo, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanotti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsini, P.</span><span> </span><span class="NLM_article-title">Discovery of entrectinib: A new 3-aminoindazole as a potent anaplastic lymphoma dinase (ALK), c-ros oncogene 1 kinase (ROS1), and pan-tropomyosin receptor kinases (pan-TRKs) inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">3392</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00064</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00064" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3392-340&issue=7&author=M.+Menichincheriauthor=E.+Ardiniauthor=P.+Magnaghiauthor=N.+Avanziauthor=P.+Banfiauthor=R.+Bossiauthor=L.+Buffaauthor=G.+Canevariauthor=L.+Cerianiauthor=M.+Colomboauthor=L.+Cortiauthor=D.+Donatiauthor=M.+Fasoliniauthor=E.+Felderauthor=C.+Fiorelliauthor=F.+Fiorentiniauthor=A.+Galvaniauthor=A.+Isacchiauthor=A.+L.+Borgiaauthor=C.+Marchionniauthor=M.+Nesiauthor=C.+Orreniusauthor=A.+Panzeriauthor=E.+Pesentiauthor=L.+Rusconiauthor=M.+B.+Saccardoauthor=E.+Vanottiauthor=E.+Perroneauthor=P.+Orsini&title=Discovery+of+entrectinib%3A+A+new+3-aminoindazole+as+a+potent+anaplastic+lymphoma+dinase+%28ALK%29%2C+c-ros+oncogene+1+kinase+%28ROS1%29%2C+and+pan-tropomyosin+receptor+kinases+%28pan-TRKs%29+inhibitor&doi=10.1021%2Facs.jmedchem.6b00064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00064%26sid%3Dliteratum%253Aachs%26aulast%3DMenichincheri%26aufirst%3DM.%26aulast%3DArdini%26aufirst%3DE.%26aulast%3DMagnaghi%26aufirst%3DP.%26aulast%3DAvanzi%26aufirst%3DN.%26aulast%3DBanfi%26aufirst%3DP.%26aulast%3DBossi%26aufirst%3DR.%26aulast%3DBuffa%26aufirst%3DL.%26aulast%3DCanevari%26aufirst%3DG.%26aulast%3DCeriani%26aufirst%3DL.%26aulast%3DColombo%26aufirst%3DM.%26aulast%3DCorti%26aufirst%3DL.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DFasolini%26aufirst%3DM.%26aulast%3DFelder%26aufirst%3DE.%26aulast%3DFiorelli%26aufirst%3DC.%26aulast%3DFiorentini%26aufirst%3DF.%26aulast%3DGalvani%26aufirst%3DA.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DBorgia%26aufirst%3DA.%2BL.%26aulast%3DMarchionni%26aufirst%3DC.%26aulast%3DNesi%26aufirst%3DM.%26aulast%3DOrrenius%26aufirst%3DC.%26aulast%3DPanzeri%26aufirst%3DA.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DRusconi%26aufirst%3DL.%26aulast%3DSaccardo%26aufirst%3DM.%2BB.%26aulast%3DVanotti%26aufirst%3DE.%26aulast%3DPerrone%26aufirst%3DE.%26aulast%3DOrsini%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520entrectinib%253A%2520A%2520new%25203-aminoindazole%2520as%2520a%2520potent%2520anaplastic%2520lymphoma%2520dinase%2520%2528ALK%2529%252C%2520c-ros%2520oncogene%25201%2520kinase%2520%2528ROS1%2529%252C%2520and%2520pan-tropomyosin%2520receptor%2520kinases%2520%2528pan-TRKs%2529%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D7%26spage%3D3392%26epage%3D340%26doi%3D10.1021%2Facs.jmedchem.6b00064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Smith, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elfiky, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logothetis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corn, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelzang, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harzstark, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaishampayan, U. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spira, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lara, P. N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoffski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheffold, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weitzman, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, M.</span><span> </span><span class="NLM_article-title">Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span><span class="refDoi"> DOI: 10.1200/JCO.2012.45.0494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1200%2FJCO.2012.45.0494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23169517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1SktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=412-419&issue=4&author=D.+C.+Smithauthor=M.+R.+Smithauthor=C.+Sweeneyauthor=A.+A.+Elfikyauthor=C.+Logothetisauthor=P.+G.+Cornauthor=N.+J.+Vogelzangauthor=E.+J.+Smallauthor=A.+L.+Harzstarkauthor=M.+S.+Gordonauthor=U.+N.+Vaishampayanauthor=N.+B.+Haasauthor=A.+I.+Spiraauthor=P.+N.+Laraauthor=C.+C.+Linauthor=S.+Srinivasauthor=A.+Sellaauthor=P.+Schoffskiauthor=C.+Scheffoldauthor=A.+L.+Weitzmanauthor=M.+Hussain&title=Cabozantinib+in+patients+with+advanced+prostate+cancer%3A+results+of+a+phase+II+randomized+discontinuation+trial&doi=10.1200%2FJCO.2012.45.0494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial</span></div><div class="casAuthors">Smith, David C.; Smith, Matthew R.; Sweeney, Christopher; Elfiky, Aymen A.; Logothetis, Christopher; Corn, Paul G.; Vogelzang, Nicholas J.; Small, Eric J.; Harzstark, Andrea L.; Gordon, Michael S.; Vaishampayan, Ulka N.; Haas, Naomi B.; Spira, Alexander I.; Lara, Primo N., Jr.; Lin, Chia-Chi; Srinivas, Sandy; Sella, Avishay; Schoffski, Patrick; Scheffold, Christian; Weitzman, Aaron L.; Hussain, Maha</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">412-419</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Cabozantinib (XL 184) is an orally bioavailable tyrosine kinase inhibitor with activity against MET and vascular endothelial growth factor receptor 2.  We evaluated the activity of cabozantinib in patients with castration-resistant prostate cancer (CRPC) in a phase II randomized discontinuation trial with an expansion cohort.  Patients and Methods: Patients received 100 mg of cabozantinib daily.  Those with stable disease per RECIST at 12 wk were randomly assigned to cabozantinib or placebo.  Primary end points were objective response rate at 12 wk and progression-free survival (PFS) after random assignment.  Results: One hundred seventy-one men with CRPC were enrolled.  Random assignment was halted early based on the obsd. activity of cabozantinib.  Seventy-two percent of patients had regression in soft tissue lesions, whereas 68% of evaluable patients had improvement on bone scan, including complete resoln. in 12%.  The objective response rate at 12 wk was 5%, with stable disease in 75% of patients.  Thirty-one patients with stable disease at week 12 were randomly assigned.  Median PFS was 23.9 wk (95% CI, 10.7 to 62.4 wk) with cabozantinib and 5.9 wk (95% CI, 5.4 to 6.6 wk) with placebo (hazard ratio, 0.12; P < .001).  Serum total alk. phosphatase and plasma cross-linked C-terminal telopeptide of type I collagen were reduced by ≥ 50% in 57% of evaluable patients.  On retrospective review, bone pain improved in 67% of evaluable patients, with a decrease in narcotic use in 56%.  The most common grade 3 adverse events were fatigue (16%), hypertension (12%), and hand-foot syndrome (8%).  Conclusion: Cabozantinib has clin. activity in men with CRPC, including redn. of soft tissue lesions, improvement in PFS, resoln. of bone scans, and redns. in bone turnover markers, pain, and narcotic use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp67noyYrKzMbVg90H21EOLACvtfcHk0ljRqYsgXGIe3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1SktLc%253D&md5=4c627f002eb30bc9583a3203e01daf23</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1200%2FJCO.2012.45.0494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2012.45.0494%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BC.%26aulast%3DSmith%26aufirst%3DM.%2BR.%26aulast%3DSweeney%26aufirst%3DC.%26aulast%3DElfiky%26aufirst%3DA.%2BA.%26aulast%3DLogothetis%26aufirst%3DC.%26aulast%3DCorn%26aufirst%3DP.%2BG.%26aulast%3DVogelzang%26aufirst%3DN.%2BJ.%26aulast%3DSmall%26aufirst%3DE.%2BJ.%26aulast%3DHarzstark%26aufirst%3DA.%2BL.%26aulast%3DGordon%26aufirst%3DM.%2BS.%26aulast%3DVaishampayan%26aufirst%3DU.%2BN.%26aulast%3DHaas%26aufirst%3DN.%2BB.%26aulast%3DSpira%26aufirst%3DA.%2BI.%26aulast%3DLara%26aufirst%3DP.%2BN.%26aulast%3DLin%26aufirst%3DC.%2BC.%26aulast%3DSrinivas%26aufirst%3DS.%26aulast%3DSella%26aufirst%3DA.%26aulast%3DSchoffski%26aufirst%3DP.%26aulast%3DScheffold%26aufirst%3DC.%26aulast%3DWeitzman%26aufirst%3DA.%2BL.%26aulast%3DHussain%26aufirst%3DM.%26atitle%3DCabozantinib%2520in%2520patients%2520with%2520advanced%2520prostate%2520cancer%253A%2520results%2520of%2520a%2520phase%2520II%2520randomized%2520discontinuation%2520trial%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2013%26volume%3D31%26issue%3D4%26spage%3D412%26epage%3D419%26doi%3D10.1200%2FJCO.2012.45.0494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Basch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Autio, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weitzman, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheffold, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathkopf, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higano, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harzstark, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartor, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelzang, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bono, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corn, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schimmoller, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scher, H. I.</span><span> </span><span class="NLM_article-title">Effects of cabozantinib on pain and narcotic use in patients with castration-resistant prostate cancer: results from a phase 2 nonrandomized expansion cohort</span> <span class="citation_source-journal">Eur. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">310</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span><span class="refDoi"> DOI: 10.1016/j.eururo.2014.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.eururo.2014.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=24631409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlWlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=310-318&issue=2&author=E.+Baschauthor=K.+A.+Autioauthor=M.+R.+Smithauthor=A.+V.+Bennettauthor=A.+L.+Weitzmanauthor=C.+Scheffoldauthor=C.+Sweeneyauthor=D.+E.+Rathkopfauthor=D.+C.+Smithauthor=D.+J.+Georgeauthor=C.+S.+Higanoauthor=A.+L.+Harzstarkauthor=A.+O.+Sartorauthor=M.+S.+Gordonauthor=N.+J.+Vogelzangauthor=J.+S.+de+Bonoauthor=N.+B.+Haasauthor=P.+G.+Cornauthor=F.+Schimmollerauthor=H.+I.+Scher&title=Effects+of+cabozantinib+on+pain+and+narcotic+use+in+patients+with+castration-resistant+prostate+cancer%3A+results+from+a+phase+2+nonrandomized+expansion+cohort&doi=10.1016%2Fj.eururo.2014.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Cabozantinib on Pain and Narcotic Use in Patients with Castration-resistant Prostate Cancer: Results from a Phase 2 Nonrandomized Expansion Cohort</span></div><div class="casAuthors">Basch, Ethan; Autio, Karen A.; Smith, Matthew R.; Bennett, Antonia V.; Weitzman, Aaron L.; Scheffold, Christian; Sweeney, Christopher; Rathkopf, Dana E.; Smith, David C.; George, Daniel J.; Higano, Celestia S.; Harzstark, Andrea L.; Sartor, A. Oliver; Gordon, Michael S.; Vogelzang, Nicholas J.; de Bono, Johann S.; Haas, Naomi B.; Corn, Paul G.; Schimmoller, Frauke; Scher, Howard I.</div><div class="citationInfo"><span class="NLM_cas:title">European Urology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">310-318</span>CODEN:
                <span class="NLM_cas:coden">EUURAV</span>;
        ISSN:<span class="NLM_cas:issn">0302-2838</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pain neg. affects quality of life for cancer patients.  Preliminary data in metastatic castration-resistant prostate cancer (mCRPC) suggested a benefit of the oral tyrosine kinase inhibitor cabozantinib to pain palliation.  Prospective evaluation of cabozantinib's benefits on pain and narcotic use in mCRPC.This was a nonrandomized expansion (NRE) cohort (n = 144) of a phase 2 randomized discontinuation trial in docetaxel-refractory mCRPC patients.  Pain and interference of symptoms with sleep and general activity were electronically self-reported daily for 7-d intervals at baseline and regularly scheduled throughout the study.  Mean per-patient scores were calcd. for each interval.  Narcotic use was recorded daily during the same intervals.Open-label cabozantinib (100 mg or 40 mg).  The following stringent response definition was used: clin. meaningful pain redn. (≥30% improvement in mean scores from baseline) confirmed at a later interval without concomitant increases in narcotics.  Only patients with moderate or severe baseline pain were analyzed.Sixty-five patients with moderate or severe baseline pain were evaluable.  Of these, 27 (42%) experienced pain palliation according to the stringent response definition.  Thirty-seven patients (57%) had clin. meaningful pain relief at two consecutive intervals, reported ≥6 wk apart in the majority.  Forty-four patients (68%) had palliation at one or more intervals; 36 (55%) decreased narcotics use during one or more intervals.  Clin. meaningful pain redn. was assocd. with significant (p ≤ 0.001) improvements in sleep quality and general activity.  A limitation of this study was its open-label design.  Cabozantinib demonstrated clin. meaningful pain palliation, reduced or eliminated patients' narcotic use, and improved patient functioning, thus meriting prospective validation in phase 3 studies.We evaluated the potential of cabozantinib to improve symptoms in patients with metastatic prostate cancer that no longer responds to std. therapies.  We saw a promising redn. in pain and reduced need for narcotic painkillers.  Larger, well-controlled trials are necessary to confirm these findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeS-LVjhcfabVg90H21EOLACvtfcHk0lhI3nHHp8spng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlWlsbg%253D&md5=b26c80832e6294bf8d63112eed0dc187</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2Fj.eururo.2014.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.eururo.2014.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DBasch%26aufirst%3DE.%26aulast%3DAutio%26aufirst%3DK.%2BA.%26aulast%3DSmith%26aufirst%3DM.%2BR.%26aulast%3DBennett%26aufirst%3DA.%2BV.%26aulast%3DWeitzman%26aufirst%3DA.%2BL.%26aulast%3DScheffold%26aufirst%3DC.%26aulast%3DSweeney%26aufirst%3DC.%26aulast%3DRathkopf%26aufirst%3DD.%2BE.%26aulast%3DSmith%26aufirst%3DD.%2BC.%26aulast%3DGeorge%26aufirst%3DD.%2BJ.%26aulast%3DHigano%26aufirst%3DC.%2BS.%26aulast%3DHarzstark%26aufirst%3DA.%2BL.%26aulast%3DSartor%26aufirst%3DA.%2BO.%26aulast%3DGordon%26aufirst%3DM.%2BS.%26aulast%3DVogelzang%26aufirst%3DN.%2BJ.%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DHaas%26aufirst%3DN.%2BB.%26aulast%3DCorn%26aufirst%3DP.%2BG.%26aulast%3DSchimmoller%26aufirst%3DF.%26aulast%3DScher%26aufirst%3DH.%2BI.%26atitle%3DEffects%2520of%2520cabozantinib%2520on%2520pain%2520and%2520narcotic%2520use%2520in%2520patients%2520with%2520castration-resistant%2520prostate%2520cancer%253A%2520results%2520from%2520a%2520phase%25202%2520nonrandomized%2520expansion%2520cohort%26jtitle%3DEur.%2520Urol.%26date%3D2015%26volume%3D67%26issue%3D2%26spage%3D310%26epage%3D318%26doi%3D10.1016%2Fj.eururo.2014.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Mantyh, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koltzenburg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendell, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tive, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, D. L.</span><span> </span><span class="NLM_article-title">Antagonism of nerve growth factor-TrkA signaling and the relief of pain</span> <span class="citation_source-journal">Anesthesiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span><span class="refDoi"> DOI: 10.1097/ALN.0b013e31821b1ac5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1097%2FALN.0b013e31821b1ac5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2011&pages=189-204&issue=1&author=P.+W.+Mantyhauthor=M.+Koltzenburgauthor=L.+M.+Mendellauthor=L.+Tiveauthor=D.+L.+Shelton&title=Antagonism+of+nerve+growth+factor-TrkA+signaling+and+the+relief+of+pain&doi=10.1097%2FALN.0b013e31821b1ac5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1097%2FALN.0b013e31821b1ac5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FALN.0b013e31821b1ac5%26sid%3Dliteratum%253Aachs%26aulast%3DMantyh%26aufirst%3DP.%2BW.%26aulast%3DKoltzenburg%26aufirst%3DM.%26aulast%3DMendell%26aufirst%3DL.%2BM.%26aulast%3DTive%26aufirst%3DL.%26aulast%3DShelton%26aufirst%3DD.%2BL.%26atitle%3DAntagonism%2520of%2520nerve%2520growth%2520factor-TrkA%2520signaling%2520and%2520the%2520relief%2520of%2520pain%26jtitle%3DAnesthesiology%26date%3D2011%26volume%3D115%26issue%3D1%26spage%3D189%26epage%3D204%26doi%3D10.1097%2FALN.0b013e31821b1ac5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Eskander, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruparel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Por, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeske, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, K. M.</span><span> </span><span class="NLM_article-title">Persistent nociception triggered by nerve growth factor (NGF) is mediated by TRPV1 and oxidative mechanisms</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">8593</span><span class="NLM_x">–</span> <span class="NLM_lpage">8603</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3993-14.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1523%2FJNEUROSCI.3993-14.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=26041925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVGhtLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=8593-8603&issue=22&author=M.+A.+Eskanderauthor=S.+Ruparelauthor=D.+P.+Greenauthor=P.+B.+Chenauthor=E.+D.+Porauthor=N.+A.+Jeskeauthor=X.+Gaoauthor=E.+R.+Floresauthor=K.+M.+Hargreaves&title=Persistent+nociception+triggered+by+nerve+growth+factor+%28NGF%29+is+mediated+by+TRPV1+and+oxidative+mechanisms&doi=10.1523%2FJNEUROSCI.3993-14.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Persistent nociception triggered by nerve growth factor (NGF) is mediated by TRPV1 and oxidative mechanisms</span></div><div class="casAuthors">Eskander, Michael A.; Ruparel, Shivani; Green, Dustin P.; Chen, Paul B.; Por, Elaine D.; Jeske, Nathaniel A.; Gao, Xiaoli; Flores, Eric R.; Hargreaves, Kenneth M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8593-8603</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Nerve growth factor (NGF) is elevated in certain chronic pain conditions and is a sufficient stimulus to cause lasting pain in humans, but the actual mechanisms underlying the persistent effects of NGF remain incompletely understood.  We developed a rat model of NGF-induced persistent thermal hyperalgesia and mech. allodynia to det. the role of transient receptor potential vanilloid 1 (TRPV1) and oxidative mechanisms in the persistent effects of NGF.  Persistent thermal hypersensitivity and mech. allodynia require de novo protein translation and are mediated by TRPV1 and oxidative mechanisms.  By comparing effects after systemic (s.c.), spinal (intrathecal) or hindpaw (intraplantar) injections of test compds., we detd. that TRPV1 and oxidn. mediate persistent thermal hypersensitivity via peripheral and spinal sites of action and mech. allodynia via only a spinal site of action.  Therefore, NGF-evoked thermal and mech. allodynia are mediated by spatially distinct mechanisms.  NGF treatment evoked sustained increases in peripheral and central TRPV1 activity, as demonstrated by increased capsaicin-evoked nocifensive responses, increased calcitonin gene-related peptide release from hindpaw skin biopsies, and increased capsaicin-evoked inward current and membrane expression of TRPV1 protein in dorsal root ganglia neurons.  Finally, we showed that NGF treatment increased concns. of linoleic and arachidonic-acid-derived oxidized TRPV1 agonists in spinal cord and skin biopsies.  Furthermore, increases in oxidized TRPV1-active lipids were reduced by peripheral and spinal injections of compds. that completely blocked persistent nociception.  Collectively, these data indicate that NGF evokes a persistent nociceptive state mediated by increased TRPV1 activity and oxidative mechanisms, including increased prodn. of oxidized lipid TRPV1 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgNXdRqaQm_bVg90H21EOLACvtfcHk0lhI3nHHp8spng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVGhtLjL&md5=e510c89475efb8be3b9ed3b6a8f46fae</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3993-14.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3993-14.2015%26sid%3Dliteratum%253Aachs%26aulast%3DEskander%26aufirst%3DM.%2BA.%26aulast%3DRuparel%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DD.%2BP.%26aulast%3DChen%26aufirst%3DP.%2BB.%26aulast%3DPor%26aufirst%3DE.%2BD.%26aulast%3DJeske%26aufirst%3DN.%2BA.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DFlores%26aufirst%3DE.%2BR.%26aulast%3DHargreaves%26aufirst%3DK.%2BM.%26atitle%3DPersistent%2520nociception%2520triggered%2520by%2520nerve%2520growth%2520factor%2520%2528NGF%2529%2520is%2520mediated%2520by%2520TRPV1%2520and%2520oxidative%2520mechanisms%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26issue%3D22%26spage%3D8593%26epage%3D8603%26doi%3D10.1523%2FJNEUROSCI.3993-14.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Brito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjea, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rybak, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramkumar, V.</span><span> </span><span class="NLM_article-title">TRPV1: A potential drug target for treating various diseases</span> <span class="citation_source-journal">Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span><span class="refDoi"> DOI: 10.3390/cells3020517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.3390%2Fcells3020517" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=517-545&issue=2&author=R.+Britoauthor=S.+Shethauthor=D.+Mukherjeaauthor=L.+P.+Rybakauthor=V.+Ramkumar&title=TRPV1%3A+A+potential+drug+target+for+treating+various+diseases&doi=10.3390%2Fcells3020517"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.3390%2Fcells3020517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcells3020517%26sid%3Dliteratum%253Aachs%26aulast%3DBrito%26aufirst%3DR.%26aulast%3DSheth%26aufirst%3DS.%26aulast%3DMukherjea%26aufirst%3DD.%26aulast%3DRybak%26aufirst%3DL.%2BP.%26aulast%3DRamkumar%26aufirst%3DV.%26atitle%3DTRPV1%253A%2520A%2520potential%2520drug%2520target%2520for%2520treating%2520various%2520diseases%26jtitle%3DCells%26date%3D2014%26volume%3D3%26issue%3D2%26spage%3D517%26epage%3D545%26doi%3D10.3390%2Fcells3020517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Zhuo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. C.</span><span> </span><span class="NLM_article-title">New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1551</span><span class="NLM_x">–</span> <span class="NLM_lpage">1565</span><span class="refDoi"> DOI: 10.1016/j.peptides.2011.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.peptides.2011.05.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=1551-1565&issue=7&author=J.+L.+Zhuoauthor=X.+C.+Li&title=New+insights+and+perspectives+on+intrarenal+renin-angiotensin+system%3A+focus+on+intracrine%2Fintracellular+angiotensin+II&doi=10.1016%2Fj.peptides.2011.05.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2011.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2011.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DZhuo%26aufirst%3DJ.%2BL.%26aulast%3DLi%26aufirst%3DX.%2BC.%26atitle%3DNew%2520insights%2520and%2520perspectives%2520on%2520intrarenal%2520renin-angiotensin%2520system%253A%2520focus%2520on%2520intracrine%252Fintracellular%2520angiotensin%2520II%26jtitle%3DPeptides%26date%3D2011%26volume%3D32%26issue%3D7%26spage%3D1551%26epage%3D1565%26doi%3D10.1016%2Fj.peptides.2011.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Paul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poyan Mehr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreutz, R.</span><span> </span><span class="NLM_article-title">Physiology of local renin-angiotensin systems</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span><span class="refDoi"> DOI: 10.1152/physrev.00036.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1152%2Fphysrev.00036.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=16816138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFGgtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2006&pages=747-803&issue=3&author=M.+Paulauthor=A.+Poyan+Mehrauthor=R.+Kreutz&title=Physiology+of+local+renin-angiotensin+systems&doi=10.1152%2Fphysrev.00036.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Physiology of local renin-angiotensin systems</span></div><div class="casAuthors">Paul, Martin; Mehr, Ali Poyan; Kreutz, Reinhold</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">747-803</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Since the first identification of renin by Tigerstedt and Bergmann in 1898, the renin-angiotensin system (RAS) has been extensively studied.  The current view of the system is characterized by an increased complexity, as evidenced by the discovery of new functional components and pathways of the RAS.  In recent years, the pathophysiol. implications of the system have been the main focus of attention, and inhibitors of the RAS such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin (ANG) II receptor blockers have become important clin. tools in the treatment of cardiovascular and renal diseases such as hypertension, heart failure, and diabetic nephropathy.  Nevertheless, the tissue RAS also plays an important role in mediating diverse physiol. functions.  These focus not only on the classical actions of ANG on the cardiovascular system, namely, the maintenance of cardiovascular homeostasis, but also on other functions.  Recently, the research efforts studying these noncardiovascular effects of the RAS have intensified, and a large body of data are now available to support the existence of numerous organ-based RAS exerting diverse physiol. effects.  ANG II has direct effects at the cellular level and can influence, for example, cell growth and differentiation, but also may play a role as a mediator of apoptosis.  These universal paracrine and autocrine actions may be important in many organ systems and can mediate important physiol. stimuli.  Transgenic overexpression and knock-out strategies of RAS genes in animals have also shown a central functional role of the RAS in prenatal development.  Taken together, these findings may become increasingly important in the study of organ physiol. but also for a fresh look at the implications of these findings for organ pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKp3eItFqu97Vg90H21EOLACvtfcHk0lhWlAxfv4IMrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFGgtLk%253D&md5=40e6a797915c900a07a9c2e6b94a278b</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00036.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00036.2005%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DM.%26aulast%3DPoyan%2BMehr%26aufirst%3DA.%26aulast%3DKreutz%26aufirst%3DR.%26atitle%3DPhysiology%2520of%2520local%2520renin-angiotensin%2520systems%26jtitle%3DPhysiol.%2520Rev.%26date%3D2006%26volume%3D86%26issue%3D3%26spage%3D747%26epage%3D803%26doi%3D10.1152%2Fphysrev.00036.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Robles, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerezo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez-Gallego, R.</span><span> </span><span class="NLM_article-title">Renin-angiotensin system blocking drugs</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">14</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1177/1074248413501018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1177%2F1074248413501018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=24038019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjt1antr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=14-33&issue=1&author=N.+R.+Roblesauthor=I.+Cerezoauthor=R.+Hernandez-Gallego&title=Renin-angiotensin+system+blocking+drugs&doi=10.1177%2F1074248413501018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Renin-angiotensin system blocking drugs</span></div><div class="casAuthors">Robles, Nicolas Roberto; Cerezo, Isis; Hernandez-Gallego, Roman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cardiovascular Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-33</span>CODEN:
                <span class="NLM_cas:coden">JCPTFE</span>;
        ISSN:<span class="NLM_cas:issn">1074-2484</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  The two major classes of drugs that target the RAS are the angiotensin-converting enzyme (ACE) inhibitors and the selective ATI receptor blockers (ARBs).  Although both of these drug classes target angiotensin II, the differences in their mechanisms of action have implications for their effects on other pathways and receptors that may have therapeutic implications.  Both ACEIs and ARBs are effective antihypertensive agents that have been shown to reduce the risk of cardiovascular and renal events.  Direct inhibition of renin-the most proximal aspect of the RAS-became clin. feasible from 2007 with the introduction of aliskiren.  This latter drug has been shown to be efficacious for the management of hypertension.  Combined therapy of direct renin-inhibitors with ACEIs or ARBs has been tested in some clin. situations as congestive HF and proteinuria with diverse results.  This article tries to offer an updated review of current knowledge on the use of RAS blocking drugs in clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7D2SrqMqDDrVg90H21EOLACvtfcHk0lhWlAxfv4IMrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjt1antr4%253D&md5=57c4b520a8f0938176f84f3d49b215fd</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1177%2F1074248413501018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1074248413501018%26sid%3Dliteratum%253Aachs%26aulast%3DRobles%26aufirst%3DN.%2BR.%26aulast%3DCerezo%26aufirst%3DI.%26aulast%3DHernandez-Gallego%26aufirst%3DR.%26atitle%3DRenin-angiotensin%2520system%2520blocking%2520drugs%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%2520Ther.%26date%3D2014%26volume%3D19%26issue%3D1%26spage%3D14%26epage%3D33%26doi%3D10.1177%2F1074248413501018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Inagami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kambayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichiki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuzuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamakawa, T.</span><span> </span><span class="NLM_article-title">Angiotensin receptors: molecular biology and signalling</span> <span class="citation_source-journal">Clin. Exp. Pharmacol. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">544</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span><span class="refDoi"> DOI: 10.1046/j.1440-1681.1999.03086.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1046%2Fj.1440-1681.1999.03086.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10405785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADyaK1MXktlCls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1999&pages=544-549&issue=7&author=T.+Inagamiauthor=Y.+Kambayashiauthor=T.+Ichikiauthor=S.+Tsuzukiauthor=S.+Eguchiauthor=T.+Yamakawa&title=Angiotensin+receptors%3A+molecular+biology+and+signalling&doi=10.1046%2Fj.1440-1681.1999.03086.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Angiotensin receptors: molecular biology and signalling</span></div><div class="casAuthors">Inagami, Tadashi; Kambayashi, Yoshikazu; Ichiki, Toshihiro; Tsuzuki, Satoshi; Eguchi, Satoru; Yamakawa, Tadashi</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Pharmacology and Physiology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">544-549</span>CODEN:
                <span class="NLM_cas:coden">CEXPB9</span>;
        ISSN:<span class="NLM_cas:issn">0305-1870</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A review, with 53 refs.  The active peptide hormone angiotensin II (AngII) is formed from its prohormone angiotensinogen by way of inactive angiotensin I.  The highly specific protease, renin, responsible for the initiation of this system was elusive and considered unstable.  The authors isolated it in a pure and stable form from the kidney of the pig, human, rat, and land submandibular glands of the mouse.  It was shown that there is only one type of renin with highly stringent substrate specificity, except certain strains of the mouse which have two gene products.  The well-known diversity of action of AngII can be attributed to the presence of more than two subtypes, AT1 and AT2, as well as multiple signaling pathways for both of them.  The first subtype AT1 was shown to mediate most of the traditionally recognized AngII functions such as vasoconstriction, electrolyte homeostasis etc.  Although the identification of the signaling modes of the second subtype AT2 still remains elusive, the authors and others have shown evidence that its action is generally antagonistic to that of AT1.  AT2 inhibits AT1 (growth factor-stimulated cell growth), AT2 attenuates the vasoconstriction induced by AT1.  Since AT2 seems to mediate nitric oxide formation in the renal cells, it may initiate a natriuretic pathway in contrast to the sodium-retaining action of AT1-mediated AngII action.  Newer mechanisms and functions of these and other receptors will be clarified by the combination of mol., cellular and integrated physiol. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN7QoHmJDv3bVg90H21EOLACvtfcHk0ljU_rYW7cok3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktlCls78%253D&md5=001dd88b2d1e82e26baa5c11272afb67</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1046%2Fj.1440-1681.1999.03086.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1440-1681.1999.03086.x%26sid%3Dliteratum%253Aachs%26aulast%3DInagami%26aufirst%3DT.%26aulast%3DKambayashi%26aufirst%3DY.%26aulast%3DIchiki%26aufirst%3DT.%26aulast%3DTsuzuki%26aufirst%3DS.%26aulast%3DEguchi%26aufirst%3DS.%26aulast%3DYamakawa%26aufirst%3DT.%26atitle%3DAngiotensin%2520receptors%253A%2520molecular%2520biology%2520and%2520signalling%26jtitle%3DClin.%2520Exp.%2520Pharmacol.%2520Physiol.%26date%3D1999%26volume%3D26%26issue%3D7%26spage%3D544%26epage%3D549%26doi%3D10.1046%2Fj.1440-1681.1999.03086.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Inagami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitami, Y.</span><span> </span><span class="NLM_article-title">Molecular biology of angiotensin II receptors: an overview</span> <span class="citation_source-journal">J. Hypertens. Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">S83</span><span class="NLM_x">–</span> <span class="NLM_lpage">S94</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1994&pages=S83-S94&issue=10&author=T.+Inagamiauthor=D.+F.+Guoauthor=Y.+Kitami&title=Molecular+biology+of+angiotensin+II+receptors%3A+an+overview"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInagami%26aufirst%3DT.%26aulast%3DGuo%26aufirst%3DD.%2BF.%26aulast%3DKitami%26aufirst%3DY.%26atitle%3DMolecular%2520biology%2520of%2520angiotensin%2520II%2520receptors%253A%2520an%2520overview%26jtitle%3DJ.%2520Hypertens.%2520Suppl.%26date%3D1994%26volume%3D12%26issue%3D10%26spage%3DS83%26epage%3DS94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Smith, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muralidharan, A.</span><span> </span><span class="NLM_article-title">Targeting angiotensin II type 2 receptor pathways to treat neuropathic pain and inflammatory pain</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1517/14728222.2014.957673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1517%2F14728222.2014.957673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=25315162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFSnsr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2015&pages=25-35&issue=1&author=M.+T.+Smithauthor=A.+Muralidharan&title=Targeting+angiotensin+II+type+2+receptor+pathways+to+treat+neuropathic+pain+and+inflammatory+pain&doi=10.1517%2F14728222.2014.957673"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting angiotensin II type 2 receptor pathways to treat neuropathic pain and inflammatory pain</span></div><div class="casAuthors">Smith, Maree T.; Muralidharan, Arjun</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-35</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Introduction: Neuropathic pain and chronic inflammatory pain are large unmet medical needs.  Over the past two decades, numerous 'pain targets' have been identified for analgesic drug discovery.  Despite promising results in rodent pain models, many compds. modulating such targets lacked efficacy in clin. trials.  An exception is oral EMA401, a small-mol. angiotensin II type 2 receptor (AT2R) antagonist.  Areas covered: Herein, angiotensin II/AT2R signaling-induced hyperexcitability and abnormal sprouting of cultured dorsal root ganglion neurons, together with radioligand binding, pharmacokinetics, analgesic efficacy and mode of action of small-mol. AT2R antagonists in rodent models of peripheral neuropathic and chronic inflammatory pain, are reviewed.  The findings of a successful Phase IIa clin. trial of EMA401 in patients with neuropathic pain are presented in brief.  Expert opinion: The functional importance of angiotensin II/AT2R signaling has remained enigmatic for decades, and there are no clin. available medications that target the AT2R.  However, on the basis of preclin. findings and recent clin. trial data showing that the peripherally restricted, small-mol. AT2R antagonist, EMA401, successfully alleviated neuropathic pain in a Phase II clin. trial, the AT2R is receiving considerable attention as a new therapeutic target with human validation for the relief of peripheral neuropathic and chronic inflammatory pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIBBwwcYIQQLVg90H21EOLACvtfcHk0ljU_rYW7cok3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFSnsr7L&md5=77a6befc95f7813aedf93415b0a5e64f</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1517%2F14728222.2014.957673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2014.957673%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DM.%2BT.%26aulast%3DMuralidharan%26aufirst%3DA.%26atitle%3DTargeting%2520angiotensin%2520II%2520type%25202%2520receptor%2520pathways%2520to%2520treat%2520neuropathic%2520pain%2520and%2520inflammatory%2520pain%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2015%26volume%3D19%26issue%3D1%26spage%3D25%26epage%3D35%26doi%3D10.1517%2F14728222.2014.957673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Bali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaggi, A. S.</span><span> </span><span class="NLM_article-title">Renin-angiotensin system in pain: existing in a double life?</span> <span class="citation_source-journal">JRAAS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span><span class="refDoi"> DOI: 10.1177/1470320313503694</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1177%2F1470320313503694" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVWnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=329-340&issue=4&author=A.+Baliauthor=N.+Singhauthor=A.+S.+Jaggi&title=Renin-angiotensin+system+in+pain%3A+existing+in+a+double+life%3F&doi=10.1177%2F1470320313503694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Renin-angiotensin system in pain: existing in a double life?</span></div><div class="casAuthors">Bali, Anjana; Singh, Nirmal; Jaggi, Amteshwar Singh</div><div class="citationInfo"><span class="NLM_cas:title">JRAAS</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-340, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">JRAAAG</span>;
        ISSN:<span class="NLM_cas:issn">1470-3203</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Apart from the well-documented role of the renin-angiotensin-aldosterone system (RAAS) in regulating the blood pressure and other related parameters, its role in modulating different physiol./pathol. functions, including pain, has also been described.  Like its dual role in regulating stress-related anxiety and cognitive functions, its dual role has also been documented in pain modulation in different disease states.  Drugs blocking the RAAS activation, viz., renin inhibitors, angiotensin converting enzyme (ACE) inhibitors, AT1 receptor antagonists and aldosterone antagonists, have been shown to produce beneficial effects in migraine and neuropathic and nociceptive pain.  Their beneficial effects have been mainly attributed to inhibition of the inflammatory cascade of reactions by inhibiting the generation of key cytokines, including tumor necrosis factor (TNF)-α.  On the contrary, clin. as well as preclin. studies have also shown the pain-inducing actions of renin-angiotensin system (RAS) blocking drugs.  Furthermore, the pain-relieving actions of angiotensin II (AngII) and pain-inducing actions of AT1 blockers have also been described.  The pain-inducing actions of ACE inhibitors have been mainly attributed to interference with metab. of bradykinin and substance P, while the analgesic actions of AngII have been mainly related to activation of brain localized AT2 receptors and release of endogenous opioids.  The present review describes the dual role of the RAAS in different states of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHWN3H0mTcR7Vg90H21EOLACvtfcHk0ljU_rYW7cok3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVWnsr4%253D&md5=4085c4a2e96afcba67a8ea99639916e4</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1177%2F1470320313503694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1470320313503694%26sid%3Dliteratum%253Aachs%26aulast%3DBali%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DN.%26aulast%3DJaggi%26aufirst%3DA.%2BS.%26atitle%3DRenin-angiotensin%2520system%2520in%2520pain%253A%2520existing%2520in%2520a%2520double%2520life%253F%26jtitle%3DJRAAS%26date%3D2014%26volume%3D15%26issue%3D4%26spage%3D329%26epage%3D340%26doi%3D10.1177%2F1470320313503694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">de Mos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huygen, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stricker, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dieleman, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturkenboom, M. C.</span><span> </span><span class="NLM_article-title">The association between ACE inhibitors and the complex regional pain syndrome: Suggestions for a neuro-inflammatory pathogenesis of CRPS</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span><span class="refDoi"> DOI: 10.1016/j.pain.2008.12.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.pain.2008.12.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2009&pages=218-224&issue=3&author=M.+de+Mosauthor=F.+J.+Huygenauthor=B.+H.+Strickerauthor=J.+P.+Dielemanauthor=M.+C.+Sturkenboom&title=The+association+between+ACE+inhibitors+and+the+complex+regional+pain+syndrome%3A+Suggestions+for+a+neuro-inflammatory+pathogenesis+of+CRPS&doi=10.1016%2Fj.pain.2008.12.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2008.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2008.12.032%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BMos%26aufirst%3DM.%26aulast%3DHuygen%26aufirst%3DF.%2BJ.%26aulast%3DStricker%26aufirst%3DB.%2BH.%26aulast%3DDieleman%26aufirst%3DJ.%2BP.%26aulast%3DSturkenboom%26aufirst%3DM.%2BC.%26atitle%3DThe%2520association%2520between%2520ACE%2520inhibitors%2520and%2520the%2520complex%2520regional%2520pain%2520syndrome%253A%2520Suggestions%2520for%2520a%2520neuro-inflammatory%2520pathogenesis%2520of%2520CRPS%26jtitle%3DPain%26date%3D2009%26volume%3D142%26issue%3D3%26spage%3D218%26epage%3D224%26doi%3D10.1016%2Fj.pain.2008.12.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Rohit</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishna, G.</span><span> </span><span class="NLM_article-title">Effects of captopril and losartan on thermal and chemical induced pain in mice</span> <span class="citation_source-journal">Indian J. Physiol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=17051737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFaqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=169-174&issue=2&author=+Rohitauthor=C.+Raoauthor=G.+Krishna&title=Effects+of+captopril+and+losartan+on+thermal+and+chemical+induced+pain+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of captopril and losartan on thermal and chemical induced pain in mice</span></div><div class="casAuthors">Rohit; Chakradhar, Rao U. S.; Gopala, Krishna H. N.</div><div class="citationInfo"><span class="NLM_cas:title">Indian Journal of Physiology and Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">169-174</span>CODEN:
                <span class="NLM_cas:coden">IJPPAZ</span>;
        ISSN:<span class="NLM_cas:issn">0019-5499</span>.
    
            (<span class="NLM_cas:orgname">Association of Physiologists and Pharmacologists of India</span>)
        </div><div class="casAbstract">Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers antagonists (ARAs) are widely used compds. in various cardiovascular disorders.  ACEIs, but not ARAs, inhibit the enzyme dipeptidyl carboxypeptidase which is involved in the conversion of angiotensin I to II and degrdn. of kinins like bradykinin and substance P.  Bradykinin and substance P are potent mediators of inflammation and pain.  Hence the study was undertaken to evaluate the effects of captopril (an ACEI) and losartan (an ARA-AT1 receptor antagonist) on thermal and chem. induced nociception by employing hot plate and acetic acid induced writhing tests resp. in mice.  Inbred albino mice weighing between 25-30 g were used and they were divided into two sets, each set contg. 7 groups.  Control groups received normal saline and the remaining six groups received three doses (0.5, 1 and 2 mg/kg) of captopril and three doses (0.5, 1 and 2 mg/kg) of losartan.  Drugs were administered i.p. fifteen minutes before placing the animal over the hot plate or 30 min before injecting 0.6% acetic acid.  Both drugs dose dependently reduced the reaction time in hot plate method.  In chem. induced writhing test, both the drugs reduced the latency of onset of writhing and in captopril pretreated groups, acetic acid induced sustained abdominal contraction without any intermittent relaxation.  However, in losartan pretreated animals acetic acid just increased the no. of writhings without sustained abdominal contraction.  Thus, our study suggests that both drugs have hyperalgesic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE0CLMxZTFVrVg90H21EOLACvtfcHk0ljS1Yictnc0Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFaqtbw%253D&md5=bb3bf0c89f712027a4283162e8603a7e</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRohit%26aulast%3DRao%26aufirst%3DC.%26aulast%3DKrishna%26aufirst%3DG.%26atitle%3DEffects%2520of%2520captopril%2520and%2520losartan%2520on%2520thermal%2520and%2520chemical%2520induced%2520pain%2520in%2520mice%26jtitle%3DIndian%2520J.%2520Physiol.%2520Pharmacol.%26date%3D2006%26volume%3D50%26issue%3D2%26spage%3D169%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Laflamme, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Gasparo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payet, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo-Payet, N.</span><span> </span><span class="NLM_article-title">Angiotensin II induction of neurite outgrowth by AT2 receptors in NG108–15 cells. Effect counteracted by the AT1 receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x"> (</span><span class="NLM_issue">37</span><span class="NLM_x">) </span> <span class="NLM_fpage">22729</span><span class="NLM_x">–</span> <span class="NLM_lpage">22735</span><span class="refDoi"> DOI: 10.1074/jbc.271.37.22729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1074%2Fjbc.271.37.22729" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=22729-22735&issue=37&author=L.+Laflammeauthor=M.+de+Gasparoauthor=J.+M.+Galloauthor=M.+D.+Payetauthor=N.+Gallo-Payet&title=Angiotensin+II+induction+of+neurite+outgrowth+by+AT2+receptors+in+NG108%E2%80%9315+cells.+Effect+counteracted+by+the+AT1+receptors&doi=10.1074%2Fjbc.271.37.22729"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.37.22729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.37.22729%26sid%3Dliteratum%253Aachs%26aulast%3DLaflamme%26aufirst%3DL.%26aulast%3Dde%2BGasparo%26aufirst%3DM.%26aulast%3DGallo%26aufirst%3DJ.%2BM.%26aulast%3DPayet%26aufirst%3DM.%2BD.%26aulast%3DGallo-Payet%26aufirst%3DN.%26atitle%3DAngiotensin%2520II%2520induction%2520of%2520neurite%2520outgrowth%2520by%2520AT2%2520receptors%2520in%2520NG108%25E2%2580%259315%2520cells.%2520Effect%2520counteracted%2520by%2520the%2520AT1%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26issue%3D37%26spage%3D22729%26epage%3D22735%26doi%3D10.1074%2Fjbc.271.37.22729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Anand, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yiangou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korchev, Y. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, P.</span><span> </span><span class="NLM_article-title">Angiotensin II type 2 receptor (AT2 R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons</span> <span class="citation_source-journal">Eur. J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1012</span><span class="NLM_x">–</span> <span class="NLM_lpage">1026</span><span class="refDoi"> DOI: 10.1002/j.1532-2149.2012.00269.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1002%2Fj.1532-2149.2012.00269.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23255326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKhsrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=1012-1026&issue=7&author=U.+Anandauthor=P.+Facerauthor=Y.+Yiangouauthor=M.+Sinisiauthor=M.+Foxauthor=T.+McCarthyauthor=C.+Bountraauthor=Y.+E.+Korchevauthor=P.+Anand&title=Angiotensin+II+type+2+receptor+%28AT2+R%29+localization+and+antagonist-mediated+inhibition+of+capsaicin+responses+and+neurite+outgrowth+in+human+and+rat+sensory+neurons&doi=10.1002%2Fj.1532-2149.2012.00269.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Angiotensin II type 2 receptor (AT2R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons</span></div><div class="casAuthors">Anand, U.; Facer, P.; Yiangou, Y.; Sinisi, M.; Fox, M.; McCarthy, T.; Bountra, C.; Korchev, Y. E.; Anand, P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pain (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1012-1026</span>CODEN:
                <span class="NLM_cas:coden">EJPAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1090-3801</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background : The angiotensin II (AngII) receptor subtype 2 (AT2R) is expressed in sensory neurons and may play a role in nociception and neuronal regeneration.  Methods : We used immunostaining with characterized antibodies to study the localization of AT2R in cultured human and rat dorsal root ganglion (DRG) neurons and a range of human tissues.  The effects of AngII and AT2R antagonist EMA401 on capsaicin responses in cultured human and rat (DRG) neurons were measured with calcium imaging, on neurite length and d. with Gap43 immunostaining, and on cyclic adenosine monophosphate (cAMP) expression using immunofluorescence.  Results : AT2R expression was localized in small-/medium-sized cultured neurons of human and rat DRG.  Treatment with the AT2R antagonist EMA401 resulted in dose-related functional inhibition of capsaicin responses (IC50=10nmol/L), which was reversed by 8-bromo-cAMP, and reduced neurite length and d.; AngII treatment significantly enhanced capsaicin responses, cAMP levels and neurite outgrowth.  The AT1R antagonist losartan had no effect on capsaicin responses.  AT2R was localized in sensory neurons of human DRG, and nerve fibers in peripheral nerves, skin, urinary bladder and bowel.  A majority sub-population (60%) of small-/medium-diam. neuronal cells were immunopos. in both control post-mortem and avulsion-injured human DRG; some very small neurons appeared to be intensely immunoreactive, with TRPV1 co-localization.  While AT2R levels were reduced in human limb peripheral nerve segments proximal to injury, they were preserved in painful neuromas.  Conclusions : AT2R antagonists could be particularly useful in the treatment of chronic pain and hypersensitivity assocd. with abnormal nerve sprouting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXE7j5pUExILVg90H21EOLACvtfcHk0ljS1Yictnc0Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKhsrnF&md5=9550c73afcb055fb9144251b1f7d1872</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1002%2Fj.1532-2149.2012.00269.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fj.1532-2149.2012.00269.x%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DU.%26aulast%3DFacer%26aufirst%3DP.%26aulast%3DYiangou%26aufirst%3DY.%26aulast%3DSinisi%26aufirst%3DM.%26aulast%3DFox%26aufirst%3DM.%26aulast%3DMcCarthy%26aufirst%3DT.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DKorchev%26aufirst%3DY.%2BE.%26aulast%3DAnand%26aufirst%3DP.%26atitle%3DAngiotensin%2520II%2520type%25202%2520receptor%2520%2528AT2%2520R%2529%2520localization%2520and%2520antagonist-mediated%2520inhibition%2520of%2520capsaicin%2520responses%2520and%2520neurite%2520outgrowth%2520in%2520human%2520and%2520rat%2520sensory%2520neurons%26jtitle%3DEur.%2520J.%2520Pain%26date%3D2013%26volume%3D17%26issue%3D7%26spage%3D1012%26epage%3D1026%26doi%3D10.1002%2Fj.1532-2149.2012.00269.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Plouffe, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimond, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaudry, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo-Payet, N.</span><span> </span><span class="NLM_article-title">Role of tyrosine kinase receptors in angiotensin II AT2 receptor signaling: involvement in neurite outgrowth and in p42/p44mapk activation in NG108–15 cells</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">4646</span><span class="NLM_x">–</span> <span class="NLM_lpage">4654</span><span class="refDoi"> DOI: 10.1210/en.2005-1315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1210%2Fen.2005-1315" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2006&pages=4646-4654&issue=10&author=B.+Plouffeauthor=M.+O.+Guimondauthor=H.+Beaudryauthor=N.+Gallo-Payet&title=Role+of+tyrosine+kinase+receptors+in+angiotensin+II+AT2+receptor+signaling%3A+involvement+in+neurite+outgrowth+and+in+p42%2Fp44mapk+activation+in+NG108%E2%80%9315+cells&doi=10.1210%2Fen.2005-1315"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1210%2Fen.2005-1315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2005-1315%26sid%3Dliteratum%253Aachs%26aulast%3DPlouffe%26aufirst%3DB.%26aulast%3DGuimond%26aufirst%3DM.%2BO.%26aulast%3DBeaudry%26aufirst%3DH.%26aulast%3DGallo-Payet%26aufirst%3DN.%26atitle%3DRole%2520of%2520tyrosine%2520kinase%2520receptors%2520in%2520angiotensin%2520II%2520AT2%2520receptor%2520signaling%253A%2520involvement%2520in%2520neurite%2520outgrowth%2520and%2520in%2520p42%252Fp44mapk%2520activation%2520in%2520NG108%25E2%2580%259315%2520cells%26jtitle%3DEndocrinology%26date%3D2006%26volume%3D147%26issue%3D10%26spage%3D4646%26epage%3D4654%26doi%3D10.1210%2Fen.2005-1315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Chakrabarty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blacklock, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svojanovsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. G.</span><span> </span><span class="NLM_article-title">Estrogen elicits dorsal root ganglion axon sprouting via a renin-angiotensin system</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">3452</span><span class="NLM_x">–</span> <span class="NLM_lpage">3460</span><span class="refDoi"> DOI: 10.1210/en.2008-0061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1210%2Fen.2008-0061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2008&pages=3452-3460&issue=7&author=A.+Chakrabartyauthor=A.+Blacklockauthor=S.+Svojanovskyauthor=P.+G.+Smith&title=Estrogen+elicits+dorsal+root+ganglion+axon+sprouting+via+a+renin-angiotensin+system&doi=10.1210%2Fen.2008-0061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1210%2Fen.2008-0061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2008-0061%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarty%26aufirst%3DA.%26aulast%3DBlacklock%26aufirst%3DA.%26aulast%3DSvojanovsky%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DP.%2BG.%26atitle%3DEstrogen%2520elicits%2520dorsal%2520root%2520ganglion%2520axon%2520sprouting%2520via%2520a%2520renin-angiotensin%2520system%26jtitle%3DEndocrinology%26date%3D2008%26volume%3D149%26issue%3D7%26spage%3D3452%26epage%3D3460%26doi%3D10.1210%2Fen.2008-0061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Guimond, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo-Payet, N.</span><span> </span><span class="NLM_article-title">How does angiotensin AT(2) receptor activation help neuronal differentiation and improve neuronal pathological situations?</span> <span class="citation_source-journal">Front. Endocrinol. (Lausanne, Switz.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="refDoi"> DOI: 10.3389/fendo.2012.00164</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.3389%2Ffendo.2012.00164" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23267346" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=164&author=M.+O.+Guimondauthor=N.+Gallo-Payet&title=How+does+angiotensin+AT%282%29+receptor+activation+help+neuronal+differentiation+and+improve+neuronal+pathological+situations%3F&doi=10.3389%2Ffendo.2012.00164"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.3389%2Ffendo.2012.00164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffendo.2012.00164%26sid%3Dliteratum%253Aachs%26aulast%3DGuimond%26aufirst%3DM.%2BO.%26aulast%3DGallo-Payet%26aufirst%3DN.%26atitle%3DHow%2520does%2520angiotensin%2520AT%25282%2529%2520receptor%2520activation%2520help%2520neuronal%2520differentiation%2520and%2520improve%2520neuronal%2520pathological%2520situations%253F%26jtitle%3DFront.%2520Endocrinol.%2520%2528Lausanne%252C%2520Switz.%2529%26date%3D2012%26volume%3D3%26spage%3D164%26doi%3D10.3389%2Ffendo.2012.00164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Guimond, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallinder, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alterman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo-Payet, N.</span><span> </span><span class="NLM_article-title">Comparative functional properties of two structurally similar selective nonpeptide drug-like ligands for the angiotensin II type-2 (AT(2)) receptor. Effects on neurite outgrowth in NG108–15 cells</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">699</span><span class="NLM_x"> (</span><span class="NLM_issue">1–3</span><span class="NLM_x">) </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2012.11.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.ejphar.2012.11.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23211679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitlaqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=699&publication_year=2013&pages=160-171&issue=1%E2%80%933&author=M.+O.+Guimondauthor=C.+Wallinderauthor=M.+Altermanauthor=A.+Hallbergauthor=N.+Gallo-Payet&title=Comparative+functional+properties+of+two+structurally+similar+selective+nonpeptide+drug-like+ligands+for+the+angiotensin+II+type-2+%28AT%282%29%29+receptor.+Effects+on+neurite+outgrowth+in+NG108%E2%80%9315+cells&doi=10.1016%2Fj.ejphar.2012.11.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative functional properties of two structurally similar selective nonpeptide drug-like ligands for the angiotensin II type-2 (AT2) receptor. Effects on neurite outgrowth in NG108-15 cells</span></div><div class="casAuthors">Guimond, Marie-Odile; Wallinder, Charlotta; Alterman, Mathias; Hallberg, Anders; Gallo-Payet, Nicole</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">699</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">160-171</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There is increasing evidence that angiotensin II (Ang II), through binding to the type 2 (AT2) receptor may have beneficial effects in various physiol. and pathol. situations.  However, specific action presumably mediated by the angiotensin AT2 receptor has been hampered by the absence of appropriate selective ligands.  The aim of this study was to compare the biol. properties of two related and selective drug-like nonpeptide AT2 ligands, namely an agonist called M024 (also known as Compd. 21) and a new ligand, presumably an antagonist, C38/M132, (originally called C38).  Properties of the compds. were investigated in NG108-15 cells expressing angiotensin AT2 receptor and known to develop neurite outgrowth upon Ang II stimulation.  NG108-15 cells stimulated for three days with C21/M024 (0.1 or 100 nM) exhibited the same neurite outgrowth as cells stimulated with Ang II (100 nM) while co-incubation of Ang II or C21/M024 with C38/M132 (10 or 100 nM) inhibited their effects, similarly to the angiotensin AT2 receptor antagonist, PD123319 (10 μM).  As Ang II, C21/M024 induced a Rap1-dependent activation of p42/p44mapk whereas preincubation of cells with C38/M132 inhibited p42/p44mapk and Rap1 activation induced by Ang II.  Three-day treatment with C21/M024 or Ang II decreased cell no. in culture, an effect that was rescued by preincubation with C38/M132.  Taken together, these results indicate that the nonpeptide ligand C21/M024 is a potent angiotensin AT2 receptor agonist while C38/M132 acts as an antagonist.  These selective nonpeptide angiotensin AT2 ligands may represent unique and long-awaited tools for the pursuit of in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppSbhxynZSXrVg90H21EOLACvtfcHk0lgjL0nWcbcf5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitlaqtrs%253D&md5=4654d2d54485809d948577c0390c0a74</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2012.11.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2012.11.032%26sid%3Dliteratum%253Aachs%26aulast%3DGuimond%26aufirst%3DM.%2BO.%26aulast%3DWallinder%26aufirst%3DC.%26aulast%3DAlterman%26aufirst%3DM.%26aulast%3DHallberg%26aufirst%3DA.%26aulast%3DGallo-Payet%26aufirst%3DN.%26atitle%3DComparative%2520functional%2520properties%2520of%2520two%2520structurally%2520similar%2520selective%2520nonpeptide%2520drug-like%2520ligands%2520for%2520the%2520angiotensin%2520II%2520type-2%2520%2528AT%25282%2529%2529%2520receptor.%2520Effects%2520on%2520neurite%2520outgrowth%2520in%2520NG108%25E2%2580%259315%2520cells%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D699%26issue%3D1%25E2%2580%25933%26spage%3D160%26epage%3D171%26doi%3D10.1016%2Fj.ejphar.2012.11.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Smith, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyse, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, S. R.</span><span> </span><span class="NLM_article-title">Small molecule angiotensin II type 2 receptor (AT2R) antagonists as novel analgesics for neuropathic pain: comparative pharmacokinetics, radioligand binding, and efficacy in rats</span> <span class="citation_source-journal">Pain Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">692</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span><span class="refDoi"> DOI: 10.1111/pme.12063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1111%2Fpme.12063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23489258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADC%252BC3svmtVKisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=692-705&issue=5&author=M.+T.+Smithauthor=B.+D.+Wyseauthor=S.+R.+Edwards&title=Small+molecule+angiotensin+II+type+2+receptor+%28AT2R%29+antagonists+as+novel+analgesics+for+neuropathic+pain%3A+comparative+pharmacokinetics%2C+radioligand+binding%2C+and+efficacy+in+rats&doi=10.1111%2Fpme.12063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule angiotensin II type 2 receptor (AT2R) antagonists as novel analgesics for neuropathic pain: comparative pharmacokinetics, radioligand binding, and efficacy in rats</span></div><div class="casAuthors">Smith Maree T; Wyse Bruce D; Edwards Stephen R</div><div class="citationInfo"><span class="NLM_cas:title">Pain medicine (Malden, Mass.)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">692-705</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Neuropathic pain is an area of unmet clinical need.  The objective of this study was to define the pharmacokinetics, oral bioavailability, and efficacy in rats of small molecule antagonists of the angiotensin II type 2 receptor (AT2R) for the relief of neuropathic pain.  DESIGN AND METHODS:  Adult male Sprague-Dawley (SD) rats received single intravenous (1-10 mg/kg) or oral (5-10 mg/kg) bolus doses of EMA200, EMA300, EMA400 or EMA401 (S-enantiomer of EMA400).  Blood samples were collected immediately pre-dose and at specified times over a 12- to 24-hour post-dosing period.  Liquid chromatography tandem mass spectrometry was used to measure plasma drug concentrations.  Efficacy was assessed in adult male SD rats with a unilateral chronic constriction injury (CCI) of the sciatic nerve.  RESULTS:  After intravenous administration in rats, mean (±standard error of the mean) plasma clearance for EMA200, EMA300, EMA400, and EMA401 was 9.3, 6.1, 0.7, and 1.1 L/hour/kg, respectively.  After oral dosing, the dose-normalized systemic exposures of EMA400 and EMA401 were 20- to 30-fold and 50- to 60-fold higher than that for EMA300 and EMA200, respectively.  The oral bioavailability of EMA400 and EMA401 was similar at ∼30%, whereas it was only 5.9% and 7.1% for EMA200 and EMA300, respectively.  In CCI rats, single intraperitoneal bolus doses of EMA200, EMA300, and EMA400 evoked dose-dependent pain relief.  The pain relief potency rank order in CCI rats was EMA400 > EMA300 > EMA200 in agreement with the dose-normalized systemic exposure rank order in SD rats.  CONCLUSION:  The small molecule AT2R antagonist, EMA401, is in clinical development as a novel analgesic for the relief of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSjI5YuvrZVpNts4TFFB11gfW6udTcc2ebOTMb5dlh0h7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svmtVKisg%253D%253D&md5=5a5aecc9c63f4a49d650978d90603471</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1111%2Fpme.12063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpme.12063%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DM.%2BT.%26aulast%3DWyse%26aufirst%3DB.%2BD.%26aulast%3DEdwards%26aufirst%3DS.%2BR.%26atitle%3DSmall%2520molecule%2520angiotensin%2520II%2520type%25202%2520receptor%2520%2528AT2R%2529%2520antagonists%2520as%2520novel%2520analgesics%2520for%2520neuropathic%2520pain%253A%2520comparative%2520pharmacokinetics%252C%2520radioligand%2520binding%252C%2520and%2520efficacy%2520in%2520rats%26jtitle%3DPain%2520Med.%26date%3D2013%26volume%3D14%26issue%3D5%26spage%3D692%26epage%3D705%26doi%3D10.1111%2Fpme.12063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Smith, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodruff, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyse, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muralidharan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walther, T.</span><span> </span><span class="NLM_article-title">A small molecule angiotensin II type 2 receptor (AT2R) antagonist produces analgesia in a rat model of neuropathic pain by inhibition of p38 mitogen-activated protein kinase (MAPK) and p44/p42 MAPK activation in the dorsal root ganglia</span> <span class="citation_source-journal">Pain Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1557</span><span class="NLM_x">–</span> <span class="NLM_lpage">1568</span><span class="refDoi"> DOI: 10.1111/pme.12157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1111%2Fpme.12157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23742186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADC%252BC3sjgtl2hsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=1557-1568&issue=10&author=M.+T.+Smithauthor=T.+M.+Woodruffauthor=B.+D.+Wyseauthor=A.+Muralidharanauthor=T.+Walther&title=A+small+molecule+angiotensin+II+type+2+receptor+%28AT2R%29+antagonist+produces+analgesia+in+a+rat+model+of+neuropathic+pain+by+inhibition+of+p38+mitogen-activated+protein+kinase+%28MAPK%29+and+p44%2Fp42+MAPK+activation+in+the+dorsal+root+ganglia&doi=10.1111%2Fpme.12157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule angiotensin II type 2 receptor (AT2R) antagonist produces analgesia in a rat model of neuropathic pain by inhibition of p38 mitogen-activated protein kinase (MAPK) and p44/p42 MAPK activation in the dorsal root ganglia</span></div><div class="casAuthors">Smith Maree T; Woodruff Trent M; Wyse Bruce D; Muralidharan Arjun; Walther Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Pain medicine (Malden, Mass.)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1557-68</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  There is an unmet clinical need for novel analgesics for neuropathic pain.  This study was designed to elucidate the mechanism through which EMA300, a small molecule antagonist of the angiotensin II type 2 receptor (AT2R) with >1,000-fold selectivity over the angiotensin II type 1 receptor, produces analgesia in a rodent model of neuropathic pain.  DESIGN AND METHODS:  Groups of AT2R knockout, hemizygotes, and wild-type mice with a chronic constriction injury (CCI) of the sciatic nerve received single intraperitoneal (i.p.) bolus doses of EMA300 (100 or 300 mg/kg), and analgesic efficacy was assessed.  Groups of control, sham-operated, and CCI rats were euthanized and perfusion fixed.  Lumbar dorsal root ganglia (DRGs) were removed for investigation of the mechanism through which EMA300 alleviates neuropathic pain.  RESULTS:  EMA300 analgesia was abolished in AT2R knockout CCI mice with intermediate responses in the hemizygotes, affirming the AT2R as the target mediating EMA300 analgesia.  In CCI rats, DRG immunofluorescence (IF) levels for angiotensin II, the main endogenous ligand of the AT2R, were increased ∼1.5-2.0-fold (P < 0.05) cf. sham-controls.  Mean DRG IF levels for activated p38 (pp38) and activated p44/p42 (pp44/pp42) MAPK were also increased ∼1.5-2.0-fold (P < 0.05) cf. sham-controls.  At the time of peak EMA300 analgesia in CCI rats, mean DRG levels of pp38 MAPK and pp44/pp42 MAPK (but not angiotensin II) were reduced to match the respective levels in sham-controls.  CONCLUSION:  Augmented angiotensin II/AT2R signaling in the DRGs of CCI rats is attenuated by EMA300 to block p38 MAPK and p44/p42 MAPK activation, a mechanism with clinical validity for alleviating neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXnivkNFx8x--MdeMhXAHkfW6udTcc2eYa871fK5hUfLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjgtl2hsA%253D%253D&md5=58e8198bfaf990ad99b1b887abd88611</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1111%2Fpme.12157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpme.12157%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DM.%2BT.%26aulast%3DWoodruff%26aufirst%3DT.%2BM.%26aulast%3DWyse%26aufirst%3DB.%2BD.%26aulast%3DMuralidharan%26aufirst%3DA.%26aulast%3DWalther%26aufirst%3DT.%26atitle%3DA%2520small%2520molecule%2520angiotensin%2520II%2520type%25202%2520receptor%2520%2528AT2R%2529%2520antagonist%2520produces%2520analgesia%2520in%2520a%2520rat%2520model%2520of%2520neuropathic%2520pain%2520by%2520inhibition%2520of%2520p38%2520mitogen-activated%2520protein%2520kinase%2520%2528MAPK%2529%2520and%2520p44%252Fp42%2520MAPK%2520activation%2520in%2520the%2520dorsal%2520root%2520ganglia%26jtitle%3DPain%2520Med.%26date%3D2013%26volume%3D14%26issue%3D10%26spage%3D1557%26epage%3D1568%26doi%3D10.1111%2Fpme.12157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Muralidharan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyse, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. T.</span><span> </span><span class="NLM_article-title">Analgesic efficacy and mode of action of a selective small molecule angiotensin II type 2 receptor antagonist in a rat model of prostate cancer-induced bone pain</span> <span class="citation_source-journal">Pain Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span><span class="refDoi"> DOI: 10.1111/pme.12258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1111%2Fpme.12258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=24433468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADC%252BC2czmtlajtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=93-110&issue=1&author=A.+Muralidharanauthor=B.+D.+Wyseauthor=M.+T.+Smith&title=Analgesic+efficacy+and+mode+of+action+of+a+selective+small+molecule+angiotensin+II+type+2+receptor+antagonist+in+a+rat+model+of+prostate+cancer-induced+bone+pain&doi=10.1111%2Fpme.12258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Analgesic efficacy and mode of action of a selective small molecule angiotensin II type 2 receptor antagonist in a rat model of prostate cancer-induced bone pain</span></div><div class="casAuthors">Muralidharan Arjun; Wyse Bruce D; Smith Maree T</div><div class="citationInfo"><span class="NLM_cas:title">Pain medicine (Malden, Mass.)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-110</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  The pathobiology of prostate cancer (PCa)-induced bone pain (PCIBP) has both inflammatory and neuropathic components.  Previously, we showed that small molecule angiotensin II type 2 receptor (AT2 R) antagonists with >1,000-fold selectivity over the angiotensin II type 1 receptor produced dose-dependent analgesia in a rat model of neuropathic pain.  Here, we assessed the analgesic efficacy and mode of action of the AT2 R antagonist, EMA200, in a rat model of PCIBP.  METHODS:  At 14-21 days after unilateral intratibial injection of AT3B PCa cells, rats exhibiting hindpaw hypersensitivity received single intravenous bolus doses of EMA200 (0.3-10 mg/kg) or vehicle, and analgesic efficacy was assessed.  The mode of action was investigated using immunohistochemical, Western blot, and/or molecular biological methods in lumbar dorsal root ganglia (DRGs) removed from drug-naive and EMA200-treated PCIBP rats relative to sham-control rats.  RESULTS:  Intravenous bolus doses of EMA200 produced dose-dependent analgesia in PCIBP rats.  Lumbar DRG levels of angiotensin II, nerve growth factor (NGF), tyrosine kinase A (TrkA), phospho-p38 mitogen-activated protein kinase (MAPK), and phospho-p44/p42 MAPK, but not the AT2 R, were increased significantly (P < 0.05) in PCIBP rats, c.f. the corresponding levels for sham controls.  EMA200 produced analgesia in PCIBP rats by reducing elevated angiotensin II levels in the lumbar DRGs to attenuate augmented angiotensin II/AT2 R signaling.  This in turn reduced augmented NGF/TrkA signaling in the lumbar DRGs.  The net result was inhibition of p38 MAPK and p44/p42 MAPK activation.  CONCLUSION:  Small molecule AT2 R antagonists are worthy of further investigation as novel analgesics for relief of intractable PCIBP and other pain types where hyperalgesia worsens symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAiSkGgy9eIeb6AVA-44PTfW6udTcc2eYa871fK5hUfLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czmtlajtg%253D%253D&md5=9b89cedf036b082b91c1fd7052cac7ae</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1111%2Fpme.12258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpme.12258%26sid%3Dliteratum%253Aachs%26aulast%3DMuralidharan%26aufirst%3DA.%26aulast%3DWyse%26aufirst%3DB.%2BD.%26aulast%3DSmith%26aufirst%3DM.%2BT.%26atitle%3DAnalgesic%2520efficacy%2520and%2520mode%2520of%2520action%2520of%2520a%2520selective%2520small%2520molecule%2520angiotensin%2520II%2520type%25202%2520receptor%2520antagonist%2520in%2520a%2520rat%2520model%2520of%2520prostate%2520cancer-induced%2520bone%2520pain%26jtitle%3DPain%2520Med.%26date%3D2014%26volume%3D15%26issue%3D1%26spage%3D93%26epage%3D110%26doi%3D10.1111%2Fpme.12258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Chakrabarty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. G.</span><span> </span><span class="NLM_article-title">Angiotensin II receptor type 2 activation is required for cutaneous sensory hyperinnervation and hypersensitivity in a rat hind paw model of inflammatory pain</span> <span class="citation_source-journal">J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1053</span><span class="NLM_x">–</span> <span class="NLM_lpage">1065</span><span class="refDoi"> DOI: 10.1016/j.jpain.2013.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.jpain.2013.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23726047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovVSqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=1053-1065&issue=10&author=A.+Chakrabartyauthor=Z.+Liaoauthor=P.+G.+Smith&title=Angiotensin+II+receptor+type+2+activation+is+required+for+cutaneous+sensory+hyperinnervation+and+hypersensitivity+in+a+rat+hind+paw+model+of+inflammatory+pain&doi=10.1016%2Fj.jpain.2013.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Angiotensin II Receptor Type 2 Activation Is Required for Cutaneous Sensory Hyperinnervation and Hypersensitivity in a Rat Hind Paw Model of Inflammatory Pain</span></div><div class="casAuthors">Chakrabarty, Anuradha; Liao, Zhaohui; Smith, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1053-1065</span>CODEN:
                <span class="NLM_cas:coden">JPOAB5</span>;
        ISSN:<span class="NLM_cas:issn">1526-5900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Many pain syndromes are assocd. with abnormal proliferation of peripheral sensory fibers.  We showed previously that angiotensin II, acting through its type 2 receptor (AT2), stimulates axon outgrowth by cultured dorsal root ganglion neurons.  In this study, we assessed whether AT2 mediates nociceptor hyperinnervation in the rodent hind paw model of inflammatory pain.  Plantar injection of complete Freund's adjuvant (CFA), but not saline, produced marked thermal and mech. hypersensitivity through 7 days.  This was accompanied by proliferation of dermal and epidermal PGP9.5-immunoreactive (ir) and calcitonin gene-related peptide-immunoreactive (CGRP-ir) axons, and dermal axons immunoreactive for GFRα2 but not tyrosine hydroxylase or neurofilament H.  Continuous infusion of the AT2 antagonist PD123319 beginning with CFA injection completely prevented hyperinnervation as well as hypersensitivity over a 7-day period.  A single PD123319 injection 7 days after CFA also reversed thermal hypersensitivity and partially reversed mech. hypersensitivity 3 h later, without affecting cutaneous innervation.  Angiotensin II-synthesizing proteins renin and angiotensinogen were largely absent after saline but abundant in T cells and macrophages in CFA-injected paws with or without PD123319.  Thus, emigrant cells at the site of inflammation apparently establish a renin-angiotensin system, and AT2 activation elicits nociceptor sprouting and heightened thermal and mech. sensitivity.Short-term AT2 activation is a potent contributor to thermal hypersensitivity, whereas long-term effects (such as hyperinnervation) also contribute to mech. hypersensitivity.  Pharmacol. blockade of AT2 signaling represents a potential therapeutic strategy aimed at biol. mechanisms underlying chronic inflammatory pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUf7QG_tTBs7Vg90H21EOLACvtfcHk0liVOJpikmI_yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovVSqtro%253D&md5=3ffc9b78efebb2e50dc7a9f39cd6c164</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2013.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2013.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarty%26aufirst%3DA.%26aulast%3DLiao%26aufirst%3DZ.%26aulast%3DSmith%26aufirst%3DP.%2BG.%26atitle%3DAngiotensin%2520II%2520receptor%2520type%25202%2520activation%2520is%2520required%2520for%2520cutaneous%2520sensory%2520hyperinnervation%2520and%2520hypersensitivity%2520in%2520a%2520rat%2520hind%2520paw%2520model%2520of%2520inflammatory%2520pain%26jtitle%3DJ.%2520Pain%26date%3D2013%26volume%3D14%26issue%3D10%26spage%3D1053%26epage%3D1065%26doi%3D10.1016%2Fj.jpain.2013.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Rice, A. S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dworkin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCloud, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desem, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raff, M.</span><span> </span><span class="NLM_article-title">EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">383</span><span class="NLM_x"> (</span><span class="NLM_issue">9929</span><span class="NLM_x">) </span> <span class="NLM_fpage">1637</span><span class="NLM_x">–</span> <span class="NLM_lpage">1647</span><span class="refDoi"> DOI: 10.1016/S0140-6736(13)62337-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2FS0140-6736%2813%2962337-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2014&pages=1637-1647&issue=9929&author=A.+S.+C.+Riceauthor=R.+H.+Dworkinauthor=T.+D.+McCarthyauthor=P.+Anandauthor=C.+Bountraauthor=P.+I.+McCloudauthor=J.+Hillauthor=G.+Cutterauthor=G.+Kitsonauthor=N.+Desemauthor=M.+Raff&title=EMA401%2C+an+orally+administered+highly+selective+angiotensin+II+type+2+receptor+antagonist%2C+as+a+novel+treatment+for+postherpetic+neuralgia%3A+a+randomised%2C+double-blind%2C+placebo-controlled+phase+2+clinical+trial&doi=10.1016%2FS0140-6736%2813%2962337-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2813%2962337-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252813%252962337-5%26sid%3Dliteratum%253Aachs%26aulast%3DRice%26aufirst%3DA.%2BS.%2BC.%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26aulast%3DMcCarthy%26aufirst%3DT.%2BD.%26aulast%3DAnand%26aufirst%3DP.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DMcCloud%26aufirst%3DP.%2BI.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DCutter%26aufirst%3DG.%26aulast%3DKitson%26aufirst%3DG.%26aulast%3DDesem%26aufirst%3DN.%26aulast%3DRaff%26aufirst%3DM.%26atitle%3DEMA401%252C%2520an%2520orally%2520administered%2520highly%2520selective%2520angiotensin%2520II%2520type%25202%2520receptor%2520antagonist%252C%2520as%2520a%2520novel%2520treatment%2520for%2520postherpetic%2520neuralgia%253A%2520a%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%2520phase%25202%2520clinical%2520trial%26jtitle%3DLancet%26date%3D2014%26volume%3D383%26issue%3D9929%26spage%3D1637%26epage%3D1647%26doi%3D10.1016%2FS0140-6736%2813%2962337-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate receptor signaling</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span><span class="refDoi"> DOI: 10.1146/annurev.biochem.78.072407.103733</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1146%2Fannurev.biochem.78.072407.103733" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=19231986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1Ghu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=743-768&author=H.+Rosenauthor=P.+J.+Gonzalez-Cabreraauthor=M.+G.+Sannaauthor=S.+Brown&title=Sphingosine+1-phosphate+receptor+signaling&doi=10.1146%2Fannurev.biochem.78.072407.103733"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate receptor signaling</span></div><div class="casAuthors">Rosen, Hugh; Gonzalez-Cabrera, Pedro J.; Sanna, M. Germana; Brown, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">743-768</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The sphingosine 1-phosphate (S1P) receptor signaling system is a productive model system.  A hydrophobic zwitterionic lysophospholipid ligand with difficult phys. properties interacts with 5 high-affinity G protein-coupled receptors to generate multiple downstream signals.  These signals modulate homeostasis and pathol. on a steep agonist concn.-response curve.  Ligand presence is essential for vascular development and endothelial integrity, while acute increases in ligand concns. result in cardiac death.  Understanding this integrated biochem. system has exemplified the impact of both genetics and chem.  Developing specific tools with defined biochem. properties for the reversible modulation of signals in real time has been essential to complement insights gained from genetic approaches that may be irreversible and compensated.  Despite its knife-edge between life and death, this system, based in part on receptor subtype selectivity and in part on differential attenuation of deleterious signals, now appears to be on the cusp of meaningful therapy for multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT_vass2lPj7Vg90H21EOLACvtfcHk0liHnqaZShZdlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1Ghu78%253D&md5=d76c5ea98a0cbf52d2c986252964822a</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.78.072407.103733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.78.072407.103733%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DBrown%26aufirst%3DS.%26atitle%3DSphingosine%25201-phosphate%2520receptor%2520signaling%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2009%26volume%3D78%26spage%3D743%26epage%3D768%26doi%3D10.1146%2Fannurev.biochem.78.072407.103733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Kolesnick, R.</span><span> </span><span class="NLM_article-title">The therapeutic potential of modulating the ceramide/sphingomyelin pathway</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1172/JCI0216127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1172%2FJCI0216127" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2002&pages=3-8&issue=1&author=R.+Kolesnick&title=The+therapeutic+potential+of+modulating+the+ceramide%2Fsphingomyelin+pathway&doi=10.1172%2FJCI0216127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1172%2FJCI0216127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI0216127%26sid%3Dliteratum%253Aachs%26aulast%3DKolesnick%26aufirst%3DR.%26atitle%3DThe%2520therapeutic%2520potential%2520of%2520modulating%2520the%2520ceramide%252Fsphingomyelin%2520pathway%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2002%26volume%3D110%26issue%3D1%26spage%3D3%26epage%3D8%26doi%3D10.1172%2FJCI0216127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Maceyka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine kinase, sphingosine-1-phosphate, and apoptosis</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1585</span><span class="NLM_x"> (</span><span class="NLM_issue">2–3</span><span class="NLM_x">) </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span><span class="refDoi"> DOI: 10.1016/S1388-1981(02)00341-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2FS1388-1981%2802%2900341-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=12531554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivVyjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1585&publication_year=2002&pages=193-201&issue=2%E2%80%933&author=M.+Maceykaauthor=S.+G.+Payneauthor=S.+Milstienauthor=S.+Spiegel&title=Sphingosine+kinase%2C+sphingosine-1-phosphate%2C+and+apoptosis&doi=10.1016%2FS1388-1981%2802%2900341-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine kinase, sphingosine-1-phosphate, and apoptosis</span></div><div class="casAuthors">Maceyka, Michael; Payne, Shawn G.; Milstien, Sheldon; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1585</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">193-201</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The sphingolipid metabolites ceramide (Cer), sphingosine (Sph), and sphingosine-1-phosphate (S1P) play an important role in the regulation of cell proliferation, survival, and cell death.  Cer and Sph usually inhibit proliferation and promote apoptosis, while the further metabolite S1P stimulates growth and suppresses apoptosis.  Because these metabolites are interconvertible, it has been proposed that it is not the abs. amts. of these metabolites but rather their relative levels that dets. cell fate.  The relevance of this sphingolipid rheostat and its role in regulating cell fate has been borne out by work in many labs using many different cell types and exptl. manipulations.  A central finding of these studies is that Sph kinase (SphK), the enzyme that phosphorylates Sph to form S1P, is a crit. regulator of the sphingolipid rheostat, as it not only produces the pro-growth, anti-apoptotic messenger S1P, but also decreases levels of pro-apoptotic Cer and Sph.  Given the role of the sphingolipid rheostat in regulating growth and apoptosis, it is not surprising that sphingolipid metab. is often found to be disregulated in cancer, a disease characterized by enhanced cell growth, diminished cell death, or both.  Anticancer therapeutics targeting SphK are potentially clin. relevant.  Indeed, inhibition of SphK has been shown to suppress gastric tumor growth and conversely, overexpression of SphK increases tumorigenicity.  Moreover, S1P has also been shown to regulate angiogenesis, or new blood vessel formation, which is crit. for tumor progression.  Furthermore, there is intriguing new evidence that S1P can act in an autocrine and/or paracrine fashion to regulate blood vessel formation.  Thus, SphK may not only protect tumors from apoptosis, it may also increase their vascularization, further enhancing growth.  The cytoprotective effects of SphK/S1P may also be important for clin. benefit, as S1P has been shown to protect oocytes from radiation-induced cell death in vivo.  Here we review the growing literature on the regulation of SphK and the role of SphK and its product, S1P, in apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQFFL1hOzF2LVg90H21EOLACvtfcHk0liHnqaZShZdlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivVyjtg%253D%253D&md5=df46c1ee03cc777f4500a042595b70bc</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2FS1388-1981%2802%2900341-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1388-1981%252802%252900341-4%26sid%3Dliteratum%253Aachs%26aulast%3DMaceyka%26aufirst%3DM.%26aulast%3DPayne%26aufirst%3DS.%2BG.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine%2520kinase%252C%2520sphingosine-1-phosphate%252C%2520and%2520apoptosis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2002%26volume%3D1585%26issue%3D2%25E2%2580%25933%26spage%3D193%26epage%3D201%26doi%3D10.1016%2FS1388-1981%2802%2900341-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Pyne, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate and cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">503</span><span class="refDoi"> DOI: 10.1038/nrc2875</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnrc2875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=20555359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsFKis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=489-503&issue=7&author=N.+J.+Pyneauthor=S.+Pyne&title=Sphingosine+1-phosphate+and+cancer&doi=10.1038%2Fnrc2875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate and cancer</span></div><div class="casAuthors">Pyne, Nigel J.; Pyne, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">489-503</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is substantial evidence that sphingosine 1-phosphate (S1P) is involved in cancer.  S1P regulates processes such as inflammation, which can drive tumorigenesis; neovascularization, which provides cancer cells with nutrients and oxygen; and cell growth and survival.  This occurs at multiple levels and involves S1P receptors, sphingosine kinases, S1P phosphatases and S1P lyase.  This Review summarizes current research findings and examines the potential for new therapeutics designed to alter S1P signalling and function in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopcjXMo4lyC7Vg90H21EOLACvtfcHk0ljgIAiqd3ZhPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsFKis7s%253D&md5=b6963178dfee638d875f652546d009bc</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1038%2Fnrc2875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2875%26sid%3Dliteratum%253Aachs%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DPyne%26aufirst%3DS.%26atitle%3DSphingosine%25201-phosphate%2520and%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26issue%3D7%26spage%3D489%26epage%3D503%26doi%3D10.1038%2Fnrc2875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Takabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paugh, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">″Inside-out″ signaling of sphingosine-1-phosphate: therapeutic targets</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span><span class="refDoi"> DOI: 10.1124/pr.107.07113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1124%2Fpr.107.07113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=18552276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlWlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=181-195&issue=2&author=K.+Takabeauthor=S.+W.+Paughauthor=S.+Milstienauthor=S.+Spiegel&title=%E2%80%B3Inside-out%E2%80%B3+signaling+of+sphingosine-1-phosphate%3A+therapeutic+targets&doi=10.1124%2Fpr.107.07113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">"Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets</span></div><div class="casAuthors">Takabe, Kazuaki; Paugh, Steven W.; Milstien, Sheldon; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-195</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P) is abioactive sphingolipid metabolite involved in many crit. cellular processes including proliferation, survival, and migration, as well as angiogenesis and allergic responses.  S1P levels inside cells are tightly regulated by the balance between its synthesis by sphingosine kinases and degrdn.  S1P is interconvertible with ceramide, which is a crit. mediator of apoptosis.  It has been postulated that the ratio between S1P and ceramide dets. cell fate.  Activation of sphingosine kinase by a variety of agonists increases intracellular S1P, which in turn can function intracellularly as a second messenger or be secreted out of the cell and act extracellularly by binding to and signaling through S1P receptors in autocrine and/or paracrine manners.  Recent studies suggest that this "inside-out" signaling by S1P may play a role in many human diseases, including cancer, atherosclerosis, inflammation, and autoimmune disorders such as multiple sclerosis.  In this review we summarize metab. of S1P, mechanisms of sphingosine kinase activation, and S1P receptors and their downstream signaling pathways and examine relationships to multiple disease processes.  In particular, we describe recent preclin. and clin. trials of therapies targeting S1P signaling, including 2-amino-2-propane-1,3-diol hydrochloride (FTY720, fingolimod), S1P receptor agonists, sphingosine kinase inhibitors, and anti-S1P monoclonal antibody.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqGsVVT4kXgrVg90H21EOLACvtfcHk0ljgIAiqd3ZhPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlWlsr0%253D&md5=ae97fc6340cde0c6d2f2b181bff31932</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1124%2Fpr.107.07113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.107.07113%26sid%3Dliteratum%253Aachs%26aulast%3DTakabe%26aufirst%3DK.%26aulast%3DPaugh%26aufirst%3DS.%2BW.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3D%25E2%2580%25B3Inside-out%25E2%2580%25B3%2520signaling%2520of%2520sphingosine-1-phosphate%253A%2520therapeutic%2520targets%26jtitle%3DPharmacol.%2520Rev.%26date%3D2008%26volume%3D60%26issue%3D2%26spage%3D181%26epage%3D195%26doi%3D10.1124%2Fpr.107.07113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Santos, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">Drugging sphingosine kinases</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span><span class="refDoi"> DOI: 10.1021/cb5008426</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb5008426" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=225-233&issue=1&author=W.+L.+Santosauthor=K.+R.+Lynch&title=Drugging+sphingosine+kinases&doi=10.1021%2Fcb5008426"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fcb5008426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb5008426%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DW.%2BL.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DDrugging%2520sphingosine%2520kinases%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26issue%3D1%26spage%3D225%26epage%3D233%26doi%3D10.1021%2Fcb5008426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Visentin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vekich, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibbald, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matteo, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garland, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbadini, R. A.</span><span> </span><span class="NLM_article-title">Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span><span class="refDoi"> DOI: 10.1016/j.ccr.2006.02.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.ccr.2006.02.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=225-238&issue=3&author=B.+Visentinauthor=J.+A.+Vekichauthor=B.+J.+Sibbaldauthor=A.+L.+Cavalliauthor=K.+M.+Morenoauthor=R.+G.+Matteoauthor=W.+A.+Garlandauthor=Y.+Luauthor=S.+Yuauthor=H.+S.+Hallauthor=V.+Kundraauthor=G.+B.+Millsauthor=R.+A.+Sabbadini&title=Validation+of+an+anti-sphingosine-1-phosphate+antibody+as+a+potential+therapeutic+in+reducing+growth%2C+invasion%2C+and+angiogenesis+in+multiple+tumor+lineages&doi=10.1016%2Fj.ccr.2006.02.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.02.023%26sid%3Dliteratum%253Aachs%26aulast%3DVisentin%26aufirst%3DB.%26aulast%3DVekich%26aufirst%3DJ.%2BA.%26aulast%3DSibbald%26aufirst%3DB.%2BJ.%26aulast%3DCavalli%26aufirst%3DA.%2BL.%26aulast%3DMoreno%26aufirst%3DK.%2BM.%26aulast%3DMatteo%26aufirst%3DR.%2BG.%26aulast%3DGarland%26aufirst%3DW.%2BA.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DHall%26aufirst%3DH.%2BS.%26aulast%3DKundra%26aufirst%3DV.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DSabbadini%26aufirst%3DR.%2BA.%26atitle%3DValidation%2520of%2520an%2520anti-sphingosine-1-phosphate%2520antibody%2520as%2520a%2520potential%2520therapeutic%2520in%2520reducing%2520growth%252C%2520invasion%252C%2520and%2520angiogenesis%2520in%2520multiple%2520tumor%2520lineages%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26issue%3D3%26spage%3D225%26epage%3D238%26doi%3D10.1016%2Fj.ccr.2006.02.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Marsolais, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span><span class="refDoi"> DOI: 10.1038/nrd2356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnrd2356" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=297-307&issue=4&author=D.+Marsolaisauthor=H.+Rosen&title=Chemical+modulators+of+sphingosine-1-phosphate+receptors+as+barrier-oriented+therapeutic+molecules&doi=10.1038%2Fnrd2356"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1038%2Fnrd2356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2356%26sid%3Dliteratum%253Aachs%26aulast%3DMarsolais%26aufirst%3DD.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DChemical%2520modulators%2520of%2520sphingosine-1-phosphate%2520receptors%2520as%2520barrier-oriented%2520therapeutic%2520molecules%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26issue%3D4%26spage%3D297%26epage%3D307%26doi%3D10.1038%2Fnrd2356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Subei, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, J. A.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate receptor modulators in multiple sclerosis</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">575</span><span class="refDoi"> DOI: 10.1007/s40263-015-0261-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1007%2Fs40263-015-0261-z" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=565-575&issue=7&author=A.+M.+Subeiauthor=J.+A.+Cohen&title=Sphingosine+1-phosphate+receptor+modulators+in+multiple+sclerosis&doi=10.1007%2Fs40263-015-0261-z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1007%2Fs40263-015-0261-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40263-015-0261-z%26sid%3Dliteratum%253Aachs%26aulast%3DSubei%26aufirst%3DA.%2BM.%26aulast%3DCohen%26aufirst%3DJ.%2BA.%26atitle%3DSphingosine%25201-phosphate%2520receptor%2520modulators%2520in%2520multiple%2520sclerosis%26jtitle%3DCNS%2520Drugs%26date%3D2015%26volume%3D29%26issue%3D7%26spage%3D565%26epage%3D575%26doi%3D10.1007%2Fs40263-015-0261-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Calabresi, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radue, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffery, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rammohan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reder, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollmer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agius, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kappos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stites, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappiello, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Rosenstiel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lublin, F. D.</span><span> </span><span class="NLM_article-title">Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span><span class="refDoi"> DOI: 10.1016/S1474-4422(14)70049-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2FS1474-4422%2814%2970049-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=24685276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltl2msbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=545-556&issue=6&author=P.+A.+Calabresiauthor=E.+W.+Radueauthor=D.+Goodinauthor=D.+Jefferyauthor=K.+W.+Rammohanauthor=A.+T.+Rederauthor=T.+Vollmerauthor=M.+A.+Agiusauthor=L.+Kapposauthor=T.+Stitesauthor=B.+Liauthor=L.+Cappielloauthor=P.+von+Rosenstielauthor=F.+D.+Lublin&title=Safety+and+efficacy+of+fingolimod+in+patients+with+relapsing-remitting+multiple+sclerosis+%28FREEDOMS+II%29%3A+a+double-blind%2C+randomised%2C+placebo-controlled%2C+phase+3+trial&doi=10.1016%2FS1474-4422%2814%2970049-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial</span></div><div class="casAuthors">Calabresi, Peter A.; Radue, Ernst-Wilhelm; Goodin, Douglas; Jeffery, Douglas; Rammohan, Kottil W.; Reder, Anthony T.; Vollmer, Timothy; Agius, Mark A.; Kappos, Ludwig; Stites, Tracy; Li, Bingbing; Cappiello, Linda; von Rosenstiel, Philipp; Lublin, Fred D.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">545-556</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Fingolimod has shown redns. in clin. and MRI disease activity in patients with relapsing-remitting multiple sclerosis.  We further assessed the efficacy and safety of fingolimod in such patients.We did this placebo-controlled, double-blind phase 3 study predominantly in the USA (101 of 117 centers).  Using a computer-generated sequence, we randomly allocated eligible patients-those aged 18-55 years with relapsing-remitting multiple sclerosis-to receive fingolimod 0·5 mg, fingolimod 1·25 mg, or placebo orally once daily (1:1:1; stratified by study center).  On Nov 12, 2009, all patients assigned to fingolimod 1·25 mg were switched to the 0·5 mg dose in a blinded manner after a review of data from other phase 3 trials and recommendation from the data and safety monitoring board, but were analyzed as being in the 1·25 mg group in the primary outcome anal.  Our primary endpoint was annualised relapse rate at month 24, analyzed by intention to treat.  Secondary endpoints included percentage brain vol. change (PBVC) from baseline and time-to-disability-progression confirmed at 3 mo.  This trial is registered with ClinicalTrilals.gov, no. NCT00355134.Between June 30, 2006, and March 4, 2009, we enrolled and randomly allocated 1083 patients: 370 to fingolimod 1·25 mg, 358 to fingolimod 0·5 mg, and 355 to placebo.  Mean annualised relapse rate was 0·40 (95% CI 0·34-0·48) in patients given placebo and 0·21 (0·17-0·25) in patients given fingolimod 0·5 mg: rate ratio 0·52 (95% CI 0·40-0·66; p<0·0001), corresponding to a redn. of 48% with fingolimod 0·5 mg vs. placebo.  Mean PBVC was -0·86 (SD 1·22) for fingolimod 0·5 mg vs. -1·28 (1·50) for placebo (treatment difference -0·41, 95% CI -0·62 to -0·20; p=0·0002).  We recorded no statistically significant between-group difference in confirmed disability progression (hazard rate 0·83 with fingolimod 0·5 mg vs placebo; 95% CI 0·61-1·12; p=0·227).  Fingolimod 0·5 mg caused more of the following adverse events vs. placebo: lymphopenia (27 [8%] patients vs 0 patients), increased alanine aminotransferase (29 [8%] vs six [2%]), herpes zoster infection (nine [3%] vs three [1%]), hypertension (32 [9%] vs 11 [3%]), first-dose bradycardia (five [1%] vs one [<0·5%]), and first-degree atrioventricular block (17 [5%] vs seven [2%]). 53 (15%) of 358 patients given fingolimod 0·5 mg and 45 (13%) of 355 patients given placebo had serious adverse events over 24 mo, which included basal-cell carcinoma (ten [3%] patients vs two [1%] patients), macular edema (three [1%] vs two [1%]), infections (11 [3%] vs four [1%]), and neoplasms (13 [4%] vs eight [2%]).Our findings expand knowledge of the safety profile of fingolimod and strengthen evidence for its beneficial effects on relapse rates in patients with relapsing-remitting multiple sclerosis.  We saw no effect of fingolimod on disability progression.  Our findings substantiate the beneficial profile of fingolimod as a disease-modifying agent in the management of patients with relapsing-remitting multiple sclerosis.Novartis Pharma AG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofGYMIpkt51bVg90H21EOLACvtfcHk0ljz1XBzyXIkvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltl2msbc%253D&md5=d4bfa88221a214dc2ad0bba52bcd7942</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2814%2970049-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252814%252970049-3%26sid%3Dliteratum%253Aachs%26aulast%3DCalabresi%26aufirst%3DP.%2BA.%26aulast%3DRadue%26aufirst%3DE.%2BW.%26aulast%3DGoodin%26aufirst%3DD.%26aulast%3DJeffery%26aufirst%3DD.%26aulast%3DRammohan%26aufirst%3DK.%2BW.%26aulast%3DReder%26aufirst%3DA.%2BT.%26aulast%3DVollmer%26aufirst%3DT.%26aulast%3DAgius%26aufirst%3DM.%2BA.%26aulast%3DKappos%26aufirst%3DL.%26aulast%3DStites%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DCappiello%26aufirst%3DL.%26aulast%3Dvon%2BRosenstiel%26aufirst%3DP.%26aulast%3DLublin%26aufirst%3DF.%2BD.%26atitle%3DSafety%2520and%2520efficacy%2520of%2520fingolimod%2520in%2520patients%2520with%2520relapsing-remitting%2520multiple%2520sclerosis%2520%2528FREEDOMS%2520II%2529%253A%2520a%2520double-blind%252C%2520randomised%252C%2520placebo-controlled%252C%2520phase%25203%2520trial%26jtitle%3DLancet%2520Neurol.%26date%3D2014%26volume%3D13%26issue%3D6%26spage%3D545%26epage%3D556%26doi%3D10.1016%2FS1474-4422%2814%2970049-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Edsall, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirianov, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">6952</span><span class="NLM_x">–</span> <span class="NLM_lpage">6960</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1523%2FJNEUROSCI.17-18-06952.1997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=9278531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADyaK2sXmtVKmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=6952-6960&issue=18&author=L.+C.+Edsallauthor=G.+G.+Pirianovauthor=S.+Spiegel&title=Involvement+of+sphingosine+1-phosphate+in+nerve+growth+factor-mediated+neuronal+survival+and+differentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation</span></div><div class="casAuthors">Edsall, Lisa Cseh; Pirianov, Grisha G.; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6952-6960</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Sphingolipid metabolites, such as ceramide and sphingosine-1-phosphate (SPP), are emerging as a new class of second messengers involved in cellular proliferation, differentiation, and apoptosis.  Nerve growth factor (NGF), a neurotrophic factor for pheochromocytoma PC12 cells, induced a biphasic increase in the activity of sphingosine kinase, the enzyme that catalyzes the formation of SPP.  This activation was blocked by K252a, an inhibitor of tyrosine kinase A (trkA).  A rapid 1.7-fold increase was followed by a marked prolonged increase reaching a max. of fourfold to fivefold stimulation with a concomitant increase in SPP levels and a corresponding decrease in endogenous sphingosine levels.  Levels of ceramide, the precursor of sphingosine, were only slightly decreased by NGF in serum-contg. medium.  However, NGF decreased the elevation of ceramide induced by serum withdrawal.  Treatment of PC12 cells with SPP did not induce neurite outgrowth or neurofilament expression, yet it enhanced neurofilament expression elicited by suboptimal doses of NGF.  Moreover, SPP also protected PC12 cells from apoptosis induced by serum withdrawal.  To further substantiate a role for SPP in the cytoprotective actions of NGF, the authors found that N,N-dimethylsphingosine, a competitive inhibitor of sphingosine kinase, also induced apoptosis and interfered with the survival effect of NGF.  These effects were counteracted by exogenous SPP.  Moreover, other structurally related compds., such as dihydrosphingosine 1-phosphate and lysophosphatidic acid, had no significant protective effects.  Our results suggest that activation of sphingosine kinase and subsequent formation of SPP may play an important role in the differentiation and survival effects induced by NGF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTaKUxmMT2abVg90H21EOLACvtfcHk0ljz1XBzyXIkvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtVKmtbg%253D&md5=02ff0f011cb062b201cfcc8709c9649d</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.17-18-06952.1997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.17-18-06952.1997%26sid%3Dliteratum%253Aachs%26aulast%3DEdsall%26aufirst%3DL.%2BC.%26aulast%3DPirianov%26aufirst%3DG.%2BG.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DInvolvement%2520of%2520sphingosine%25201-phosphate%2520in%2520nerve%2520growth%2520factor-mediated%2520neuronal%2520survival%2520and%2520differentiation%26jtitle%3DJ.%2520Neurosci.%26date%3D1997%26volume%3D17%26issue%3D18%26spage%3D6952%26epage%3D6960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Toman, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watterson, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maceyka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigbee, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Differential transactivation of sphingosine-1-phosphate receptors modulates NGF-induced neurite extension</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span><span class="refDoi"> DOI: 10.1083/jcb.200402016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1083%2Fjcb.200402016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2004&pages=381-392&issue=3&author=R.+E.+Tomanauthor=S.+G.+Payneauthor=K.+R.+Wattersonauthor=M.+Maceykaauthor=N.+H.+Leeauthor=S.+Milstienauthor=J.+W.+Bigbeeauthor=S.+Spiegel&title=Differential+transactivation+of+sphingosine-1-phosphate+receptors+modulates+NGF-induced+neurite+extension&doi=10.1083%2Fjcb.200402016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200402016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200402016%26sid%3Dliteratum%253Aachs%26aulast%3DToman%26aufirst%3DR.%2BE.%26aulast%3DPayne%26aufirst%3DS.%2BG.%26aulast%3DWatterson%26aufirst%3DK.%2BR.%26aulast%3DMaceyka%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DN.%2BH.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DBigbee%26aufirst%3DJ.%2BW.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DDifferential%2520transactivation%2520of%2520sphingosine-1-phosphate%2520receptors%2520modulates%2520NGF-induced%2520neurite%2520extension%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2004%26volume%3D166%26issue%3D3%26spage%3D381%26epage%3D392%26doi%3D10.1083%2Fjcb.200402016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Farquhar-Smith, P.</span><span> </span><span class="NLM_article-title">Chemotherapy-induced neuropathic pain</span> <span class="citation_source-journal">Curr. Opin. Support. Palliat. Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span><span class="refDoi"> DOI: 10.1097/SPC.0b013e328342f9cc</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1097%2FSPC.0b013e328342f9cc" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=21192267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADC%252BC3M7ptFeguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2011&pages=1-7&issue=1&author=P.+Farquhar-Smith&title=Chemotherapy-induced+neuropathic+pain&doi=10.1097%2FSPC.0b013e328342f9cc"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Chemotherapy-induced neuropathic pain</span></div><div class="casAuthors">Farquhar-Smith Paul</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in supportive and palliative care</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  To discuss the importance, clinical features, possible pathology and treatments of chemotherapy-induced neuropathic pain.  Newer biological agents such as bortezomib will be considered in greater detail.  RECENT FINDINGS:  Chemotherapy-induced peripheral neuropathy (CIPN) is a frequent complication of common anticancer therapies.  It may lead to treatment compromise, significantly adds to the symptom burden and interferes with quality of life of cancer survivors.  Recent investigations have identified processes involved in CIPN which may give some insight for the development of novel treatments.  CIPN induced by different anticancer therapies may be heterogeneous and present as distinct neuropathic pains.  Recent work has focussed on the newer anticancer drugs such as bortezomib.  Contemporaneous studies have failed to find good evidence for the use of several common antineuropathic agents and further research is required.  SUMMARY:  Painful CIPN remains under recognized and undertreated.  It is an important cause of pain during cancer treatment and is a common pain in the cancer survivor.  Difficulties in assessment and limitations in treatment contribute to management problems.  Improvements in education (patient and clinician), assessment and treatment would potentially reduce the often debilitating effects of painful CIPN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQxwKI7CCF9MkEgZCMqtRBifW6udTcc2ebpY5g09dVd6Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7ptFeguw%253D%253D&md5=df8fb7704b64121a31a531790eb167ee</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1097%2FSPC.0b013e328342f9cc&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FSPC.0b013e328342f9cc%26sid%3Dliteratum%253Aachs%26aulast%3DFarquhar-Smith%26aufirst%3DP.%26atitle%3DChemotherapy-induced%2520neuropathic%2520pain%26jtitle%3DCurr.%2520Opin.%2520Support.%2520Palliat.%2520Care%26date%3D2011%26volume%3D5%26issue%3D1%26spage%3D1%26epage%3D7%26doi%3D10.1097%2FSPC.0b013e328342f9cc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Nakahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funakoshi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tojo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuoka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, T.</span><span> </span><span class="NLM_article-title">Role of nerve growth factor-tyrosine kinase receptor A signaling in paclitaxel-induced peripheral neuropathy in rats</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">444</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2014.01.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.bbrc.2014.01.082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2014&pages=415-419&issue=3&author=Y.+Nakahashiauthor=Y.+Kamiyaauthor=K.+Funakoshiauthor=T.+Miyazakiauthor=K.+Uchimotoauthor=K.+Tojoauthor=K.+Ogawaauthor=T.+Fukuokaauthor=T.+Goto&title=Role+of+nerve+growth+factor-tyrosine+kinase+receptor+A+signaling+in+paclitaxel-induced+peripheral+neuropathy+in+rats&doi=10.1016%2Fj.bbrc.2014.01.082"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2014.01.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2014.01.082%26sid%3Dliteratum%253Aachs%26aulast%3DNakahashi%26aufirst%3DY.%26aulast%3DKamiya%26aufirst%3DY.%26aulast%3DFunakoshi%26aufirst%3DK.%26aulast%3DMiyazaki%26aufirst%3DT.%26aulast%3DUchimoto%26aufirst%3DK.%26aulast%3DTojo%26aufirst%3DK.%26aulast%3DOgawa%26aufirst%3DK.%26aulast%3DFukuoka%26aufirst%3DT.%26aulast%3DGoto%26aufirst%3DT.%26atitle%3DRole%2520of%2520nerve%2520growth%2520factor-tyrosine%2520kinase%2520receptor%2520A%2520signaling%2520in%2520paclitaxel-induced%2520peripheral%2520neuropathy%2520in%2520rats%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2014%26volume%3D444%26issue%3D3%26spage%3D415%26epage%3D419%26doi%3D10.1016%2Fj.bbrc.2014.01.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Janes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Little, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamocki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snider, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuzzocrea, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bieberich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeid, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrache, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicol, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span> </span><span class="NLM_article-title">The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x"> (</span><span class="NLM_issue">30</span><span class="NLM_x">) </span> <span class="NLM_fpage">21082</span><span class="NLM_x">–</span> <span class="NLM_lpage">21097</span><span class="refDoi"> DOI: 10.1074/jbc.M114.569574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1074%2Fjbc.M114.569574" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=21082-21097&issue=30&author=K.+Janesauthor=J.+W.+Littleauthor=C.+Liauthor=L.+Bryantauthor=C.+Chenauthor=Z.+Chenauthor=K.+Kamockiauthor=T.+Doyleauthor=A.+Sniderauthor=E.+Espositoauthor=S.+Cuzzocreaauthor=E.+Bieberichauthor=L.+Obeidauthor=I.+Petracheauthor=G.+Nicolauthor=W.+L.+Neumannauthor=D.+Salvemini&title=The+development+and+maintenance+of+paclitaxel-induced+neuropathic+pain+require+activation+of+the+sphingosine+1-phosphate+receptor+subtype+1&doi=10.1074%2Fjbc.M114.569574"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.569574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.569574%26sid%3Dliteratum%253Aachs%26aulast%3DJanes%26aufirst%3DK.%26aulast%3DLittle%26aufirst%3DJ.%2BW.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DBryant%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DKamocki%26aufirst%3DK.%26aulast%3DDoyle%26aufirst%3DT.%26aulast%3DSnider%26aufirst%3DA.%26aulast%3DEsposito%26aufirst%3DE.%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DBieberich%26aufirst%3DE.%26aulast%3DObeid%26aufirst%3DL.%26aulast%3DPetrache%26aufirst%3DI.%26aulast%3DNicol%26aufirst%3DG.%26aulast%3DNeumann%26aufirst%3DW.%2BL.%26aulast%3DSalvemini%26aufirst%3DD.%26atitle%3DThe%2520development%2520and%2520maintenance%2520of%2520paclitaxel-induced%2520neuropathic%2520pain%2520require%2520activation%2520of%2520the%2520sphingosine%25201-phosphate%2520receptor%2520subtype%25201%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26issue%3D30%26spage%3D21082%26epage%3D21097%26doi%3D10.1074%2Fjbc.M114.569574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Zhang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasko, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicol, G. D.</span><span> </span><span class="NLM_article-title">Ceramide, a putative second messenger for nerve growth factor, modulates the TTX-resistant Na+current and delayed rectifier K+current in rat sensory neurons</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">544</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span><span class="refDoi"> DOI: 10.1113/jphysiol.2002.024265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1113%2Fjphysiol.2002.024265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=12381813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD38Xos12qur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=544&publication_year=2002&pages=385-402&issue=2&author=Y.+H.+Zhangauthor=M.+R.+Vaskoauthor=G.+D.+Nicol&title=Ceramide%2C+a+putative+second+messenger+for+nerve+growth+factor%2C+modulates+the+TTX-resistant+Na%2Bcurrent+and+delayed+rectifier+K%2Bcurrent+in+rat+sensory+neurons&doi=10.1113%2Fjphysiol.2002.024265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide, a putative second messenger for nerve growth factor, modulates the TTX-resistant Na+ current and delayed rectifier K+ current in rat sensory neurons</span></div><div class="casAuthors">Zhang, Y. H.; Vasko, M. R.; Nicol, G. D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">544</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">385-402</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Because nerve growth factor (NGF) is elevated during inflammation and is known to activate the sphingomyelin signaling pathway, the authors examd. whether NGF and its putative second messenger, ceramide, could modulate the excitability of capsaicin-sensitive adult and embryonic sensory neurons.  Using the whole-cell patch-clamp recording technique, exposure of isolated sensory neurons to either 100 ng ml-1 NGF or 1 μM N-acetyl sphingosine (C2-ceramide) produced a 3- to 4-fold increase in the no. of action potentials (APs) evoked by a ramp of depolarizing current in a time-dependent manner.  Intracellular perfusion with bacterial sphingomyelinase (SMase) also increased the no. of APs suggesting that the release of native ceramide enhanced neuronal excitability.  Glutathione, an inhibitor of neutral SMase, completely blocked the NGF-induced augmentation of AP firing, whereas dithiothreitol, an inhibitor of acidic SMase, was without effect.  In the presence of glutathione and NGF, exogenous ceramide still enhanced the no. of evoked APs, indicating that the sensitizing action of ceramide was downstream of NGF.  To investigate the mechanisms of action for NGF and ceramide, isolated membrane currents were examd.  Both NGF and ceramide facilitated the peak amplitude of the TTX-resistant sodium current (TTX-R INa) by approx. 1.5-fold and shifted the activation to more hyperpolarized voltages.  In addn., NGF and ceramide suppressed an outward potassium current (IK) by ∼35%.  Ceramide reduced IK in a concn.-dependent manner.  Isolation of the NGF- and ceramide-sensitive currents indicates that they were delayed rectifier types of IK.  The inflammatory prostaglandin, PGE2, produced an addnl. suppression of IK after exposure to ceramide (∼35%), suggesting that these agents might act on different targets.  Thus, the authors' findings indicate that the pro-inflammatory agent, NGF, can rapidly enhance the excitability of sensory neurons.  This NGF-induced sensitization is probably mediated by activation of the sphingomyelin signaling pathway to liberate ceramide(s), wherein ceramide appears to be the second messenger involved in modulating neuronal excitability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6ABXsSR1mU7Vg90H21EOLACvtfcHk0lj7ghSEfInUOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xos12qur4%253D&md5=aabb1a74a3ca385e302e2db273a8a231</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2002.024265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2002.024265%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DVasko%26aufirst%3DM.%2BR.%26aulast%3DNicol%26aufirst%3DG.%2BD.%26atitle%3DCeramide%252C%2520a%2520putative%2520second%2520messenger%2520for%2520nerve%2520growth%2520factor%252C%2520modulates%2520the%2520TTX-resistant%2520Na%252Bcurrent%2520and%2520delayed%2520rectifier%2520K%252Bcurrent%2520in%2520rat%2520sensory%2520neurons%26jtitle%3DJ.%2520Physiol.%26date%3D2002%26volume%3D544%26issue%3D2%26spage%3D385%26epage%3D402%26doi%3D10.1113%2Fjphysiol.2002.024265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Zhang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicol, G. D.</span><span> </span><span class="NLM_article-title">NGF-mediated sensitization of the excitability of rat sensory neurons is prevented by a blocking antibody to the p75 neurotrophin receptor</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">366</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span><span class="refDoi"> DOI: 10.1016/j.neulet.2004.05.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.neulet.2004.05.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2004&pages=187-192&issue=2&author=Y.+H.+Zhangauthor=G.+D.+Nicol&title=NGF-mediated+sensitization+of+the+excitability+of+rat+sensory+neurons+is+prevented+by+a+blocking+antibody+to+the+p75+neurotrophin+receptor&doi=10.1016%2Fj.neulet.2004.05.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2004.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2004.05.042%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DNicol%26aufirst%3DG.%2BD.%26atitle%3DNGF-mediated%2520sensitization%2520of%2520the%2520excitability%2520of%2520rat%2520sensory%2520neurons%2520is%2520prevented%2520by%2520a%2520blocking%2520antibody%2520to%2520the%2520p75%2520neurotrophin%2520receptor%26jtitle%3DNeurosci.%2520Lett.%26date%3D2004%26volume%3D366%26issue%3D2%26spage%3D187%26epage%3D192%26doi%3D10.1016%2Fj.neulet.2004.05.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Zhang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasko, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicol, G. D.</span><span> </span><span class="NLM_article-title">Intracellular sphingosine 1-phosphate mediates the increased excitability produced by nerve growth factor in rat sensory neurons</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">575</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.1113/jphysiol.2006.111575</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1113%2Fjphysiol.2006.111575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=16740613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD28XpslaitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=575&publication_year=2006&pages=101-113&issue=1&author=Y.+H.+Zhangauthor=M.+R.+Vaskoauthor=G.+D.+Nicol&title=Intracellular+sphingosine+1-phosphate+mediates+the+increased+excitability+produced+by+nerve+growth+factor+in+rat+sensory+neurons&doi=10.1113%2Fjphysiol.2006.111575"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular sphingosine 1-phosphate mediates the increased excitability produced by nerve growth factor in rat sensory neurons</span></div><div class="casAuthors">Zhang, Y. H.; Vasko, M. R.; Nicol, G. D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">575</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-113</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Our previous studies found that nerve growth factor (NGF), via ceramide, enhanced the no. of action potentials (APs) evoked by a ramp of depolarizing current in capsaicin-sensitive sensory neurons.  Ceramide can be metabolized by ceramidase to sphingosine (Sph), and Sph to sphingosine 1-phosphate (S1P) by sphingosine kinase.  It is well established that each of these products of sphingomyelin metab. can act as intracellular signaling mols.  This raises the question as to whether the enhanced excitability produced by NGF was mediated directly by ceramide or required addnl. metab. to Sph and(or) S1P.  Sph applied externally did not affect the neuronal excitability, whereas internally perfused Sph augmented the no. of APs evoked by the depolarizing ramp.  Furthermore, internally perfused S1P enhanced the no. of evoked APs.  This sensitizing action of NGF, ceramide and internally perfused Sph was abolished by dimethylsphingosine (DMS), an inhibitor of sphingosine kinase.  In contrast, internally perfused S1P enhanced the no. of evoked APs in the presence of DMS.  These observations support the idea that the metab. of ceramide/Sph to S1P is crit. for the sphingolipid-induced modulation of excitability.  Both internally perfused Sph and S1P inhibited the outward K+ current by 25-35% for the step to +60 mV.  The Sph- and S1P-sensitive currents had very similar current-voltage relations, suggesting that they were likely to be the same.  In addn., the Sph-induced suppression of the K+ current was blocked by pretreatment with DMS.  These findings demonstrate that intracellular S1P derived from ceramide acts as an internal second messenger to regulate membrane excitability; however, the effector system whereby S1P modulates excitability remains undetd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFy475RsyhxrVg90H21EOLACvtfcHk0liRqekTr0t65A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpslaitLw%253D&md5=16566dcc5a97cac1b9d88b3afaaafd93</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2006.111575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2006.111575%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DVasko%26aufirst%3DM.%2BR.%26aulast%3DNicol%26aufirst%3DG.%2BD.%26atitle%3DIntracellular%2520sphingosine%25201-phosphate%2520mediates%2520the%2520increased%2520excitability%2520produced%2520by%2520nerve%2520growth%2520factor%2520in%2520rat%2520sensory%2520neurons%26jtitle%3DJ.%2520Physiol.%26date%3D2006%26volume%3D575%26issue%3D1%26spage%3D101%26epage%3D113%26doi%3D10.1113%2Fjphysiol.2006.111575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Welch, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim-Selley, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, D. E.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate receptors as emerging targets for treatment of pain</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1551</span><span class="NLM_x">–</span> <span class="NLM_lpage">1562</span><span class="refDoi"> DOI: 10.1016/j.bcp.2012.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.bcp.2012.08.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=1551-1562&issue=12&author=S.+P.+Welchauthor=L.+J.+Sim-Selleyauthor=D.+E.+Selley&title=Sphingosine-1-phosphate+receptors+as+emerging+targets+for+treatment+of+pain&doi=10.1016%2Fj.bcp.2012.08.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DWelch%26aufirst%3DS.%2BP.%26aulast%3DSim-Selley%26aufirst%3DL.%2BJ.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26atitle%3DSphingosine-1-phosphate%2520receptors%2520as%2520emerging%2520targets%2520for%2520treatment%2520of%2520pain%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26issue%3D12%26spage%3D1551%26epage%3D1562%26doi%3D10.1016%2Fj.bcp.2012.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Salvemini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kress, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicol, G.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span><span class="refDoi"> DOI: 10.1016/j.tips.2012.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.tips.2012.12.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=110-118&issue=2&author=D.+Salveminiauthor=T.+Doyleauthor=M.+Kressauthor=G.+Nicol&title=Therapeutic+targeting+of+the+ceramide-to-sphingosine+1-phosphate+pathway+in+pain&doi=10.1016%2Fj.tips.2012.12.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2012.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2012.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DSalvemini%26aufirst%3DD.%26aulast%3DDoyle%26aufirst%3DT.%26aulast%3DKress%26aufirst%3DM.%26aulast%3DNicol%26aufirst%3DG.%26atitle%3DTherapeutic%2520targeting%2520of%2520the%2520ceramide-to-sphingosine%25201-phosphate%2520pathway%2520in%2520pain%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2013%26volume%3D34%26issue%3D2%26spage%3D110%26epage%3D118%26doi%3D10.1016%2Fj.tips.2012.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Ghasemi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dargahi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadiani, A.</span><span> </span><span class="NLM_article-title">Integrated sphingosine-1 phosphate signaling in the central nervous system: From physiological equilibrium to pathological damage</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">156</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span><span class="refDoi"> DOI: 10.1016/j.phrs.2015.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.phrs.2015.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=26772814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC28XlvF2ruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2016&pages=156-164&author=R.+Ghasemiauthor=L.+Dargahiauthor=A.+Ahmadiani&title=Integrated+sphingosine-1+phosphate+signaling+in+the+central+nervous+system%3A+From+physiological+equilibrium+to+pathological+damage&doi=10.1016%2Fj.phrs.2015.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated sphingosine-1 phosphate signaling in the central nervous system: From physiological equilibrium to pathological damage</span></div><div class="casAuthors">Ghasemi, Rasoul; Dargahi, Leila; Ahmadiani, Abolhassan</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">156-164</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingosine-1 phosphate (S1P), a bioactive sphingolipid metabolite, plays an essential role in cellular homeostasis.  It is well evidenced that enzymes responsible for S1P prodn., as well as S1P receptors are expressed in the central nervous system (CNS), implying that S1P may contribute to CNS physiol.  In current review, we will present the current knowledge about developmental and neuromodulatory functions of S1P in the brain.  Considering neuroprotective effects of S1P, we also review the relation between S1P and cellular autophagy, mitochondrial function, oxidative stress and apoptosis as well as mol. pathways underlying neuroprotective effects of S1P.  Given these pivotal functions, in the last section, we will summarize latest findings about possible contribution of S1P dysregulation in neurol. disorders like Alzheimer's disease and multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMdXasL3dZZbVg90H21EOLACvtfcHk0liRqekTr0t65A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlvF2ruw%253D%253D&md5=20d2150b1cc69a981cec2d2669ab18a9</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2015.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2015.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DGhasemi%26aufirst%3DR.%26aulast%3DDargahi%26aufirst%3DL.%26aulast%3DAhmadiani%26aufirst%3DA.%26atitle%3DIntegrated%2520sphingosine-1%2520phosphate%2520signaling%2520in%2520the%2520central%2520nervous%2520system%253A%2520From%2520physiological%2520equilibrium%2520to%2520pathological%2520damage%26jtitle%3DPharmacol.%2520Res.%26date%3D2016%26volume%3D104%26spage%3D156%26epage%3D164%26doi%3D10.1016%2Fj.phrs.2015.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Doyle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeid, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate acting via the S1P1 receptor is a downstream signaling pathway in ceramide-induced hyperalgesia</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">499</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1016/j.neulet.2011.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.neulet.2011.05.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=499&publication_year=2011&pages=4-8&issue=1&author=T.+Doyleauthor=Z.+Chenauthor=L.+M.+Obeidauthor=D.+Salvemini&title=Sphingosine-1-phosphate+acting+via+the+S1P1+receptor+is+a+downstream+signaling+pathway+in+ceramide-induced+hyperalgesia&doi=10.1016%2Fj.neulet.2011.05.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2011.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2011.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26aulast%3DSalvemini%26aufirst%3DD.%26atitle%3DSphingosine-1-phosphate%2520acting%2520via%2520the%2520S1P1%2520receptor%2520is%2520a%2520downstream%2520signaling%2520pathway%2520in%2520ceramide-induced%2520hyperalgesia%26jtitle%3DNeurosci.%2520Lett.%26date%3D2011%26volume%3D499%26issue%3D1%26spage%3D4%26epage%3D8%26doi%3D10.1016%2Fj.neulet.2011.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Coste, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marian, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenneis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angioni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popp, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geisslinger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholich, K.</span><span> </span><span class="NLM_article-title">Antinociceptive activity of the S1P-receptor agonist FTY720</span> <span class="citation_source-journal">J. Cell. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">995</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span><span class="refDoi"> DOI: 10.1111/j.1582-4934.2008.00160.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1111%2Fj.1582-4934.2008.00160.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=18494940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotlCrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=995-1004&issue=3&author=O.+Costeauthor=S.+Pierreauthor=C.+Marianauthor=C.+Brenneisauthor=C.+Angioniauthor=H.+Schmidtauthor=L.+Poppauthor=G.+Geisslingerauthor=K.+Scholich&title=Antinociceptive+activity+of+the+S1P-receptor+agonist+FTY720&doi=10.1111%2Fj.1582-4934.2008.00160.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive activity of the S1P-receptor agonist FTY720</span></div><div class="casAuthors">Coste, Ovidiu; Pierre, Sandra; Marian, Claudiu; Brenneis, Christian; Angioni, Carlo; Schmidt, Helmut; Popp, Laura; Geisslinger, Gerd; Scholich, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">995-1004</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-1838</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">FTY720 is a novel immunosuppressive drug that inhibits the egress of lymphocytes from secondary lymphoid tissues and thymus.  In its phosphorylated form FTY720 is a potent S1P receptor agonist.  Recently it was also shown that FTY720 can reduce prostaglandin synthesis through the direct inhibition of the cytosolic phospholipase A2 (cPLA2).  Since prostaglandins are important mediators of nociception, we studied the effects of FTY720 in different models of nociception.  We found that i.p. administration of FTY720 reduced dose-dependently the nociceptive behavior of rats in the formalin assay.  Although the antinociceptive doses of FTY720 were too low to alter the lymphocyte count, prostanoid concns. in the plasma were dramatically reduced.  Surprisingly, intrathecally administered FTY720 reduced the nociceptive behavior in the formalin assay without altering spinal prostaglandin synthesis, indicating that addnl. antinociceptive mechanisms beside the inhibition of prostaglandin synthesis are involved.  Accordingly, FTY720 reduced also the nociceptive behavior in the spared nerve injury model for neuropathic pain which does not depend on prostaglandin synthesis.  In this model the antinociceptive effect of FTY720 was similar to gabapentin, a commonly used drug to treat neuropathic pain.  Taken together we show for the first time that FTY720 possesses antinociceptive properties and that FTY720 reduces nociceptive behavior during neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGori6j7gyCKPbVg90H21EOLACvtfcHk0lgrkUZwpBLwaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotlCrtbc%253D&md5=0fa8b016d379762110196225a52a436b</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2008.00160.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2008.00160.x%26sid%3Dliteratum%253Aachs%26aulast%3DCoste%26aufirst%3DO.%26aulast%3DPierre%26aufirst%3DS.%26aulast%3DMarian%26aufirst%3DC.%26aulast%3DBrenneis%26aufirst%3DC.%26aulast%3DAngioni%26aufirst%3DC.%26aulast%3DSchmidt%26aufirst%3DH.%26aulast%3DPopp%26aufirst%3DL.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DScholich%26aufirst%3DK.%26atitle%3DAntinociceptive%2520activity%2520of%2520the%2520S1P-receptor%2520agonist%2520FTY720%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2008%26volume%3D12%26issue%3D3%26spage%3D995%26epage%3D1004%26doi%3D10.1111%2Fj.1582-4934.2008.00160.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitajo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span> </span><span class="NLM_article-title">The p75 receptor is associated with inflammatory thermal hypersensitivity</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">3566</span><span class="NLM_x">–</span> <span class="NLM_lpage">3574</span><span class="refDoi"> DOI: 10.1002/jnr.21808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1002%2Fjnr.21808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=18709654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFaksL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2008&pages=3566-3574&issue=16&author=T.+Watanabeauthor=T.+Itoauthor=G.+Inoueauthor=S.+Ohtoriauthor=K.+Kitajoauthor=H.+Doyaauthor=K.+Takahashiauthor=T.+Yamashita&title=The+p75+receptor+is+associated+with+inflammatory+thermal+hypersensitivity&doi=10.1002%2Fjnr.21808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">The p75 receptor is associated with inflammatory thermal hypersensitivity</span></div><div class="casAuthors">Watanabe, Tomoko; Ito, Toshinori; Inoue, Gen; Ohtori, Seiji; Kitajo, Keiko; Doya, Hideo; Takahashi, Kazuhisa; Yamashita, Toshihide</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3566-3574</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Inflammatory pain, characterized by a decrease in the nociceptive threshold, arises through the actions of inflammatory mediators, and one of the key mols. is nerve growth factor (NGF).  Here we report that the administration of neutralizing antibody to the neurotrophin receptor p75 (p75NTR) blocks hyperalgesia, which develops with complete Freund's adjuvant (CFA)-induced inflammation or with an intraplantar injection of NGF.  Although CFA injection results in the up-regulation of calcitonin gene-related peptide (CGRP) levels in the primary sensory neurons, blocking p75NTR abolishes this effect.  We further demonstrate that pro-NGF is the predominant ligand of p75NTR in vivo.  Plasmin treatment, which is intended to decomp. pro-NGF, ameliorates CFA-induced hyperalgesia.  In addn., an intraplantar injection of pro-NGF induces hyperalgesia.  These data together suggest that pro-NGF, as well as mature NGF, binding to p75NTR plays an important role in inflammation-induced hyperalgesia.  Interference in the binding may provide a therapeutic approach for the treatment of inflammatory pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo_k-EZ0uxA7Vg90H21EOLACvtfcHk0lgrkUZwpBLwaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFaksL%252FL&md5=812052edf4620c2c289e09d024af0cfd</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1002%2Fjnr.21808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.21808%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DG.%26aulast%3DOhtori%26aufirst%3DS.%26aulast%3DKitajo%26aufirst%3DK.%26aulast%3DDoya%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DYamashita%26aufirst%3DT.%26atitle%3DThe%2520p75%2520receptor%2520is%2520associated%2520with%2520inflammatory%2520thermal%2520hypersensitivity%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2008%26volume%3D86%26issue%3D16%26spage%3D3566%26epage%3D3574%26doi%3D10.1002%2Fjnr.21808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Lewin, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nykjaer, A.</span><span> </span><span class="NLM_article-title">Pro-neurotrophins, sortilin, and nociception</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span><span class="refDoi"> DOI: 10.1111/ejn.12466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1111%2Fejn.12466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=24494677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADC%252BC2cvitFKruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=363-374&issue=3&author=G.+R.+Lewinauthor=A.+Nykjaer&title=Pro-neurotrophins%2C+sortilin%2C+and+nociception&doi=10.1111%2Fejn.12466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Pro-neurotrophins, sortilin, and nociception</span></div><div class="casAuthors">Lewin Gary R; Nykjaer Anders</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">363-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nerve growth factor (NGF) signaling is important in the development and functional maintenance of nociceptors, but it also plays a central role in initiating and sustaining heat and mechanical hyperalgesia following inflammation.  NGF signaling in pain has traditionally been thought of as primarily engaging the classic high-affinity receptor tyrosine kinase receptor TrkA to initiate sensitization events.  However, the discovery that secreted proforms of nerve NGF have biological functions distinct from the processed mature factors raised the possibility that these proneurotrophins (proNTs) may have distinct function in painful conditions.  ProNTs engage a novel receptor system that is distinct from that of mature neurotrophins, consisting of sortilin, a type I membrane protein belonging to the VPS10p family, and its co-receptor, the classic low-affinity neurotrophin receptor p75NTR.  Here, we review how this new receptor system may itself function with or independently of the classic TrkA system in regulating inflammatory or neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTVCk9mnvysEYvKgEt20y1XfW6udTcc2eY7-PoFIlZ-Xrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvitFKruw%253D%253D&md5=237452c8a1786c6357dde53531fb73b3</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1111%2Fejn.12466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fejn.12466%26sid%3Dliteratum%253Aachs%26aulast%3DLewin%26aufirst%3DG.%2BR.%26aulast%3DNykjaer%26aufirst%3DA.%26atitle%3DPro-neurotrophins%252C%2520sortilin%252C%2520and%2520nociception%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2014%26volume%3D39%26issue%3D3%26spage%3D363%26epage%3D374%26doi%3D10.1111%2Fejn.12466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Bucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alifano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cogli, L.</span><span> </span><span class="NLM_article-title">The role of rab proteins in neuronal cells and in the trafficking of neurotrophin receptors</span> <span class="citation_source-journal">Membranes (Basel, Switz.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">642</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span><span class="refDoi"> DOI: 10.3390/membranes4040642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.3390%2Fmembranes4040642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=25295627" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=642-677&issue=4&author=C.+Bucciauthor=P.+Alifanoauthor=L.+Cogli&title=The+role+of+rab+proteins+in+neuronal+cells+and+in+the+trafficking+of+neurotrophin+receptors&doi=10.3390%2Fmembranes4040642"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.3390%2Fmembranes4040642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmembranes4040642%26sid%3Dliteratum%253Aachs%26aulast%3DBucci%26aufirst%3DC.%26aulast%3DAlifano%26aufirst%3DP.%26aulast%3DCogli%26aufirst%3DL.%26atitle%3DThe%2520role%2520of%2520rab%2520proteins%2520in%2520neuronal%2520cells%2520and%2520in%2520the%2520trafficking%2520of%2520neurotrophin%2520receptors%26jtitle%3DMembranes%2520%2528Basel%252C%2520Switz.%2529%26date%3D2014%26volume%3D4%26issue%3D4%26spage%3D642%26epage%3D677%26doi%3D10.3390%2Fmembranes4040642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group">Ramer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisby, M. A.</span><span> </span><span class="NLM_article-title">Adrenergic innervation of rat sensory ganglia following proximal or distal painful sciatic neuropathy: distinct mechanisms revealed by anti-NGF treatment</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span><span class="refDoi"> DOI: 10.1046/j.1460-9568.1999.00491.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1046%2Fj.1460-9568.1999.00491.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10103077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADyaK1M3gtleisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1999&pages=837-846&issue=3&author=M.+S.+Ramerauthor=M.+A.+Bisby&title=Adrenergic+innervation+of+rat+sensory+ganglia+following+proximal+or+distal+painful+sciatic+neuropathy%3A+distinct+mechanisms+revealed+by+anti-NGF+treatment&doi=10.1046%2Fj.1460-9568.1999.00491.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Adrenergic innervation of rat sensory ganglia following proximal or distal painful sciatic neuropathy: distinct mechanisms revealed by anti-NGF treatment</span></div><div class="casAuthors">Ramer M S; Bisby M A</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">837-46</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Sympathetic axons invade dorsal root ganglia (DRG) following nerve injury, and activity in the resulting pericellular axonal 'baskets' may underlie painful sympathetic-sensory coupling.  Sympathetic sprouting into the DRG may be stimulated by nerve growth factor (NGF).  To test this hypothesis, we investigated the effect of daily anti-NGF administration on pain and on sprouting in the DRG induced by chronic sciatic constriction injury (CCI) or L5 spinal nerve ligation (SNL).  These models have been shown to differ subtly in the onset of pain behaviours and adrenergic sprouting, and we now demonstrate a fundamental difference in the way sympathetic axons invade the DRG: after CCI, perivascular noradrenergic collaterals sprouted into the DRG in a manner dependent upon peripherally derived NGF.  In contrast, after SNL, regenerating sympathetic axons were diverted towards the DRG from the spinal nerve by the obstructing ligature, and this effect was only moderately impeded by anti-NGF.  The differential dependence on anti-NGF suggests that adrenergic innervation of the DRG after SNL and CCI may reflect regenerative and collateral sprouting, respectively.  Pain behaviour was similarly affected: anti-NGF completely prevented CCI-induced thermal hyperalgesia and mechanoallodynia, but the same treatment only partly relieved these symptoms following SNL.  These differences emphasize that although CCI and SNL may result in similar behavioural abnormalities, the underlying mechanisms may be governed by distinct processes, differentially dependent on peripheral NGF.  These mechanistic differences will have to be considered in the development of appropriate treatment strategies for neuropathic pain produced by different types of pathology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkPSbze1UMNpggzHGM8X5CfW6udTcc2eaOeRd7ufGyALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3gtleisg%253D%253D&md5=3a39fc4417aa3acc7ba58bf5bd344352</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1046%2Fj.1460-9568.1999.00491.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1460-9568.1999.00491.x%26sid%3Dliteratum%253Aachs%26aulast%3DRamer%26aufirst%3DM.%2BS.%26aulast%3DBisby%26aufirst%3DM.%2BA.%26atitle%3DAdrenergic%2520innervation%2520of%2520rat%2520sensory%2520ganglia%2520following%2520proximal%2520or%2520distal%2520painful%2520sciatic%2520neuropathy%253A%2520distinct%2520mechanisms%2520revealed%2520by%2520anti-NGF%2520treatment%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D1999%26volume%3D11%26issue%3D3%26spage%3D837%26epage%3D846%26doi%3D10.1046%2Fj.1460-9568.1999.00491.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group">Nicol, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasko, M. R.</span><span> </span><span class="NLM_article-title">Unraveling the story of NGF-mediated sensitization of nociceptive sensory neurons: ON or OFF the Trks?</span> <span class="citation_source-journal">Mol. Interventions</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1124/mi.7.1.6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1124%2Fmi.7.1.6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=26-41&issue=1&author=G.+D.+Nicolauthor=M.+R.+Vasko&title=Unraveling+the+story+of+NGF-mediated+sensitization+of+nociceptive+sensory+neurons%3A+ON+or+OFF+the+Trks%3F&doi=10.1124%2Fmi.7.1.6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1124%2Fmi.7.1.6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmi.7.1.6%26sid%3Dliteratum%253Aachs%26aulast%3DNicol%26aufirst%3DG.%2BD.%26aulast%3DVasko%26aufirst%3DM.%2BR.%26atitle%3DUnraveling%2520the%2520story%2520of%2520NGF-mediated%2520sensitization%2520of%2520nociceptive%2520sensory%2520neurons%253A%2520ON%2520or%2520OFF%2520the%2520Trks%253F%26jtitle%3DMol.%2520Interventions%26date%3D2007%26volume%3D7%26issue%3D1%26spage%3D26%26epage%3D41%26doi%3D10.1124%2Fmi.7.1.6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">Murakami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, T.</span><span> </span><span class="NLM_article-title">The molecular mechanisms of chronic inflammation development</span> <span class="citation_source-journal">Front. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="refDoi"> DOI: 10.3389/fimmu.2012.00323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.3389%2Ffimmu.2012.00323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23162547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADC%252BC3s7ksVWqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=323&author=M.+Murakamiauthor=T.+Hirano&title=The+molecular+mechanisms+of+chronic+inflammation+development&doi=10.3389%2Ffimmu.2012.00323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular mechanisms of chronic inflammation development</span></div><div class="casAuthors">Murakami Masaaki; Hirano Toshio</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">323</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEklVjjTrq5E2yPDyEFiigfW6udTcc2eaOeRd7ufGyALntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7ksVWqtw%253D%253D&md5=71025f3e312b2571680307984c9003ba</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2012.00323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2012.00323%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DM.%26aulast%3DHirano%26aufirst%3DT.%26atitle%3DThe%2520molecular%2520mechanisms%2520of%2520chronic%2520inflammation%2520development%26jtitle%3DFront.%2520Immunol.%26date%3D2012%26volume%3D3%26spage%3D323%26doi%3D10.3389%2Ffimmu.2012.00323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group">Pezet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, S. B.</span><span> </span><span class="NLM_article-title">Neurotrophins: mediators and modulators of pain</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">538</span><span class="refDoi"> DOI: 10.1146/annurev.neuro.29.051605.112929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1146%2Fannurev.neuro.29.051605.112929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=16776595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVeit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=507-538&author=S.+Pezetauthor=S.+B.+McMahon&title=Neurotrophins%3A+mediators+and+modulators+of+pain&doi=10.1146%2Fannurev.neuro.29.051605.112929"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotrophins: mediators and modulators of pain</span></div><div class="casAuthors">Pezet, Sophie; McMahon, Stephen B.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">507-538</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The neurotrophin family of neurotrophic factors are well-known for their effects on neuronal survival and growth.  Over the past decade, considerable evidence has accumulated from both humans and animals that one neurotrophin, nerve growth factor (NGF), is a peripheral pain mediator, particularly in inflammatory pain states.  NGF is upregulated in a wide variety of inflammatory conditions, and NGF-neutralizing mols. are effective analgesic agents in many models of persistent pain.  Such mols. are now being evaluated in clin. trials.  NGF regulates the expression of a 2nd neurotrophin, brain-derived neurotrophic factor (BDNF), in nociceptors.  BDNF is released when nociceptors are activated, and it acts as a central modulator of pain.  The chapter reviews the evidence for these roles (and briefly the effects of other neurotrophins), the range of conditions under which they act, and their mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWZk1aBEFejLVg90H21EOLACvtfcHk0liyVP8QHXCy4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVeit7w%253D&md5=8c9d57612ae9466e9c73776be0b8a104</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.29.051605.112929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.29.051605.112929%26sid%3Dliteratum%253Aachs%26aulast%3DPezet%26aufirst%3DS.%26aulast%3DMcMahon%26aufirst%3DS.%2BB.%26atitle%3DNeurotrophins%253A%2520mediators%2520and%2520modulators%2520of%2520pain%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2006%26volume%3D29%26spage%3D507%26epage%3D538%26doi%3D10.1146%2Fannurev.neuro.29.051605.112929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group">Lewin, G. R.; Carter, B. D.</span><span> </span><span class="NLM_article-title">Neurotrophic Factors</span>. In  <span class="citation_source-book">Handbook of Experimental Pharmacology</span>; <span class="NLM_contrib-group">Rosenthal, W.</span>, Ed.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">220</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1007%2F978-3-642-45106-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=G.+R.+Lewin&author=B.+D.+Carterauthor=W.+Rosenthal&title=Handbook+of+Experimental+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-45106-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-45106-5%26sid%3Dliteratum%253Aachs%26aulast%3DLewin%26aufirst%3DG.%2BR.%26atitle%3DNeurotrophic%2520Factors%26btitle%3DHandbook%2520of%2520Experimental%2520Pharmacology%26aulast%3DRosenthal%26aufirst%3DW.%26pub%3DSpringer%26date%3D2014%26volume%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group">Shu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendell, L. M.</span><span> </span><span class="NLM_article-title">Nerve growth factor acutely sensitizes the response of adult rat sensory neurons to capsaicin</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span><span class="refDoi"> DOI: 10.1016/S0304-3940(99)00701-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2FS0304-3940%2899%2900701-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=159-162&issue=3&author=X.+Shuauthor=L.+M.+Mendell&title=Nerve+growth+factor+acutely+sensitizes+the+response+of+adult+rat+sensory+neurons+to+capsaicin&doi=10.1016%2FS0304-3940%2899%2900701-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2899%2900701-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252899%252900701-6%26sid%3Dliteratum%253Aachs%26aulast%3DShu%26aufirst%3DX.%26aulast%3DMendell%26aufirst%3DL.%2BM.%26atitle%3DNerve%2520growth%2520factor%2520acutely%2520sensitizes%2520the%2520response%2520of%2520adult%2520rat%2520sensory%2520neurons%2520to%2520capsaicin%26jtitle%3DNeurosci.%2520Lett.%26date%3D1999%26volume%3D274%26issue%3D3%26spage%3D159%26epage%3D162%26doi%3D10.1016%2FS0304-3940%2899%2900701-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group">Schmieg, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menendez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiavo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terenzio, M.</span><span> </span><span class="NLM_article-title">Signalling endosomes in axonal transport: travel updates on the molecular highway</span> <span class="citation_source-journal">Semin. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span><span class="refDoi"> DOI: 10.1016/j.semcdb.2013.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.semcdb.2013.10.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=32-43&author=N.+Schmiegauthor=G.+Menendezauthor=G.+Schiavoauthor=M.+Terenzio&title=Signalling+endosomes+in+axonal+transport%3A+travel+updates+on+the+molecular+highway&doi=10.1016%2Fj.semcdb.2013.10.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1016%2Fj.semcdb.2013.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcdb.2013.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DSchmieg%26aufirst%3DN.%26aulast%3DMenendez%26aufirst%3DG.%26aulast%3DSchiavo%26aufirst%3DG.%26aulast%3DTerenzio%26aufirst%3DM.%26atitle%3DSignalling%2520endosomes%2520in%2520axonal%2520transport%253A%2520travel%2520updates%2520on%2520the%2520molecular%2520highway%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2014%26volume%3D27%26spage%3D32%26epage%3D43%26doi%3D10.1016%2Fj.semcdb.2013.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group">Woolf, C. J.</span><span> </span><span class="NLM_article-title">Evidence for a central component of post-injury pain hypersensitivity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x"> (</span><span class="NLM_issue">5944</span><span class="NLM_x">) </span> <span class="NLM_fpage">686</span><span class="NLM_x">–</span> <span class="NLM_lpage">688</span><span class="refDoi"> DOI: 10.1038/306686a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2F306686a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=1983&pages=686-688&issue=5944&author=C.+J.+Woolf&title=Evidence+for+a+central+component+of+post-injury+pain+hypersensitivity&doi=10.1038%2F306686a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1038%2F306686a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F306686a0%26sid%3Dliteratum%253Aachs%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26atitle%3DEvidence%2520for%2520a%2520central%2520component%2520of%2520post-injury%2520pain%2520hypersensitivity%26jtitle%3DNature%26date%3D1983%26volume%3D306%26issue%3D5944%26spage%3D686%26epage%3D688%26doi%3D10.1038%2F306686a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group">Apfel, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiideman, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dormia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snider, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, J. A.</span><span> </span><span class="NLM_article-title">Nerve growth factor regulates the expression of brain-derived neurotrophic factor mRNA in the peripheral nervous system</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span><span class="refDoi"> DOI: 10.1006/mcne.1996.0010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1006%2Fmcne.1996.0010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=8731481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADyaK28XisFOls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=134-142&issue=2&author=S.+C.+Apfelauthor=D.+E.+Wrightauthor=A.+M.+Wiidemanauthor=C.+Dormiaauthor=W.+D.+Sniderauthor=J.+A.+Kessler&title=Nerve+growth+factor+regulates+the+expression+of+brain-derived+neurotrophic+factor+mRNA+in+the+peripheral+nervous+system&doi=10.1006%2Fmcne.1996.0010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Nerve growth factor regulates the expression of brain-derived neurotrophic factor mRNA in the peripheral nervous system</span></div><div class="casAuthors">Apfel, Stuart C.; Wright, Douglas E.; Wiideman, Andrea M.; Dormia, Christine; Snider, William D.; Kessler, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">134-42</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Neurotrophins are profound regulators of neuronal survival in the developing peripheral nervous system and are synthesized by peripheral neurons themselves both during development and in maturity.  Neuronal neurotrophin expression may be importantly related to survival of mature neurons, both in normal and pathol. states.  The authors show here that brain-derived neurotrophic factor (BDNF) gene expression in dorsal root ganglia is strongly stimulated in vivo by another neurotrophin, nerve growth factor (NGF).  Furthermore, colocalization studies show that many BDNF-expressing sensory neurons also express trk A, the high-affinity NGF receptor.  These results demonstrate a novel regulatory mechanism for neurotrophin gene expression and suggest a paracrine function for neurotrophins in mature animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrk_nRMRncJ7Vg90H21EOLACvtfcHk0liyVP8QHXCy4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisFOls7k%253D&md5=d6e0d5a175ef6fce4c63fdedb328c53a</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1996.0010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1996.0010%26sid%3Dliteratum%253Aachs%26aulast%3DApfel%26aufirst%3DS.%2BC.%26aulast%3DWright%26aufirst%3DD.%2BE.%26aulast%3DWiideman%26aufirst%3DA.%2BM.%26aulast%3DDormia%26aufirst%3DC.%26aulast%3DSnider%26aufirst%3DW.%2BD.%26aulast%3DKessler%26aufirst%3DJ.%2BA.%26atitle%3DNerve%2520growth%2520factor%2520regulates%2520the%2520expression%2520of%2520brain-derived%2520neurotrophic%2520factor%2520mRNA%2520in%2520the%2520peripheral%2520nervous%2520system%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D1996%26volume%3D7%26issue%3D2%26spage%3D134%26epage%3D142%26doi%3D10.1006%2Fmcne.1996.0010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group">Kerr, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradbury, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dassan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, S. W.</span><span> </span><span class="NLM_article-title">Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">5138</span><span class="NLM_x">–</span> <span class="NLM_lpage">5148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1523%2FJNEUROSCI.19-12-05138.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10366647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADyaK1MXjvVGisLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=5138-5148&issue=12&author=B.+J.+Kerrauthor=E.+J.+Bradburyauthor=D.+L.+Bennettauthor=P.+M.+Trivediauthor=P.+Dassanauthor=J.+Frenchauthor=D.+B.+Sheltonauthor=S.+B.+McMahonauthor=S.+W.+Thompson&title=Brain-derived+neurotrophic+factor+modulates+nociceptive+sensory+inputs+and+NMDA-evoked+responses+in+the+rat+spinal+cord"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord</span></div><div class="casAuthors">Kerr, B. J.; Bradbury, E. J.; Bennett, D. L. H.; Trivedi, P. M.; Dassan, P.; French, J.; Shelton, D. B.; McMahon, S. B.; Thompson, S. W. N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5138-5148</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Central sensitization, the hyperexcitability of spinal processing that often accompanies peripheral injury, is a major component of many persistent pain states.  Here we report that the neurotrophin, brain-derived neurotrophic factor (BDNF), is a modulator of excitability within the spinal cord and contributes to the mechanism of central sensitization.  BDNF, localized in primary sensory neuron cell bodies and central terminals, potentiates nociceptive spinal reflex responses in an in vitro spinal cord prepn. and induces c-fos expression in dorsal horn neurons.  NMDA receptor-mediated responses, known as a major contributor to central sensitization, were significantly enhanced by exogenous BDNF.  Systemic NGF treatment, a procedure that mimics peripheral inflammatory states, raises BDNF levels in sensory neurons and increases nociceptive spinal reflex excitability.  This increased central excitability is reduced by trkB-IgG, a BDNF antagonist.  We also show directly that inflammatory pain-related behavior depends on BDNF release in vivo.  Thus, behavioral nociceptive responses induced by intraplantar formalin and by intraplantar carrageenan are significantly attenuated by trkB-IgG.  Hence BDNF is appropriately localized and regulated in inflammatory states and is sufficient and necessary for the expression of central sensitization in the spinal cord.  We propose that BDNF may function as a modulator of central sensitization in pathol. states, and our results suggest that pharmacol. antagonism of BDNF may prove an effective and novel analgesic strategy for the treatment of persistent inflammatory pain states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosX2vupF5UubVg90H21EOLACvtfcHk0lgljHr3kJxR0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvVGisLw%253D&md5=93a603e464632cf5b9fcd0e79effeb94</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.19-12-05138.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.19-12-05138.1999%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DB.%2BJ.%26aulast%3DBradbury%26aufirst%3DE.%2BJ.%26aulast%3DBennett%26aufirst%3DD.%2BL.%26aulast%3DTrivedi%26aufirst%3DP.%2BM.%26aulast%3DDassan%26aufirst%3DP.%26aulast%3DFrench%26aufirst%3DJ.%26aulast%3DShelton%26aufirst%3DD.%2BB.%26aulast%3DMcMahon%26aufirst%3DS.%2BB.%26aulast%3DThompson%26aufirst%3DS.%2BW.%26atitle%3DBrain-derived%2520neurotrophic%2520factor%2520modulates%2520nociceptive%2520sensory%2520inputs%2520and%2520NMDA-evoked%2520responses%2520in%2520the%2520rat%2520spinal%2520cord%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26issue%3D12%26spage%3D5138%26epage%3D5148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group">Rivera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas-Crusells, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahtinen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viitanen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanobashvili, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokaia, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Airaksinen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voipio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaila, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saarma, M.</span><span> </span><span class="NLM_article-title">BDNF-induced TrkB activation down-regulates the K+-Cl- cotransporter KCC2 and impairs neuronal Cl- extrusion</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">752</span><span class="refDoi"> DOI: 10.1083/jcb.200209011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1083%2Fjcb.200209011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2002&pages=747-752&issue=5&author=C.+Riveraauthor=H.+Liauthor=J.+Thomas-Crusellsauthor=H.+Lahtinenauthor=T.+Viitanenauthor=A.+Nanobashviliauthor=Z.+Kokaiaauthor=M.+S.+Airaksinenauthor=J.+Voipioauthor=K.+Kailaauthor=M.+Saarma&title=BDNF-induced+TrkB+activation+down-regulates+the+K%2B-Cl-+cotransporter+KCC2+and+impairs+neuronal+Cl-+extrusion&doi=10.1083%2Fjcb.200209011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200209011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200209011%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DThomas-Crusells%26aufirst%3DJ.%26aulast%3DLahtinen%26aufirst%3DH.%26aulast%3DViitanen%26aufirst%3DT.%26aulast%3DNanobashvili%26aufirst%3DA.%26aulast%3DKokaia%26aufirst%3DZ.%26aulast%3DAiraksinen%26aufirst%3DM.%2BS.%26aulast%3DVoipio%26aufirst%3DJ.%26aulast%3DKaila%26aufirst%3DK.%26aulast%3DSaarma%26aufirst%3DM.%26atitle%3DBDNF-induced%2520TrkB%2520activation%2520down-regulates%2520the%2520K%252B-Cl-%2520cotransporter%2520KCC2%2520and%2520impairs%2520neuronal%2520Cl-%2520extrusion%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2002%26volume%3D159%26issue%3D5%26spage%3D747%26epage%3D752%26doi%3D10.1083%2Fjcb.200209011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group">Coull, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beggs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boudreau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boivin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gravel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Koninck, Y.</span><span> </span><span class="NLM_article-title">BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">438</span><span class="NLM_x"> (</span><span class="NLM_issue">7070</span><span class="NLM_x">) </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1021</span><span class="refDoi"> DOI: 10.1038/nature04223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnature04223" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=438&publication_year=2005&pages=1017-1021&issue=7070&author=J.+A.+Coullauthor=S.+Beggsauthor=D.+Boudreauauthor=D.+Boivinauthor=M.+Tsudaauthor=K.+Inoueauthor=C.+Gravelauthor=M.+W.+Salterauthor=Y.+De+Koninck&title=BDNF+from+microglia+causes+the+shift+in+neuronal+anion+gradient+underlying+neuropathic+pain&doi=10.1038%2Fnature04223"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1038%2Fnature04223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04223%26sid%3Dliteratum%253Aachs%26aulast%3DCoull%26aufirst%3DJ.%2BA.%26aulast%3DBeggs%26aufirst%3DS.%26aulast%3DBoudreau%26aufirst%3DD.%26aulast%3DBoivin%26aufirst%3DD.%26aulast%3DTsuda%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DGravel%26aufirst%3DC.%26aulast%3DSalter%26aufirst%3DM.%2BW.%26aulast%3DDe%2BKoninck%26aufirst%3DY.%26atitle%3DBDNF%2520from%2520microglia%2520causes%2520the%2520shift%2520in%2520neuronal%2520anion%2520gradient%2520underlying%2520neuropathic%2520pain%26jtitle%3DNature%26date%3D2005%26volume%3D438%26issue%3D7070%26spage%3D1017%26epage%3D1021%26doi%3D10.1038%2Fnature04223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112a','cit112b','cit112c'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 25 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Samuel Obeng, Takato Hiranita, Francisco León, Lance R. McMahon, <span class="NLM_string-name hlFld-ContribAuthor">Christopher R. McCurdy</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6523-6548. <a href="https://doi.org/10.1021/acs.jmedchem.1c00028" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00028%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BApproaches%25252C%252BDrug%252BCandidates%25252C%252Band%252BTargets%252Bin%252BPain%252BDrug%252BDiscovery%26aulast%3DObeng%26aufirst%3DSamuel%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D07012021%26date%3D06052021%26volume%3D64%26issue%3D10%26spage%3D6523%26epage%3D6548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Govindan Subramanian, Paul D. Johnson, Theresa Zachary, Nicole Roush, Yaqi Zhu, Scott J. Bowen, Ann Janssen, Brian A. Duclos, Tracey Williams, Christopher Javens, Nancy Dekki Shalaly, Daniel Martinez Molina, Arthur J. Wittwer, <span class="NLM_string-name hlFld-ContribAuthor">Jeffrey L. Hirsch</span>. </span><span class="cited-content_cbyCitation_article-title">Deciphering the Allosteric Binding Mechanism of the Human Tropomyosin Receptor Kinase A (hTrkA) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2019,</strong> <em>14 </em>
                                    (6)
                                     , 1205-1216. <a href="https://doi.org/10.1021/acschembio.9b00126" title="DOI URL">https://doi.org/10.1021/acschembio.9b00126</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.9b00126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.9b00126%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DDeciphering%252Bthe%252BAllosteric%252BBinding%252BMechanism%252Bof%252Bthe%252BHuman%252BTropomyosin%252BReceptor%252BKinase%252BA%252B%252528hTrkA%252529%252BInhibitors%26aulast%3DSubramanian%26aufirst%3DGovindan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15022019%26date%3D06052019%26date%3D14052019%26date%3D06052019%26volume%3D14%26issue%3D6%26spage%3D1205%26epage%3D1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Samo Turk, Benjamin Merget, Sameh Eid, <span class="NLM_string-name hlFld-ContribAuthor">Simone Fulle</span>. </span><span class="cited-content_cbyCitation_article-title">From Cancer to Pain Target by Automated Selectivity Inversion of a Clinical Candidate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (11)
                                     , 4851-4859. <a href="https://doi.org/10.1021/acs.jmedchem.8b00140" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00140</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00140%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFrom%252BCancer%252Bto%252BPain%252BTarget%252Bby%252BAutomated%252BSelectivity%252BInversion%252Bof%252Ba%252BClinical%252BCandidate%26aulast%3DTurk%26aufirst%3DSamo%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27012018%26date%3D24052018%26date%3D10052018%26volume%3D61%26issue%3D11%26spage%3D4851%26epage%3D4859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shunzhou  Wan</span>, <span class="hlFld-ContribAuthor ">Agastya P.  Bhati</span>, <span class="hlFld-ContribAuthor ">Sarah  Skerratt</span>, <span class="hlFld-ContribAuthor ">Kiyoyuki  Omoto</span>, <span class="hlFld-ContribAuthor ">Veerabahu  Shanmugasundaram</span>, <span class="hlFld-ContribAuthor ">Sharan K.  Bagal</span>, and <span class="hlFld-ContribAuthor ">Peter V.  Coveney</span>  . </span><span class="cited-content_cbyCitation_article-title">Evaluation and Characterization of Trk Kinase Inhibitors for the Treatment of Pain: Reliable Binding Affinity Predictions from Theory and Computation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (4)
                                     , 897-909. <a href="https://doi.org/10.1021/acs.jcim.6b00780" title="DOI URL">https://doi.org/10.1021/acs.jcim.6b00780</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.6b00780&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.6b00780%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DEvaluation%252Band%252BCharacterization%252Bof%252BTrk%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BPain%25253A%252BReliable%252BBinding%252BAffinity%252BPredictions%252Bfrom%252BTheory%252Band%252BComputation%26aulast%3DWan%26aufirst%3DShunzhou%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D21122016%26date%3D04042017%26date%3D24042017%26date%3D20032017%26volume%3D57%26issue%3D4%26spage%3D897%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen  Xue</span>, <span class="hlFld-ContribAuthor ">Wen  Shi</span>, <span class="hlFld-ContribAuthor ">Yunfan  Kong</span>, <span class="hlFld-ContribAuthor ">Mitchell  Kuss</span>, <span class="hlFld-ContribAuthor ">Bin  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Anisotropic scaffolds for peripheral nerve and spinal cord regeneration. </span><span class="cited-content_cbyCitation_journal-name">Bioactive Materials</span><span> <strong>2021,</strong> <em>6 </em>
                                    (11)
                                     , 4141-4160. <a href="https://doi.org/10.1016/j.bioactmat.2021.04.019" title="DOI URL">https://doi.org/10.1016/j.bioactmat.2021.04.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioactmat.2021.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioactmat.2021.04.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioactive%2520Materials%26atitle%3DAnisotropic%252Bscaffolds%252Bfor%252Bperipheral%252Bnerve%252Band%252Bspinal%252Bcord%252Bregeneration%26aulast%3DXue%26aufirst%3DWen%26date%3D2021%26volume%3D6%26issue%3D11%26spage%3D4141%26epage%3D4160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mladjan  Golubovic</span>, <span class="hlFld-ContribAuthor ">Tomislav  Kostic</span>, <span class="hlFld-ContribAuthor ">Miodrag  Djordjevic</span>, <span class="hlFld-ContribAuthor ">Velimir  Peric</span>, <span class="hlFld-ContribAuthor ">Milan  Lazarevic</span>, <span class="hlFld-ContribAuthor ">Dragan J.  Milic</span>, <span class="hlFld-ContribAuthor ">Vesna  Marjanovic</span>, <span class="hlFld-ContribAuthor ">Aleksandar M.  Veselinović</span>. </span><span class="cited-content_cbyCitation_article-title">In silico development of potential therapeutic for the pain treatment by inhibiting voltage-gated sodium channel 1.7. </span><span class="cited-content_cbyCitation_journal-name">Computers in Biology and Medicine</span><span> <strong>2021,</strong> <em>132 </em>, 104346. <a href="https://doi.org/10.1016/j.compbiomed.2021.104346" title="DOI URL">https://doi.org/10.1016/j.compbiomed.2021.104346</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiomed.2021.104346&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiomed.2021.104346%26sid%3Dliteratum%253Aachs%26jtitle%3DComputers%2520in%2520Biology%2520and%2520Medicine%26atitle%3DIn%252Bsilico%252Bdevelopment%252Bof%252Bpotential%252Btherapeutic%252Bfor%252Bthe%252Bpain%252Btreatment%252Bby%252Binhibiting%252Bvoltage-gated%252Bsodium%252Bchannel%252B1.7%26aulast%3DGolubovic%26aufirst%3DMladjan%26date%3D2021%26volume%3D132%26spage%3D104346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Luo</span>, <span class="hlFld-ContribAuthor ">Yanshan  Gong</span>, <span class="hlFld-ContribAuthor ">Fan  Qiu</span>, <span class="hlFld-ContribAuthor ">Yi  Yuan</span>, <span class="hlFld-ContribAuthor ">Wenwen  Jia</span>, <span class="hlFld-ContribAuthor ">Zhongmin  Liu</span>, <span class="hlFld-ContribAuthor ">Ling  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">NGF nanoparticles enhance the potency of transplanted human umbilical cord mesenchymal stem cells for myocardial repair. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Physiology-Heart and Circulatory Physiology</span><span> <strong>2021,</strong> <em>320 </em>
                                    (5)
                                     , H1959-H1974. <a href="https://doi.org/10.1152/ajpheart.00855.2020" title="DOI URL">https://doi.org/10.1152/ajpheart.00855.2020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/ajpheart.00855.2020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fajpheart.00855.2020%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Physiology-Heart%2520and%2520Circulatory%2520Physiology%26atitle%3DNGF%252Bnanoparticles%252Benhance%252Bthe%252Bpotency%252Bof%252Btransplanted%252Bhuman%252Bumbilical%252Bcord%252Bmesenchymal%252Bstem%252Bcells%252Bfor%252Bmyocardial%252Brepair%26aulast%3DLuo%26aufirst%3DWei%26date%3D2021%26volume%3D320%26issue%3D5%26spage%3DH1959%26epage%3DH1974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyun  Wu</span>, <span class="hlFld-ContribAuthor ">Qinlan  Li</span>, <span class="hlFld-ContribAuthor ">Shanhe  Wan</span>, <span class="hlFld-ContribAuthor ">Jiajie  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular dynamics simulation and free energy calculation studies of the binding mechanism of allosteric inhibitors with TrkA kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>39 </em>
                                    (1)
                                     , 202-208. <a href="https://doi.org/10.1080/07391102.2019.1708798" title="DOI URL">https://doi.org/10.1080/07391102.2019.1708798</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1708798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1708798%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DMolecular%252Bdynamics%252Bsimulation%252Band%252Bfree%252Benergy%252Bcalculation%252Bstudies%252Bof%252Bthe%252Bbinding%252Bmechanism%252Bof%252Ballosteric%252Binhibitors%252Bwith%252BTrkA%252Bkinase%26aulast%3DWu%26aufirst%3DXiaoyun%26date%3D2021%26date%3D2019%26volume%3D39%26issue%3D1%26spage%3D202%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Line Bay  Sørensen</span>, <span class="hlFld-ContribAuthor ">Parisa  Gazerani</span>, <span class="hlFld-ContribAuthor ">Kathleen A  Sluka</span>, <span class="hlFld-ContribAuthor ">Thomas  Graven-Nielsen</span>. </span><span class="cited-content_cbyCitation_article-title">Repeated Injections of Low-Dose Nerve Growth Factor (NGF) in Healthy Humans Maintain Muscle Pain and Facilitate Ischemic Contraction–Evoked Pain. </span><span class="cited-content_cbyCitation_journal-name">Pain Medicine</span><span> <strong>2020,</strong> <em>21 </em>
                                    (12)
                                     , 3488-3498. <a href="https://doi.org/10.1093/pm/pnaa315" title="DOI URL">https://doi.org/10.1093/pm/pnaa315</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/pm/pnaa315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fpm%2Fpnaa315%26sid%3Dliteratum%253Aachs%26jtitle%3DPain%2520Medicine%26atitle%3DRepeated%252BInjections%252Bof%252BLow-Dose%252BNerve%252BGrowth%252BFactor%252B%252528NGF%252529%252Bin%252BHealthy%252BHumans%252BMaintain%252BMuscle%252BPain%252Band%252BFacilitate%252BIschemic%252BContraction%2525E2%252580%252593Evoked%252BPain%26aulast%3DS%25C3%25B8rensen%26aufirst%3DLine%2BBay%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D12%26spage%3D3488%26epage%3D3498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Falin  Patel</span>, <span class="hlFld-ContribAuthor ">Demere K.  Hess</span>, <span class="hlFld-ContribAuthor ">Dermot P.  Maher</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-nerve growth factor antibodies for the treatment of low back pain. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Clinical Pharmacology</span><span> <strong>2020,</strong> <em>13 </em>
                                    (6)
                                     , 631-639. <a href="https://doi.org/10.1080/17512433.2020.1772052" title="DOI URL">https://doi.org/10.1080/17512433.2020.1772052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17512433.2020.1772052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17512433.2020.1772052%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Clinical%2520Pharmacology%26atitle%3DAnti-nerve%252Bgrowth%252Bfactor%252Bantibodies%252Bfor%252Bthe%252Btreatment%252Bof%252Blow%252Bback%252Bpain%26aulast%3DPatel%26aufirst%3DFalin%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D6%26spage%3D631%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen-Guang  Zhao</span>, <span class="hlFld-ContribAuthor ">Wei  Sun</span>, <span class="hlFld-ContribAuthor ">Fen  Ju</span>, <span class="hlFld-ContribAuthor ">Hong  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-Long  Sun</span>, <span class="hlFld-ContribAuthor ">Xiang  Mou</span>, <span class="hlFld-ContribAuthor ">Hua  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">Analgesic Effects of Directed Repetitive Transcranial Magnetic Stimulation in Acute Neuropathic Pain After Spinal Cord Injury. </span><span class="cited-content_cbyCitation_journal-name">Pain Medicine</span><span> <strong>2020,</strong> <em>21 </em>
                                    (6)
                                     , 1216-1223. <a href="https://doi.org/10.1093/pm/pnz290" title="DOI URL">https://doi.org/10.1093/pm/pnz290</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/pm/pnz290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fpm%2Fpnz290%26sid%3Dliteratum%253Aachs%26jtitle%3DPain%2520Medicine%26atitle%3DAnalgesic%252BEffects%252Bof%252BDirected%252BRepetitive%252BTranscranial%252BMagnetic%252BStimulation%252Bin%252BAcute%252BNeuropathic%252BPain%252BAfter%252BSpinal%252BCord%252BInjury%26aulast%3DZhao%26aufirst%3DChen-Guang%26date%3D2020%26date%3D2019%26volume%3D21%26issue%3D6%26spage%3D1216%26epage%3D1223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William R.  Reed</span>, <span class="hlFld-ContribAuthor ">Joshua W.  Little</span>, <span class="hlFld-ContribAuthor ">Carla R.  Lima</span>, <span class="hlFld-ContribAuthor ">Robert E.  Sorge</span>, <span class="hlFld-ContribAuthor ">Ceren  Yarar-Fisher</span>, <span class="hlFld-ContribAuthor ">Mualla  Eraslan</span>, <span class="hlFld-ContribAuthor ">Christopher P.  Hurt</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Ness</span>, <span class="hlFld-ContribAuthor ">Jianguo G.  Gu</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Martins</span>, <span class="hlFld-ContribAuthor ">Peng  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Spinal Mobilization Prevents NGF-Induced Trunk Mechanical Hyperalgesia and Attenuates Expression of CGRP. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2020,</strong> <em>14 </em><a href="https://doi.org/10.3389/fnins.2020.00385" title="DOI URL">https://doi.org/10.3389/fnins.2020.00385</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2020.00385&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2020.00385%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DSpinal%252BMobilization%252BPrevents%252BNGF-Induced%252BTrunk%252BMechanical%252BHyperalgesia%252Band%252BAttenuates%252BExpression%252Bof%252BCGRP%26aulast%3DReed%26aufirst%3DWilliam%2BR.%26date%3D2020%26date%3D2020%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Franz  Hefti</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacology of nerve growth factor and discovery of tanezumab, an anti-nerve growth factor antibody and pain therapeutic. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2020,</strong> <em>154 </em>, 104240. <a href="https://doi.org/10.1016/j.phrs.2019.04.024" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.04.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.04.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.04.024%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DPharmacology%252Bof%252Bnerve%252Bgrowth%252Bfactor%252Band%252Bdiscovery%252Bof%252Btanezumab%25252C%252Ban%252Banti-nerve%252Bgrowth%252Bfactor%252Bantibody%252Band%252Bpain%252Btherapeutic%26aulast%3DHefti%26aufirst%3DFranz%26date%3D2020%26volume%3D154%26spage%3D104240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María del Carmen  Díaz-Galindo</span>, <span class="hlFld-ContribAuthor ">Denisse  Calderón-Vallejo</span>, <span class="hlFld-ContribAuthor ">Carlos  Olvera-Sandoval</span>, <span class="hlFld-ContribAuthor ">J. Luis  Quintanar</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic approaches of trophic factors in animal models and in patients with spinal cord injury. </span><span class="cited-content_cbyCitation_journal-name">Growth Factors</span><span> <strong>2020,</strong> <em>38 </em>
                                    (1)
                                     , 1-15. <a href="https://doi.org/10.1080/08977194.2020.1753724" title="DOI URL">https://doi.org/10.1080/08977194.2020.1753724</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/08977194.2020.1753724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F08977194.2020.1753724%26sid%3Dliteratum%253Aachs%26jtitle%3DGrowth%2520Factors%26atitle%3DTherapeutic%252Bapproaches%252Bof%252Btrophic%252Bfactors%252Bin%252Banimal%252Bmodels%252Band%252Bin%252Bpatients%252Bwith%252Bspinal%252Bcord%252Binjury%26aulast%3DD%25C3%25ADaz-Galindo%26aufirst%3DMar%25C3%25ADa%2Bdel%2BCarmen%26date%3D2020%26date%3D2020%26volume%3D38%26issue%3D1%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lijia  Mai</span>, <span class="hlFld-ContribAuthor ">Fang  Huang</span>, <span class="hlFld-ContribAuthor ">Xiao  Zhu</span>, <span class="hlFld-ContribAuthor ">Hongwen  He</span>, <span class="hlFld-ContribAuthor ">Wenguo  Fan</span>. </span><span class="cited-content_cbyCitation_article-title"><p>Role of Nerve Growth Factor in Orofacial Pain</p>. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pain Research</span><span> <strong>2020,</strong> <em>Volume 13 </em>, 1875-1882. <a href="https://doi.org/10.2147/JPR.S250030" title="DOI URL">https://doi.org/10.2147/JPR.S250030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/JPR.S250030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FJPR.S250030%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pain%2520Research%26atitle%3D%25253Cp%25253ERole%252Bof%252BNerve%252BGrowth%252BFactor%252Bin%252BOrofacial%252BPain%25253C%25252Fp%25253E%26aulast%3DMai%26aufirst%3DLijia%26date%3D2020%26date%3D2020%26volume%3DVolume%252013%26spage%3D1875%26epage%3D1882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">De-jiang  Kong</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Han-xun  Wang</span>, <span class="hlFld-ContribAuthor ">Ming-xing  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Mao-sheng  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular determinants for ligand binding at Nav1.4 and Nav1.7 channels: Experimental affinity results analyzed by molecular modeling. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2019,</strong> <em>83 </em>, 107132. <a href="https://doi.org/10.1016/j.compbiolchem.2019.107132" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2019.107132</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2019.107132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2019.107132%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DMolecular%252Bdeterminants%252Bfor%252Bligand%252Bbinding%252Bat%252BNav1.4%252Band%252BNav1.7%252Bchannels%25253A%252BExperimental%252Baffinity%252Bresults%252Banalyzed%252Bby%252Bmolecular%252Bmodeling%26aulast%3DKong%26aufirst%3DDe-jiang%26date%3D2019%26volume%3D83%26spage%3D107132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Miao</span>, <span class="hlFld-ContribAuthor ">Kun  Ma</span>, <span class="hlFld-ContribAuthor ">Dong  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaoxing  Wu</span>, <span class="hlFld-ContribAuthor ">Sheng  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting tropomyosin receptor kinase for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>175 </em>, 129-148. <a href="https://doi.org/10.1016/j.ejmech.2019.04.053" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.04.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.04.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.04.053%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Btropomyosin%252Breceptor%252Bkinase%252Bfor%252Bcancer%252Btherapy%26aulast%3DMiao%26aufirst%3DQi%26date%3D2019%26volume%3D175%26spage%3D129%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María José  Alcaraz</span>, <span class="hlFld-ContribAuthor ">María Isabel  Guillén</span>, <span class="hlFld-ContribAuthor ">María Luisa  Ferrándiz</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging therapeutic agents in osteoarthritis. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2019,</strong> <em>165 </em>, 4-16. <a href="https://doi.org/10.1016/j.bcp.2019.02.034" title="DOI URL">https://doi.org/10.1016/j.bcp.2019.02.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2019.02.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2019.02.034%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DEmerging%252Btherapeutic%252Bagents%252Bin%252Bosteoarthritis%26aulast%3DAlcaraz%26aufirst%3DMar%25C3%25ADa%2BJos%25C3%25A9%26date%3D2019%26volume%3D165%26spage%3D4%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Line B.  Sørensen</span>, <span class="hlFld-ContribAuthor ">Shellie A.  Boudreau</span>, <span class="hlFld-ContribAuthor ">Parisa  Gazerani</span>, <span class="hlFld-ContribAuthor ">Thomas  Graven-Nielsen</span>. </span><span class="cited-content_cbyCitation_article-title">Enlarged Areas of Pain and Pressure Hypersensitivityby Spatially Distributed Intramuscular Injections ofLow-Dose Nerve Growth Factor. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Pain</span><span> <strong>2019,</strong> <em>20 </em>
                                    (5)
                                     , 566-576. <a href="https://doi.org/10.1016/j.jpain.2018.11.005" title="DOI URL">https://doi.org/10.1016/j.jpain.2018.11.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpain.2018.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpain.2018.11.005%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Pain%26atitle%3DEnlarged%252BAreas%252Bof%252BPain%252Band%252BPressure%252BHypersensitivityby%252BSpatially%252BDistributed%252BIntramuscular%252BInjections%252BofLow-Dose%252BNerve%252BGrowth%252BFactor%26aulast%3DS%25C3%25B8rensen%26aufirst%3DLine%2BB.%26date%3D2019%26volume%3D20%26issue%3D5%26spage%3D566%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antón L.  Martínez</span>, <span class="hlFld-ContribAuthor ">José  Brea</span>, <span class="hlFld-ContribAuthor ">Xavier  Monroy</span>, <span class="hlFld-ContribAuthor ">Manuel  Merlos</span>, <span class="hlFld-ContribAuthor ">Javier  Burgueño</span>, <span class="hlFld-ContribAuthor ">María Isabel  Loza</span>. </span><span class="cited-content_cbyCitation_article-title">A New Model of Sensorial Neuron-Like Cells for HTS of Novel Analgesics for Neuropathic Pain. </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2019,</strong> <em>24 </em>
                                    (2)
                                     , 158-168. <a href="https://doi.org/10.1177/2472555218810323" title="DOI URL">https://doi.org/10.1177/2472555218810323</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2472555218810323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2472555218810323%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DA%252BNew%252BModel%252Bof%252BSensorial%252BNeuron-Like%252BCells%252Bfor%252BHTS%252Bof%252BNovel%252BAnalgesics%252Bfor%252BNeuropathic%252BPain%26aulast%3DMart%25C3%25ADnez%26aufirst%3DAnt%25C3%25B3n%2BL.%26date%3D2019%26date%3D2018%26volume%3D24%26issue%3D2%26spage%3D158%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonid I.  Belen’kii</span>, <span class="hlFld-ContribAuthor ">Yulia. B.  Evdokimenkova</span>. </span><span class="cited-content_cbyCitation_article-title">The literature of heterocyclic chemistry, part XVII, 2017. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 337-418. <a href="https://doi.org/10.1016/bs.aihch.2019.01.003" title="DOI URL">https://doi.org/10.1016/bs.aihch.2019.01.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2019.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2019.01.003%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252Bliterature%252Bof%252Bheterocyclic%252Bchemistry%25252C%252Bpart%252BXVII%25252C%252B2017%26aulast%3DBelen%25E2%2580%2599kii%26aufirst%3DLeonid%2BI.%26date%3D2019%26spage%3D337%26epage%3D418%26pub%3DElsevier%26date%3D2019%26volume%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingxing  Wang</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Dejiang  Kong</span>, <span class="hlFld-ContribAuthor ">Hailun  Jiang</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Maosheng  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">In silico exploration of aryl sulfonamide analogs as voltage-gated sodium channel 1.7 inhibitors by using 3D-QSAR, molecular docking study, and molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2018,</strong> <em>77 </em>, 214-225. <a href="https://doi.org/10.1016/j.compbiolchem.2018.10.009" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2018.10.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2018.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2018.10.009%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DIn%252Bsilico%252Bexploration%252Bof%252Baryl%252Bsulfonamide%252Banalogs%252Bas%252Bvoltage-gated%252Bsodium%252Bchannel%252B1.7%252Binhibitors%252Bby%252Busing%252B3D-QSAR%25252C%252Bmolecular%252Bdocking%252Bstudy%25252C%252Band%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DWang%26aufirst%3DMingxing%26date%3D2018%26volume%3D77%26spage%3D214%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrizia  Monteleone</span>, <span class="hlFld-ContribAuthor ">Carolina G.  Nicoletti</span>, <span class="hlFld-ContribAuthor ">Mario  Stampanoni Bassi</span>, <span class="hlFld-ContribAuthor ">Ennio  Iezzi</span>, <span class="hlFld-ContribAuthor ">Fabio  Buttari</span>, <span class="hlFld-ContribAuthor ">Roberto  Furlan</span>, <span class="hlFld-ContribAuthor ">Annamaria  Finardi</span>, <span class="hlFld-ContribAuthor ">Girolama A.  Marfia</span>, <span class="hlFld-ContribAuthor ">Diego  Centonze</span>, <span class="hlFld-ContribAuthor ">Francesco  Mori</span>. </span><span class="cited-content_cbyCitation_article-title">Nerve growth factor is elevated in the CSF of patients with multiple sclerosis and central neuropathic pain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroimmunology</span><span> <strong>2018,</strong> <em>314 </em>, 89-93. <a href="https://doi.org/10.1016/j.jneuroim.2017.11.012" title="DOI URL">https://doi.org/10.1016/j.jneuroim.2017.11.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jneuroim.2017.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jneuroim.2017.11.012%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroimmunology%26atitle%3DNerve%252Bgrowth%252Bfactor%252Bis%252Belevated%252Bin%252Bthe%252BCSF%252Bof%252Bpatients%252Bwith%252Bmultiple%252Bsclerosis%252Band%252Bcentral%252Bneuropathic%252Bpain%26aulast%3DMonteleone%26aufirst%3DFabrizia%26date%3D2018%26volume%3D314%26spage%3D89%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  Hou</span>, <span class="hlFld-ContribAuthor ">Linpei  Jia</span>, <span class="hlFld-ContribAuthor ">Ying  Zhang</span>, <span class="hlFld-ContribAuthor ">Wei  Ji</span>, <span class="hlFld-ContribAuthor ">Hai  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Activation of the NGF/TrkA signaling pathway attenuates diabetic erectile dysfunction. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (62)
                                     , 105692-105702. <a href="https://doi.org/10.18632/oncotarget.22389" title="DOI URL">https://doi.org/10.18632/oncotarget.22389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.22389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.22389%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DActivation%252Bof%252Bthe%252BNGF%25252FTrkA%252Bsignaling%252Bpathway%252Battenuates%252Bdiabetic%252Berectile%252Bdysfunction%26aulast%3DHou%26aufirst%3DYi%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D62%26spage%3D105692%26epage%3D105702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bernard  Bannwarth</span>, <span class="hlFld-ContribAuthor ">Marie  Kostine</span>. </span><span class="cited-content_cbyCitation_article-title">Nerve Growth Factor Antagonists: Is the Future of Monoclonal Antibodies Becoming Clearer?. </span><span class="cited-content_cbyCitation_journal-name">Drugs</span><span> <strong>2017,</strong> <em>77 </em>
                                    (13)
                                     , 1377-1387. <a href="https://doi.org/10.1007/s40265-017-0781-6" title="DOI URL">https://doi.org/10.1007/s40265-017-0781-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40265-017-0781-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40265-017-0781-6%26sid%3Dliteratum%253Aachs%26jtitle%3DDrugs%26atitle%3DNerve%252BGrowth%252BFactor%252BAntagonists%25253A%252BIs%252Bthe%252BFuture%252Bof%252BMonoclonal%252BAntibodies%252BBecoming%252BClearer%25253F%26aulast%3DBannwarth%26aufirst%3DBernard%26date%3D2017%26date%3D2017%26volume%3D77%26issue%3D13%26spage%3D1377%26epage%3D1387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Neurotrophin dimers NGF, BDNF, NT-4, and NT-3 bind to their cognate receptors TrkA, TrkB, and TrkC, as well as to the common p75 receptor. Binding to the extracellular receptors triggers downstream intracellular signaling pathways.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. NGF–TrkA canonical pathway, showing potential mechanisms for pharmacological intervention. Dimers of proNGF are converted to mature NGF dimers, which can initiate receptor dimerization and bind to TrkA and p75. In neuronal cells, NGF–TrkA binding induces the phosphorylation of multiple tyrosines and triggers downstream signaling through the PI3K, Ras, and PLCγ pathways. This leads to neurite outgrowth and other pharmacodymanic effects. Intervention of NGF–TrkA mediated signaling can occur via several mechanisms. Mechanism A: Sequestration of the NGF dimer. Mechanism B: Antagonism of the TrkA receptor. Mechanism C: Antagonism of the p75 receptor. Mechanism D: Inhibition of the intracellular TrkA kinase.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Chemical structures of NGF binders.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Chemical structures of potential TrkA binders.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Aligned overlay of seven pan-Trk inhibitors bound to the TrkA ATP site. The image was derived from the following ligand–protein structures: PDB ID codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4A0J">4A0J</a> (red), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMS">4PMS</a> (pink), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMP">4PMP</a> (blue), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMT">4PMT</a> (yellow), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMM">4PMM</a> (brown), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YNE">4YNE</a> (orange), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YPS">4YPS</a> (light blue). Two apo structures (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GT5">4GT5</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4F0I">4F0I</a>) were included. The residues unique to TrkA (R593 and R599) are highlighted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. AstraZeneca pan-Trk inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Merck pan-Trk inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Pfizer pan-Trk inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structure of <b>17</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Array TrkA inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Merck selective TrkA inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Clinical TrkA inhibitors for pain and psoriasis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Clinical TrkA inhibitors for oncological indications.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. X-ray crystal structures of type I and type II inhibitors in the TrkA active site. These structures demonstrate the relative proximity of mutant TrkA residues to the ligands. (A) X-ray crystal structure of <b>31</b> bound to TrkA (PDB ID code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YPS">4YPS</a>), with highlighted mutations. (B) X-ray crystal structure of <b>32</b> bound to TrkA (PDB ID code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMM">4PMM</a>), with highlighted mutations. (C) Chemical structures of <b>31</b> and <b>32</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Renin–angiotensin system (RAS) pathway and differentiation of some effects mediated by the AT1R and AT2R receptors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0017.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Ang II binds to the GPCR AT<sub>2</sub>R and triggers transactivation of the TrkA pathway, leading to end points such as neurite outgrowth. In a manner similar to NGF-stimulated downstream signaling, these effects can be inhibited by pan-Trk and MEK inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0018.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Selective AT<sub>2</sub>R modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0019.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Ceramide–S1P biosynthetic pathway. Ceramides are converted to S1P through the action of ceremidases and sphingosine kinases. S1P-mediated signaling occurs via five GPCRs S1PR1–5.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0020.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. S1P1 modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/medium/jm-2016-00964p_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0001.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. NGF and proNGF-mediated effects have been linked to inflammation, peripheral sensitization, central sensitization, and sympathetic neuron effects. All of these effects may play distinct roles in NGF-mediated hyperalgesia.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-1/acs.jmedchem.6b00964/20170106/images/large/jm-2016-00964p_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00964&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68241" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68241" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 180 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Wolkerstorfer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handler, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buschmann, H.</span><span> </span><span class="NLM_article-title">New approaches to treating pain</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1103</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.12.103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.bmcl.2015.12.103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=1103-1119&issue=4&author=A.+Wolkerstorferauthor=N.+Handlerauthor=H.+Buschmann&title=New+approaches+to+treating+pain&doi=10.1016%2Fj.bmcl.2015.12.103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.12.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.12.103%26sid%3Dliteratum%253Aachs%26aulast%3DWolkerstorfer%26aufirst%3DA.%26aulast%3DHandler%26aufirst%3DN.%26aulast%3DBuschmann%26aufirst%3DH.%26atitle%3DNew%2520approaches%2520to%2520treating%2520pain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D4%26spage%3D1103%26epage%3D1119%26doi%3D10.1016%2Fj.bmcl.2015.12.103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Wu, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raja, S. N.</span><span> </span><span class="NLM_article-title">Treatment of acute postoperative pain</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x"> (</span><span class="NLM_issue">9784</span><span class="NLM_x">) </span> <span class="NLM_fpage">2215</span><span class="NLM_x">–</span> <span class="NLM_lpage">2225</span><span class="refDoi"> DOI: 10.1016/S0140-6736(11)60245-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2FS0140-6736%2811%2960245-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2011&pages=2215-2225&issue=9784&author=C.+L.+Wuauthor=S.+N.+Raja&title=Treatment+of+acute+postoperative+pain&doi=10.1016%2FS0140-6736%2811%2960245-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2811%2960245-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252811%252960245-6%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DC.%2BL.%26aulast%3DRaja%26aufirst%3DS.%2BN.%26atitle%3DTreatment%2520of%2520acute%2520postoperative%2520pain%26jtitle%3DLancet%26date%3D2011%26volume%3D377%26issue%3D9784%26spage%3D2215%26epage%3D2225%26doi%3D10.1016%2FS0140-6736%2811%2960245-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Barkin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barkin, D.</span><span> </span><span class="NLM_article-title">Pharmacologic management of acute and chronic pain: focus on drug interactions and patient-specific pharmacotherapeutic selection</span> <span class="citation_source-journal">South. Med. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">756</span><span class="NLM_x">–</span> <span class="NLM_lpage">770</span><span class="refDoi"> DOI: 10.1097/00007611-200108000-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1097%2F00007611-200108000-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=11549189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADC%252BD3MvpvFOksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2001&pages=756-770&issue=8&author=R.+L.+Barkinauthor=D.+Barkin&title=Pharmacologic+management+of+acute+and+chronic+pain%3A+focus+on+drug+interactions+and+patient-specific+pharmacotherapeutic+selection&doi=10.1097%2F00007611-200108000-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic management of acute and chronic pain: focus on drug interactions and patient-specific pharmacotherapeutic selection</span></div><div class="casAuthors">Barkin R L; Barkin D</div><div class="citationInfo"><span class="NLM_cas:title">Southern medical journal</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">756-70</span>
        ISSN:<span class="NLM_cas:issn">0038-4348</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7vc2U2qv_wmgRQsDqrjW_fW6udTcc2eZlq6ZyeZqLO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MvpvFOksQ%253D%253D&md5=fd08ceb6c29f6678479b8bd7fb69d27d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2F00007611-200108000-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00007611-200108000-00003%26sid%3Dliteratum%253Aachs%26aulast%3DBarkin%26aufirst%3DR.%2BL.%26aulast%3DBarkin%26aufirst%3DD.%26atitle%3DPharmacologic%2520management%2520of%2520acute%2520and%2520chronic%2520pain%253A%2520focus%2520on%2520drug%2520interactions%2520and%2520patient-specific%2520pharmacotherapeutic%2520selection%26jtitle%3DSouth.%2520Med.%2520J.%26date%3D2001%26volume%3D94%26issue%3D8%26spage%3D756%26epage%3D770%26doi%3D10.1097%2F00007611-200108000-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Kuner, R.</span><span> </span><span class="NLM_article-title">Central mechanisms of pathological pain</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1258</span><span class="NLM_x">–</span> <span class="NLM_lpage">1266</span><span class="refDoi"> DOI: 10.1038/nm.2231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnm.2231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=20948531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1yrs7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=1258-1266&issue=11&author=R.+Kuner&title=Central+mechanisms+of+pathological+pain&doi=10.1038%2Fnm.2231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Central mechanisms of pathological pain</span></div><div class="casAuthors">Kuner, Rohini</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1258-1266</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chronic pain is a major challenge to clin. practice and basic science.  The peripheral and central neural networks that mediate nociception show extensive plasticity in pathol. disease states.  Disease-induced plasticity can occur at both structural and functional levels and is manifest as changes in individual mols., synapses, cellular function and network activity.  Recent work has yielded a better understanding of communication within the neural matrix of physiol. pain and has also brought important advances in concepts of injury-induced hyperalgesia and tactile allodynia and how these might contribute to the complex, multidimensional state of chronic pain.  This review focuses on the mol. determinants of network plasticity in the central nervous system (CNS) and discusses their relevance to the development of new therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL6m9PZhXyPbVg90H21EOLACvtfcHk0lgKt1onDCFZ5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1yrs7vJ&md5=5ab1f2a13d957c8d5cfe10ff596c7ba2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnm.2231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2231%26sid%3Dliteratum%253Aachs%26aulast%3DKuner%26aufirst%3DR.%26atitle%3DCentral%2520mechanisms%2520of%2520pathological%2520pain%26jtitle%3DNat.%2520Med.%26date%3D2010%26volume%3D16%26issue%3D11%26spage%3D1258%26epage%3D1266%26doi%3D10.1038%2Fnm.2231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Neumann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doubell, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolf, C. J.</span><span> </span><span class="NLM_article-title">Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">384</span><span class="NLM_x"> (</span><span class="NLM_issue">6607</span><span class="NLM_x">) </span> <span class="NLM_fpage">360</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span><span class="refDoi"> DOI: 10.1038/384360a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2F384360a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=1996&pages=360-364&issue=6607&author=S.+Neumannauthor=T.+P.+Doubellauthor=T.+Leslieauthor=C.+J.+Woolf&title=Inflammatory+pain+hypersensitivity+mediated+by+phenotypic+switch+in+myelinated+primary+sensory+neurons&doi=10.1038%2F384360a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F384360a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F384360a0%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DS.%26aulast%3DDoubell%26aufirst%3DT.%2BP.%26aulast%3DLeslie%26aufirst%3DT.%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26atitle%3DInflammatory%2520pain%2520hypersensitivity%2520mediated%2520by%2520phenotypic%2520switch%2520in%2520myelinated%2520primary%2520sensory%2520neurons%26jtitle%3DNature%26date%3D1996%26volume%3D384%26issue%3D6607%26spage%3D360%26epage%3D364%26doi%3D10.1038%2F384360a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Turk, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cahana, A.</span><span> </span><span class="NLM_article-title">Treatment of chronic non-cancer pain</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x"> (</span><span class="NLM_issue">9784</span><span class="NLM_x">) </span> <span class="NLM_fpage">2226</span><span class="NLM_x">–</span> <span class="NLM_lpage">2235</span><span class="refDoi"> DOI: 10.1016/S0140-6736(11)60402-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2FS0140-6736%2811%2960402-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=2011&pages=2226-2235&issue=9784&author=D.+C.+Turkauthor=H.+D.+Wilsonauthor=A.+Cahana&title=Treatment+of+chronic+non-cancer+pain&doi=10.1016%2FS0140-6736%2811%2960402-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2811%2960402-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252811%252960402-9%26sid%3Dliteratum%253Aachs%26aulast%3DTurk%26aufirst%3DD.%2BC.%26aulast%3DWilson%26aufirst%3DH.%2BD.%26aulast%3DCahana%26aufirst%3DA.%26atitle%3DTreatment%2520of%2520chronic%2520non-cancer%2520pain%26jtitle%3DLancet%26date%3D2011%26volume%3D377%26issue%3D9784%26spage%3D2226%26epage%3D2235%26doi%3D10.1016%2FS0140-6736%2811%2960402-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Moore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derry, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccleston, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalso, E.</span><span> </span><span class="NLM_article-title">Expect analgesic failure; pursue analgesic success</span> <span class="citation_source-journal">BMJ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">f2690</span><span class="refDoi"> DOI: 10.1136/bmj.f2690</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1136%2Fbmj.f2690" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2013&pages=f2690&author=A.+Mooreauthor=S.+Derryauthor=C.+Ecclestonauthor=E.+Kalso&title=Expect+analgesic+failure%3B+pursue+analgesic+success&doi=10.1136%2Fbmj.f2690"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1136%2Fbmj.f2690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.f2690%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DDerry%26aufirst%3DS.%26aulast%3DEccleston%26aufirst%3DC.%26aulast%3DKalso%26aufirst%3DE.%26atitle%3DExpect%2520analgesic%2520failure%253B%2520pursue%2520analgesic%2520success%26jtitle%3DBMJ.%26date%3D2013%26volume%3D346%26spage%3Df2690%26doi%3D10.1136%2Fbmj.f2690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Whiteside, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adedoyin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leventhal, L.</span><span> </span><span class="NLM_article-title">Predictive validity of animal pain models? A comparison of the pharmacokinetic-pharmacodynamic relationship for pain drugs in rats and humans</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">775</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2008.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.neuropharm.2008.01.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2008&pages=767-775&issue=5&author=G.+T.+Whitesideauthor=A.+Adedoyinauthor=L.+Leventhal&title=Predictive+validity+of+animal+pain+models%3F+A+comparison+of+the+pharmacokinetic-pharmacodynamic+relationship+for+pain+drugs+in+rats+and+humans&doi=10.1016%2Fj.neuropharm.2008.01.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DWhiteside%26aufirst%3DG.%2BT.%26aulast%3DAdedoyin%26aufirst%3DA.%26aulast%3DLeventhal%26aufirst%3DL.%26atitle%3DPredictive%2520validity%2520of%2520animal%2520pain%2520models%253F%2520A%2520comparison%2520of%2520the%2520pharmacokinetic-pharmacodynamic%2520relationship%2520for%2520pain%2520drugs%2520in%2520rats%2520and%2520humans%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D54%26issue%3D5%26spage%3D767%26epage%3D775%26doi%3D10.1016%2Fj.neuropharm.2008.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Vanderah, T. W.</span><span> </span><span class="NLM_article-title">Pathophysiology of pain</span> <span class="citation_source-journal">Med. Clin. North Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span><span class="refDoi"> DOI: 10.1016/j.mcna.2006.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.mcna.2006.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=17164100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADC%252BD28jis1CrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2007&pages=1-12&issue=1&author=T.+W.+Vanderah&title=Pathophysiology+of+pain&doi=10.1016%2Fj.mcna.2006.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Pathophysiology of pain</span></div><div class="casAuthors">Vanderah Todd W</div><div class="citationInfo"><span class="NLM_cas:title">The Medical clinics of North America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-12</span>
        ISSN:<span class="NLM_cas:issn">0025-7125</span>.
    </div><div class="casAbstract">The processing and interpretation of pain signals is a complex process that entails excitation of peripheral nerves, local interactions within the spinal dorsal horn, and the activation of ascending and descending circuits that comprise a loop from the spinal cord to supraspinal structures and finally exciting nociceptive inputs at the spinal level.  Although the "circuits" described here appear to be part of normal pain processing, the system demonstrates a remarkable ability to undergo neuroplastic transformations when nociceptive inputs are extended over time, and such adaptations function as a pronociceptive positive feedback loop.  Manipulations directed to disrupt any of the nodes of this pain facilitatory loop may effectively disrupt the maintenance of the sensitized pain state and diminish or abolish neuropathic pain.  Understanding the ascending and descending pain facilitatory circuits may provide for the design of rational therapies that do not interfere with normal sensory processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2WlrXRgm5ODDnmmyUf5qOfW6udTcc2ebyZK-tbNh3TLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28jis1CrsQ%253D%253D&md5=b1c1ee6f2fc3564bd7546aa230a31fe1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.mcna.2006.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcna.2006.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DVanderah%26aufirst%3DT.%2BW.%26atitle%3DPathophysiology%2520of%2520pain%26jtitle%3DMed.%2520Clin.%2520North%2520Am.%26date%3D2007%26volume%3D91%26issue%3D1%26spage%3D1%26epage%3D12%26doi%3D10.1016%2Fj.mcna.2006.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Watson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawbarn, D.</span><span> </span><span class="NLM_article-title">Targeting nerve growth factor in pain: what is the therapeutic potential?</span> <span class="citation_source-journal">BioDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span><span class="refDoi"> DOI: 10.2165/0063030-200822060-00002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.2165%2F0063030-200822060-00002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=349-359&issue=6&author=J.+J.+Watsonauthor=S.+J.+Allenauthor=D.+Dawbarn&title=Targeting+nerve+growth+factor+in+pain%3A+what+is+the+therapeutic+potential%3F&doi=10.2165%2F0063030-200822060-00002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2165%2F0063030-200822060-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F0063030-200822060-00002%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DJ.%2BJ.%26aulast%3DAllen%26aufirst%3DS.%2BJ.%26aulast%3DDawbarn%26aufirst%3DD.%26atitle%3DTargeting%2520nerve%2520growth%2520factor%2520in%2520pain%253A%2520what%2520is%2520the%2520therapeutic%2520potential%253F%26jtitle%3DBioDrugs%26date%3D2008%26volume%3D22%26issue%3D6%26spage%3D349%26epage%3D359%26doi%3D10.2165%2F0063030-200822060-00002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Aloe, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocco, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manni, L.</span><span> </span><span class="NLM_article-title">Nerve growth factor: from the early discoveries to the potential clinical use</span> <span class="citation_source-journal">J. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="refDoi"> DOI: 10.1186/1479-5876-10-239</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1186%2F1479-5876-10-239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23190582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVygu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=239&author=L.+Aloeauthor=M.+L.+Roccoauthor=P.+Bianchiauthor=L.+Manni&title=Nerve+growth+factor%3A+from+the+early+discoveries+to+the+potential+clinical+use&doi=10.1186%2F1479-5876-10-239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Nerve growth factor: from the early discoveries to the potential clinical use</span></div><div class="casAuthors">Aloe, Luigi; Rocco, Maria Luisa; Bianchi, Patrizia; Manni, Luigi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Translational Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">239</span>CODEN:
                <span class="NLM_cas:coden">JTMOBV</span>;
        ISSN:<span class="NLM_cas:issn">1479-5876</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  The physiol. role of the neurotrophin nerve growth factor (NGF) has been characterized, since its discovery in the 1950s, first in the sensory and autonomic nervous system, then in central nervous, endocrine and immune systems.  NGF plays its trophic role both during development and in adulthood, ensuring the maintenance of phenotypic and functional characteristic of several populations of neurons as well as immune cells.  From a translational standpoint, the action of NGF on cholinergic neurons of the basal forebrain and on sensory neurons in dorsal root ganglia first gained researcher's attention, in view of possible clin. use in Alzheimer's disease patients and in peripheral neuropathies resp.  The translational and clin. research on NGF have, since then, enlarged the spectrum of diseases that could benefit from NGF treatment, at the same time highlighting possible limitations in the use of the neurotrophin as a drug.  In this review we give a comprehensive account for almost all of the clin. trials attempted until now by using NGF.  A perspective on future development for translational research on NGF is also discussed, in view of recent proposals for innovative delivery strategies and/or for addnl. pathologies to be treated, such as ocular and skin diseases, gliomas, traumatic brain injuries, vascular and immune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDpiSAKFf3brVg90H21EOLACvtfcHk0ljb4ooaQm9Kxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVygu7s%253D&md5=0f77c7c760a53f4e8268ba9d6ea7a769</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1186%2F1479-5876-10-239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1479-5876-10-239%26sid%3Dliteratum%253Aachs%26aulast%3DAloe%26aufirst%3DL.%26aulast%3DRocco%26aufirst%3DM.%2BL.%26aulast%3DBianchi%26aufirst%3DP.%26aulast%3DManni%26aufirst%3DL.%26atitle%3DNerve%2520growth%2520factor%253A%2520from%2520the%2520early%2520discoveries%2520to%2520the%2520potential%2520clinical%2520use%26jtitle%3DJ.%2520Transl.%2520Med.%26date%3D2012%26volume%3D10%26spage%3D239%26doi%3D10.1186%2F1479-5876-10-239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bannwarth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostine, M.</span><span> </span><span class="NLM_article-title">Targeting nerve growth factor (NGF) for pain management: what does the future hold for NGF antagonists?</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">619</span><span class="NLM_x">–</span> <span class="NLM_lpage">626</span><span class="refDoi"> DOI: 10.1007/s40265-014-0208-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1007%2Fs40265-014-0208-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=619-626&issue=6&author=B.+Bannwarthauthor=M.+Kostine&title=Targeting+nerve+growth+factor+%28NGF%29+for+pain+management%3A+what+does+the+future+hold+for+NGF+antagonists%3F&doi=10.1007%2Fs40265-014-0208-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1007%2Fs40265-014-0208-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-014-0208-6%26sid%3Dliteratum%253Aachs%26aulast%3DBannwarth%26aufirst%3DB.%26aulast%3DKostine%26aufirst%3DM.%26atitle%3DTargeting%2520nerve%2520growth%2520factor%2520%2528NGF%2529%2520for%2520pain%2520management%253A%2520what%2520does%2520the%2520future%2520hold%2520for%2520NGF%2520antagonists%253F%26jtitle%3DDrugs%26date%3D2014%26volume%3D74%26issue%3D6%26spage%3D619%26epage%3D626%26doi%3D10.1007%2Fs40265-014-0208-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Ribatti, D.</span><span> </span><span class="NLM_article-title">The failed attribution of the Nobel Prize for Medicine or Physiology to Viktor Hamburger for the discovery of nerve growth factor</span> <span class="citation_source-journal">Brain Res. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="refDoi"> DOI: 10.1016/j.brainresbull.2016.02.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.brainresbull.2016.02.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=26930162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjs1Ghu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2016&pages=306&author=D.+Ribatti&title=The+failed+attribution+of+the+Nobel+Prize+for+Medicine+or+Physiology+to+Viktor+Hamburger+for+the+discovery+of+nerve+growth+factor&doi=10.1016%2Fj.brainresbull.2016.02.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The failed attribution of the Nobel Prize for Medicine or Physiology to Viktor Hamburger for the discovery of Nerve Growth Factor</span></div><div class="casAuthors">Ribatti, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">306-309</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The announcement in Oct. 1986 that the Nobel Prize for Physiol. or Medicine was to awarded to Rita Levi Montalcini and Stanley Cohen for the discovery of nerve growth factor (NGF) and epidermal growth factor, resp., caused many to wonder why Viktor Hamburger in whose lab. the initial work was done had not been included in the award.  This article try to reconstruct the history of the discovery of NGF with the aim to re-establish a correct dynamic of the events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGqu8dstVhcLVg90H21EOLACvtfcHk0ljb4ooaQm9Kxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjs1Ghu7w%253D&md5=c30d7ddaf3262e46675da5870a3cc18a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresbull.2016.02.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresbull.2016.02.019%26sid%3Dliteratum%253Aachs%26aulast%3DRibatti%26aufirst%3DD.%26atitle%3DThe%2520failed%2520attribution%2520of%2520the%2520Nobel%2520Prize%2520for%2520Medicine%2520or%2520Physiology%2520to%2520Viktor%2520Hamburger%2520for%2520the%2520discovery%2520of%2520nerve%2520growth%2520factor%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2016%26volume%3D124%26spage%3D306%26doi%3D10.1016%2Fj.brainresbull.2016.02.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Cohen, S.</span><span> </span><span class="NLM_article-title">Purification of a nerve-growth promoting protein from the mouse salivary gland and its neuro-cytotoxic antiserum</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">302</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span><span class="refDoi"> DOI: 10.1073/pnas.46.3.302</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1073%2Fpnas.46.3.302" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1960&pages=302-311&issue=3&author=S.+Cohen&title=Purification+of+a+nerve-growth+promoting+protein+from+the+mouse+salivary+gland+and+its+neuro-cytotoxic+antiserum&doi=10.1073%2Fpnas.46.3.302"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.46.3.302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.46.3.302%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DS.%26atitle%3DPurification%2520of%2520a%2520nerve-growth%2520promoting%2520protein%2520from%2520the%2520mouse%2520salivary%2520gland%2520and%2520its%2520neuro-cytotoxic%2520antiserum%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1960%26volume%3D46%26issue%3D3%26spage%3D302%26epage%3D311%26doi%3D10.1073%2Fpnas.46.3.302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Levi-Montalcini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booker, B.</span><span> </span><span class="NLM_article-title">Excessive growth of the sympathetic ganglia evoked by a protein isolated from mouse salivary glands</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span><span class="refDoi"> DOI: 10.1073/pnas.46.3.373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1073%2Fpnas.46.3.373" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1960&pages=373-384&issue=3&author=R.+Levi-Montalciniauthor=B.+Booker&title=Excessive+growth+of+the+sympathetic+ganglia+evoked+by+a+protein+isolated+from+mouse+salivary+glands&doi=10.1073%2Fpnas.46.3.373"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.46.3.373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.46.3.373%26sid%3Dliteratum%253Aachs%26aulast%3DLevi-Montalcini%26aufirst%3DR.%26aulast%3DBooker%26aufirst%3DB.%26atitle%3DExcessive%2520growth%2520of%2520the%2520sympathetic%2520ganglia%2520evoked%2520by%2520a%2520protein%2520isolated%2520from%2520mouse%2520salivary%2520glands%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1960%26volume%3D46%26issue%3D3%26spage%3D373%26epage%3D384%26doi%3D10.1073%2Fpnas.46.3.373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Levi-Montalcini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booker, B.</span><span> </span><span class="NLM_article-title">Destruction of the sympathetic ganglia in mammals by an antiserum to a nerve-growth protein</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">384</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span><span class="refDoi"> DOI: 10.1073/pnas.46.3.384</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1073%2Fpnas.46.3.384" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1960&pages=384-391&issue=3&author=R.+Levi-Montalciniauthor=B.+Booker&title=Destruction+of+the+sympathetic+ganglia+in+mammals+by+an+antiserum+to+a+nerve-growth+protein&doi=10.1073%2Fpnas.46.3.384"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.46.3.384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.46.3.384%26sid%3Dliteratum%253Aachs%26aulast%3DLevi-Montalcini%26aufirst%3DR.%26aulast%3DBooker%26aufirst%3DB.%26atitle%3DDestruction%2520of%2520the%2520sympathetic%2520ganglia%2520in%2520mammals%2520by%2520an%2520antiserum%2520to%2520a%2520nerve-growth%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1960%26volume%3D46%26issue%3D3%26spage%3D384%26epage%3D391%26doi%3D10.1073%2Fpnas.46.3.384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Gotz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koster, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raulf, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lottspeich, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schartl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoenen, H.</span><span> </span><span class="NLM_article-title">Neurotrophin-6 is a new member of the nerve growth factor family</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x"> (</span><span class="NLM_issue">6503</span><span class="NLM_x">) </span> <span class="NLM_fpage">266</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1038/372266a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2F372266a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=1994&pages=266-269&issue=6503&author=R.+Gotzauthor=R.+Kosterauthor=C.+Winklerauthor=F.+Raulfauthor=F.+Lottspeichauthor=M.+Schartlauthor=H.+Thoenen&title=Neurotrophin-6+is+a+new+member+of+the+nerve+growth+factor+family&doi=10.1038%2F372266a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2F372266a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F372266a0%26sid%3Dliteratum%253Aachs%26aulast%3DGotz%26aufirst%3DR.%26aulast%3DKoster%26aufirst%3DR.%26aulast%3DWinkler%26aufirst%3DC.%26aulast%3DRaulf%26aufirst%3DF.%26aulast%3DLottspeich%26aufirst%3DF.%26aulast%3DSchartl%26aufirst%3DM.%26aulast%3DThoenen%26aufirst%3DH.%26atitle%3DNeurotrophin-6%2520is%2520a%2520new%2520member%2520of%2520the%2520nerve%2520growth%2520factor%2520family%26jtitle%3DNature%26date%3D1994%26volume%3D372%26issue%3D6503%26spage%3D266%26epage%3D269%26doi%3D10.1038%2F372266a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Robinson, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. F.</span><span> </span><span class="NLM_article-title">The protein tyrosine kinase family of the human genome</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">49</span><span class="NLM_x">) </span> <span class="NLM_fpage">5548</span><span class="NLM_x">–</span> <span class="NLM_lpage">5557</span><span class="refDoi"> DOI: 10.1038/sj.onc.1203957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fsj.onc.1203957" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=5548-5557&issue=49&author=D.+R.+Robinsonauthor=Y.+M.+Wuauthor=S.+F.+Lin&title=The+protein+tyrosine+kinase+family+of+the+human+genome&doi=10.1038%2Fsj.onc.1203957"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1203957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1203957%26sid%3Dliteratum%253Aachs%26aulast%3DRobinson%26aufirst%3DD.%2BR.%26aulast%3DWu%26aufirst%3DY.%2BM.%26aulast%3DLin%26aufirst%3DS.%2BF.%26atitle%3DThe%2520protein%2520tyrosine%2520kinase%2520family%2520of%2520the%2520human%2520genome%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26issue%3D49%26spage%3D5548%26epage%3D5557%26doi%3D10.1038%2Fsj.onc.1203957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Longo, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massa, S. M.</span><span> </span><span class="NLM_article-title">Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span><span class="refDoi"> DOI: 10.1038/nrd4024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnrd4024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=507-525&issue=7&author=F.+M.+Longoauthor=S.+M.+Massa&title=Small-molecule+modulation+of+neurotrophin+receptors%3A+a+strategy+for+the+treatment+of+neurological+disease&doi=10.1038%2Fnrd4024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnrd4024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4024%26sid%3Dliteratum%253Aachs%26aulast%3DLongo%26aufirst%3DF.%2BM.%26aulast%3DMassa%26aufirst%3DS.%2BM.%26atitle%3DSmall-molecule%2520modulation%2520of%2520neurotrophin%2520receptors%253A%2520a%2520strategy%2520for%2520the%2520treatment%2520of%2520neurological%2520disease%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2013%26volume%3D12%26issue%3D7%26spage%3D507%26epage%3D525%26doi%3D10.1038%2Fnrd4024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Huang, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichardt, L. F.</span><span> </span><span class="NLM_article-title">TRK receptors: roles in neuronal signal transduction</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">642</span><span class="refDoi"> DOI: 10.1146/annurev.biochem.72.121801.161629</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1146%2Fannurev.biochem.72.121801.161629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=12676795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntFSgtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2003&pages=609-642&author=E.+J.+Huangauthor=L.+F.+Reichardt&title=TRK+receptors%3A+roles+in+neuronal+signal+transduction&doi=10.1146%2Fannurev.biochem.72.121801.161629"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Trk receptors: roles in neuronal signal transduction</span></div><div class="casAuthors">Huang, Eric J.; Reichardt, Louis F.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">609-642</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Trk receptors are a family of 3 receptor tyrosine kinases, each of which can be activated by ≥1 of 4 neurotrophins-nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and neurotrophins 3 and 4 (NT3 and NT4).  Neurotrophin signaling through these receptors regulates cell survival, proliferation, the fate of neural precursors, axon and dendrite growth and patterning, and the expression and activity of functionally important proteins, such as ion channels and neurotransmitter receptors.  In the adult nervous system, the Trk receptors regulate synaptic strength and plasticity.  The cytoplasmic domains of Trk receptors contain several sites of tyrosine phosphorylation that recruit intermediates in intracellular signaling cascades.  As a result, Trk receptor signaling activates several small G proteins, including Ras, Rap-1, and the Cdc-42-Rac-Rho family, as well as pathways regulated by MAP kinase, PI 3-kinase and phospholipase-C-γ (PLC-γ).  Trk receptor activation has different consequences in different cells, and the specificity of downstream Trk receptor-mediated signaling is controlled through expression of intermediates in these signaling pathways and membrane trafficking that regulates localization of different signaling constituents.  Perhaps the most fascinating aspect of Trk receptor-mediated signaling is its interplay with signaling promoted by the pan-neurotrophin receptor p75NTR.  P75NTR activates a distinct set of signaling pathways within cells that are in some instances synergistic and in other instances antagonistic to those activated by Trk receptors.  Several of these are proapoptotic but are suppressed by Trk receptor-initiated signaling.  P75NTR also influences the conformations of Trk receptors; this modifies ligand-binding specificity and affinity with important developmental consequences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooH3Pdvfi72LVg90H21EOLACvtfcHk0lhFTNr9hpx5Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntFSgtbo%253D&md5=939bf60802da0a203c2e0d8585e28dd9</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.72.121801.161629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.72.121801.161629%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DE.%2BJ.%26aulast%3DReichardt%26aufirst%3DL.%2BF.%26atitle%3DTRK%2520receptors%253A%2520roles%2520in%2520neuronal%2520signal%2520transduction%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2003%26volume%3D72%26spage%3D609%26epage%3D642%26doi%3D10.1146%2Fannurev.biochem.72.121801.161629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Vaegter, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fjorback, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glerup, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skeldal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kjolby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyengaard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessarollo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewin, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willnow, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nykjaer, A.</span><span> </span><span class="NLM_article-title">Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">54</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span><span class="refDoi"> DOI: 10.1038/nn.2689</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnn.2689" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=21102451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVGhsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=54-61&issue=1&author=C.+B.+Vaegterauthor=P.+Jansenauthor=A.+W.+Fjorbackauthor=S.+Glerupauthor=S.+Skeldalauthor=M.+Kjolbyauthor=M.+Richnerauthor=B.+Erdmannauthor=J.+R.+Nyengaardauthor=L.+Tessarolloauthor=G.+R.+Lewinauthor=T.+E.+Willnowauthor=M.+V.+Chaoauthor=A.+Nykjaer&title=Sortilin+associates+with+Trk+receptors+to+enhance+anterograde+transport+and+neurotrophin+signaling&doi=10.1038%2Fnn.2689"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling</span></div><div class="casAuthors">Vaegter, Christian B.; Jansen, Pernille; Fjorback, Anja W.; Glerup, Simon; Skeldal, Sune; Kjolby, Mads; Richner, Mette; Erdmann, Bettina; Nyengaard, Jens R.; Tessarollo, Lino; Lewin, Gary R.; Willnow, Thomas E.; Chao, Moses V.; Nykjaer, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">54-61</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Binding of target-derived neurotrophins to Trk receptors at nerve terminals is required to stimulate neuronal survival, differentiation, innervation and synaptic plasticity.  The distance between the soma and nerve terminal is great, making efficient anterograde Trk transport crit. for Trk synaptic translocation and signaling.  The mechanism responsible for this trafficking remains poorly understood.  Here we show that the sorting receptor sortilin interacts with TrkA, TrkB and TrkC and enables their anterograde axonal transport, thereby enhancing neurotrophin signaling.  Cultured DRG neurons lacking sortilin showed blunted MAP kinase signaling and reduced neurite outgrowth upon stimulation with NGF.  Moreover, deficiency for sortilin markedly aggravated TrkA, TrkB and TrkC phenotypes present in p75NTR knockouts, and resulted in increased embryonic lethality and sympathetic neuropathy in mice heterozygous for TrkA.  Our findings demonstrate a role for sortilin as an anterograde trafficking receptor for Trk and a pos. modulator of neurotrophin-induced neuronal survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZIPWyylrZS7Vg90H21EOLACvtfcHk0ljScm6R47ZPCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVGhsrrO&md5=e1ca0f312adee49bc431849d7f2a4b59</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnn.2689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2689%26sid%3Dliteratum%253Aachs%26aulast%3DVaegter%26aufirst%3DC.%2BB.%26aulast%3DJansen%26aufirst%3DP.%26aulast%3DFjorback%26aufirst%3DA.%2BW.%26aulast%3DGlerup%26aufirst%3DS.%26aulast%3DSkeldal%26aufirst%3DS.%26aulast%3DKjolby%26aufirst%3DM.%26aulast%3DRichner%26aufirst%3DM.%26aulast%3DErdmann%26aufirst%3DB.%26aulast%3DNyengaard%26aufirst%3DJ.%2BR.%26aulast%3DTessarollo%26aufirst%3DL.%26aulast%3DLewin%26aufirst%3DG.%2BR.%26aulast%3DWillnow%26aufirst%3DT.%2BE.%26aulast%3DChao%26aufirst%3DM.%2BV.%26aulast%3DNykjaer%26aufirst%3DA.%26atitle%3DSortilin%2520associates%2520with%2520Trk%2520receptors%2520to%2520enhance%2520anterograde%2520transport%2520and%2520neurotrophin%2520signaling%26jtitle%3DNat.%2520Neurosci.%26date%3D2011%26volume%3D14%26issue%3D1%26spage%3D54%26epage%3D61%26doi%3D10.1038%2Fnn.2689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Nykjaer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jansen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kliemannel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willnow, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hempstead, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, C. M.</span><span> </span><span class="NLM_article-title">Sortilin is essential for proNGF-induced neuronal cell death</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">427</span><span class="NLM_x"> (</span><span class="NLM_issue">6977</span><span class="NLM_x">) </span> <span class="NLM_fpage">843</span><span class="NLM_x">–</span> <span class="NLM_lpage">848</span><span class="refDoi"> DOI: 10.1038/nature02319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnature02319" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2004&pages=843-848&issue=6977&author=A.+Nykjaerauthor=R.+Leeauthor=K.+K.+Tengauthor=P.+Jansenauthor=P.+Madsenauthor=M.+S.+Nielsenauthor=C.+Jacobsenauthor=M.+Kliemannelauthor=E.+Schwarzauthor=T.+E.+Willnowauthor=B.+L.+Hempsteadauthor=C.+M.+Petersen&title=Sortilin+is+essential+for+proNGF-induced+neuronal+cell+death&doi=10.1038%2Fnature02319"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnature02319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02319%26sid%3Dliteratum%253Aachs%26aulast%3DNykjaer%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DR.%26aulast%3DTeng%26aufirst%3DK.%2BK.%26aulast%3DJansen%26aufirst%3DP.%26aulast%3DMadsen%26aufirst%3DP.%26aulast%3DNielsen%26aufirst%3DM.%2BS.%26aulast%3DJacobsen%26aufirst%3DC.%26aulast%3DKliemannel%26aufirst%3DM.%26aulast%3DSchwarz%26aufirst%3DE.%26aulast%3DWillnow%26aufirst%3DT.%2BE.%26aulast%3DHempstead%26aufirst%3DB.%2BL.%26aulast%3DPetersen%26aufirst%3DC.%2BM.%26atitle%3DSortilin%2520is%2520essential%2520for%2520proNGF-induced%2520neuronal%2520cell%2520death%26jtitle%3DNature%26date%3D2004%26volume%3D427%26issue%3D6977%26spage%3D843%26epage%3D848%26doi%3D10.1038%2Fnature02319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Shooter, E. M.</span><span> </span><span class="NLM_article-title">Early days of the nerve growth factor proteins</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">629</span><span class="refDoi"> DOI: 10.1146/annurev.neuro.24.1.601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1146%2Fannurev.neuro.24.1.601" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=11283322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD3MXls1Shs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2001&pages=601-629&author=E.+M.+Shooter&title=Early+days+of+the+nerve+growth+factor+proteins&doi=10.1146%2Fannurev.neuro.24.1.601"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Early days of the nerve growth factor proteins</span></div><div class="casAuthors">Shooter, Eric M.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">601-629</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 131 refs.  Adult male mouse submaxillary glands served as the preferred starting material for the isolation of the nerve growth factor (NGF) proteins in most of the isolation studies done.  Two types of NGF proteins were isolated from exts. of the gland, a high-mol.-wt. 7S NGF complex and a low-mol.-wt. protein variously called NGF, βNGF, or 2.5S NGF.  The latter, which mediated all known biol. functions of NGF, were closely related forms of a basic NGF dimer in which the N and C termini of two monomers (chains) were modified by proteolytic enzymes to different extents with no effect on biol. activity.  The βNGF dimer showed a novel protein structure in which the two chains interacted non-covalently over a wide surface.  Correspondingly, the βNGF dimer was found to be unusually stable and the form through which NGFs actions were mediated at physiol. concns.  The βNGF dimer was one of three subunits in 7S NGF; the other two were the γ subunit, an arginine esteropeptidase or kallikrein, and the α subunit, an inactive kallikrein.  Two zinc ions were also present in the complex and contributed greatly to its stability.  There was much debate about whether 7S NGF was a specific protein complex of interacting subunits and, if so, what functions it might play in the biol. of NGF.  Observations of the inhibition of the enzyme activity of the γ subunit and of the biol. activity of βNGF in 7S NGF were important in detg. that 7S NGF was a naturally occurring complex and the sole source of NGF in the gland ext. or in saliva.  Specific interactions between the active site of the γ subunit and the C-terminal arginine residues of the NGF chains, confirmed in the three-dimensional structure of 7S NGF, suggested a role for the γ subunit in pro-NGF processing during the assembly of 7S NGF.  In spite of the detailed knowledge of 7S NGF structure, no information on the role of this complex in the neurobiol. of NGF has emerged.  With the exception of the submaxillary gland of an African rodent, no other source of NGF has been convincingly shown to synthesize the α and γ subunits, and they may well be irrelevant to NGFs actions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGid60QKZVx7Vg90H21EOLACvtfcHk0ljScm6R47ZPCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXls1Shs7k%253D&md5=d3d5b31b8aef548d95069ebd6c9ee27e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.24.1.601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.24.1.601%26sid%3Dliteratum%253Aachs%26aulast%3DShooter%26aufirst%3DE.%2BM.%26atitle%3DEarly%2520days%2520of%2520the%2520nerve%2520growth%2520factor%2520proteins%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2001%26volume%3D24%26spage%3D601%26epage%3D629%26doi%3D10.1146%2Fannurev.neuro.24.1.601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Lee, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kermani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teng, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hempstead, B. L.</span><span> </span><span class="NLM_article-title">Regulation of cell survival by secreted proneurotrophins</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x"> (</span><span class="NLM_issue">5548</span><span class="NLM_x">) </span> <span class="NLM_fpage">1945</span><span class="NLM_x">–</span> <span class="NLM_lpage">1948</span><span class="refDoi"> DOI: 10.1126/science.1065057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1126%2Fscience.1065057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2001&pages=1945-1948&issue=5548&author=R.+Leeauthor=P.+Kermaniauthor=K.+K.+Tengauthor=B.+L.+Hempstead&title=Regulation+of+cell+survival+by+secreted+proneurotrophins&doi=10.1126%2Fscience.1065057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1126%2Fscience.1065057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1065057%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DR.%26aulast%3DKermani%26aufirst%3DP.%26aulast%3DTeng%26aufirst%3DK.%2BK.%26aulast%3DHempstead%26aufirst%3DB.%2BL.%26atitle%3DRegulation%2520of%2520cell%2520survival%2520by%2520secreted%2520proneurotrophins%26jtitle%3DScience%26date%3D2001%26volume%3D294%26issue%3D5548%26spage%3D1945%26epage%3D1948%26doi%3D10.1126%2Fscience.1065057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Levi-Montalcini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaper, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Toso, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, A.</span><span> </span><span class="NLM_article-title">Nerve growth factor: from neurotrophin to neurokine</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">514</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span><span class="refDoi"> DOI: 10.1016/S0166-2236(96)10058-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2FS0166-2236%2896%2910058-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1996&pages=514-520&issue=11&author=R.+Levi-Montalciniauthor=S.+D.+Skaperauthor=R.+Dal+Tosoauthor=L.+Petrelliauthor=A.+Leon&title=Nerve+growth+factor%3A+from+neurotrophin+to+neurokine&doi=10.1016%2FS0166-2236%2896%2910058-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0166-2236%2896%2910058-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0166-2236%252896%252910058-8%26sid%3Dliteratum%253Aachs%26aulast%3DLevi-Montalcini%26aufirst%3DR.%26aulast%3DSkaper%26aufirst%3DS.%2BD.%26aulast%3DDal%2BToso%26aufirst%3DR.%26aulast%3DPetrelli%26aufirst%3DL.%26aulast%3DLeon%26aufirst%3DA.%26atitle%3DNerve%2520growth%2520factor%253A%2520from%2520neurotrophin%2520to%2520neurokine%26jtitle%3DTrends%2520Neurosci.%26date%3D1996%26volume%3D19%26issue%3D11%26spage%3D514%26epage%3D520%26doi%3D10.1016%2FS0166-2236%2896%2910058-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Asaumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakanishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asahara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takigawa, M.</span><span> </span><span class="NLM_article-title">Expression of neurotrophins and their receptors (TRK) during fracture healing</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">625</span><span class="NLM_x">–</span> <span class="NLM_lpage">633</span><span class="refDoi"> DOI: 10.1016/S8756-3282(00)00281-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2FS8756-3282%2800%2900281-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2000&pages=625-633&issue=6&author=K.+Asaumiauthor=T.+Nakanishiauthor=H.+Asaharaauthor=H.+Inoueauthor=M.+Takigawa&title=Expression+of+neurotrophins+and+their+receptors+%28TRK%29+during+fracture+healing&doi=10.1016%2FS8756-3282%2800%2900281-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2FS8756-3282%2800%2900281-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS8756-3282%252800%252900281-7%26sid%3Dliteratum%253Aachs%26aulast%3DAsaumi%26aufirst%3DK.%26aulast%3DNakanishi%26aufirst%3DT.%26aulast%3DAsahara%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DH.%26aulast%3DTakigawa%26aufirst%3DM.%26atitle%3DExpression%2520of%2520neurotrophins%2520and%2520their%2520receptors%2520%2528TRK%2529%2520during%2520fracture%2520healing%26jtitle%3DBone%26date%3D2000%26volume%3D26%26issue%3D6%26spage%3D625%26epage%3D633%26doi%3D10.1016%2FS8756-3282%2800%2900281-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Vidaltamayo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mery, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles-Angeles, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robles-Diaz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiriart, M.</span><span> </span><span class="NLM_article-title">Expression of nerve growth factor in human pancreatic beta cells</span> <span class="citation_source-journal">Growth Factors</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">3–4</span><span class="NLM_x">) </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1080/08977190310001629566</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1080%2F08977190310001629566" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=103-107&issue=3%E2%80%934&author=R.+Vidaltamayoauthor=C.+M.+Meryauthor=A.+Angeles-Angelesauthor=G.+Robles-Diazauthor=M.+Hiriart&title=Expression+of+nerve+growth+factor+in+human+pancreatic+beta+cells&doi=10.1080%2F08977190310001629566"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1080%2F08977190310001629566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F08977190310001629566%26sid%3Dliteratum%253Aachs%26aulast%3DVidaltamayo%26aufirst%3DR.%26aulast%3DMery%26aufirst%3DC.%2BM.%26aulast%3DAngeles-Angeles%26aufirst%3DA.%26aulast%3DRobles-Diaz%26aufirst%3DG.%26aulast%3DHiriart%26aufirst%3DM.%26atitle%3DExpression%2520of%2520nerve%2520growth%2520factor%2520in%2520human%2520pancreatic%2520beta%2520cells%26jtitle%3DGrowth%2520Factors%26date%3D2003%26volume%3D21%26issue%3D3%25E2%2580%25934%26spage%3D103%26epage%3D107%26doi%3D10.1080%2F08977190310001629566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Apfel, S. C.</span><span> </span><span class="NLM_article-title">Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?</span> <span class="citation_source-journal">Int. Rev. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span><span class="refDoi"> DOI: 10.1016/S0074-7742(02)50083-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2FS0074-7742%2802%2950083-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=12198818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD38XotFaqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2002&pages=393-413&author=S.+C.+Apfel&title=Nerve+growth+factor+for+the+treatment+of+diabetic+neuropathy%3A+what+went+wrong%2C+what+went+right%2C+and+what+does+the+future+hold%3F&doi=10.1016%2FS0074-7742%2802%2950083-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Nerve growth factor for the treatment of diabetic neuropathy: What went wrong, what went right, and what does the future hold?</span></div><div class="casAuthors">Apfel, Stuart C.</div><div class="citationInfo"><span class="NLM_cas:title">International Review of Neurobiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">Neurobiology of Diabetic Neuropathy</span>),
    <span class="NLM_cas:pages">393-413</span>CODEN:
                <span class="NLM_cas:coden">IRNEAE</span>;
        ISSN:<span class="NLM_cas:issn">0074-7742</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review.  Since their discovery in the 1950s, neurotrophic factors have raised expectations that their clin. application to neurodegenerative diseases might provide an effective therapy for what are now un-treatable conditions.  Nerve growth factor (NGF) was the first neurotrophic factor to be discovered and was one of the earliest to proceed to clin. trials.  NGF, which is selectively trophic for small fiber sensory and sympathetic neurons, was selected as a potential therapy for diabetic polyneuropathy because of the serious consequences assocd. with degeneration of those neuronal populations in this condition.  In addn., evidence shows that reduced availability of NGF may contribute to the pathogenesis of diabetic neuropathy, and animal models of neuropathy respond to the exogenous administration of NGF.  Two sets of phase II clin. trials suggested that recombinant human NGF (rhNGF) administration was effective at ameliorating the symptoms assocd. with both diabetic polyneuropathy and HIV-related neuropathy.  These early studies, however, revealed that painful side effects were dose limiting for NGF.  A large-scale phase III clin. trial of 1019 patients randomized to receive either rhNGF or placebo for 48 wk failed to confirm the earlier indications of efficacy.  Among the explanations offered for the.  Discrepancy between the two sets of trials was a robust placebo effect, inadequate dosage, different study populations, and changes to the formulation of rhNGF for the phase III trial.  As a result of the phase III outcome, Genentech has decided not to proceed with further development of rhNGF.  (c) 2002 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq52cViByBYYLVg90H21EOLACvtfcHk0lgdO8PNzigEpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotFaqu74%253D&md5=d6678c623fd58a4590863c74992d337d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0074-7742%2802%2950083-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0074-7742%252802%252950083-0%26sid%3Dliteratum%253Aachs%26aulast%3DApfel%26aufirst%3DS.%2BC.%26atitle%3DNerve%2520growth%2520factor%2520for%2520the%2520treatment%2520of%2520diabetic%2520neuropathy%253A%2520what%2520went%2520wrong%252C%2520what%2520went%2520right%252C%2520and%2520what%2520does%2520the%2520future%2520hold%253F%26jtitle%3DInt.%2520Rev.%2520Neurobiol.%26date%3D2002%26volume%3D50%26spage%3D393%26epage%3D413%26doi%3D10.1016%2FS0074-7742%2802%2950083-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Lewin, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendell, L. M.</span><span> </span><span class="NLM_article-title">Nerve growth factor-induced hyperalgesia in the neonatal and adult rat</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">2136</span><span class="NLM_x">–</span> <span class="NLM_lpage">2148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1523%2FJNEUROSCI.13-05-02136.1993" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=8478693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADyaK3sXksVWktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1993&pages=2136-2148&issue=5&author=G.+R.+Lewinauthor=A.+M.+Ritterauthor=L.+M.+Mendell&title=Nerve+growth+factor-induced+hyperalgesia+in+the+neonatal+and+adult+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Nerve growth factor-induced hyperalgesia in the neonatal and adult rat</span></div><div class="casAuthors">Lewin, Gary R.; Ritter, Amy M.; Mendell, Lorne M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2136-48</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">Recently, the authors have shown that the interaction between NGF and sensory neurons in early postnatal periods is restricted in nociceptive afferents.  Here the authors show that administration of excess NGF to neonatal or mature animals can lead to a profound behavioral hyperalgesia.  Neonatal NGF treatment (postnatal day 0-14) resulted in a profound mech. hyperalgesia that persisted until the rats had reached maturity (6 wk of age).  This hyperalgesia could be explained by an NGF-mediated sensitization of Aδ nociceptive efferents to mech. stimuli.  This peripheral sensitization wore off with a time course similar to that of the behavioral hyperalgesia.  Treatment of animals from the second postnatal week until 5 wk of age (juveniles) led to a very similar behavioral hyperalgesia; however, there was no corresponding sensitization of Aδ nociceptors to mech. stimuli.  Finally, one group of adult animals (5 wk old) was treated daily with single injections of NGF for between 1 and 4 days.  Within 24 h after the first NGF injection, these animals developed a mech. hyperalgesia of the same magnitude seen after neonatal and juvenile NGF treatments.  No sensitization of Aδ nociceptive afferents was obsd. in these animals.  In addn. to the mech. hyperalgesia, the animals also developed a heat hyperalgesia after one injection of NGF.  The heat hyperalgesia was apparent within 15 min after the injection; however, signs of mech. hyperalgesia were not seen until 6 h after the injection.  It appears that the NGF-induced mech. hyperalgesia is brought about by different mechanisms in neonatal and adult rats.  Furthermore, in adult animals the NGF-induced mech. and heat hyperalgesia also appear to be attributable to two different mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyAxazTfbN4bVg90H21EOLACvtfcHk0lgdO8PNzigEpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXksVWktbs%253D&md5=fdad295b662f2163d2bc7c8f095c9885</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.13-05-02136.1993&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.13-05-02136.1993%26sid%3Dliteratum%253Aachs%26aulast%3DLewin%26aufirst%3DG.%2BR.%26aulast%3DRitter%26aufirst%3DA.%2BM.%26aulast%3DMendell%26aufirst%3DL.%2BM.%26atitle%3DNerve%2520growth%2520factor-induced%2520hyperalgesia%2520in%2520the%2520neonatal%2520and%2520adult%2520rat%26jtitle%3DJ.%2520Neurosci.%26date%3D1993%26volume%3D13%26issue%3D5%26spage%3D2136%26epage%3D2148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Indo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuruta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karim, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsubuchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tonoki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awaya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, I.</span><span> </span><span class="NLM_article-title">Mutations in the TrkA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span><span class="refDoi"> DOI: 10.1038/ng0896-485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fng0896-485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=8696348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADyaK28XkslOmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1996&pages=485-488&issue=4&author=Y.+Indoauthor=M.+Tsurutaauthor=Y.+Hayashidaauthor=M.+A.+Karimauthor=K.+Ohtaauthor=T.+Kawanoauthor=H.+Mitsubuchiauthor=H.+Tonokiauthor=Y.+Awayaauthor=I.+Matsuda&title=Mutations+in+the+TrkA%2FNGF+receptor+gene+in+patients+with+congenital+insensitivity+to+pain+with+anhidrosis&doi=10.1038%2Fng0896-485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis</span></div><div class="casAuthors">Indo, Yasuhiro; Tsuruta, Motoko; Hayashida, Yumi; Karim, Mohammad Azharul; Ohta, Kohji; Kawano, Tomoyasu; Mitsubuchi, Hiroshi; Tonoki, Hidefumi; Awaya, Yutaka; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">485-488</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">Congenital insensitivity to pain with anhidrosis (CIPA; MIM 256800) is an autosomal-recessive disorder characterized by recurrent episodes of unexplained fever, anhidrosis (absence of sweating) and absence of reaction to noxious stimuli, self-mutilating behavior and mental retardation.  The genetic basis for CIPA is unknown.  Nerve growth factor (NGF) induces neurite outgrowth and promotes survival of embryonic sensory and sympathetic neurons.  Mice lacking the gene for TrkA, a receptor tyrosine kinase for NGF, share dramatic phenotypic features of CIPA, including loss of responses to painful stimuli, although anhidrosis is not apparent in these animals.  The authors therefore considered the human TRKA homolog as a candidate for the CIPA gene.  The mRNA and genomic DNA encoding TRKA were analyzed in three unrelated CIPA patients who had consanguineous parents.  The authors detected a deletion-, splice- and missense-mutation in the tyrosine kinase domain in these three patients.  The authors' findings strongly suggest that defects in TRKA cause CIPA and that the NGF-TRKA system has a crucial role in the development and function of the nociceptive reception as well as establishment of thermoregulation via sweating in humans.  These results also implicate genes encoding other TRK and neurotrophin family members as candidates for developmental defect(s) of the nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH30N0w9neObVg90H21EOLACvtfcHk0lgdO8PNzigEpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkslOmsr8%253D&md5=53c0d396e836a911528c2b9878bc0423</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fng0896-485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng0896-485%26sid%3Dliteratum%253Aachs%26aulast%3DIndo%26aufirst%3DY.%26aulast%3DTsuruta%26aufirst%3DM.%26aulast%3DHayashida%26aufirst%3DY.%26aulast%3DKarim%26aufirst%3DM.%2BA.%26aulast%3DOhta%26aufirst%3DK.%26aulast%3DKawano%26aufirst%3DT.%26aulast%3DMitsubuchi%26aufirst%3DH.%26aulast%3DTonoki%26aufirst%3DH.%26aulast%3DAwaya%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DI.%26atitle%3DMutations%2520in%2520the%2520TrkA%252FNGF%2520receptor%2520gene%2520in%2520patients%2520with%2520congenital%2520insensitivity%2520to%2520pain%2520with%2520anhidrosis%26jtitle%3DNat.%2520Genet.%26date%3D1996%26volume%3D13%26issue%3D4%26spage%3D485%26epage%3D488%26doi%3D10.1038%2Fng0896-485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Holmes, D.</span><span> </span><span class="NLM_article-title">Anti-NGF painkillers back on track?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">338</span><span class="refDoi"> DOI: 10.1038/nrd3732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnrd3732" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=337-338&issue=5&author=D.+Holmes&title=Anti-NGF+painkillers+back+on+track%3F&doi=10.1038%2Fnrd3732"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnrd3732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3732%26sid%3Dliteratum%253Aachs%26aulast%3DHolmes%26aufirst%3DD.%26atitle%3DAnti-NGF%2520painkillers%2520back%2520on%2520track%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26issue%3D5%26spage%3D337%26epage%3D338%26doi%3D10.1038%2Fnrd3732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Mullard, A.</span><span> </span><span class="NLM_article-title">Drug developers reboot anti-NGF pain programmes</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span><span class="refDoi"> DOI: 10.1038/nrd4612</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnrd4612" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=297-298&issue=5&author=A.+Mullard&title=Drug+developers+reboot+anti-NGF+pain+programmes&doi=10.1038%2Fnrd4612"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fnrd4612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4612%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DDrug%2520developers%2520reboot%2520anti-NGF%2520pain%2520programmes%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26issue%3D5%26spage%3D297%26epage%3D298%26doi%3D10.1038%2Fnrd4612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Reuther, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, Q. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caligiuri, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Der, C. J.</span><span> </span><span class="NLM_article-title">Identification and characterization of an activating TrkA deletion mutation in acute myeloid leukemia</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">8655</span><span class="NLM_x">–</span> <span class="NLM_lpage">8666</span><span class="refDoi"> DOI: 10.1128/MCB.20.23.8655-8666.2000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1128%2FMCB.20.23.8655-8666.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=11073967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFGkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=8655-8666&issue=23&author=G.+W.+Reutherauthor=Q.+T.+Lambertauthor=M.+A.+Caligiuriauthor=C.+J.+Der&title=Identification+and+characterization+of+an+activating+TrkA+deletion+mutation+in+acute+myeloid+leukemia&doi=10.1128%2FMCB.20.23.8655-8666.2000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of an activating TrkA deletion mutation in acute myeloid leukemia</span></div><div class="casAuthors">Reuther, Gary W.; Lambert, Que T.; Caligiuri, Michael A.; Der, Channing J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8655-8666</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">In this study, the authors utilized retroviral transfer of cDNA libraries to identify oncogenes that are expressed in acute myeloid leukemia (AML).  From screens using two different cell types as targets for cellular transformation, a single cDNA encoding a variant of the TrkA protooncogene was isolated.  The protein product of this protooncogene, TrkA, is a receptor tyrosine kinase for nerve growth factor.  The isolated transforming cDNA encoded a TrkA protein that contains a 75-amino-acid deletion in the extracellular domain of the receptor and was named ΔTrkA.  ΔTrkA readily transformed fibroblast and epithelial cell lines.  The deletion resulted in activation of the tyrosine kinase domain leading to constitutive tyrosine phosphorylation of the protein.  Expression of ΔTrkA in cells led to the constitutive activation of intracellular signaling pathways that include Ras, extracellular signal-regulated kinase/mitogen-activated protein kinase, and Akt.  Importantly, ΔTrkA altered the apoptotic and growth properties of 32D myeloid progenitor cells, suggesting ΔTrkA may have contributed to the development and/or maintenance of the myeloid leukemia from which it was isolated.  Unlike Bcr-Abl, expression of ΔTrkA did not activate Stat5 in these cells.  The authors have detected expression of ΔTrkA in the original AML sample by reverse transcriptase PCR and by Western blot anal.  While previous TrkA mutations identified from human tumors involved fusion to other proteins, this report is the initial demonstration that deletions within TrkA may play a role in human cancers.  Finally, this report is the first to indicate mutations in TrkA may contribute to leukemogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN8fS7H2J4Y7Vg90H21EOLACvtfcHk0lhIGCSX8-20cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFGkurk%253D&md5=38b1eb897615f27b6034468a05cfb913</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1128%2FMCB.20.23.8655-8666.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.20.23.8655-8666.2000%26sid%3Dliteratum%253Aachs%26aulast%3DReuther%26aufirst%3DG.%2BW.%26aulast%3DLambert%26aufirst%3DQ.%2BT.%26aulast%3DCaligiuri%26aufirst%3DM.%2BA.%26aulast%3DDer%26aufirst%3DC.%2BJ.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520an%2520activating%2520TrkA%2520deletion%2520mutation%2520in%2520acute%2520myeloid%2520leukemia%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2000%26volume%3D20%26issue%3D23%26spage%3D8655%26epage%3D8666%26doi%3D10.1128%2FMCB.20.23.8655-8666.2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Tacconelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappabianca, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desantis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessitore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetuschi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sferra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rucci, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argenti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Screpanti, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, A. R.</span><span> </span><span class="NLM_article-title">TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span><span class="refDoi"> DOI: 10.1016/j.ccr.2004.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.ccr.2004.09.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=347-360&issue=4&author=A.+Tacconelliauthor=A.+R.+Farinaauthor=L.+Cappabiancaauthor=G.+Desantisauthor=A.+Tessitoreauthor=A.+Vetuschiauthor=R.+Sferraauthor=N.+Rucciauthor=B.+Argentiauthor=I.+Screpantiauthor=A.+Gulinoauthor=A.+R.+Mackay&title=TrkA+alternative+splicing%3A+a+regulated+tumor-promoting+switch+in+human+neuroblastoma&doi=10.1016%2Fj.ccr.2004.09.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2004.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2004.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DTacconelli%26aufirst%3DA.%26aulast%3DFarina%26aufirst%3DA.%2BR.%26aulast%3DCappabianca%26aufirst%3DL.%26aulast%3DDesantis%26aufirst%3DG.%26aulast%3DTessitore%26aufirst%3DA.%26aulast%3DVetuschi%26aufirst%3DA.%26aulast%3DSferra%26aufirst%3DR.%26aulast%3DRucci%26aufirst%3DN.%26aulast%3DArgenti%26aufirst%3DB.%26aulast%3DScrepanti%26aufirst%3DI.%26aulast%3DGulino%26aufirst%3DA.%26aulast%3DMackay%26aufirst%3DA.%2BR.%26atitle%3DTrkA%2520alternative%2520splicing%253A%2520a%2520regulated%2520tumor-promoting%2520switch%2520in%2520human%2520neuroblastoma%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D6%26issue%3D4%26spage%3D347%26epage%3D360%26doi%3D10.1016%2Fj.ccr.2004.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Vaishnavi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebele, R. C.</span><span> </span><span class="NLM_article-title">TRKing down an old oncogene in a new era of targeted therapy</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-14-0765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1158%2F2159-8290.CD-14-0765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=25527197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=25-34&issue=1&author=A.+Vaishnaviauthor=A.+T.+Leauthor=R.+C.+Doebele&title=TRKing+down+an+old+oncogene+in+a+new+era+of+targeted+therapy&doi=10.1158%2F2159-8290.CD-14-0765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">TRKing Down an Old Oncogene in a New Era of Targeted Therapy</span></div><div class="casAuthors">Vaishnavi, Aria; Le, Anh T.; Doebele, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-34</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The use of high-throughput next-generation sequencing techniques in multiple tumor types during the last few years has identified NTRK1, 2, and 3 gene rearrangements encoding novel oncogenic fusions in 19 different tumor types to date.  These recent developments have led us to revisit an old oncogene, Trk (originally identified as OncD), which encodes the TPM3-NTRK1 gene fusion and was one of the first transforming chromosomal rearrangements identified 32 years ago.  However, no drug has yet been approved by the FDA for cancers harboring this oncogene.  This review will discuss the biol. of the TRK family of receptors, their role in human cancer, the types of oncogenic alterations, and drugs that are currently in development for this family of oncogene targets.  Significance: Precision oncol. approaches have accelerated recently due to advancements in our ability to detect oncogenic mutations in tumor samples.  Oncogenic alterations, most commonly gene fusions, have now been detected for the genes encoding the TRKA, TRKB, and TRKC receptor tyrosine kinases across multiple tumor types.  The scientific rationale for the targeting of the TRK oncogene family will be discussed here.  Cancer Discov; 5(1); 25-34. ©2014 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKUH4ooHY0TbVg90H21EOLACvtfcHk0lhIGCSX8-20cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCntbw%253D&md5=02103d46d85b6dc948dba58d32ffba9f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-14-0765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-14-0765%26sid%3Dliteratum%253Aachs%26aulast%3DVaishnavi%26aufirst%3DA.%26aulast%3DLe%26aufirst%3DA.%2BT.%26aulast%3DDoebele%26aufirst%3DR.%2BC.%26atitle%3DTRKing%2520down%2520an%2520old%2520oncogene%2520in%2520a%2520new%2520era%2520of%2520targeted%2520therapy%26jtitle%3DCancer%2520Discovery%26date%3D2015%26volume%3D5%26issue%3D1%26spage%3D25%26epage%3D34%26doi%3D10.1158%2F2159-8290.CD-14-0765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Fischer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wictorin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorklund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, F. H.</span><span> </span><span class="NLM_article-title">Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span><span class="refDoi"> DOI: 10.1038/329065a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2F329065a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=1987&pages=65-68&author=W.+Fischerauthor=K.+Wictorinauthor=A.+Bjorklundauthor=L.+R.+Williamsauthor=S.+Varonauthor=F.+H.+Gage&title=Amelioration+of+cholinergic+neuron+atrophy+and+spatial+memory+impairment+in+aged+rats+by+nerve+growth+factor&doi=10.1038%2F329065a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2F329065a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F329065a0%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DW.%26aulast%3DWictorin%26aufirst%3DK.%26aulast%3DBjorklund%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DL.%2BR.%26aulast%3DVaron%26aufirst%3DS.%26aulast%3DGage%26aufirst%3DF.%2BH.%26atitle%3DAmelioration%2520of%2520cholinergic%2520neuron%2520atrophy%2520and%2520spatial%2520memory%2520impairment%2520in%2520aged%2520rats%2520by%2520nerve%2520growth%2520factor%26jtitle%3DNature%26date%3D1987%26volume%3D329%26spage%3D65%26epage%3D68%26doi%3D10.1038%2F329065a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Fischer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjorklund, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gage, F. H.</span><span> </span><span class="NLM_article-title">NGF improves spatial memory in aged rodents as a function of age</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1889</span><span class="NLM_x">–</span> <span class="NLM_lpage">1906</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1523%2FJNEUROSCI.11-07-01889.1991" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1648601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADyaK3MXmslWnsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1991&pages=1889-1906&issue=7&author=W.+Fischerauthor=A.+Bjorklundauthor=K.+Chenauthor=F.+H.+Gage&title=NGF+improves+spatial+memory+in+aged+rodents+as+a+function+of+age"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">NGF improves spatial memory in aged rodents as a function of age</span></div><div class="casAuthors">Fischer, W.; Bjoerklund, A.; Chen, K.; Gage, F. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1889-906</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    </div><div class="casAbstract">Aged rats were tested for place navigation in a circular water maze for spatial memory ability at 18 and 30 mo of age; 45% of the 18-mo-old rats displayed impaired place navigation performance relative to young control rats, while all 30-mo-old rats were impaired.  The aged impaired rats were retested twice during nerve growth factor (NGF) infusion in the right lateral brain ventricle.  In the 18-mo-old group, NGF improved retention of previously acquired place navigation performance and improved spatial acuity over the former platform site when the invisible platform was removed.  NGF also had an effect in the much more severely impaired 30-mo-old rats.  While the vehicle-infused aged rats showed a progressive decline in the performance between the first and second test weeks, the performance of the NGF-infused rats remained stable.  These effects were confounded by a progressive decline in swim speed seen in the vehicle-infused animals.  The 30-mo-old vehicle-infused control rats showed a cell loss and cell shrinkage relative to the young control rats in the brain septal/diagonal band area, striatum, and nucleus basalis as assessed by NGF-receptor (NGFr) and choline acetyltransferase (ChAT) double-label immunocytochem.  An increase in the size but not in the no. of cells was obsd. on the side of the NGF infusion in the 30-mo-old NGF-infused rats.  While there was no decrease in the size or no. of labeled cells in the 18-mo-old rats, the ChAT-pos. neurons in the 18-mo-old NGF-infused rats showed hypertrophy on the side of infusion.  The effect of exogenous NGF on spatial memory performance is more pronounced in younger impaired (18-mo-old) animals than in those of more advanced age.  A morphol. response to NGF can be obtained not only in older animals where cholinergic neuronal shrinkage and cell loss occurs, but also in young impaired rats where cholinergic cellular atrophy has not yet evolved.  The behavioral effects of intraventricular NGF infusion may be mediated via the cholinergic/NGFr-pos. neurons in the forebrain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqI6_uWuoF1zLVg90H21EOLACvtfcHk0lj9cERaCOxdtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXmslWnsL8%253D&md5=fd3c6ae9b86999445ede8e40f9f836a9</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.11-07-01889.1991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.11-07-01889.1991%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DW.%26aulast%3DBjorklund%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DGage%26aufirst%3DF.%2BH.%26atitle%3DNGF%2520improves%2520spatial%2520memory%2520in%2520aged%2520rodents%2520as%2520a%2520function%2520of%2520age%26jtitle%3DJ.%2520Neurosci.%26date%3D1991%26volume%3D11%26issue%3D7%26spage%3D1889%26epage%3D1906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Williams, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksdotter-Jonhagen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granholm, A. C.</span><span> </span><span class="NLM_article-title">Nerve growth factor in treatment and pathogenesis of Alzheimer’s disease</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span><span class="refDoi"> DOI: 10.1016/j.pneurobio.2006.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.pneurobio.2006.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=17084014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1agtrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2006&pages=114-128&issue=3&author=B.+J.+Williamsauthor=M.+Eriksdotter-Jonhagenauthor=A.+C.+Granholm&title=Nerve+growth+factor+in+treatment+and+pathogenesis+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.pneurobio.2006.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Nerve growth factor in treatment and pathogenesis of Alzheimer's disease</span></div><div class="casAuthors">Williams, Brice J.; Eriksdotter-Jonhagen, Maria; Granholm, Ann-Charlotte</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">114-128</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The etiol. of Alzheimer's disease (AD) is still unknown.  In addn., this terrible neurodegenerative disease will increase exponentially over the next two decades due to longer lifespan and an aging "baby-boomer" generation.  All treatments currently approved for AD have moderate efficacy in slowing the rate of cognitive decline in patients, and no efficacy in halting progression of the disease.  Hence, there is an urgent need for new drug targets and delivery methods to slow or reverse the progression of AD.  One mol. that has received much attention in its potential therapeutic role in AD is nerve growth factor (NGF).  This review will demonstrate data from humans and animals which promote NGF as a potential therapeutic target by (1) outlining the hypothesis behind using NGF for the treatment of AD, (2) reviewing both the normal and AD altered signaling pathways and effects of NGF in the central nervous system (CNS), and (3) examg. the results of NGF treatment obtained from animal models of AD and AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3F5y9G_7z2LVg90H21EOLACvtfcHk0lj9cERaCOxdtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1agtrrK&md5=60f6ce40adead8899dc71df667ce95cf</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2006.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2006.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DB.%2BJ.%26aulast%3DEriksdotter-Jonhagen%26aufirst%3DM.%26aulast%3DGranholm%26aufirst%3DA.%2BC.%26atitle%3DNerve%2520growth%2520factor%2520in%2520treatment%2520and%2520pathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DProg.%2520Neurobiol.%26date%3D2006%26volume%3D80%26issue%3D3%26spage%3D114%26epage%3D128%26doi%3D10.1016%2Fj.pneurobio.2006.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Freund-Michel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frossard, N.</span><span> </span><span class="NLM_article-title">The nerve growth factor and its receptors in airway inflammatory diseases</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span><span class="refDoi"> DOI: 10.1016/j.pharmthera.2007.07.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.pharmthera.2007.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=17915332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2008&pages=52-76&issue=1&author=V.+Freund-Michelauthor=N.+Frossard&title=The+nerve+growth+factor+and+its+receptors+in+airway+inflammatory+diseases&doi=10.1016%2Fj.pharmthera.2007.07.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The nerve growth factor and its receptors in airway inflammatory diseases</span></div><div class="casAuthors">Freund-Michel, V.; Frossard, N.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-76</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The nerve growth factor (NGF) belongs to the neurotrophin family and induces its effects through activation of 2 distinct receptor types: the tropomyosin-related kinase A (TrkA) receptor, carrying an intrinsic tyrosine kinase activity in its intracellular domain, and the receptor p75 for neurotrophins (p75NTR), belonging to the death receptor family.  Through activation of its TrkA receptor, NGF activates signaling pathways, including phospholipase Cγ (PLCγ), phosphatidyl-inositol 3-kinase (PI3K), the small G protein Ras, and mitogen-activated protein kinases (MAPK).  Through its p75NTR receptor, NGF activates proapoptotic signaling pathways including the MAPK c-Jun N-terminal kinase (JNK), ceramides, and the small G protein Rac, but also activates pathways promoting cell survival through the transcription factor nuclear factor-κB (NF-κB).  NGF was first described by Rita Levi-Montalcini and collaborators as an important factor involved in nerve differentiation and survival.  Another role for NGF has since been established in inflammation, in particular of the airways, with increased NGF levels in chronic inflammatory diseases.  In this review, we will first describe NGF structure and synthesis and NGF receptors and their signaling pathways.  We will then provide information about NGF in the airways, describing its expression and regulation, as well as pointing out its potential role in inflammation, hyperresponsiveness, and remodelling process obsd. in airway inflammatory diseases, in particular in asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryL5sKp8p6obVg90H21EOLACvtfcHk0liVdti1zEnUUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSmtL3I&md5=de21b156da9ed0e8629f4e413d394204</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2007.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2007.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DFreund-Michel%26aufirst%3DV.%26aulast%3DFrossard%26aufirst%3DN.%26atitle%3DThe%2520nerve%2520growth%2520factor%2520and%2520its%2520receptors%2520in%2520airway%2520inflammatory%2520diseases%26jtitle%3DPharmacol.%2520Ther.%26date%3D2008%26volume%3D117%26issue%3D1%26spage%3D52%26epage%3D76%26doi%3D10.1016%2Fj.pharmthera.2007.07.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Kumar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahal, B. A.</span><span> </span><span class="NLM_article-title">NGF - the TrkA to successful pain treatment</span> <span class="citation_source-journal">J. Pain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">287</span><span class="refDoi"> DOI: 10.2147/JPR.S33408</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.2147%2FJPR.S33408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23028238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Gns73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=279-287&author=V.+Kumarauthor=B.+A.+Mahal&title=NGF+-+the+TrkA+to+successful+pain+treatment&doi=10.2147%2FJPR.S33408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">NGF - the TrkA to successful pain treatment</span></div><div class="casAuthors">Kumar, Vinayak; Mahal, Brandon A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">279-287</span>CODEN:
                <span class="NLM_cas:coden">JPROEV</span>;
        ISSN:<span class="NLM_cas:issn">1178-7090</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Chronic pain arising from various pathol. conditions such as osteoarthritis, low back or spinal injuries, cancer, and urol. chronic pelvic pain syndromes presents significant challenges in diagnosis and treatment.  Specifically, since the underlying cause of these pain syndromes is unknown or heterogeneous, physicians diagnose and treat patients based on the symptoms presented.  Nerve growth factor (NGF) has been recognized as an important mediator of chronic pain in many pathol. conditions, and has been shown to be upregulated in a subset of individuals suffering from such pain syndromes.  These findings have led to the development of anti-NGF monoclonal antibodies such as tanezumab as potentially effective therapeutics for chronic pain.  Although tanezumab has reached Phase II and III clin. trials, the trials of anti-NGF antibodies were halted due to safety concerns.  Some of these trials of anti-NGF treatment have had statistically significant decreases in pain, while others have yielded inconclusive results.  These findings are suggestive of, though do not prove, target (NGF) neutralization in chronic pain syndromes.  A biomarker-driven anti-NGF clin. study layout is proposed that incorporates NGF measurements in the relevant samples before and after treatment, in addn. to collecting the pain scores.  This approach might not only confirm the mechanism of tanezumab's action in these chronic pain patients, but should establish NGF levels as a predictive biomarker for patients who can benefit from anti-NGF treatment, thereby creating a personalized approach to pain treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTezlmq4_Q-LVg90H21EOLACvtfcHk0liVdti1zEnUUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Gns73E&md5=b9d05c6bb8d1c9dc327755220d1cca9a</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.2147%2FJPR.S33408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FJPR.S33408%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DV.%26aulast%3DMahal%26aufirst%3DB.%2BA.%26atitle%3DNGF%2520-%2520the%2520TrkA%2520to%2520successful%2520pain%2520treatment%26jtitle%3DJ.%2520Pain%2520Res.%26date%3D2012%26volume%3D5%26spage%3D279%26epage%3D287%26doi%3D10.2147%2FJPR.S33408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. T.</span><span> </span><span class="NLM_article-title">Neurotrophins and neuropathic pain: Role in pathobiology</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">10657</span><span class="NLM_x">–</span> <span class="NLM_lpage">10688</span><span class="refDoi"> DOI: 10.3390/molecules200610657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.3390%2Fmolecules200610657" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=10657-10688&issue=6&author=N.+Khanauthor=M.+T.+Smith&title=Neurotrophins+and+neuropathic+pain%3A+Role+in+pathobiology&doi=10.3390%2Fmolecules200610657"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.3390%2Fmolecules200610657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules200610657%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DM.%2BT.%26atitle%3DNeurotrophins%2520and%2520neuropathic%2520pain%253A%2520Role%2520in%2520pathobiology%26jtitle%3DMolecules%26date%3D2015%26volume%3D20%26issue%3D6%26spage%3D10657%26epage%3D10688%26doi%3D10.3390%2Fmolecules200610657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Watson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahey, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Worm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engels, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nijkamp, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroemer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawbarn, D.</span><span> </span><span class="NLM_article-title">TrkAd5: A novel therapeutic agent for treatment of inflammatory pain and asthma</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1122</span><span class="NLM_x">–</span> <span class="NLM_lpage">1129</span><span class="refDoi"> DOI: 10.1124/jpet.105.095844</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1124%2Fjpet.105.095844" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=16284276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1Sgsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2006&pages=1122-1129&issue=3&author=J.+J.+Watsonauthor=M.+S.+Faheyauthor=E.+van+den+Wormauthor=F.+Engelsauthor=F.+P.+Nijkampauthor=P.+Stroemerauthor=S.+McMahonauthor=S.+J.+Allenauthor=D.+Dawbarn&title=TrkAd5%3A+A+novel+therapeutic+agent+for+treatment+of+inflammatory+pain+and+asthma&doi=10.1124%2Fjpet.105.095844"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">TrkAd5: a novel therapeutic agent for treatment of inflammatory pain and asthma</span></div><div class="casAuthors">Watson, Judy J.; Fahey, Mark S.; van den Worm, Edwin; Engels, Ferdi; Nijkamp, Frans P.; Stroemer, Paul; McMahon, Steve; Allen, Shelley J.; Dawbarn, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1122-1129</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Elevated levels of nerve growth factor have been linked to the onset and persistence of many pain-related disorders and asthma.  Described here are the design, expression, refolding, and purifn. of a monomeric (nonstrand-swapped) form of the binding domain of the nerve growth factor receptor, designated TrkAd5.  We have shown that TrkAd5 produced recombinantly binds nerve growth factor with picomolar affinity.  TrkAd5 has been characterized using a variety of biophys. and biochem. assays and is shown here to be stable in both plasma and urine.  The palliative effects of TrkAd5 are demonstrated in animal models of inflammatory pain and allergic asthma.  We conclude that TrkAd5 will prove effective in ameliorating both acute and chronic conditions where nerve growth factor acts as a mediator and suggest a role for its application in vivo as a novel therapeutic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosUDfwwgGbFbVg90H21EOLACvtfcHk0liVdti1zEnUUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1Sgsrs%253D&md5=78c386d11bfae7ac6704282cc2e524c8</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.095844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.095844%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DJ.%2BJ.%26aulast%3DFahey%26aufirst%3DM.%2BS.%26aulast%3Dvan%2Bden%2BWorm%26aufirst%3DE.%26aulast%3DEngels%26aufirst%3DF.%26aulast%3DNijkamp%26aufirst%3DF.%2BP.%26aulast%3DStroemer%26aufirst%3DP.%26aulast%3DMcMahon%26aufirst%3DS.%26aulast%3DAllen%26aufirst%3DS.%2BJ.%26aulast%3DDawbarn%26aufirst%3DD.%26atitle%3DTrkAd5%253A%2520A%2520novel%2520therapeutic%2520agent%2520for%2520treatment%2520of%2520inflammatory%2520pain%2520and%2520asthma%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D316%26issue%3D3%26spage%3D1122%26epage%3D1129%26doi%3D10.1124%2Fjpet.105.095844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Eibl, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, G. M.</span><span> </span><span class="NLM_article-title">Structural, biological, and pharmacological strategies for the inhibition of nerve growth factor</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1266</span><span class="NLM_x">–</span> <span class="NLM_lpage">1275</span><span class="refDoi"> DOI: 10.1016/j.neuint.2012.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.neuint.2012.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23103525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslSmur3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=1266-1275&issue=8&author=J.+K.+Eiblauthor=B.+C.+Strasserauthor=G.+M.+Ross&title=Structural%2C+biological%2C+and+pharmacological+strategies+for+the+inhibition+of+nerve+growth+factor&doi=10.1016%2Fj.neuint.2012.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Structural, biological, and pharmacological strategies for the inhibition of nerve growth factor</span></div><div class="casAuthors">Eibl, Joseph K.; Strasser, Bridget C.; Ross, Gregory M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1266-1275</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Nerve growth factor (NGF) is crit. for the development and maintenance of sympathetic and sensory neurons in the developing nervous system, including nociceptors.  In the adult nervous system, NGF is known to produce significant pain signals by binding to the TrkA and p75NTR receptors.  Several pathol. pain disorders are assocd. with nerve growth factor dysregulation, including neuropathic pain, osteoarthritic pain, and hyperalgesia.  Currently, clin. management of these pathologies has relied on the use of opioid and non-steroidal anti-inflammatory drugs (NSAID).  However, several chronic pain conditions demonstrate insensitivity to NSAID treatment or the development of detrimental opioid-related side effects, including addiction.  As NGF plays an important role in pain generation; antibodies, small mols. and peptides have been designed to antagonize NGF.  In this review, we discuss the structural biol. of NGF ligand/receptor interaction, and we review current biol. and pharmacol. strategies to modulate NGF-related pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKGRvNw-JhELVg90H21EOLACvtfcHk0ljQTCrLbB_2zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslSmur3F&md5=a358288eb52094421bb4aa390a959f38</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2012.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2012.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DEibl%26aufirst%3DJ.%2BK.%26aulast%3DStrasser%26aufirst%3DB.%2BC.%26aulast%3DRoss%26aufirst%3DG.%2BM.%26atitle%3DStructural%252C%2520biological%252C%2520and%2520pharmacological%2520strategies%2520for%2520the%2520inhibition%2520of%2520nerve%2520growth%2520factor%26jtitle%3DNeurochem.%2520Int.%26date%3D2012%26volume%3D61%26issue%3D8%26spage%3D1266%26epage%3D1275%26doi%3D10.1016%2Fj.neuint.2012.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Weskamp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichardt, L. F.</span><span> </span><span class="NLM_article-title">Evidence that biological activity of NGF is mediated through a novel subclass of high affinity receptors</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">649</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span><span class="refDoi"> DOI: 10.1016/0896-6273(91)90067-A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2F0896-6273%2891%2990067-A" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1991&pages=649-663&issue=4&author=G.+Weskampauthor=L.+F.+Reichardt&title=Evidence+that+biological+activity+of+NGF+is+mediated+through+a+novel+subclass+of+high+affinity+receptors&doi=10.1016%2F0896-6273%2891%2990067-A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2F0896-6273%2891%2990067-A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0896-6273%252891%252990067-A%26sid%3Dliteratum%253Aachs%26aulast%3DWeskamp%26aufirst%3DG.%26aulast%3DReichardt%26aufirst%3DL.%2BF.%26atitle%3DEvidence%2520that%2520biological%2520activity%2520of%2520NGF%2520is%2520mediated%2520through%2520a%2520novel%2520subclass%2520of%2520high%2520affinity%2520receptors%26jtitle%3DNeuron%26date%3D1991%26volume%3D6%26issue%3D4%26spage%3D649%26epage%3D663%26doi%3D10.1016%2F0896-6273%2891%2990067-A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Mischel, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vining, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valletta, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mobley, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichardt, L. F.</span><span> </span><span class="NLM_article-title">The extracellular domain of p75NTR is necessary to inhibit neurotrophin-3 signaling through TrkA</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">11294</span><span class="NLM_x">–</span> <span class="NLM_lpage">11301</span><span class="refDoi"> DOI: 10.1074/jbc.M005132200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1074%2Fjbc.M005132200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=11294-11301&issue=14&author=P.+S.+Mischelauthor=S.+G.+Smithauthor=E.+R.+Viningauthor=J.+S.+Vallettaauthor=W.+C.+Mobleyauthor=L.+F.+Reichardt&title=The+extracellular+domain+of+p75NTR+is+necessary+to+inhibit+neurotrophin-3+signaling+through+TrkA&doi=10.1074%2Fjbc.M005132200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M005132200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M005132200%26sid%3Dliteratum%253Aachs%26aulast%3DMischel%26aufirst%3DP.%2BS.%26aulast%3DSmith%26aufirst%3DS.%2BG.%26aulast%3DVining%26aufirst%3DE.%2BR.%26aulast%3DValletta%26aufirst%3DJ.%2BS.%26aulast%3DMobley%26aufirst%3DW.%2BC.%26aulast%3DReichardt%26aufirst%3DL.%2BF.%26atitle%3DThe%2520extracellular%2520domain%2520of%2520p75NTR%2520is%2520necessary%2520to%2520inhibit%2520neurotrophin-3%2520signaling%2520through%2520TrkA%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D14%26spage%3D11294%26epage%3D11301%26doi%3D10.1074%2Fjbc.M005132200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Khodorova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicol, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strichartz, G.</span><span> </span><span class="NLM_article-title">The p75NTR signaling cascade mediates mechanical hyperalgesia induced by nerve growth factor injected into the rat hind paw</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">254</span><span class="NLM_x">, </span> <span class="NLM_fpage">312</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2013.09.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.neuroscience.2013.09.046" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2013&pages=312-323&author=A.+Khodorovaauthor=G.+D.+Nicolauthor=G.+Strichartz&title=The+p75NTR+signaling+cascade+mediates+mechanical+hyperalgesia+induced+by+nerve+growth+factor+injected+into+the+rat+hind+paw&doi=10.1016%2Fj.neuroscience.2013.09.046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2013.09.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2013.09.046%26sid%3Dliteratum%253Aachs%26aulast%3DKhodorova%26aufirst%3DA.%26aulast%3DNicol%26aufirst%3DG.%2BD.%26aulast%3DStrichartz%26aufirst%3DG.%26atitle%3DThe%2520p75NTR%2520signaling%2520cascade%2520mediates%2520mechanical%2520hyperalgesia%2520induced%2520by%2520nerve%2520growth%2520factor%2520injected%2520into%2520the%2520rat%2520hind%2520paw%26jtitle%3DNeuroscience%26date%3D2013%26volume%3D254%26spage%3D312%26epage%3D323%26doi%3D10.1016%2Fj.neuroscience.2013.09.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Rogers, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atmosukarto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berhanu, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matusica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macardle, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, R. A.</span><span> </span><span class="NLM_article-title">Functional monoclonal antibodies to p75 neurotrophin receptor raised in knockout mice</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">120</span><span class="refDoi"> DOI: 10.1016/j.jneumeth.2006.05.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.jneumeth.2006.05.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=16828166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOrt7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2006&pages=109-120&issue=1&author=M.+L.+Rogersauthor=I.+Atmosukartoauthor=D.+A.+Berhanuauthor=D.+Matusicaauthor=P.+Macardleauthor=R.+A.+Rush&title=Functional+monoclonal+antibodies+to+p75+neurotrophin+receptor+raised+in+knockout+mice&doi=10.1016%2Fj.jneumeth.2006.05.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Functional monoclonal antibodies to p75 neurotrophin receptor raised in knockout mice</span></div><div class="casAuthors">Rogers, Mary-Louise; Atmosukarto, Ines; Berhanu, Degu A.; Matusica, Dusan; Macardle, Peter; Rush, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Methods</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">109-120</span>CODEN:
                <span class="NLM_cas:coden">JNMEDT</span>;
        ISSN:<span class="NLM_cas:issn">0165-0270</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In this study, p75NTREXONIII knockout mice were used as immune-naive hosts to produce functional antibodies to human p75NTR.  Three monoclonal antibodies were produced and named MLR1, MLR2 and MLR3, and isotyped as IgG1, IgG2a and IgG2a, resp.  MLR1 and MLR2 bound to human p75NTR with higher affinity than the well-characterized ME20.4 in ELISA and also recognized p75NTR present on neurons in both rat and mouse.  MLR1 and MLR2 bound to nerves known to express p75NTR following injection into Balb/C mice but not p75NTREXONIII knockout mice, indicating the antibodies are directed against the ligand binding extracellular region absent in knockout mice.  Both MLR1 and MLR2 partially blocked NGF induced cell death in a mouse cell-line that expresses p75NTR but not TrKA.  Importantly, intracerebroventricular injections indicated MLR2 was internalized within the cell bodies of mouse basal forebrain neurons, further demonstrating that this antibody is biol. active.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpz9-1b8V3Mb7Vg90H21EOLACvtfcHk0ljQTCrLbB_2zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOrt7jK&md5=d393f749a916461e16b7a6e496daf521</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.jneumeth.2006.05.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneumeth.2006.05.022%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DM.%2BL.%26aulast%3DAtmosukarto%26aufirst%3DI.%26aulast%3DBerhanu%26aufirst%3DD.%2BA.%26aulast%3DMatusica%26aufirst%3DD.%26aulast%3DMacardle%26aufirst%3DP.%26aulast%3DRush%26aufirst%3DR.%2BA.%26atitle%3DFunctional%2520monoclonal%2520antibodies%2520to%2520p75%2520neurotrophin%2520receptor%2520raised%2520in%2520knockout%2520mice%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2006%26volume%3D158%26issue%3D1%26spage%3D109%26epage%3D120%26doi%3D10.1016%2Fj.jneumeth.2006.05.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Ugolini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Covaceuszach, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cattaneo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavone, F.</span><span> </span><span class="NLM_article-title">The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2985</span><span class="NLM_x">–</span> <span class="NLM_lpage">2990</span><span class="refDoi"> DOI: 10.1073/pnas.0611253104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1073%2Fpnas.0611253104" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=2985-2990&issue=8&author=G.+Ugoliniauthor=S.+Marinelliauthor=S.+Covaceuszachauthor=A.+Cattaneoauthor=F.+Pavone&title=The+function+neutralizing+anti-TrkA+antibody+MNAC13+reduces+inflammatory+and+neuropathic+pain&doi=10.1073%2Fpnas.0611253104"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0611253104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0611253104%26sid%3Dliteratum%253Aachs%26aulast%3DUgolini%26aufirst%3DG.%26aulast%3DMarinelli%26aufirst%3DS.%26aulast%3DCovaceuszach%26aufirst%3DS.%26aulast%3DCattaneo%26aufirst%3DA.%26aulast%3DPavone%26aufirst%3DF.%26atitle%3DThe%2520function%2520neutralizing%2520anti-TrkA%2520antibody%2520MNAC13%2520reduces%2520inflammatory%2520and%2520neuropathic%2520pain%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26issue%3D8%26spage%3D2985%26epage%3D2990%26doi%3D10.1073%2Fpnas.0611253104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Rapp, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walmsley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mottl, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ignatius, A.</span><span> </span><span class="NLM_article-title">Analgesia via blockade of NGF/TrkA signaling does not influence fracture healing in mice</span> <span class="citation_source-journal">J. Orthop. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1235</span><span class="NLM_x">–</span> <span class="NLM_lpage">1241</span><span class="refDoi"> DOI: 10.1002/jor.22892</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1002%2Fjor.22892" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=25876530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFyjtLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=1235-1241&issue=8&author=A.+E.+Rappauthor=J.+Kronerauthor=S.+Baurauthor=F.+Schmidauthor=A.+Walmsleyauthor=H.+Mottlauthor=A.+Ignatius&title=Analgesia+via+blockade+of+NGF%2FTrkA+signaling+does+not+influence+fracture+healing+in+mice&doi=10.1002%2Fjor.22892"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Analgesia via blockade of NGF/TrkA signaling does not influence fracture healing in mice</span></div><div class="casAuthors">Rapp, Anna E.; Kroner, Jochen; Baur, Stephanie; Schmid, Fabian; Walmsley, Adrian; Mottl, Harald; Ignatius, Anita</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Orthopaedic Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1235-1241</span>CODEN:
                <span class="NLM_cas:coden">JOREDR</span>;
        ISSN:<span class="NLM_cas:issn">0736-0266</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Abatement of fracture-related pain is important in patient welfare.  However, the frequently used non-steroidal anti-inflammatory drugs are considered to impair fracture healing through blockade of cyclooxygenase-2.  An alternative for fracture-related pain treatment may be blockade of nerve growth factor (NGF)/neurotrophic tyrosine kinase receptor type 1 (TrkA) signaling.  Because the effect of blocking this signal-pathway on bone healing has not been extensively investigated, we addressed this issue by applying neutralizing antibodies that target NGF and TrkA, resp., in a mouse fracture model.  Mice with a knock-in for human TrkA underwent femur osteotomy and were randomly allocated to phosphate-buffered-saline, anti-NGF-antibody, or anti-TrkA-antibody treatment.  The analgesic effect of the antibodies was detd. from the activity and the ground reaction force of the operated limb.  The effect of antibody administration on fracture healing was assessed by histomorphometry, micro-computed tomog., and biomechanics.  NGF/TrkA-signaling blockade had no neg. effect on fracture healing as callus formation and maturation were not altered.  Mice treated with anti-TrkA antibody displayed significantly greater activity on post-operative day 2 compared to PBS treatment indicating effective analgesia.  Our data indicate, that blockade of NGF/TrkA signaling via specific neutralizing antibodies for pain redn. during fracture healing does not influence fracture healing. cpr 2015 Orthopaedic Research Society.  Published by Wiley Periodicals, Inc.  J Orthop Res 33:1235-1241, 2015.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEtHU7OIeAtLVg90H21EOLACvtfcHk0limcY6KSYy3og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFyjtLrK&md5=caf13e9694d5a232164331078311c514</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fjor.22892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjor.22892%26sid%3Dliteratum%253Aachs%26aulast%3DRapp%26aufirst%3DA.%2BE.%26aulast%3DKroner%26aufirst%3DJ.%26aulast%3DBaur%26aufirst%3DS.%26aulast%3DSchmid%26aufirst%3DF.%26aulast%3DWalmsley%26aufirst%3DA.%26aulast%3DMottl%26aufirst%3DH.%26aulast%3DIgnatius%26aufirst%3DA.%26atitle%3DAnalgesia%2520via%2520blockade%2520of%2520NGF%252FTrkA%2520signaling%2520does%2520not%2520influence%2520fracture%2520healing%2520in%2520mice%26jtitle%3DJ.%2520Orthop.%2520Res.%26date%3D2015%26volume%3D33%26issue%3D8%26spage%3D1235%26epage%3D1241%26doi%3D10.1002%2Fjor.22892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Cunningham, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, L. A.</span><span> </span><span class="NLM_article-title">Autophosphorylation of activation loop tyrosines regulates signaling by the TRK nerve growth factor receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">10957</span><span class="NLM_x">–</span> <span class="NLM_lpage">10967</span><span class="refDoi"> DOI: 10.1074/jbc.272.16.10957</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1074%2Fjbc.272.16.10957" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=10957-10967&issue=16&author=M.+E.+Cunninghamauthor=R.+M.+Stephensauthor=D.+R.+Kaplanauthor=L.+A.+Greene&title=Autophosphorylation+of+activation+loop+tyrosines+regulates+signaling+by+the+TRK+nerve+growth+factor+receptor&doi=10.1074%2Fjbc.272.16.10957"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.16.10957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.16.10957%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DM.%2BE.%26aulast%3DStephens%26aufirst%3DR.%2BM.%26aulast%3DKaplan%26aufirst%3DD.%2BR.%26aulast%3DGreene%26aufirst%3DL.%2BA.%26atitle%3DAutophosphorylation%2520of%2520activation%2520loop%2520tyrosines%2520regulates%2520signaling%2520by%2520the%2520TRK%2520nerve%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26issue%3D16%26spage%3D10957%26epage%3D10967%26doi%3D10.1074%2Fjbc.272.16.10957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Kaplan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, F. D.</span><span> </span><span class="NLM_article-title">Neurotrophin signal transduction in the nervous system</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span><span class="refDoi"> DOI: 10.1016/S0959-4388(00)00092-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2FS0959-4388%2800%2900092-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=381-391&issue=3&author=D.+R.+Kaplanauthor=F.+D.+Miller&title=Neurotrophin+signal+transduction+in+the+nervous+system&doi=10.1016%2FS0959-4388%2800%2900092-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS0959-4388%2800%2900092-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-4388%252800%252900092-1%26sid%3Dliteratum%253Aachs%26aulast%3DKaplan%26aufirst%3DD.%2BR.%26aulast%3DMiller%26aufirst%3DF.%2BD.%26atitle%3DNeurotrophin%2520signal%2520transduction%2520in%2520the%2520nervous%2520system%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D2000%26volume%3D10%26issue%3D3%26spage%3D381%26epage%3D391%26doi%3D10.1016%2FS0959-4388%2800%2900092-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Ji, R. R.; Kawasaki, Y.; Zhuang, Z. Y.; Wen, Y. R.; Zhang, Y. Q.</span><span> </span><span class="NLM_article-title">Protein kinases as potential targets for the treatment of pathological pain</span>. In  <span class="citation_source-book">Analgesia</span>; <span class="NLM_series">Handbook of Experimental Pharmacology</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin, Heidelberg</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">177</span>, pp  <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1007/978-3-540-33823-9_13</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1007%2F978-3-540-33823-9_13" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=359-389&author=R.+R.+Ji&author=Y.+Kawasaki&author=Z.+Y.+Zhuang&author=Y.+R.+Wen&author=Y.+Q.+Zhang&title=Analgesia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2F978-3-540-33823-9_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-540-33823-9_13%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DR.%2BR.%26atitle%3DProtein%2520kinases%2520as%2520potential%2520targets%2520for%2520the%2520treatment%2520of%2520pathological%2520pain%26btitle%3DAnalgesia%26pub%3DSpringer%26date%3D2007%26volume%3D177%26spage%3D359%26epage%3D389%26doi%3D10.1007%2F978-3-540-33823-9_13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNaughton, P. A.</span><span> </span><span class="NLM_article-title">NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">4211</span><span class="NLM_x">–</span> <span class="NLM_lpage">4223</span><span class="refDoi"> DOI: 10.1038/sj.emboj.7600893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fsj.emboj.7600893" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2005&pages=4211-4223&issue=24&author=X.+Zhangauthor=J.+Huangauthor=P.+A.+McNaughton&title=NGF+rapidly+increases+membrane+expression+of+TRPV1+heat-gated+ion+channels&doi=10.1038%2Fsj.emboj.7600893"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7600893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7600893%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DMcNaughton%26aufirst%3DP.%2BA.%26atitle%3DNGF%2520rapidly%2520increases%2520membrane%2520expression%2520of%2520TRPV1%2520heat-gated%2520ion%2520channels%26jtitle%3DEMBO%2520J.%26date%3D2005%26volume%3D24%26issue%3D24%26spage%3D4211%26epage%3D4223%26doi%3D10.1038%2Fsj.emboj.7600893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Structural and functional properties of the TRK family of neurotrophin receptors</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">766</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="NLM_x">–</span> <span class="NLM_lpage">458</span><span class="refDoi"> DOI: 10.1111/j.1749-6632.1995.tb26693.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1111%2Fj.1749-6632.1995.tb26693.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=766&publication_year=1995&pages=442-458&author=M.+Barbacid&title=Structural+and+functional+properties+of+the+TRK+family+of+neurotrophin+receptors&doi=10.1111%2Fj.1749-6632.1995.tb26693.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.1995.tb26693.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.1995.tb26693.x%26sid%3Dliteratum%253Aachs%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DStructural%2520and%2520functional%2520properties%2520of%2520the%2520TRK%2520family%2520of%2520neurotrophin%2520receptors%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1995%26volume%3D766%26spage%3D442%26epage%3D458%26doi%3D10.1111%2Fj.1749-6632.1995.tb26693.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Wells, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClendon, C. L.</span><span> </span><span class="NLM_article-title">Reaching for high-hanging fruit in drug discovery at protein-protein interfaces</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x"> (</span><span class="NLM_issue">7172</span><span class="NLM_x">) </span> <span class="NLM_fpage">1001</span><span class="NLM_x">–</span> <span class="NLM_lpage">1009</span><span class="refDoi"> DOI: 10.1038/nature06526</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnature06526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=18075579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVaqtr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2007&pages=1001-1009&issue=7172&author=J.+A.+Wellsauthor=C.+L.+McClendon&title=Reaching+for+high-hanging+fruit+in+drug+discovery+at+protein-protein+interfaces&doi=10.1038%2Fnature06526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Reaching for high-hanging fruit in drug discovery at protein-protein interfaces</span></div><div class="casAuthors">Wells, James A.; McClendon, Christopher L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">450</span>
        (<span class="NLM_cas:issue">7172</span>),
    <span class="NLM_cas:pages">1001-1009</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Targeting the interfaces between proteins has huge therapeutic potential, but discovering small-mol. drugs that disrupt protein-protein interactions is an enormous challenge.  Several recent success stories, however, indicate that protein-protein interfaces might be more tractable than has been thought.  These studies discovered small mols. that bind with drug-like potencies to 'hotspots' on the contact surfaces involved in protein-protein interactions.  Remarkably, these small mols. bind deeper within the contact surface of the target protein, and bind with much higher efficiencies, than do the contact atoms of the natural protein partner.  Some of these small mols. are now making their way through clin. trials, so this high-hanging fruit might not be far out of reach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoj-nGR3BqqkrVg90H21EOLACvtfcHk0liLxmDxEZ8BnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVaqtr7F&md5=e7ed69fd8c362a71c4b99f029c16a6fc</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1038%2Fnature06526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06526%26sid%3Dliteratum%253Aachs%26aulast%3DWells%26aufirst%3DJ.%2BA.%26aulast%3DMcClendon%26aufirst%3DC.%2BL.%26atitle%3DReaching%2520for%2520high-hanging%2520fruit%2520in%2520drug%2520discovery%2520at%2520protein-protein%2520interfaces%26jtitle%3DNature%26date%3D2007%26volume%3D450%26issue%3D7172%26spage%3D1001%26epage%3D1009%26doi%3D10.1038%2Fnature06526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span> </span><span class="NLM_article-title">Trk kinase inhibitors as new treatments for cancer and pain</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span><span class="refDoi"> DOI: 10.1517/13543770902721261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1517%2F13543770902721261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=19441906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjslWlu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=305-319&issue=3&author=T.+Wangauthor=D.+Yuauthor=M.+L.+Lamb&title=Trk+kinase+inhibitors+as+new+treatments+for+cancer+and+pain&doi=10.1517%2F13543770902721261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Trk kinase inhibitors as new treatments for cancer and pain</span></div><div class="casAuthors">Wang, Tao; Yu, Dingwei; Lamb, Michelle L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-319</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Tropomyosin-related kinases (Trks) are a family of receptor tyrosine kinases activated by neurotrophins.  Trks play important roles in pain sensation as well as tumor cell growth and survival signaling.  Thus, inhibitors of Trk receptor kinases might provide targeted treatments for pain and cancer.  Objective: This paper reviews those patent applications since 2002 claiming small-mol. inhibitors of Trk receptor kinases.  Methods: Primary literature and patents were searched with SciFinder and Google Scholar.  Patents were selected based on their relevance to Trks and were evaluated and representative compds. were listed as examples.  Results/conclusion: Several series of Trk inhibitors with excellent in vitro potencies have been reported and a no. of compds. have gone into the clinic.  It should be noted that few of these inhibitors are Trk selective, demonstrating that targeting Trk kinases for treatment of pain and/or cancer offers a promising but also challenging approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvknvXUUz2DbVg90H21EOLACvtfcHk0liLxmDxEZ8BnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjslWlu7o%253D&md5=ffc2d3e33102631cac7b89dce7f96a5a</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1517%2F13543770902721261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770902721261%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26atitle%3DTrk%2520kinase%2520inhibitors%2520as%2520new%2520treatments%2520for%2520cancer%2520and%2520pain%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26issue%3D3%26spage%3D305%26epage%3D319%26doi%3D10.1517%2F13543770902721261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">McCarthy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, E.</span><span> </span><span class="NLM_article-title">Tropomyosin receptor kinase inhibitors: a patent update 2009 – 2013</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">744</span><span class="refDoi"> DOI: 10.1517/13543776.2014.910195</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1517%2F13543776.2014.910195" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=24809946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVSqtr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=731-744&issue=7&author=C.+McCarthyauthor=E.+Walker&title=Tropomyosin+receptor+kinase+inhibitors%3A+a+patent+update+2009+%E2%80%93+2013&doi=10.1517%2F13543776.2014.910195"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Tropomyosin receptor kinase inhibitors: a patent update 2009 - 2013</span></div><div class="casAuthors">McCarthy, Clive; Walker, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">731-744</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Tropomyosin receptor kinases (Trks) are a family of three similar tyrosine kinases activated by peptide hormones of the neurotrophin family.  The nerve growth factor antibody tanezumab has provided clin. proof of concept for inhibition of the TrkA pathway in pain.  As an alternative modality, small-mol. inhibitors of the Trks have been pursued in recent years to probe the role of these neurotrophin pathways in pain, cancer and other indications.  Areas covered: This paper reviews the patent literature between mid-2009 and 2013, claiming inhibitors of Trk family members as the primary biol. targets.  Addnl. patents have been reviewed where Trk is not the main kinase of interest but in which high Trk potency is obsd. and the chem. matter is particularly noteworthy.  Patents pre-dating this period have been reviewed previously.  Scifinder and Google were used to find relevant patents and clin. information using Trk or Tropomyosin as the search term.  Expert opinion: Considerable recent progress has been made in the identification of selective pan Trk inhibitors with pharmacodynamic and pharmacokinetic properties appropriate for clin. evaluation.  Inhibitors of both active and inactive conformations of the Trks as well as peripherally restricted mols. have been identified.  Furthermore, TrkA-selective allosteric inhibitors have recently been disclosed, which enables the biol. of this isoform to be probed.  The recent identification of a TrkA gene fusion in a subset of lung cancer patients will increase further the attraction of Trk inhibition to the pharmaceutical industry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjXwkruGnLXbVg90H21EOLACvtfcHk0li1OMusNhABVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVSqtr7L&md5=b924331cd9d69192bc10f53424997550</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.910195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.910195%26sid%3Dliteratum%253Aachs%26aulast%3DMcCarthy%26aufirst%3DC.%26aulast%3DWalker%26aufirst%3DE.%26atitle%3DTropomyosin%2520receptor%2520kinase%2520inhibitors%253A%2520a%2520patent%2520update%25202009%2520%25E2%2580%2593%25202013%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26issue%3D7%26spage%3D731%26epage%3D744%26doi%3D10.1517%2F13543776.2014.910195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Owolabi, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizkalla, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riopelle, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamboj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ossipov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porreca, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. K. H.</span><span> </span><span class="NLM_article-title">Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the rat</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1271</span><span class="NLM_x">–</span> <span class="NLM_lpage">1276</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10336516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADyaK1MXjtlGnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=1271-1276&issue=3&author=J.+B.+Owolabiauthor=G.+Rizkallaauthor=A.+Tehimauthor=G.+M.+Rossauthor=R.+J.+Riopelleauthor=R.+Kambojauthor=M.+Ossipovauthor=D.+Bianauthor=S.+Wegertauthor=F.+Porrecaauthor=D.+K.+H.+Lee&title=Characterization+of+antiallodynic+actions+of+ALE-0540%2C+a+novel+nerve+growth+factor+receptor+antagonist%2C+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of antiallodynic actions of ALE-0540, a novel nerve growth factor receptor antagonist, in the rat</span></div><div class="casAuthors">Owolabi, Joshua B.; Rizkalla, Geihan; Tehim, Ashok; Ross, Gregory M.; Riopelle, Richard J.; Kamboj, Rajender; Ossipov, Michael; Bian, Di; Wegert, Sandara; Porreca, Frank; Lee, David K. H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1271-1276</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">There is growing evidence that nerve growth factor (NGF) may function as a mediator of persistent pain states.  We have identified a novel nonpeptidic mol., ALE-0540, that inhibits the binding of NGF to tyrosine kinase (Trk) A or both p75 and TrkA (IC50 5.88±1.87 μM, 3.72±1.3 μM, resp.), as well as signal transduction and biol. responses mediated by TrkA receptors.  ALE-0540 was tested in models of neuropathic pain and thermally-induced inflammatory pain, using two routes of administration, a systemic i.p. and a spinal intrathecal (i.t.) route.  Morphine was also tested for comparison in the antiallodynia model using mech. stimuli.  We show that either i.p. or i.t. administration of ALE-0540 in rats produced antiallodynia in the L5/L6 ligation model of neuropathic pain.  The calcd. A50 values (and 95% confidence intervals) for ALE-0540 administered i.p. and i.t. were 38 (17.5-83) mg/kg and 34.6 (17.3-69.4) μg, resp.  ALE-0540 given i.t., at doses of 30 and 60 μg, also blocked tactile allodynia in the thermal sensitization model.  Although morphine displayed greater potency [A50 value of 7.1 (5.6-8.8) mg/kg] than ALE-0540 in anti-allodynic effect when given i.p. to L5/L6-ligated rats, it was not active when administered i.t.  These data suggest that a blockade of NGF bioactivity using a NGF receptor antagonist is capable of blocking neuropathic and inflammatory pain and further support the hypothesis that NGF is involved in signaling pathways assocd. with these pain states.  ALE-0540 represents a nonpeptidic small mol. which can be used to examine mechanisms leading to the development of agents for the treatment of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw3lh6om5ZiLVg90H21EOLACvtfcHk0li1OMusNhABVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtlGnsrk%253D&md5=e1576d13ebdd40ab80a4dc1333a622bb</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOwolabi%26aufirst%3DJ.%2BB.%26aulast%3DRizkalla%26aufirst%3DG.%26aulast%3DTehim%26aufirst%3DA.%26aulast%3DRoss%26aufirst%3DG.%2BM.%26aulast%3DRiopelle%26aufirst%3DR.%2BJ.%26aulast%3DKamboj%26aufirst%3DR.%26aulast%3DOssipov%26aufirst%3DM.%26aulast%3DBian%26aufirst%3DD.%26aulast%3DWegert%26aufirst%3DS.%26aulast%3DPorreca%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DD.%2BK.%2BH.%26atitle%3DCharacterization%2520of%2520antiallodynic%2520actions%2520of%2520ALE-0540%252C%2520a%2520novel%2520nerve%2520growth%2520factor%2520receptor%2520antagonist%252C%2520in%2520the%2520rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26issue%3D3%26spage%3D1271%26epage%3D1276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Colquhoun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrance, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shamovsky, I. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riopelle, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, G. M.</span><span> </span><span class="NLM_article-title">Differential activity of the nerve growth factor (NGF) antagonist PD90780 [7-(benzolylamino)-4,9-dihydro-4-methyl-9-oxo-pyrazolo[5,1-b]quinazoline-2-carbox ylic acid] suggests altered NGF–p75NTR interactions in the presence of TrkA</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">310</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">511</span><span class="refDoi"> DOI: 10.1124/jpet.104.066225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1124%2Fjpet.104.066225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=15051797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVyks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=310&publication_year=2004&pages=505-511&issue=2&author=A.+Colquhounauthor=G.+M.+Lawranceauthor=I.+L.+Shamovskyauthor=R.+J.+Riopelleauthor=G.+M.+Ross&title=Differential+activity+of+the+nerve+growth+factor+%28NGF%29+antagonist+PD90780+%5B7-%28benzolylamino%29-4%2C9-dihydro-4-methyl-9-oxo-pyrazolo%5B5%2C1-b%5Dquinazoline-2-carbox+ylic+acid%5D+suggests+altered+NGF%E2%80%93p75NTR+interactions+in+the+presence+of+TrkA&doi=10.1124%2Fjpet.104.066225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Differential activity of the nerve growth factor (NGF) antagonist PD90780 [7-(benzolylamino)-4,9-dihydro-4-methyl-9-oxo-pyrazolo[5,1-b]quinazoline-2-carboxylic acid] suggests altered NGF-p75NTR interactions in the presence of TrkA</span></div><div class="casAuthors">Colquhoun, Amy; Lawrance, Gail M.; Shamovsky, Igor L.; Riopelle, Richard J.; Ross, Gregory M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">310</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">505-511</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The neurotrophin nerve growth factor (NGF) binds to two receptor types: the tyrosine kinase receptor TrkA and the common neurotrophin receptor p75NTR.  Although many of the biol. effects of NGF (such as neuronal growth and survival) are assocd. with TrkA activation, p75NTR also contributes to these activities by enhancing the action of TrkA when receptors are coexpressed.  The NGF antagonist PD90780 [7-(benzolylamino)-4,9-dihydro-4-methyl-9-oxo-pyrazolo[5,1-b]quinazoline-2-carboxylic acid] interacts with NGF, preventing its binding to p75NTR.  In this study, the actions of this compd. are further explored, and it is found that PD90780 is not able to inhibit the binding of either brain-derived neurotrophic factor or neurotrophin-3 to p75NTR, consistent with the direct interactions of the antagonist with NGF.  In addn., the authors demonstrate that the ability of PD90780 to inhibit NGF-p75NTR interactions is lower when receptors are coexpressed, compared with when p75NTR is the only neurotrophin receptor expressed.  These results suggest that the interaction between NGF and the p75NTR receptor is altered when TrkA is coexpressed.  This alteration can be exploited in the development of antagonists that will selectively inhibit the pro-apoptotic actions of p75NTR when expressed in the absence of TrkA, although having less effect on the pro-survival effects of p75NTR mediated by enhanced TrkA activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC9Y-OzilC0LVg90H21EOLACvtfcHk0li1OMusNhABVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVyks7g%253D&md5=d9414b35a3360c1452e78f0034eeff99</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.066225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.066225%26sid%3Dliteratum%253Aachs%26aulast%3DColquhoun%26aufirst%3DA.%26aulast%3DLawrance%26aufirst%3DG.%2BM.%26aulast%3DShamovsky%26aufirst%3DI.%2BL.%26aulast%3DRiopelle%26aufirst%3DR.%2BJ.%26aulast%3DRoss%26aufirst%3DG.%2BM.%26atitle%3DDifferential%2520activity%2520of%2520the%2520nerve%2520growth%2520factor%2520%2528NGF%2529%2520antagonist%2520PD90780%2520%255B7-%2528benzolylamino%2529-4%252C9-dihydro-4-methyl-9-oxo-pyrazolo%255B5%252C1-b%255Dquinazoline-2-carbox%2520ylic%2520acid%255D%2520suggests%2520altered%2520NGF%25E2%2580%2593p75NTR%2520interactions%2520in%2520the%2520presence%2520of%2520TrkA%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D310%26issue%3D2%26spage%3D505%26epage%3D511%26doi%3D10.1124%2Fjpet.104.066225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Niederhauser, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schubenel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusznir, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hertel, C.</span><span> </span><span class="NLM_article-title">NGF ligand alters NGF signaling via p75NTR and TrkA</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span><span class="refDoi"> DOI: 10.1002/1097-4547(20000801)61:3<263::AID-JNR4>3.0.CO;2-M</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1002%2F1097-4547%2820000801%2961%3A3%3C263%3A%3AAID-JNR4%3E3.0.CO%3B2-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10900073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlslCnt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2000&pages=263-272&issue=3&author=O.+Niederhauserauthor=M.+Mangoldauthor=R.+Schubenelauthor=E.+A.+Kusznirauthor=D.+Schmidtauthor=C.+Hertel&title=NGF+ligand+alters+NGF+signaling+via+p75NTR+and+TrkA&doi=10.1002%2F1097-4547%2820000801%2961%3A3%3C263%3A%3AAID-JNR4%3E3.0.CO%3B2-M"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">NGF ligand alters NGF signaling via p75NTR and TrkA</span></div><div class="casAuthors">Niederhauser, O.; Mangold, M.; Schubenel, R.; Kusznir, E. A.; Schmidt, D.; Hertel, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">263-272</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Nerve growth factor (NGF) binds to two neurotrophin receptors: p75NTR and p140Trk (TrkA).  Both receptors dimerize in response to NGF binding.  TrkA homodimers and heteromers of TrkA and p75NTR promote cell survival, whereas homodimers of p75NTR mediate apoptosis upon binding of NGF.  The interaction between receptor and NGF can be inhibited either on the level of the ligand by altering NGF conformation so that NGF is no longer recognized by the receptor or on the level of the receptor by blocking the binding site of p75NTR or TrkA.  The effect of altering NGF conformation on NGF signaling was investigated in two neuron-like cell lines: in human SK-N-MC cells that express only p75NTR and in rat PC12 cells that express both p75NTR and TrkA.  In the present study Ro 08-2750 binds to the NGF dimer thereby probably inducing a change in its conformation such that NGF cannot bind to p75NTR anymore.  In SK-N-MC cells this leads to inhibition of NGF-induced programmed cell death.  In PC12 cells enhanced signaling through TrkA was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbIJ4XSeSjorVg90H21EOLACvtfcHk0lgO0y9qfL41Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlslCnt7k%253D&md5=1b080455cf33e1f2e307b7d3377b36ed</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2F1097-4547%2820000801%2961%3A3%3C263%3A%3AAID-JNR4%3E3.0.CO%3B2-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1097-4547%252820000801%252961%253A3%253C263%253A%253AAID-JNR4%253E3.0.CO%253B2-M%26sid%3Dliteratum%253Aachs%26aulast%3DNiederhauser%26aufirst%3DO.%26aulast%3DMangold%26aufirst%3DM.%26aulast%3DSchubenel%26aufirst%3DR.%26aulast%3DKusznir%26aufirst%3DE.%2BA.%26aulast%3DSchmidt%26aufirst%3DD.%26aulast%3DHertel%26aufirst%3DC.%26atitle%3DNGF%2520ligand%2520alters%2520NGF%2520signaling%2520via%2520p75NTR%2520and%2520TrkA%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2000%26volume%3D61%26issue%3D3%26spage%3D263%26epage%3D272%26doi%3D10.1002%2F1097-4547%2820000801%2961%3A3%3C263%3A%3AAID-JNR4%3E3.0.CO%3B2-M" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Eibl, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, G. M.</span><span> </span><span class="NLM_article-title">Identification of novel pyrazoloquinazolinecarboxilate analogues to inhibit nerve growth factor in vitro</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">708</span><span class="NLM_x"> (</span><span class="NLM_issue">1–3</span><span class="NLM_x">) </span> <span class="NLM_fpage">30</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2013.03.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.ejphar.2013.03.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23528360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnslChs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=708&publication_year=2013&pages=30-37&issue=1%E2%80%933&author=J.+K.+Eiblauthor=B.+C.+Strasserauthor=G.+M.+Ross&title=Identification+of+novel+pyrazoloquinazolinecarboxilate+analogues+to+inhibit+nerve+growth+factor+in+vitro&doi=10.1016%2Fj.ejphar.2013.03.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel pyrazoloquinazolinecarboxilate analogues to inhibit nerve growth factor in vitro</span></div><div class="casAuthors">Eibl, Joseph K.; Strasser, Bridget C.; Ross, Gregory M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">708</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">30-37</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nerve growth factor (NGF) is known to regulate the development and survival of select populations of neurons via its binding/activation of the TrkA and p75NTR receptors.  However, in some physiol. circumstances NGF dysregulation can result in debilitating pathologies, including diabetic neuropathies, interstitial cystitis and fibromyalgia.  Thus, the identification of small mols. which inhibit NGF signalling have significant therapeutic potential.  PD 90780, Ro 08-2750, and ALE 0540 are small mols. that have been reported to bind and inhibit NGF activity.  Importantly, the docking site of these compds. is hypothesised to occur at the loop I/IV cleft of NGF-a region which is required for efficient and selective binding of this neurotrophin to its receptor(s).  Mol. modeling predicts a no. of previously reported NGF antagonists (PD 90780, ALE 0540, and Ro 08-2750) share conserved mol. features, and these drug-like small mols. have the ability to bind and modify the mol. topol. of NGF.  In order to understand the putative mechanism of binding, we synthesized a pyrazoloquinazolinecarboxilate analog series and tested each compd. in an NGF-dependent PC12 cell differentiation assay.  In vitro data confirms that the pyrazoloquinazolinecarboxilate analogs functionally inhibit NGF's effects on PC12 cell differentiation.  The results of this study provide evidence to refine the docking mode of pyrazoloquinazolinecarboxilate based compds. for the purposes of inhibiting NGF in vitro.  In addn., we identified series analog PQC 083 (IC50=7.0 μM; CI=5.4-10.1 μM) which displays markedly higher potency than previously described NGF antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1TfVNfQymVLVg90H21EOLACvtfcHk0lgO0y9qfL41Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnslChs7s%253D&md5=beaffd63679cf8794197a9791c0ac85e</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2013.03.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2013.03.029%26sid%3Dliteratum%253Aachs%26aulast%3DEibl%26aufirst%3DJ.%2BK.%26aulast%3DStrasser%26aufirst%3DB.%2BC.%26aulast%3DRoss%26aufirst%3DG.%2BM.%26atitle%3DIdentification%2520of%2520novel%2520pyrazoloquinazolinecarboxilate%2520analogues%2520to%2520inhibit%2520nerve%2520growth%2520factor%2520in%2520vitro%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D708%26issue%3D1%25E2%2580%25933%26spage%3D30%26epage%3D37%26doi%3D10.1016%2Fj.ejphar.2013.03.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Vaudry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stork, P. J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarovici, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiden, L. E.</span><span> </span><span class="NLM_article-title">Signaling pathways for PC12 cell differentiation: Making the right connections</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x"> (</span><span class="NLM_issue">5573</span><span class="NLM_x">) </span> <span class="NLM_fpage">1648</span><span class="NLM_x">–</span> <span class="NLM_lpage">1649</span><span class="refDoi"> DOI: 10.1126/science.1071552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1126%2Fscience.1071552" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=12040181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlCht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=1648-1649&issue=5573&author=D.+Vaudryauthor=P.+J.+S.+Storkauthor=P.+Lazaroviciauthor=L.+E.+Eiden&title=Signaling+pathways+for+PC12+cell+differentiation%3A+Making+the+right+connections&doi=10.1126%2Fscience.1071552"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Signaling pathways for PC12 cell differentiation: Making the right connections</span></div><div class="casAuthors">Vaudry, D.; Stork, P. J. S.; Lazarovici, P.; Elden, L. E.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5573</span>),
    <span class="NLM_cas:pages">1648-1649</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review with 21 refs.  A key issue in signal transduction is how signaling pathways common to many systems, so-called canonical signaling cassettes, integrate signals from mols. having a wide spectrum of activities, such as hormones and neurotrophins, to deliver distinct biol. outcomes.  The neuroendocrine cell line PC12, derived from rat pheochromocytoma, provides an example of how one canonical signaling cassette, the Raf MAP kinase kinase (MEK)/ERK kinase pathway, can promote distinct outcomes, which in this case include neuritogenesis, gene induction, and proliferation.  Two growth hormones, epidermal growth factor (EGF) and nerve growth factor (NGF), use the same pathway to cause PC12 proliferation and differentiation, resp.  In addn., pituitary adenylate cyclase-activating polypeptide (PACAP), a neurotransmitter that also causes differentiation, uses the same canonical cassette as NGF but in a different way.  The connections Map for PC12 cell differentiation brings into focus the complex array of specific cellular responses that rely on canonical signal transduction systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSCVAyxMm8vbVg90H21EOLACvtfcHk0lgO0y9qfL41Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlCht7Y%253D&md5=51576d884b0ad0ee49a869c5e3a3e5cd</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1126%2Fscience.1071552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1071552%26sid%3Dliteratum%253Aachs%26aulast%3DVaudry%26aufirst%3DD.%26aulast%3DStork%26aufirst%3DP.%2BJ.%2BS.%26aulast%3DLazarovici%26aufirst%3DP.%26aulast%3DEiden%26aufirst%3DL.%2BE.%26atitle%3DSignaling%2520pathways%2520for%2520PC12%2520cell%2520differentiation%253A%2520Making%2520the%2520right%2520connections%26jtitle%3DScience%26date%3D2002%26volume%3D296%26issue%3D5573%26spage%3D1648%26epage%3D1649%26doi%3D10.1126%2Fscience.1071552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Sheffield, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, G. M.</span><span> </span><span class="NLM_article-title">Characterizing nerve growth factor-p75(NTR) interactions and small molecule inhibition using surface plasmon resonance spectroscopy</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">493</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span><span class="refDoi"> DOI: 10.1016/j.ab.2015.09.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.ab.2015.09.019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=493&publication_year=2016&pages=21-26&author=K.+S.+Sheffieldauthor=A.+E.+Kennedyauthor=J.+A.+Scottauthor=G.+M.+Ross&title=Characterizing+nerve+growth+factor-p75%28NTR%29+interactions+and+small+molecule+inhibition+using+surface+plasmon+resonance+spectroscopy&doi=10.1016%2Fj.ab.2015.09.019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2015.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2015.09.019%26sid%3Dliteratum%253Aachs%26aulast%3DSheffield%26aufirst%3DK.%2BS.%26aulast%3DKennedy%26aufirst%3DA.%2BE.%26aulast%3DScott%26aufirst%3DJ.%2BA.%26aulast%3DRoss%26aufirst%3DG.%2BM.%26atitle%3DCharacterizing%2520nerve%2520growth%2520factor-p75%2528NTR%2529%2520interactions%2520and%2520small%2520molecule%2520inhibition%2520using%2520surface%2520plasmon%2520resonance%2520spectroscopy%26jtitle%3DAnal.%2520Biochem.%26date%3D2016%26volume%3D493%26spage%3D21%26epage%3D26%26doi%3D10.1016%2Fj.ab.2015.09.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Jang, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinshenker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, K.</span><span> </span><span class="NLM_article-title">Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">644</span><span class="NLM_x">–</span> <span class="NLM_lpage">656</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2009.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.chembiol.2009.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=19549602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFamurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=644-656&issue=6&author=S.+W.+Jangauthor=X.+Liuauthor=C.+B.+Chanauthor=D.+Weinshenkerauthor=R.+A.+Hallauthor=G.+Xiaoauthor=K.+Ye&title=Amitriptyline+is+a+TrkA+and+TrkB+receptor+agonist+that+promotes+TrkA%2FTrkB+heterodimerization+and+has+potent+neurotrophic+activity&doi=10.1016%2Fj.chembiol.2009.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Amitriptyline is a TrkA and TrkB Receptor Agonist that Promotes TrkA/TrkB Heterodimerization and Has Potent Neurotrophic Activity</span></div><div class="casAuthors">Jang, Sung-Wuk; Liu, Xia; Chan, Chi-Bun; Weinshenker, David; Hall, Randy A.; Xiao, Ge; Ye, Keqiang</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">644-656</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Neurotrophins, the cognate ligands for the Trk receptors, are homodimers and induce Trk dimerization through a sym. bivalent mechanism.  We report here that amitriptyline, an antidepressant drug, directly binds TrkA and TrkB and triggers their dimerization and activation.  Amitriptyline, but not any other tricyclic or selective serotonin reuptake inhibitor antidepressants, promotes TrkA autophosphorylation in primary neurons and induces neurite outgrowth in PC12 cells.  Amitriptyline binds the extracellular domain of both TrkA and TrkB and promotes TrkA-TrkB receptor heterodimerization.  Truncation of amitriptyline binding motif on TrkA abrogates the receptor dimerization by amitriptyline.  Administration of amitriptyline to mice activates both receptors and significantly reduces kainic acid-triggered neuronal cell death.  Inhibition of TrkA, but not TrkB, abolishes amitriptyline's neuroprotective effect without impairing its antidepressant activity.  Thus, amitriptyline acts as a TrkA and TrkB agonist and possesses marked neurotrophic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAY4RCL5dTxrVg90H21EOLACvtfcHk0lhxancNMhypTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFamurs%253D&md5=4dd25ed2cfe6ee57b17a6957dcfaeb1d</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2009.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2009.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DJang%26aufirst%3DS.%2BW.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DChan%26aufirst%3DC.%2BB.%26aulast%3DWeinshenker%26aufirst%3DD.%26aulast%3DHall%26aufirst%3DR.%2BA.%26aulast%3DXiao%26aufirst%3DG.%26aulast%3DYe%26aufirst%3DK.%26atitle%3DAmitriptyline%2520is%2520a%2520TrkA%2520and%2520TrkB%2520receptor%2520agonist%2520that%2520promotes%2520TrkA%252FTrkB%2520heterodimerization%2520and%2520has%2520potent%2520neurotrophic%2520activity%26jtitle%3DChem.%2520Biol.%26date%3D2009%26volume%3D16%26issue%3D6%26spage%3D644%26epage%3D656%26doi%3D10.1016%2Fj.chembiol.2009.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Urfer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsoulfas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parada, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presta, L. G.</span><span> </span><span class="NLM_article-title">An immunoglobulin-like domain determines the specificity of neurotrophin receptors</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">2795</span><span class="NLM_x">–</span> <span class="NLM_lpage">2805</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=2795-2805&issue=12&author=R.+Urferauthor=P.+Tsoulfasauthor=L.+O%E2%80%99Connellauthor=D.+L.+Sheltonauthor=L.+F.+Paradaauthor=L.+G.+Presta&title=An+immunoglobulin-like+domain+determines+the+specificity+of+neurotrophin+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUrfer%26aufirst%3DR.%26aulast%3DTsoulfas%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DL.%26aulast%3DShelton%26aufirst%3DD.%2BL.%26aulast%3DParada%26aufirst%3DL.%2BF.%26aulast%3DPresta%26aufirst%3DL.%2BG.%26atitle%3DAn%2520immunoglobulin-like%2520domain%2520determines%2520the%2520specificity%2520of%2520neurotrophin%2520receptors%26jtitle%3DEMBO%2520J.%26date%3D1995%26volume%3D14%26issue%3D12%26spage%3D2795%26epage%3D2805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vos, A. M.</span><span> </span><span class="NLM_article-title">Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">401</span><span class="NLM_x"> (</span><span class="NLM_issue">6749</span><span class="NLM_x">) </span> <span class="NLM_fpage">184</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span><span class="refDoi"> DOI: 10.1038/43705</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2F43705" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=1999&pages=184-188&issue=6749&author=C.+Wiesmannauthor=M.+H.+Ultschauthor=S.+H.+Bassauthor=A.+M.+de+Vos&title=Crystal+structure+of+nerve+growth+factor+in+complex+with+the+ligand-binding+domain+of+the+TrkA+receptor&doi=10.1038%2F43705"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2F43705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F43705%26sid%3Dliteratum%253Aachs%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DBass%26aufirst%3DS.%2BH.%26aulast%3Dde%2BVos%26aufirst%3DA.%2BM.%26atitle%3DCrystal%2520structure%2520of%2520nerve%2520growth%2520factor%2520in%2520complex%2520with%2520the%2520ligand-binding%2520domain%2520of%2520the%2520TrkA%2520receptor%26jtitle%3DNature%26date%3D1999%26volume%3D401%26issue%3D6749%26spage%3D184%26epage%3D188%26doi%3D10.1038%2F43705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henrich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vos, A. M.</span><span> </span><span class="NLM_article-title">Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">159</span><span class="refDoi"> DOI: 10.1006/jmbi.1999.2816</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1006%2Fjmbi.1999.2816" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=1999&pages=149-159&issue=1&author=M.+H.+Ultschauthor=C.+Wiesmannauthor=L.+C.+Simmonsauthor=J.+Henrichauthor=M.+Yangauthor=D.+Reillyauthor=S.+H.+Bassauthor=A.+M.+de+Vos&title=Crystal+structures+of+the+neurotrophin-binding+domain+of+TrkA%2C+TrkB+and+TrkC&doi=10.1006%2Fjmbi.1999.2816"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1999.2816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1999.2816%26sid%3Dliteratum%253Aachs%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DSimmons%26aufirst%3DL.%2BC.%26aulast%3DHenrich%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DReilly%26aufirst%3DD.%26aulast%3DBass%26aufirst%3DS.%2BH.%26aulast%3Dde%2BVos%26aufirst%3DA.%2BM.%26atitle%3DCrystal%2520structures%2520of%2520the%2520neurotrophin-binding%2520domain%2520of%2520TrkA%252C%2520TrkB%2520and%2520TrkC%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1999%26volume%3D290%26issue%3D1%26spage%3D149%26epage%3D159%26doi%3D10.1006%2Fjmbi.1999.2816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">McNamee, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burleigh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gompels, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawbarn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincent, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglis, J. J.</span><span> </span><span class="NLM_article-title">Treatment of murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non-inflammatory joint pain</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span><span class="refDoi"> DOI: 10.1016/j.pain.2010.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.pain.2010.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=20350782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1Smtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2010&pages=386-392&issue=2&author=K.+E.+McNameeauthor=A.+Burleighauthor=L.+L.+Gompelsauthor=M.+Feldmannauthor=S.+J.+Allenauthor=R.+O.+Williamsauthor=D.+Dawbarnauthor=T.+L.+Vincentauthor=J.+J.+Inglis&title=Treatment+of+murine+osteoarthritis+with+TrkAd5+reveals+a+pivotal+role+for+nerve+growth+factor+in+non-inflammatory+joint+pain&doi=10.1016%2Fj.pain.2010.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non-inflammatory joint pain</span></div><div class="casAuthors">McNamee, Kay E.; Burleigh, Annika; Gompels, Luke L.; Feldmann, Marc; Allen, Shelley J.; Williams, Richard O.; Dawbarn, David; Vincent, Tonia L.; Inglis, Julia J.</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">149</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">386-392</span>CODEN:
                <span class="NLM_cas:coden">PAINDB</span>;
        ISSN:<span class="NLM_cas:issn">0304-3959</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The origin of pain in osteoarthritis is poorly understood, but it is generally thought to arise from inflammation within the innervated structures of the joint, such as the synovium, capsule and bone.  We investigated the role of nerve growth factor (NGF) in pain development in murine OA, and the analgesic efficacy of the sol. NGF receptor, TrkAD5.  OA was induced in mice by destabilization of the medial meniscus and pain was assessed by measuring hind-limb wt. distribution.  RNA was extd. from joints, and NGF and TNF expressions were quantified.  The effect of tumor necrosis factor (TNF) and neutrophil blockade on NGF expression and pain were also assessed.  NGF was induced in the joints during both post-operative (day 3) and OA (16 wk) pain, but not in the non-painful stage of disease (8 wk post-surgery).  TrkAd5 was highly effective at suppressing pain in both phases.  Induction of NGF in the post-operative phase of pain was TNF-dependent as anti-TNF reduced NGF expression in the joint and abrogated pain.  However, TNF was not regulated in the late OA joints, and pain was not affected by anti-TNF therapy.  Fucoidan, by suppressing cellular infiltration into the joint, was able to suppress post-operative, but not late OA pain.  These results indicate that NGF is an important mediator of OA pain and that TrkAd5 represents a potent novel analgesic in this condition.  They also suggest that, unlike post-operative pain, induction of pain in OA may not necessarily be driven by classical inflammatory processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpebZ9OZVUorrVg90H21EOLACvtfcHk0lhxancNMhypTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1Smtrk%253D&md5=a165ee69fc33270b1b12fce44509ec2c</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2010.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2010.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DMcNamee%26aufirst%3DK.%2BE.%26aulast%3DBurleigh%26aufirst%3DA.%26aulast%3DGompels%26aufirst%3DL.%2BL.%26aulast%3DFeldmann%26aufirst%3DM.%26aulast%3DAllen%26aufirst%3DS.%2BJ.%26aulast%3DWilliams%26aufirst%3DR.%2BO.%26aulast%3DDawbarn%26aufirst%3DD.%26aulast%3DVincent%26aufirst%3DT.%2BL.%26aulast%3DInglis%26aufirst%3DJ.%2BJ.%26atitle%3DTreatment%2520of%2520murine%2520osteoarthritis%2520with%2520TrkAd5%2520reveals%2520a%2520pivotal%2520role%2520for%2520nerve%2520growth%2520factor%2520in%2520non-inflammatory%2520joint%2520pain%26jtitle%3DPain%26date%3D2010%26volume%3D149%26issue%3D2%26spage%3D386%26epage%3D392%26doi%3D10.1016%2Fj.pain.2010.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Shoemark, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fahey, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyler, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scoltock, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, R. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickenden, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmings, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawbarn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jane, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sessions, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crump, M. P.</span><span> </span><span class="NLM_article-title">Design and nuclear magnetic resonance (NMR) structure determination of the second extracellular immunoglobulin tyrosine kinase A (TrkAIg2) domain construct for binding site elucidation in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">767</span><span class="NLM_x">–</span> <span class="NLM_lpage">777</span><span class="refDoi"> DOI: 10.1021/jm501307e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501307e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=767-777&issue=2&author=D.+K.+Shoemarkauthor=C.+Williamsauthor=M.+S.+Faheyauthor=J.+J.+Watsonauthor=S.+J.+Tylerauthor=S.+J.+Scoltockauthor=R.+Z.+Ellisauthor=E.+Wickendenauthor=A.+J.+Burtonauthor=J.+L.+Hemmingsauthor=C.+D.+Baileyauthor=D.+Dawbarnauthor=D.+E.+Janeauthor=C.+L.+Willisauthor=R.+B.+Sessionsauthor=S.+J.+Allenauthor=M.+P.+Crump&title=Design+and+nuclear+magnetic+resonance+%28NMR%29+structure+determination+of+the+second+extracellular+immunoglobulin+tyrosine+kinase+A+%28TrkAIg2%29+domain+construct+for+binding+site+elucidation+in+drug+discovery&doi=10.1021%2Fjm501307e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm501307e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501307e%26sid%3Dliteratum%253Aachs%26aulast%3DShoemark%26aufirst%3DD.%2BK.%26aulast%3DWilliams%26aufirst%3DC.%26aulast%3DFahey%26aufirst%3DM.%2BS.%26aulast%3DWatson%26aufirst%3DJ.%2BJ.%26aulast%3DTyler%26aufirst%3DS.%2BJ.%26aulast%3DScoltock%26aufirst%3DS.%2BJ.%26aulast%3DEllis%26aufirst%3DR.%2BZ.%26aulast%3DWickenden%26aufirst%3DE.%26aulast%3DBurton%26aufirst%3DA.%2BJ.%26aulast%3DHemmings%26aufirst%3DJ.%2BL.%26aulast%3DBailey%26aufirst%3DC.%2BD.%26aulast%3DDawbarn%26aufirst%3DD.%26aulast%3DJane%26aufirst%3DD.%2BE.%26aulast%3DWillis%26aufirst%3DC.%2BL.%26aulast%3DSessions%26aufirst%3DR.%2BB.%26aulast%3DAllen%26aufirst%3DS.%2BJ.%26aulast%3DCrump%26aufirst%3DM.%2BP.%26atitle%3DDesign%2520and%2520nuclear%2520magnetic%2520resonance%2520%2528NMR%2529%2520structure%2520determination%2520of%2520the%2520second%2520extracellular%2520immunoglobulin%2520tyrosine%2520kinase%2520A%2520%2528TrkAIg2%2529%2520domain%2520construct%2520for%2520binding%2520site%2520elucidation%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D2%26spage%3D767%26epage%3D777%26doi%3D10.1021%2Fjm501307e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span><span class="refDoi"> DOI: 10.1038/nrc2559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&issue=1&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors&doi=10.1038%2Fnrc2559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0lht-O3b5jhE5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26issue%3D1%26spage%3D28%26epage%3D39%26doi%3D10.1038%2Fnrc2559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Goodwin, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianchetta, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgoon, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mabon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strobel, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamman, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlins, D. B.</span><span> </span><span class="NLM_article-title">Discovery of a Type III inhibitor of LIM kinase 2 that binds in a DFG-out conformation</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span><span class="refDoi"> DOI: 10.1021/ml500242y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500242y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=53-57&issue=1&author=N.+C.+Goodwinauthor=G.+Cianchettaauthor=H.+A.+Burgoonauthor=J.+Healyauthor=R.+Mabonauthor=E.+D.+Strobelauthor=J.+Allenauthor=S.+Wangauthor=B.+D.+Hammanauthor=D.+B.+Rawlins&title=Discovery+of+a+Type+III+inhibitor+of+LIM+kinase+2+that+binds+in+a+DFG-out+conformation&doi=10.1021%2Fml500242y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fml500242y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500242y%26sid%3Dliteratum%253Aachs%26aulast%3DGoodwin%26aufirst%3DN.%2BC.%26aulast%3DCianchetta%26aufirst%3DG.%26aulast%3DBurgoon%26aufirst%3DH.%2BA.%26aulast%3DHealy%26aufirst%3DJ.%26aulast%3DMabon%26aufirst%3DR.%26aulast%3DStrobel%26aufirst%3DE.%2BD.%26aulast%3DAllen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DHamman%26aufirst%3DB.%2BD.%26aulast%3DRawlins%26aufirst%3DD.%2BB.%26atitle%3DDiscovery%2520of%2520a%2520Type%2520III%2520inhibitor%2520of%2520LIM%2520kinase%25202%2520that%2520binds%2520in%2520a%2520DFG-out%2520conformation%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D1%26spage%3D53%26epage%3D57%26doi%3D10.1021%2Fml500242y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Cherry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. H.</span><span> </span><span class="NLM_article-title">Recent kinase and kinase inhibitor X-ray structures: mechanisms of inhibition and selectivity insights</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span><span class="refDoi"> DOI: 10.2174/0929867043455792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.2174%2F0929867043455792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=15032722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWgs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=663-673&issue=6&author=M.+Cherryauthor=D.+H.+Williams&title=Recent+kinase+and+kinase+inhibitor+X-ray+structures%3A+mechanisms+of+inhibition+and+selectivity+insights&doi=10.2174%2F0929867043455792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Recent kinase and kinase inhibitor x-ray structures: mechanisms of inhibition and selectivity insights</span></div><div class="casAuthors">Cherry, M.; Williams, D. H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">663-673</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent years have seen an explosion in the no. of publicly available x-ray crystal structures of protein kinases.  These structures have provided a wealth of information on the regulatory mechanisms, conformational plasticity and drugability of this important family of enzymes.  Drawing upon structural information, new insights into the development of protein kinase inhibitors are discussed including de-novo design, mol. templates for ATP competitive inhibitors and alternative mechanisms of inhibition.  The highly conserved nature of the ATP binding site is of central concern to drug development and the concept of a selectivity profile has arisen with structure-based design emerging as a key tool for addressing the challenges of specificity.  In addn., protein-ligand complexes, where the enzyme is in an inactive conformation, signify an alternate approach to protein kinase inhibition.  The belief that an inactive kinase presents a less conserved target is reviewed using observations on the structural changes occurring during protein kinase regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB19ovXBL1mrVg90H21EOLACvtfcHk0lh9-gm2wrYA8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWgs7w%253D&md5=63c621c012a6e1cc9f795565580d7492</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.2174%2F0929867043455792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043455792%26sid%3Dliteratum%253Aachs%26aulast%3DCherry%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26atitle%3DRecent%2520kinase%2520and%2520kinase%2520inhibitor%2520X-ray%2520structures%253A%2520mechanisms%2520of%2520inhibition%2520and%2520selectivity%2520insights%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26issue%3D6%26spage%3D663%26epage%3D673%26doi%3D10.2174%2F0929867043455792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Bertrand, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kothe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupuy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gladysheva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valtre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crenne, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieu, M.</span><span> </span><span class="NLM_article-title">The crystal structures of TrkA and TrkB suggest key regions for achieving selective inhibition</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">423</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">453</span><span class="refDoi"> DOI: 10.1016/j.jmb.2012.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.jmb.2012.08.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=423&publication_year=2012&pages=439-453&issue=3&author=T.+Bertrandauthor=M.+Kotheauthor=J.+Liuauthor=A.+Dupuyauthor=A.+Rakauthor=P.+F.+Berneauthor=S.+Davisauthor=T.+Gladyshevaauthor=C.+Valtreauthor=J.+Y.+Crenneauthor=M.+Mathieu&title=The+crystal+structures+of+TrkA+and+TrkB+suggest+key+regions+for+achieving+selective+inhibition&doi=10.1016%2Fj.jmb.2012.08.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2012.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2012.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DBertrand%26aufirst%3DT.%26aulast%3DKothe%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DDupuy%26aufirst%3DA.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DBerne%26aufirst%3DP.%2BF.%26aulast%3DDavis%26aufirst%3DS.%26aulast%3DGladysheva%26aufirst%3DT.%26aulast%3DValtre%26aufirst%3DC.%26aulast%3DCrenne%26aufirst%3DJ.%2BY.%26aulast%3DMathieu%26aufirst%3DM.%26atitle%3DThe%2520crystal%2520structures%2520of%2520TrkA%2520and%2520TrkB%2520suggest%2520key%2520regions%2520for%2520achieving%2520selective%2520inhibition%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2012%26volume%3D423%26issue%3D3%26spage%3D439%26epage%3D453%26doi%3D10.1016%2Fj.jmb.2012.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Albaugh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkisova, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreusch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karanewsky, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molteni, V.</span><span> </span><span class="NLM_article-title">Discovery of GNF-5837, a selective TRK inhibitor with efficacy in rodent cancer tumor models</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span><span class="refDoi"> DOI: 10.1021/ml200261d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml200261d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=140-145&issue=2&author=P.+Albaughauthor=Y.+Fanauthor=Y.+Miauthor=F.+Sunauthor=F.+Adrianauthor=N.+Liauthor=Y.+Jiaauthor=Y.+Sarkisovaauthor=A.+Kreuschauthor=T.+Hoodauthor=M.+Luauthor=G.+Liuauthor=S.+Huangauthor=Z.+Liuauthor=J.+Lorenauthor=T.+Tuntlandauthor=D.+S.+Karanewskyauthor=H.+M.+Seidelauthor=V.+Molteni&title=Discovery+of+GNF-5837%2C+a+selective+TRK+inhibitor+with+efficacy+in+rodent+cancer+tumor+models&doi=10.1021%2Fml200261d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fml200261d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200261d%26sid%3Dliteratum%253Aachs%26aulast%3DAlbaugh%26aufirst%3DP.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DAdrian%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DSarkisova%26aufirst%3DY.%26aulast%3DKreusch%26aufirst%3DA.%26aulast%3DHood%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLoren%26aufirst%3DJ.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DKaranewsky%26aufirst%3DD.%2BS.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DMolteni%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520GNF-5837%252C%2520a%2520selective%2520TRK%2520inhibitor%2520with%2520efficacy%2520in%2520rodent%2520cancer%2520tumor%2520models%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26issue%3D2%26spage%3D140%26epage%3D145%26doi%3D10.1021%2Fml200261d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioannidis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyne, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjogren, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thress, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. J.</span><span> </span><span class="NLM_article-title">Discovery of disubstituted imidazo[4,5-b]pyridines and purines as potent TrkA inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">709</span><span class="refDoi"> DOI: 10.1021/ml300074j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml300074j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=705-709&issue=9&author=T.+Wangauthor=M.+L.+Lambauthor=M.+H.+Blockauthor=A.+M.+Daviesauthor=Y.+Hanauthor=E.+Hoffmannauthor=S.+Ioannidisauthor=J.+A.+Joseyauthor=Z.+Y.+Liuauthor=P.+D.+Lyneauthor=T.+MacIntyreauthor=P.+J.+Mohrauthor=C.+A.+Omerauthor=T.+Sjogrenauthor=K.+Thressauthor=B.+Wangauthor=H.+Wangauthor=D.+Yuauthor=H.+J.+Zhang&title=Discovery+of+disubstituted+imidazo%5B4%2C5-b%5Dpyridines+and+purines+as+potent+TrkA+inhibitors&doi=10.1021%2Fml300074j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Fml300074j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300074j%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DBlock%26aufirst%3DM.%2BH.%26aulast%3DDavies%26aufirst%3DA.%2BM.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DHoffmann%26aufirst%3DE.%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DLiu%26aufirst%3DZ.%2BY.%26aulast%3DLyne%26aufirst%3DP.%2BD.%26aulast%3DMacIntyre%26aufirst%3DT.%26aulast%3DMohr%26aufirst%3DP.%2BJ.%26aulast%3DOmer%26aufirst%3DC.%2BA.%26aulast%3DSjogren%26aufirst%3DT.%26aulast%3DThress%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DH.%2BJ.%26atitle%3DDiscovery%2520of%2520disubstituted%2520imidazo%255B4%252C5-b%255Dpyridines%2520and%2520purines%2520as%2520potent%2520TrkA%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26issue%3D9%26spage%3D705%26epage%3D709%26doi%3D10.1021%2Fml300074j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Stachel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henze, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanda, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egbertson, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manley, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brnardic, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grobler, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanney, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krasowska-Zoladek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilodeau, M. T.</span><span> </span><span class="NLM_article-title">Maximizing diversity from a kinase screen: identification of novel and selective pan-Trk inhibitors for chronic pain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">5800</span><span class="NLM_x">–</span> <span class="NLM_lpage">5816</span><span class="refDoi"> DOI: 10.1021/jm5006429</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5006429" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5800-5816&issue=13&author=S.+J.+Stachelauthor=J.+M.+Sandersauthor=D.+A.+Henzeauthor=M.+T.+Ruddauthor=H.+P.+Suauthor=Y.+Liauthor=K.+K.+Nandaauthor=M.+S.+Egbertsonauthor=P.+J.+Manleyauthor=K.+L.+Jonesauthor=E.+J.+Brnardicauthor=A.+Greenauthor=J.+A.+Groblerauthor=B.+Hanneyauthor=M.+Leitlauthor=M.+T.+Laiauthor=V.+Munshiauthor=D.+Murphyauthor=K.+Rickertauthor=D.+Rileyauthor=A.+Krasowska-Zoladekauthor=C.+Daleyauthor=P.+Zuckauthor=S.+A.+Kaneauthor=M.+T.+Bilodeau&title=Maximizing+diversity+from+a+kinase+screen%3A+identification+of+novel+and+selective+pan-Trk+inhibitors+for+chronic+pain&doi=10.1021%2Fjm5006429"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm5006429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5006429%26sid%3Dliteratum%253Aachs%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26aulast%3DSanders%26aufirst%3DJ.%2BM.%26aulast%3DHenze%26aufirst%3DD.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DSu%26aufirst%3DH.%2BP.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DNanda%26aufirst%3DK.%2BK.%26aulast%3DEgbertson%26aufirst%3DM.%2BS.%26aulast%3DManley%26aufirst%3DP.%2BJ.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DBrnardic%26aufirst%3DE.%2BJ.%26aulast%3DGreen%26aufirst%3DA.%26aulast%3DGrobler%26aufirst%3DJ.%2BA.%26aulast%3DHanney%26aufirst%3DB.%26aulast%3DLeitl%26aufirst%3DM.%26aulast%3DLai%26aufirst%3DM.%2BT.%26aulast%3DMunshi%26aufirst%3DV.%26aulast%3DMurphy%26aufirst%3DD.%26aulast%3DRickert%26aufirst%3DK.%26aulast%3DRiley%26aufirst%3DD.%26aulast%3DKrasowska-Zoladek%26aufirst%3DA.%26aulast%3DDaley%26aufirst%3DC.%26aulast%3DZuck%26aufirst%3DP.%26aulast%3DKane%26aufirst%3DS.%2BA.%26aulast%3DBilodeau%26aufirst%3DM.%2BT.%26atitle%3DMaximizing%2520diversity%2520from%2520a%2520kinase%2520screen%253A%2520identification%2520of%2520novel%2520and%2520selective%2520pan-Trk%2520inhibitors%2520for%2520chronic%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D13%26spage%3D5800%26epage%3D5816%26doi%3D10.1021%2Fjm5006429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Choi, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rucker, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albaugh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopiuk, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Che, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culazzo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tompkins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phung, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreusch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaudhary, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prashad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molteni, V.</span><span> </span><span class="NLM_article-title">(R)-2-Phenylpyrrolidine substituted imidazopyridazines: A new class of potent and selective pan-TRK inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00050</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00050" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=562-567&issue=5&author=H.+S.+Choiauthor=P.+V.+Ruckerauthor=Z.+Wangauthor=Y.+Fanauthor=P.+Albaughauthor=G.+Chopiukauthor=F.+Gessierauthor=F.+Sunauthor=F.+Adrianauthor=G.+Liuauthor=T.+Hoodauthor=N.+Liauthor=Y.+Jiaauthor=J.+Cheauthor=S.+McCormackauthor=A.+Liauthor=J.+Liauthor=A.+Steffyauthor=A.+Culazzoauthor=C.+Tompkinsauthor=V.+Phungauthor=A.+Kreuschauthor=M.+Luauthor=B.+Huauthor=A.+Chaudharyauthor=M.+Prashadauthor=T.+Tuntlandauthor=B.+Liuauthor=J.+Harrisauthor=H.+M.+Seidelauthor=J.+Lorenauthor=V.+Molteni&title=%28R%29-2-Phenylpyrrolidine+substituted+imidazopyridazines%3A+A+new+class+of+potent+and+selective+pan-TRK+inhibitors&doi=10.1021%2Facsmedchemlett.5b00050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00050%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BS.%26aulast%3DRucker%26aufirst%3DP.%2BV.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DAlbaugh%26aufirst%3DP.%26aulast%3DChopiuk%26aufirst%3DG.%26aulast%3DGessier%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DAdrian%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DHood%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DChe%26aufirst%3DJ.%26aulast%3DMcCormack%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSteffy%26aufirst%3DA.%26aulast%3DCulazzo%26aufirst%3DA.%26aulast%3DTompkins%26aufirst%3DC.%26aulast%3DPhung%26aufirst%3DV.%26aulast%3DKreusch%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DChaudhary%26aufirst%3DA.%26aulast%3DPrashad%26aufirst%3DM.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DHarris%26aufirst%3DJ.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DLoren%26aufirst%3DJ.%26aulast%3DMolteni%26aufirst%3DV.%26atitle%3D%2528R%2529-2-Phenylpyrrolidine%2520substituted%2520imidazopyridazines%253A%2520A%2520new%2520class%2520of%2520potent%2520and%2520selective%2520pan-TRK%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D5%26spage%3D562%26epage%3D567%26doi%3D10.1021%2Facsmedchemlett.5b00050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyne, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaus, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thress, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span> </span><span class="NLM_article-title">Identification of 4-aminopyrazolylpyrimidines as potent inhibitors of Trk kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">4672</span><span class="NLM_x">–</span> <span class="NLM_lpage">4684</span><span class="refDoi"> DOI: 10.1021/jm800343j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800343j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4672-4684&issue=15&author=T.+Wangauthor=M.+L.+Lambauthor=D.+A.+Scottauthor=H.+Wangauthor=M.+H.+Blockauthor=P.+D.+Lyneauthor=J.+W.+Leeauthor=A.+M.+Daviesauthor=H.-J.+Zhangauthor=Y.+Zhuauthor=F.+Guauthor=Y.+Hanauthor=B.+Wangauthor=P.+J.+Mohrauthor=R.+J.+Kausauthor=J.+A.+Joseyauthor=E.+Hoffmannauthor=K.+Thressauthor=T.+MacIntyreauthor=H.+Wangauthor=C.+A.+Omerauthor=D.+Yu&title=Identification+of+4-aminopyrazolylpyrimidines+as+potent+inhibitors+of+Trk+kinases&doi=10.1021%2Fjm800343j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm800343j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800343j%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DScott%26aufirst%3DD.%2BA.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DBlock%26aufirst%3DM.%2BH.%26aulast%3DLyne%26aufirst%3DP.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BW.%26aulast%3DDavies%26aufirst%3DA.%2BM.%26aulast%3DZhang%26aufirst%3DH.-J.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DF.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%2BJ.%26aulast%3DKaus%26aufirst%3DR.%2BJ.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DHoffmann%26aufirst%3DE.%26aulast%3DThress%26aufirst%3DK.%26aulast%3DMacIntyre%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DOmer%26aufirst%3DC.%2BA.%26aulast%3DYu%26aufirst%3DD.%26atitle%3DIdentification%2520of%25204-aminopyrazolylpyrimidines%2520as%2520potent%2520inhibitors%2520of%2520Trk%2520kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D15%26spage%3D4672%26epage%3D4684%26doi%3D10.1021%2Fjm800343j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Thress, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macintyre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webster, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zage, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweidler-McKay, P. A.</span><span> </span><span class="NLM_article-title">Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1818</span><span class="NLM_x">–</span> <span class="NLM_lpage">1827</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-0036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1158%2F1535-7163.MCT-09-0036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=19509272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVymsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=1818-1827&issue=7&author=K.+Thressauthor=T.+Macintyreauthor=H.+Wangauthor=D.+Whitstonauthor=Z.+Y.+Liuauthor=E.+Hoffmannauthor=T.+Wangauthor=J.+L.+Brownauthor=K.+Websterauthor=C.+Omerauthor=P.+E.+Zageauthor=L.+Zengauthor=P.+A.+Zweidler-McKay&title=Identification+and+preclinical+characterization+of+AZ-23%2C+a+novel%2C+selective%2C+and+orally+bioavailable+inhibitor+of+the+Trk+kinase+pathway&doi=10.1158%2F1535-7163.MCT-09-0036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and preclinical characterization of AZ-23, a novel, selective, and orally bioavailable inhibitor of the Trk kinase pathway</span></div><div class="casAuthors">Thress, Kenneth; MacIntyre, Terry; Wang, Haiyun; Whitston, Dave; Liu, Zhong-Ying; Hoffmann, Ethan; Wang, Tao; Brown, Jeffrey L.; Webster, Kevin; Omer, Charles; Zage, Peter E.; Zeng, Lizhi; Zweidler-McKay, Patrick A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1818-1827</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Tropomyosin-related kinases (TrkA, TrkB, and TrkC) are receptor tyrosine kinases that, along with their ligands, the neurotrophins, are involved in neuronal cell growth, development, and survival.  The Trk-neurotrophin pathway may also play a role in tumorigenesis through oncogenic fusions, mutations, and autocrine signaling, prompting the development of novel Trk inhibitors as agents for cancer therapy.  This report describes the identification of AZ-23, a novel, potent, and selective Trk kinase inhibitor.  In vitro studies with AZ-23 showed improved selectivity over previous compds. and inhibition of Trk kinase activity in cells at low nanomolar concns.  AZ-23 showed in vivo TrkA kinase inhibition and efficacy in mice following oral administration in a TrkA-driven allograft model and significant tumor growth inhibition in a Trk-expressing xenograft model of neuroblastoma.  AZ-23 represents a potent and selective Trk kinase inhibitor from a novel series with the potential for use as a treatment for cancer. [Mol Cancer Ther 2009;8(7):1818-27].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG2uvCSID5vbVg90H21EOLACvtfcHk0lj1LcNqDxIOVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVymsro%253D&md5=8501f75147407ee64920fd4f5e733536</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0036%26sid%3Dliteratum%253Aachs%26aulast%3DThress%26aufirst%3DK.%26aulast%3DMacintyre%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWhitston%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DZ.%2BY.%26aulast%3DHoffmann%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DBrown%26aufirst%3DJ.%2BL.%26aulast%3DWebster%26aufirst%3DK.%26aulast%3DOmer%26aufirst%3DC.%26aulast%3DZage%26aufirst%3DP.%2BE.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DZweidler-McKay%26aufirst%3DP.%2BA.%26atitle%3DIdentification%2520and%2520preclinical%2520characterization%2520of%2520AZ-23%252C%2520a%2520novel%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520the%2520Trk%2520kinase%2520pathway%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26issue%3D7%26spage%3D1818%26epage%3D1827%26doi%3D10.1158%2F1535-7163.MCT-09-0036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Peer, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brassil, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeill, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreisl, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fine, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figg, W. D.</span><span> </span><span class="NLM_article-title">A novel uHPLC-MS/MS method for the quantitation of AZD7451 (AZ12607092) in human plasma</span> <span class="citation_source-journal">J. Chromatogr. B: Anal. Technol. Biomed. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">942–943</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span><span class="refDoi"> DOI: 10.1016/j.jchromb.2013.10.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.jchromb.2013.10.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=24239935" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFSjsr7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=942%E2%80%93943&publication_year=2013&pages=107-112&author=C.+J.+Peerauthor=J.+L.+Brownauthor=T.+J.+Martinauthor=J.+Rothauthor=S.+D.+Spencerauthor=P.+Brassilauthor=K.+A.+McNeillauthor=T.+N.+Kreislauthor=H.+A.+Fineauthor=W.+D.+Figg&title=A+novel+uHPLC-MS%2FMS+method+for+the+quantitation+of+AZD7451+%28AZ12607092%29+in+human+plasma&doi=10.1016%2Fj.jchromb.2013.10.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">A novel uHPLC-MS/MS method for the quantitation of AZD7451 (AZ12607092) in human plasma</span></div><div class="casAuthors">Peer, Cody J.; Brown, Jeffrey L.; Martin, Timothy J.; Roth, Jeffrey; Spencer, Shawn D.; Brassil, Patrick; McNeill, Katharine A.; Kreisl, Teri N.; Fine, Howard A.; Figg, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">942-943</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107-112</span>CODEN:
                <span class="NLM_cas:coden">JCBAAI</span>;
        ISSN:<span class="NLM_cas:issn">1570-0232</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tropomyosin-related kinases (Trk) are tyrosine kinase receptors implicated in tumor proliferation, invasion, and survival signaling across a no. of tumors, making them potentially attractive targets for the treatment of cancer.  AZD7451 is a potent and selective inhibitor of Trk kinases currently undergoing a Phase I dose escalation in glioblastoma multiforme at the National Cancer Institute.  A key part of early clin. testing for AZD7451 involves demonstrating that pharmacokinetic half-life and clin. exposures of AZD7451 are sufficient to inhibit Trk receptors in preclin. models.  To address this need, an ultra sensitive anal. method was developed to measure the AZD7451 profile in human plasma.  A liq.-liq. extn. recovered >80% of AZD7451 before quant. anal. by ultra HPLC-MS/MS.  A Varian Polaris C18-A column and a mass transition of m/z 383.5 → 340.5 (m/z 389.6 → 342.0 for the internal std. [2H6]-AZD7451) was used, and a dynamic calibration range of 0.5-1000 ng/mL was established, which provided a sensitive (<8.5% deviation), and precise (<6%) quant. assay for AZD7451.  AZD7451 demonstrated stability in human plasma at room temp. for 24 h (<7% change) and after extn. at 4 °C for 24 h (<8% change), and was stable through 4 freeze/thaw cycles (<8% change).  This method was used to measure AZD7451 plasma levels in clin. samples to confirm the sensitivity at several time points following AZD7451 treatment in subjects with glioblastoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2cHE9S8DbbbVg90H21EOLACvtfcHk0lgjpBygNR68tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFSjsr7J&md5=5581356ffce207f1bdd08dcf7857be8f</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.jchromb.2013.10.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jchromb.2013.10.023%26sid%3Dliteratum%253Aachs%26aulast%3DPeer%26aufirst%3DC.%2BJ.%26aulast%3DBrown%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DT.%2BJ.%26aulast%3DRoth%26aufirst%3DJ.%26aulast%3DSpencer%26aufirst%3DS.%2BD.%26aulast%3DBrassil%26aufirst%3DP.%26aulast%3DMcNeill%26aufirst%3DK.%2BA.%26aulast%3DKreisl%26aufirst%3DT.%2BN.%26aulast%3DFine%26aufirst%3DH.%2BA.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26atitle%3DA%2520novel%2520uHPLC-MS%252FMS%2520method%2520for%2520the%2520quantitation%2520of%2520AZD7451%2520%2528AZ12607092%2529%2520in%2520human%2520plasma%26jtitle%3DJ.%2520Chromatogr.%2520B%253A%2520Anal.%2520Technol.%2520Biomed.%2520Life%2520Sci.%26date%3D2013%26volume%3D942%25E2%2580%2593943%26spage%3D107%26epage%3D112%26doi%3D10.1016%2Fj.jchromb.2013.10.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Ängeby Möller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berge, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenfors, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, C. I.</span><span> </span><span class="NLM_article-title">Using gait analysis to assess weight bearing in rats with Freunds complete adjuvant-induced monoarthritis to improve predictivity: Interfering with the cyclooxygenase and nerve growth factor pathways</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">756</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2015.02.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.ejphar.2015.02.050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=25792342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADC%252BC2MnmtFyqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=756&publication_year=2015&pages=75-84&author=K.+%C3%84ngeby+M%C3%B6llerauthor=O.+G.+Bergeauthor=A.+Finnauthor=C.+Stenforsauthor=C.+I.+Svensson&title=Using+gait+analysis+to+assess+weight+bearing+in+rats+with+Freunds+complete+adjuvant-induced+monoarthritis+to+improve+predictivity%3A+Interfering+with+the+cyclooxygenase+and+nerve+growth+factor+pathways&doi=10.1016%2Fj.ejphar.2015.02.050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Using gait analysis to assess weight bearing in rats with Freund s complete adjuvant-induced monoarthritis to improve predictivity: Interfering with the cyclooxygenase and nerve growth factor pathways</span></div><div class="casAuthors">Angeby Moller Kristina; Berge Odd-Geir; Finn Anja; Svensson Camilla I; Stenfors Carina</div><div class="citationInfo"><span class="NLM_cas:title">European journal of pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">756</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lack of predictive power for drug effects has been a major criticism against animal pain models.  It is therefore important to define the utility and limitations of different models.  The aim of this study was to extend previous work on gait analysis as a tool to investigate pharmacological effects in monoarthritic rats, specifically to test the hypothesis that monoarthritis induced by Freund s complete adjuvant (FCA) provides a better estimate of overall analgesic efficacy of established, and novel, clinically effective and ineffective therapeutic approaches.  Male rats injected intra-articularly into one ankle joint with FCA (1.0mg/ml) were treated with the monoclonal antibody to nerve growth factor (NGF), MEDI-578, the inhibitors of tropomyosin receptor kinases A, B and C (pan-Trk) AZ6623 or AZ7092, the transient receptor potential vanilloid 1 (TRPV1) inhibitor AZD1386, or the cyclooxygenase (COX) inhibitors naproxen, ibuprofen, valdecoxib or rofecoxib.  Effects on weight bearing during locomotion were tested using video capture of print images.  The apparent efficacy in this model was Trk inhibitors≥anti-NGF antibody>COX inhibitors.  The TRPV1 inhibitor was ineffective.  Together with previous data, the results support using gait-related parameters in the monoarthritis model.  FCA as induction agent seems to provide a good overall prediction of analgesic efficacy in disorders with inflammatory joint pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTQ30J7GRfW7ftos8R3JUhXfW6udTcc2eZpMWcSM_XP5rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnmtFyqtQ%253D%253D&md5=ceed9ee163ac51450b928170822887b1</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.02.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.02.050%26sid%3Dliteratum%253Aachs%26aulast%3D%25C3%2584ngeby%2BM%25C3%25B6ller%26aufirst%3DK.%26aulast%3DBerge%26aufirst%3DO.%2BG.%26aulast%3DFinn%26aufirst%3DA.%26aulast%3DStenfors%26aufirst%3DC.%26aulast%3DSvensson%26aufirst%3DC.%2BI.%26atitle%3DUsing%2520gait%2520analysis%2520to%2520assess%2520weight%2520bearing%2520in%2520rats%2520with%2520Freunds%2520complete%2520adjuvant-induced%2520monoarthritis%2520to%2520improve%2520predictivity%253A%2520Interfering%2520with%2520the%2520cyclooxygenase%2520and%2520nerve%2520growth%2520factor%2520pathways%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D756%26spage%3D75%26epage%3D84%26doi%3D10.1016%2Fj.ejphar.2015.02.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Skerratt, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagal, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilsland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bungay, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morao, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nedderman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skinner, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stupple, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldrona, G.</span><span> </span><span class="NLM_article-title">he Discovery of a Potent, Selective and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of Pain</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span><span class="NLM_elocation-id"></span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00850</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00850" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+E.+Skerrattauthor=M.+Andrewsauthor=S.+K.+Bagalauthor=J.+Bilslandauthor=D.+Brownauthor=P.+J.+Bungayauthor=S.+Coleauthor=K.+R.+Gibsonauthor=R.+Jonesauthor=I.+Moraoauthor=A.+Neddermanauthor=K.+Omotoauthor=C.+Robinsonauthor=T.+Ryckmansauthor=K.+Skinnerauthor=P.+Stuppleauthor=G.+Waldrona&title=he+Discovery+of+a+Potent%2C+Selective+and+Peripherally+Restricted+Pan-Trk+Inhibitor+%28PF-06273340%29+for+the+Treatment+of+Pain&doi=10.1021%2Facs.jmedchem.6b00850"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00850%26sid%3Dliteratum%253Aachs%26aulast%3DSkerratt%26aufirst%3DS.%2BE.%26aulast%3DAndrews%26aufirst%3DM.%26aulast%3DBagal%26aufirst%3DS.%2BK.%26aulast%3DBilsland%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBungay%26aufirst%3DP.%2BJ.%26aulast%3DCole%26aufirst%3DS.%26aulast%3DGibson%26aufirst%3DK.%2BR.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DMorao%26aufirst%3DI.%26aulast%3DNedderman%26aufirst%3DA.%26aulast%3DOmoto%26aufirst%3DK.%26aulast%3DRobinson%26aufirst%3DC.%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DSkinner%26aufirst%3DK.%26aulast%3DStupple%26aufirst%3DP.%26aulast%3DWaldrona%26aufirst%3DG.%26atitle%3Dhe%2520Discovery%2520of%2520a%2520Potent%252C%2520Selective%2520and%2520Peripherally%2520Restricted%2520Pan-Trk%2520Inhibitor%2520%2528PF-06273340%2529%2520for%2520the%2520Treatment%2520of%2520Pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26doi%3D10.1021%2Facs.jmedchem.6b00850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Andrews, S. W.</span>Allosteric Small Molecule Inhibitors of the NGF/TrkA Pathway, A New Approach to Treating Inflammatory Pain; <span class="NLM_publisher-name">Array Biopharma Publications</span>: <span class="NLM_publisher-loc">Boulder, CO</span>; <a href="http://www.arraybiopharma.com/files/6313/9810/8021/PubAttachment587.pdf" class="extLink">http://www.arraybiopharma.com/files/6313/9810/8021/PubAttachment587.pdf</a> (accessed August 25,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+W.+Andrews&title=Allosteric+Small+Molecule+Inhibitors+of+the+NGF%2FTrkA+Pathway%2C+A+New+Approach+to+Treating+Inflammatory+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26jtitle%3DAllosteric%2520Small%2520Molecule%2520Inhibitors%2520of%2520the%2520NGF%252FTrkA%2520Pathway%252C%2520A%2520New%2520Approach%2520to%2520Treating%2520Inflammatory%2520Pain%26pub%3DArray%2520Biopharma%2520Publications%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Burris, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brose, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farago, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebele, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruickshank, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, J. A.</span><span> </span><span class="NLM_article-title">A first-in-human study of LOXO-101, a highly selective inhibitor of the tropomyosin receptor kinase (TRK) family</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">15 suppl</span><span class="NLM_x">) </span> <span class="NLM_fpage">TPS2624</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2015&pages=TPS2624&issue=15+suppl&author=H.+A.+Burrisauthor=M.+S.+Broseauthor=A.+T.+Shawauthor=T.+M.+Bauerauthor=A.+F.+Faragoauthor=R.+C.+Doebeleauthor=S.+Smithauthor=M.+Fernandesauthor=S.+Cruickshankauthor=J.+A.+Low&title=A+first-in-human+study+of+LOXO-101%2C+a+highly+selective+inhibitor+of+the+tropomyosin+receptor+kinase+%28TRK%29+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurris%26aufirst%3DH.%2BA.%26aulast%3DBrose%26aufirst%3DM.%2BS.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26aulast%3DBauer%26aufirst%3DT.%2BM.%26aulast%3DFarago%26aufirst%3DA.%2BF.%26aulast%3DDoebele%26aufirst%3DR.%2BC.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DFernandes%26aufirst%3DM.%26aulast%3DCruickshank%26aufirst%3DS.%26aulast%3DLow%26aufirst%3DJ.%2BA.%26atitle%3DA%2520first-in-human%2520study%2520of%2520LOXO-101%252C%2520a%2520highly%2520selective%2520inhibitor%2520of%2520the%2520tropomyosin%2520receptor%2520kinase%2520%2528TRK%2529%2520family%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2015%26volume%3D33%26issue%3D15%2520suppl%26spage%3DTPS2624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Gomez Tromp, A.; Bouhana, K. S.; Jiang, Y.; Seo, J.; Wallace, R. D.; Lee, P. A.; Andrews, S. W.</span>Potent and Selective, Oral Small Molecule Inhibitors of Tropomyosin-Related Receptor Kinase A (TrkA) for the Treatment of Pain; <span class="NLM_publisher-name">Array Biopharma Publications</span>: <span class="NLM_publisher-loc">Boulder, CO</span>; <a href="http://www.arraybiopharma.com/files/9413/9810/7989/PubAttachment533.pdf" class="extLink">http://www.arraybiopharma.com/files/9413/9810/7989/PubAttachment533.pdf</a> (accessed August 25,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Gomez+Tromp&author=K.+S.+Bouhana&author=Y.+Jiang&author=J.+Seo&author=R.+D.+Wallace&author=P.+A.+Lee&author=S.+W.+Andrews&title=Potent+and+Selective%2C+Oral+Small+Molecule+Inhibitors+of+Tropomyosin-Related+Receptor+Kinase+A+%28TrkA%29+for+the+Treatment+of+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DGomez%2BTromp%26aufirst%3DA.%26jtitle%3DPotent%2520and%2520Selective%252C%2520Oral%2520Small%2520Molecule%2520Inhibitors%2520of%2520Tropomyosin-Related%2520Receptor%2520Kinase%2520A%2520%2528TrkA%2529%2520for%2520the%2520Treatment%2520of%2520Pain%26pub%3DArray%2520Biopharma%2520Publications%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Bouhana, K. S.; Pheneger, J.; Gomez, A. M.; Wallace, R. D.; Jiang, Y.; Seo, J.; Lee, P. A.; Andrews, S. W.</span>Oral selective small molecule inhibitors of the TrkA receptor are disease modifying and provide pain relief in a rat rheumatoid arthritis model<span class="NLM_publisher-name">Array Biopharma Publications</span>: <span class="NLM_publisher-loc">Boulder, CO</span>; <a href="http://www.arraybiopharma.com/files/1113/9810/7998/PubAttachment532.pdf" class="extLink">http://www.arraybiopharma.com/files/1113/9810/7998/PubAttachment532.pdf</a> (accessed<span class="NLM_x"> </span><span class="NLM_year">August 25, 2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=August+25%2C+2016&author=K.+S.+Bouhana&author=J.+Pheneger&author=A.+M.+Gomez&author=R.+D.+Wallace&author=Y.+Jiang&author=J.+Seo&author=P.+A.+Lee&author=S.+W.+Andrews&title=Oral+selective+small+molecule+inhibitors+of+the+TrkA+receptor+are+disease+modifying+and+provide+pain+relief+in+a+rat+rheumatoid+arthritis+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DBouhana%26aufirst%3DK.%2BS.%26jtitle%3DOral%2520selective%2520small%2520molecule%2520inhibitors%2520of%2520the%2520TrkA%2520receptor%2520are%2520disease%2520modifying%2520and%2520provide%2520pain%2520relief%2520in%2520a%2520rat%2520rheumatoid%2520arthritis%2520model%26pub%3DArray%2520Biopharma%2520Publications%26date%3DAugust%252025%252C%25202016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Nwosu, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mapp, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, D. A.</span><span> </span><span class="NLM_article-title">Blocking the tropomyosin receptor kinase A (TrkA) receptor inhibits pain behaviour in two rat models of osteoarthritis</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1246</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span><span class="refDoi"> DOI: 10.1136/annrheumdis-2014-207203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1136%2Fannrheumdis-2014-207203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=26286016" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivV2qtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2016&pages=1246-1254&issue=6&author=L.+N.+Nwosuauthor=P.+I.+Mappauthor=V.+Chapmanauthor=D.+A.+Walsh&title=Blocking+the+tropomyosin+receptor+kinase+A+%28TrkA%29+receptor+inhibits+pain+behaviour+in+two+rat+models+of+osteoarthritis&doi=10.1136%2Fannrheumdis-2014-207203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Blocking the tropomyosin receptor kinase A (TrkA) receptor inhibits pain behaviour in two rat models of osteoarthritis</span></div><div class="casAuthors">Nwosu, Lilian N.; Mapp, Paul I.; Chapman, Victoria; Walsh, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1246-1254</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Objectives: Tropomyosin receptor kinase A (TrkA) mediates nociceptor sensitization by nerve growth factor (NGF), but it is unknown whether selective TrkA inhibition will be an effective strategy for treating osteoarthritis (OA) pain.  We detd. the effects of a TrkA inhibitor (AR786) on pain behavior, synovitis and joint pathol. in two rat OA models.  Methods: Knee OA was induced in rats by intraarticular monosodium-iodoacetate (MIA) injection or meniscal transection (MNX) and compared with saline injected or sham-operated controls.  Pain behavior was assessed as wt.-bearing asymmetry and paw withdrawal threshold to punctate stimulation.  Oral doses (30 mg/kg) of AR786 or vehicle were administered twice daily in either preventive (day -1 to -27) or treatment (day 14-28) protocols.  Effect maintenance was evaluated for 2 wk after treatment discontinuation.  Alterations in knee structure (cartilage, subchondral bone and synovium) were examd. by macroscopic visualization of articular surfaces and histopathol.  Results: Preventive AR786 treatment inhibited pain behavior development and therapeutic treatment attenuated established pain behavior.  Wt.-bearing asymmetry increased 1 wk after treatment discontinuation, but remained less than in vehicle-treated arthritic rats, whereas paw withdrawal thresholds returned to levels of untreated rats within 5 days of treatment discontinuation.  AR786 treatment reduced MIA-induced synovitis and did not significantly affect osteochondral pathol. in either model.  Conclusions: Blocking NGF activity by inhibiting TrkA reduced pain behavior in two rat models of OA.  Analgesia was obsd. both using preventive and treatment protocols, and was sustained after treatment discontinuation.  Selective inhibitors of TrkA therefore hold potential for OA pain relief.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWAm0vTz5k3rVg90H21EOLACvtfcHk0lhhgW_HBq74Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivV2qtrc%253D&md5=a0159f007c97c40704266844aad93ca1</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2014-207203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2014-207203%26sid%3Dliteratum%253Aachs%26aulast%3DNwosu%26aufirst%3DL.%2BN.%26aulast%3DMapp%26aufirst%3DP.%2BI.%26aulast%3DChapman%26aufirst%3DV.%26aulast%3DWalsh%26aufirst%3DD.%2BA.%26atitle%3DBlocking%2520the%2520tropomyosin%2520receptor%2520kinase%2520A%2520%2528TrkA%2529%2520receptor%2520inhibits%2520pain%2520behaviour%2520in%2520two%2520rat%2520models%2520of%2520osteoarthritis%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2016%26volume%3D75%26issue%3D6%26spage%3D1246%26epage%3D1254%26doi%3D10.1136%2Fannrheumdis-2014-207203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Ashraf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouhana, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pheneger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, D. A.</span><span> </span><span class="NLM_article-title">Selective inhibition of tropomyosin-receptor-kinase A (TrkA) reduces pain and joint damage in two rat models of inflammatory arthritis</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">97</span><span class="refDoi"> DOI: 10.1186/s13075-016-0996-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1186%2Fs13075-016-0996-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=27145816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADC%252BC28bmsFenuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=97&issue=1&author=S.+Ashrafauthor=K.+S.+Bouhanaauthor=J.+Phenegerauthor=S.+W.+Andrewsauthor=D.+A.+Walsh&title=Selective+inhibition+of+tropomyosin-receptor-kinase+A+%28TrkA%29+reduces+pain+and+joint+damage+in+two+rat+models+of+inflammatory+arthritis&doi=10.1186%2Fs13075-016-0996-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Selective inhibition of tropomyosin-receptor-kinase A (TrkA) reduces pain and joint damage in two rat models of inflammatory arthritis</span></div><div class="casAuthors">Ashraf Sadaf; Walsh David A; Bouhana Karyn S; Pheneger Jed; Andrews Steven W</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis research & therapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Inflammation is an essential component of arthritis pain.  Nerve growth factor (NGF) plays a key role in acute and chronic pain states especially those associated with inflammation.  NGF acts through tropomyosin-receptor-kinase A (TrkA).  NGF blockade has reduced arthritis pain in clinical trials.  We explored the mechanisms within the joint which may contribute to the analgesic effects of NGF by selectively inhibiting TrkA in carrageenan-induced or collagen-induced joint pain behaviour.  The goal of the current study was to elucidate whether inflammation is central to the efficacy for NGF blockade.  METHODS:  Rats were injected in their left knees with 2 % carrageenan or saline.  Collagen-induced arthritis (CIA) was induced by intradermal injections of a mixture of bovine type II collagen (0.2 mg) and incomplete Freund's adjuvant (0.2 mg).  Oral doses (30 mg/kg) of AR786 or vehicle control were given twice daily after arthritis induction.  Ibuprofen-treated (35 mg/kg, orally, once daily) rats with CIA were used as positive analgesic controls.  Pain behaviour was measured as hind-limb weight-bearing asymmetry and hind-paw withdrawal thresholds to von Frey hair stimulation (carrageenan synovitis), or withdrawal to joint compression using a Randall Selitto device (CIA).  Inflammation was measured as increased knee joint diameter and by histopathological analysis.  RESULTS:  Intra-articular injections of carrageenan or induction of CIA was each associated with pain behaviour and synovial inflammation.  Systemic administration of the TrkA inhibitor AR786 reduced carrageenan-induced or CIA-induced pain behaviour to control values, and inhibited joint swelling and histological evidence of synovial inflammation and joint damage.  CONCLUSIONS:  By using two models of varying inflammation we demonstrate for the first time that selective inhibition of TrkA may reduce carrageenan-induced or CIA-induced pain behaviour in rats, in part through potentially inhibiting synovial inflammation, although direct effects on sensory nerves are also likely.  Our observations suggest that inflammatory arthritis causes pain and the presence of inflammation is fundamental to the beneficial effects (reduction in pain and pathology) of NGF blockade.  Further research should determine whether TrkA inhibition may ameliorate human inflammatory arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfpZvkFFze1ohLSh9fo81bfW6udTcc2eaNrjX3v597Zbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28bmsFenuw%253D%253D&md5=c9802179f8aa6e07b4fe5ff3a4e92a0b</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1186%2Fs13075-016-0996-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13075-016-0996-z%26sid%3Dliteratum%253Aachs%26aulast%3DAshraf%26aufirst%3DS.%26aulast%3DBouhana%26aufirst%3DK.%2BS.%26aulast%3DPheneger%26aufirst%3DJ.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DWalsh%26aufirst%3DD.%2BA.%26atitle%3DSelective%2520inhibition%2520of%2520tropomyosin-receptor-kinase%2520A%2520%2528TrkA%2529%2520reduces%2520pain%2520and%2520joint%2520damage%2520in%2520two%2520rat%2520models%2520of%2520inflammatory%2520arthritis%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2016%26volume%3D18%26issue%3D1%26spage%3D97%26doi%3D10.1186%2Fs13075-016-0996-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Andrews, S. W.; Blake, J. F.; Brandhuber, B. J.; Kercher, T.; Winski, S. L.</span><span> </span><span class="NLM_article-title"><i>N</i>-(Monocyclic aryl), <i>N</i>′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors</span>. WO2014/078325A1, May 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+W.+Andrews&author=J.+F.+Blake&author=B.+J.+Brandhuber&author=T.+Kercher&author=S.+L.+Winski&title=N-%28Monocyclic+aryl%29%2C+N%E2%80%B2-pyrazolyl-urea%2C+thiourea%2C+guanidine+and+cyanoguanidine+compounds+as+TrkA+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26atitle%3DN-%2528Monocyclic%2520aryl%2529%252C%2520N%25E2%2580%25B2-pyrazolyl-urea%252C%2520thiourea%252C%2520guanidine%2520and%2520cyanoguanidine%2520compounds%2520as%2520TrkA%2520kinase%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Brandhuber, B. J.; Jiang, Y.; Kolakowski, G. R.; Winski, S. L.</span><span> </span><span class="NLM_article-title">Pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors</span>. WO2014/078417A1, May 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=B.+J.+Brandhuber&author=Y.+Jiang&author=G.+R.+Kolakowski&author=S.+L.+Winski&title=Pyrazolyl+urea%2C+thiourea%2C+guanidine+and+cyanoguanidine+compounds+as+TrkA+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrandhuber%26aufirst%3DB.%2BJ.%26atitle%3DPyrazolyl%2520urea%252C%2520thiourea%252C%2520guanidine%2520and%2520cyanoguanidine%2520compounds%2520as%2520TrkA%2520kinase%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Brandhuber, B. J.; Jiang, Y.; Kolakowski, G. R.; Winski, S. L.</span><span> </span><span class="NLM_article-title">Thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors</span>. WO2014/078322A1, May 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=B.+J.+Brandhuber&author=Y.+Jiang&author=G.+R.+Kolakowski&author=S.+L.+Winski&title=Thiazolyl+and+oxazolyl+urea%2C+thiourea%2C+guanidine+and+cyanoguanidine+compounds+as+TrkA+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrandhuber%26aufirst%3DB.%2BJ.%26atitle%3DThiazolyl%2520and%2520oxazolyl%2520urea%252C%2520thiourea%252C%2520guanidine%2520and%2520cyanoguanidine%2520compounds%2520as%2520TrkA%2520kinase%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Allen, S.; Brandhuber, B. J.; Kercher, T.; Kolakowski, G. R.; Winski, S. L.</span><span> </span><span class="NLM_article-title"><i>N</i>-Pyrrolidinyl, <i>N</i>′-pyrazolyl- urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors</span>. WO2014/078323A1, May 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Allen&author=B.+J.+Brandhuber&author=T.+Kercher&author=G.+R.+Kolakowski&author=S.+L.+Winski&title=N-Pyrrolidinyl%2C+N%E2%80%B2-pyrazolyl-+urea%2C+thiourea%2C+guanidine+and+cyanoguanidine+compounds+as+TrkA+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DS.%26atitle%3DN-Pyrrolidinyl%252C%2520N%25E2%2580%25B2-pyrazolyl-%2520urea%252C%2520thiourea%252C%2520guanidine%2520and%2520cyanoguanidine%2520compounds%2520as%2520TrkA%2520kinase%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Allen, S.; Blake, J. F.; Brandhuber, B. J.; Jiang, Y.; Kolakowski, G. R.; Xu, R.; Winski, S. L.</span><span> </span><span class="NLM_article-title"><i>N</i>-Bicyclic aryl,<i>N</i>′-pyrazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors</span>. WO2014/078328A1, May 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Allen&author=J.+F.+Blake&author=B.+J.+Brandhuber&author=Y.+Jiang&author=G.+R.+Kolakowski&author=R.+Xu&author=S.+L.+Winski&title=N-Bicyclic+aryl%2CN%E2%80%B2-pyrazolyl+urea%2C+thiourea%2C+guanidine+and+cyanoguanidine+compounds+as+TrkA+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DS.%26atitle%3DN-Bicyclic%2520aryl%252CN%25E2%2580%25B2-pyrazolyl%2520urea%252C%2520thiourea%252C%2520guanidine%2520and%2520cyanoguanidine%2520compounds%2520as%2520TrkA%2520kinase%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Blake, J. F.; Brandhuber, B. J.; Haas, J.; Newhouse, B.; Thomas, A. A.; Winski, S. L.</span><span> </span><span class="NLM_article-title"><i>N</i>-(Arylalkyl)-<i>N</i>′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors</span>. WO2014/078331A1, May 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=J.+F.+Blake&author=B.+J.+Brandhuber&author=J.+Haas&author=B.+Newhouse&author=A.+A.+Thomas&author=S.+L.+Winski&title=N-%28Arylalkyl%29-N%E2%80%B2-pyrazolyl-urea%2C+thiourea%2C+guanidine+and+cyanoguanidine+compounds+as+TrkA+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlake%26aufirst%3DJ.%2BF.%26atitle%3DN-%2528Arylalkyl%2529-N%25E2%2580%25B2-pyrazolyl-urea%252C%2520thiourea%252C%2520guanidine%2520and%2520cyanoguanidine%2520compounds%2520as%2520TrkA%2520kinase%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Allen, S.; Andrews, S. W.; Blake, J. F.; Brandhuber, B. J.; Jiang, Y.; Kercher, T.; Winski, S. L.</span><span> </span><span class="NLM_article-title">Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors</span>. WO2014/078372A1, May 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Allen&author=S.+W.+Andrews&author=J.+F.+Blake&author=B.+J.+Brandhuber&author=Y.+Jiang&author=T.+Kercher&author=S.+L.+Winski&title=Pyrrolidinyl+urea%2C+thiourea%2C+guanidine+and+cyanoguanidine+compounds+as+TrkA+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DS.%26atitle%3DPyrrolidinyl%2520urea%252C%2520thiourea%252C%2520guanidine%2520and%2520cyanoguanidine%2520compounds%2520as%2520TrkA%2520kinase%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Allen, S.; Andrews, S. W.; Blake, J. F.; Brandhuber, B. J.; Condroski, K. R.; Haas, J.; Jiang, Y.; Kercher, T.; Kolakowski, G. R.; Winski, S. L.</span><span> </span><span class="NLM_article-title">Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors</span>. WO2014/078378A1, May 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Allen&author=S.+W.+Andrews&author=J.+F.+Blake&author=B.+J.+Brandhuber&author=K.+R.+Condroski&author=J.+Haas&author=Y.+Jiang&author=T.+Kercher&author=G.+R.+Kolakowski&author=S.+L.+Winski&title=Pyrrolidinyl+urea%2C+thiourea%2C+guanidine+and+cyanoguanidine+compounds+as+TrkA+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DS.%26atitle%3DPyrrolidinyl%2520urea%252C%2520thiourea%252C%2520guanidine%2520and%2520cyanoguanidine%2520compounds%2520as%2520TrkA%2520kinase%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Allen, S.; Brandhuber, B. J.; Condroski, K. R.; Huang, L.; Kercher, T.; Winski, S. L.</span><span> </span><span class="NLM_article-title">Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors</span>. WO2014/078408A1, May 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Allen&author=B.+J.+Brandhuber&author=K.+R.+Condroski&author=L.+Huang&author=T.+Kercher&author=S.+L.+Winski&title=Bicyclic+heteroaryl+urea%2C+thiourea%2C+guanidine+and+cyanoguanidine+compounds+as+TrkA+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DS.%26atitle%3DBicyclic%2520heteroaryl%2520urea%252C%2520thiourea%252C%2520guanidine%2520and%2520cyanoguanidine%2520compounds%2520as%2520TrkA%2520kinase%2520inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Allen, S.; Andrews, S. W.; Blake, J. F.; Brandhuber, B. J.; Haas, J.; Jiang, Y.; Kercher, T.; Kolakowski, G. R.; Thomas, A. A.; Winski, S. L.</span><span> </span><span class="NLM_article-title">Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of pain</span>. WO2014/078454A1, May 22,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=S.+Allen&author=S.+W.+Andrews&author=J.+F.+Blake&author=B.+J.+Brandhuber&author=J.+Haas&author=Y.+Jiang&author=T.+Kercher&author=G.+R.+Kolakowski&author=A.+A.+Thomas&author=S.+L.+Winski&title=Bicyclic+urea%2C+thiourea%2C+guanidine+and+cyanoguanidine+compounds+useful+for+the+treatment+of+pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DS.%26atitle%3DBicyclic%2520urea%252C%2520thiourea%252C%2520guanidine%2520and%2520cyanoguanidine%2520compounds%2520useful%2520for%2520the%2520treatment%2520of%2520pain%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span> </span><span class="NLM_article-title">Array Biopharma and Asahi Kasei Pharma Corporation announce development and commercialization collaboration for novel pain and inflammation program</span>. Array Biopharma News; <span class="NLM_publisher-name">Array BioPharma</span>: <span class="NLM_publisher-loc">Boulder, CO</span>, March 31,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span><a href="http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&amp;p=irol-newsArticle&amp;ID=2152125" class="extLink">http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-newsArticle&ID=2152125</a> (accessed August 25,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Array+Biopharma+and+Asahi+Kasei+Pharma+Corporation+announce+development+and+commercialization+collaboration+for+novel+pain+and+inflammation+program.+Array+Biopharma+News%3B+Array+BioPharma%3A+Boulder%2C+CO%2C+March+31%2C+2016%3B+http%3A%2F%2Finvestor.arraybiopharma.com%2Fphoenix.zhtml%3Fc%3D123810%26p%3Dirol-newsArticle%26ID%3D2152125+%28accessed+August+25%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DArray%2520Biopharma%2520and%2520Asahi%2520Kasei%2520Pharma%2520Corporation%2520announce%2520development%2520and%2520commercialization%2520collaboration%2520for%2520novel%2520pain%2520and%2520inflammation%2520program%26jtitle%3DArray%2520Biopharma%2520News%26pub%3DArray%2520BioPharma%26date%3D2016%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Shipe, W.; Mercer, S.; Fraley, M.; Wood, B.; Babaoglu, K.; Bhandari, N.; Boyce, C.; Chen, Y.; Cooke, A.; Feng, K.; Henze, D.; Kim, A.; Kuo, Y.; Lee, J.; Liu, P.; Lu, X.; Ma, B.; Manley, P.; McCauley, J.; McWherter, M.; Meng, D.; Mitchell, H.; Morris, W.; Niu, X.; Parker, D.; Price, E.; Schirripa, K.; Struyk, A.; Stump, C.; Su, H.; Wu, J.</span><span> </span><span class="NLM_article-title">Lead optimization of a series of selective TrkA inhibitors for the treatment of pain</span>.  <span class="citation_source-book">251st National Meeting of the American Chemical Society, March 13–17, 2016, San Diego, CA</span>; <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span> <span class="NLM_fpage">MEDI-23</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=MEDI-23&author=W.+Shipe&author=S.+Mercer&author=M.+Fraley&author=B.+Wood&author=K.+Babaoglu&author=N.+Bhandari&author=C.+Boyce&author=Y.+Chen&author=A.+Cooke&author=K.+Feng&author=D.+Henze&author=A.+Kim&author=Y.+Kuo&author=J.+Lee&author=P.+Liu&author=X.+Lu&author=B.+Ma&author=P.+Manley&author=J.+McCauley&author=M.+McWherter&author=D.+Meng&author=H.+Mitchell&author=W.+Morris&author=X.+Niu&author=D.+Parker&author=E.+Price&author=K.+Schirripa&author=A.+Struyk&author=C.+Stump&author=H.+Su&author=J.+Wu&title=251st+National+Meeting+of+the+American+Chemical+Society%2C+March+13%E2%80%9317%2C+2016%2C+San+Diego%2C+CA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DShipe%26aufirst%3DW.%26atitle%3DLead%2520optimization%2520of%2520a%2520series%2520of%2520selective%2520TrkA%2520inhibitors%2520for%2520the%2520treatment%2520of%2520pain%26btitle%3D251st%2520National%2520Meeting%2520of%2520the%2520American%2520Chemical%2520Society%252C%2520March%252013%25E2%2580%259317%252C%25202016%252C%2520San%2520Diego%252C%2520CA%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2016%26spage%3DMEDI-23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Gingrich, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessner, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudkins, R. L.</span><span> </span><span class="NLM_article-title">Synthesis, Modeling, and In Vitro Activity of (3′S)-epi-K-252a Analogues. Elucidating the Stereochemical Requirements of the 3′-Sugar Alcohol on TrkA Tyrosine Kinase Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">3776</span><span class="NLM_x">–</span> <span class="NLM_lpage">3783</span><span class="refDoi"> DOI: 10.1021/jm040178m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040178m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3776-3783&issue=11&author=D.+E.+Gingrichauthor=S.+X.+Yangauthor=G.+W.+Gessnerauthor=T.+S.+Angelesauthor=R.+L.+Hudkins&title=Synthesis%2C+Modeling%2C+and+In+Vitro+Activity+of+%283%E2%80%B2S%29-epi-K-252a+Analogues.+Elucidating+the+Stereochemical+Requirements+of+the+3%E2%80%B2-Sugar+Alcohol+on+TrkA+Tyrosine+Kinase+Activity&doi=10.1021%2Fjm040178m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjm040178m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040178m%26sid%3Dliteratum%253Aachs%26aulast%3DGingrich%26aufirst%3DD.%2BE.%26aulast%3DYang%26aufirst%3DS.%2BX.%26aulast%3DGessner%26aufirst%3DG.%2BW.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26atitle%3DSynthesis%252C%2520Modeling%252C%2520and%2520In%2520Vitro%2520Activity%2520of%2520%25283%25E2%2580%25B2S%2529-epi-K-252a%2520Analogues.%2520Elucidating%2520the%2520Stereochemical%2520Requirements%2520of%2520the%25203%25E2%2580%25B2-Sugar%2520Alcohol%2520on%2520TrkA%2520Tyrosine%2520Kinase%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D11%26spage%3D3776%26epage%3D3783%26doi%3D10.1021%2Fjm040178m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Roblin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yosipovitch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainero, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickramasinghe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, P.</span><span> </span><span class="NLM_article-title">Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis</span> <span class="citation_source-journal">Acta Derm. Venereol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span><span class="refDoi"> DOI: 10.2340/00015555-2047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.2340%2F00015555-2047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=25594427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpvFKlsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2015&pages=542-548&issue=5&author=D.+Roblinauthor=G.+Yosipovitchauthor=B.+Boyceauthor=J.+Robinsonauthor=J.+Sandyauthor=V.+Maineroauthor=R.+Wickramasingheauthor=U.+Anandauthor=P.+Anand&title=Topical+TrkA+Kinase+Inhibitor+CT327+is+an+Effective%2C+Novel+Therapy+for+the+Treatment+of+Pruritus+due+to+Psoriasis%3A+Results+from+Experimental+Studies%2C+and+Efficacy+and+Safety+of+CT327+in+a+Phase+2b+Clinical+Trial+in+Patients+with+Psoriasis&doi=10.2340%2F00015555-2047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Topical TrkA kinase inhibitor CT327 is an effective, novel therapy for the treatment of pruritus due to psoriasis: results from experimental studies, and efficacy and safety of CT327 in a phase 2b clinical trial in patients with psoriasis</span></div><div class="casAuthors">Roblin, David; Yosipovitch, Gil; Boyce, Brent; Robinson, John; Sandy, James; Mainero, Valentina; Wickramasinghe, Ro; Anand, Uma; Anand, Praveen</div><div class="citationInfo"><span class="NLM_cas:title">Acta Dermato-Venereologica</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">542-548</span>CODEN:
                <span class="NLM_cas:coden">ADVEA4</span>;
        ISSN:<span class="NLM_cas:issn">1651-2057</span>.
    
            (<span class="NLM_cas:orgname">Acta Dermato-Venereologica</span>)
        </div><div class="casAbstract">Pruritus is an important symptom in psoriasis with no targeted treatment.  Tropomyosin-receptor kinase A (TrkA) is assocd. with pruritus and psoriatic plaque formation.  We report the efficacy of a TrkA inhibitor, CT327, on pruritus in psoriasis.  A randomized, double-blind, vehicle-controlled Phase 2b clin. trial was conducted in 160 subjects.  No effect was found on psoriasis severity using Investigator's Global Assessment (primary endpoint).  However, clin. and statistically significant redns. in pruritus were obsd. in the 108 patient subset reporting at least moderate pruritus at baseline (37.1 mm visual analog scale improvement (95% CI [-37.5, -6.2], p = 0.0067) for lowest dose; secondary endpoint).  Significant modified Psoriasis Area and Severity Index redns. were found in this subset (p < 0.05).  Expts. exploring capsaicin-mediated calcium influx, important in pruritus signalling, were performed in sensory neurons.  CT327 inhibited capsaicin responses, indicating action at the nerve growth factor-TrkA-TRPV1 pathway.  TrkA is a key target in pruritus, and CT327 has potential to become an effective and safe first-in-class treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8WBRUrNe3eLVg90H21EOLACvtfcHk0lidfk04dCVB5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpvFKlsrY%253D&md5=b4d26ea98f83154edab76a0a8546717e</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.2340%2F00015555-2047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2340%252F00015555-2047%26sid%3Dliteratum%253Aachs%26aulast%3DRoblin%26aufirst%3DD.%26aulast%3DYosipovitch%26aufirst%3DG.%26aulast%3DBoyce%26aufirst%3DB.%26aulast%3DRobinson%26aufirst%3DJ.%26aulast%3DSandy%26aufirst%3DJ.%26aulast%3DMainero%26aufirst%3DV.%26aulast%3DWickramasinghe%26aufirst%3DR.%26aulast%3DAnand%26aufirst%3DU.%26aulast%3DAnand%26aufirst%3DP.%26atitle%3DTopical%2520TrkA%2520Kinase%2520Inhibitor%2520CT327%2520is%2520an%2520Effective%252C%2520Novel%2520Therapy%2520for%2520the%2520Treatment%2520of%2520Pruritus%2520due%2520to%2520Psoriasis%253A%2520Results%2520from%2520Experimental%2520Studies%252C%2520and%2520Efficacy%2520and%2520Safety%2520of%2520CT327%2520in%2520a%2520Phase%25202b%2520Clinical%2520Trial%2520in%2520Patients%2520with%2520Psoriasis%26jtitle%3DActa%2520Derm.%2520Venereol.%26date%3D2015%26volume%3D95%26issue%3D5%26spage%3D542%26epage%3D548%26doi%3D10.2340%2F00015555-2047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Creabilis, S. A.</span><span> </span><span class="NLM_article-title">Creabilis Announces Headline Results of its Phase 2b Trial of Topical TrkA Kinase Inhibitor CT327</span>. PRNewswire, May 10,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span><a href="http://www.prnewswire.com/news-releases/creabilis-announces-headline-results-of-its-phase-2b-trial-of-topical-TrkA-kinase-inhibitor-ct327-206885021.html" class="extLink">http://www.prnewswire.com/news-releases/creabilis-announces-headline-results-of-its-phase-2b-trial-of-topical-TrkA-kinase-inhibitor-ct327-206885021.html</a> (accessed August 25,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+A.+Creabilis&title=Creabilis+Announces+Headline+Results+of+its+Phase+2b+Trial+of+Topical+TrkA+Kinase+Inhibitor+CT327"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DCreabilis%26aufirst%3DS.%2BA.%26atitle%3DCreabilis%2520Announces%2520Headline%2520Results%2520of%2520its%2520Phase%25202b%2520Trial%2520of%2520Topical%2520TrkA%2520Kinase%2520Inhibitor%2520CT327%26jtitle%3DPRNewswire%26date%3D2013%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Flannery, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blasioli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donahue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gladysheva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dagher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vardanyan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bangari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourque, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philbrook, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, G. L.</span><span> </span><span class="NLM_article-title">Efficacy of a novel, locally delivered TrkA inhibitor in preclinical models of OA and joint pain</span> <span class="citation_source-journal">Osteoarthritis Cartilage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">A45</span><span class="NLM_x">–</span> <span class="NLM_lpage">A46</span><span class="refDoi"> DOI: 10.1016/j.joca.2015.02.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.joca.2015.02.100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=A45-A46&author=C.+R.+Flanneryauthor=N.+Moranauthor=D.+Blasioliauthor=K.+Donahueauthor=J.+Kaneauthor=T.+Gladyshevaauthor=R.+Dagherauthor=R.+Fangauthor=A.+Vardanyanauthor=D.+Bangariauthor=C.+Hoauthor=A.+Bourqueauthor=M.+Santosauthor=M.+Philbrookauthor=G.+L.+Matthews&title=Efficacy+of+a+novel%2C+locally+delivered+TrkA+inhibitor+in+preclinical+models+of+OA+and+joint+pain&doi=10.1016%2Fj.joca.2015.02.100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.joca.2015.02.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.joca.2015.02.100%26sid%3Dliteratum%253Aachs%26aulast%3DFlannery%26aufirst%3DC.%2BR.%26aulast%3DMoran%26aufirst%3DN.%26aulast%3DBlasioli%26aufirst%3DD.%26aulast%3DDonahue%26aufirst%3DK.%26aulast%3DKane%26aufirst%3DJ.%26aulast%3DGladysheva%26aufirst%3DT.%26aulast%3DDagher%26aufirst%3DR.%26aulast%3DFang%26aufirst%3DR.%26aulast%3DVardanyan%26aufirst%3DA.%26aulast%3DBangari%26aufirst%3DD.%26aulast%3DHo%26aufirst%3DC.%26aulast%3DBourque%26aufirst%3DA.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DPhilbrook%26aufirst%3DM.%26aulast%3DMatthews%26aufirst%3DG.%2BL.%26atitle%3DEfficacy%2520of%2520a%2520novel%252C%2520locally%2520delivered%2520TrkA%2520inhibitor%2520in%2520preclinical%2520models%2520of%2520OA%2520and%2520joint%2520pain%26jtitle%3DOsteoarthritis%2520Cartilage%26date%3D2015%26volume%3D23%26spage%3DA45%26epage%3DA46%26doi%3D10.1016%2Fj.joca.2015.02.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><div class="note"><p class="first last">Sanofi</p></div>. <span> </span><span class="NLM_article-title">First-in-human study with ascending single intra-articular doses of GZ389988 in patients with painful osteoarthritis of the knee</span>.  <span class="citation_source-book">ClinicalTrials.gov</span>; <span class="NLM_publisher-name">National Library of Medicine (U.S.)</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="https://clinicaltrials.gov/ct2/show/NCT02424942" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02424942</a> (accessed August 25,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Sanofi.+First-in-human+study+with+ascending+single+intra-articular+doses+of+GZ389988+in+patients+with+painful+osteoarthritis+of+the+knee.+ClinicalTrials.gov%3B+National+Library+of+Medicine+%28U.S.%29%3A+Bethesda%2C+MD%2C+2015%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02424942+%28accessed+August+25%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DFirst-in-human%2520study%2520with%2520ascending%2520single%2520intra-articular%2520doses%2520of%2520GZ389988%2520in%2520patients%2520with%2520painful%2520osteoarthritis%2520of%2520the%2520knee%26btitle%3DClinicalTrials.gov%26pub%3DNational%2520Library%2520of%2520Medicine%2520%2528U.S.%2529%26date%3D2015%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Kane, J. L.,  Jr.; Matthews, G.; Metz, M.; Kothe, M.; Liu, J.; Scholte, A.</span><span> </span><span class="NLM_article-title">Tropomyosin-related kinase (TRK) inhibitors</span>. US 2015/0158847A1, June 11,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+L.+Kane&author=G.+Matthews&author=M.+Metz&author=M.+Kothe&author=J.+Liu&author=A.+Scholte&title=Tropomyosin-related+kinase+%28TRK%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKane%26aufirst%3DJ.%2BL.%26atitle%3DTropomyosin-related%2520kinase%2520%2528TRK%2529%2520inhibitors%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span> </span><span class="NLM_article-title">Purdue Pharma L.P. announces acquisition of TrkA program from VM Pharma LLC</span>. PRNewswire, September 8,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.prnewswire.com/news-releases/purdue-pharma-lp-announces-acquisition-of-TrkA-program-from-vm-pharma-llc-300138832.html" class="extLink">http://www.prnewswire.com/news-releases/purdue-pharma-lp-announces-acquisition-of-TrkA-program-from-vm-pharma-llc-300138832.html</a> (accessed August 25,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Purdue+Pharma+L.P.+announces+acquisition+of+TrkA+program+from+VM+Pharma+LLC.+PRNewswire%2C+September+8%2C+2015%3B+http%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fpurdue-pharma-lp-announces-acquisition-of-TrkA-program-from-vm-pharma-llc-300138832.html+%28accessed+August+25%2C+2015%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DPurdue%2520Pharma%2520L.P.%2520announces%2520acquisition%2520of%2520TrkA%2520program%2520from%2520VM%2520Pharma%2520LLC%26jtitle%3DPRNewswire%26date%3D2015%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Wu, J. J.; Wang, L.</span><span> </span><span class="NLM_article-title">Crystalline forms of tryosine kinase inhibitors and their salts</span>. US 2015/0174124A1, June 25,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+J.+Wu&author=L.+Wang&title=Crystalline+forms+of+tryosine+kinase+inhibitors+and+their+salts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%2BJ.%26atitle%3DCrystalline%2520forms%2520of%2520tryosine%2520kinase%2520inhibitors%2520and%2520their%2520salts%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Wu, J. J.</span><span> </span><span class="NLM_article-title">Compositions of compounds and uses thereof</span>. US 2015/0218132A1, August 6,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+J.+Wu&title=Compositions+of+compounds+and+uses+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%2BJ.%26atitle%3DCompositions%2520of%2520compounds%2520and%2520uses%2520thereof%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Nagaura, T.; Yasuhiro, T.; Oda, K.; Ezaki, Y.; Koyanagi, T.; Itadani, S.; Nitta, H.; Wakazono, H.; Katsumata, S.; Hirota, Y.</span><span> </span><span class="NLM_article-title">Selective and peripheral-specific TRK inhibitor shows potent analgesic effect comparable to morphine in rat osteoarthritis model without cns toxicity</span>.  <span class="citation_source-book">Abstracts of Papers, American College or Rheumatology Annual Meeting, Boston, MA November 14–19, 2014</span>; <span class="NLM_publisher-name">American College of Rheumatology</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span> <span class="NLM_fpage">Abstract 267</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=Abstract+267&author=T.+Nagaura&author=T.+Yasuhiro&author=K.+Oda&author=Y.+Ezaki&author=T.+Koyanagi&author=S.+Itadani&author=H.+Nitta&author=H.+Wakazono&author=S.+Katsumata&author=Y.+Hirota&title=Abstracts+of+Papers%2C+American+College+or+Rheumatology+Annual+Meeting%2C+Boston%2C+MA+November+14%E2%80%9319%2C+2014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNagaura%26aufirst%3DT.%26atitle%3DSelective%2520and%2520peripheral-specific%2520TRK%2520inhibitor%2520shows%2520potent%2520analgesic%2520effect%2520comparable%2520to%2520morphine%2520in%2520rat%2520osteoarthritis%2520model%2520without%2520cns%2520toxicity%26btitle%3DAbstracts%2520of%2520Papers%252C%2520American%2520College%2520or%2520Rheumatology%2520Annual%2520Meeting%252C%2520Boston%252C%2520MA%2520November%252014%25E2%2580%259319%252C%25202014%26pub%3DAmerican%2520College%2520of%2520Rheumatology%26date%3D2014%26spage%3DAbstract%2520267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><div class="note"><p class="first last">Ono Pharmaceutical Co. Ltd.</p></div><span> </span><span class="NLM_article-title">A study to evaluate safety, tolerability, pharmacokinetics and pharmacology of ONO-4474 in healthy volunteers</span>.  <span class="citation_source-book">ClinicalTrials.gov</span>; <span class="NLM_publisher-name">National Library of Medicine (U.S.)</span>: <span class="NLM_publisher-loc">Bethesda, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="https://clinicaltrials.gov/ct2/show/NCT02454387" class="extLink">https://clinicaltrials.gov/ct2/show/NCT02454387</a> (accessed August 25,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ono+Pharmaceutical+Co.+Ltd.+A+study+to+evaluate+safety%2C+tolerability%2C+pharmacokinetics+and+pharmacology+of+ONO-4474+in+healthy+volunteers.+ClinicalTrials.gov%3B+National+Library+of+Medicine+%28U.S.%29%3A+Bethesda%2C+MD%2C+2015%3B+https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02454387+%28accessed+August+25%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26atitle%3DA%2520study%2520to%2520evaluate%2520safety%252C%2520tolerability%252C%2520pharmacokinetics%2520and%2520pharmacology%2520of%2520ONO-4474%2520in%2520healthy%2520volunteers%26btitle%3DClinicalTrials.gov%26pub%3DNational%2520Library%2520of%2520Medicine%2520%2528U.S.%2529%26date%3D2015%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Passiglia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caparica, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovannetti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giallombardo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Listi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diana, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirrincione, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caglevic, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raez, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolfo, C.</span><span> </span><span class="NLM_article-title">The potential of neurotrophic tyrosine kinase (NTRK) inhibitors for treating lung cancer</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span><span class="refDoi"> DOI: 10.1517/13543784.2016.1152261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1517%2F13543784.2016.1152261" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=385-392&issue=4&author=F.+Passigliaauthor=R.+Caparicaauthor=E.+Giovannettiauthor=M.+Giallombardoauthor=A.+Listiauthor=P.+Dianaauthor=G.+Cirrincioneauthor=C.+Caglevicauthor=L.+E.+Raezauthor=A.+Russoauthor=C.+Rolfo&title=The+potential+of+neurotrophic+tyrosine+kinase+%28NTRK%29+inhibitors+for+treating+lung+cancer&doi=10.1517%2F13543784.2016.1152261"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112a&amp;dbid=16384&amp;doi=10.1517%2F13543784.2016.1152261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2016.1152261%26sid%3Dliteratum%253Aachs%26aulast%3DPassiglia%26aufirst%3DF.%26aulast%3DCaparica%26aufirst%3DR.%26aulast%3DGiovannetti%26aufirst%3DE.%26aulast%3DGiallombardo%26aufirst%3DM.%26aulast%3DListi%26aufirst%3DA.%26aulast%3DDiana%26aufirst%3DP.%26aulast%3DCirrincione%26aufirst%3DG.%26aulast%3DCaglevic%26aufirst%3DC.%26aulast%3DRaez%26aufirst%3DL.%2BE.%26aulast%3DRusso%26aufirst%3DA.%26aulast%3DRolfo%26aufirst%3DC.%26atitle%3DThe%2520potential%2520of%2520neurotrophic%2520tyrosine%2520kinase%2520%2528NTRK%2529%2520inhibitors%2520for%2520treating%2520lung%2520cancer%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2016%26volume%3D25%26issue%3D4%26spage%3D385%26epage%3D392%26doi%3D10.1517%2F13543784.2016.1152261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit112b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Patwardhan, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivy, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Stanchina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span> </span><span class="NLM_article-title">Significant blockade of multiple receptor tyrosine kinases by MGCD-516 (Sitravatinib), a novel small molecule inhibitor, shows potent anti-tumor activity in preclinical models of sarcoma</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">4093</span><span class="NLM_x">–</span> <span class="NLM_lpage">4109</span><span class="refDoi"> DOI: 10.18632/oncotarget.6547</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.18632%2Foncotarget.6547" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=4093-4109&issue=4&author=P.+P.+Patwardhanauthor=K.+S.+Ivyauthor=E.+Musiauthor=E.+de+Stanchinaauthor=G.+K.+Schwartz&title=Significant+blockade+of+multiple+receptor+tyrosine+kinases+by+MGCD-516+%28Sitravatinib%29%2C+a+novel+small+molecule+inhibitor%2C+shows+potent+anti-tumor+activity+in+preclinical+models+of+sarcoma&doi=10.18632%2Foncotarget.6547"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112b&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.6547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.6547%26sid%3Dliteratum%253Aachs%26aulast%3DPatwardhan%26aufirst%3DP.%2BP.%26aulast%3DIvy%26aufirst%3DK.%2BS.%26aulast%3DMusi%26aufirst%3DE.%26aulast%3Dde%2BStanchina%26aufirst%3DE.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26atitle%3DSignificant%2520blockade%2520of%2520multiple%2520receptor%2520tyrosine%2520kinases%2520by%2520MGCD-516%2520%2528Sitravatinib%2529%252C%2520a%2520novel%2520small%2520molecule%2520inhibitor%252C%2520shows%2520potent%2520anti-tumor%2520activity%2520in%2520preclinical%2520models%2520of%2520sarcoma%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26issue%3D4%26spage%3D4093%26epage%3D4109%26doi%3D10.18632%2Foncotarget.6547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit112c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Smith, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leary, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booth, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ensinger, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patt, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patt, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutkoski, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samarakoon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Telikepalli, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogeti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogeti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clare, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, D. L.</span><span> </span><span class="NLM_article-title">Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">2023</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-14-1105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1158%2F1535-7163.MCT-14-1105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=26285778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVegs7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=2023-34&issue=9&author=B.+D.+Smithauthor=M.+D.+Kaufmanauthor=C.+B.+Learyauthor=B.+A.+Turnerauthor=S.+C.+Wiseauthor=Y.+M.+Ahnauthor=R.+J.+Boothauthor=T.+M.+Caldwellauthor=C.+L.+Ensingerauthor=M.+M.+Hoodauthor=W.+P.+Luauthor=T.+W.+Pattauthor=W.+C.+Pattauthor=T.+J.+Rutkoskiauthor=T.+Samarakoonauthor=H.+Telikepalliauthor=L.+Vogetiauthor=S.+Vogetiauthor=K.+M.+Yatesauthor=L.+Chunauthor=L.+J.+Stewartauthor=M.+Clareauthor=D.+L.+Flynn&title=Altiratinib+Inhibits+Tumor+Growth%2C+Invasion%2C+Angiogenesis%2C+and+Microenvironment-Mediated+Drug+Resistance+via+Balanced+Inhibition+of+MET%2C+TIE2%2C+and+VEGFR2&doi=10.1158%2F1535-7163.MCT-14-1105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112cR"><div class="casContent"><span class="casTitleNuber">112c</span><div class="casTitle"><span class="NLM_cas:atitle">Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2</span></div><div class="casAuthors">Smith, Bryan D.; Kaufman, Michael D.; Leary, Cynthia B.; Turner, Benjamin A.; Wise, Scott C.; Ahn, Yu Mi; Booth, R. John; Caldwell, Timothy M.; Ensinger, Carol L.; Hood, Molly M.; Lu, Wei-Ping; Patt, Tristan W.; Patt, William C.; Rutkoski, Thomas J.; Samarakoon, Thiwanka; Telikepalli, Hanumaiah; Vogeti, Lakshminarayana; Vogeti, Subha; Yates, Karen M.; Chun, Lawrence; Stewart, Lance J.; Clare, Michael; Flynn, Daniel L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2023-2034</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Altiratinib (DCC-2701) was designed based on the rationale of engineering a single therapeutic agent able to address multiple hallmarks of cancer (1).  Specifically, altiratinib inhibits not only mechanisms of tumor initiation and progression, but also drug resistance mechanisms in the tumor and microenvironment through balanced inhibition of MET, TIE2 (TEK), and VEGFR2 (KDR) kinases.  This profile was achieved by optimizing binding into the switch control pocket of all three kinases, inducing type II inactive conformations.  Altiratinib durably inhibits MET, both wild-type and mutated forms, in vitro and in vivo.  Through its balanced inhibitory potency vs. MET, TIE2, and VEGFR2, altiratinib provides an agent that inhibits three major evasive (re)vascularization and resistance pathways (HGF, ANG, and VEGF) and blocks tumor invasion and metastasis.  Altiratinib exhibits properties amenable to oral administration and exhibits substantial blood-brain barrier penetration, an attribute of significance for eventual treatment of brain cancers and brain metastases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9E33eWjRqBrVg90H21EOLACvtfcHk0lh04B9IGEjI3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVegs7vE&md5=34170ba7d22a7fbcea68715fd6a2179b</span></div><a href="/servlet/linkout?suffix=cit112c&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-14-1105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-14-1105%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DB.%2BD.%26aulast%3DKaufman%26aufirst%3DM.%2BD.%26aulast%3DLeary%26aufirst%3DC.%2BB.%26aulast%3DTurner%26aufirst%3DB.%2BA.%26aulast%3DWise%26aufirst%3DS.%2BC.%26aulast%3DAhn%26aufirst%3DY.%2BM.%26aulast%3DBooth%26aufirst%3DR.%2BJ.%26aulast%3DCaldwell%26aufirst%3DT.%2BM.%26aulast%3DEnsinger%26aufirst%3DC.%2BL.%26aulast%3DHood%26aufirst%3DM.%2BM.%26aulast%3DLu%26aufirst%3DW.%2BP.%26aulast%3DPatt%26aufirst%3DT.%2BW.%26aulast%3DPatt%26aufirst%3DW.%2BC.%26aulast%3DRutkoski%26aufirst%3DT.%2BJ.%26aulast%3DSamarakoon%26aufirst%3DT.%26aulast%3DTelikepalli%26aufirst%3DH.%26aulast%3DVogeti%26aufirst%3DL.%26aulast%3DVogeti%26aufirst%3DS.%26aulast%3DYates%26aufirst%3DK.%2BM.%26aulast%3DChun%26aufirst%3DL.%26aulast%3DStewart%26aufirst%3DL.%2BJ.%26aulast%3DClare%26aufirst%3DM.%26aulast%3DFlynn%26aufirst%3DD.%2BL.%26atitle%3DAltiratinib%2520Inhibits%2520Tumor%2520Growth%252C%2520Invasion%252C%2520Angiogenesis%252C%2520and%2520Microenvironment-Mediated%2520Drug%2520Resistance%2520via%2520Balanced%2520Inhibition%2520of%2520MET%252C%2520TIE2%252C%2520and%2520VEGFR2%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2015%26volume%3D14%26issue%3D9%26spage%3D2023%26epage%3D34%26doi%3D10.1158%2F1535-7163.MCT-14-1105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Vaishnavi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelletti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kako, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butaney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahale, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisner, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilling, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berge, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kryukov, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garraway, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammerman, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varella-Garcia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janne, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebele, R. C.</span><span> </span><span class="NLM_article-title">Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1469</span><span class="NLM_x">–</span> <span class="NLM_lpage">1472</span><span class="refDoi"> DOI: 10.1038/nm.3352</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnm.3352" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=24162815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yiurrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1469-1472&issue=11&author=A.+Vaishnaviauthor=M.+Capellettiauthor=A.+T.+Leauthor=S.+Kakoauthor=M.+Butaneyauthor=D.+Ercanauthor=S.+Mahaleauthor=K.+D.+Daviesauthor=D.+L.+Aisnerauthor=A.+B.+Pillingauthor=E.+M.+Bergeauthor=J.+Kimauthor=H.+Sasakiauthor=S.+I.+Parkauthor=G.+Kryukovauthor=L.+A.+Garrawayauthor=P.+S.+Hammermanauthor=J.+Haasauthor=S.+W.+Andrewsauthor=D.+Lipsonauthor=P.+J.+Stephensauthor=V.+A.+Millerauthor=M.+Varella-Garciaauthor=P.+A.+Janneauthor=R.+C.+Doebele&title=Oncogenic+and+drug-sensitive+NTRK1+rearrangements+in+lung+cancer&doi=10.1038%2Fnm.3352"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer</span></div><div class="casAuthors">Vaishnavi, Aria; Capelletti, Marzia; Le, Anh T.; Kako, Severine; Butaney, Mohit; Ercan, Dalia; Mahale, Sakshi; Davies, Kurtis D.; Aisner, Dara L.; Pilling, Amanda B.; Berge, Eamon M.; Kim, Jhingook; Sasaki, Hidefumi; Park, Seung-il; Kryukov, Gregory; Garraway, Levi A.; Hammerman, Peter S.; Haas, Julia; Andrews, Steven W.; Lipson, Doron; Stephens, Philip J.; Miller, Vince A.; Varella-Garcia, Marileila; Jaenne, Pasi A.; Doebele, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1469-1472</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We identified new gene fusions in patients with lung cancer harboring the kinase domain of the NTRK1 gene that encodes the high-affinity nerve growth factor receptor (TRKA protein).  Both the MPRIP-NTRK1 and CD74-NTRK1 fusions lead to constitutive TRKA kinase activity and are oncogenic.  Treatment of cells expressing NTRK1 fusions with inhibitors of TRKA kinase activity inhibited autophosphorylation of TRKA and cell growth.  Tumor samples from 3 of 91 patients with lung cancer (3.3%) without known oncogenic alterations assayed by next-generation sequencing or fluorescence in situ hybridization demonstrated evidence of NTRK1 gene fusions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBHNoZGMQLMrVg90H21EOLACvtfcHk0lg-p0BChYGIGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yiurrI&md5=23b413826ea700bd831eadbfde270615</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1038%2Fnm.3352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3352%26sid%3Dliteratum%253Aachs%26aulast%3DVaishnavi%26aufirst%3DA.%26aulast%3DCapelletti%26aufirst%3DM.%26aulast%3DLe%26aufirst%3DA.%2BT.%26aulast%3DKako%26aufirst%3DS.%26aulast%3DButaney%26aufirst%3DM.%26aulast%3DErcan%26aufirst%3DD.%26aulast%3DMahale%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DK.%2BD.%26aulast%3DAisner%26aufirst%3DD.%2BL.%26aulast%3DPilling%26aufirst%3DA.%2BB.%26aulast%3DBerge%26aufirst%3DE.%2BM.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DS.%2BI.%26aulast%3DKryukov%26aufirst%3DG.%26aulast%3DGarraway%26aufirst%3DL.%2BA.%26aulast%3DHammerman%26aufirst%3DP.%2BS.%26aulast%3DHaas%26aufirst%3DJ.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DLipson%26aufirst%3DD.%26aulast%3DStephens%26aufirst%3DP.%2BJ.%26aulast%3DMiller%26aufirst%3DV.%2BA.%26aulast%3DVarella-Garcia%26aufirst%3DM.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26aulast%3DDoebele%26aufirst%3DR.%2BC.%26atitle%3DOncogenic%2520and%2520drug-sensitive%2520NTRK1%2520rearrangements%2520in%2520lung%2520cancer%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26issue%3D11%26spage%3D1469%26epage%3D1472%26doi%3D10.1038%2Fnm.3352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Farago, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzikansky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drilon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Multani, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornby, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow-Maneval, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iafrate, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. T.</span><span> </span><span class="NLM_article-title">Durable clinical response to entrectinib in NTRK1-rearranged non-small cell lung cancer</span> <span class="citation_source-journal">J. Thorac. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1670</span><span class="NLM_x">–</span> <span class="NLM_lpage">1674</span><span class="refDoi"> DOI: 10.1097/01.JTO.0000473485.38553.f0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1097%2F01.JTO.0000473485.38553.f0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=26565381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvF2it7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1670-1674&issue=12&author=A.+F.+Faragoauthor=L.+P.+Leauthor=Z.+Zhengauthor=A.+Muzikanskyauthor=A.+Drilonauthor=M.+Patelauthor=T.+M.+Bauerauthor=S.+V.+Liuauthor=S.+H.+Ouauthor=D.+Jackmanauthor=D.+B.+Costaauthor=P.+S.+Multaniauthor=G.+G.+Liauthor=Z.+Hornbyauthor=E.+Chow-Manevalauthor=D.+Luoauthor=J.+E.+Limauthor=A.+J.+Iafrateauthor=A.+T.+Shaw&title=Durable+clinical+response+to+entrectinib+in+NTRK1-rearranged+non-small+cell+lung+cancer&doi=10.1097%2F01.JTO.0000473485.38553.f0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer</span></div><div class="casAuthors">Farago, Anna F.; Le, Long P.; Zheng, Zongli; Muzikansky, Alona; Drilon, Alexander; Patel, Manish; Bauer, Todd M.; Liu, Stephen V.; Ou, Sai-Hong I.; Jackman, David; Costa, Daniel B.; Multani, Pratik S.; Li, Gary G.; Hornby, Zachary; Chow-Maneval, Edna; Luo, David; Lim, Jonathan E.; Iafrate, Anthony J.; Shaw, Alice T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thoracic Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1670-1674</span>CODEN:
                <span class="NLM_cas:coden">JTOOB7</span>;
        ISSN:<span class="NLM_cas:issn">1556-0864</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Introduction: Chromosomal rearrangements involving neurotrophic tyrosine kinase 1 (NTRK1) occur in a subset of non-small cell lung cancers (NSCLCs) and other solid tumor malignancies, leading to expression of an oncogenic TrkA fusion protein.  Entrectinib (RXDX-101) is an orally available tyrosine kinase inhibitor, including TrkA.  We sought to det. the frequency of NTRK1 rearrangements in NSCLC and to assess the clin. activity of entrectinib.  Methods: We screened 1378 cases of NSCLC using anchored multiplex polymerase chain reaction (AMP).  A patient with an NTRK1 gene rearrangement was enrolled onto a Phase 1 dose escalation study of entrectinib in adult patients with locally advanced or metastatic tumors (NCT02097810).  We assessed safety and response to treatment.  Results: We identified NTRK1 gene rearrangements at a frequency of 0.1% in this cohort.  A patient with stage IV lung adenocrcinoma with an SQSTM1-NTRK1 fusion transcript expression was treated with entrectinib.  Entrectinib was well tolerated, with no grade 3-4 adverse events.  Within three weeks of starting on treatment, the patient reported resoln. of prior dyspnea and pain.  Restaging CT scans demonstrated a RECIST partial response (PR) and complete resoln. of all brain metastases.  This patient has continued on treatment for over 6 mo with an ongoing PR.  Conclusions: Entrectinib demonstrated significant anti-tumor activity in a patient with NSCLC harboring an SQSTM1-NTRK1 gene rearrangement, indicating that entrectinib may be an effective therapy for tumors with NTRK gene rearrangements, including those with central nervous system metastases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9e_5UdIxTprVg90H21EOLACvtfcHk0lg-p0BChYGIGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvF2it7rN&md5=1d0160c35a3bdbdcb2ebd01313cc18ba</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1097%2F01.JTO.0000473485.38553.f0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.JTO.0000473485.38553.f0%26sid%3Dliteratum%253Aachs%26aulast%3DFarago%26aufirst%3DA.%2BF.%26aulast%3DLe%26aufirst%3DL.%2BP.%26aulast%3DZheng%26aufirst%3DZ.%26aulast%3DMuzikansky%26aufirst%3DA.%26aulast%3DDrilon%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DBauer%26aufirst%3DT.%2BM.%26aulast%3DLiu%26aufirst%3DS.%2BV.%26aulast%3DOu%26aufirst%3DS.%2BH.%26aulast%3DJackman%26aufirst%3DD.%26aulast%3DCosta%26aufirst%3DD.%2BB.%26aulast%3DMultani%26aufirst%3DP.%2BS.%26aulast%3DLi%26aufirst%3DG.%2BG.%26aulast%3DHornby%26aufirst%3DZ.%26aulast%3DChow-Maneval%26aufirst%3DE.%26aulast%3DLuo%26aufirst%3DD.%26aulast%3DLim%26aufirst%3DJ.%2BE.%26aulast%3DIafrate%26aufirst%3DA.%2BJ.%26aulast%3DShaw%26aufirst%3DA.%2BT.%26atitle%3DDurable%2520clinical%2520response%2520to%2520entrectinib%2520in%2520NTRK1-rearranged%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DJ.%2520Thorac.%2520Oncol.%26date%3D2015%26volume%3D10%26issue%3D12%26spage%3D1670%26epage%3D1674%26doi%3D10.1097%2F01.JTO.0000473485.38553.f0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Russo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misale, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siravegna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crisafulli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzari, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rospo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novara, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mussolin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartolini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cam, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wild, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Nicolantonio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siena, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span> </span><span class="NLM_article-title">Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-15-0940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1158%2F2159-8290.CD-15-0940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=26546295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC28XptlCrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=36-44&issue=1&author=M.+Russoauthor=S.+Misaleauthor=G.+Weiauthor=G.+Siravegnaauthor=G.+Crisafulliauthor=L.+Lazzariauthor=G.+Cortiauthor=G.+Rospoauthor=L.+Novaraauthor=B.+Mussolinauthor=A.+Bartoliniauthor=N.+Camauthor=R.+Patelauthor=S.+Yanauthor=R.+Shoemakerauthor=R.+Wildauthor=F.+Di+Nicolantonioauthor=A.+S.+Bianchiauthor=G.+Liauthor=S.+Sienaauthor=A.+Bardelli&title=Acquired+resistance+to+the+TRK+inhibitor+entrectinib+in+colorectal+cancer&doi=10.1158%2F2159-8290.CD-15-0940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer</span></div><div class="casAuthors">Russo, Mariangela; Misale, Sandra; Wei, Ge; Siravegna, Giulia; Crisafulli, Giovanni; Lazzari, Luca; Corti, Giorgio; Rospo, Giuseppe; Novara, Luca; Mussolin, Benedetta; Bartolini, Alice; Cam, Nicholas; Patel, Roopal; Yan, Shunqi; Shoemaker, Robert; Wild, Robert; Di Nicolantonio, Federica; Bianchi, Andrea Sartore; Li, Gang; Siena, Salvatore; Bardelli, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-44</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Entrectinib is a first-in-class pan-TRK kinase inhibitor currently undergoing clin. testing in colorectal cancer and other tumor types.  A patient with metastatic colorectal cancer harboring an LMNA-NTRK1 rearrangement displayed a remarkable response to treatment with entrectinib, which was followed by the emergence of resistance.  To characterize the mol. bases of the patient's relapse, circulating tumor DNA (ctDNA) was collected longitudinally during treatment, and a tissue biopsy, obtained before entrectinib treatment, was transplanted in mice (xenopatient), which then received the same entrectinib regimen until resistance developed.  Genetic profiling of ctDNA and xenopatient samples showed acquisition of two point mutations in the catalytic domain of NTRK1, p.G595R and p.G667C.  Biochem. and pharmacol. anal. in multiple preclin. models confirmed that either mutation renders the TRKA kinase insensitive to entrectinib.  These findings can be immediately exploited to design next-generation TRKA inhibitors.  Significance: We provide proof of principle that analyses of xenopatients (avatar) and liq. biopsies allow the identification of drug resistance mechanisms in parallel with clin. treatment of an individual patient.  We describe for the first time that p.G595R and p.G667C TRKA mutations drive acquired resistance to entrectinib in colorectal cancers carrying NTRK1 rearrangements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1Unyh1xjaoLVg90H21EOLACvtfcHk0lg-p0BChYGIGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptlCrsA%253D%253D&md5=5baa54a784e355b6afa50336b2708052</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-15-0940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-15-0940%26sid%3Dliteratum%253Aachs%26aulast%3DRusso%26aufirst%3DM.%26aulast%3DMisale%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DG.%26aulast%3DSiravegna%26aufirst%3DG.%26aulast%3DCrisafulli%26aufirst%3DG.%26aulast%3DLazzari%26aufirst%3DL.%26aulast%3DCorti%26aufirst%3DG.%26aulast%3DRospo%26aufirst%3DG.%26aulast%3DNovara%26aufirst%3DL.%26aulast%3DMussolin%26aufirst%3DB.%26aulast%3DBartolini%26aufirst%3DA.%26aulast%3DCam%26aufirst%3DN.%26aulast%3DPatel%26aufirst%3DR.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DShoemaker%26aufirst%3DR.%26aulast%3DWild%26aufirst%3DR.%26aulast%3DDi%2BNicolantonio%26aufirst%3DF.%26aulast%3DBianchi%26aufirst%3DA.%2BS.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DSiena%26aufirst%3DS.%26aulast%3DBardelli%26aufirst%3DA.%26atitle%3DAcquired%2520resistance%2520to%2520the%2520TRK%2520inhibitor%2520entrectinib%2520in%2520colorectal%2520cancer%26jtitle%3DCancer%2520Discovery%26date%3D2016%26volume%3D6%26issue%3D1%26spage%3D36%26epage%3D44%26doi%3D10.1158%2F2159-8290.CD-15-0940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Doebele, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaishnavi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada-Bernal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keysar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimeno, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varella-Garcia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisner, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morosini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuch, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, J. A.</span><span> </span><span class="NLM_article-title">An oncogenic NTRK fusion in a patient with soft-tissue sarcoma with response to the Tropomyosin-Related Kinase inhibitor LOXO-101</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1049</span><span class="NLM_x">–</span> <span class="NLM_lpage">1057</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-15-0443</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1158%2F2159-8290.CD-15-0443" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=1049-1057&issue=10&author=R.+C.+Doebeleauthor=L.+E.+Davisauthor=A.+Vaishnaviauthor=A.+T.+Leauthor=A.+Estrada-Bernalauthor=S.+Keysarauthor=A.+Jimenoauthor=M.+Varella-Garciaauthor=D.+L.+Aisnerauthor=Y.+Liauthor=P.+J.+Stephensauthor=D.+Morosiniauthor=B.+B.+Tuchauthor=M.+Fernandesauthor=N.+Nandaauthor=J.+A.+Low&title=An+oncogenic+NTRK+fusion+in+a+patient+with+soft-tissue+sarcoma+with+response+to+the+Tropomyosin-Related+Kinase+inhibitor+LOXO-101&doi=10.1158%2F2159-8290.CD-15-0443"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-15-0443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-15-0443%26sid%3Dliteratum%253Aachs%26aulast%3DDoebele%26aufirst%3DR.%2BC.%26aulast%3DDavis%26aufirst%3DL.%2BE.%26aulast%3DVaishnavi%26aufirst%3DA.%26aulast%3DLe%26aufirst%3DA.%2BT.%26aulast%3DEstrada-Bernal%26aufirst%3DA.%26aulast%3DKeysar%26aufirst%3DS.%26aulast%3DJimeno%26aufirst%3DA.%26aulast%3DVarella-Garcia%26aufirst%3DM.%26aulast%3DAisner%26aufirst%3DD.%2BL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DStephens%26aufirst%3DP.%2BJ.%26aulast%3DMorosini%26aufirst%3DD.%26aulast%3DTuch%26aufirst%3DB.%2BB.%26aulast%3DFernandes%26aufirst%3DM.%26aulast%3DNanda%26aufirst%3DN.%26aulast%3DLow%26aufirst%3DJ.%2BA.%26atitle%3DAn%2520oncogenic%2520NTRK%2520fusion%2520in%2520a%2520patient%2520with%2520soft-tissue%2520sarcoma%2520with%2520response%2520to%2520the%2520Tropomyosin-Related%2520Kinase%2520inhibitor%2520LOXO-101%26jtitle%3DCancer%2520Discovery%26date%3D2015%26volume%3D5%26issue%3D10%26spage%3D1049%26epage%3D1057%26doi%3D10.1158%2F2159-8290.CD-15-0443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Menichincheri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnaghi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avanzi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banfi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bossi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buffa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canevari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceriani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fasolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorelli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiorentini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgia, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchionni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orrenius, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panzeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesenti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusconi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saccardo, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanotti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrone, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsini, P.</span><span> </span><span class="NLM_article-title">Discovery of entrectinib: A new 3-aminoindazole as a potent anaplastic lymphoma dinase (ALK), c-ros oncogene 1 kinase (ROS1), and pan-tropomyosin receptor kinases (pan-TRKs) inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">3392</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00064</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00064" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3392-340&issue=7&author=M.+Menichincheriauthor=E.+Ardiniauthor=P.+Magnaghiauthor=N.+Avanziauthor=P.+Banfiauthor=R.+Bossiauthor=L.+Buffaauthor=G.+Canevariauthor=L.+Cerianiauthor=M.+Colomboauthor=L.+Cortiauthor=D.+Donatiauthor=M.+Fasoliniauthor=E.+Felderauthor=C.+Fiorelliauthor=F.+Fiorentiniauthor=A.+Galvaniauthor=A.+Isacchiauthor=A.+L.+Borgiaauthor=C.+Marchionniauthor=M.+Nesiauthor=C.+Orreniusauthor=A.+Panzeriauthor=E.+Pesentiauthor=L.+Rusconiauthor=M.+B.+Saccardoauthor=E.+Vanottiauthor=E.+Perroneauthor=P.+Orsini&title=Discovery+of+entrectinib%3A+A+new+3-aminoindazole+as+a+potent+anaplastic+lymphoma+dinase+%28ALK%29%2C+c-ros+oncogene+1+kinase+%28ROS1%29%2C+and+pan-tropomyosin+receptor+kinases+%28pan-TRKs%29+inhibitor&doi=10.1021%2Facs.jmedchem.6b00064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00064%26sid%3Dliteratum%253Aachs%26aulast%3DMenichincheri%26aufirst%3DM.%26aulast%3DArdini%26aufirst%3DE.%26aulast%3DMagnaghi%26aufirst%3DP.%26aulast%3DAvanzi%26aufirst%3DN.%26aulast%3DBanfi%26aufirst%3DP.%26aulast%3DBossi%26aufirst%3DR.%26aulast%3DBuffa%26aufirst%3DL.%26aulast%3DCanevari%26aufirst%3DG.%26aulast%3DCeriani%26aufirst%3DL.%26aulast%3DColombo%26aufirst%3DM.%26aulast%3DCorti%26aufirst%3DL.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DFasolini%26aufirst%3DM.%26aulast%3DFelder%26aufirst%3DE.%26aulast%3DFiorelli%26aufirst%3DC.%26aulast%3DFiorentini%26aufirst%3DF.%26aulast%3DGalvani%26aufirst%3DA.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DBorgia%26aufirst%3DA.%2BL.%26aulast%3DMarchionni%26aufirst%3DC.%26aulast%3DNesi%26aufirst%3DM.%26aulast%3DOrrenius%26aufirst%3DC.%26aulast%3DPanzeri%26aufirst%3DA.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DRusconi%26aufirst%3DL.%26aulast%3DSaccardo%26aufirst%3DM.%2BB.%26aulast%3DVanotti%26aufirst%3DE.%26aulast%3DPerrone%26aufirst%3DE.%26aulast%3DOrsini%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520entrectinib%253A%2520A%2520new%25203-aminoindazole%2520as%2520a%2520potent%2520anaplastic%2520lymphoma%2520dinase%2520%2528ALK%2529%252C%2520c-ros%2520oncogene%25201%2520kinase%2520%2528ROS1%2529%252C%2520and%2520pan-tropomyosin%2520receptor%2520kinases%2520%2528pan-TRKs%2529%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D7%26spage%3D3392%26epage%3D340%26doi%3D10.1021%2Facs.jmedchem.6b00064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Smith, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elfiky, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logothetis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corn, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelzang, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harzstark, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaishampayan, U. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spira, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lara, P. N.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoffski, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheffold, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weitzman, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, M.</span><span> </span><span class="NLM_article-title">Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span><span class="refDoi"> DOI: 10.1200/JCO.2012.45.0494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1200%2FJCO.2012.45.0494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23169517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1SktLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=412-419&issue=4&author=D.+C.+Smithauthor=M.+R.+Smithauthor=C.+Sweeneyauthor=A.+A.+Elfikyauthor=C.+Logothetisauthor=P.+G.+Cornauthor=N.+J.+Vogelzangauthor=E.+J.+Smallauthor=A.+L.+Harzstarkauthor=M.+S.+Gordonauthor=U.+N.+Vaishampayanauthor=N.+B.+Haasauthor=A.+I.+Spiraauthor=P.+N.+Laraauthor=C.+C.+Linauthor=S.+Srinivasauthor=A.+Sellaauthor=P.+Schoffskiauthor=C.+Scheffoldauthor=A.+L.+Weitzmanauthor=M.+Hussain&title=Cabozantinib+in+patients+with+advanced+prostate+cancer%3A+results+of+a+phase+II+randomized+discontinuation+trial&doi=10.1200%2FJCO.2012.45.0494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial</span></div><div class="casAuthors">Smith, David C.; Smith, Matthew R.; Sweeney, Christopher; Elfiky, Aymen A.; Logothetis, Christopher; Corn, Paul G.; Vogelzang, Nicholas J.; Small, Eric J.; Harzstark, Andrea L.; Gordon, Michael S.; Vaishampayan, Ulka N.; Haas, Naomi B.; Spira, Alexander I.; Lara, Primo N., Jr.; Lin, Chia-Chi; Srinivas, Sandy; Sella, Avishay; Schoffski, Patrick; Scheffold, Christian; Weitzman, Aaron L.; Hussain, Maha</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">412-419</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose: Cabozantinib (XL 184) is an orally bioavailable tyrosine kinase inhibitor with activity against MET and vascular endothelial growth factor receptor 2.  We evaluated the activity of cabozantinib in patients with castration-resistant prostate cancer (CRPC) in a phase II randomized discontinuation trial with an expansion cohort.  Patients and Methods: Patients received 100 mg of cabozantinib daily.  Those with stable disease per RECIST at 12 wk were randomly assigned to cabozantinib or placebo.  Primary end points were objective response rate at 12 wk and progression-free survival (PFS) after random assignment.  Results: One hundred seventy-one men with CRPC were enrolled.  Random assignment was halted early based on the obsd. activity of cabozantinib.  Seventy-two percent of patients had regression in soft tissue lesions, whereas 68% of evaluable patients had improvement on bone scan, including complete resoln. in 12%.  The objective response rate at 12 wk was 5%, with stable disease in 75% of patients.  Thirty-one patients with stable disease at week 12 were randomly assigned.  Median PFS was 23.9 wk (95% CI, 10.7 to 62.4 wk) with cabozantinib and 5.9 wk (95% CI, 5.4 to 6.6 wk) with placebo (hazard ratio, 0.12; P < .001).  Serum total alk. phosphatase and plasma cross-linked C-terminal telopeptide of type I collagen were reduced by ≥ 50% in 57% of evaluable patients.  On retrospective review, bone pain improved in 67% of evaluable patients, with a decrease in narcotic use in 56%.  The most common grade 3 adverse events were fatigue (16%), hypertension (12%), and hand-foot syndrome (8%).  Conclusion: Cabozantinib has clin. activity in men with CRPC, including redn. of soft tissue lesions, improvement in PFS, resoln. of bone scans, and redns. in bone turnover markers, pain, and narcotic use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp67noyYrKzMbVg90H21EOLACvtfcHk0lgvFfjYPdC_HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1SktLc%253D&md5=4c627f002eb30bc9583a3203e01daf23</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1200%2FJCO.2012.45.0494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2012.45.0494%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DD.%2BC.%26aulast%3DSmith%26aufirst%3DM.%2BR.%26aulast%3DSweeney%26aufirst%3DC.%26aulast%3DElfiky%26aufirst%3DA.%2BA.%26aulast%3DLogothetis%26aufirst%3DC.%26aulast%3DCorn%26aufirst%3DP.%2BG.%26aulast%3DVogelzang%26aufirst%3DN.%2BJ.%26aulast%3DSmall%26aufirst%3DE.%2BJ.%26aulast%3DHarzstark%26aufirst%3DA.%2BL.%26aulast%3DGordon%26aufirst%3DM.%2BS.%26aulast%3DVaishampayan%26aufirst%3DU.%2BN.%26aulast%3DHaas%26aufirst%3DN.%2BB.%26aulast%3DSpira%26aufirst%3DA.%2BI.%26aulast%3DLara%26aufirst%3DP.%2BN.%26aulast%3DLin%26aufirst%3DC.%2BC.%26aulast%3DSrinivas%26aufirst%3DS.%26aulast%3DSella%26aufirst%3DA.%26aulast%3DSchoffski%26aufirst%3DP.%26aulast%3DScheffold%26aufirst%3DC.%26aulast%3DWeitzman%26aufirst%3DA.%2BL.%26aulast%3DHussain%26aufirst%3DM.%26atitle%3DCabozantinib%2520in%2520patients%2520with%2520advanced%2520prostate%2520cancer%253A%2520results%2520of%2520a%2520phase%2520II%2520randomized%2520discontinuation%2520trial%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2013%26volume%3D31%26issue%3D4%26spage%3D412%26epage%3D419%26doi%3D10.1200%2FJCO.2012.45.0494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Basch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Autio, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weitzman, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheffold, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathkopf, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higano, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harzstark, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartor, A. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelzang, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Bono, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corn, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schimmoller, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scher, H. I.</span><span> </span><span class="NLM_article-title">Effects of cabozantinib on pain and narcotic use in patients with castration-resistant prostate cancer: results from a phase 2 nonrandomized expansion cohort</span> <span class="citation_source-journal">Eur. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">310</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span><span class="refDoi"> DOI: 10.1016/j.eururo.2014.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.eururo.2014.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=24631409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlWlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=310-318&issue=2&author=E.+Baschauthor=K.+A.+Autioauthor=M.+R.+Smithauthor=A.+V.+Bennettauthor=A.+L.+Weitzmanauthor=C.+Scheffoldauthor=C.+Sweeneyauthor=D.+E.+Rathkopfauthor=D.+C.+Smithauthor=D.+J.+Georgeauthor=C.+S.+Higanoauthor=A.+L.+Harzstarkauthor=A.+O.+Sartorauthor=M.+S.+Gordonauthor=N.+J.+Vogelzangauthor=J.+S.+de+Bonoauthor=N.+B.+Haasauthor=P.+G.+Cornauthor=F.+Schimmollerauthor=H.+I.+Scher&title=Effects+of+cabozantinib+on+pain+and+narcotic+use+in+patients+with+castration-resistant+prostate+cancer%3A+results+from+a+phase+2+nonrandomized+expansion+cohort&doi=10.1016%2Fj.eururo.2014.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Cabozantinib on Pain and Narcotic Use in Patients with Castration-resistant Prostate Cancer: Results from a Phase 2 Nonrandomized Expansion Cohort</span></div><div class="casAuthors">Basch, Ethan; Autio, Karen A.; Smith, Matthew R.; Bennett, Antonia V.; Weitzman, Aaron L.; Scheffold, Christian; Sweeney, Christopher; Rathkopf, Dana E.; Smith, David C.; George, Daniel J.; Higano, Celestia S.; Harzstark, Andrea L.; Sartor, A. Oliver; Gordon, Michael S.; Vogelzang, Nicholas J.; de Bono, Johann S.; Haas, Naomi B.; Corn, Paul G.; Schimmoller, Frauke; Scher, Howard I.</div><div class="citationInfo"><span class="NLM_cas:title">European Urology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">310-318</span>CODEN:
                <span class="NLM_cas:coden">EUURAV</span>;
        ISSN:<span class="NLM_cas:issn">0302-2838</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pain neg. affects quality of life for cancer patients.  Preliminary data in metastatic castration-resistant prostate cancer (mCRPC) suggested a benefit of the oral tyrosine kinase inhibitor cabozantinib to pain palliation.  Prospective evaluation of cabozantinib's benefits on pain and narcotic use in mCRPC.This was a nonrandomized expansion (NRE) cohort (n = 144) of a phase 2 randomized discontinuation trial in docetaxel-refractory mCRPC patients.  Pain and interference of symptoms with sleep and general activity were electronically self-reported daily for 7-d intervals at baseline and regularly scheduled throughout the study.  Mean per-patient scores were calcd. for each interval.  Narcotic use was recorded daily during the same intervals.Open-label cabozantinib (100 mg or 40 mg).  The following stringent response definition was used: clin. meaningful pain redn. (≥30% improvement in mean scores from baseline) confirmed at a later interval without concomitant increases in narcotics.  Only patients with moderate or severe baseline pain were analyzed.Sixty-five patients with moderate or severe baseline pain were evaluable.  Of these, 27 (42%) experienced pain palliation according to the stringent response definition.  Thirty-seven patients (57%) had clin. meaningful pain relief at two consecutive intervals, reported ≥6 wk apart in the majority.  Forty-four patients (68%) had palliation at one or more intervals; 36 (55%) decreased narcotics use during one or more intervals.  Clin. meaningful pain redn. was assocd. with significant (p ≤ 0.001) improvements in sleep quality and general activity.  A limitation of this study was its open-label design.  Cabozantinib demonstrated clin. meaningful pain palliation, reduced or eliminated patients' narcotic use, and improved patient functioning, thus meriting prospective validation in phase 3 studies.We evaluated the potential of cabozantinib to improve symptoms in patients with metastatic prostate cancer that no longer responds to std. therapies.  We saw a promising redn. in pain and reduced need for narcotic painkillers.  Larger, well-controlled trials are necessary to confirm these findings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeS-LVjhcfabVg90H21EOLACvtfcHk0ljS9Q9FpN6BCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlWlsbg%253D&md5=b26c80832e6294bf8d63112eed0dc187</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2Fj.eururo.2014.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.eururo.2014.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DBasch%26aufirst%3DE.%26aulast%3DAutio%26aufirst%3DK.%2BA.%26aulast%3DSmith%26aufirst%3DM.%2BR.%26aulast%3DBennett%26aufirst%3DA.%2BV.%26aulast%3DWeitzman%26aufirst%3DA.%2BL.%26aulast%3DScheffold%26aufirst%3DC.%26aulast%3DSweeney%26aufirst%3DC.%26aulast%3DRathkopf%26aufirst%3DD.%2BE.%26aulast%3DSmith%26aufirst%3DD.%2BC.%26aulast%3DGeorge%26aufirst%3DD.%2BJ.%26aulast%3DHigano%26aufirst%3DC.%2BS.%26aulast%3DHarzstark%26aufirst%3DA.%2BL.%26aulast%3DSartor%26aufirst%3DA.%2BO.%26aulast%3DGordon%26aufirst%3DM.%2BS.%26aulast%3DVogelzang%26aufirst%3DN.%2BJ.%26aulast%3Dde%2BBono%26aufirst%3DJ.%2BS.%26aulast%3DHaas%26aufirst%3DN.%2BB.%26aulast%3DCorn%26aufirst%3DP.%2BG.%26aulast%3DSchimmoller%26aufirst%3DF.%26aulast%3DScher%26aufirst%3DH.%2BI.%26atitle%3DEffects%2520of%2520cabozantinib%2520on%2520pain%2520and%2520narcotic%2520use%2520in%2520patients%2520with%2520castration-resistant%2520prostate%2520cancer%253A%2520results%2520from%2520a%2520phase%25202%2520nonrandomized%2520expansion%2520cohort%26jtitle%3DEur.%2520Urol.%26date%3D2015%26volume%3D67%26issue%3D2%26spage%3D310%26epage%3D318%26doi%3D10.1016%2Fj.eururo.2014.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Mantyh, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koltzenburg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendell, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tive, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, D. L.</span><span> </span><span class="NLM_article-title">Antagonism of nerve growth factor-TrkA signaling and the relief of pain</span> <span class="citation_source-journal">Anesthesiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span><span class="refDoi"> DOI: 10.1097/ALN.0b013e31821b1ac5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1097%2FALN.0b013e31821b1ac5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2011&pages=189-204&issue=1&author=P.+W.+Mantyhauthor=M.+Koltzenburgauthor=L.+M.+Mendellauthor=L.+Tiveauthor=D.+L.+Shelton&title=Antagonism+of+nerve+growth+factor-TrkA+signaling+and+the+relief+of+pain&doi=10.1097%2FALN.0b013e31821b1ac5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1097%2FALN.0b013e31821b1ac5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FALN.0b013e31821b1ac5%26sid%3Dliteratum%253Aachs%26aulast%3DMantyh%26aufirst%3DP.%2BW.%26aulast%3DKoltzenburg%26aufirst%3DM.%26aulast%3DMendell%26aufirst%3DL.%2BM.%26aulast%3DTive%26aufirst%3DL.%26aulast%3DShelton%26aufirst%3DD.%2BL.%26atitle%3DAntagonism%2520of%2520nerve%2520growth%2520factor-TrkA%2520signaling%2520and%2520the%2520relief%2520of%2520pain%26jtitle%3DAnesthesiology%26date%3D2011%26volume%3D115%26issue%3D1%26spage%3D189%26epage%3D204%26doi%3D10.1097%2FALN.0b013e31821b1ac5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Eskander, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruparel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Por, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeske, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, K. M.</span><span> </span><span class="NLM_article-title">Persistent nociception triggered by nerve growth factor (NGF) is mediated by TRPV1 and oxidative mechanisms</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">8593</span><span class="NLM_x">–</span> <span class="NLM_lpage">8603</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3993-14.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1523%2FJNEUROSCI.3993-14.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=26041925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVGhtLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=8593-8603&issue=22&author=M.+A.+Eskanderauthor=S.+Ruparelauthor=D.+P.+Greenauthor=P.+B.+Chenauthor=E.+D.+Porauthor=N.+A.+Jeskeauthor=X.+Gaoauthor=E.+R.+Floresauthor=K.+M.+Hargreaves&title=Persistent+nociception+triggered+by+nerve+growth+factor+%28NGF%29+is+mediated+by+TRPV1+and+oxidative+mechanisms&doi=10.1523%2FJNEUROSCI.3993-14.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Persistent nociception triggered by nerve growth factor (NGF) is mediated by TRPV1 and oxidative mechanisms</span></div><div class="casAuthors">Eskander, Michael A.; Ruparel, Shivani; Green, Dustin P.; Chen, Paul B.; Por, Elaine D.; Jeske, Nathaniel A.; Gao, Xiaoli; Flores, Eric R.; Hargreaves, Kenneth M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8593-8603</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Nerve growth factor (NGF) is elevated in certain chronic pain conditions and is a sufficient stimulus to cause lasting pain in humans, but the actual mechanisms underlying the persistent effects of NGF remain incompletely understood.  We developed a rat model of NGF-induced persistent thermal hyperalgesia and mech. allodynia to det. the role of transient receptor potential vanilloid 1 (TRPV1) and oxidative mechanisms in the persistent effects of NGF.  Persistent thermal hypersensitivity and mech. allodynia require de novo protein translation and are mediated by TRPV1 and oxidative mechanisms.  By comparing effects after systemic (s.c.), spinal (intrathecal) or hindpaw (intraplantar) injections of test compds., we detd. that TRPV1 and oxidn. mediate persistent thermal hypersensitivity via peripheral and spinal sites of action and mech. allodynia via only a spinal site of action.  Therefore, NGF-evoked thermal and mech. allodynia are mediated by spatially distinct mechanisms.  NGF treatment evoked sustained increases in peripheral and central TRPV1 activity, as demonstrated by increased capsaicin-evoked nocifensive responses, increased calcitonin gene-related peptide release from hindpaw skin biopsies, and increased capsaicin-evoked inward current and membrane expression of TRPV1 protein in dorsal root ganglia neurons.  Finally, we showed that NGF treatment increased concns. of linoleic and arachidonic-acid-derived oxidized TRPV1 agonists in spinal cord and skin biopsies.  Furthermore, increases in oxidized TRPV1-active lipids were reduced by peripheral and spinal injections of compds. that completely blocked persistent nociception.  Collectively, these data indicate that NGF evokes a persistent nociceptive state mediated by increased TRPV1 activity and oxidative mechanisms, including increased prodn. of oxidized lipid TRPV1 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgNXdRqaQm_bVg90H21EOLACvtfcHk0ljS9Q9FpN6BCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVGhtLjL&md5=e510c89475efb8be3b9ed3b6a8f46fae</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3993-14.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3993-14.2015%26sid%3Dliteratum%253Aachs%26aulast%3DEskander%26aufirst%3DM.%2BA.%26aulast%3DRuparel%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DD.%2BP.%26aulast%3DChen%26aufirst%3DP.%2BB.%26aulast%3DPor%26aufirst%3DE.%2BD.%26aulast%3DJeske%26aufirst%3DN.%2BA.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DFlores%26aufirst%3DE.%2BR.%26aulast%3DHargreaves%26aufirst%3DK.%2BM.%26atitle%3DPersistent%2520nociception%2520triggered%2520by%2520nerve%2520growth%2520factor%2520%2528NGF%2529%2520is%2520mediated%2520by%2520TRPV1%2520and%2520oxidative%2520mechanisms%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26issue%3D22%26spage%3D8593%26epage%3D8603%26doi%3D10.1523%2FJNEUROSCI.3993-14.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Brito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjea, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rybak, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramkumar, V.</span><span> </span><span class="NLM_article-title">TRPV1: A potential drug target for treating various diseases</span> <span class="citation_source-journal">Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">545</span><span class="refDoi"> DOI: 10.3390/cells3020517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.3390%2Fcells3020517" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2014&pages=517-545&issue=2&author=R.+Britoauthor=S.+Shethauthor=D.+Mukherjeaauthor=L.+P.+Rybakauthor=V.+Ramkumar&title=TRPV1%3A+A+potential+drug+target+for+treating+various+diseases&doi=10.3390%2Fcells3020517"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.3390%2Fcells3020517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcells3020517%26sid%3Dliteratum%253Aachs%26aulast%3DBrito%26aufirst%3DR.%26aulast%3DSheth%26aufirst%3DS.%26aulast%3DMukherjea%26aufirst%3DD.%26aulast%3DRybak%26aufirst%3DL.%2BP.%26aulast%3DRamkumar%26aufirst%3DV.%26atitle%3DTRPV1%253A%2520A%2520potential%2520drug%2520target%2520for%2520treating%2520various%2520diseases%26jtitle%3DCells%26date%3D2014%26volume%3D3%26issue%3D2%26spage%3D517%26epage%3D545%26doi%3D10.3390%2Fcells3020517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Zhuo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. C.</span><span> </span><span class="NLM_article-title">New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1551</span><span class="NLM_x">–</span> <span class="NLM_lpage">1565</span><span class="refDoi"> DOI: 10.1016/j.peptides.2011.05.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.peptides.2011.05.012" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=1551-1565&issue=7&author=J.+L.+Zhuoauthor=X.+C.+Li&title=New+insights+and+perspectives+on+intrarenal+renin-angiotensin+system%3A+focus+on+intracrine%2Fintracellular+angiotensin+II&doi=10.1016%2Fj.peptides.2011.05.012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2011.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2011.05.012%26sid%3Dliteratum%253Aachs%26aulast%3DZhuo%26aufirst%3DJ.%2BL.%26aulast%3DLi%26aufirst%3DX.%2BC.%26atitle%3DNew%2520insights%2520and%2520perspectives%2520on%2520intrarenal%2520renin-angiotensin%2520system%253A%2520focus%2520on%2520intracrine%252Fintracellular%2520angiotensin%2520II%26jtitle%3DPeptides%26date%3D2011%26volume%3D32%26issue%3D7%26spage%3D1551%26epage%3D1565%26doi%3D10.1016%2Fj.peptides.2011.05.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Paul, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poyan Mehr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreutz, R.</span><span> </span><span class="NLM_article-title">Physiology of local renin-angiotensin systems</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">803</span><span class="refDoi"> DOI: 10.1152/physrev.00036.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1152%2Fphysrev.00036.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=16816138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFGgtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2006&pages=747-803&issue=3&author=M.+Paulauthor=A.+Poyan+Mehrauthor=R.+Kreutz&title=Physiology+of+local+renin-angiotensin+systems&doi=10.1152%2Fphysrev.00036.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Physiology of local renin-angiotensin systems</span></div><div class="casAuthors">Paul, Martin; Mehr, Ali Poyan; Kreutz, Reinhold</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">747-803</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Since the first identification of renin by Tigerstedt and Bergmann in 1898, the renin-angiotensin system (RAS) has been extensively studied.  The current view of the system is characterized by an increased complexity, as evidenced by the discovery of new functional components and pathways of the RAS.  In recent years, the pathophysiol. implications of the system have been the main focus of attention, and inhibitors of the RAS such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin (ANG) II receptor blockers have become important clin. tools in the treatment of cardiovascular and renal diseases such as hypertension, heart failure, and diabetic nephropathy.  Nevertheless, the tissue RAS also plays an important role in mediating diverse physiol. functions.  These focus not only on the classical actions of ANG on the cardiovascular system, namely, the maintenance of cardiovascular homeostasis, but also on other functions.  Recently, the research efforts studying these noncardiovascular effects of the RAS have intensified, and a large body of data are now available to support the existence of numerous organ-based RAS exerting diverse physiol. effects.  ANG II has direct effects at the cellular level and can influence, for example, cell growth and differentiation, but also may play a role as a mediator of apoptosis.  These universal paracrine and autocrine actions may be important in many organ systems and can mediate important physiol. stimuli.  Transgenic overexpression and knock-out strategies of RAS genes in animals have also shown a central functional role of the RAS in prenatal development.  Taken together, these findings may become increasingly important in the study of organ physiol. but also for a fresh look at the implications of these findings for organ pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKp3eItFqu97Vg90H21EOLACvtfcHk0lgAmnndGJw4pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFGgtLk%253D&md5=40e6a797915c900a07a9c2e6b94a278b</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00036.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00036.2005%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DM.%26aulast%3DPoyan%2BMehr%26aufirst%3DA.%26aulast%3DKreutz%26aufirst%3DR.%26atitle%3DPhysiology%2520of%2520local%2520renin-angiotensin%2520systems%26jtitle%3DPhysiol.%2520Rev.%26date%3D2006%26volume%3D86%26issue%3D3%26spage%3D747%26epage%3D803%26doi%3D10.1152%2Fphysrev.00036.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Robles, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerezo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez-Gallego, R.</span><span> </span><span class="NLM_article-title">Renin-angiotensin system blocking drugs</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">14</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1177/1074248413501018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1177%2F1074248413501018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=24038019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjt1antr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=14-33&issue=1&author=N.+R.+Roblesauthor=I.+Cerezoauthor=R.+Hernandez-Gallego&title=Renin-angiotensin+system+blocking+drugs&doi=10.1177%2F1074248413501018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Renin-angiotensin system blocking drugs</span></div><div class="casAuthors">Robles, Nicolas Roberto; Cerezo, Isis; Hernandez-Gallego, Roman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cardiovascular Pharmacology and Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-33</span>CODEN:
                <span class="NLM_cas:coden">JCPTFE</span>;
        ISSN:<span class="NLM_cas:issn">1074-2484</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  The two major classes of drugs that target the RAS are the angiotensin-converting enzyme (ACE) inhibitors and the selective ATI receptor blockers (ARBs).  Although both of these drug classes target angiotensin II, the differences in their mechanisms of action have implications for their effects on other pathways and receptors that may have therapeutic implications.  Both ACEIs and ARBs are effective antihypertensive agents that have been shown to reduce the risk of cardiovascular and renal events.  Direct inhibition of renin-the most proximal aspect of the RAS-became clin. feasible from 2007 with the introduction of aliskiren.  This latter drug has been shown to be efficacious for the management of hypertension.  Combined therapy of direct renin-inhibitors with ACEIs or ARBs has been tested in some clin. situations as congestive HF and proteinuria with diverse results.  This article tries to offer an updated review of current knowledge on the use of RAS blocking drugs in clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7D2SrqMqDDrVg90H21EOLACvtfcHk0lgAmnndGJw4pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjt1antr4%253D&md5=57c4b520a8f0938176f84f3d49b215fd</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1177%2F1074248413501018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1074248413501018%26sid%3Dliteratum%253Aachs%26aulast%3DRobles%26aufirst%3DN.%2BR.%26aulast%3DCerezo%26aufirst%3DI.%26aulast%3DHernandez-Gallego%26aufirst%3DR.%26atitle%3DRenin-angiotensin%2520system%2520blocking%2520drugs%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%2520Ther.%26date%3D2014%26volume%3D19%26issue%3D1%26spage%3D14%26epage%3D33%26doi%3D10.1177%2F1074248413501018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Inagami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kambayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichiki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuzuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eguchi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamakawa, T.</span><span> </span><span class="NLM_article-title">Angiotensin receptors: molecular biology and signalling</span> <span class="citation_source-journal">Clin. Exp. Pharmacol. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">544</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span><span class="refDoi"> DOI: 10.1046/j.1440-1681.1999.03086.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1046%2Fj.1440-1681.1999.03086.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10405785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADyaK1MXktlCls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1999&pages=544-549&issue=7&author=T.+Inagamiauthor=Y.+Kambayashiauthor=T.+Ichikiauthor=S.+Tsuzukiauthor=S.+Eguchiauthor=T.+Yamakawa&title=Angiotensin+receptors%3A+molecular+biology+and+signalling&doi=10.1046%2Fj.1440-1681.1999.03086.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Angiotensin receptors: molecular biology and signalling</span></div><div class="casAuthors">Inagami, Tadashi; Kambayashi, Yoshikazu; Ichiki, Toshihiro; Tsuzuki, Satoshi; Eguchi, Satoru; Yamakawa, Tadashi</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Pharmacology and Physiology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">544-549</span>CODEN:
                <span class="NLM_cas:coden">CEXPB9</span>;
        ISSN:<span class="NLM_cas:issn">0305-1870</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A review, with 53 refs.  The active peptide hormone angiotensin II (AngII) is formed from its prohormone angiotensinogen by way of inactive angiotensin I.  The highly specific protease, renin, responsible for the initiation of this system was elusive and considered unstable.  The authors isolated it in a pure and stable form from the kidney of the pig, human, rat, and land submandibular glands of the mouse.  It was shown that there is only one type of renin with highly stringent substrate specificity, except certain strains of the mouse which have two gene products.  The well-known diversity of action of AngII can be attributed to the presence of more than two subtypes, AT1 and AT2, as well as multiple signaling pathways for both of them.  The first subtype AT1 was shown to mediate most of the traditionally recognized AngII functions such as vasoconstriction, electrolyte homeostasis etc.  Although the identification of the signaling modes of the second subtype AT2 still remains elusive, the authors and others have shown evidence that its action is generally antagonistic to that of AT1.  AT2 inhibits AT1 (growth factor-stimulated cell growth), AT2 attenuates the vasoconstriction induced by AT1.  Since AT2 seems to mediate nitric oxide formation in the renal cells, it may initiate a natriuretic pathway in contrast to the sodium-retaining action of AT1-mediated AngII action.  Newer mechanisms and functions of these and other receptors will be clarified by the combination of mol., cellular and integrated physiol. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN7QoHmJDv3bVg90H21EOLACvtfcHk0lhLtbAB5oPquA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktlCls78%253D&md5=001dd88b2d1e82e26baa5c11272afb67</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1046%2Fj.1440-1681.1999.03086.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1440-1681.1999.03086.x%26sid%3Dliteratum%253Aachs%26aulast%3DInagami%26aufirst%3DT.%26aulast%3DKambayashi%26aufirst%3DY.%26aulast%3DIchiki%26aufirst%3DT.%26aulast%3DTsuzuki%26aufirst%3DS.%26aulast%3DEguchi%26aufirst%3DS.%26aulast%3DYamakawa%26aufirst%3DT.%26atitle%3DAngiotensin%2520receptors%253A%2520molecular%2520biology%2520and%2520signalling%26jtitle%3DClin.%2520Exp.%2520Pharmacol.%2520Physiol.%26date%3D1999%26volume%3D26%26issue%3D7%26spage%3D544%26epage%3D549%26doi%3D10.1046%2Fj.1440-1681.1999.03086.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Inagami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitami, Y.</span><span> </span><span class="NLM_article-title">Molecular biology of angiotensin II receptors: an overview</span> <span class="citation_source-journal">J. Hypertens. Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">S83</span><span class="NLM_x">–</span> <span class="NLM_lpage">S94</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1994&pages=S83-S94&issue=10&author=T.+Inagamiauthor=D.+F.+Guoauthor=Y.+Kitami&title=Molecular+biology+of+angiotensin+II+receptors%3A+an+overview"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DInagami%26aufirst%3DT.%26aulast%3DGuo%26aufirst%3DD.%2BF.%26aulast%3DKitami%26aufirst%3DY.%26atitle%3DMolecular%2520biology%2520of%2520angiotensin%2520II%2520receptors%253A%2520an%2520overview%26jtitle%3DJ.%2520Hypertens.%2520Suppl.%26date%3D1994%26volume%3D12%26issue%3D10%26spage%3DS83%26epage%3DS94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Smith, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muralidharan, A.</span><span> </span><span class="NLM_article-title">Targeting angiotensin II type 2 receptor pathways to treat neuropathic pain and inflammatory pain</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span><span class="refDoi"> DOI: 10.1517/14728222.2014.957673</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1517%2F14728222.2014.957673" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=25315162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFSnsr7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2015&pages=25-35&issue=1&author=M.+T.+Smithauthor=A.+Muralidharan&title=Targeting+angiotensin+II+type+2+receptor+pathways+to+treat+neuropathic+pain+and+inflammatory+pain&doi=10.1517%2F14728222.2014.957673"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting angiotensin II type 2 receptor pathways to treat neuropathic pain and inflammatory pain</span></div><div class="casAuthors">Smith, Maree T.; Muralidharan, Arjun</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-35</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Introduction: Neuropathic pain and chronic inflammatory pain are large unmet medical needs.  Over the past two decades, numerous 'pain targets' have been identified for analgesic drug discovery.  Despite promising results in rodent pain models, many compds. modulating such targets lacked efficacy in clin. trials.  An exception is oral EMA401, a small-mol. angiotensin II type 2 receptor (AT2R) antagonist.  Areas covered: Herein, angiotensin II/AT2R signaling-induced hyperexcitability and abnormal sprouting of cultured dorsal root ganglion neurons, together with radioligand binding, pharmacokinetics, analgesic efficacy and mode of action of small-mol. AT2R antagonists in rodent models of peripheral neuropathic and chronic inflammatory pain, are reviewed.  The findings of a successful Phase IIa clin. trial of EMA401 in patients with neuropathic pain are presented in brief.  Expert opinion: The functional importance of angiotensin II/AT2R signaling has remained enigmatic for decades, and there are no clin. available medications that target the AT2R.  However, on the basis of preclin. findings and recent clin. trial data showing that the peripherally restricted, small-mol. AT2R antagonist, EMA401, successfully alleviated neuropathic pain in a Phase II clin. trial, the AT2R is receiving considerable attention as a new therapeutic target with human validation for the relief of peripheral neuropathic and chronic inflammatory pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIBBwwcYIQQLVg90H21EOLACvtfcHk0lhLtbAB5oPquA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFSnsr7L&md5=77a6befc95f7813aedf93415b0a5e64f</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1517%2F14728222.2014.957673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2014.957673%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DM.%2BT.%26aulast%3DMuralidharan%26aufirst%3DA.%26atitle%3DTargeting%2520angiotensin%2520II%2520type%25202%2520receptor%2520pathways%2520to%2520treat%2520neuropathic%2520pain%2520and%2520inflammatory%2520pain%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2015%26volume%3D19%26issue%3D1%26spage%3D25%26epage%3D35%26doi%3D10.1517%2F14728222.2014.957673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Bali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaggi, A. S.</span><span> </span><span class="NLM_article-title">Renin-angiotensin system in pain: existing in a double life?</span> <span class="citation_source-journal">JRAAS</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">340</span><span class="refDoi"> DOI: 10.1177/1470320313503694</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1177%2F1470320313503694" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVWnsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=329-340&issue=4&author=A.+Baliauthor=N.+Singhauthor=A.+S.+Jaggi&title=Renin-angiotensin+system+in+pain%3A+existing+in+a+double+life%3F&doi=10.1177%2F1470320313503694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Renin-angiotensin system in pain: existing in a double life?</span></div><div class="casAuthors">Bali, Anjana; Singh, Nirmal; Jaggi, Amteshwar Singh</div><div class="citationInfo"><span class="NLM_cas:title">JRAAS</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">329-340, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">JRAAAG</span>;
        ISSN:<span class="NLM_cas:issn">1470-3203</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Apart from the well-documented role of the renin-angiotensin-aldosterone system (RAAS) in regulating the blood pressure and other related parameters, its role in modulating different physiol./pathol. functions, including pain, has also been described.  Like its dual role in regulating stress-related anxiety and cognitive functions, its dual role has also been documented in pain modulation in different disease states.  Drugs blocking the RAAS activation, viz., renin inhibitors, angiotensin converting enzyme (ACE) inhibitors, AT1 receptor antagonists and aldosterone antagonists, have been shown to produce beneficial effects in migraine and neuropathic and nociceptive pain.  Their beneficial effects have been mainly attributed to inhibition of the inflammatory cascade of reactions by inhibiting the generation of key cytokines, including tumor necrosis factor (TNF)-α.  On the contrary, clin. as well as preclin. studies have also shown the pain-inducing actions of renin-angiotensin system (RAS) blocking drugs.  Furthermore, the pain-relieving actions of angiotensin II (AngII) and pain-inducing actions of AT1 blockers have also been described.  The pain-inducing actions of ACE inhibitors have been mainly attributed to interference with metab. of bradykinin and substance P, while the analgesic actions of AngII have been mainly related to activation of brain localized AT2 receptors and release of endogenous opioids.  The present review describes the dual role of the RAAS in different states of pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHWN3H0mTcR7Vg90H21EOLACvtfcHk0lhLtbAB5oPquA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVWnsr4%253D&md5=4085c4a2e96afcba67a8ea99639916e4</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1177%2F1470320313503694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1470320313503694%26sid%3Dliteratum%253Aachs%26aulast%3DBali%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DN.%26aulast%3DJaggi%26aufirst%3DA.%2BS.%26atitle%3DRenin-angiotensin%2520system%2520in%2520pain%253A%2520existing%2520in%2520a%2520double%2520life%253F%26jtitle%3DJRAAS%26date%3D2014%26volume%3D15%26issue%3D4%26spage%3D329%26epage%3D340%26doi%3D10.1177%2F1470320313503694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">de Mos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huygen, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stricker, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dieleman, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sturkenboom, M. C.</span><span> </span><span class="NLM_article-title">The association between ACE inhibitors and the complex regional pain syndrome: Suggestions for a neuro-inflammatory pathogenesis of CRPS</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span><span class="refDoi"> DOI: 10.1016/j.pain.2008.12.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.pain.2008.12.032" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2009&pages=218-224&issue=3&author=M.+de+Mosauthor=F.+J.+Huygenauthor=B.+H.+Strickerauthor=J.+P.+Dielemanauthor=M.+C.+Sturkenboom&title=The+association+between+ACE+inhibitors+and+the+complex+regional+pain+syndrome%3A+Suggestions+for+a+neuro-inflammatory+pathogenesis+of+CRPS&doi=10.1016%2Fj.pain.2008.12.032"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2008.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2008.12.032%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BMos%26aufirst%3DM.%26aulast%3DHuygen%26aufirst%3DF.%2BJ.%26aulast%3DStricker%26aufirst%3DB.%2BH.%26aulast%3DDieleman%26aufirst%3DJ.%2BP.%26aulast%3DSturkenboom%26aufirst%3DM.%2BC.%26atitle%3DThe%2520association%2520between%2520ACE%2520inhibitors%2520and%2520the%2520complex%2520regional%2520pain%2520syndrome%253A%2520Suggestions%2520for%2520a%2520neuro-inflammatory%2520pathogenesis%2520of%2520CRPS%26jtitle%3DPain%26date%3D2009%26volume%3D142%26issue%3D3%26spage%3D218%26epage%3D224%26doi%3D10.1016%2Fj.pain.2008.12.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Rohit</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishna, G.</span><span> </span><span class="NLM_article-title">Effects of captopril and losartan on thermal and chemical induced pain in mice</span> <span class="citation_source-journal">Indian J. Physiol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=17051737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFaqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=169-174&issue=2&author=+Rohitauthor=C.+Raoauthor=G.+Krishna&title=Effects+of+captopril+and+losartan+on+thermal+and+chemical+induced+pain+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of captopril and losartan on thermal and chemical induced pain in mice</span></div><div class="casAuthors">Rohit; Chakradhar, Rao U. S.; Gopala, Krishna H. N.</div><div class="citationInfo"><span class="NLM_cas:title">Indian Journal of Physiology and Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">169-174</span>CODEN:
                <span class="NLM_cas:coden">IJPPAZ</span>;
        ISSN:<span class="NLM_cas:issn">0019-5499</span>.
    
            (<span class="NLM_cas:orgname">Association of Physiologists and Pharmacologists of India</span>)
        </div><div class="casAbstract">Angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers antagonists (ARAs) are widely used compds. in various cardiovascular disorders.  ACEIs, but not ARAs, inhibit the enzyme dipeptidyl carboxypeptidase which is involved in the conversion of angiotensin I to II and degrdn. of kinins like bradykinin and substance P.  Bradykinin and substance P are potent mediators of inflammation and pain.  Hence the study was undertaken to evaluate the effects of captopril (an ACEI) and losartan (an ARA-AT1 receptor antagonist) on thermal and chem. induced nociception by employing hot plate and acetic acid induced writhing tests resp. in mice.  Inbred albino mice weighing between 25-30 g were used and they were divided into two sets, each set contg. 7 groups.  Control groups received normal saline and the remaining six groups received three doses (0.5, 1 and 2 mg/kg) of captopril and three doses (0.5, 1 and 2 mg/kg) of losartan.  Drugs were administered i.p. fifteen minutes before placing the animal over the hot plate or 30 min before injecting 0.6% acetic acid.  Both drugs dose dependently reduced the reaction time in hot plate method.  In chem. induced writhing test, both the drugs reduced the latency of onset of writhing and in captopril pretreated groups, acetic acid induced sustained abdominal contraction without any intermittent relaxation.  However, in losartan pretreated animals acetic acid just increased the no. of writhings without sustained abdominal contraction.  Thus, our study suggests that both drugs have hyperalgesic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE0CLMxZTFVrVg90H21EOLACvtfcHk0liUONrIQ1YBwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFaqtbw%253D&md5=bb3bf0c89f712027a4283162e8603a7e</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRohit%26aulast%3DRao%26aufirst%3DC.%26aulast%3DKrishna%26aufirst%3DG.%26atitle%3DEffects%2520of%2520captopril%2520and%2520losartan%2520on%2520thermal%2520and%2520chemical%2520induced%2520pain%2520in%2520mice%26jtitle%3DIndian%2520J.%2520Physiol.%2520Pharmacol.%26date%3D2006%26volume%3D50%26issue%3D2%26spage%3D169%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Laflamme, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Gasparo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payet, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo-Payet, N.</span><span> </span><span class="NLM_article-title">Angiotensin II induction of neurite outgrowth by AT2 receptors in NG108–15 cells. Effect counteracted by the AT1 receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x"> (</span><span class="NLM_issue">37</span><span class="NLM_x">) </span> <span class="NLM_fpage">22729</span><span class="NLM_x">–</span> <span class="NLM_lpage">22735</span><span class="refDoi"> DOI: 10.1074/jbc.271.37.22729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1074%2Fjbc.271.37.22729" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=22729-22735&issue=37&author=L.+Laflammeauthor=M.+de+Gasparoauthor=J.+M.+Galloauthor=M.+D.+Payetauthor=N.+Gallo-Payet&title=Angiotensin+II+induction+of+neurite+outgrowth+by+AT2+receptors+in+NG108%E2%80%9315+cells.+Effect+counteracted+by+the+AT1+receptors&doi=10.1074%2Fjbc.271.37.22729"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.37.22729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.37.22729%26sid%3Dliteratum%253Aachs%26aulast%3DLaflamme%26aufirst%3DL.%26aulast%3Dde%2BGasparo%26aufirst%3DM.%26aulast%3DGallo%26aufirst%3DJ.%2BM.%26aulast%3DPayet%26aufirst%3DM.%2BD.%26aulast%3DGallo-Payet%26aufirst%3DN.%26atitle%3DAngiotensin%2520II%2520induction%2520of%2520neurite%2520outgrowth%2520by%2520AT2%2520receptors%2520in%2520NG108%25E2%2580%259315%2520cells.%2520Effect%2520counteracted%2520by%2520the%2520AT1%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26issue%3D37%26spage%3D22729%26epage%3D22735%26doi%3D10.1074%2Fjbc.271.37.22729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Anand, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yiangou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinisi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korchev, Y. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, P.</span><span> </span><span class="NLM_article-title">Angiotensin II type 2 receptor (AT2 R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons</span> <span class="citation_source-journal">Eur. J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1012</span><span class="NLM_x">–</span> <span class="NLM_lpage">1026</span><span class="refDoi"> DOI: 10.1002/j.1532-2149.2012.00269.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1002%2Fj.1532-2149.2012.00269.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23255326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVKhsrnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=1012-1026&issue=7&author=U.+Anandauthor=P.+Facerauthor=Y.+Yiangouauthor=M.+Sinisiauthor=M.+Foxauthor=T.+McCarthyauthor=C.+Bountraauthor=Y.+E.+Korchevauthor=P.+Anand&title=Angiotensin+II+type+2+receptor+%28AT2+R%29+localization+and+antagonist-mediated+inhibition+of+capsaicin+responses+and+neurite+outgrowth+in+human+and+rat+sensory+neurons&doi=10.1002%2Fj.1532-2149.2012.00269.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Angiotensin II type 2 receptor (AT2R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons</span></div><div class="casAuthors">Anand, U.; Facer, P.; Yiangou, Y.; Sinisi, M.; Fox, M.; McCarthy, T.; Bountra, C.; Korchev, Y. E.; Anand, P.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pain (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1012-1026</span>CODEN:
                <span class="NLM_cas:coden">EJPAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1090-3801</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background : The angiotensin II (AngII) receptor subtype 2 (AT2R) is expressed in sensory neurons and may play a role in nociception and neuronal regeneration.  Methods : We used immunostaining with characterized antibodies to study the localization of AT2R in cultured human and rat dorsal root ganglion (DRG) neurons and a range of human tissues.  The effects of AngII and AT2R antagonist EMA401 on capsaicin responses in cultured human and rat (DRG) neurons were measured with calcium imaging, on neurite length and d. with Gap43 immunostaining, and on cyclic adenosine monophosphate (cAMP) expression using immunofluorescence.  Results : AT2R expression was localized in small-/medium-sized cultured neurons of human and rat DRG.  Treatment with the AT2R antagonist EMA401 resulted in dose-related functional inhibition of capsaicin responses (IC50=10nmol/L), which was reversed by 8-bromo-cAMP, and reduced neurite length and d.; AngII treatment significantly enhanced capsaicin responses, cAMP levels and neurite outgrowth.  The AT1R antagonist losartan had no effect on capsaicin responses.  AT2R was localized in sensory neurons of human DRG, and nerve fibers in peripheral nerves, skin, urinary bladder and bowel.  A majority sub-population (60%) of small-/medium-diam. neuronal cells were immunopos. in both control post-mortem and avulsion-injured human DRG; some very small neurons appeared to be intensely immunoreactive, with TRPV1 co-localization.  While AT2R levels were reduced in human limb peripheral nerve segments proximal to injury, they were preserved in painful neuromas.  Conclusions : AT2R antagonists could be particularly useful in the treatment of chronic pain and hypersensitivity assocd. with abnormal nerve sprouting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXE7j5pUExILVg90H21EOLACvtfcHk0liUONrIQ1YBwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVKhsrnF&md5=9550c73afcb055fb9144251b1f7d1872</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1002%2Fj.1532-2149.2012.00269.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fj.1532-2149.2012.00269.x%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DU.%26aulast%3DFacer%26aufirst%3DP.%26aulast%3DYiangou%26aufirst%3DY.%26aulast%3DSinisi%26aufirst%3DM.%26aulast%3DFox%26aufirst%3DM.%26aulast%3DMcCarthy%26aufirst%3DT.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DKorchev%26aufirst%3DY.%2BE.%26aulast%3DAnand%26aufirst%3DP.%26atitle%3DAngiotensin%2520II%2520type%25202%2520receptor%2520%2528AT2%2520R%2529%2520localization%2520and%2520antagonist-mediated%2520inhibition%2520of%2520capsaicin%2520responses%2520and%2520neurite%2520outgrowth%2520in%2520human%2520and%2520rat%2520sensory%2520neurons%26jtitle%3DEur.%2520J.%2520Pain%26date%3D2013%26volume%3D17%26issue%3D7%26spage%3D1012%26epage%3D1026%26doi%3D10.1002%2Fj.1532-2149.2012.00269.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Plouffe, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimond, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaudry, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo-Payet, N.</span><span> </span><span class="NLM_article-title">Role of tyrosine kinase receptors in angiotensin II AT2 receptor signaling: involvement in neurite outgrowth and in p42/p44mapk activation in NG108–15 cells</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">4646</span><span class="NLM_x">–</span> <span class="NLM_lpage">4654</span><span class="refDoi"> DOI: 10.1210/en.2005-1315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1210%2Fen.2005-1315" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=2006&pages=4646-4654&issue=10&author=B.+Plouffeauthor=M.+O.+Guimondauthor=H.+Beaudryauthor=N.+Gallo-Payet&title=Role+of+tyrosine+kinase+receptors+in+angiotensin+II+AT2+receptor+signaling%3A+involvement+in+neurite+outgrowth+and+in+p42%2Fp44mapk+activation+in+NG108%E2%80%9315+cells&doi=10.1210%2Fen.2005-1315"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1210%2Fen.2005-1315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2005-1315%26sid%3Dliteratum%253Aachs%26aulast%3DPlouffe%26aufirst%3DB.%26aulast%3DGuimond%26aufirst%3DM.%2BO.%26aulast%3DBeaudry%26aufirst%3DH.%26aulast%3DGallo-Payet%26aufirst%3DN.%26atitle%3DRole%2520of%2520tyrosine%2520kinase%2520receptors%2520in%2520angiotensin%2520II%2520AT2%2520receptor%2520signaling%253A%2520involvement%2520in%2520neurite%2520outgrowth%2520and%2520in%2520p42%252Fp44mapk%2520activation%2520in%2520NG108%25E2%2580%259315%2520cells%26jtitle%3DEndocrinology%26date%3D2006%26volume%3D147%26issue%3D10%26spage%3D4646%26epage%3D4654%26doi%3D10.1210%2Fen.2005-1315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Chakrabarty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blacklock, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svojanovsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. G.</span><span> </span><span class="NLM_article-title">Estrogen elicits dorsal root ganglion axon sprouting via a renin-angiotensin system</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">3452</span><span class="NLM_x">–</span> <span class="NLM_lpage">3460</span><span class="refDoi"> DOI: 10.1210/en.2008-0061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1210%2Fen.2008-0061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2008&pages=3452-3460&issue=7&author=A.+Chakrabartyauthor=A.+Blacklockauthor=S.+Svojanovskyauthor=P.+G.+Smith&title=Estrogen+elicits+dorsal+root+ganglion+axon+sprouting+via+a+renin-angiotensin+system&doi=10.1210%2Fen.2008-0061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1210%2Fen.2008-0061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fen.2008-0061%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarty%26aufirst%3DA.%26aulast%3DBlacklock%26aufirst%3DA.%26aulast%3DSvojanovsky%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DP.%2BG.%26atitle%3DEstrogen%2520elicits%2520dorsal%2520root%2520ganglion%2520axon%2520sprouting%2520via%2520a%2520renin-angiotensin%2520system%26jtitle%3DEndocrinology%26date%3D2008%26volume%3D149%26issue%3D7%26spage%3D3452%26epage%3D3460%26doi%3D10.1210%2Fen.2008-0061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Guimond, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo-Payet, N.</span><span> </span><span class="NLM_article-title">How does angiotensin AT(2) receptor activation help neuronal differentiation and improve neuronal pathological situations?</span> <span class="citation_source-journal">Front. Endocrinol. (Lausanne, Switz.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">164</span><span class="refDoi"> DOI: 10.3389/fendo.2012.00164</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.3389%2Ffendo.2012.00164" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23267346" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=164&author=M.+O.+Guimondauthor=N.+Gallo-Payet&title=How+does+angiotensin+AT%282%29+receptor+activation+help+neuronal+differentiation+and+improve+neuronal+pathological+situations%3F&doi=10.3389%2Ffendo.2012.00164"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.3389%2Ffendo.2012.00164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffendo.2012.00164%26sid%3Dliteratum%253Aachs%26aulast%3DGuimond%26aufirst%3DM.%2BO.%26aulast%3DGallo-Payet%26aufirst%3DN.%26atitle%3DHow%2520does%2520angiotensin%2520AT%25282%2529%2520receptor%2520activation%2520help%2520neuronal%2520differentiation%2520and%2520improve%2520neuronal%2520pathological%2520situations%253F%26jtitle%3DFront.%2520Endocrinol.%2520%2528Lausanne%252C%2520Switz.%2529%26date%3D2012%26volume%3D3%26spage%3D164%26doi%3D10.3389%2Ffendo.2012.00164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Guimond, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallinder, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alterman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo-Payet, N.</span><span> </span><span class="NLM_article-title">Comparative functional properties of two structurally similar selective nonpeptide drug-like ligands for the angiotensin II type-2 (AT(2)) receptor. Effects on neurite outgrowth in NG108–15 cells</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">699</span><span class="NLM_x"> (</span><span class="NLM_issue">1–3</span><span class="NLM_x">) </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2012.11.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.ejphar.2012.11.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23211679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitlaqtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=699&publication_year=2013&pages=160-171&issue=1%E2%80%933&author=M.+O.+Guimondauthor=C.+Wallinderauthor=M.+Altermanauthor=A.+Hallbergauthor=N.+Gallo-Payet&title=Comparative+functional+properties+of+two+structurally+similar+selective+nonpeptide+drug-like+ligands+for+the+angiotensin+II+type-2+%28AT%282%29%29+receptor.+Effects+on+neurite+outgrowth+in+NG108%E2%80%9315+cells&doi=10.1016%2Fj.ejphar.2012.11.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative functional properties of two structurally similar selective nonpeptide drug-like ligands for the angiotensin II type-2 (AT2) receptor. Effects on neurite outgrowth in NG108-15 cells</span></div><div class="casAuthors">Guimond, Marie-Odile; Wallinder, Charlotta; Alterman, Mathias; Hallberg, Anders; Gallo-Payet, Nicole</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">699</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">160-171</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There is increasing evidence that angiotensin II (Ang II), through binding to the type 2 (AT2) receptor may have beneficial effects in various physiol. and pathol. situations.  However, specific action presumably mediated by the angiotensin AT2 receptor has been hampered by the absence of appropriate selective ligands.  The aim of this study was to compare the biol. properties of two related and selective drug-like nonpeptide AT2 ligands, namely an agonist called M024 (also known as Compd. 21) and a new ligand, presumably an antagonist, C38/M132, (originally called C38).  Properties of the compds. were investigated in NG108-15 cells expressing angiotensin AT2 receptor and known to develop neurite outgrowth upon Ang II stimulation.  NG108-15 cells stimulated for three days with C21/M024 (0.1 or 100 nM) exhibited the same neurite outgrowth as cells stimulated with Ang II (100 nM) while co-incubation of Ang II or C21/M024 with C38/M132 (10 or 100 nM) inhibited their effects, similarly to the angiotensin AT2 receptor antagonist, PD123319 (10 μM).  As Ang II, C21/M024 induced a Rap1-dependent activation of p42/p44mapk whereas preincubation of cells with C38/M132 inhibited p42/p44mapk and Rap1 activation induced by Ang II.  Three-day treatment with C21/M024 or Ang II decreased cell no. in culture, an effect that was rescued by preincubation with C38/M132.  Taken together, these results indicate that the nonpeptide ligand C21/M024 is a potent angiotensin AT2 receptor agonist while C38/M132 acts as an antagonist.  These selective nonpeptide angiotensin AT2 ligands may represent unique and long-awaited tools for the pursuit of in vivo studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppSbhxynZSXrVg90H21EOLACvtfcHk0lhFIZNTjCiCDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitlaqtrs%253D&md5=4654d2d54485809d948577c0390c0a74</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2012.11.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2012.11.032%26sid%3Dliteratum%253Aachs%26aulast%3DGuimond%26aufirst%3DM.%2BO.%26aulast%3DWallinder%26aufirst%3DC.%26aulast%3DAlterman%26aufirst%3DM.%26aulast%3DHallberg%26aufirst%3DA.%26aulast%3DGallo-Payet%26aufirst%3DN.%26atitle%3DComparative%2520functional%2520properties%2520of%2520two%2520structurally%2520similar%2520selective%2520nonpeptide%2520drug-like%2520ligands%2520for%2520the%2520angiotensin%2520II%2520type-2%2520%2528AT%25282%2529%2529%2520receptor.%2520Effects%2520on%2520neurite%2520outgrowth%2520in%2520NG108%25E2%2580%259315%2520cells%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D699%26issue%3D1%25E2%2580%25933%26spage%3D160%26epage%3D171%26doi%3D10.1016%2Fj.ejphar.2012.11.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Smith, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyse, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, S. R.</span><span> </span><span class="NLM_article-title">Small molecule angiotensin II type 2 receptor (AT2R) antagonists as novel analgesics for neuropathic pain: comparative pharmacokinetics, radioligand binding, and efficacy in rats</span> <span class="citation_source-journal">Pain Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">692</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span><span class="refDoi"> DOI: 10.1111/pme.12063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1111%2Fpme.12063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23489258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADC%252BC3svmtVKisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=692-705&issue=5&author=M.+T.+Smithauthor=B.+D.+Wyseauthor=S.+R.+Edwards&title=Small+molecule+angiotensin+II+type+2+receptor+%28AT2R%29+antagonists+as+novel+analgesics+for+neuropathic+pain%3A+comparative+pharmacokinetics%2C+radioligand+binding%2C+and+efficacy+in+rats&doi=10.1111%2Fpme.12063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule angiotensin II type 2 receptor (AT2R) antagonists as novel analgesics for neuropathic pain: comparative pharmacokinetics, radioligand binding, and efficacy in rats</span></div><div class="casAuthors">Smith Maree T; Wyse Bruce D; Edwards Stephen R</div><div class="citationInfo"><span class="NLM_cas:title">Pain medicine (Malden, Mass.)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">692-705</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Neuropathic pain is an area of unmet clinical need.  The objective of this study was to define the pharmacokinetics, oral bioavailability, and efficacy in rats of small molecule antagonists of the angiotensin II type 2 receptor (AT2R) for the relief of neuropathic pain.  DESIGN AND METHODS:  Adult male Sprague-Dawley (SD) rats received single intravenous (1-10 mg/kg) or oral (5-10 mg/kg) bolus doses of EMA200, EMA300, EMA400 or EMA401 (S-enantiomer of EMA400).  Blood samples were collected immediately pre-dose and at specified times over a 12- to 24-hour post-dosing period.  Liquid chromatography tandem mass spectrometry was used to measure plasma drug concentrations.  Efficacy was assessed in adult male SD rats with a unilateral chronic constriction injury (CCI) of the sciatic nerve.  RESULTS:  After intravenous administration in rats, mean (±standard error of the mean) plasma clearance for EMA200, EMA300, EMA400, and EMA401 was 9.3, 6.1, 0.7, and 1.1 L/hour/kg, respectively.  After oral dosing, the dose-normalized systemic exposures of EMA400 and EMA401 were 20- to 30-fold and 50- to 60-fold higher than that for EMA300 and EMA200, respectively.  The oral bioavailability of EMA400 and EMA401 was similar at ∼30%, whereas it was only 5.9% and 7.1% for EMA200 and EMA300, respectively.  In CCI rats, single intraperitoneal bolus doses of EMA200, EMA300, and EMA400 evoked dose-dependent pain relief.  The pain relief potency rank order in CCI rats was EMA400 > EMA300 > EMA200 in agreement with the dose-normalized systemic exposure rank order in SD rats.  CONCLUSION:  The small molecule AT2R antagonist, EMA401, is in clinical development as a novel analgesic for the relief of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSjI5YuvrZVpNts4TFFB11gfW6udTcc2ebayOurURbNLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svmtVKisg%253D%253D&md5=5a5aecc9c63f4a49d650978d90603471</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1111%2Fpme.12063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpme.12063%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DM.%2BT.%26aulast%3DWyse%26aufirst%3DB.%2BD.%26aulast%3DEdwards%26aufirst%3DS.%2BR.%26atitle%3DSmall%2520molecule%2520angiotensin%2520II%2520type%25202%2520receptor%2520%2528AT2R%2529%2520antagonists%2520as%2520novel%2520analgesics%2520for%2520neuropathic%2520pain%253A%2520comparative%2520pharmacokinetics%252C%2520radioligand%2520binding%252C%2520and%2520efficacy%2520in%2520rats%26jtitle%3DPain%2520Med.%26date%3D2013%26volume%3D14%26issue%3D5%26spage%3D692%26epage%3D705%26doi%3D10.1111%2Fpme.12063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Smith, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodruff, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyse, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muralidharan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walther, T.</span><span> </span><span class="NLM_article-title">A small molecule angiotensin II type 2 receptor (AT2R) antagonist produces analgesia in a rat model of neuropathic pain by inhibition of p38 mitogen-activated protein kinase (MAPK) and p44/p42 MAPK activation in the dorsal root ganglia</span> <span class="citation_source-journal">Pain Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1557</span><span class="NLM_x">–</span> <span class="NLM_lpage">1568</span><span class="refDoi"> DOI: 10.1111/pme.12157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1111%2Fpme.12157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23742186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADC%252BC3sjgtl2hsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=1557-1568&issue=10&author=M.+T.+Smithauthor=T.+M.+Woodruffauthor=B.+D.+Wyseauthor=A.+Muralidharanauthor=T.+Walther&title=A+small+molecule+angiotensin+II+type+2+receptor+%28AT2R%29+antagonist+produces+analgesia+in+a+rat+model+of+neuropathic+pain+by+inhibition+of+p38+mitogen-activated+protein+kinase+%28MAPK%29+and+p44%2Fp42+MAPK+activation+in+the+dorsal+root+ganglia&doi=10.1111%2Fpme.12157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule angiotensin II type 2 receptor (AT2R) antagonist produces analgesia in a rat model of neuropathic pain by inhibition of p38 mitogen-activated protein kinase (MAPK) and p44/p42 MAPK activation in the dorsal root ganglia</span></div><div class="casAuthors">Smith Maree T; Woodruff Trent M; Wyse Bruce D; Muralidharan Arjun; Walther Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Pain medicine (Malden, Mass.)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1557-68</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  There is an unmet clinical need for novel analgesics for neuropathic pain.  This study was designed to elucidate the mechanism through which EMA300, a small molecule antagonist of the angiotensin II type 2 receptor (AT2R) with >1,000-fold selectivity over the angiotensin II type 1 receptor, produces analgesia in a rodent model of neuropathic pain.  DESIGN AND METHODS:  Groups of AT2R knockout, hemizygotes, and wild-type mice with a chronic constriction injury (CCI) of the sciatic nerve received single intraperitoneal (i.p.) bolus doses of EMA300 (100 or 300 mg/kg), and analgesic efficacy was assessed.  Groups of control, sham-operated, and CCI rats were euthanized and perfusion fixed.  Lumbar dorsal root ganglia (DRGs) were removed for investigation of the mechanism through which EMA300 alleviates neuropathic pain.  RESULTS:  EMA300 analgesia was abolished in AT2R knockout CCI mice with intermediate responses in the hemizygotes, affirming the AT2R as the target mediating EMA300 analgesia.  In CCI rats, DRG immunofluorescence (IF) levels for angiotensin II, the main endogenous ligand of the AT2R, were increased ∼1.5-2.0-fold (P < 0.05) cf. sham-controls.  Mean DRG IF levels for activated p38 (pp38) and activated p44/p42 (pp44/pp42) MAPK were also increased ∼1.5-2.0-fold (P < 0.05) cf. sham-controls.  At the time of peak EMA300 analgesia in CCI rats, mean DRG levels of pp38 MAPK and pp44/pp42 MAPK (but not angiotensin II) were reduced to match the respective levels in sham-controls.  CONCLUSION:  Augmented angiotensin II/AT2R signaling in the DRGs of CCI rats is attenuated by EMA300 to block p38 MAPK and p44/p42 MAPK activation, a mechanism with clinical validity for alleviating neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXnivkNFx8x--MdeMhXAHkfW6udTcc2eax7nCs9Mdj1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjgtl2hsA%253D%253D&md5=58e8198bfaf990ad99b1b887abd88611</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1111%2Fpme.12157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpme.12157%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DM.%2BT.%26aulast%3DWoodruff%26aufirst%3DT.%2BM.%26aulast%3DWyse%26aufirst%3DB.%2BD.%26aulast%3DMuralidharan%26aufirst%3DA.%26aulast%3DWalther%26aufirst%3DT.%26atitle%3DA%2520small%2520molecule%2520angiotensin%2520II%2520type%25202%2520receptor%2520%2528AT2R%2529%2520antagonist%2520produces%2520analgesia%2520in%2520a%2520rat%2520model%2520of%2520neuropathic%2520pain%2520by%2520inhibition%2520of%2520p38%2520mitogen-activated%2520protein%2520kinase%2520%2528MAPK%2529%2520and%2520p44%252Fp42%2520MAPK%2520activation%2520in%2520the%2520dorsal%2520root%2520ganglia%26jtitle%3DPain%2520Med.%26date%3D2013%26volume%3D14%26issue%3D10%26spage%3D1557%26epage%3D1568%26doi%3D10.1111%2Fpme.12157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Muralidharan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyse, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. T.</span><span> </span><span class="NLM_article-title">Analgesic efficacy and mode of action of a selective small molecule angiotensin II type 2 receptor antagonist in a rat model of prostate cancer-induced bone pain</span> <span class="citation_source-journal">Pain Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">93</span><span class="NLM_x">–</span> <span class="NLM_lpage">110</span><span class="refDoi"> DOI: 10.1111/pme.12258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1111%2Fpme.12258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=24433468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADC%252BC2czmtlajtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=93-110&issue=1&author=A.+Muralidharanauthor=B.+D.+Wyseauthor=M.+T.+Smith&title=Analgesic+efficacy+and+mode+of+action+of+a+selective+small+molecule+angiotensin+II+type+2+receptor+antagonist+in+a+rat+model+of+prostate+cancer-induced+bone+pain&doi=10.1111%2Fpme.12258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Analgesic efficacy and mode of action of a selective small molecule angiotensin II type 2 receptor antagonist in a rat model of prostate cancer-induced bone pain</span></div><div class="casAuthors">Muralidharan Arjun; Wyse Bruce D; Smith Maree T</div><div class="citationInfo"><span class="NLM_cas:title">Pain medicine (Malden, Mass.)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-110</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  The pathobiology of prostate cancer (PCa)-induced bone pain (PCIBP) has both inflammatory and neuropathic components.  Previously, we showed that small molecule angiotensin II type 2 receptor (AT2 R) antagonists with >1,000-fold selectivity over the angiotensin II type 1 receptor produced dose-dependent analgesia in a rat model of neuropathic pain.  Here, we assessed the analgesic efficacy and mode of action of the AT2 R antagonist, EMA200, in a rat model of PCIBP.  METHODS:  At 14-21 days after unilateral intratibial injection of AT3B PCa cells, rats exhibiting hindpaw hypersensitivity received single intravenous bolus doses of EMA200 (0.3-10 mg/kg) or vehicle, and analgesic efficacy was assessed.  The mode of action was investigated using immunohistochemical, Western blot, and/or molecular biological methods in lumbar dorsal root ganglia (DRGs) removed from drug-naive and EMA200-treated PCIBP rats relative to sham-control rats.  RESULTS:  Intravenous bolus doses of EMA200 produced dose-dependent analgesia in PCIBP rats.  Lumbar DRG levels of angiotensin II, nerve growth factor (NGF), tyrosine kinase A (TrkA), phospho-p38 mitogen-activated protein kinase (MAPK), and phospho-p44/p42 MAPK, but not the AT2 R, were increased significantly (P < 0.05) in PCIBP rats, c.f. the corresponding levels for sham controls.  EMA200 produced analgesia in PCIBP rats by reducing elevated angiotensin II levels in the lumbar DRGs to attenuate augmented angiotensin II/AT2 R signaling.  This in turn reduced augmented NGF/TrkA signaling in the lumbar DRGs.  The net result was inhibition of p38 MAPK and p44/p42 MAPK activation.  CONCLUSION:  Small molecule AT2 R antagonists are worthy of further investigation as novel analgesics for relief of intractable PCIBP and other pain types where hyperalgesia worsens symptoms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAiSkGgy9eIeb6AVA-44PTfW6udTcc2eax7nCs9Mdj1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2czmtlajtg%253D%253D&md5=9b89cedf036b082b91c1fd7052cac7ae</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1111%2Fpme.12258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpme.12258%26sid%3Dliteratum%253Aachs%26aulast%3DMuralidharan%26aufirst%3DA.%26aulast%3DWyse%26aufirst%3DB.%2BD.%26aulast%3DSmith%26aufirst%3DM.%2BT.%26atitle%3DAnalgesic%2520efficacy%2520and%2520mode%2520of%2520action%2520of%2520a%2520selective%2520small%2520molecule%2520angiotensin%2520II%2520type%25202%2520receptor%2520antagonist%2520in%2520a%2520rat%2520model%2520of%2520prostate%2520cancer-induced%2520bone%2520pain%26jtitle%3DPain%2520Med.%26date%3D2014%26volume%3D15%26issue%3D1%26spage%3D93%26epage%3D110%26doi%3D10.1111%2Fpme.12258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Chakrabarty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. G.</span><span> </span><span class="NLM_article-title">Angiotensin II receptor type 2 activation is required for cutaneous sensory hyperinnervation and hypersensitivity in a rat hind paw model of inflammatory pain</span> <span class="citation_source-journal">J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1053</span><span class="NLM_x">–</span> <span class="NLM_lpage">1065</span><span class="refDoi"> DOI: 10.1016/j.jpain.2013.04.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.jpain.2013.04.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23726047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovVSqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=1053-1065&issue=10&author=A.+Chakrabartyauthor=Z.+Liaoauthor=P.+G.+Smith&title=Angiotensin+II+receptor+type+2+activation+is+required+for+cutaneous+sensory+hyperinnervation+and+hypersensitivity+in+a+rat+hind+paw+model+of+inflammatory+pain&doi=10.1016%2Fj.jpain.2013.04.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Angiotensin II Receptor Type 2 Activation Is Required for Cutaneous Sensory Hyperinnervation and Hypersensitivity in a Rat Hind Paw Model of Inflammatory Pain</span></div><div class="casAuthors">Chakrabarty, Anuradha; Liao, Zhaohui; Smith, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pain</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1053-1065</span>CODEN:
                <span class="NLM_cas:coden">JPOAB5</span>;
        ISSN:<span class="NLM_cas:issn">1526-5900</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Many pain syndromes are assocd. with abnormal proliferation of peripheral sensory fibers.  We showed previously that angiotensin II, acting through its type 2 receptor (AT2), stimulates axon outgrowth by cultured dorsal root ganglion neurons.  In this study, we assessed whether AT2 mediates nociceptor hyperinnervation in the rodent hind paw model of inflammatory pain.  Plantar injection of complete Freund's adjuvant (CFA), but not saline, produced marked thermal and mech. hypersensitivity through 7 days.  This was accompanied by proliferation of dermal and epidermal PGP9.5-immunoreactive (ir) and calcitonin gene-related peptide-immunoreactive (CGRP-ir) axons, and dermal axons immunoreactive for GFRα2 but not tyrosine hydroxylase or neurofilament H.  Continuous infusion of the AT2 antagonist PD123319 beginning with CFA injection completely prevented hyperinnervation as well as hypersensitivity over a 7-day period.  A single PD123319 injection 7 days after CFA also reversed thermal hypersensitivity and partially reversed mech. hypersensitivity 3 h later, without affecting cutaneous innervation.  Angiotensin II-synthesizing proteins renin and angiotensinogen were largely absent after saline but abundant in T cells and macrophages in CFA-injected paws with or without PD123319.  Thus, emigrant cells at the site of inflammation apparently establish a renin-angiotensin system, and AT2 activation elicits nociceptor sprouting and heightened thermal and mech. sensitivity.Short-term AT2 activation is a potent contributor to thermal hypersensitivity, whereas long-term effects (such as hyperinnervation) also contribute to mech. hypersensitivity.  Pharmacol. blockade of AT2 signaling represents a potential therapeutic strategy aimed at biol. mechanisms underlying chronic inflammatory pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUf7QG_tTBs7Vg90H21EOLACvtfcHk0ljGuUzuNO9EYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovVSqtro%253D&md5=3ffc9b78efebb2e50dc7a9f39cd6c164</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2Fj.jpain.2013.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpain.2013.04.002%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarty%26aufirst%3DA.%26aulast%3DLiao%26aufirst%3DZ.%26aulast%3DSmith%26aufirst%3DP.%2BG.%26atitle%3DAngiotensin%2520II%2520receptor%2520type%25202%2520activation%2520is%2520required%2520for%2520cutaneous%2520sensory%2520hyperinnervation%2520and%2520hypersensitivity%2520in%2520a%2520rat%2520hind%2520paw%2520model%2520of%2520inflammatory%2520pain%26jtitle%3DJ.%2520Pain%26date%3D2013%26volume%3D14%26issue%3D10%26spage%3D1053%26epage%3D1065%26doi%3D10.1016%2Fj.jpain.2013.04.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Rice, A. S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dworkin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bountra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCloud, P. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desem, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raff, M.</span><span> </span><span class="NLM_article-title">EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">383</span><span class="NLM_x"> (</span><span class="NLM_issue">9929</span><span class="NLM_x">) </span> <span class="NLM_fpage">1637</span><span class="NLM_x">–</span> <span class="NLM_lpage">1647</span><span class="refDoi"> DOI: 10.1016/S0140-6736(13)62337-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2FS0140-6736%2813%2962337-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2014&pages=1637-1647&issue=9929&author=A.+S.+C.+Riceauthor=R.+H.+Dworkinauthor=T.+D.+McCarthyauthor=P.+Anandauthor=C.+Bountraauthor=P.+I.+McCloudauthor=J.+Hillauthor=G.+Cutterauthor=G.+Kitsonauthor=N.+Desemauthor=M.+Raff&title=EMA401%2C+an+orally+administered+highly+selective+angiotensin+II+type+2+receptor+antagonist%2C+as+a+novel+treatment+for+postherpetic+neuralgia%3A+a+randomised%2C+double-blind%2C+placebo-controlled+phase+2+clinical+trial&doi=10.1016%2FS0140-6736%2813%2962337-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2813%2962337-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252813%252962337-5%26sid%3Dliteratum%253Aachs%26aulast%3DRice%26aufirst%3DA.%2BS.%2BC.%26aulast%3DDworkin%26aufirst%3DR.%2BH.%26aulast%3DMcCarthy%26aufirst%3DT.%2BD.%26aulast%3DAnand%26aufirst%3DP.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DMcCloud%26aufirst%3DP.%2BI.%26aulast%3DHill%26aufirst%3DJ.%26aulast%3DCutter%26aufirst%3DG.%26aulast%3DKitson%26aufirst%3DG.%26aulast%3DDesem%26aufirst%3DN.%26aulast%3DRaff%26aufirst%3DM.%26atitle%3DEMA401%252C%2520an%2520orally%2520administered%2520highly%2520selective%2520angiotensin%2520II%2520type%25202%2520receptor%2520antagonist%252C%2520as%2520a%2520novel%2520treatment%2520for%2520postherpetic%2520neuralgia%253A%2520a%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%2520phase%25202%2520clinical%2520trial%26jtitle%3DLancet%26date%3D2014%26volume%3D383%26issue%3D9929%26spage%3D1637%26epage%3D1647%26doi%3D10.1016%2FS0140-6736%2813%2962337-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez-Cabrera, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanna, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, S.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate receptor signaling</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span><span class="refDoi"> DOI: 10.1146/annurev.biochem.78.072407.103733</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1146%2Fannurev.biochem.78.072407.103733" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=19231986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXos1Ghu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2009&pages=743-768&author=H.+Rosenauthor=P.+J.+Gonzalez-Cabreraauthor=M.+G.+Sannaauthor=S.+Brown&title=Sphingosine+1-phosphate+receptor+signaling&doi=10.1146%2Fannurev.biochem.78.072407.103733"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate receptor signaling</span></div><div class="casAuthors">Rosen, Hugh; Gonzalez-Cabrera, Pedro J.; Sanna, M. Germana; Brown, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">743-768</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The sphingosine 1-phosphate (S1P) receptor signaling system is a productive model system.  A hydrophobic zwitterionic lysophospholipid ligand with difficult phys. properties interacts with 5 high-affinity G protein-coupled receptors to generate multiple downstream signals.  These signals modulate homeostasis and pathol. on a steep agonist concn.-response curve.  Ligand presence is essential for vascular development and endothelial integrity, while acute increases in ligand concns. result in cardiac death.  Understanding this integrated biochem. system has exemplified the impact of both genetics and chem.  Developing specific tools with defined biochem. properties for the reversible modulation of signals in real time has been essential to complement insights gained from genetic approaches that may be irreversible and compensated.  Despite its knife-edge between life and death, this system, based in part on receptor subtype selectivity and in part on differential attenuation of deleterious signals, now appears to be on the cusp of meaningful therapy for multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT_vass2lPj7Vg90H21EOLACvtfcHk0lgU6-R87dYi6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXos1Ghu78%253D&md5=d76c5ea98a0cbf52d2c986252964822a</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1146%2Fannurev.biochem.78.072407.103733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.biochem.78.072407.103733%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DGonzalez-Cabrera%26aufirst%3DP.%2BJ.%26aulast%3DSanna%26aufirst%3DM.%2BG.%26aulast%3DBrown%26aufirst%3DS.%26atitle%3DSphingosine%25201-phosphate%2520receptor%2520signaling%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2009%26volume%3D78%26spage%3D743%26epage%3D768%26doi%3D10.1146%2Fannurev.biochem.78.072407.103733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Kolesnick, R.</span><span> </span><span class="NLM_article-title">The therapeutic potential of modulating the ceramide/sphingomyelin pathway</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1172/JCI0216127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1172%2FJCI0216127" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2002&pages=3-8&issue=1&author=R.+Kolesnick&title=The+therapeutic+potential+of+modulating+the+ceramide%2Fsphingomyelin+pathway&doi=10.1172%2FJCI0216127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1172%2FJCI0216127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI0216127%26sid%3Dliteratum%253Aachs%26aulast%3DKolesnick%26aufirst%3DR.%26atitle%3DThe%2520therapeutic%2520potential%2520of%2520modulating%2520the%2520ceramide%252Fsphingomyelin%2520pathway%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2002%26volume%3D110%26issue%3D1%26spage%3D3%26epage%3D8%26doi%3D10.1172%2FJCI0216127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Maceyka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Sphingosine kinase, sphingosine-1-phosphate, and apoptosis</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1585</span><span class="NLM_x"> (</span><span class="NLM_issue">2–3</span><span class="NLM_x">) </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span><span class="refDoi"> DOI: 10.1016/S1388-1981(02)00341-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2FS1388-1981%2802%2900341-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=12531554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivVyjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1585&publication_year=2002&pages=193-201&issue=2%E2%80%933&author=M.+Maceykaauthor=S.+G.+Payneauthor=S.+Milstienauthor=S.+Spiegel&title=Sphingosine+kinase%2C+sphingosine-1-phosphate%2C+and+apoptosis&doi=10.1016%2FS1388-1981%2802%2900341-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine kinase, sphingosine-1-phosphate, and apoptosis</span></div><div class="casAuthors">Maceyka, Michael; Payne, Shawn G.; Milstien, Sheldon; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">1585</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">193-201</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The sphingolipid metabolites ceramide (Cer), sphingosine (Sph), and sphingosine-1-phosphate (S1P) play an important role in the regulation of cell proliferation, survival, and cell death.  Cer and Sph usually inhibit proliferation and promote apoptosis, while the further metabolite S1P stimulates growth and suppresses apoptosis.  Because these metabolites are interconvertible, it has been proposed that it is not the abs. amts. of these metabolites but rather their relative levels that dets. cell fate.  The relevance of this sphingolipid rheostat and its role in regulating cell fate has been borne out by work in many labs using many different cell types and exptl. manipulations.  A central finding of these studies is that Sph kinase (SphK), the enzyme that phosphorylates Sph to form S1P, is a crit. regulator of the sphingolipid rheostat, as it not only produces the pro-growth, anti-apoptotic messenger S1P, but also decreases levels of pro-apoptotic Cer and Sph.  Given the role of the sphingolipid rheostat in regulating growth and apoptosis, it is not surprising that sphingolipid metab. is often found to be disregulated in cancer, a disease characterized by enhanced cell growth, diminished cell death, or both.  Anticancer therapeutics targeting SphK are potentially clin. relevant.  Indeed, inhibition of SphK has been shown to suppress gastric tumor growth and conversely, overexpression of SphK increases tumorigenicity.  Moreover, S1P has also been shown to regulate angiogenesis, or new blood vessel formation, which is crit. for tumor progression.  Furthermore, there is intriguing new evidence that S1P can act in an autocrine and/or paracrine fashion to regulate blood vessel formation.  Thus, SphK may not only protect tumors from apoptosis, it may also increase their vascularization, further enhancing growth.  The cytoprotective effects of SphK/S1P may also be important for clin. benefit, as S1P has been shown to protect oocytes from radiation-induced cell death in vivo.  Here we review the growing literature on the regulation of SphK and the role of SphK and its product, S1P, in apoptosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQFFL1hOzF2LVg90H21EOLACvtfcHk0lgU6-R87dYi6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivVyjtg%253D%253D&md5=df46c1ee03cc777f4500a042595b70bc</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2FS1388-1981%2802%2900341-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1388-1981%252802%252900341-4%26sid%3Dliteratum%253Aachs%26aulast%3DMaceyka%26aufirst%3DM.%26aulast%3DPayne%26aufirst%3DS.%2BG.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DSphingosine%2520kinase%252C%2520sphingosine-1-phosphate%252C%2520and%2520apoptosis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2002%26volume%3D1585%26issue%3D2%25E2%2580%25933%26spage%3D193%26epage%3D201%26doi%3D10.1016%2FS1388-1981%2802%2900341-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Pyne, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyne, S.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate and cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">503</span><span class="refDoi"> DOI: 10.1038/nrc2875</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnrc2875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=20555359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC3cXnsFKis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=489-503&issue=7&author=N.+J.+Pyneauthor=S.+Pyne&title=Sphingosine+1-phosphate+and+cancer&doi=10.1038%2Fnrc2875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine 1-phosphate and cancer</span></div><div class="casAuthors">Pyne, Nigel J.; Pyne, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">489-503</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is substantial evidence that sphingosine 1-phosphate (S1P) is involved in cancer.  S1P regulates processes such as inflammation, which can drive tumorigenesis; neovascularization, which provides cancer cells with nutrients and oxygen; and cell growth and survival.  This occurs at multiple levels and involves S1P receptors, sphingosine kinases, S1P phosphatases and S1P lyase.  This Review summarizes current research findings and examines the potential for new therapeutics designed to alter S1P signalling and function in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopcjXMo4lyC7Vg90H21EOLACvtfcHk0lgHAlxJwK_5rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXnsFKis7s%253D&md5=b6963178dfee638d875f652546d009bc</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1038%2Fnrc2875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2875%26sid%3Dliteratum%253Aachs%26aulast%3DPyne%26aufirst%3DN.%2BJ.%26aulast%3DPyne%26aufirst%3DS.%26atitle%3DSphingosine%25201-phosphate%2520and%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26issue%3D7%26spage%3D489%26epage%3D503%26doi%3D10.1038%2Fnrc2875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Takabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paugh, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">″Inside-out″ signaling of sphingosine-1-phosphate: therapeutic targets</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span><span class="refDoi"> DOI: 10.1124/pr.107.07113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1124%2Fpr.107.07113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=18552276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlWlsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2008&pages=181-195&issue=2&author=K.+Takabeauthor=S.+W.+Paughauthor=S.+Milstienauthor=S.+Spiegel&title=%E2%80%B3Inside-out%E2%80%B3+signaling+of+sphingosine-1-phosphate%3A+therapeutic+targets&doi=10.1124%2Fpr.107.07113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">"Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets</span></div><div class="casAuthors">Takabe, Kazuaki; Paugh, Steven W.; Milstien, Sheldon; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-195</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Sphingosine 1-phosphate (S1P) is abioactive sphingolipid metabolite involved in many crit. cellular processes including proliferation, survival, and migration, as well as angiogenesis and allergic responses.  S1P levels inside cells are tightly regulated by the balance between its synthesis by sphingosine kinases and degrdn.  S1P is interconvertible with ceramide, which is a crit. mediator of apoptosis.  It has been postulated that the ratio between S1P and ceramide dets. cell fate.  Activation of sphingosine kinase by a variety of agonists increases intracellular S1P, which in turn can function intracellularly as a second messenger or be secreted out of the cell and act extracellularly by binding to and signaling through S1P receptors in autocrine and/or paracrine manners.  Recent studies suggest that this "inside-out" signaling by S1P may play a role in many human diseases, including cancer, atherosclerosis, inflammation, and autoimmune disorders such as multiple sclerosis.  In this review we summarize metab. of S1P, mechanisms of sphingosine kinase activation, and S1P receptors and their downstream signaling pathways and examine relationships to multiple disease processes.  In particular, we describe recent preclin. and clin. trials of therapies targeting S1P signaling, including 2-amino-2-propane-1,3-diol hydrochloride (FTY720, fingolimod), S1P receptor agonists, sphingosine kinase inhibitors, and anti-S1P monoclonal antibody.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqGsVVT4kXgrVg90H21EOLACvtfcHk0lgHAlxJwK_5rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlWlsr0%253D&md5=ae97fc6340cde0c6d2f2b181bff31932</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1124%2Fpr.107.07113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.107.07113%26sid%3Dliteratum%253Aachs%26aulast%3DTakabe%26aufirst%3DK.%26aulast%3DPaugh%26aufirst%3DS.%2BW.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3D%25E2%2580%25B3Inside-out%25E2%2580%25B3%2520signaling%2520of%2520sphingosine-1-phosphate%253A%2520therapeutic%2520targets%26jtitle%3DPharmacol.%2520Rev.%26date%3D2008%26volume%3D60%26issue%3D2%26spage%3D181%26epage%3D195%26doi%3D10.1124%2Fpr.107.07113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Santos, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">Drugging sphingosine kinases</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span><span class="refDoi"> DOI: 10.1021/cb5008426</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb5008426" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=225-233&issue=1&author=W.+L.+Santosauthor=K.+R.+Lynch&title=Drugging+sphingosine+kinases&doi=10.1021%2Fcb5008426"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fcb5008426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb5008426%26sid%3Dliteratum%253Aachs%26aulast%3DSantos%26aufirst%3DW.%2BL.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DDrugging%2520sphingosine%2520kinases%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26issue%3D1%26spage%3D225%26epage%3D233%26doi%3D10.1021%2Fcb5008426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Visentin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vekich, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibbald, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matteo, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garland, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kundra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbadini, R. A.</span><span> </span><span class="NLM_article-title">Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">238</span><span class="refDoi"> DOI: 10.1016/j.ccr.2006.02.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.ccr.2006.02.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=225-238&issue=3&author=B.+Visentinauthor=J.+A.+Vekichauthor=B.+J.+Sibbaldauthor=A.+L.+Cavalliauthor=K.+M.+Morenoauthor=R.+G.+Matteoauthor=W.+A.+Garlandauthor=Y.+Luauthor=S.+Yuauthor=H.+S.+Hallauthor=V.+Kundraauthor=G.+B.+Millsauthor=R.+A.+Sabbadini&title=Validation+of+an+anti-sphingosine-1-phosphate+antibody+as+a+potential+therapeutic+in+reducing+growth%2C+invasion%2C+and+angiogenesis+in+multiple+tumor+lineages&doi=10.1016%2Fj.ccr.2006.02.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.02.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.02.023%26sid%3Dliteratum%253Aachs%26aulast%3DVisentin%26aufirst%3DB.%26aulast%3DVekich%26aufirst%3DJ.%2BA.%26aulast%3DSibbald%26aufirst%3DB.%2BJ.%26aulast%3DCavalli%26aufirst%3DA.%2BL.%26aulast%3DMoreno%26aufirst%3DK.%2BM.%26aulast%3DMatteo%26aufirst%3DR.%2BG.%26aulast%3DGarland%26aufirst%3DW.%2BA.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DHall%26aufirst%3DH.%2BS.%26aulast%3DKundra%26aufirst%3DV.%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DSabbadini%26aufirst%3DR.%2BA.%26atitle%3DValidation%2520of%2520an%2520anti-sphingosine-1-phosphate%2520antibody%2520as%2520a%2520potential%2520therapeutic%2520in%2520reducing%2520growth%252C%2520invasion%252C%2520and%2520angiogenesis%2520in%2520multiple%2520tumor%2520lineages%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D9%26issue%3D3%26spage%3D225%26epage%3D238%26doi%3D10.1016%2Fj.ccr.2006.02.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Marsolais, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span><span class="refDoi"> DOI: 10.1038/nrd2356</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnrd2356" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=297-307&issue=4&author=D.+Marsolaisauthor=H.+Rosen&title=Chemical+modulators+of+sphingosine-1-phosphate+receptors+as+barrier-oriented+therapeutic+molecules&doi=10.1038%2Fnrd2356"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1038%2Fnrd2356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2356%26sid%3Dliteratum%253Aachs%26aulast%3DMarsolais%26aufirst%3DD.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DChemical%2520modulators%2520of%2520sphingosine-1-phosphate%2520receptors%2520as%2520barrier-oriented%2520therapeutic%2520molecules%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26issue%3D4%26spage%3D297%26epage%3D307%26doi%3D10.1038%2Fnrd2356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Subei, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, J. A.</span><span> </span><span class="NLM_article-title">Sphingosine 1-phosphate receptor modulators in multiple sclerosis</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">575</span><span class="refDoi"> DOI: 10.1007/s40263-015-0261-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1007%2Fs40263-015-0261-z" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=565-575&issue=7&author=A.+M.+Subeiauthor=J.+A.+Cohen&title=Sphingosine+1-phosphate+receptor+modulators+in+multiple+sclerosis&doi=10.1007%2Fs40263-015-0261-z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1007%2Fs40263-015-0261-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40263-015-0261-z%26sid%3Dliteratum%253Aachs%26aulast%3DSubei%26aufirst%3DA.%2BM.%26aulast%3DCohen%26aufirst%3DJ.%2BA.%26atitle%3DSphingosine%25201-phosphate%2520receptor%2520modulators%2520in%2520multiple%2520sclerosis%26jtitle%3DCNS%2520Drugs%26date%3D2015%26volume%3D29%26issue%3D7%26spage%3D565%26epage%3D575%26doi%3D10.1007%2Fs40263-015-0261-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Calabresi, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radue, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffery, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rammohan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reder, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vollmer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agius, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kappos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stites, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappiello, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Rosenstiel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lublin, F. D.</span><span> </span><span class="NLM_article-title">Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">545</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span><span class="refDoi"> DOI: 10.1016/S1474-4422(14)70049-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2FS1474-4422%2814%2970049-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=24685276" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltl2msbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=545-556&issue=6&author=P.+A.+Calabresiauthor=E.+W.+Radueauthor=D.+Goodinauthor=D.+Jefferyauthor=K.+W.+Rammohanauthor=A.+T.+Rederauthor=T.+Vollmerauthor=M.+A.+Agiusauthor=L.+Kapposauthor=T.+Stitesauthor=B.+Liauthor=L.+Cappielloauthor=P.+von+Rosenstielauthor=F.+D.+Lublin&title=Safety+and+efficacy+of+fingolimod+in+patients+with+relapsing-remitting+multiple+sclerosis+%28FREEDOMS+II%29%3A+a+double-blind%2C+randomised%2C+placebo-controlled%2C+phase+3+trial&doi=10.1016%2FS1474-4422%2814%2970049-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial</span></div><div class="casAuthors">Calabresi, Peter A.; Radue, Ernst-Wilhelm; Goodin, Douglas; Jeffery, Douglas; Rammohan, Kottil W.; Reder, Anthony T.; Vollmer, Timothy; Agius, Mark A.; Kappos, Ludwig; Stites, Tracy; Li, Bingbing; Cappiello, Linda; von Rosenstiel, Philipp; Lublin, Fred D.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">545-556</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Fingolimod has shown redns. in clin. and MRI disease activity in patients with relapsing-remitting multiple sclerosis.  We further assessed the efficacy and safety of fingolimod in such patients.We did this placebo-controlled, double-blind phase 3 study predominantly in the USA (101 of 117 centers).  Using a computer-generated sequence, we randomly allocated eligible patients-those aged 18-55 years with relapsing-remitting multiple sclerosis-to receive fingolimod 0·5 mg, fingolimod 1·25 mg, or placebo orally once daily (1:1:1; stratified by study center).  On Nov 12, 2009, all patients assigned to fingolimod 1·25 mg were switched to the 0·5 mg dose in a blinded manner after a review of data from other phase 3 trials and recommendation from the data and safety monitoring board, but were analyzed as being in the 1·25 mg group in the primary outcome anal.  Our primary endpoint was annualised relapse rate at month 24, analyzed by intention to treat.  Secondary endpoints included percentage brain vol. change (PBVC) from baseline and time-to-disability-progression confirmed at 3 mo.  This trial is registered with ClinicalTrilals.gov, no. NCT00355134.Between June 30, 2006, and March 4, 2009, we enrolled and randomly allocated 1083 patients: 370 to fingolimod 1·25 mg, 358 to fingolimod 0·5 mg, and 355 to placebo.  Mean annualised relapse rate was 0·40 (95% CI 0·34-0·48) in patients given placebo and 0·21 (0·17-0·25) in patients given fingolimod 0·5 mg: rate ratio 0·52 (95% CI 0·40-0·66; p<0·0001), corresponding to a redn. of 48% with fingolimod 0·5 mg vs. placebo.  Mean PBVC was -0·86 (SD 1·22) for fingolimod 0·5 mg vs. -1·28 (1·50) for placebo (treatment difference -0·41, 95% CI -0·62 to -0·20; p=0·0002).  We recorded no statistically significant between-group difference in confirmed disability progression (hazard rate 0·83 with fingolimod 0·5 mg vs placebo; 95% CI 0·61-1·12; p=0·227).  Fingolimod 0·5 mg caused more of the following adverse events vs. placebo: lymphopenia (27 [8%] patients vs 0 patients), increased alanine aminotransferase (29 [8%] vs six [2%]), herpes zoster infection (nine [3%] vs three [1%]), hypertension (32 [9%] vs 11 [3%]), first-dose bradycardia (five [1%] vs one [<0·5%]), and first-degree atrioventricular block (17 [5%] vs seven [2%]). 53 (15%) of 358 patients given fingolimod 0·5 mg and 45 (13%) of 355 patients given placebo had serious adverse events over 24 mo, which included basal-cell carcinoma (ten [3%] patients vs two [1%] patients), macular edema (three [1%] vs two [1%]), infections (11 [3%] vs four [1%]), and neoplasms (13 [4%] vs eight [2%]).Our findings expand knowledge of the safety profile of fingolimod and strengthen evidence for its beneficial effects on relapse rates in patients with relapsing-remitting multiple sclerosis.  We saw no effect of fingolimod on disability progression.  Our findings substantiate the beneficial profile of fingolimod as a disease-modifying agent in the management of patients with relapsing-remitting multiple sclerosis.Novartis Pharma AG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofGYMIpkt51bVg90H21EOLACvtfcHk0li6xczNtdIpGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltl2msbc%253D&md5=d4bfa88221a214dc2ad0bba52bcd7942</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2814%2970049-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252814%252970049-3%26sid%3Dliteratum%253Aachs%26aulast%3DCalabresi%26aufirst%3DP.%2BA.%26aulast%3DRadue%26aufirst%3DE.%2BW.%26aulast%3DGoodin%26aufirst%3DD.%26aulast%3DJeffery%26aufirst%3DD.%26aulast%3DRammohan%26aufirst%3DK.%2BW.%26aulast%3DReder%26aufirst%3DA.%2BT.%26aulast%3DVollmer%26aufirst%3DT.%26aulast%3DAgius%26aufirst%3DM.%2BA.%26aulast%3DKappos%26aufirst%3DL.%26aulast%3DStites%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DCappiello%26aufirst%3DL.%26aulast%3Dvon%2BRosenstiel%26aufirst%3DP.%26aulast%3DLublin%26aufirst%3DF.%2BD.%26atitle%3DSafety%2520and%2520efficacy%2520of%2520fingolimod%2520in%2520patients%2520with%2520relapsing-remitting%2520multiple%2520sclerosis%2520%2528FREEDOMS%2520II%2529%253A%2520a%2520double-blind%252C%2520randomised%252C%2520placebo-controlled%252C%2520phase%25203%2520trial%26jtitle%3DLancet%2520Neurol.%26date%3D2014%26volume%3D13%26issue%3D6%26spage%3D545%26epage%3D556%26doi%3D10.1016%2FS1474-4422%2814%2970049-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Edsall, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirianov, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">6952</span><span class="NLM_x">–</span> <span class="NLM_lpage">6960</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1523%2FJNEUROSCI.17-18-06952.1997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=9278531" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADyaK2sXmtVKmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=6952-6960&issue=18&author=L.+C.+Edsallauthor=G.+G.+Pirianovauthor=S.+Spiegel&title=Involvement+of+sphingosine+1-phosphate+in+nerve+growth+factor-mediated+neuronal+survival+and+differentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation</span></div><div class="casAuthors">Edsall, Lisa Cseh; Pirianov, Grisha G.; Spiegel, Sarah</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6952-6960</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Sphingolipid metabolites, such as ceramide and sphingosine-1-phosphate (SPP), are emerging as a new class of second messengers involved in cellular proliferation, differentiation, and apoptosis.  Nerve growth factor (NGF), a neurotrophic factor for pheochromocytoma PC12 cells, induced a biphasic increase in the activity of sphingosine kinase, the enzyme that catalyzes the formation of SPP.  This activation was blocked by K252a, an inhibitor of tyrosine kinase A (trkA).  A rapid 1.7-fold increase was followed by a marked prolonged increase reaching a max. of fourfold to fivefold stimulation with a concomitant increase in SPP levels and a corresponding decrease in endogenous sphingosine levels.  Levels of ceramide, the precursor of sphingosine, were only slightly decreased by NGF in serum-contg. medium.  However, NGF decreased the elevation of ceramide induced by serum withdrawal.  Treatment of PC12 cells with SPP did not induce neurite outgrowth or neurofilament expression, yet it enhanced neurofilament expression elicited by suboptimal doses of NGF.  Moreover, SPP also protected PC12 cells from apoptosis induced by serum withdrawal.  To further substantiate a role for SPP in the cytoprotective actions of NGF, the authors found that N,N-dimethylsphingosine, a competitive inhibitor of sphingosine kinase, also induced apoptosis and interfered with the survival effect of NGF.  These effects were counteracted by exogenous SPP.  Moreover, other structurally related compds., such as dihydrosphingosine 1-phosphate and lysophosphatidic acid, had no significant protective effects.  Our results suggest that activation of sphingosine kinase and subsequent formation of SPP may play an important role in the differentiation and survival effects induced by NGF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTaKUxmMT2abVg90H21EOLACvtfcHk0li6xczNtdIpGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtVKmtbg%253D&md5=02ff0f011cb062b201cfcc8709c9649d</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.17-18-06952.1997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.17-18-06952.1997%26sid%3Dliteratum%253Aachs%26aulast%3DEdsall%26aufirst%3DL.%2BC.%26aulast%3DPirianov%26aufirst%3DG.%2BG.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DInvolvement%2520of%2520sphingosine%25201-phosphate%2520in%2520nerve%2520growth%2520factor-mediated%2520neuronal%2520survival%2520and%2520differentiation%26jtitle%3DJ.%2520Neurosci.%26date%3D1997%26volume%3D17%26issue%3D18%26spage%3D6952%26epage%3D6960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Toman, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watterson, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maceyka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigbee, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, S.</span><span> </span><span class="NLM_article-title">Differential transactivation of sphingosine-1-phosphate receptors modulates NGF-induced neurite extension</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span><span class="refDoi"> DOI: 10.1083/jcb.200402016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1083%2Fjcb.200402016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2004&pages=381-392&issue=3&author=R.+E.+Tomanauthor=S.+G.+Payneauthor=K.+R.+Wattersonauthor=M.+Maceykaauthor=N.+H.+Leeauthor=S.+Milstienauthor=J.+W.+Bigbeeauthor=S.+Spiegel&title=Differential+transactivation+of+sphingosine-1-phosphate+receptors+modulates+NGF-induced+neurite+extension&doi=10.1083%2Fjcb.200402016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200402016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200402016%26sid%3Dliteratum%253Aachs%26aulast%3DToman%26aufirst%3DR.%2BE.%26aulast%3DPayne%26aufirst%3DS.%2BG.%26aulast%3DWatterson%26aufirst%3DK.%2BR.%26aulast%3DMaceyka%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DN.%2BH.%26aulast%3DMilstien%26aufirst%3DS.%26aulast%3DBigbee%26aufirst%3DJ.%2BW.%26aulast%3DSpiegel%26aufirst%3DS.%26atitle%3DDifferential%2520transactivation%2520of%2520sphingosine-1-phosphate%2520receptors%2520modulates%2520NGF-induced%2520neurite%2520extension%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2004%26volume%3D166%26issue%3D3%26spage%3D381%26epage%3D392%26doi%3D10.1083%2Fjcb.200402016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Farquhar-Smith, P.</span><span> </span><span class="NLM_article-title">Chemotherapy-induced neuropathic pain</span> <span class="citation_source-journal">Curr. Opin. Support. Palliat. Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span><span class="refDoi"> DOI: 10.1097/SPC.0b013e328342f9cc</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1097%2FSPC.0b013e328342f9cc" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=21192267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADC%252BC3M7ptFeguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2011&pages=1-7&issue=1&author=P.+Farquhar-Smith&title=Chemotherapy-induced+neuropathic+pain&doi=10.1097%2FSPC.0b013e328342f9cc"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Chemotherapy-induced neuropathic pain</span></div><div class="casAuthors">Farquhar-Smith Paul</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in supportive and palliative care</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  To discuss the importance, clinical features, possible pathology and treatments of chemotherapy-induced neuropathic pain.  Newer biological agents such as bortezomib will be considered in greater detail.  RECENT FINDINGS:  Chemotherapy-induced peripheral neuropathy (CIPN) is a frequent complication of common anticancer therapies.  It may lead to treatment compromise, significantly adds to the symptom burden and interferes with quality of life of cancer survivors.  Recent investigations have identified processes involved in CIPN which may give some insight for the development of novel treatments.  CIPN induced by different anticancer therapies may be heterogeneous and present as distinct neuropathic pains.  Recent work has focussed on the newer anticancer drugs such as bortezomib.  Contemporaneous studies have failed to find good evidence for the use of several common antineuropathic agents and further research is required.  SUMMARY:  Painful CIPN remains under recognized and undertreated.  It is an important cause of pain during cancer treatment and is a common pain in the cancer survivor.  Difficulties in assessment and limitations in treatment contribute to management problems.  Improvements in education (patient and clinician), assessment and treatment would potentially reduce the often debilitating effects of painful CIPN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQxwKI7CCF9MkEgZCMqtRBifW6udTcc2eZ1lAfkhLDXT7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7ptFeguw%253D%253D&md5=df8fb7704b64121a31a531790eb167ee</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1097%2FSPC.0b013e328342f9cc&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FSPC.0b013e328342f9cc%26sid%3Dliteratum%253Aachs%26aulast%3DFarquhar-Smith%26aufirst%3DP.%26atitle%3DChemotherapy-induced%2520neuropathic%2520pain%26jtitle%3DCurr.%2520Opin.%2520Support.%2520Palliat.%2520Care%26date%3D2011%26volume%3D5%26issue%3D1%26spage%3D1%26epage%3D7%26doi%3D10.1097%2FSPC.0b013e328342f9cc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Nakahashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamiya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funakoshi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tojo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuoka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goto, T.</span><span> </span><span class="NLM_article-title">Role of nerve growth factor-tyrosine kinase receptor A signaling in paclitaxel-induced peripheral neuropathy in rats</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">444</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2014.01.082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.bbrc.2014.01.082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=444&publication_year=2014&pages=415-419&issue=3&author=Y.+Nakahashiauthor=Y.+Kamiyaauthor=K.+Funakoshiauthor=T.+Miyazakiauthor=K.+Uchimotoauthor=K.+Tojoauthor=K.+Ogawaauthor=T.+Fukuokaauthor=T.+Goto&title=Role+of+nerve+growth+factor-tyrosine+kinase+receptor+A+signaling+in+paclitaxel-induced+peripheral+neuropathy+in+rats&doi=10.1016%2Fj.bbrc.2014.01.082"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2014.01.082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2014.01.082%26sid%3Dliteratum%253Aachs%26aulast%3DNakahashi%26aufirst%3DY.%26aulast%3DKamiya%26aufirst%3DY.%26aulast%3DFunakoshi%26aufirst%3DK.%26aulast%3DMiyazaki%26aufirst%3DT.%26aulast%3DUchimoto%26aufirst%3DK.%26aulast%3DTojo%26aufirst%3DK.%26aulast%3DOgawa%26aufirst%3DK.%26aulast%3DFukuoka%26aufirst%3DT.%26aulast%3DGoto%26aufirst%3DT.%26atitle%3DRole%2520of%2520nerve%2520growth%2520factor-tyrosine%2520kinase%2520receptor%2520A%2520signaling%2520in%2520paclitaxel-induced%2520peripheral%2520neuropathy%2520in%2520rats%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2014%26volume%3D444%26issue%3D3%26spage%3D415%26epage%3D419%26doi%3D10.1016%2Fj.bbrc.2014.01.082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Janes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Little, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamocki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snider, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuzzocrea, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bieberich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeid, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrache, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicol, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span> </span><span class="NLM_article-title">The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x"> (</span><span class="NLM_issue">30</span><span class="NLM_x">) </span> <span class="NLM_fpage">21082</span><span class="NLM_x">–</span> <span class="NLM_lpage">21097</span><span class="refDoi"> DOI: 10.1074/jbc.M114.569574</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1074%2Fjbc.M114.569574" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=21082-21097&issue=30&author=K.+Janesauthor=J.+W.+Littleauthor=C.+Liauthor=L.+Bryantauthor=C.+Chenauthor=Z.+Chenauthor=K.+Kamockiauthor=T.+Doyleauthor=A.+Sniderauthor=E.+Espositoauthor=S.+Cuzzocreaauthor=E.+Bieberichauthor=L.+Obeidauthor=I.+Petracheauthor=G.+Nicolauthor=W.+L.+Neumannauthor=D.+Salvemini&title=The+development+and+maintenance+of+paclitaxel-induced+neuropathic+pain+require+activation+of+the+sphingosine+1-phosphate+receptor+subtype+1&doi=10.1074%2Fjbc.M114.569574"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.569574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.569574%26sid%3Dliteratum%253Aachs%26aulast%3DJanes%26aufirst%3DK.%26aulast%3DLittle%26aufirst%3DJ.%2BW.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DBryant%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DKamocki%26aufirst%3DK.%26aulast%3DDoyle%26aufirst%3DT.%26aulast%3DSnider%26aufirst%3DA.%26aulast%3DEsposito%26aufirst%3DE.%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DBieberich%26aufirst%3DE.%26aulast%3DObeid%26aufirst%3DL.%26aulast%3DPetrache%26aufirst%3DI.%26aulast%3DNicol%26aufirst%3DG.%26aulast%3DNeumann%26aufirst%3DW.%2BL.%26aulast%3DSalvemini%26aufirst%3DD.%26atitle%3DThe%2520development%2520and%2520maintenance%2520of%2520paclitaxel-induced%2520neuropathic%2520pain%2520require%2520activation%2520of%2520the%2520sphingosine%25201-phosphate%2520receptor%2520subtype%25201%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26issue%3D30%26spage%3D21082%26epage%3D21097%26doi%3D10.1074%2Fjbc.M114.569574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Zhang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasko, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicol, G. D.</span><span> </span><span class="NLM_article-title">Ceramide, a putative second messenger for nerve growth factor, modulates the TTX-resistant Na+current and delayed rectifier K+current in rat sensory neurons</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">544</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span><span class="refDoi"> DOI: 10.1113/jphysiol.2002.024265</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1113%2Fjphysiol.2002.024265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=12381813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD38Xos12qur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=544&publication_year=2002&pages=385-402&issue=2&author=Y.+H.+Zhangauthor=M.+R.+Vaskoauthor=G.+D.+Nicol&title=Ceramide%2C+a+putative+second+messenger+for+nerve+growth+factor%2C+modulates+the+TTX-resistant+Na%2Bcurrent+and+delayed+rectifier+K%2Bcurrent+in+rat+sensory+neurons&doi=10.1113%2Fjphysiol.2002.024265"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Ceramide, a putative second messenger for nerve growth factor, modulates the TTX-resistant Na+ current and delayed rectifier K+ current in rat sensory neurons</span></div><div class="casAuthors">Zhang, Y. H.; Vasko, M. R.; Nicol, G. D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">544</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">385-402</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Because nerve growth factor (NGF) is elevated during inflammation and is known to activate the sphingomyelin signaling pathway, the authors examd. whether NGF and its putative second messenger, ceramide, could modulate the excitability of capsaicin-sensitive adult and embryonic sensory neurons.  Using the whole-cell patch-clamp recording technique, exposure of isolated sensory neurons to either 100 ng ml-1 NGF or 1 μM N-acetyl sphingosine (C2-ceramide) produced a 3- to 4-fold increase in the no. of action potentials (APs) evoked by a ramp of depolarizing current in a time-dependent manner.  Intracellular perfusion with bacterial sphingomyelinase (SMase) also increased the no. of APs suggesting that the release of native ceramide enhanced neuronal excitability.  Glutathione, an inhibitor of neutral SMase, completely blocked the NGF-induced augmentation of AP firing, whereas dithiothreitol, an inhibitor of acidic SMase, was without effect.  In the presence of glutathione and NGF, exogenous ceramide still enhanced the no. of evoked APs, indicating that the sensitizing action of ceramide was downstream of NGF.  To investigate the mechanisms of action for NGF and ceramide, isolated membrane currents were examd.  Both NGF and ceramide facilitated the peak amplitude of the TTX-resistant sodium current (TTX-R INa) by approx. 1.5-fold and shifted the activation to more hyperpolarized voltages.  In addn., NGF and ceramide suppressed an outward potassium current (IK) by ∼35%.  Ceramide reduced IK in a concn.-dependent manner.  Isolation of the NGF- and ceramide-sensitive currents indicates that they were delayed rectifier types of IK.  The inflammatory prostaglandin, PGE2, produced an addnl. suppression of IK after exposure to ceramide (∼35%), suggesting that these agents might act on different targets.  Thus, the authors' findings indicate that the pro-inflammatory agent, NGF, can rapidly enhance the excitability of sensory neurons.  This NGF-induced sensitization is probably mediated by activation of the sphingomyelin signaling pathway to liberate ceramide(s), wherein ceramide appears to be the second messenger involved in modulating neuronal excitability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6ABXsSR1mU7Vg90H21EOLACvtfcHk0lhuLtDUR2Cmpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xos12qur4%253D&md5=aabb1a74a3ca385e302e2db273a8a231</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2002.024265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2002.024265%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DVasko%26aufirst%3DM.%2BR.%26aulast%3DNicol%26aufirst%3DG.%2BD.%26atitle%3DCeramide%252C%2520a%2520putative%2520second%2520messenger%2520for%2520nerve%2520growth%2520factor%252C%2520modulates%2520the%2520TTX-resistant%2520Na%252Bcurrent%2520and%2520delayed%2520rectifier%2520K%252Bcurrent%2520in%2520rat%2520sensory%2520neurons%26jtitle%3DJ.%2520Physiol.%26date%3D2002%26volume%3D544%26issue%3D2%26spage%3D385%26epage%3D402%26doi%3D10.1113%2Fjphysiol.2002.024265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Zhang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicol, G. D.</span><span> </span><span class="NLM_article-title">NGF-mediated sensitization of the excitability of rat sensory neurons is prevented by a blocking antibody to the p75 neurotrophin receptor</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">366</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span><span class="refDoi"> DOI: 10.1016/j.neulet.2004.05.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.neulet.2004.05.042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2004&pages=187-192&issue=2&author=Y.+H.+Zhangauthor=G.+D.+Nicol&title=NGF-mediated+sensitization+of+the+excitability+of+rat+sensory+neurons+is+prevented+by+a+blocking+antibody+to+the+p75+neurotrophin+receptor&doi=10.1016%2Fj.neulet.2004.05.042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2004.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2004.05.042%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DNicol%26aufirst%3DG.%2BD.%26atitle%3DNGF-mediated%2520sensitization%2520of%2520the%2520excitability%2520of%2520rat%2520sensory%2520neurons%2520is%2520prevented%2520by%2520a%2520blocking%2520antibody%2520to%2520the%2520p75%2520neurotrophin%2520receptor%26jtitle%3DNeurosci.%2520Lett.%26date%3D2004%26volume%3D366%26issue%3D2%26spage%3D187%26epage%3D192%26doi%3D10.1016%2Fj.neulet.2004.05.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Zhang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasko, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicol, G. D.</span><span> </span><span class="NLM_article-title">Intracellular sphingosine 1-phosphate mediates the increased excitability produced by nerve growth factor in rat sensory neurons</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">575</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span><span class="refDoi"> DOI: 10.1113/jphysiol.2006.111575</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1113%2Fjphysiol.2006.111575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=16740613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD28XpslaitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=575&publication_year=2006&pages=101-113&issue=1&author=Y.+H.+Zhangauthor=M.+R.+Vaskoauthor=G.+D.+Nicol&title=Intracellular+sphingosine+1-phosphate+mediates+the+increased+excitability+produced+by+nerve+growth+factor+in+rat+sensory+neurons&doi=10.1113%2Fjphysiol.2006.111575"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular sphingosine 1-phosphate mediates the increased excitability produced by nerve growth factor in rat sensory neurons</span></div><div class="casAuthors">Zhang, Y. H.; Vasko, M. R.; Nicol, G. D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">575</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">101-113</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Our previous studies found that nerve growth factor (NGF), via ceramide, enhanced the no. of action potentials (APs) evoked by a ramp of depolarizing current in capsaicin-sensitive sensory neurons.  Ceramide can be metabolized by ceramidase to sphingosine (Sph), and Sph to sphingosine 1-phosphate (S1P) by sphingosine kinase.  It is well established that each of these products of sphingomyelin metab. can act as intracellular signaling mols.  This raises the question as to whether the enhanced excitability produced by NGF was mediated directly by ceramide or required addnl. metab. to Sph and(or) S1P.  Sph applied externally did not affect the neuronal excitability, whereas internally perfused Sph augmented the no. of APs evoked by the depolarizing ramp.  Furthermore, internally perfused S1P enhanced the no. of evoked APs.  This sensitizing action of NGF, ceramide and internally perfused Sph was abolished by dimethylsphingosine (DMS), an inhibitor of sphingosine kinase.  In contrast, internally perfused S1P enhanced the no. of evoked APs in the presence of DMS.  These observations support the idea that the metab. of ceramide/Sph to S1P is crit. for the sphingolipid-induced modulation of excitability.  Both internally perfused Sph and S1P inhibited the outward K+ current by 25-35% for the step to +60 mV.  The Sph- and S1P-sensitive currents had very similar current-voltage relations, suggesting that they were likely to be the same.  In addn., the Sph-induced suppression of the K+ current was blocked by pretreatment with DMS.  These findings demonstrate that intracellular S1P derived from ceramide acts as an internal second messenger to regulate membrane excitability; however, the effector system whereby S1P modulates excitability remains undetd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFy475RsyhxrVg90H21EOLACvtfcHk0liSX-YuiuvWoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpslaitLw%253D&md5=16566dcc5a97cac1b9d88b3afaaafd93</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2006.111575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2006.111575%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%2BH.%26aulast%3DVasko%26aufirst%3DM.%2BR.%26aulast%3DNicol%26aufirst%3DG.%2BD.%26atitle%3DIntracellular%2520sphingosine%25201-phosphate%2520mediates%2520the%2520increased%2520excitability%2520produced%2520by%2520nerve%2520growth%2520factor%2520in%2520rat%2520sensory%2520neurons%26jtitle%3DJ.%2520Physiol.%26date%3D2006%26volume%3D575%26issue%3D1%26spage%3D101%26epage%3D113%26doi%3D10.1113%2Fjphysiol.2006.111575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Welch, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim-Selley, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selley, D. E.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate receptors as emerging targets for treatment of pain</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1551</span><span class="NLM_x">–</span> <span class="NLM_lpage">1562</span><span class="refDoi"> DOI: 10.1016/j.bcp.2012.08.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.bcp.2012.08.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=1551-1562&issue=12&author=S.+P.+Welchauthor=L.+J.+Sim-Selleyauthor=D.+E.+Selley&title=Sphingosine-1-phosphate+receptors+as+emerging+targets+for+treatment+of+pain&doi=10.1016%2Fj.bcp.2012.08.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2012.08.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2012.08.010%26sid%3Dliteratum%253Aachs%26aulast%3DWelch%26aufirst%3DS.%2BP.%26aulast%3DSim-Selley%26aufirst%3DL.%2BJ.%26aulast%3DSelley%26aufirst%3DD.%2BE.%26atitle%3DSphingosine-1-phosphate%2520receptors%2520as%2520emerging%2520targets%2520for%2520treatment%2520of%2520pain%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D84%26issue%3D12%26spage%3D1551%26epage%3D1562%26doi%3D10.1016%2Fj.bcp.2012.08.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Salvemini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doyle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kress, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicol, G.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span><span class="refDoi"> DOI: 10.1016/j.tips.2012.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.tips.2012.12.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=110-118&issue=2&author=D.+Salveminiauthor=T.+Doyleauthor=M.+Kressauthor=G.+Nicol&title=Therapeutic+targeting+of+the+ceramide-to-sphingosine+1-phosphate+pathway+in+pain&doi=10.1016%2Fj.tips.2012.12.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2012.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2012.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DSalvemini%26aufirst%3DD.%26aulast%3DDoyle%26aufirst%3DT.%26aulast%3DKress%26aufirst%3DM.%26aulast%3DNicol%26aufirst%3DG.%26atitle%3DTherapeutic%2520targeting%2520of%2520the%2520ceramide-to-sphingosine%25201-phosphate%2520pathway%2520in%2520pain%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2013%26volume%3D34%26issue%3D2%26spage%3D110%26epage%3D118%26doi%3D10.1016%2Fj.tips.2012.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Ghasemi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dargahi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadiani, A.</span><span> </span><span class="NLM_article-title">Integrated sphingosine-1 phosphate signaling in the central nervous system: From physiological equilibrium to pathological damage</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">156</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span><span class="refDoi"> DOI: 10.1016/j.phrs.2015.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.phrs.2015.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=26772814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BC28XlvF2ruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2016&pages=156-164&author=R.+Ghasemiauthor=L.+Dargahiauthor=A.+Ahmadiani&title=Integrated+sphingosine-1+phosphate+signaling+in+the+central+nervous+system%3A+From+physiological+equilibrium+to+pathological+damage&doi=10.1016%2Fj.phrs.2015.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated sphingosine-1 phosphate signaling in the central nervous system: From physiological equilibrium to pathological damage</span></div><div class="casAuthors">Ghasemi, Rasoul; Dargahi, Leila; Ahmadiani, Abolhassan</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">156-164</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Sphingosine-1 phosphate (S1P), a bioactive sphingolipid metabolite, plays an essential role in cellular homeostasis.  It is well evidenced that enzymes responsible for S1P prodn., as well as S1P receptors are expressed in the central nervous system (CNS), implying that S1P may contribute to CNS physiol.  In current review, we will present the current knowledge about developmental and neuromodulatory functions of S1P in the brain.  Considering neuroprotective effects of S1P, we also review the relation between S1P and cellular autophagy, mitochondrial function, oxidative stress and apoptosis as well as mol. pathways underlying neuroprotective effects of S1P.  Given these pivotal functions, in the last section, we will summarize latest findings about possible contribution of S1P dysregulation in neurol. disorders like Alzheimer's disease and multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMdXasL3dZZbVg90H21EOLACvtfcHk0liSX-YuiuvWoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlvF2ruw%253D%253D&md5=20d2150b1cc69a981cec2d2669ab18a9</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2015.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2015.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DGhasemi%26aufirst%3DR.%26aulast%3DDargahi%26aufirst%3DL.%26aulast%3DAhmadiani%26aufirst%3DA.%26atitle%3DIntegrated%2520sphingosine-1%2520phosphate%2520signaling%2520in%2520the%2520central%2520nervous%2520system%253A%2520From%2520physiological%2520equilibrium%2520to%2520pathological%2520damage%26jtitle%3DPharmacol.%2520Res.%26date%3D2016%26volume%3D104%26spage%3D156%26epage%3D164%26doi%3D10.1016%2Fj.phrs.2015.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Doyle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obeid, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvemini, D.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate acting via the S1P1 receptor is a downstream signaling pathway in ceramide-induced hyperalgesia</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">499</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span><span class="refDoi"> DOI: 10.1016/j.neulet.2011.05.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.neulet.2011.05.018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=499&publication_year=2011&pages=4-8&issue=1&author=T.+Doyleauthor=Z.+Chenauthor=L.+M.+Obeidauthor=D.+Salvemini&title=Sphingosine-1-phosphate+acting+via+the+S1P1+receptor+is+a+downstream+signaling+pathway+in+ceramide-induced+hyperalgesia&doi=10.1016%2Fj.neulet.2011.05.018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2011.05.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2011.05.018%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DObeid%26aufirst%3DL.%2BM.%26aulast%3DSalvemini%26aufirst%3DD.%26atitle%3DSphingosine-1-phosphate%2520acting%2520via%2520the%2520S1P1%2520receptor%2520is%2520a%2520downstream%2520signaling%2520pathway%2520in%2520ceramide-induced%2520hyperalgesia%26jtitle%3DNeurosci.%2520Lett.%26date%3D2011%26volume%3D499%26issue%3D1%26spage%3D4%26epage%3D8%26doi%3D10.1016%2Fj.neulet.2011.05.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Coste, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marian, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenneis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angioni, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popp, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geisslinger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholich, K.</span><span> </span><span class="NLM_article-title">Antinociceptive activity of the S1P-receptor agonist FTY720</span> <span class="citation_source-journal">J. Cell. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">995</span><span class="NLM_x">–</span> <span class="NLM_lpage">1004</span><span class="refDoi"> DOI: 10.1111/j.1582-4934.2008.00160.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1111%2Fj.1582-4934.2008.00160.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=18494940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD1cXotlCrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=995-1004&issue=3&author=O.+Costeauthor=S.+Pierreauthor=C.+Marianauthor=C.+Brenneisauthor=C.+Angioniauthor=H.+Schmidtauthor=L.+Poppauthor=G.+Geisslingerauthor=K.+Scholich&title=Antinociceptive+activity+of+the+S1P-receptor+agonist+FTY720&doi=10.1111%2Fj.1582-4934.2008.00160.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Antinociceptive activity of the S1P-receptor agonist FTY720</span></div><div class="casAuthors">Coste, Ovidiu; Pierre, Sandra; Marian, Claudiu; Brenneis, Christian; Angioni, Carlo; Schmidt, Helmut; Popp, Laura; Geisslinger, Gerd; Scholich, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular and Molecular Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">995-1004</span>CODEN:
                <span class="NLM_cas:coden">JCMMC9</span>;
        ISSN:<span class="NLM_cas:issn">1582-1838</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">FTY720 is a novel immunosuppressive drug that inhibits the egress of lymphocytes from secondary lymphoid tissues and thymus.  In its phosphorylated form FTY720 is a potent S1P receptor agonist.  Recently it was also shown that FTY720 can reduce prostaglandin synthesis through the direct inhibition of the cytosolic phospholipase A2 (cPLA2).  Since prostaglandins are important mediators of nociception, we studied the effects of FTY720 in different models of nociception.  We found that i.p. administration of FTY720 reduced dose-dependently the nociceptive behavior of rats in the formalin assay.  Although the antinociceptive doses of FTY720 were too low to alter the lymphocyte count, prostanoid concns. in the plasma were dramatically reduced.  Surprisingly, intrathecally administered FTY720 reduced the nociceptive behavior in the formalin assay without altering spinal prostaglandin synthesis, indicating that addnl. antinociceptive mechanisms beside the inhibition of prostaglandin synthesis are involved.  Accordingly, FTY720 reduced also the nociceptive behavior in the spared nerve injury model for neuropathic pain which does not depend on prostaglandin synthesis.  In this model the antinociceptive effect of FTY720 was similar to gabapentin, a commonly used drug to treat neuropathic pain.  Taken together we show for the first time that FTY720 possesses antinociceptive properties and that FTY720 reduces nociceptive behavior during neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGori6j7gyCKPbVg90H21EOLACvtfcHk0ljF1cCPh3wYhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXotlCrtbc%253D&md5=0fa8b016d379762110196225a52a436b</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2008.00160.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2008.00160.x%26sid%3Dliteratum%253Aachs%26aulast%3DCoste%26aufirst%3DO.%26aulast%3DPierre%26aufirst%3DS.%26aulast%3DMarian%26aufirst%3DC.%26aulast%3DBrenneis%26aufirst%3DC.%26aulast%3DAngioni%26aufirst%3DC.%26aulast%3DSchmidt%26aufirst%3DH.%26aulast%3DPopp%26aufirst%3DL.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DScholich%26aufirst%3DK.%26atitle%3DAntinociceptive%2520activity%2520of%2520the%2520S1P-receptor%2520agonist%2520FTY720%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2008%26volume%3D12%26issue%3D3%26spage%3D995%26epage%3D1004%26doi%3D10.1111%2Fj.1582-4934.2008.00160.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitajo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span> </span><span class="NLM_article-title">The p75 receptor is associated with inflammatory thermal hypersensitivity</span> <span class="citation_source-journal">J. Neurosci. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">3566</span><span class="NLM_x">–</span> <span class="NLM_lpage">3574</span><span class="refDoi"> DOI: 10.1002/jnr.21808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1002%2Fjnr.21808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=18709654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFaksL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2008&pages=3566-3574&issue=16&author=T.+Watanabeauthor=T.+Itoauthor=G.+Inoueauthor=S.+Ohtoriauthor=K.+Kitajoauthor=H.+Doyaauthor=K.+Takahashiauthor=T.+Yamashita&title=The+p75+receptor+is+associated+with+inflammatory+thermal+hypersensitivity&doi=10.1002%2Fjnr.21808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">The p75 receptor is associated with inflammatory thermal hypersensitivity</span></div><div class="casAuthors">Watanabe, Tomoko; Ito, Toshinori; Inoue, Gen; Ohtori, Seiji; Kitajo, Keiko; Doya, Hideo; Takahashi, Kazuhisa; Yamashita, Toshihide</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3566-3574</span>CODEN:
                <span class="NLM_cas:coden">JNREDK</span>;
        ISSN:<span class="NLM_cas:issn">0360-4012</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Inflammatory pain, characterized by a decrease in the nociceptive threshold, arises through the actions of inflammatory mediators, and one of the key mols. is nerve growth factor (NGF).  Here we report that the administration of neutralizing antibody to the neurotrophin receptor p75 (p75NTR) blocks hyperalgesia, which develops with complete Freund's adjuvant (CFA)-induced inflammation or with an intraplantar injection of NGF.  Although CFA injection results in the up-regulation of calcitonin gene-related peptide (CGRP) levels in the primary sensory neurons, blocking p75NTR abolishes this effect.  We further demonstrate that pro-NGF is the predominant ligand of p75NTR in vivo.  Plasmin treatment, which is intended to decomp. pro-NGF, ameliorates CFA-induced hyperalgesia.  In addn., an intraplantar injection of pro-NGF induces hyperalgesia.  These data together suggest that pro-NGF, as well as mature NGF, binding to p75NTR plays an important role in inflammation-induced hyperalgesia.  Interference in the binding may provide a therapeutic approach for the treatment of inflammatory pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo_k-EZ0uxA7Vg90H21EOLACvtfcHk0ljF1cCPh3wYhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFaksL%252FL&md5=812052edf4620c2c289e09d024af0cfd</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1002%2Fjnr.21808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjnr.21808%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DG.%26aulast%3DOhtori%26aufirst%3DS.%26aulast%3DKitajo%26aufirst%3DK.%26aulast%3DDoya%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DYamashita%26aufirst%3DT.%26atitle%3DThe%2520p75%2520receptor%2520is%2520associated%2520with%2520inflammatory%2520thermal%2520hypersensitivity%26jtitle%3DJ.%2520Neurosci.%2520Res.%26date%3D2008%26volume%3D86%26issue%3D16%26spage%3D3566%26epage%3D3574%26doi%3D10.1002%2Fjnr.21808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Lewin, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nykjaer, A.</span><span> </span><span class="NLM_article-title">Pro-neurotrophins, sortilin, and nociception</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span><span class="refDoi"> DOI: 10.1111/ejn.12466</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1111%2Fejn.12466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=24494677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADC%252BC2cvitFKruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=363-374&issue=3&author=G.+R.+Lewinauthor=A.+Nykjaer&title=Pro-neurotrophins%2C+sortilin%2C+and+nociception&doi=10.1111%2Fejn.12466"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Pro-neurotrophins, sortilin, and nociception</span></div><div class="casAuthors">Lewin Gary R; Nykjaer Anders</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">363-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nerve growth factor (NGF) signaling is important in the development and functional maintenance of nociceptors, but it also plays a central role in initiating and sustaining heat and mechanical hyperalgesia following inflammation.  NGF signaling in pain has traditionally been thought of as primarily engaging the classic high-affinity receptor tyrosine kinase receptor TrkA to initiate sensitization events.  However, the discovery that secreted proforms of nerve NGF have biological functions distinct from the processed mature factors raised the possibility that these proneurotrophins (proNTs) may have distinct function in painful conditions.  ProNTs engage a novel receptor system that is distinct from that of mature neurotrophins, consisting of sortilin, a type I membrane protein belonging to the VPS10p family, and its co-receptor, the classic low-affinity neurotrophin receptor p75NTR.  Here, we review how this new receptor system may itself function with or independently of the classic TrkA system in regulating inflammatory or neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTVCk9mnvysEYvKgEt20y1XfW6udTcc2eZvuQz_3WwHcbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvitFKruw%253D%253D&md5=237452c8a1786c6357dde53531fb73b3</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1111%2Fejn.12466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fejn.12466%26sid%3Dliteratum%253Aachs%26aulast%3DLewin%26aufirst%3DG.%2BR.%26aulast%3DNykjaer%26aufirst%3DA.%26atitle%3DPro-neurotrophins%252C%2520sortilin%252C%2520and%2520nociception%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D2014%26volume%3D39%26issue%3D3%26spage%3D363%26epage%3D374%26doi%3D10.1111%2Fejn.12466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Bucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alifano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cogli, L.</span><span> </span><span class="NLM_article-title">The role of rab proteins in neuronal cells and in the trafficking of neurotrophin receptors</span> <span class="citation_source-journal">Membranes (Basel, Switz.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">642</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span><span class="refDoi"> DOI: 10.3390/membranes4040642</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.3390%2Fmembranes4040642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=25295627" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=642-677&issue=4&author=C.+Bucciauthor=P.+Alifanoauthor=L.+Cogli&title=The+role+of+rab+proteins+in+neuronal+cells+and+in+the+trafficking+of+neurotrophin+receptors&doi=10.3390%2Fmembranes4040642"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.3390%2Fmembranes4040642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmembranes4040642%26sid%3Dliteratum%253Aachs%26aulast%3DBucci%26aufirst%3DC.%26aulast%3DAlifano%26aufirst%3DP.%26aulast%3DCogli%26aufirst%3DL.%26atitle%3DThe%2520role%2520of%2520rab%2520proteins%2520in%2520neuronal%2520cells%2520and%2520in%2520the%2520trafficking%2520of%2520neurotrophin%2520receptors%26jtitle%3DMembranes%2520%2528Basel%252C%2520Switz.%2529%26date%3D2014%26volume%3D4%26issue%3D4%26spage%3D642%26epage%3D677%26doi%3D10.3390%2Fmembranes4040642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group">Ramer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bisby, M. A.</span><span> </span><span class="NLM_article-title">Adrenergic innervation of rat sensory ganglia following proximal or distal painful sciatic neuropathy: distinct mechanisms revealed by anti-NGF treatment</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span><span class="refDoi"> DOI: 10.1046/j.1460-9568.1999.00491.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1046%2Fj.1460-9568.1999.00491.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10103077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADyaK1M3gtleisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1999&pages=837-846&issue=3&author=M.+S.+Ramerauthor=M.+A.+Bisby&title=Adrenergic+innervation+of+rat+sensory+ganglia+following+proximal+or+distal+painful+sciatic+neuropathy%3A+distinct+mechanisms+revealed+by+anti-NGF+treatment&doi=10.1046%2Fj.1460-9568.1999.00491.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Adrenergic innervation of rat sensory ganglia following proximal or distal painful sciatic neuropathy: distinct mechanisms revealed by anti-NGF treatment</span></div><div class="casAuthors">Ramer M S; Bisby M A</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">837-46</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">Sympathetic axons invade dorsal root ganglia (DRG) following nerve injury, and activity in the resulting pericellular axonal 'baskets' may underlie painful sympathetic-sensory coupling.  Sympathetic sprouting into the DRG may be stimulated by nerve growth factor (NGF).  To test this hypothesis, we investigated the effect of daily anti-NGF administration on pain and on sprouting in the DRG induced by chronic sciatic constriction injury (CCI) or L5 spinal nerve ligation (SNL).  These models have been shown to differ subtly in the onset of pain behaviours and adrenergic sprouting, and we now demonstrate a fundamental difference in the way sympathetic axons invade the DRG: after CCI, perivascular noradrenergic collaterals sprouted into the DRG in a manner dependent upon peripherally derived NGF.  In contrast, after SNL, regenerating sympathetic axons were diverted towards the DRG from the spinal nerve by the obstructing ligature, and this effect was only moderately impeded by anti-NGF.  The differential dependence on anti-NGF suggests that adrenergic innervation of the DRG after SNL and CCI may reflect regenerative and collateral sprouting, respectively.  Pain behaviour was similarly affected: anti-NGF completely prevented CCI-induced thermal hyperalgesia and mechanoallodynia, but the same treatment only partly relieved these symptoms following SNL.  These differences emphasize that although CCI and SNL may result in similar behavioural abnormalities, the underlying mechanisms may be governed by distinct processes, differentially dependent on peripheral NGF.  These mechanistic differences will have to be considered in the development of appropriate treatment strategies for neuropathic pain produced by different types of pathology.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkPSbze1UMNpggzHGM8X5CfW6udTcc2eZvuQz_3WwHcbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3gtleisg%253D%253D&md5=3a39fc4417aa3acc7ba58bf5bd344352</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1046%2Fj.1460-9568.1999.00491.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1460-9568.1999.00491.x%26sid%3Dliteratum%253Aachs%26aulast%3DRamer%26aufirst%3DM.%2BS.%26aulast%3DBisby%26aufirst%3DM.%2BA.%26atitle%3DAdrenergic%2520innervation%2520of%2520rat%2520sensory%2520ganglia%2520following%2520proximal%2520or%2520distal%2520painful%2520sciatic%2520neuropathy%253A%2520distinct%2520mechanisms%2520revealed%2520by%2520anti-NGF%2520treatment%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D1999%26volume%3D11%26issue%3D3%26spage%3D837%26epage%3D846%26doi%3D10.1046%2Fj.1460-9568.1999.00491.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group">Nicol, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasko, M. R.</span><span> </span><span class="NLM_article-title">Unraveling the story of NGF-mediated sensitization of nociceptive sensory neurons: ON or OFF the Trks?</span> <span class="citation_source-journal">Mol. Interventions</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span><span class="refDoi"> DOI: 10.1124/mi.7.1.6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1124%2Fmi.7.1.6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=26-41&issue=1&author=G.+D.+Nicolauthor=M.+R.+Vasko&title=Unraveling+the+story+of+NGF-mediated+sensitization+of+nociceptive+sensory+neurons%3A+ON+or+OFF+the+Trks%3F&doi=10.1124%2Fmi.7.1.6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1124%2Fmi.7.1.6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmi.7.1.6%26sid%3Dliteratum%253Aachs%26aulast%3DNicol%26aufirst%3DG.%2BD.%26aulast%3DVasko%26aufirst%3DM.%2BR.%26atitle%3DUnraveling%2520the%2520story%2520of%2520NGF-mediated%2520sensitization%2520of%2520nociceptive%2520sensory%2520neurons%253A%2520ON%2520or%2520OFF%2520the%2520Trks%253F%26jtitle%3DMol.%2520Interventions%26date%3D2007%26volume%3D7%26issue%3D1%26spage%3D26%26epage%3D41%26doi%3D10.1124%2Fmi.7.1.6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">Murakami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirano, T.</span><span> </span><span class="NLM_article-title">The molecular mechanisms of chronic inflammation development</span> <span class="citation_source-journal">Front. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="refDoi"> DOI: 10.3389/fimmu.2012.00323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.3389%2Ffimmu.2012.00323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=23162547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A280%3ADC%252BC3s7ksVWqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=323&author=M.+Murakamiauthor=T.+Hirano&title=The+molecular+mechanisms+of+chronic+inflammation+development&doi=10.3389%2Ffimmu.2012.00323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular mechanisms of chronic inflammation development</span></div><div class="casAuthors">Murakami Masaaki; Hirano Toshio</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in immunology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">323</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEklVjjTrq5E2yPDyEFiigfW6udTcc2eZvuQz_3WwHcbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7ksVWqtw%253D%253D&md5=71025f3e312b2571680307984c9003ba</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2012.00323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2012.00323%26sid%3Dliteratum%253Aachs%26aulast%3DMurakami%26aufirst%3DM.%26aulast%3DHirano%26aufirst%3DT.%26atitle%3DThe%2520molecular%2520mechanisms%2520of%2520chronic%2520inflammation%2520development%26jtitle%3DFront.%2520Immunol.%26date%3D2012%26volume%3D3%26spage%3D323%26doi%3D10.3389%2Ffimmu.2012.00323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group">Pezet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, S. B.</span><span> </span><span class="NLM_article-title">Neurotrophins: mediators and modulators of pain</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">538</span><span class="refDoi"> DOI: 10.1146/annurev.neuro.29.051605.112929</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1146%2Fannurev.neuro.29.051605.112929" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=16776595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVeit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=507-538&author=S.+Pezetauthor=S.+B.+McMahon&title=Neurotrophins%3A+mediators+and+modulators+of+pain&doi=10.1146%2Fannurev.neuro.29.051605.112929"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotrophins: mediators and modulators of pain</span></div><div class="casAuthors">Pezet, Sophie; McMahon, Stephen B.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">507-538</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The neurotrophin family of neurotrophic factors are well-known for their effects on neuronal survival and growth.  Over the past decade, considerable evidence has accumulated from both humans and animals that one neurotrophin, nerve growth factor (NGF), is a peripheral pain mediator, particularly in inflammatory pain states.  NGF is upregulated in a wide variety of inflammatory conditions, and NGF-neutralizing mols. are effective analgesic agents in many models of persistent pain.  Such mols. are now being evaluated in clin. trials.  NGF regulates the expression of a 2nd neurotrophin, brain-derived neurotrophic factor (BDNF), in nociceptors.  BDNF is released when nociceptors are activated, and it acts as a central modulator of pain.  The chapter reviews the evidence for these roles (and briefly the effects of other neurotrophins), the range of conditions under which they act, and their mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWZk1aBEFejLVg90H21EOLACvtfcHk0lihvkr6L64oRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVeit7w%253D&md5=8c9d57612ae9466e9c73776be0b8a104</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.29.051605.112929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.29.051605.112929%26sid%3Dliteratum%253Aachs%26aulast%3DPezet%26aufirst%3DS.%26aulast%3DMcMahon%26aufirst%3DS.%2BB.%26atitle%3DNeurotrophins%253A%2520mediators%2520and%2520modulators%2520of%2520pain%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2006%26volume%3D29%26spage%3D507%26epage%3D538%26doi%3D10.1146%2Fannurev.neuro.29.051605.112929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group">Lewin, G. R.; Carter, B. D.</span><span> </span><span class="NLM_article-title">Neurotrophic Factors</span>. In  <span class="citation_source-book">Handbook of Experimental Pharmacology</span>; <span class="NLM_contrib-group">Rosenthal, W.</span>, Ed.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">220</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1007%2F978-3-642-45106-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=G.+R.+Lewin&author=B.+D.+Carterauthor=W.+Rosenthal&title=Handbook+of+Experimental+Pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-45106-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-45106-5%26sid%3Dliteratum%253Aachs%26aulast%3DLewin%26aufirst%3DG.%2BR.%26atitle%3DNeurotrophic%2520Factors%26btitle%3DHandbook%2520of%2520Experimental%2520Pharmacology%26aulast%3DRosenthal%26aufirst%3DW.%26pub%3DSpringer%26date%3D2014%26volume%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group">Shu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendell, L. M.</span><span> </span><span class="NLM_article-title">Nerve growth factor acutely sensitizes the response of adult rat sensory neurons to capsaicin</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span><span class="refDoi"> DOI: 10.1016/S0304-3940(99)00701-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2FS0304-3940%2899%2900701-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=159-162&issue=3&author=X.+Shuauthor=L.+M.+Mendell&title=Nerve+growth+factor+acutely+sensitizes+the+response+of+adult+rat+sensory+neurons+to+capsaicin&doi=10.1016%2FS0304-3940%2899%2900701-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1016%2FS0304-3940%2899%2900701-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0304-3940%252899%252900701-6%26sid%3Dliteratum%253Aachs%26aulast%3DShu%26aufirst%3DX.%26aulast%3DMendell%26aufirst%3DL.%2BM.%26atitle%3DNerve%2520growth%2520factor%2520acutely%2520sensitizes%2520the%2520response%2520of%2520adult%2520rat%2520sensory%2520neurons%2520to%2520capsaicin%26jtitle%3DNeurosci.%2520Lett.%26date%3D1999%26volume%3D274%26issue%3D3%26spage%3D159%26epage%3D162%26doi%3D10.1016%2FS0304-3940%2899%2900701-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group">Schmieg, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menendez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiavo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terenzio, M.</span><span> </span><span class="NLM_article-title">Signalling endosomes in axonal transport: travel updates on the molecular highway</span> <span class="citation_source-journal">Semin. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span><span class="refDoi"> DOI: 10.1016/j.semcdb.2013.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1016%2Fj.semcdb.2013.10.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=32-43&author=N.+Schmiegauthor=G.+Menendezauthor=G.+Schiavoauthor=M.+Terenzio&title=Signalling+endosomes+in+axonal+transport%3A+travel+updates+on+the+molecular+highway&doi=10.1016%2Fj.semcdb.2013.10.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1016%2Fj.semcdb.2013.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.semcdb.2013.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DSchmieg%26aufirst%3DN.%26aulast%3DMenendez%26aufirst%3DG.%26aulast%3DSchiavo%26aufirst%3DG.%26aulast%3DTerenzio%26aufirst%3DM.%26atitle%3DSignalling%2520endosomes%2520in%2520axonal%2520transport%253A%2520travel%2520updates%2520on%2520the%2520molecular%2520highway%26jtitle%3DSemin.%2520Cell%2520Dev.%2520Biol.%26date%3D2014%26volume%3D27%26spage%3D32%26epage%3D43%26doi%3D10.1016%2Fj.semcdb.2013.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group">Woolf, C. J.</span><span> </span><span class="NLM_article-title">Evidence for a central component of post-injury pain hypersensitivity</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x"> (</span><span class="NLM_issue">5944</span><span class="NLM_x">) </span> <span class="NLM_fpage">686</span><span class="NLM_x">–</span> <span class="NLM_lpage">688</span><span class="refDoi"> DOI: 10.1038/306686a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2F306686a0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=1983&pages=686-688&issue=5944&author=C.+J.+Woolf&title=Evidence+for+a+central+component+of+post-injury+pain+hypersensitivity&doi=10.1038%2F306686a0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1038%2F306686a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F306686a0%26sid%3Dliteratum%253Aachs%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26atitle%3DEvidence%2520for%2520a%2520central%2520component%2520of%2520post-injury%2520pain%2520hypersensitivity%26jtitle%3DNature%26date%3D1983%26volume%3D306%26issue%3D5944%26spage%3D686%26epage%3D688%26doi%3D10.1038%2F306686a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group">Apfel, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiideman, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dormia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snider, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, J. A.</span><span> </span><span class="NLM_article-title">Nerve growth factor regulates the expression of brain-derived neurotrophic factor mRNA in the peripheral nervous system</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span><span class="refDoi"> DOI: 10.1006/mcne.1996.0010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1006%2Fmcne.1996.0010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=8731481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADyaK28XisFOls7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=134-142&issue=2&author=S.+C.+Apfelauthor=D.+E.+Wrightauthor=A.+M.+Wiidemanauthor=C.+Dormiaauthor=W.+D.+Sniderauthor=J.+A.+Kessler&title=Nerve+growth+factor+regulates+the+expression+of+brain-derived+neurotrophic+factor+mRNA+in+the+peripheral+nervous+system&doi=10.1006%2Fmcne.1996.0010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Nerve growth factor regulates the expression of brain-derived neurotrophic factor mRNA in the peripheral nervous system</span></div><div class="casAuthors">Apfel, Stuart C.; Wright, Douglas E.; Wiideman, Andrea M.; Dormia, Christine; Snider, William D.; Kessler, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">134-42</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Neurotrophins are profound regulators of neuronal survival in the developing peripheral nervous system and are synthesized by peripheral neurons themselves both during development and in maturity.  Neuronal neurotrophin expression may be importantly related to survival of mature neurons, both in normal and pathol. states.  The authors show here that brain-derived neurotrophic factor (BDNF) gene expression in dorsal root ganglia is strongly stimulated in vivo by another neurotrophin, nerve growth factor (NGF).  Furthermore, colocalization studies show that many BDNF-expressing sensory neurons also express trk A, the high-affinity NGF receptor.  These results demonstrate a novel regulatory mechanism for neurotrophin gene expression and suggest a paracrine function for neurotrophins in mature animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrk_nRMRncJ7Vg90H21EOLACvtfcHk0lihvkr6L64oRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisFOls7k%253D&md5=d6e0d5a175ef6fce4c63fdedb328c53a</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1006%2Fmcne.1996.0010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.1996.0010%26sid%3Dliteratum%253Aachs%26aulast%3DApfel%26aufirst%3DS.%2BC.%26aulast%3DWright%26aufirst%3DD.%2BE.%26aulast%3DWiideman%26aufirst%3DA.%2BM.%26aulast%3DDormia%26aufirst%3DC.%26aulast%3DSnider%26aufirst%3DW.%2BD.%26aulast%3DKessler%26aufirst%3DJ.%2BA.%26atitle%3DNerve%2520growth%2520factor%2520regulates%2520the%2520expression%2520of%2520brain-derived%2520neurotrophic%2520factor%2520mRNA%2520in%2520the%2520peripheral%2520nervous%2520system%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D1996%26volume%3D7%26issue%3D2%26spage%3D134%26epage%3D142%26doi%3D10.1006%2Fmcne.1996.0010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group">Kerr, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradbury, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dassan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">French, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, S. W.</span><span> </span><span class="NLM_article-title">Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">5138</span><span class="NLM_x">–</span> <span class="NLM_lpage">5148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1523%2FJNEUROSCI.19-12-05138.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10366647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=1%3ACAS%3A528%3ADyaK1MXjvVGisLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=5138-5148&issue=12&author=B.+J.+Kerrauthor=E.+J.+Bradburyauthor=D.+L.+Bennettauthor=P.+M.+Trivediauthor=P.+Dassanauthor=J.+Frenchauthor=D.+B.+Sheltonauthor=S.+B.+McMahonauthor=S.+W.+Thompson&title=Brain-derived+neurotrophic+factor+modulates+nociceptive+sensory+inputs+and+NMDA-evoked+responses+in+the+rat+spinal+cord"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord</span></div><div class="casAuthors">Kerr, B. J.; Bradbury, E. J.; Bennett, D. L. H.; Trivedi, P. M.; Dassan, P.; French, J.; Shelton, D. B.; McMahon, S. B.; Thompson, S. W. N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5138-5148</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Central sensitization, the hyperexcitability of spinal processing that often accompanies peripheral injury, is a major component of many persistent pain states.  Here we report that the neurotrophin, brain-derived neurotrophic factor (BDNF), is a modulator of excitability within the spinal cord and contributes to the mechanism of central sensitization.  BDNF, localized in primary sensory neuron cell bodies and central terminals, potentiates nociceptive spinal reflex responses in an in vitro spinal cord prepn. and induces c-fos expression in dorsal horn neurons.  NMDA receptor-mediated responses, known as a major contributor to central sensitization, were significantly enhanced by exogenous BDNF.  Systemic NGF treatment, a procedure that mimics peripheral inflammatory states, raises BDNF levels in sensory neurons and increases nociceptive spinal reflex excitability.  This increased central excitability is reduced by trkB-IgG, a BDNF antagonist.  We also show directly that inflammatory pain-related behavior depends on BDNF release in vivo.  Thus, behavioral nociceptive responses induced by intraplantar formalin and by intraplantar carrageenan are significantly attenuated by trkB-IgG.  Hence BDNF is appropriately localized and regulated in inflammatory states and is sufficient and necessary for the expression of central sensitization in the spinal cord.  We propose that BDNF may function as a modulator of central sensitization in pathol. states, and our results suggest that pharmacol. antagonism of BDNF may prove an effective and novel analgesic strategy for the treatment of persistent inflammatory pain states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosX2vupF5UubVg90H21EOLACvtfcHk0lghwhnKSq__CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvVGisLw%253D&md5=93a603e464632cf5b9fcd0e79effeb94</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.19-12-05138.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.19-12-05138.1999%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DB.%2BJ.%26aulast%3DBradbury%26aufirst%3DE.%2BJ.%26aulast%3DBennett%26aufirst%3DD.%2BL.%26aulast%3DTrivedi%26aufirst%3DP.%2BM.%26aulast%3DDassan%26aufirst%3DP.%26aulast%3DFrench%26aufirst%3DJ.%26aulast%3DShelton%26aufirst%3DD.%2BB.%26aulast%3DMcMahon%26aufirst%3DS.%2BB.%26aulast%3DThompson%26aufirst%3DS.%2BW.%26atitle%3DBrain-derived%2520neurotrophic%2520factor%2520modulates%2520nociceptive%2520sensory%2520inputs%2520and%2520NMDA-evoked%2520responses%2520in%2520the%2520rat%2520spinal%2520cord%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26issue%3D12%26spage%3D5138%26epage%3D5148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group">Rivera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas-Crusells, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahtinen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viitanen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanobashvili, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokaia, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Airaksinen, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voipio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaila, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saarma, M.</span><span> </span><span class="NLM_article-title">BDNF-induced TrkB activation down-regulates the K+-Cl- cotransporter KCC2 and impairs neuronal Cl- extrusion</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">752</span><span class="refDoi"> DOI: 10.1083/jcb.200209011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1083%2Fjcb.200209011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2002&pages=747-752&issue=5&author=C.+Riveraauthor=H.+Liauthor=J.+Thomas-Crusellsauthor=H.+Lahtinenauthor=T.+Viitanenauthor=A.+Nanobashviliauthor=Z.+Kokaiaauthor=M.+S.+Airaksinenauthor=J.+Voipioauthor=K.+Kailaauthor=M.+Saarma&title=BDNF-induced+TrkB+activation+down-regulates+the+K%2B-Cl-+cotransporter+KCC2+and+impairs+neuronal+Cl-+extrusion&doi=10.1083%2Fjcb.200209011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200209011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200209011%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DThomas-Crusells%26aufirst%3DJ.%26aulast%3DLahtinen%26aufirst%3DH.%26aulast%3DViitanen%26aufirst%3DT.%26aulast%3DNanobashvili%26aufirst%3DA.%26aulast%3DKokaia%26aufirst%3DZ.%26aulast%3DAiraksinen%26aufirst%3DM.%2BS.%26aulast%3DVoipio%26aufirst%3DJ.%26aulast%3DKaila%26aufirst%3DK.%26aulast%3DSaarma%26aufirst%3DM.%26atitle%3DBDNF-induced%2520TrkB%2520activation%2520down-regulates%2520the%2520K%252B-Cl-%2520cotransporter%2520KCC2%2520and%2520impairs%2520neuronal%2520Cl-%2520extrusion%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2002%26volume%3D159%26issue%3D5%26spage%3D747%26epage%3D752%26doi%3D10.1083%2Fjcb.200209011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group">Coull, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beggs, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boudreau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boivin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gravel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salter, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Koninck, Y.</span><span> </span><span class="NLM_article-title">BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">438</span><span class="NLM_x"> (</span><span class="NLM_issue">7070</span><span class="NLM_x">) </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1021</span><span class="refDoi"> DOI: 10.1038/nature04223</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;key=10.1038%2Fnature04223" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=438&publication_year=2005&pages=1017-1021&issue=7070&author=J.+A.+Coullauthor=S.+Beggsauthor=D.+Boudreauauthor=D.+Boivinauthor=M.+Tsudaauthor=K.+Inoueauthor=C.+Gravelauthor=M.+W.+Salterauthor=Y.+De+Koninck&title=BDNF+from+microglia+causes+the+shift+in+neuronal+anion+gradient+underlying+neuropathic+pain&doi=10.1038%2Fnature04223"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1038%2Fnature04223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04223%26sid%3Dliteratum%253Aachs%26aulast%3DCoull%26aufirst%3DJ.%2BA.%26aulast%3DBeggs%26aufirst%3DS.%26aulast%3DBoudreau%26aufirst%3DD.%26aulast%3DBoivin%26aufirst%3DD.%26aulast%3DTsuda%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DGravel%26aufirst%3DC.%26aulast%3DSalter%26aufirst%3DM.%2BW.%26aulast%3DDe%2BKoninck%26aufirst%3DY.%26atitle%3DBDNF%2520from%2520microglia%2520causes%2520the%2520shift%2520in%2520neuronal%2520anion%2520gradient%2520underlying%2520neuropathic%2520pain%26jtitle%3DNature%26date%3D2005%26volume%3D438%26issue%3D7070%26spage%3D1017%26epage%3D1021%26doi%3D10.1038%2Fnature04223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4A0J" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4A0J','PDB','4A0J'); return false;">PDB: 4A0J</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMS','PDB','4PMS'); return false;">PDB: 4PMS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMP','PDB','4PMP'); return false;">PDB: 4PMP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMT','PDB','4PMT'); return false;">PDB: 4PMT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMM','PDB','4PMM'); return false;">PDB: 4PMM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YNE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YNE','PDB','4YNE'); return false;">PDB: 4YNE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YPS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YPS','PDB','4YPS'); return false;">PDB: 4YPS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GT5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GT5','PDB','4GT5'); return false;">PDB: 4GT5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4F0I" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4F0I','PDB','4F0I'); return false;">PDB: 4F0I</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00964&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-1%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00964%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00964" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b49bcedff3dc4","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
